0001615774-16-008831.txt : 20161209 0001615774-16-008831.hdr.sgml : 20161209 20161209164644 ACCESSION NUMBER: 0001615774-16-008831 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 30 FILED AS OF DATE: 20161209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Shuttle Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001685462 IRS NUMBER: 461747648 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-215027 FILM NUMBER: 162044542 BUSINESS ADDRESS: STREET 1: 1 RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (240) 403-4212 MAIL ADDRESS: STREET 1: 1 RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 S-1 1 s104853_s1.htm S-1

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM S-1

 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

SHUTTLE PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

Maryland   2834   46-174648

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification No.)

 

1 Research Court, Suite 450

Rockville, Maryland 20850

(240) 403-4212

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive officer)

 

Anatoly Dritschilo, M.D.

Chief Executive Officer

1 Research Court, Suite 450

Rockville, Maryland 20850

(240) 403-4212

(Name, address, including zip code, and telephone number,

including area code, of agent for service)

 

Copies to:

Dale S. Bergman, Esq.

Gutierrez Bergman Boulris, P.L.L.C.

100 Almeria Avenue, Suite 340

Coral Gables, Florida 33134

(305) 358-5100

 

Approximate date of commencement of proposed sale to the public:  From time to time after the effective date of this Registration Statement.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box.  x

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

 Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer ¨ Smaller reporting company x
(Do not check if a smaller reporting company)   

 

CALCULATION OF REGISTRATION FEE

 

Title of each class of Securities to be

Registered(1)

 

Amount

to be

Registered

  

Proposed

Maximum

Offering

Price Per

Share (2) (3)

  

Proposed

Maximum

Aggregate

Offering

Price

  

Amount of

Registration

Fee

 
                     
Common stock, par value $0.01 per share   4,500,000   $8.00   $36,000,000   $4,172.40 

 

(1) This registration statement covers the sale by the registrant of up to 4,500,000 shares of common stock in a direct public offering.

 

(2) The offering price has been estimated solely for the purpose of computing the amount of the registration fee in accordance with Rule 457 based on the fixed offering price of shares of common stock in the direct public offering.

 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

   

 

 

The information in this preliminary prospectus is not complete and may be changed.  We may not sell these securities nor may offers to buy these securities be accepted until the registration statement filed with the Securities and Exchange Commission becomes effective.  This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

SUBJECT TO COMPLETION, DATED DECEMBER 9, 2016

 

PROSPECTUS

 

4,500,000 Shares of Common Stock

 

SHUTTLE PHARMACEUTICALS, INC.

1 Research Court, Suite 450

Rockville, Maryland 20850

(240) 403-4212

 

Purchase Price: $8.00 per Share

Maximum Offering: $36,000,000

 

This is the initial public offering of common stock of Shuttle Pharmaceuticals, Inc. (the “Company”). We are offering for sale a total of 4,500,000 shares of common stock at a fixed price of $8.00 per share for the duration of this offering (the “Offering”). We intend to apply to have the shares of common stock listed on NYSE MKT, subject to our sale of a sufficient number of shares in the Offering to meet the listing requirements of NYSE MKT. There can be no assurance that an application for listing the shares on NYSE MKT or on any other market will be approved.

 

The Offering is a direct public offering being conducted on a “self-underwritten, best efforts” basis, which means (a) no minimum number of shares need be subscribed for in order for the Company to consummate the sale of any of the shares and utilize the proceeds therefrom; and (b) the Company will not use the services of an underwriter and our executive officers and directors will attempt to sell the shares directly to investors. Notwithstanding the foregoing, the Company does not intend to consummate the sale of any shares until it has received subscriptions and payment for at least 1,125,000 shares ($9,000,000) and will maintain subscription proceeds in a segregated account until such time. Thereafter, however, subscription proceeds will be paid directly to the Company and will not be held in a segregated or escrow account. Our executive officers and directors will not receive commissions or any other remuneration from any such sales.

 

The shares will be offered for sale for a period of one hundred and eighty (180) days from the date of this prospectus, unless extended by our board of directors for period or periods of up to an aggregate of an additional one hundred and eighty (180) days.

 

The Company is an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and as such, may elect to comply with certain reduced public company reporting requirements for future filings.

 

The purchase of the shares of common stock offered through this prospectus involves a high degree of risk.  See the section of this prospectus entitled “Risk Factors” beginning at page 13.

 

Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus.  Any representation to the contrary is a criminal offense.

 

The prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

The date of this prospectus is ____________, 2016

 

   

 

 

TABLE OF CONTENTS

 

  Page
   
PROSPECTUS SUMMARY 4
SUMMARY FINANCIAL INFORMATION 11
RISK FACTORS 13
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS  39
USE OF PROCEEDS 41
DIVIDEND POLICY 41
CAPITALIZATION 42
DILUTION 42
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 44
BUSINESS 47
MANAGEMENT 64
EXECUTIVE COMPENSATION 68
PRINCIPAL SHAREHOLDERS 71
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 72
DESCRIPTION OF CAPITAL STOCK 73
SHARES ELIGIBLE FOR FUTURE SALE 76
PLAN OF DISTRIBUTION 76
LEGAL MATTERS 78
EXPERTS 78
WHERE YOU CAN FIND MORE INFORMATION 78
DISCLOSURE OF SEC POSITION ON INDEMNIFICATION FOR SECURITIES ACT LIABILITIES 78
INDEX TO FINANCIAL STATEMENTS 79

 

 

 

You should rely only on the information contained in this prospectus. We have not authorized any dealer, salesperson or other person to provide you with information concerning us, except for the information contained in this prospectus. The information contained in this prospectus is complete and accurate only as of the date on the front cover page of this prospectus, regardless when the time of delivery of this prospectus or the sale of any common stock. This prospectus is not an offer to sell, nor is it a solicitation of an offer to buy, our common stock in any jurisdiction in which the offer or sale is not permitted.

 

 

 

Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we operate or plan to operate, including our general expectations and market position, market opportunity and market share, is based on information from our own management estimates and research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge, which we believe to be reasonable. Our management estimates have not been verified by any independent source, and we have not independently verified any third-party information. In addition, assumptions and estimates of our and our industry’s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in “Risk Factors.” These and other factors could cause our future performance to differ materially from our assumptions and estimates. See “Special Note Regarding Forward-Looking Statements.”

 

 3 

 

 

PROSPECTUS SUMMARY

 

This summary provides an overview of all material information contained in this prospectus.  It does not contain all the information you should consider before making a decision to purchase our shares of common stock in the Offering.  You should very carefully and thoroughly read the more detailed information in this prospectus and review our financial statements and all other information that is included in this prospectus.

 

Unless the context otherwise requires, references in this prospectus to “Shuttle,” “the Company,” “we,” “our” and “us” refers to Shuttle Pharmaceuticals, Inc.

 

Overview

 

Shuttle is a specialty pharmaceutical company founded in 2012, with the goal of becoming the first U.S. pharmaceutical company focused on the development and commercialization of innovative first-in-class drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy (“RT”). Our objective is to improve the outcomes of cancer treatment through RT and reducing its side effects by:

 

·sensitizing growing cancer cells, rendering them more susceptible to the effects of RT;
·sensitizing hypoxic cells in tumors that resist regular RT; and
·activating the DNA damage response pathway to protect normal cells located near cancers.

 

To date, we have developed, to clinical stage, small molecule strategies to sensitize growing cancer cells in tumors to conventional RT and to sensitize treatment resistant, hypoxic cancer cells in tumors to large fraction radiation therapy using stereotactic body radiation therapy (“SBRT”). A pre-clinical technology delivery platform using histone deacetylase (“HDAC”) inhibitors, which are designed to target cancer cells while protecting healthy tissue/normal cells, further enhances our product pipeline. Shuttle has two clinical stages, first in class product candidates that we believe will deliver these benefits in conjunction with our technology platform:

 

·Ropidoxuridine, an orally available halogenated pyrimidine with strong cancer radiation sensitizing properties, is our lead “clinical phase” product candidate. Halogenated pyrimidines are incorporated into DNA by rapidly growing cancer cells and become more sensitive to the effects of RT. We have received a Small Business Innovation Research (“SBIR”) contract from the National Institutes of Health (“NIH”) to fund a Phase 1 clinical trial at and in collaboration with Brown University -Lifespan/Rhode Island Hospital to determine safety and the maximum tolerated dose in patients with advanced gastrointestinal cancers. In connection with the trial, the National Cancer Institute (“NCI”) has approved the Phase 1 clinical protocol and agreed to provide drug and clinical data management support to Rhode Island Hospital. If we receive positive results from the Phase 1 clinical trial, we plan to advance to Phase 1b and Phase 2 clinical trials of using ropidoxuridine in conjunction with RT treatments of patients with brain tumors and soft tissue sarcomas.

 

·Doranidazole, an injectable hypoxic cell radiation sensitizer, is our second “clinical phase” product candidate. As cancer cells outgrow the blood supply and oxygen availability becomes limiting, regions of hypoxia develop within a tumor. Cancer cells under hypoxic conditions are more resistant to the killing effects of RT. Electron affinic drugs, such as doranidazole are able to reach areas of tumor hypoxia to effect radiation sensitization, thereby offering the potential to improve the outcomes of RT treatment by increasing hypoxic cell kill. Unfortunately, first and second generation hypoxic sensitizers used to date have shown neurologic toxicity and little clinical benefit. Doranidazole, which has been developed in Japan by Pola Pharmaceuticals, Inc. (“Pola Pharma”), has been well-tolerated in clinical studies conducted in Japan and has shown improved survival in a randomized Phase 3 clinical trial of advanced pancreatic cancers, when used in combination with intra-operative radiation therapy (“IORT”), as opposed to treatment by IORT alone. Shuttle has secured an exclusive option to license doranizadole for development and commercialization in the U.S. We intend to focus on the use of doranidazole for treatment of pancreatic, lung and liver cancers in combination with large fraction SBRT, which is RT administered in large doses over a several day period as opposed to conventional RT, which is generally administered in small daily doses over an extended period of several weeks.

 

 4 

 

 

In addition to our two primary product candidates, we are developing and planning to commercialize other cancer radiation sensitizers with radiation protecting properties, which target protecting normal tissue during the administration of RT and other first in class products utilizing our HDAC small molecule technology platform.

 

We have also been awarded two SBIR contracts from the NIH to:

 

·develop prostate cancer cell lines for African-American men, who are at higher risk for prostate cancer, with donor matched normal prostate cells, with the goal of establishing 50 prostate cancer cell lines for research aimed at treating prostate cancer in African American men; and

 

·develop predictive biomarkers of prostate patient outcomes following treatment with SBRT.

 

The SBIR program is designed to encourage small business to engage in Federal Research/Research and Development (“R/R&D”) that has the potential for commercialization.

 

The Company was founded by members of the faculty at the Georgetown University Medical School in Washington, D.C., all of whom have significant experiences in the fields of radiation oncology and medicinal chemistry.

 

Market Opportunity

 

The American Cancer Society (Cancer Facts & Figures 2016) estimates 1,685,210 new cancer cases and 595,690 cancer deaths in the U.S. and according to the American Society for Radiation Oncology, more than 50% of patients undergo RT at some point in the treatment of their diseases. Cancers treated with RT include lung, breast, brain, ovarian, esophageal, pancreatic, rectal, head and neck, uterine, lymphoma and sarcoma. The annual U.S. market for radiation oncology, technology and therapeutics currently exceeds $5.5 billion.

 

Currently, there is no radiation sensitizer drug which has been approved by the U.S. Food and Drug Administration (the “FDA”). Present treatment utilizes “off-label” drugs, which are cytotoxic agents that also sensitize, but do not have radiation sensitization as an FDA approved indication. Moreover, since the “off-label” drugs for sensitizing cancers are cytotoxic, they are often associated with intrinsic acute and chronic side effects. Nevertheless, current drugs used to sensitize cancers to RT have shown small, but clinically significant improvements in disease control and survival and are typically included in standard-of-care treatment recommendations for cancers of the head and neck, brain, lung, esophagus, stomach, pancreas, liver and bladder. As a result, the Company believes that there is a significant market opportunity for its product candidates.

 

Our Strategy

 

Our objectives are to (a) establish ropidoxuridine as the first radiation sensitizer approved by the FDA for use in conjunction with RT in treating advanced gastrointestinal cancer, high grade brain tumors and bone and soft tissue sarcomas; (b) establish doranidazole as a first line therapy in conjunction with SBRT in treating inoperable pancreatic, advanced lung and unresectable liver cancers; and (c) apply our small molecule HDAC delivery platform to the development of other radiation oncology drugs, such as approved radiation protectors. To achieve these objectives, our strategy is as follows:

 

·Complete the SBIR funded Phase 1 clinical trial for ropidoxuridine in conjunction with RT for the treatment of advanced gastrointestinal cancer, which trial commenced in January 2016 and, assuming positive results, proceed to Phase 1b, 2 and 3 clinical trials, followed by submission of an New Drug Application (“NDA”) and ultimately secure FDA approval for marketing;

 

·Commence clinical proof of concept studies followed by clinical trials for ropidoxuridine use in conjunction with RT for the treatment of high grade brain tumors and bone and soft tissue sarcomas, with the ultimate goal of securing FDA approval for these additional indications;

 

·Exercise the option to license doranidazole from Pola Pharma for development and commercialization in the U.S. and use pre-clinical and clinical studies performed in Japan to expedite conducting any needed additional clinical studies in the U.S., with the ultimate goal of securing FDA approval for the use of doranidazole in conjunction with SBRT for the treatment of inoperable pancreatic, advanced lung and unresectable liver cancers;

 

 5 

 

 

·Continue research and development of our HDAC small molecule delivery platform and exploit our platform and our intellectual property portfolio to develop other radiation oncology product candidates, as well as additional indications for existing product candidates;

 

·Assuming positive results from proof of concept studies and Phase 1 and Phase 2 clinical trials, seek to establish collaborative partnerships with other pharmaceutical companies to complete development of, manufacture and market our product candidates both domestically and internationally;

 

·Complete the SBIR funded Phase 1 research contracts we were awarded by the NIH to develop (a) prostate cancer cellular lines for African-American men, to improve diagnosis and treatment with a goal of reducing the higher incidence of such cancer prevalent in African American men; and (b) molecular biomarkers for cancer responsiveness to SBRT treatment; and

 

·Explore potential acquisitions of compatible product portfolios or companies.

 

Risk Factors

 

Our business is subject to a number of risks you should be aware of before making an investment decision. These risks are discussed more fully in the “Risk Factors” section of this prospectus immediately following this prospectus summary. These risks include the following:

 

·Our success is primarily dependent on the successful development, regulatory approval and commercialization of our product candidates, both of which are in the early stages of development.

 

·Our approach to the discovery and development of innovative radiation oncology drugs based on our HDAC small molecule delivery platform is novel, unproven and may not result in marketable products.

 

·We have no source of predictable revenue, have incurred significant losses since inception, may never become profitable and may incur substantial and increasing net losses for the foreseeable future as we continue development of, and seek regulatory approvals for, our product candidates.

 

·If clinical trials of our product candidates fail to demonstrate safety and efficacy, we may be unable to obtain regulatory approvals and commercialize our product candidates.

 

·We are subject to regulatory approval processes that are lengthy, time-consuming and unpredictable. We may not obtain approval for any of our product candidates from the FDA or foreign regulatory authorities.

 

·Even if we obtain regulatory approval, the market may not be receptive to our product candidates.

 

·We may not be able to establish the collaborative partnerships with other pharmaceutical companies, through which we expect to complete development of, obtain marketing approval for and, if approved, manufacture and market our product candidates.

 

·We may encounter difficulties satisfying the requirements of clinical trial protocols, including patient enrollment.

 

·We may not be able to successfully negotiate a license with Pola Pharma for the rights to develop and commercialize Doranidazole, which is one of our principal product candidates.

 

 6 

 

 

·It is difficult and costly to protect our intellectual property rights.

 

·We may face competition from other companies in our field or claims from third parties alleging infringement of their intellectual property.

 

·We may be unable to recruit or retain key employees, including our senior management team.

 

·We will likely need to obtain significant additional funding on acceptable terms to continue operations.

 

We are a Phase 1 clinical stage pharmaceutical company with a limited operating history upon which you can evaluate our business and prospects. Specialty pharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. We do not currently have any product candidates in advanced clinical trials or approved for sale, and we continue to incur significant research and development and general and administrative expenses related to our operations. In addition, we have limited experience and have not yet demonstrated an ability to successfully overcome many of the risks and uncertainties frequently encountered by companies in new and rapidly evolving fields, particularly in the specialty pharmaceutical industry. We have not generated any revenue and have incurred losses in each year since our founding in December 2012. Our net losses for the years ended December 31, 2015 and 2014 were $289,991 and $328,534, respectively. Our net losses for the nine months ended September 30, 2016 and 2015 were $248,845 and $263,302, respectively. As of September 30, 2016, we had an accumulated deficit of $979,113. We expect to continue to incur significant losses for the foreseeable future. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods.

 

Further, we have not submitted an application for or received marketing approval for any of our product candidates. Regulatory approval of our product candidates is not guaranteed, and the approval process is expensive and may take several years.

 

Implications of Being an Emerging Growth Company

 

As a company with less than $1.0 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the JOBS Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure and other requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:

 

·being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” disclosure;

 

·not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting;

 

·not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements;

 

·reduced disclosure obligations regarding executive compensation; and

 

·exemptions from the requirements of holding a non-binding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

 

 7 

 

 

We may take advantage of these provisions for up to five years or such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company if we have more than $1.0 billion in annual revenues, have more than $700 million in market value of our capital stock held by non-affiliates or issue more than $1 billion of non-convertible debt over a three-year period. We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage of some reduced reporting burdens in this prospectus. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold stock.

 

In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have irrevocably elected not to avail ourselves of this extended transition period for adopting new or revised accounting standards and, therefore we will be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.

 

Corporate Information

 

The Company was formed as a limited liability company in the state of Maryland in December 2012 and was converted to a corporation in August 2016. Our executive offices are located at 1 Research Court, Suite 450, Rockville, Maryland 20850 and our telephone number is (240) 403-4212.   Our corporate website is www.shuttlepharma.com. Information appearing on our corporate website is not part of this prospectus.

 

 8 

 

 

The Offering

 

Issuer: Shuttle Pharmaceuticals, Inc.

 

Shares of common stock offered by us: 4,500,000 shares.

 

Shares of common stock to be outstanding immediately after this Offering:

49,522,270 shares (1).

   
Purchase price: $8.00 per share.
   
Total Offering: $36,000,000

 

Plan of Distribution:

The Offering is a direct public offering being conducted on a “best efforts, self-underwritten” basis, which means (a) no minimum number of shares need be subscribed for in order for the Company to consummate the sale of any of the shares and utilize the proceeds therefrom; and (b) the Company will not use the services of an underwriter and our executive officers and directors will attempt to sell the shares directly to investors. Notwithstanding the foregoing, the Company does not intend to consummate the sale of any shares until it has received subscriptions and payment for at least 1,125,000 shares ($9,000,000) and will maintain subscription proceeds in a segregated account until such time. Thereafter, however, subscription proceeds will be paid directly to the Company and will not be held in a segregated or escrow account. Our executive officers and directors will not receive commissions or any other remuneration from any such sales.

 

In offering the shares on our behalf, our executive officers and directors will rely on the “safe harbor” provisions of SEC Rule 3a4-1, promulgated under the Exchange. Generally speaking, Rule 3a4-1 provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with an issuer that participate in the sale of the securities of such issuer.

 

The shares will be offered for sale for a period of one hundred and eighty (180) days from the date of this prospectus, unless extended by our board of directors for period or periods of up to an aggregate of an additional one hundred and eighty (180) days.

 

Dividend policy:

 

We have never paid cash dividends on our common stock and we do not anticipate paying any cash dividends in the foreseeable future. See “Dividend Policy.”

 

Use of proceeds: We estimate that the net proceeds from this Offering will be approximately $35,750,000 if all 4,500,000 shares are purchased, after deducting Offering expenses. We expect to use the net proceeds from this Offering to fund preclinical and clinical trials of product candidates, continued HCAC small molecule technology platform development, working capital and general corporate purposes, as well as potential acquisition or in-licensing activities. See “Use of Proceeds.

 

Proposed NYSE MKT symbol: “____”

 

 9 

 

 

Risk Factors: You should carefully read and consider the information set forth under “Risk Factors” and all other information included in this prospectus for a discussion of factors that you should consider before deciding to invest in shares of our common stock.

 

 

 

(1)Includes 22,270 shares of our common stock which will be issued upon the first closing under this Offering upon the mandatory conversion of $120,250 in principal amount of the Company’s 7.5% Convertible Promissory Notes due August 31, 2018 (the “Convertible Notes”), which were issued in a private offering in August 2016. Does not include 7,500,000 shares of our common stock reserved for issuance under our 2016 Incentive Stock Plan.

 

 10 

 

 

SUMMARY FINANCIAL INFORMATION

 

The following summary financial data should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and the Financial Statements and Notes thereto, included elsewhere in this prospectus.

 

   For the Years Ended
December 31,
   For the Nine Months Ended
September 30,
 
Statement of Operations  2015   2014   2016   2015 
           (Unaudited)   (Unaudited) 
Revenue  $-   $-   $-   $- 
Operating expenses                    
Research and development-net of contracts   214,519    280,665    121,705    232,163 
General and administrative   77,140    51,258    126,477    32,500 
Total operating expenses   291,659    331,923    248,182    264,663 
                     
Loss from operations   (291,659)   (331,923)   (248,182)   (264,663)
                     
Other Income (expense)                    
Interest Income-related party   1,668    3,389    443    1,361 
Interest expense   -    -    (1,106)   - 
                     
Net loss  $(289,991)  $(328,534)  $(248,845)  $(263,302)

  

 11 

 

 

Balance Sheet

 

   As of 
   December 31,
2015
  

September 30,

2016

 
        (unaudited) 
ASSETS          
           
Current assets          
Cash and cash equivalents  $128,837   $120,091 
Contract receivable   46,648    79,707 
Note receivable-related party   24,728    4,912 
Prepaid expenses   -    7,125 
           
Total current assets   200,213    211,835 
           
Property and equipment, net   54,096    44,573 
           
Total Assets  $254,309   $256,408 
           
LIABILITIES AND MEMBERS’ EQUITY          
           
Current liabilities          
Accrued expenses  $4,577   $68,445 
Accrued interest payable   -    898 
Note payable-related party   -    45,928 
           
Total current liabilities  $4,577   $115,271 
           
Total long term liabilities          
Convertible notes payable   -    120,250 
           
Total liabilities  $-   $235,521 
           
Equity          
Members equity  $254,309   $- 
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares outstanding as of September 30, 2016   -    - 
Common stock, $0.01 par value, 100,000,000 shares authorized, 45,000,000 shares issued and outstanding as of September 30, 2016   -    450,000 
Additional paid-in capital   -    550,000)
Retained earnings   -    (979,113)
Total Stockholder’s equity   -    20,887 
Total equity  $254,309   $256,408 

 

 12 

 

 

RISK FACTORS

 

An investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors and all the other information in this prospectus before you decide to buy our common stock. If any of the following risks related to our business actually occurs, our business, financial condition, operating results, and prospects would be adversely affected. The market price of our common stock could decline due to any of these risks and uncertainties related to our business, or related to an investment in our common stock, and you may lose part or all of your investment.

 

Risks Related to Our Business

 

Our success is primarily dependent on the successful development, regulatory approval and commercialization of our product candidates, all of which are in the early stages of development.

 

We currently have two clinical stage product candidates which are in the early stages of development, ropidoxuridine, which is undergoing an SBIR funded Phase 1 clinical trial at Lifespan/Rhode Island Hospital and doranidazole, which has been developed by Pola Pharma in Japan and for which certain clinical studies have been performed in Japan. None of our product candidates have gained marketing approval for sale in the United States or any other country, and we cannot guarantee that we will ever have marketable products. To date, we have invested substantially all of our efforts and financial resources in the research and development and commercial planning for our two current product candidates and our HDAC small molecule delivery platform. Our near-term prospects, including our ability to finance our Company and generate revenue, as well as our future growth, will depend heavily on the successful development, marketing approval and commercialization of our product candidates. The clinical and commercial success of product candidates will depend on a number of factors, including the following:

 

·initiating and obtaining favorable results from our Phase 1 clinical trial for IPdR and proceeding to Phase 1(b), 2 and 3 clinical trials, which may be slower or cost more than we currently anticipate;

 

·exercising our option to license doranidazole from Pola Pharma for further development and commercialization in the U.S, and subsequently implement a clinical trial program for this product candidate as;

 

·even if our clinical trials are successful, there can be no assurance that the FDA will agree that we have satisfactorily demonstrated safety or efficacy or that the FDA will not raise new issues regarding the design of our clinical trials;

 

·our ability to demonstrate the safety and efficacy of our product candidates to the satisfaction of the FDA;

 

·whether we are required by the FDA to conduct additional clinical trials to support the approval of our product candidates;

 

·the acceptance by the FDA of our proposed parameters for regulatory approval, including our proposed indication, endpoints and endpoint measurement tools relating to our product candidates;

 

·the incidence, duration and severity of adverse side effects;

 

·the timely receipt of necessary marketing approvals from the FDA;

 

·whether we are able to secure collaborations for completing the development and, if approved, commercialization of our product candidates;

 

·the effectiveness of our and our potential collaborators’ marketing, sales and distribution strategy and operations of product candidates that are approved;

 

·our success in educating physicians and patients about the benefits, administration and use of our product candidates;

 

 13 

 

 

·the ability of our third-party manufacturers and potential collaborators to manufacture clinical trial and commercial supplies of our product candidates to remain in good standing with regulatory bodies, and to develop, validate and maintain commercially viable manufacturing processes that are compliant with current Good Manufacturing Practices (“cGMP”) regulations;

 

·our ability to successfully commercialize our product candidates, if approved for marketing;

 

·our ability to enforce our intellectual property rights;

 

·our ability to avoid third-party patent interference or patent infringement claims;

 

·acceptance of our product candidates as safe and effective by patients and the medical community; and

 

·a continued acceptable safety profile of our product candidates following approval.

 

Many of these factors are beyond our control. Accordingly, we cannot assure you that we will ever be able to generate revenue through the sale of our product candidates. Any one of these factors or other factors discussed in this prospectus could affect our ability to successfully commercialize product candidates, which could impact our ability to earn sufficient revenues to transition from a developmental stage company and continue our business. If we are not successful in obtaining marketing approval of and commercializing our product candidates, or are significantly delayed in doing so, our business will be materially harmed.

 

We have a limited operating history and have incurred significant losses since our inception, and we anticipate that we will continue to incur losses for the foreseeable future and may never achieve or maintain profitability.

 

We are a Phase 1 clinical stage pharmaceutical company with a limited operating history upon which you can evaluate our business and prospects. Specialty pharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. We do not currently have any product candidates in advanced clinical trials or approved for sale, and we continue to incur significant research and development and general and administrative expenses related to our operations. In addition, we have limited experience and have not yet demonstrated an ability to successfully overcome many of the risks and uncertainties frequently encountered by companies in new and rapidly evolving fields, particularly in the specialty pharmaceutical industry. We have not generated any revenue and have incurred losses in each year since our founding in December 2012. Our net losses for the years ended December 31, 2015 and 2014 were $289,991 and $328,534, respectively. Our net losses for the nine months ended September 30, 2016 and 2015 were $248,845 and $263,302, respectively. As of September 30, 2016, we had an accumulated deficit of $979,113. We expect to continue to incur significant losses for the foreseeable future. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods.

 

We currently have no source of product sales revenue.

We have not generated any revenues from commercial sales of our product candidates. Our ability to generate product revenue depends upon our ability to successfully develop and commercialize products, including any of our current product candidates or other product candidates that we may develop, in-license or acquire in the future. We do not anticipate generating revenue from the sale of products for the foreseeable future. Our ability to generate future product revenue from our current or future product candidates also depends on a number of additional factors, including our ability to:

 

·successfully complete research and clinical development of current and future product candidates, either directly or through collaborative relationships;

 

·establish and maintain supply and manufacturing relationships with third parties, and ensure adequate and legally compliant manufacturing of bulk drug substances and drug products to maintain that supply;

 

 14 

 

 

·obtain regulatory approval from relevant regulatory authorities in jurisdictions where we intend to market our product candidates, either directly or through collaborative relationships;

 

·launch and commercialize future product candidates for which we obtain marketing approval, if any, through collaborative partners;

 

·obtain coverage and adequate product reimbursement from third-party payors, including government payors;

 

·achieve market acceptance for our products, if any;

 

·establish, maintain and protect our intellectual property rights; and

 

·Attract, hire and retain qualified personnel.

 

In addition, because of the numerous risks and uncertainties associated with clinical product development, including that our product candidates may not advance through development or achieve the endpoints of applicable clinical trials, we are unable to predict the timing or amount of any potential future product sales revenues. Our expenses also could increase beyond expectations if we decide to or are required by the FDA, or comparable foreign regulatory authorities, to perform studies or trials in addition to those that we currently anticipate. Even if we complete the development and regulatory processes described above, we anticipate incurring significant costs associated with launching and commercializing these products.

 

The market may not be receptive to our product candidates based on our novel therapeutic modality, and we may not generate any future revenue from the sale or licensing of product candidates.

 

Even if approval is obtained for a product candidate, we may not generate or sustain revenue from sales of the product due to factors such as whether the product can be sold at a competitive cost and otherwise accepted in the market. The product candidates that we are developing are based on a new delivery platform therapeutic approaches (there currently is no drug which has FDA approval for indications of radiation sensitization). Market participants with significant influence over acceptance of new treatments, such as physicians and third-party payors, may not accept our delivery platform, and we may not be able to convince the medical community and third-party payors to accept and use, or to provide favorable reimbursement for, any product candidates developed by us. Market acceptance of our product candidates will depend on, among other factors:

 

·the timing of our receipt of any marketing and commercialization approvals;

 

·the terms of any approvals and the countries in which approvals are obtained;

 

·the safety and efficacy of our product candidates;

 

·the prevalence and severity of any adverse side effects associated with our product candidates;

 

·limitations or warnings contained in any labeling approved by the FDA or other regulatory authority;

 

·relative convenience and ease of administration of our product candidates;

 

·the success of our physician education programs;

 

·the availability of adequate government and third-party payor reimbursement;

 

·the pricing of our products, particularly as compared to alternative treatments; and

 

·availability of alternative effective products for indications our product candidates are intended to treat.

 

 15 

 

 

We will require substantial additional financing to obtain marketing approval of our product candidates and commercialize our product candidates, and a failure to obtain this necessary capital when needed on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our product development, other operations or commercialization efforts.

 

Since our inception, substantially all of our resources have been dedicated to the preclinical and clinical development of our HDAC small molecule delivery platform and our initial two product candidates, ropidoxuridine and doranidazole. Our capital needs to date have been met by contributions from existing shareholders, as well as through private offerings of our securities and our SBIR contracts. We believe that we will continue to expend substantial resources for the foreseeable future on the completion of clinical development and regulatory preparedness of our product candidates, preparations for a commercial launch of our product candidates, if approved, and development of any other current or future product candidates we may choose to further develop. These expenditures will include costs associated with research and development, conducting preclinical studies and clinical trials, obtaining marketing approvals, and, if we are not able to enter into planned collaborations, manufacturing and supply as well as marketing and selling any products approved for sale. In addition, other unanticipated costs may arise. Because the outcome of any drug development process is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of our current product candidates, if approved, or future product candidates, if any.

 

We estimate that our net proceeds from this Offering will be approximately $35,750,000, if all 4,500,000 shares offered hereby are offered and sold, less Offering expenses payable by us. We believe that such proceeds together with our existing capital resources, will be sufficient to fund our operations through 2021. However, our operating plan may change as a result of factors currently unknown to us, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations. Such financing may result in dilution to shareholders, imposition of debt covenants and repayment obligations, or other restrictions that may adversely affect our business. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans.

 

Our future capital requirements depend on many factors, including:

 

  · the scope, progress, results and costs of researching and developing our current product candidates, future product candidates and conducting preclinical and clinical trials;

 

  · the cost of commercialization activities if our current product candidates and future product candidates are approved for sale, including securing collaborative ventures for completing development of, securing marketing approval for and ultimately marketing, selling and distributing our product candidates, if approved or building a corporate infrastructure if we have to undertake these activities directly;

 

  · our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of such agreements;

 

  · the number and characteristics of any additional product candidates we may develop or acquire;

 

  · any product liability or other lawsuits related to our products or commenced against us;

 

  · the expenses needed to attract and retain skilled personnel;

 

  · the costs associated with being a public company;

 

  · the costs involved in preparing, filing, prosecuting, maintaining, defending and enforcing patent claims, including litigation costs and the outcome of such litigation; and

 

  · the timing, receipt and amount of sales of, or royalties on, any future approved products, if any.

 

 16 

 

 

Additional funds may not be available when we need them, on terms that are acceptable to us, or at all. If adequate funds are not available to us on a timely basis, we may be required to:

 

  · delay, limit, reduce or terminate preclinical studies, clinical trials or other development activities for our current product candidates or future product candidates, if any;

 

  · delay, limit, reduce or terminate our research and development activities; or

 

  · delay, limit, reduce or terminate our establishment of sales and marketing capabilities or other activities that may be necessary to commercialize our current or future product candidates.

 

Raising additional capital may cause dilution to our existing shareholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.

 

We may seek additional capital through a combination of public and private equity offerings, debt financings, strategic collaborations and alliances and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a shareholder. The incurrence of indebtedness would result in increased fixed payment obligations and could involve certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. If we raise additional funds through strategic collaborations and alliances and licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies or product candidates or grant licenses on terms unfavorable to us.

 

Our product candidates are in early stages of development and may fail in development or suffer delays that materially adversely affect their commercial viability.

 

We have no products on the market and all of our product candidates are in early stages of development. Our ability to achieve and sustain profitability depends on obtaining regulatory approvals, including institutional review board (“IRB”) approval, for and successfully commercializing our product candidates, either alone or with third parties. Before obtaining regulatory approval for the commercial distribution of our product candidates, we or a collaborator must conduct extensive preclinical tests and clinical trials to demonstrate the safety and efficacy in humans of our product candidates. Preclinical testing and clinical trials are expensive, difficult to design and implement, can take many years to complete and are uncertain as to outcome. The start or end of a clinical study is often delayed or halted due to changing regulatory requirements, manufacturing challenges, required clinical trial administrative actions, slower than anticipated patient enrollment, changing standards of care, availability or prevalence of use of a comparative drug or required prior therapy, clinical outcomes or financial constraints. For instance, delays or difficulties in patient enrollment or difficulties in retaining trial participants can result in increased costs, longer development times or termination of a clinical trial. Clinical trials of a new product candidate require the enrollment of a sufficient number of patients, including patients who are suffering from the disease the product candidate is intended to treat and who meet other eligibility criteria. Rates of patient enrollment are affected by many factors, including the size of the patient population, the eligibility criteria for the clinical trial, the age and condition of the patients, the stage and severity of disease, the nature of the protocol, the proximity of patients to clinical sites and the availability of effective treatments for the relevant disease.

 

A product candidate can unexpectedly fail at any stage of preclinical and clinical development. The historical failure rate for product candidates is high due to scientific feasibility, safety, efficacy, changing standards of medical care and other variables. The results from preclinical testing or early clinical trials of a product candidate may not predict the results that will be obtained in later phase clinical trials of the product candidate. We, the FDA or other applicable regulatory authorities may suspend clinical trials of a product candidate at any time for various reasons, including a belief that subjects participating in such trials are being exposed to unacceptable health risks or adverse side effects. We may not have the financial resources to continue development of, or to enter into collaborations for, a product candidate if we experience any problems or other unforeseen events that delay or prevent regulatory approval of, or our ability to commercialize, product candidates, including:

 

 17 

 

 

  · negative or inconclusive results from our clinical trials or the clinical trials of others for product candidates similar to ours, leading to a decision or requirement to conduct additional preclinical testing or clinical trials or abandon a program;

 

  · serious and unexpected drug-related side effects experienced by participants in our clinical trials or by individuals using drugs similar to our product candidates;

 

  · delays in submitting an Investigational New Drug application (“IND”) or delays or failure in obtaining the necessary approvals from regulators to commence a clinical trial, or a suspension or termination of a clinical trial once commenced;

 

  · conditions imposed by the FDA or comparable foreign authorities regarding the scope or design of our clinical trials;

 

  · delays in enrolling research subjects in clinical trials;

 

  · high drop-out rates of research subjects;

 

  · greater than anticipated clinical trial costs;
     
  · poor effectiveness of our product candidates during clinical trials;

 

  · unfavorable FDA or other regulatory agency inspection and review of a clinical trial site;

 

  · failure of our third-party contractors or investigators to comply with regulatory requirements or otherwise meet their contractual obligations in a timely manner, or at all;

 

  · delays and changes in regulatory requirements, policy and guidelines, including the imposition of additional regulatory oversight around clinical testing generally or with respect to our technology in particular; or

 

  · varying interpretations of data by the FDA and similar foreign regulatory agencies.

 

If third parties on which we depend to conduct our preclinical studies, or any future clinical trials, do not perform as contractually required, fail to satisfy regulatory or legal requirements or miss expected deadlines, our development program could be delayed with materially adverse effects on our business, financial condition, results of operations and prospects.

 

We are relying on a third party collaborator to conduct our Phase 1 clinical trial for ropidoxuridine and plan to rely on third party clinical investigators, contract research organizations (“CROs”), clinical data management organizations and consultants to design, conduct, supervise and monitor preclinical studies of our product candidates and will do the same for any clinical trials. Because we plan to largely rely on third parties and do not have the ability to conduct preclinical studies or clinical trials independently, we have less control over the timing, quality and other aspects of preclinical studies and clinical trials than we would if we conducted them on our own. These investigators, CROs and consultants are not our employees and we have limited control over the amount of time and resources that they dedicate to our programs. These third parties may have contractual relationships with other entities, some of which may be our competitors, which may draw time and resources from our programs. The third parties with whom we contract might not be diligent, careful or timely in conducting our preclinical studies or clinical trials, resulting in the preclinical studies or clinical trials being delayed or unsuccessful.

 

If we cannot contract with acceptable third parties on commercially reasonable terms, or at all, or if these third parties do not carry out their contractual duties, satisfy legal and regulatory requirements for the conduct of preclinical studies or clinical trials or meet expected deadlines, our clinical development programs could be delayed and otherwise adversely affected. In all events, we are responsible for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. The FDA requires clinical trials to be conducted in accordance with good clinical practices, including for conducting, recording and reporting the results of preclinical studies and clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of clinical trial participants are protected. Our reliance on third parties that we do not control does not relieve us of these responsibilities and requirements. Any such event could have a material adverse effect on our business, financial condition, results of operations and prospects.

 

 18 

 

 

Because we rely on third party manufacturing and supply partners, our supply of research and development, preclinical and clinical development materials may become limited or interrupted or may not be of satisfactory quantity or quality.

 

We rely on third party supply and manufacturing partners to supply the materials and components for, and manufacture, our research and development, preclinical and clinical trial drug supplies. We do not own manufacturing facilities or supply sources for such components and materials. There can be no assurance that our supply of research and development, preclinical and clinical development drugs and other materials will not be limited, interrupted, restricted in certain geographic regions or of satisfactory quality or continue to be available at acceptable prices. In particular, any replacement of any drug product formulation manufacturer we may use could require significant effort and expertise if there are a limited number of qualified replacements for a particular product candidate.

 

The manufacturing process for a product candidate is subject to FDA and foreign regulatory authority review. Suppliers and manufacturers must meet applicable manufacturing requirements and undergo rigorous facility and process validation tests required by regulatory authorities in order to comply with regulatory standards, such as current cGMP. In the event that any of our suppliers or manufacturers fails to comply with such requirements or to perform its obligations to us in relation to quality, timing or otherwise, or if our supply of components or other materials becomes limited or interrupted for other reasons, we may be forced to manufacture the materials ourselves, for which we currently do not have the capabilities or resources, or enter into an agreement with another third party, which we may not be able to do on reasonable terms, if at all. In some cases, the technical skills or technology required to manufacture our product candidates may be unique or proprietary to the original manufacturer and we may have difficulty, or there may be contractual restrictions prohibiting us from, transferring such skills or technology to another third party and a feasible alternative may not exist. These factors would increase our reliance on such manufacturer or require us to obtain a license from such manufacturer in order to have another third party manufacture our product candidates. If we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop product candidates in a timely manner or within budget.

 

We expect to continue to rely on third party manufacturers if we receive regulatory approval for any product candidate. To the extent that we have existing, or enter into future, manufacturing arrangements with third parties, we will depend on these third parties to perform their obligations in a timely manner consistent with contractual and regulatory requirements, including those related to quality control and assurance. If we are unable to obtain or maintain third-party manufacturing for product candidates, or to do so on commercially reasonable terms, we may not be able to develop and commercialize our product candidates successfully. Our or a third party’s failure to execute on our manufacturing requirements could adversely affect our business in a number of ways, including:

 

  · an inability to initiate or continue clinical trials of product candidates under development;

 

  · delay in submitting regulatory applications, or receiving regulatory approvals, for product candidates;

 

  · loss of the cooperation of a collaborator;

 

  · subjecting our product candidates to additional inspections by regulatory authorities;

 

  · requirements to cease distribution or to recall batches of our product candidates; and

 

  · in the event of approval to market and commercialize a product candidate, an inability to meet commercial demands for our products.

 

 19 

 

 

We may not successfully engage in strategic transactions, including any collaborations we seek, which could adversely affect our ability to develop and commercialize product candidates, impact our cash position, increase our expense and present significant distractions to our management.

 

From time to time, we may consider strategic transactions, such as collaborations, acquisitions of companies, asset purchases and out- or in-licensing of product candidates or technologies. In particular, , we will evaluate and, if strategically attractive, seek to enter into additional collaborations, including with major biotechnology or pharmaceutical companies to complete development of and market our product candidates, if approved. The competition for collaborators is intense, and the negotiation process is time-consuming and complex. Any proposed collaboration may be on terms that are not optimal for us, and we may not be able to maintain any new or existing collaboration if, for example, development or approval of a product candidate is delayed, sales of an approved product candidate do not meet expectations or the collaborator terminates the collaboration. Any such collaboration, or other strategic transaction, may require us to incur non-recurring or other charges, increase our near- and long-term expenditures and pose significant integration or implementation challenges or disrupt our management or business. These transactions would entail numerous operational and financial risks, including exposure to unknown liabilities, disruption of our business and diversion of our management’s time and attention in order to manage a collaboration or develop acquired products, product candidates or technologies, incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or costs, higher than expected collaboration, acquisition or integration costs, write-downs of assets or goodwill or impairment charges, increased amortization expenses, difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired business, impairment of relationships with key suppliers, manufacturers or customers of any acquired business due to changes in management and ownership and the inability to retain key employees of any acquired business. Accordingly, although there can be no assurance that we will undertake or successfully complete any transactions of the nature described above, any transactions that we do complete may be subject to the foregoing or other risks and have a material adverse effect on our business, results of operations, financial condition and prospects. Conversely, any failure to enter any collaboration or other strategic transaction that would be beneficial to us could delay the development and potential commercialization of our product candidates and have a negative impact on the competitiveness of any product candidate that reaches market.

 

We face competition from entities that have developed or may develop product candidates for our target disease indications, including companies developing novel treatments and technology platforms based on modalities and technology similar to ours. If these companies develop technologies or product candidates more rapidly than we do or their technologies, including delivery technologies, are more effective, our ability to develop and successfully commercialize product candidates may be adversely affected.

 

The development and commercialization of drugs is highly competitive. We compete with a variety of multinational pharmaceutical companies and specialized biotechnology companies, as well as technology being developed at universities and other research institutions. Our competitors have developed, are developing or will develop product candidates and processes competitive with our product candidates. Competitive therapeutic treatments include those that have already been approved and accepted by the medical community and any new treatments that enter the market. We believe that a significant number of products are currently under development, and may become commercially available in the future, for the treatment of conditions for which we may try to develop product candidates.

 

Many of our competitors have significantly greater financial, technical, manufacturing, marketing, sales and supply resources or experience than we have. If we successfully obtain approval for any product candidate, we will face competition based on many different factors, including the safety and effectiveness of our products, the ease with which our products can be administered and the extent to which patients accept relatively new routes of administration, the timing and scope of regulatory approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Competing products could present superior treatment alternatives, including by being more effective, safer, less expensive or marketed and sold more effectively than any products we may develop. Competitive products may make any products we develop obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. Such competitors could also recruit our employees, which could negatively impact our level of expertise and our ability to execute our business plan.

 

 20 

 

 

Any inability to attract and retain qualified key management and technical personnel would impair our ability to implement our business plan.

 

Our success largely depends on the continued service of key management and other specialized personnel, including Anatoly Dritschilo, M.D., our chief executive officer, Milton Brown, M.D., Ph.D., our chief scientific officer for chemistry, Mira Jung, Ph.D., our chief scientific officer for biology, Theodore Phillips, M.D., our clinical director and Peter Dritschilo, our president and chief financial officer. The loss of one or more members of our management team or other key employees or advisors could delay our research and development programs and materially harm our business, financial condition, results of operations and prospects. The relationships that our key managers have cultivated within our industry make us particularly dependent upon their continued employment with us. We are dependent on the continued service of our technical personnel because of the highly technical nature of our product candidates and technologies and the specialized nature of the regulatory approval process. Because our management team and key employees are not obligated to provide us with continued service, they could terminate their employment with us at any time without penalty. We do not maintain key person life insurance policies on any of our management team members or key employees. Our future success will depend in large part on our continued ability to attract and retain other highly qualified scientific, technical and management personnel, as well as personnel with expertise in clinical testing, manufacturing, governmental regulation and commercialization. We face competition for personnel from other companies, universities, public and private research institutions, government entities and other organizations.

 

If our product candidates advance into Phase 2 and 3 clinical trials, we may experience difficulties in managing our growth and expanding our operations.

 

We have limited experience in drug development and have not begun clinical trials for any of our product candidates, other than a Phase 1 clinical trial for ropidoxuridine As our product candidates enter and advance through preclinical studies and any clinical trials, we will need to expand our development, regulatory and manufacturing capabilities or contract with other organizations to provide these capabilities for us. In the future, we expect to have to manage additional relationships with collaborators or partners, suppliers and other organizations. Our ability to manage our operations and future growth will require us to continue to improve our operational, financial and management controls, reporting systems and procedures. We may not be able to implement improvements to our management information and control systems in an efficient or timely manner and may discover deficiencies in existing systems and controls.

 

If any of our product candidates are approved for marketing and commercialization and we are unable to develop sales, marketing and distribution capabilities on our own or enter into agreements with third parties to perform these functions on acceptable terms, we will be unable to commercialize successfully any such future products.

 

We currently have no sales, marketing or distribution capabilities or experience. If any of our product candidates is approved, we plan to enter into collaborations with third parties to sell, market and distribute our products. In the alternative, we would have to develop internal sales, marketing and distribution capabilities to commercialize any approved product, which would be expensive and time-consuming, or, as is more likely, enter into collaborations with third parties to perform these services. If we rely on third parties with sales, marketing and distribution capabilities to market our products or decide to co-promote products with collaborators, we will need to establish and maintain marketing and distribution arrangements with third parties, and there can be no assurance that we will be able to enter into such arrangements on acceptable terms or at all. In entering into third-party marketing or distribution arrangements, any revenue we receive will depend upon the efforts of the third parties and there can be no assurance that such third parties will establish adequate sales and distribution capabilities or be successful in gaining market acceptance of any approved product. If we decide to market our products directly, we will need to commit significant financial and managerial resources to develop a marketing and sales force with technical expertise and supporting distribution, administration and compliance capabilities. If we are not successful in commercializing any product approved in the future, either on our own or through third parties, our business, financial condition, results of operations and prospects could be materially adversely affected.

 

 21 

 

 

If we fail to comply with U.S. and foreign regulatory requirements, regulatory authorities could limit or withdraw any marketing or commercialization approvals we may receive and subject us to other penalties that could materially harm our business.

 

Even if we receive marketing and commercialization approval of a product candidate, as to which there can be no assurance we will be subject to continuing regulatory review, including in relation to adverse patient experiences with the product and clinical results that are reported after a product is made commercially available, both in the U.S. and any foreign jurisdiction in which we seek regulatory approval. The FDA has significant post-market authority, including the authority to require labeling changes based on new safety information and to require post-market studies or clinical trials to evaluate safety risks related to the use of a product or to require withdrawal of the product from the market. The FDA also has the authority to require a risk evaluation and mitigation strategies (“REMS”) plan after approval, which may impose further requirements or restrictions on the distribution or use of an approved drug. The manufacturer and manufacturing facilities we use to make a future product, if any, will also be subject to periodic review and inspection by the FDA and other regulatory agencies, including for continued compliance with cGMP requirements. The discovery of any new or previously unknown problems with our third-party manufacturers, manufacturing processes or facilities may result in restrictions on the product, manufacturer or facility, including withdrawal of the product from the market. If we rely on third-party manufacturers, we will not have control over compliance with applicable rules and regulations by such manufacturers. Any product promotion and advertising will also be subject to regulatory requirements and continuing regulatory review. If we or our collaborators, manufacturers or service providers fail to comply with applicable continuing regulatory requirements in the U.S. or foreign jurisdictions in which we seek to market our products, we or they may be subject to, among other things, fines, warning letters, holds on clinical trials, refusal by the FDA to approve pending applications or supplements to approved applications, suspension or withdrawal of regulatory approval, product recalls and seizures, refusal to permit the import or export of products, operating restrictions, injunction, civil penalties and criminal prosecution.

 

Our business entails a significant risk of product liability and our ability to obtain sufficient insurance coverage could have a material effect on our business, financial condition, results of operations or prospects.

 

Our business exposes us to significant product liability risks inherent in the development, testing, manufacturing and marketing of therapeutic treatments. Product liability claims could delay or prevent completion of our development programs. If we succeed in marketing products, such claims could result in an FDA investigation of the safety and effectiveness of our products, our manufacturing processes and facilities or our marketing programs and potentially a recall of our products or more serious enforcement action, limitations on the approved indications for which they may be used or suspension or withdrawal of approvals. Regardless of the merits or eventual outcome, liability claims may also result in decreased demand for our products, injury to our reputation, costs to defend the related litigation, a diversion of management’s time and our resources, substantial monetary awards to trial participants or patients and a decline in our stock price. We currently have product liability insurance that we believe is appropriate for our stage of development and may need to obtain higher levels prior to marketing any of our product candidates. Any insurance we have or may obtain may not provide sufficient coverage against potential liabilities. Furthermore, clinical trial and product liability insurance is becoming increasingly expensive. As a result, we may be unable to obtain sufficient insurance at a reasonable cost to protect us against losses caused by product liability claims that could have a material adverse effect on our business.

 

Our employees may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.

 

We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees could include intentional failures to comply with FDA regulations, provide accurate information to the FDA, comply with manufacturing standards we may establish, comply with federal and state healthcare fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant fines or other sanctions.

 

 22 

 

 

Our internal computer systems, or those of our CROs or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our product development programs.

 

Despite the implementation of security measures, our internal computer systems and those of our CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. Such events could cause interruptions of our operations. For instance, the loss of preclinical data or data from any future clinical trial involving our product candidates could result in delays in our development and regulatory filing efforts and significantly increase our costs. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the development of our product candidates could be delayed.

 

If we do not comply with laws regulating the protection of the environment and health and human safety, our business could be adversely affected.

 

Our research, development and manufacturing involve the use of hazardous materials and various chemicals. We maintain quantities of various flammable and toxic chemicals in our facilities in Germantown, Maryland that are required for our research, development and manufacturing activities. We are subject to federal, state and local laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials. We believe our procedures for storing, handling and disposing these materials in our Germantown facilities comply with the relevant guidelines of Germantown, the State of Maryland and the Occupational Safety and Health Administration of the U.S. Department of Labor. Although we believe that our safety procedures for handling and disposing of these materials comply with the standards mandated by applicable regulations, the risk of accidental contamination or injury from these materials cannot be eliminated. If an accident occurs, we could be held liable for resulting damages, which could be substantial. We are also subject to numerous environmental, health and workplace safety laws and regulations, including those governing laboratory procedures, exposure to blood-borne pathogens and the handling of animals and biohazardous materials. Although we maintain workers’ compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of these materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal of biological or hazardous materials. Additional federal, state and local laws and regulations affecting our operations may be adopted in the future. We may incur substantial costs to comply with, and substantial fines or penalties if we violate any of these laws or regulations.

 

Our information technology systems could face serious disruptions that could adversely affect our business.

 

Our information technology and other internal infrastructure systems, including corporate firewalls, servers, leased lines and connection to the Internet, face the risk of systemic failure that could disrupt our operations. A significant disruption in the availability of our information technology and other internal infrastructure systems could cause interruptions in our collaborations with our partners and delays in our research and development work.

 

Changes in accounting rules and regulations, or interpretations thereof, could result in unfavorable accounting charges or require us to change our compensation policies.

 

Accounting methods and policies for pharmaceutical companies, including policies governing revenue recognition, research and development and related expenses and accounting for stock-based compensation, are subject to review, interpretation and guidance from relevant accounting authorities, including the SEC. Changes to accounting methods or policies, or interpretations thereof, may require us to reclassify, restate or otherwise change or revise our financial statements, including those contained in this prospectus.

 

 23 

 

 

Risks Related to Intellectual Property

 

If we are not able to obtain and enforce patent protection for our technologies or product candidates, development and commercialization of our product candidates may be adversely affected.

 

Our success depends in part on our ability to obtain and maintain patents and other forms of intellectual property rights, including in-licenses of intellectual property rights of others, for our product candidates, methods used to manufacture our product candidates and methods for treating patients using our product candidates, as well as our ability to preserve our trade secrets, to prevent third parties from infringing upon our proprietary rights and to operate without infringing upon the proprietary rights of others. As of the date of this prospectus, we have filed four patent applications with the U.S. Patent and Trademark Office (the “USPTO”) with respect to various aspects of our HCAC small molecule delivery platform and ropidoxuridine, our lead product candidate. In addition, upon exercising our option to license doranidazole from Pola Pharma, we will also obtain the U.S. rights to patents and patent applications filed by Pola Pharma with respect thereto. We may not be able to apply for patents on certain aspects of our product candidates or delivery technologies in a timely fashion or at all. There is no guarantee that any of our pending patent applications will result in issued or granted patents, that any of our issued, granted or licensed patents will not later be found to be invalid or unenforceable or that any issued, granted or licensed patents will include claims that are sufficiently broad to cover our product candidates or delivery technologies or to provide meaningful protection from our competitors. Moreover, the patent position of specialty pharmaceutical companies can be highly uncertain because it involves complex legal and factual questions. We will be able to protect our proprietary rights from unauthorized use by third parties only to the extent that our current and future proprietary technology and product candidates are covered by valid and enforceable patents or are effectively maintained as trade secrets. If third parties disclose or misappropriate our proprietary rights, it may materially and adversely impact our position in the market.

 

The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other requirements during the patent process. There are situations in which noncompliance can result in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case. The standards applied by the USPTO and foreign patent offices in granting patents are not always applied uniformly or predictably. For example, there is no uniform worldwide policy regarding patentable subject matter or the scope of claims allowable in pharmaceutical patents. As such, we do not know the degree of future protection that we will have on our proprietary products and technology. While we will endeavor to try to protect our product candidates with intellectual property rights such as patents, as appropriate, the process of obtaining patents is time-consuming, expensive and sometimes unpredictable.

 

Once granted, patents may remain open to opposition, interference, re-examination, post-grant review, inter partes review, nullification or derivation action in court or before patent offices or similar proceedings for a given period after allowance or grant, during which time third parties can raise objections against such initial grant. In the course of such proceedings, which may continue for a protracted period of time, the patent owner may be compelled to limit the scope of the allowed or granted claims thus attacked, or may lose the allowed or granted claims altogether. In addition, there can be no assurance that:

 

  ·

others will not or may not be able to make, use or sell compounds that are the same as or similar to our product candidates but that are not covered by the claims of the patents that we own or license;

 

  · we or our licensors, collaborators or any future collaborators are the first to make the inventions covered by each of our issued patents and pending patent applications that we own or license;

 

  · we or our licensors, collaborators or any future collaborators are the first to file patent applications covering certain aspects of our inventions;

 

  · others will not independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;

 

  · A third party may not challenge our patents and, if challenged, a court may not hold that our patents are valid, enforceable and infringed;

 

 24 

 

 

  · any issued patents that we own or have licensed will provide us with any competitive advantages, or will not be challenged by third parties;

 

  · we may develop additional proprietary technologies that are patentable;.

 

  · the patents of others will not have an adverse effect on our business; and

 

  · our competitors do not conduct research and development activities in countries where we do not have enforceable patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets.

 

We intend to license patent rights from third-party owners or licensees. If such owners or licensees do not properly or successfully obtain, maintain or enforce the patents underlying such licenses, or if they retain or license to others any competing rights, our competitive position and business prospects may be adversely affected.

 

In connection with our planned license of doranidazole from Pola Pharma and in other future in-licensing opportunities, we will likely rely on intellectual property rights licensed from third parties to protect our technology. Our success will depend in part on the ability of Pola Pharma and any future licensors to obtain, maintain and enforce patent protection for our licensed intellectual property, in particular, those patents to which we have secured exclusive rights. Our licensors may not successfully prosecute the patent applications licensed to us. Even if patents issue or are granted, our licensors may fail to maintain these patents, may determine not to pursue litigation against other companies that are infringing these patents, or may pursue litigation less aggressively than we would. Further, we may not obtain exclusive rights, which would allow for third parties to develop competing products. Without protection for, or exclusive right to, the intellectual property we license, other companies might be able to offer substantially identical products for sale, which could adversely affect our competitive business position and harm our business prospects. In addition, we may sublicense our rights under third-party licenses to future collaborators or strategic partners. Any impairment of these sublicensed rights could result in termination of an agreement by one or more of any future collaborators or strategic partners.

 

We may not be able to protect our intellectual property rights throughout the world.

 

Obtaining a valid and enforceable issued or granted patent covering our technology in the U.S. and worldwide can be extremely costly. In jurisdictions where we have not obtained patent protection, competitors may use our technology to develop their own products and further, may export otherwise infringing products to territories where we have patent protection, but where it is more difficult to enforce a patent as compared to the U.S. Competitor products may compete with our future products in jurisdictions where we do not have issued or granted patents or where our issued or granted patent claims or other intellectual property rights are not sufficient to prevent competitor activities in these jurisdictions. The legal systems of certain countries, particularly certain developing countries, make it difficult to enforce patents and such countries may not recognize other types of intellectual property protection, particularly that relating to biopharmaceuticals. This could make it difficult for us to prevent the infringement of patents or marketing of competing products in violation of our proprietary rights generally in certain jurisdictions. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business.

 

We generally file a provisional patent application first (a priority filing) at the USPTO. A U.S. utility application and international application under the Patent Cooperation Treaty (PCT) are usually filed within twelve months after the priority filing. Based on the PCT filing, national and regional patent applications may be filed in the European Union, Japan, Australia and Canada and, depending on the individual case, also in any or all of, inter alia, China, India, South Korea, Singapore, Taiwan and South Africa. We have so far not filed for patent protection in all national and regional jurisdictions where such protection may be available. In addition, we may decide to abandon national and regional patent applications before grant. Finally, the grant proceeding of each national or regional patent is an independent proceeding which may lead to situations in which applications might in some jurisdictions be refused by the relevant registration authorities, while granted by others. It is also quite common that depending on the country, various scopes of patent protection may be granted on the same product candidate or technology. The laws of some jurisdictions do not protect intellectual property rights to the same extent as the laws in the U.S., and many companies have encountered significant difficulties in protecting and defending such rights in such jurisdictions. If we or our licensors encounter difficulties in protecting, or are otherwise precluded from effectively protecting, the intellectual property rights important for our business in such jurisdictions, the value of these rights may be diminished and we may face additional competition from others in those jurisdictions. Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position in the relevant jurisdiction may be impaired and our business and results of operations may be adversely affected.

 

 25 

 

 

We or our licensors, or any future collaborators or a strategic partners may become subject to third party claims or litigation alleging infringement of patents or other proprietary rights or seeking to invalidate patents or other proprietary rights, and we may need to resort to litigation to protect or enforce our patents or other proprietary rights, all of which could be costly, time consuming, delay or prevent the development and commercialization of our product candidates, or put our patents and other proprietary rights at risk.

 

We or our licensors, or any future collaborators or strategic partners may be subject to third-party claims for infringement or misappropriation of patent or other proprietary rights. We are generally obligated under our license or collaboration agreements to indemnify and hold harmless our licensors or collaborator for damages arising from intellectual property infringement by us. If we or our licensors, or any future collaborators or strategic partners are found to infringe a third party patent or other intellectual property rights, we could be required to pay damages, potentially including treble damages, if we are found to have willfully infringed. In addition, we or our licensors, collaborators or any future strategic partners may choose to seek, or be required to seek, a license from a third party, which may not be available on acceptable terms, if at all. Even if a license can be obtained on acceptable terms, the rights may be non-exclusive, which could give our competitors access to the same technology or intellectual property rights licensed to us. If we fail to obtain a required license, we or our collaborator, or any future collaborator, may be unable to effectively market product candidates based on our technology, which could limit our ability to generate revenue or achieve profitability and possibly prevent us from generating revenue sufficient to sustain our operations. In addition, we may find it necessary to pursue claims or initiate lawsuits to protect or enforce our patent or other intellectual property rights. The cost to us in defending or initiating any litigation or other proceeding relating to patent or other proprietary rights, even if resolved in our favor, could be substantial, and litigation would divert our management’s attention. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could delay our research and development efforts and limit our ability to continue our operations.

 

If we were to initiate legal proceedings against a third party to enforce a patent covering one of our products or our technology, the defendant could counterclaim that our patent is invalid or unenforceable. In patent litigation in the U.S., defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, for example, lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO, or made a misleading statement, during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art, of which we and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on one or more of our products or certain aspects of our platform technology. Such a loss of patent protection could have a material adverse impact on our business. Patents and other intellectual property rights also will not protect our technology if competitors design around our protected technology without legally infringing our patents or other intellectual property rights.

 

 26 

 

 

Intellectual property rights of third parties could adversely affect our ability to commercialize our product candidates, and we might be required to litigate or obtain licenses from third parties in order to develop or market our product candidates. Such litigation or licenses could be costly or not available on commercially reasonable terms.

 

Our competitive position may suffer if patents issued to third parties or other third party intellectual property rights cover our products or elements thereof, or our manufacture or uses relevant to our development plans. In such cases, we may not be in a position to develop or commercialize products or product candidates unless we successfully pursue litigation to nullify or invalidate the third party intellectual property right concerned, or enter into a license agreement with the intellectual property right holder, if available on commercially reasonable terms.

 

Third party intellectual property right holders may also actively bring infringement claims against us. We cannot guarantee that we will be able to successfully settle or otherwise resolve such infringement claims. If we are unable to successfully settle future claims on terms acceptable to us, we may be required to engage in or continue costly, unpredictable and time-consuming litigation and may be prevented from or experience substantial delays in marketing our products. If we fail in any such dispute, in addition to being forced to pay damages, we may be temporarily or permanently prohibited from commercializing any of our product candidates that are held to be infringing. We might, if possible, also be forced to redesign product candidates so that we no longer infringe the third party intellectual property rights. Any of these events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business.

 

If we fail to comply with our obligations under any license, collaboration or other agreements, we may be required to pay damages and could lose intellectual property rights that are necessary for developing and protecting our product candidates and delivery technologies or we could lose certain rights to grant sublicenses.

 

Our current licenses impose, and any future licenses we enter into are likely to impose, various development, commercialization, funding, milestone, royalty, diligence, sublicensing, insurance, patent prosecution and enforcement, and other obligations on us. If we breach any of these obligations, or use the intellectual property licensed to us in an unauthorized manner, we may be required to pay damages and the licensor may have the right to terminate the license, which could result in us being unable to develop, manufacture and sell products that are covered by the licensed technology or enable a competitor to gain access to the licensed technology. Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor’s rights. In addition, while we cannot currently determine the amount of the royalty obligations we would be required to pay on sales of future products, if any, the amounts may be significant. The amount of our future royalty obligations will depend on the technology and intellectual property we use in products that we successfully develop and commercialize, if any. Therefore, even if we successfully develop and commercialize products, we may be unable to achieve or maintain profitability.

 

If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be

harmed.

 

In addition to seeking patent protection for certain aspects of our product candidates and delivery technologies, we also consider trade secrets, including confidential and unpatented know-how important to the maintenance of our competitive position. We protect trade secrets and confidential and unpatented know-how, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to such knowledge, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants that obligate them to maintain confidentiality and assign their inventions to us. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts in the U.S. and certain foreign jurisdictions are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.

 

 27 

 

 

We may be subject to claims that we or our employees or consultants have wrongfully used or disclosed alleged trade secrets of our employees’ or consultants’ former employers or their clients. These claims may be costly to defend and if we do not successfully do so, we may be required to pay monetary damages and may lose valuable intellectual property rights or personnel.

 

Many of our employees were previously employed at universities or biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently pending, we may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. A loss of key research personnel or their work product could hamper our ability to commercialize, or prevent us from commercializing, our product candidates, which could severely harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.

 

If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.

 

Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.

 

Risks Related to Government Regulation

 

We may be unable to obtain U.S. or foreign regulatory approval and, as a result, unable to commercialize our product candidates.

 

Our product candidates are subject to extensive governmental regulations relating to, among other things, research, testing, development, manufacturing, safety, efficacy, approval, recordkeeping, reporting, labeling, storage, packaging, advertising and promotion, pricing, marketing and distribution of drugs. Rigorous preclinical testing and clinical trials and an extensive regulatory approval process are required to be successfully completed in the U.S. and in many foreign jurisdictions before a new drug can be marketed. Satisfaction of these and other regulatory requirements is costly, time consuming, uncertain and subject to unanticipated delays. It is possible that none of the product candidates we may develop will obtain the regulatory approvals necessary for us or our collaborators to begin selling them.

 

We have very limited experience in conducting and managing the clinical trials necessary to obtain regulatory approvals, including approval by the FDA. The time required to obtain FDA and other approvals is unpredictable but typically takes many years following the commencement of clinical trials, depending upon the type, complexity and novelty of the product candidate. The standards that the FDA and its foreign counterparts use when regulating us are not always applied predictably or uniformly and can change. Any analysis we perform of data from preclinical and clinical activities is subject to confirmation and interpretation by regulatory authorities, which could delay, limit or prevent regulatory approval. We may also encounter unexpected delays or increased costs due to new government regulations, for example, from future legislation or administrative action, or from changes in FDA policy during the period of product development, clinical trials and FDA regulatory review. It is impossible to predict whether legislative changes will be enacted, or whether FDA or foreign regulations, guidance or interpretations will be changed, or what the impact of such changes, if any, may be.

 

Any delay or failure in obtaining required approvals could have a material adverse effect on our ability to generate revenues from the particular product candidate for which we are seeking approval. Furthermore, any regulatory approval to market a product may be subject to limitations on the approved uses for which we may market the product or the labeling or other restrictions. In addition, the FDA has the authority to require a Risk Evaluation and Mitigation Strategy (REMS) plan as part of an NDA or biologics license application (BLA) or after approval, which may impose further requirements or restrictions on the distribution or use of an approved drug or biologic, such as limiting prescribing to certain physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain safe-use criteria and requiring treated patients to enroll in a registry. These limitations and restrictions may limit the size of the market for the product and affect reimbursement by third-party payors.

 

 28 

 

 

If we or our collaborators, manufacturers or service providers fail to comply with healthcare laws and regulations, we or they could be subject to enforcement actions, which could affect our ability to develop, market and sell our products and may harm our reputation.

 

We and our collaborators are subject to federal, state, and foreign healthcare laws and regulations pertaining to fraud and abuse and patients’ rights. These laws and regulations include:

 

  · the U.S. federal healthcare program anti-kickback law, which prohibits, among other things, persons from soliciting, receiving or providing remuneration, directly or indirectly, to induce either the referral of an individual for a healthcare item or service, or the purchasing or ordering of an item or service, for which payment may be made under a federal healthcare program such as Medicare or Medicaid;

 

  · the U.S. federal false claims law, which prohibits, among other things, individuals or entities from knowingly presenting or causing to be presented, claims for payment by government funded programs such as Medicare or Medicaid that are false or fraudulent, and which may apply to us by virtue of statements and representations made to customers or third parties;

 

  · the U.S. federal Health Insurance Portability and Accountability Act (HIPAA) and Health Information Technology for Economic and Clinical Health (HITECH) Act, which prohibit executing a scheme to defraud healthcare programs, impose requirements relating to the privacy, security, and transmission of individually identifiable health information, and require notification to affected individuals and regulatory authorities of certain breaches of security of individually identifiable health information;

 

  · the federal Open Payments regulations under the National Physician Payment Transparency Program have been issued under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act, and will require that manufacturers of pharmaceutical and biological drugs covered by Medicare, Medicaid, and Children’s Health Insurance Programs report all consulting fees, travel reimbursements, research grants, and other payments or gifts with values over $10 made to physicians and teaching hospitals; and

 

  · state laws comparable to each of the above federal laws, such as, for example, anti-kickback and false claims laws applicable to commercial insurers and other non-federal payors, requirements for mandatory corporate regulatory compliance programs, and laws relating to patient data privacy and security.

 

If our operations are found to be in violation of any such requirements, we may be subject to penalties, including civil or criminal penalties, monetary damages, the curtailment or restructuring of our operations, loss of eligibility to obtain approvals from the FDA, or exclusion from participation in government contracting, healthcare reimbursement or other government programs, including Medicare and Medicaid, any of which could adversely our financial results. Although effective compliance programs can mitigate the risk of investigation and prosecution for violations of these laws, these risks cannot be entirely eliminated. Any action against us for an alleged or suspected violation could cause us to incur significant legal expenses and could divert our management’s attention from the operation of our business, even if our defense is successful. In addition, achieving and sustaining compliance with applicable laws and regulations may be costly to us in terms of money, time and resources.

 

If we or our collaborators, manufacturers or service providers fail to comply with applicable federal, state or foreign laws or regulations, we could be subject to enforcement actions, which could affect our ability to develop, market and sell our products successfully and could harm our reputation and lead to reduced acceptance of our products by the market. These enforcement actions include, among others:

 

  · adverse regulatory inspection findings;

 

 29 

 

 

  · warning letters;
     
  · voluntary or mandatory product recalls or public notification or medical product safety alerts to healthcare professionals;

 

  · restrictions on, or prohibitions against, marketing our products;

 

  · restrictions on, or prohibitions against, importation or exportation of our products;

 

  · suspension of review or refusal to approve pending applications or supplements to approved applications;

 

  · exclusion from participation in government-funded healthcare programs;

 

  · exclusion from eligibility for the award of government contracts for our products;

 

  · suspension or withdrawal of product approvals;

 

  · product seizures;

 

  · injunctions; and

 

  · civil and criminal penalties and fines.

 

Any drugs we develop may become subject to unfavorable pricing regulations, third-party reimbursement practices or healthcare reform initiatives, thereby harming our business.

 

The regulations that govern marketing approvals, pricing and reimbursement for new drugs vary widely from country to country. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or product licensing approval is granted. In some foreign markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. Although we intend to monitor these regulations, our programs are currently in the early stages of development and we will not be able to assess the impact of price regulations for a number of years. As a result, we might obtain regulatory approval for a product in a particular country, but then be subject to price regulations that delay our commercial launch of the product and negatively impact the revenues we are able to generate from the sale of the product in that country.

 

Our ability to commercialize any products successfully also will depend in part on the extent to which reimbursement for these products and related treatments will be available from government health administration authorities, private health insurers and other organizations. Even if we succeed in bringing one or more products to the market, these products may not be considered cost-effective, and the amount reimbursed for any products may be insufficient to allow us to sell our products on a competitive basis. Because our programs are in the early stages of development, we are unable at this time to determine their cost effectiveness or the likely level or method of reimbursement. Increasingly, the third-party payors who reimburse patients or healthcare providers, such as government and private insurance plans, are requiring that drug companies provide them with predetermined discounts from list prices, and are seeking to reduce the prices charged or the amounts reimbursed for pharmaceutical products. If the price we are able to charge for any products we develop, or the reimbursement provided for such products, is inadequate in light of our development and other costs, our return on investment could be adversely affected.

 

Our current product candidates will need to be administered under the supervision of a physician on an outpatient basis. Under currently applicable U.S. law, certain drugs that are not usually self-administered (including injectable drugs) may be eligible for coverage under the Medicare Part B program if:

 

  · they are incident to a physician’s services;

 

 30 

 

 

  · they are reasonable and necessary for the diagnosis or treatment of the illness or injury for which they are administered according to accepted standards of medical practice; and
     
  · they have been approved by the FDA and meet other requirements of the statute.

 

There may be significant delays in obtaining coverage for newly-approved drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA. Moreover, eligibility for coverage does not imply that any drug will be reimbursed in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution. Interim payments for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. Reimbursement may be based on payments allowed for lower-cost drugs that are already reimbursed, may be incorporated into existing payments for other services and may reflect budgetary constraints or imperfections in Medicare data. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the U.S. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates. Our inability to promptly obtain coverage and adequate reimbursement rates from both government-funded and private payors for new drugs that we develop and for which we obtain regulatory approval could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our financial condition.

 

We believe that the efforts of governments and third-party payors to contain or reduce the cost of healthcare and legislative and regulatory proposals to broaden the availability of healthcare will continue to affect the business and financial condition of pharmaceutical and biopharmaceutical companies. A number of legislative and regulatory changes in the healthcare system in the U.S. and other major healthcare markets have been proposed in recent years, and such efforts have expanded substantially in recent years. These developments have included prescription drug benefit legislation that was enacted and took effect in January 2006, healthcare reform legislation enacted by certain states, and Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act (the “ACA”), a sweeping law intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending and enhance remedies against fraud and abuse. The ACA also contains provisions that will affect companies in the pharmaceutical industry and other healthcare related industries by imposing additional costs and changes to business practices. Provisions affecting pharmaceutical companies include the following:

 

  · mandatory rebates for drugs sold into the Medicaid program have been increased, and the rebate requirement has been extended to drugs used in risk-based Medicaid managed care plans;

 

  · the 340B Drug Pricing Program under the Public Health Services Act has been extended to require mandatory discounts for drug products sold to certain critical access hospitals, cancer hospitals and other covered entities;

 

  · pharmaceutical companies are required to offer discounts on brand-name drugs to patients who fall within the Medicare Part D coverage gap, commonly referred to as the “Donut Hole;” and

 

  · pharmaceutical companies are required to pay an annual non-tax deductible fee to the federal government based on each company’s market share of prior year total sales of branded products to certain federal healthcare programs, such as Medicare, Medicaid, Department of Veterans Affairs and Department of Defense. Since we expect our branded pharmaceutical sales to constitute a small portion of the total federal health program pharmaceutical market, we do not expect this annual assessment to have a material impact on our financial condition.

 

Moreover, we cannot predict what healthcare reform initiatives may be adopted in the future. Further federal and state legislative and regulatory developments are likely, and we expect ongoing initiatives in the U.S. to increase pressure on drug pricing. Such reforms could have an adverse effect on anticipated revenues from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.

 

 31 

 

 

Our ability to obtain services, reimbursement or funding from the federal government may be impacted by possible reductions in federal spending.

 

U.S. federal government agencies currently face potentially significant spending reductions. Under the Budget Control Act of 2011, the failure of Congress to enact deficit reduction measures of at least $1.2 trillion for the years 2013 through 2021 triggered automatic cuts to most federal programs. These cuts would include aggregate reductions to Medicare payments to providers of up to two percent per fiscal year, starting in 2013. Under the American Taxpayer Relief Act of 2012, which was enacted on January 1, 2013, the imposition of these automatic cuts was delayed until March 1, 2013. Certain of these automatic cuts have been implemented. The full impact on our business of these automatic cuts is uncertain. If federal spending is reduced, anticipated budgetary shortfalls may also impact the ability of relevant agencies, such as the FDA or the National Institutes of Health to continue to function at current levels. Amounts allocated to federal grants and contracts may be reduced or eliminated. These reductions may also impact the ability of relevant agencies to timely review and approve drug research and development, manufacturing, and marketing activities, which may delay our ability to develop, market and sell any products we may develop.

 

If any of our product candidates receives marketing approval and we or others later identify undesirable side effects caused by the product candidate, our ability to market and derive revenue from the product candidates could be compromised.

 

In the event that any of our product candidates receive regulatory approval and we or others identify undesirable side effects caused by one of our products, any of the following adverse events could occur, which could result in the loss of significant revenue to us and materially and adversely affect our results of operations and business:

 

  · regulatory authorities may withdraw their approval of the product or seize the product;

 

  · we may be required to recall the product or change the way the product is administered to patients;

 

  · additional restrictions may be imposed on the marketing of the particular product or the manufacturing processes for the product or any component thereof;

 

  · we may be subject to fines, injunctions or the imposition of civil or criminal penalties;

 

  · regulatory authorities may require the addition of labeling statements, such as a “black box” warning or a contraindication;

 

  · we may be required to create a Medication Guide outlining the risks of such side effects for distribution to patients;

 

  · we could be sued and held liable for harm caused to patients;

 

  · the product may become less competitive; and
     
  · our reputation

  

Risks Related to our Common Stock and this Offering

 

Our internal controls may be inadequate, which could cause our financial reporting to be unreliable and lead to misinformation being disseminated to the public.

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting.  As defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), internal control over financial reporting is a process designed by, or under the supervision of, the principal executive and principal financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 

 32 

 

 

  · pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 

  · provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and/or directors of the Company; and

  

  · provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

 

We will be required to include a report of management on the effectiveness of our internal control over financial reporting.  We expect to incur additional expenses and diversion of management’s time as a result of performing the system and process evaluation, testing and remediation required in order to comply with the management certification requirements.

 

We do not have a sufficient number of employees to segregate responsibilities and may be unable to afford increasing our staff or engaging outside consultants or professionals to overcome our lack of employees.  During the course of our testing, we may identify other deficiencies that we may not be able to timely remediate.  Moreover, effective internal controls, particularly those related to revenue recognition, are necessary for us to produce reliable financial reports and are important to help prevent financial fraud.  If we cannot provide reliable financial reports or prevent fraud, our business and operating results could be harmed, investors could lose confidence in our reported financial information, and the trading price of our common stock, if a market ever develops, could drop significantly.

  

The Jobs Act has reduced the information that the Company is required to disclose.

 

Under the Jobs Act, the information that the Company will be required to disclose has been reduced in a number of ways.

  

As a company that had gross revenues of less than $1.0 billion during the Company’s last fiscal year, the Company is an “emerging growth company,” as defined in the Jobs Act (an “EGC”). The Company will retain that status until the earliest of (a) the last day of the fiscal year which the Company has total annual gross revenues of $1,000,000,000 (as indexed for inflation in the manner set forth in the Jobs Act) or more; (b) the last day of the fiscal year of following the fifth anniversary of the date of the first sale of the common stock pursuant to an effective registration statement under the Securities Act; (c) the date on which the Company has, during the previous three year period, issued more than $1,000,000,000 in non-convertible debt; or (d) the date on which the Company is deemed to be a “large accelerated filer,” as defined in Rule 12b-2 under the Exchange Act or any successor thereto. As an EGC, the Company is relieved from the following: 

 

  · The Company is excluded from Section 404(b) of Sarbanes-Oxley Act (“Sarbanes-Oxley”), which otherwise would have required the Company’s auditors to attest to and report on the Company’s internal control over financial reporting. The JOBS Act also amended Section 103(a)(3) of Sarbanes-Oxley to provide that (i) any new rules that may be adopted by the PCAOB requiring mandatory audit firm rotation or changes to the auditor’s report to include auditor discussion and analysis (each of which is currently under consideration by the PCAOB) shall not apply to an audit of an EGC; and (ii) any other future rules adopted by the PCAOB will not apply to the Company’s audits unless the SEC determines otherwise.

 

  · The Jobs Act amended Section 7(a) of the Securities Act of 1933, as amended (the “Securities Act”) to provide that the Company need not present more than two years of audited financial statements in an initial public offering registration statement and in any other registration statement, need not present selected financial data pursuant to Item 301 of Regulation S-K for any period prior to the earliest audited period presented in connection with such initial public offering. In addition, the Company is not required to comply with any new or revised financial accounting standard until such date as a private company (i.e., a company that is not an “issuer” as defined by Section 2(a) of Sarbanes-Oxley) is required to comply with such new or revised accounting standard. Corresponding changes have been made to the Exchange Act, which relates to periodic reporting requirements, which would be applicable if the Company were required to comply with them.

 

 33 

 

 

  · As long as the Company is an EGC, the Company may comply with Item 402 of Regulation S-K, which requires extensive quantitative and qualitative disclosure regarding executive compensation, by disclosing the more limited information required of a “smaller reporting company.”

 

  · In the event that the Company registers the common stock under the Exchange Act as it intends to do, the Jobs Act will also exempt the Company from the following additional compensation-related disclosure provisions that were imposed on U.S. public companies pursuant to the Dodd-Frank Act: (i) the advisory vote on executive compensation required by Section 14A(a) of the Exchange Act; (ii) the requirements of Section 14A(b) of the Exchange Act relating to shareholder advisory votes on “golden parachute” compensation; (iii) the requirements of Section 14(i) of the Exchange Act as to disclosure relating to the relationship between executive compensation and our financial performance; and (iv) the requirement of Section 953(b)(1)of the Dodd-Frank Act, which requires disclosure as to the relationship between the compensation of the Company’s chief executive officer and median employee pay.

 

Our stock price may be volatile and purchasers of our common stock could incur substantial losses.

 

Our stock price is likely to be volatile. As a result of this volatility, investors may not be able to sell their common stock at or above the initial public offering price. The market price for our common stock may be influenced by many factors, including the other risks described in this section of the prospectus titled “Risk Factors” and the following:

 

  · the success of competitive products or technologies;

 

  · results of preclinical and clinical studies of our product candidates, or those of our competitors, our existing collaborator or any future collaborators;

 

  · regulatory or legal developments in the U.S. and other countries, especially changes in laws or regulations applicable to our products;

 

  · introductions and announcements of new products by us, our commercialization partners, or our competitors, and the timing of these introductions or announcements;

 

  · actions taken by regulatory agencies with respect to our products, clinical studies, manufacturing process or sales and marketing terms;

 

  · actual or anticipated variations in our financial results or those of companies that are perceived to be similar to us;

 

  · the success of our efforts to acquire or in-license additional technologies, products or product candidates;

 

  · developments concerning our collaborations, including but not limited to those with our sources of manufacturing supply and our commercialization partners;

 

  · announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
     
  · developments or disputes concerning patents or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our products;

 

  · our ability or inability to raise additional capital and the terms on which we raise it;

 

 34 

 

 

  · the recruitment or departure of key personnel;

 

  · changes in the structure of healthcare payment systems;
     
  · market conditions in the pharmaceutical and biotechnology sectors;

 

  · actual or anticipated changes in earnings estimates or changes in stock market analyst recommendations regarding our common stock, other comparable companies or our industry generally;

 

  · our failure or the failure of our competitors to meet analysts’ projections or guidance that we or our competitors may give to the market;

 

  · fluctuations in the valuation of companies perceived by investors to be comparable to us;

 

  · announcement and expectation of additional financing efforts;

 

  · speculation in the press or investment community;

 

  · trading volume of our common stock;

 

  · sales of our common stock by us or our shareholders;

 

  · the absence of lock-up agreements in connection with this Offering with the holders of substantially all of our outstanding shares;

 

  · the concentrated ownership of our common stock;

 

  · changes in accounting principles;

 

  · terrorist acts, acts of war or periods of widespread civil unrest;

 

  · natural disasters and other calamities; and

 

  · general economic, industry and market conditions.

 

In addition, the stock markets in general, and the markets for pharmaceutical stocks in particular, have experienced extreme volatility that has been often unrelated to the operating performance of the issuer. These broad market and industry factors may seriously harm the market price of our common stock, regardless of our operating performance.

 

You will experience immediate and substantial dilution as a result of this Offering and may experience additional dilution in the future.

 

If you purchase common stock in this Offering, you will incur immediate and substantial dilution of $         per share, representing the difference between the assumed initial public offering price of $8.00 per share and our pro forma net tangible book value per share after giving effect to this of Offering and the conversion into 22,270 shares of our $120,250 in principal amount of outstanding Convertible Notes upon the first closing of this Offering.

 

The future issuance of equity or of debt securities that are convertible into equity will dilute our share capital.

 

We may choose to raise additional capital in the future, depending on market conditions, strategic considerations and operational requirements. To the extent that additional capital is raised through the issuance of shares or other securities convertible into shares, our stockholders will be diluted. Future issuances of our common stock or other equity securities, or the perception that such sales may occur, could adversely affect the trading price of our common stock and impair our ability to raise capital through future offerings of shares or equity securities. No prediction can be made as to the effect, if any, that future sales of common stock or the availability of common stock for future sales will have on the trading price of our common stock.

 

 35 

 

 

Substantially all of our outstanding shares will not be available for public sale commencing ninety (90) days after the effectiveness of this registration statement. The sale of a significant number of our shares may cause the market price of our common stock to drop significantly.

 

Commencing ninety (90) days after the date of this prospectus, the 45,000,000 shares of our common stock outstanding as of the date of this prospectus, will be eligible for sale in the public market from time to time thereafter pursuant to Rule 144 under the Securities Act, and in some cases, subject to the volume and other restrictions of Rule 144. In addition, the 22,270 shares of common stock issuable upon conversion of our $120,250 in principal amount of our outstanding Convertible Notes will similarly be eligible for public sale commencing in February 2017. Further, we have 7,500,000 shares reserved for issuance under our 2016 Incentive Stock Plan. The sale of a significant number of shares of our common stock in the public market or the perception that such sales may occur could significantly reduce the market price of our common stock.

 

The offering price of the shares and the other terms of this Offering have been arbitrarily determined by the Company.

 

The offering price of the shares and other terms of this Offering have been arbitrarily determined by the Company and bear no relationship to the Company’s assets, book value, potential earnings or any other recognized criterion of value. In addition, no investment banker, appraiser, or other independent third party has been consulted concerning the offering price for the shares or the fairness of the offering price used for the shares.

 

This Offering is a direct public offering conducted on a “best efforts, self underwritten” basis. No minimum number of shares need be subscribed for in order for the Company to consummate the sale of any of the Shares, there will be no escrow of funds and this Offering is self-underwritten.

 

The shares are being offered on a “best efforts, self-underwritten” basis. Accordingly, (a) no minimum number of shares need be subscribed for in order for the Company to consummate the sale of any of the shares and utilize the proceeds therefrom; and (b) the Company will not use the services of an underwriter and our executive officers and directors will attempt to sell the shares directly to investors. Notwithstanding the foregoing, the Company does not intend to consummate the sale of any shares until it has received subscriptions and payment for at least 1,125,000 shares ($9,000,000) and will maintain subscription proceeds in a segregated account, until such time. Thereafter, however, subscription proceeds will be paid directly to the Company and will not be held in a segregated or escrow account. Moreover, this Offering is self-underwritten and accordingly, there is no lead underwriter who would undertake a due diligence or comparable examination of the Company, its business and affairs.

 

An active trading market for our common stock may not develop.

 

Prior to this Offering, there has been no public market for our common stock. We intend to apply to have the shares of common stock listed on NYSE MKT, subject to our sale of a sufficient number of shares in the Offering to meet the listing requirements of NYSE MKT. There can be no assurance that an application for listing the shares on NYSE MKT or on any other market will be approved. Accordingly, an active trading market for our shares may never develop or be sustained following this offering. If an active market for our common stock does not develop, it may be difficult for you to sell shares you purchase in this Offering without depressing the market price for the shares or at all.

 

Because our management will have broad discretion over the use of the net proceeds from this Offering, you may not agree with how we use them and the proceeds may not be invested successfully.

 

We intend to use the net proceeds to us from this Offering to fund offering to fund preclinical and clinical trials of product candidates, continued HDAC technology platform development, working capital and general corporate purposes, including the costs of operating as a public company, as well as potential acquisition or in-licensing activities. Therefore, our management will have broad discretion as to the use of the Offering proceeds. Accordingly, you will be relying on the judgment of our management with regard to the use of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that the proceeds will be invested in a way that does not yield a favorable, or any, return for our company.

 

 36 

 

 

If securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion regarding our stock, our stock price and trading volume could decline.

 

The trading market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business. We do not currently have and may never obtain research coverage by securities and industry analysts. If no or few securities or industry analysts commence coverage of us, the trading price for our stock would be negatively impacted. In the event we obtain securities or industry analyst coverage, if any of the analysts who cover us issue an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our target studies and operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.

 

Our board of directors has the authority, without shareholder approval, to issue preferred stock with terms that may not be beneficial to common shareholders and with the ability to affect adversely shareholder voting power and perpetuate their control over us.

 

Our Articles of Incorporation allow us to issue shares of preferred stock without any vote or further action by our shareholders.  Our board of directors has the authority to fix and determine the relative rights and preferences of preferred stock.  As a result, our board of directors could authorize the issuance of a series of preferred stock that would grant to holders the preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock and the right to the redemption of the shares, together with a premium, prior to the redemption of our common stock.

 

The ability of our executive officers and directors, who are our principal shareholders, to control our business may limit or eliminate minority shareholders’ ability to influence corporate affairs.

 

Our executive officers and directors, who are our principal shareholders, own and assuming the sale of the shares registered by them hereunder as selling shareholders, will continue to own approximately ninety percent (90%) of our issued and outstanding common stock. Accordingly, they will be able to effectively control the election of directors, as well as all other matters requiring shareholder approval.  The interests of our principal shareholders may differ from the interests of other shareholders with respect to the issuance of shares, business transactions with or sales to other companies, selection of other directors and other business decisions.  The minority shareholders have no way of overriding decisions made by our principal shareholders.  This level of control may also have an adverse impact on the market value of our shares because our principal shareholders may institute or undertake transactions, policies or programs that result in losses may not take any steps to increase our visibility in the financial community and / or may sell sufficient numbers of shares to significantly decrease our price per share.

 

Our Articles of Incorporation and By Laws provide for indemnification of officers and directors at our expense and limit their liability that may result in a major cost to us and hurt the interests of our shareholders because corporate resources may be expended for the benefit of officers and/or directors.

 

Our Articles of Incorporation and Bylaws provide for the indemnification of our officers and directors.  We have been advised that, in the opinion of the SEC, indemnification for liabilities arising under federal securities laws is against public policy as expressed in the Securities Act and is therefore, unenforceable.

 

We do not expect to pay cash dividends in the foreseeable future.

 

We have never paid cash dividends on our common stock.  We do not expect to pay cash dividends on our common stock at any time in the foreseeable future.  The future payment of dividends directly depends upon our future earnings, capital requirements, financial requirements and other factors that our board of directors will consider.  Since we do not anticipate paying cash dividends on our common stock, return on your investment, if any, will depend solely on an increase, if any, in the market value of our common stock.

 

 37 

 

 

Provisions of Maryland law may limit the ability of a third party to acquire control of our Company.

 

Certain provisions of the Maryland General Corporation Law (the “MGCL”), may have the effect of delaying, deferring or preventing a transaction or a change in control of our company that might involve a premium price for holders of our common stock or otherwise be in their best interests, including:

 

·business combination” provisions that, subject to limitations, prohibit certain business combinations between us and an “interested shareholder” (defined generally as any person who beneficially owns 10% or more of the voting power of our shares or an affiliate thereof) for five years after the most recent date on which the shareholder becomes an interested shareholder, and thereafter impose special appraisal rights and special shareholder voting requirements on these combinations; and

 

·control share” provisions that provide that “control shares” of our Company (defined as shares which, when aggregated with other shares controlled by the shareholder, entitle the shareholder to exercise one of three increasing ranges of voting power in electing directors) acquired in a “control share acquisition” (defined as the direct or indirect acquisition of ownership or control of “control shares”) have no voting rights except to the extent approved by our stockholders by the affirmative vote of at least two-thirds of all the votes entitled to be cast on the matter, excluding all interested shares.

 

At this time, we have not opted out of these provisions of the MGCL. Additionally, the MGCL permits our board of directors, without shareholder approval and delaying, deferring or preventing a transaction or a change in control of our Company that might involve a premium price for holders of our common stock or otherwise be in their best interest.

 

 38 

 

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus contains forward-looking statements that involve risks and uncertainties. All statements other than statements of historical facts contained in this prospectus are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “could,” “will,” “would,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “intend,” “predict,” “seek,” “contemplate,” “project,” “continue,” “potential,” “ongoing” or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:

 

  · the initiation, timing, progress and results of our research and development programs, preclinical studies, any clinical trials and INDs, NDAs other regulatory submissions;

 

  · our expected dependence on third party collaborators for developing, obtaining regulatory approval for and commercializing product candidates;

 

  · our receipt and timing of any milestone payments or royalties under any research collaboration and license agreement we enter into;

 

  · our ability to identify and develop product candidates;

 

  · our or a collaborator’s ability to obtain and maintain regulatory approval of any of our product candidates;

 

  · the rate and degree of market acceptance of any approved products candidates;

 

  · the commercialization of any approved product candidates;

 

  · our ability to establish and maintain additional collaborations and retain commercial rights for our product candidates subject to collaborations;

 

  · the implementation of our business model and strategic plans for our business, technologies and product candidates;

 

  · our estimates of our expenses, ongoing losses, future revenue and capital requirements;

 

  · our ability to obtain additional funds for our operations;

 

  · our ability to obtain and maintain intellectual property protection for our technologies and product candidates and our ability to operate our business without infringing the intellectual property rights of others;

 

  · our reliance on third parties to conduct our preclinical studies or any future clinical trials;

 

  · our reliance on third party supply and manufacturing partners to supply the materials and components for, and manufacture, our research and development, preclinical and clinical trial drug supplies;

 

  · our ability to attract and retain qualified key management and technical personnel;

 

  · our use of net proceeds to us from this Offering;

 

  · our expectations regarding the time during which we will be an emerging growth company under the JOBS Act;

 

  · our financial performance; and

 

 39 

 

 

  · developments relating to our competitors or our industry.

 

These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Factors that may cause actual results to differ materially from current expectations include, among other things, those described in the section titled “Risk Factors” and elsewhere in this prospectus.

 

Any forward-looking statement in this prospectus reflects our current view with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, industry and future growth. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.

 

 40 

 

 

USE OF PROCEEDS

 

The Offering is a direct public offering on a “best efforts, self underwritten” basis, which means (a) no minimum number of shares need be subscribed for in order for the Company to consummate the sale of any of the shares and utilize the proceeds therefrom; and (b) the Company will not use the services of an underwriter and our executive officers and directors will attempt to sell the shares directly to investors.

 

We estimate that the net proceeds from this Offering will be approximately $35,750,000 if all 4,500,000 shares are purchased, after deducting estimated Offering expenses. We expect to use the net proceeds from this Offering over the next twelve months for the purposes set forth in the table below. The following table sets forth a breakdown of the estimated use of the net proceeds as of the date of this prospectus, assuming the sale of 100%, 75%, 50% and 25% of the shares offered hereby:

 

Assumed Percentage of Shares Sold   100%   75%   50%   25%
Price to Public @ $8.00  $36,000,000   $27,000,000   $18,000,000   $9,000,000 
Offering expenses   250,000    250,000    250,000    250,000 
Net proceeds  $35,750,000   $26,750,000   $17,750,000   $8,750,000 
                     

Product candidate preclinical and clinical trials HDAC small molecule delivery platform research and development Product candidate research and development

   25,500,000   $17,500,000   $10,000,000   $5,500,000 
Product acquisition and in-licensing activities   1,000,000    1,000,000    1,000,000    0 
Working capital and general corporate purposes   9,250,000    6,250,000    6,750,000    3,250,000 
Total use of proceeds  $35,750,000   $26,750,000   $17,750,000   $8,750,000 

 

As indicated in the table above, if we sell only 75%, or 50%, or 25% of the shares offered for sale in this Offering, we would expect to use the resulting net proceeds for the same purposes as we would use the net proceeds from a sale of 100% of the shares, and in approximately the same proportions although we will need to prioritize our clinical studies to accomodate the availability of funding.

 

The expected use of the net proceeds from this Offering represents our intentions based upon our current plans and business conditions, which could change in the future as our plans and business conditions evolve. The amounts and timing of our actual expenditures depend on numerous factors, including the progress of our preclinical development efforts, the results of any clinical trials and other studies and any unforeseen cash needs. All of our research and development programs are at an early stage and successful development of product candidates from these programs is highly uncertain and may not result in approved products. Completion dates and completion costs can vary significantly for each product candidate and are difficult to predict. As a result, we cannot currently specify in more detail the percentage of the net proceeds that we may use for each of the listed purposes. Accordingly, we will have broad discretion in the use of the net proceeds from this offering and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our stock.

 

Pending the use of the proceeds from this offering, we intend to invest the net proceeds in short-term, interest-bearing, investment-grade securities, certificates of deposit or government securities.

 

In the event we do not sell all of the Shares being offered, we may seek additional financing to support the intended use of proceeds discussed above. If we secure additional equity funding, investors in this offering would be diluted. In all events, there can be no assurance that additional financing would be available when needed and, if available, on terms acceptable to us.

 

DIVIDEND POLICY

 

We have not paid any dividends on our common stock since inception and we currently expect that, in the foreseeable future, all earnings (if any) will be retained for the development of our business and no dividends will be declared or paid. Any future dividends will be subject to the discretion of our board of directors and will depend upon, among other things, our earnings (if any), operating results, financial condition and capital requirements, general business conditions and other pertinent facts.

 

 41 

 

 

CAPITALIZATION

 

The following table sets forth our cash and cash equivalents and capitalization as of September 30, 2016:

 

  · on an actual basis; and

 

  · on a pro forma as adjusted basis to reflect the sale of all 4,500,000 shares of common stock by us in this Offering at an initial public offering price of $8.00 per share, after deducting estimated Offering expenses payable by us and the conversion of the Convertible Notes into 22,270 shares.

 

You should read this table in conjunction with our financial statements and related notes and the sections titled “Use of Proceeds,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Description of Capital Stock” appearing elsewhere in this prospectus.

 

    AS OF SEPTEMBER 30, 2016 
    ACTUAL    PRO FORMA
AS ADJUSTED
 
Long-term debt—net of current portion  $120,250   $120,250 
           
Shareholders’ deficit:          
Common stock, $0.01 par value per share; authorized 100,000,000 shares, 45,000,000 shares issued and outstanding, actual; 49,522,270 shares issued and outstanding, pro forma as adjusted;   -0-    45,227 
           
Preferred stock, $0.01 par value per share; authorized 5,000,000 shares, 0 shares issued and outstanding actual and pro forma as adjusted   -0-    -0- 
Additional paid-in capital   -0-    35,704,773 
Accumulated deficit   (979,113)   (979,113)
           
Total stockholders’ equity (deficit)          
Total capitalization  $(858,863)  $34,891,137 

 

The number of shares of common stock issued and outstanding actual and pro forma as adjusted in the table above excludes the 7,500,000 reserved for issuance under our 2016 Incentive Stock Plan.

 

DILUTION

 

If you invest in our common stock, your interest will be diluted to the extent of the difference between the public offering price per share of our common stock that you pay and the pro forma as adjusted net tangible book value per share of our common stock after this Offering. Net tangible book value per share is determined by dividing our total tangible assets less our total liabilities by the number of shares of common stock outstanding. Our historical net tangible book value as of September 30, 2016 was $20,887 or $.0005 per share, based on 45,000,000 shares of common stock outstanding as of September 30, 2016.

 

Net tangible book value dilution per share represents the difference between the amount per share paid by new investors who purchase shares from us in this offering and the pro forma net tangible book value per share of common stock immediately after completion of this Offering. As of September 30, 2016, after giving effect to our sale of 4,500,000 shares of common stock in this Offering at an initial offering price of $8.00 per share, after deducting estimated Offering expenses that we must pay, and after giving pro forma effect to the conversion of the Convertible Notes into 22,270 shares of common stock, our pro forma as adjusted net tangible book value would have been $         , or $         per share. This represents an immediate increase in pro forma net tangible book value of $         per share to existing shareholders, and an immediate dilution in pro forma net tangible book value of $         per share to new investors purchasing shares in this Offering. The table below illustrates this per share dilution as of                     , 2016.

 

 42 

 

 

 Before
offering
   Pro-forma
after offering $36M
 
           
Initial public offering price per share  $8.00   $8.00 
Net tangible book value per share as of September 30, 2016  $0.01   $7.72 
Increase in pro forma net tangible book value per share attributable to new investors participating in this Offering and conversion of the Convertible Notes  $-0-   $34,891,137 
Pro forma as adjusted net tangible book value per share after this Offering and conversion of the Convertible Notes       $0.73 
Dilution of pro forma net tangible book value per share to new investors       $7.27 

 

The following table sets forth, on a pro forma as adjusted basis as of September 30, 2016, the number of shares of common stock purchased or to be purchased from us, the total consideration paid or to be paid and the average price per share paid or to be paid by existing holders of common stock and by new investors, at a public offering price of $8.00 per share, before deducting estimated Offering expenses that we must pay.

 

 

 

   SHARES PURCHASED   TOTAL CONSIDERATION   AVERAGE PRICE 
   NUMBER   PERCENT   AMOUNT   PERCENT   PER SHARE 
Existing stockholders   45,022,270    91%  $22,511    0%  $.0005 
New investors   4,500,000    9    36,000,000    100   8.00 
                          
Total   49,522,270    100%  $36,022,511    100%  $.727 

 

 

 

The foregoing discussion and tables are based on the number of shares of common stock outstanding as of September 30, 2016 taking into account the conversion of the Convertible Notes into 22,270 shares of our common stock as of September 30, 2016, but exclude 7.500,000 shares reserved for issuance under our 2016 Incentive Stock Plan.

 

 43 

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Results of Operations

 

Comparison of Nine Months Ended September 30, 2015 and 2016

 

The following table summarizes the results of our operations for the nine months ended September 30, 2015 and 2016:

 

   Nine Months Ended September 30,   Increase/ 
   2015   2016   (Decrease) 
Research and development-net of contracts  $232,163   $121,705   $(110,458)
General and administrative   32,500    126,477    93,977 
Other income (expense):               
Interest income   1,361    443    (918)
Interest expense   -0-    (1,106)   (1,106)
Total other income (expense)   1,361    (663)   (2,024)

 

Research and Development Expenses-Net of contracts. Research and development expenses-net of contracts $232,163 for the nine months ended September 30, 2015, as compared to $121,705 for the nine months ended September 30, 2016. The decrease of $110,458 is primarily related to the increase of NIH contract funding for the ropidoxuridine Phase 1 clinical trial for 2016. For the nine months ended September 30, 2015, reimbursement from NIH totaled $121,272 and total expenses related to research and development was $353,435, as compared to $409,069 for reimbursement from the NIH contract and $530,774 in research and development expenses for September 30, 2016.

 

General and Administrative Expenses. General and administrative expenses were $32,500 for the nine months ended September 30, 2015, as compared to $126,477 for the nine months ended September 30, 2016. This increase is primarily due to an increase in Company legal expenses, $10,825 for the nine months ended September 30, 2015 as compared to $48,138 for the nine months ended September 30, 2016, consulting expenses, $12,000 for the nine months ended September 30, 2015 as compared to $53,650 for the nine months ended September 30, 2016 and accounting expenses, $6,075 for the nine months ended September 30, 2015 as compared to $18,065 for the nine months ended September 30, 2016,

 

Other Income (Expense). Other income (expense) was approximately $1,361 for the nine months ended September 30, 2015 which consisted of interest income-related party. Other income (expense) was $(663) for the nine months ended September 30, 2016 and consisted of $1,106 of interest expense and $443 for interest income on a note payable-related party.

 

Comparison of Fiscal Years Ended December 31, 2014 and 2015

 

The following table summarizes the results of our operations for the fiscal years ended December 31, 2014 and 2015:

 

   Year Ended December 31,   Increase/ 
   2014   2015   (Decrease) 
Research and development-net of contracts  $280,665   $214,519   $(66,146)
General and administrative   51,258    77,140    25,882 
Other income (expense):               
Interest income   3,389    1,668    (1,721)
Interest expense   -0-    -0-    -0- 
Change in fair value of warrant liability   -0-    -0-    -0- 
Total other income (expense)   3,389    1,668    (1,721)

 

 44 

 

 

Research and Development Expenses. Research and development-net of contract expenses were $280,665 for the year ended December 31, 2014, as compared to $214,519 for the year ended December 31, 2015. The decrease of $66,146 is primarily related to the increase in NIH contract payments in 2015 for the IPdR Phase 1 and 2 SBIR contracts. For the year end December 31, 2014, reimbursement from NIH totaled $70,699 and total expenses related to research and development was $351,364, as compared to $281,913 for reimbursement from the NIH contract and $496,432 in research and development expenses for year ended December 31, 2015.

 

General and Administrative Expenses. General and administrative expenses were $51,258 for the year ended December 31, 2014, as compared to $77,140 for the year ended December 31, 2015. The increase of $25,882 is primarily related to an increase in legal expenses $7,314 for the year ended December 31, 2014 as compared to $19,863 for the year ended December 31, 2015 and consulting expenses, $28,299 for the year ended December 31, 2014 as compared to $40,400 for the year ended December 31, 2015.

 

Other Income (Expense). Other income was $3,389 for the year ended December 31, 2014 which consisted of interest income for a note receivable-related party. Other income was $1,668 for the year ended December 31, 2015 which consisted of interest income related to a note receivable-related party.

 

Liquidity and Capital Resources

 

As of September 30, 2016, total current assets were $211,835as compared to $200,213 on December 31, 2015.   Total current liabilities as of September 30, 2016 were $115,271 as compared to $4,577 as of December 31, 2015. The increase in current liabilities is due to the an increase in accrued expenses related to subcontract work for the NIH SBIR contract, $68, 445 and a note payable-related party, $45,928.

 

Net cash used in operating activities was $210,407 in the nine months ended September 30, 2016 compared to $238,799 for the same period in 2015.

 

Net of cash provided by investing activities was $15,483 in the nine months ended September 30, 2016 as compared to $18,983 for the same period in 2015. This activity is primarily due to the repayment of a note receivable-related party, net of acquisition of property and equipment.

 

Net cash provided by financing activities in the first nine months of 2016 was $186,178, representing the proceeds from the private offering of the Convertible Notes of $120,250, capital contributions of $20,000 and note payable-related party $45,928. This compares to $200,000 in capital contributions in the first nine months of 2015.  

 

Our capital needs to date have been met by contributions from existing shareholders, as well as through our private offerings of our securities, SBIR contracts and other grants. We believe that we will continue to expend substantial resources for the foreseeable future on the completion of clinical development and regulatory preparedness of our product candidates, preparations for a commercial launch of our product candidates, if approved, and development of any other current or future product candidates we may choose to further develop. These expenditures will include costs associated with research and development, conducting preclinical studies and clinical trials, obtaining marketing approvals, and, if we are not able to enter into planned collaborations, manufacturing and supply as well as marketing and selling any products approved for sale. In addition, other unanticipated costs may arise. Because the outcome of any drug development process is highly uncertain, we cannot reasonably estimate the actual amounts necessary to successfully complete the development and commercialization of our current product candidates, if approved, or future product candidates, if any.

 

There can be no assurance that additional financing will be available to the Company when needed, on favorable terms or otherwise.  Moreover, any such additional financing may dilute the interests of existing shareholders.  The absence of additional financing, when needed, could cause the Company to delay implementation of its business plan in whole or in part, curtail its business activities and seriously harm the Company and its prospects.

 

 45 

 

 

Critical Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.  Significant estimates included deferred revenue, costs incurred related to deferred revenue, the useful lives of property and equipment, the useful lives of intangible assets and accounting for the business combination.

 

Research and Development

 

Research and Development expenses are offset by contract receivable payments from an NIH SBIR contract that supports this scientific research. This is stated in the financials as Research and development-net of contracts.

 

Income Taxes

 

The Company accounts for income taxes in accordance with ASC 740, Accounting for Income Taxes, as clarified by ASC 740-10, Accounting for Uncertainty in Income Taxes.  Under this method, deferred income taxes are determined based on the estimated future tax effects of differences between the financial statement and tax basis of assets and liabilities given the provisions of enacted tax laws.  Deferred income tax provisions and benefits are based on changes to the assets or liabilities from year to year.  In providing for deferred taxes, the Company considers tax regulations of the jurisdictions in which the Company operates, estimates of future taxable income, and available tax planning strategies.  If tax regulations, operating results or the ability to implement tax-planning strategies vary, adjustments to the carrying value of deferred tax assets and liabilities may be required.  Valuation allowances are recorded related to deferred tax assets based on the “more likely than not” criteria of ASC 740.

 

ASC 740-10 requires that the Company recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit.  For tax positions meeting the “more-likely-than-not” threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized upon ultimate settlement with the relevant tax authority.

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

 

 46 

 

 

BUSINESS

 

Overview

 

Shuttle is a specialty pharmaceutical company founded in 2012, with the goal of becoming the first U.S. pharmaceutical company focused on the development and commercialization of innovative first-in-class drugs for sensitizing cancers to and protecting normal tissue from the effects of RT. Our objective is to improve the outcomes of cancer treatment through RT and reducing its side effects by:

 

·sensitizing growing cancer cells, rendering them more susceptible to the effects of RT;
·sensitizing hypoxic cells in tumors that resist regular RT; and
·activating the DNA damage response pathway to protect normal cells located near cancers.

 

To date, we have developed, to clinical stage, small molecule strategies to sensitize growing cancer cells in tumors to conventional RT and to sensitize treatment resistant, hypoxic cancer cells in tumors to large fraction radiation therapy using SBRT. A pre-clinical technology delivery platform using HDAC inhibitors, which are designed to target cancer cells while protecting healthy tissue, further enhances our pipeline. Shuttle has two clinical stages, first in class product candidates that we believe will deliver these benefits in conjunction with our technology platform:

 

·Ropidoxuridine, an orally available halogenated pyrimidine with strong cancer radiation sensitizing properties, is our lead “clinical phase” product candidate. Halogenated pyrimidines are incorporated into DNA by rapidly growing cancer cells and become more sensitive to the effects of RT. We have received an SBIR contract from the NIH to fund a Phase 1 clinical trial at and in collaboration with Brown University - Lifespan/Rhode Island Hospital to determine safety and the maximum tolerated dose in patients with advanced gastrointestinal cancers. In connection with the trial, NCI has approved the Phase 1 clinical protocol and agreed to provide drug and clinical data management support to Rhode Island Hospital. If we receive positive results from the Phase1 clinical trial, we plan to advance to Phase 1b and Phase 2 clinical trials of using ropidoxuridine in conjunction with RT treatments of patients with brain tumors and soft tissue sarcomas.

 

·Doranidazole, an injectable hypoxic cell radiation sensitizer, is our second “clinical phase” product candidate. As cancer cells outgrow the blood supply and oxygen availability becomes limiting, regions of hypoxia develop within a tumor. Cancer cells under hypoxic conditions are more resistant to the killing effects of RT. Electron affinic drugs, such as doranidazole are able to reach areas of tumor hypoxia to effect radiation sensitization, thereby offering the potential to improve the outcome of RT treatment by increasing hypoxic cell kill. Unfortunately, first and second generation hypoxic sensitizers used to date have shown neurologic toxicity and little clinical benefit. Doranidazole, which has been developed in Japan by Pola Pharma, has been well-tolerated in clinical studies conducted in Japan and has shown improved survival in a randomized Phase 3 clinical trial of advanced pancreatic cancers, when used in combination with IORT, as opposed to treatment by IORT alone. Shuttle has secured an exclusive option to license doranizadole for development and commercialization in the U.S. We intend to focus on the use of Doranidazole for treatment of pancreatic, lung and liver cancers in combination with large fraction SBRT, which is radiation therapy administered in large doses over a several day period as opposed to conventional RT, which is generally administered in small daily doses over an extended period of several weeks.

 

In addition to our two primary product candidates, we are developing and planning to commercialize other cancer radiation sensitizers with radiation protecting properties, which target protecting normal tissue during the administration of RT and other first-in-class products utilizing our HDAC small molecule technology platform.

 

 47 

 

 

We have also been two awarded SBIR contracts from the NIH to:

 

·develop prostate cancer cell lines from African-American men, who are at higher risk for prostate cancer, with donor matched normal prostate cells, with the goal of establishing 50 prostate cancer cell lines for research aimed at treating prostate cancer in African American men; and

 

·develop predictive biomarkers for predicting outcomes for prostate cancer patients following treatment with SBRT.

 

The SBIR program is designed to encourage small business to engage in Federal Research/Research and Development (“R/R&D“) that has the potential for commercialization.

 

The Company was founded by members of the faculty at the Georgetown University Medical School in Washington, D.C., all of whom have significant experience in the fields of radiation oncology and medicinal chemistry.

 

Market Opportunity

 

The American Cancer Society (Cancer Facts & Figures 2016) estimates 1,685,210 new cancer cases and 595,690 cancer deaths in the U.S. and according to the American Society for Radiation Oncology, more than 50% of patients undergo RT at some point in the treatment of their disease. Cancers treated with RT include, lung, breast, brain, ovarian, esophageal, pancreatic, rectal, head and neck, uterine, lymphoma and sarcoma. The annual U.S. market for radiation oncology, technology and therapeutics currently exceeds $5.5 billion.

 

Currently, there is no radiation sensitizer drug which has been approved by the FDA. Present treatment utilizes “off-label” drugs which are cytotoxic agents that also sensitize, but do not have radiation sensitization as an FDA approved indication. Moreover, since the “off-label” drugs for sensitizing cancers are cytotoxic, they are often associated with intrinsic acute and chronic side effects. Nevertheless, current drugs used to sensitize cancers to RT have shown small, but clinically significant improvements in disease control and survival and are typically included in standard-of-care treatment recommendations for cancers of the head and neck, brain, lung, esophagus, stomach, pancreas, liver and bladder. As a result, the Company believes that there is a significant market opportunity for its product candidates.

 

Our Strategy

 

Our objectives are to (a) establish ropidoxuridine as the first radiation sensitizer approved by the FDA for use in conjunction with RT in treating advanced gastrointestinal cancer, high grade brain tumors and bone and soft tissue sarcomas; (b) establish doranidazole as a first line therapy in conjunction with SBRT in treating inoperable pancreatic, advanced lung and unresectable liver cancers; and (c) apply our HDAC small molecule delivery platform to the development of other radiation oncology drugs, such as approved radiation protectors. To achieve these objectives, our strategy is as follows:

 

·Complete the SBIR funded Phase 1 clinical trial for ropidoxuridine in conjunction with RT for the treatment of advanced gastrointestinal cancer, which trial commenced in January 2016 and, assuming positive results, proceed to Phase 1b, 2 and 3 clinical trials, followed by submission of an NDA and ultimately secure FDA approval for marketing;

 

·Commence clinical proof of concept studies followed by clinical trials for ropidoxuridine use in conjunction with RT for the treatment of high grade brain tumors and bone and soft tissue sarcomas, with the ultimate goal of securing FDA approval for these additional indications;

 

·Exercise the option to license doranidazole from Pola Pharma for development and commercialization in the U.S. and use pre-clinical and clinical studies performed in Japan to expedite conducting any needed additional clinical studies in the U.S., with the ultimate goal of securing FDA approval for the use of doranidazole in conjunction with SBRT for the treatment of inoperable pancreatic, advanced lung and unresectable liver cancers;

 

·Continue research and development of our HDAC small molecule delivery platform and exploit our platform and our intellectual property portfolio to develop other radiation oncology product candidates, as well as additional indications for existing product candidates;

 

 48 

 

 

·Assuming positive results from proof of concept studies and Phase 1 and Phase 2 clinical trials, seek to establish collaborative partnerships with other pharmaceutical companies to complete development of, manufacture and market our product candidates both domestically and internationally;

 

·Complete the SBIR funded Phase 1 research contracts we were awarded by the NIH to develop (a) prostate cancer cell lines for African-American men, to improve diagnosis and treatment with a goal of reducing the higher incidence of such cancers prevalent in African American men; and (b) molecular biomarkers for cancer responsiveness to SBRT treatment; and

 

·Explore potential acquisitions of compatible product portfolios or companies.

 

Our HDAC Small Molecule Delivery Platform

 

General

 

Since our founding, we have focused a portion of our research and development efforts on our small molecule technology delivery platform which uses HDAC inhibitors, which are designed to target cancer cells, while protecting healthy tissue.

 

HDACs are a class of enzymes that regulates gene expression through chemical modification of histones and non-histone proteins. Increased HDAC activity leads to a more condensed chromatin, decreased gene expression and loss of key gene products, including tumor suppressor gene function. Inhibition of HDAC activity leads to a more open chromatin and increased expression of the key gene products. This chromatin modification underlies the epigenetic cellular regulatory system and is an area of intense investigation. We believe that our candidate HDAC inhibitor platform products provide selective anticancer activities in addition to normal cell protection from radiation injury.

 

Our research and development efforts to date have focused on discoveries of novel, dual functional molecules for potential use in cancer treatment and normal tissue radiation protection. We have produced two first-in-class molecules:

 

·SP-1-161, a candidate lead of several compounds which has demonstrated activation of the “ATM” gene product mutated in Ataxia-Telangiectasia, a human genetic disease characterized by neurological, immunological and radiobiological clinical features, such as exquisite radiation sensitivity due to the ATM gene mutation; and

 

·SP-2-59, a candidate lead of several compounds demonstrating Class II HDAC6 selective inhibition.

 

SP-1-161 - A Dual Functional Agent

 

SP-1-161 is an HDAC inhibitor of the hydroxamate chemical class of compounds and an ATM activator of the indole chemical class. HDACs modify histones and non-histone proteins, which are key components of the chromatin structure, gene expression regulation, and cell growth. HDAC inhibitors have shown to inhibit cell proliferation, angiogenesis and immunity. Eighteen human HDACs have been identified, subdivided into four classes based on sequence and functional homology. In cancer cells, HDAC activity may be elevated leading to silencing of tumor suppressor genes important for cell growth regulation and to chromosomal instability. Abnormal HDAC activity is also associated with tumor cell growth, invasion, metastasis and resistance to therapy. Therefore, inhibitors of HDACs have emerged as anti-cancer agents for cancer therapy. Vorinostat and romidepsin have been approved by the FDA for treatment of patients with relapsed or refractory T-cell lymphomas. In addition, panobinostat received FDA approval for treatment of recurrent multiple myeloma in combination with bortezomib and dexamethasone.

 

In preclinical studies, SP-1-161 inhibited the activity of pan-HDACs, and activated the ATM gene product. ATM is a critical protein for the activation of the cell stress response for cellular recovery from radiation exposure in normal cells, but not in cancer cells. ATM activates the P53 protein, referred to as the “guardian of the genome,” and serves as a tumor suppressor critical for normal cell function and activation of programmed cell death in cancer cells.

 

 49 

 

 

SP-1-161 protected normal breast epithelial cells (184A1) following exposure to ionizing radiation while increasing sensitivity of breast cancer cells (MCF7). We believe that the ability of SP-1-161 to provide this dual function in a single molecule will differentiate this molecule from other HDAC inhibitors and is an unprecedented radio-chemotherapeutic agent for treatment of cancers while protecting normal cells and will facilitate its development for use in cancer treatment.

 

SP-2-59 - A HDAC6 Selective Inhibitor

 

HDAC6 is a member of class II HDAC family and plays important roles in cancer motility, invasion, neurological diseases, and immune checkpoint, suggesting that HDAC6 inhibition may confer therapeutic benefit. HDAC6 inhibition has been most extensively studied for its role in the treatment of hematological cancers.

 

Selective inhibition of HCAC6 is expected to reduce many of the dose limiting side effects associated with non-selective HDAC inhibitors. Preclinical models suggest that selective HDAC6 inhibitors may lead to effective therapy, particularly in combinations with other cytotoxic agents. Shuttle’s discovery of selective HDAC inhibitors has yielded several HDAC6 selective candidate molecules including SP-2-59. HDAC6 inhibitors may have a role in the treatment of diseases such as multiple myeloma.

 

We are currently conducting and intend to complete preclinical efficacy and IND-enabling studies of these molecules to position them for IND application, which we would expect to file in 2018.

 

Our Product Candidates

 

Shuttle has two clinical stage, first in class product candidates ropidoxuridine and doranidazole that we believe will target cancer cells, while protecting healthy tissue, when used in conjunction with our technology platform.

 

Ropidoxuridine

 

Ropidoxuridine, an orally available halogenated pyrimidine with strong cancer radiation sensitizing properties, is our lead “clinical phase” product candidate. Halogenated pyrimidines are incorporated into DNA by rapidly growing cancer cells and become more sensitive to the effects of RT. We have received an SBIR contract from the NIH to fund a Phase 1 clinical trial at and in collaboration with Brown University - Lifespan/Rhode Island Hospital to determine safety and the maximum tolerated dose in patients with advanced gastrointestinal cancers. In connection with the trial, NCI has approved the Phase 1 clinical protocol and agreed to provide drug and clinical data management support to Rhode Island Hospital. If we receive positive results from the Phase1 clinical trial, we plan to advance to Phase 1b and Phase 2 clinical trials through a CRO using ropidoxuridine in conjunction with RT treatments of patients with brain tumors and soft tissue sarcomas.

 

Ropidoxuridine is a prodrug, a compound that, after administration is metabolized (i.e., converted within the body) into a pharmacologically active drug. Ropidoxuridine is converted to the radiation sensitizing agent iododeoxyuridine by metabolic processes following oral administration. We believe that the oral delivery of ropidoxuridine provides a significant drug delivery advantage for clinical applications with RT. The iododeoxyuridine molecules are then incorporated into the DNA of growing cancer cells to effect radiation sensitization. Reported Phase 2 clinical trials of iododeoxyuridine in combination with RT provide support for our plans to test ropidoxuridine and RT therapy in these diseases. In addition, tumors demonstrating the mis-match repair defect will allow evaluation of a precision medicine approach for testing ropidoxuridine in combination with RT.

 

The following tables provide data from reported clinical trials of iododeoxyuridine and RT therapy in brain cancers (glioblastoma multiforme) and high grade sarcomas. Our primary strategy for ropidoxuridine and RT therapy is to deliver oral drug to effect radiation sensitization of cancers.

 

 50 

 

 

Table 1. Brain Cancer Treatment

 

Tumor   Treatment   Median survival (Months)

Anaplastic astrocytomas

(Grade 3 of 4)* (21 patients)

  RT alone   24
    RT + IUdR   39

Glioblastoma Multiforme

(Grade 4 of 4)** (18 patients)

  RT alone     9
    RT + IUdR   15

 

Table 1. Efficacy compared to historical RT-alone controls for treatment of high grade primary brain tumors (RTOG*, NCI** trials)

 

**IUdR continuous IV infusion (1000 mg/m2/ day/ 14 days), Total 39 patients (F. Sullivan, et al. Int J Radiat Oncol Biol Phys. 1994; 30(3):583-90)

 

* IUdR continuous IV infusion (2000 mg/m2/ 4 day infusion/ 6 week treatment), Total 21 patients (R. Urtasun, et al. Int J Radiat Oncol Biol Phys. 1996;36(5):1163-7.)

 

 51 

 

 

Table 2. Sarcoma Treatment

 

Tumor   Treatment   Local Control at 2 years

High grade sarcomas

(resectable)***

  RT + Surgery   25%
    RT + IUdR + Surgery   45%

 

Table 2. Efficacy compared to historical RT-alone controls for treatment of high grade sarcomas (University of Michigan*** trials)

 

***16 patients treated with continuous infusion (1000-1600 mg/m2/day) plus RT (J.M. Robertson, et al. Int J Radiat Oncol Biol Phys. 1995; 31 (1):87-92).

 

Doranidazole

 

Doranidazole, an injectable hypoxic cell radiation sensitizer, is our second “clinical phase” product candidate. As cancer cells outgrow the blood supply and oxygen availability becomes limiting, regions of hypoxia develop within a tumor. Cancer cells under hypoxic conditions are more resistant to the killing effects of RT. Electron affinic drugs, such as doranidazole are able to reach areas of tumor hypoxia to effect radiation sensitization, thereby offering the potential to improve the outcomes of RT treatment by increasing hypoxic cancer cell kill. Unfortunately, first and second generation hypoxic sensitizers used to date have shown neurologic toxicity and little clinical benefit. Doranidazole, which has been developed in Japan by Pola Pharma, has been well-tolerated in clinical studies conducted in Japan and has shown improved survival in a randomized Phase 3 clinical trial of advanced pancreatic cancers, when used in combination with IORT, as opposed to treatment by IORT alone. Shuttle has secured an exclusive option to license doranizadole for development and commercialization in the U.S. We intend to focus on the use of doranidazole for treatment of pancreatic, lung and liver cancers in combination with large fraction SBRT, which is radiation therapy administered in large doses over a several day period as opposed to RT, which is generally administered in small daily doses over an extended period of several weeks.

 

We intend to build upon Phase 1 and Phase 2 clinical trials and an initial Phase 3 clinical trial conducted in Japan of doranidazole and RT for treatment of lung cancers and pancreatic cancers. Our primary strategy for doranidazole and RT is to file and receive approval for an IND in 2017, conduct Phase 1b/II clinical trials in 2018 and 2019 and commence Phase 3 clinical trials in 2020. We plan to focus on delivery of the drug by infusion prior to SBRT to effect radiation sensitization of pancreatic cancers.

 

 

 52 

 

 

 

In addition to our two primary product candidates, we are developing and planning to commercialize other cancer radiation sensitizers and radiation protectors, which target protecting normal tissue during the administration of RT, and other first-in-class products utilizing our HDAC small molecule technology platform.

 

SBIR Contracts

 

The SBIR Program

 

The Small Business Innovation Research (“SBIR”) program is designed to encourage domestic small businesses to engage in Federal Research/Research and Development (“R/R&D”) that has the potential for commercialization. Through a competitive awards-based program, SBIR enables small businesses to explore their technological potential and provides the incentive to profit from its commercialization. Some of the SBIR’s program goals include stimulating technological innovation, meeting Federal research and development needs and encouraging participation in innovation and entrepreneurship.

 

The SBIR is a three Phase program. Phase 1 is to establish the technical merit and commercial potential of the proposed R/R&D efforts, Phase 2 is to continue the R/R&D efforts initiated in Phase 1 and funding is based on the results achieved in Phase 1. Phase 3 allows for the small business to pursue commercialization objectives resulting in the Phase 1 and 2 R/R&D activities.

 

In addition to the SBIR contract to fund our Phase 1 clinical study on ropidoxuridine in combination with RT for treatment of advanced gastrointestinal cancers; we have also been awarded two additional phase I SBIR contracts from the NIH to address prostate cancer health disparities and prostate cancer biomarker development.

 

Prostate Cancer Studies to Address Health Disparities

 

Prostate cancer health disparities studies have shown that African-American men are at higher risk for developing prostate cancer, as well as at higher risk of cancer specific death rates as compared to Caucasian American men. The causes of disparities have been attributed to socioeconomic differences, environmental exposures and biological factors. Most disparities studies have been population based, in part, due to the lack of relevant in vitro and in vivo models to support biological studies.

 

Shuttle has been awarded a Phase I SBIR contract entitled “Cell-based models for prostate cancer health disparity research” to develop African-American prostate cancer cell lines with donor matched normal prostate epithelial determine the feasibility of establishing 50 prostate cancer cell lines from African American men in a subsequent Phase II application for commercial cell distribution and reagent marketing through a private-public partnership.

 

Prostate Cancer Biomarker Development

 

Patients treated for prostate cancer may experience treatment related late effects that adversely affect quality of life and may prove life-threatening. Shuttle has been awarded a Phase I SBIR contract entitled “Predictive biomarkers for prostate cancer patient sensitivity for radiation late effects” to determine the technical and commercial feasibility of a biomarker panel predictive of radiation mediated late effects in patients treated for prostate cancer.

 

Through collaboration with Georgetown University, patients treated with SBRT for prostate cancers will be analyzed for urinary and rectal symptoms and their blood will be analyzed by mass spectroscopy for predictive biomarkers. The discovery and validation of metabolite panels to serve as a predictive biomarker of patient outcomes following radiation therapy will support future development and commercialization of a diagnostic product through a Phase II SBIR effort.

 

 53 

 

 

Collaborative Arrangements

 

Once we have successfully completed Phase 1 and Phase 2 clinical trials of a potential product candidate, we intend to enter into a collaborative or strategic relationship with another pharmaceutical company or another third party to complete development of (including funding and/or conducting Phase 3 clinical trials), securing marketing approval for and manufacturing, marketing and otherwise commercializing the product candidate. Other than our exclusive option to license doranidazole from Pola Pharma, we have not entered into any collaborative arrangements with third parties and there can be no assurance that we will be able to do so on commercially reasonable terms or otherwise.

 

Intellectual Property

 

We invest significant amounts in research and development. Our research and development expenses were approximately $214,519 and $280,665 during the years ended December 31, 2015 and 2014, respectively, and $121,705 and $232,163 during the nine months ended September 30, 2016 and 2015, respectively.

 

We are seeking multifaceted protection for our intellectual property that includes licenses, confidentiality and non-disclosure agreements, copyrights, patents, trademarks and common law rights, such as trade secrets. We enter into confidentiality and proprietary rights agreements with our employees, consultants, collaborators, subcontractors and other third parties and generally control access to our documentation and proprietary information.

 

As of the date of this prospectus, we have filed four patent applications with the USPTO with respect to various aspects of our HDAC small molecule delivery platform and ropidoxuridine, our lead product candidate. In addition, upon exercising our option to license doranidazole from Pola Pharma, we will also obtain the U.S. rights to patents and patent applications filed by Pola Pharma with respect thereto.

 

Our strategy around protection of our proprietary technology, including any innovations and improvements, is to obtain worldwide patent coverage with a focus on jurisdictions that represent significant global pharmaceutical markets. Generally, patents have a term of twenty years from the earliest priority date, assuming that all maintenance fees are paid, no portion of the patent has been terminally disclaimed and the patent has not been invalidated. In certain jurisdictions, and in certain circumstances, patent terms can be extended or shortened. We are obtaining worldwide patent protection for at least novel molecules, composition of matter, pharmaceutical formulations, methods of use, including treatment of disease, methods of manufacture and other novel uses for the inventive molecules originating from our research and development efforts. We continuously assess whether it is strategically more favorable to maintain confidentiality for the “know-how” regarding a novel invention rather than pursue patent protection. For each patent application that is filed we strategically tailor our claims in accordance with the existing patent landscape around a particular technology.

 

There can be no assurance that an issued patent will remain valid and enforceable in a court of law through the entire patent term. Should the validity of a patent be challenged, the legal process associated with defending the patent can be costly and time consuming. Issued patents can be subject to oppositions, interferences and other third party challenges that can result in the revocation of the patent limit patent claims such that patent coverage lacks sufficient breadth to protect subject matter that is commercially relevant. Competitors may be able to circumvent our patents. Development and commercialization of pharmaceutical products can be subject to substantial delays and it is possible that at the time of commercialization any patent covering the product has expired or will be in force for only a short period of time following commercialization. We cannot predict with any certainty if any third party U.S. or foreign patent rights, other proprietary rights, will be deemed infringed by the use of our technology. Nor can we predict with certainty which, if any, of these rights will or may be asserted against us by third parties. Should we need to defend ourselves and our partners against any such claims, substantial costs may be incurred. Furthermore, parties making such claims may be able to obtain injunctive or other equitable relief, which could effectively block our ability to develop or commercialize some or all of our products in the U.S. and abroad, and could result in the award of substantial damages. In the event of a claim of infringement, we or our partners may be required to obtain one or more licenses from a third party. There can be no assurance that we can obtain a license on a reasonable basis should we deem it necessary to obtain rights to an alternative technology that meets our needs. The failure to obtain a license may have a material adverse effect on our business, results of operations and financial condition.

 

We also rely on trade secret protection for our confidential and proprietary information. No assurance can be given that we can meaningfully protect our trade secrets on a continuing basis. Others may independently develop substantially equivalent confidential and proprietary information or otherwise gain access to our trade secrets.

 

 54 

 

 

It is our policy to require our employees and consultants, outside scientific collaborators, sponsored researchers and other advisors who receive confidential information from us to execute confidentiality agreements upon the commencement of employment or consulting relationships. These agreements provide that all confidential information developed or made known to these individuals during the course of the individual’s relationship with the company is to be kept confidential and is not to be disclosed to third parties except in specific circumstances. The agreements provide that all inventions conceived by an employee shall be the property of the company. There can be no assurance, however, that these agreements will provide meaningful protection or adequate remedies for our trade secrets in the event of unauthorized use or disclosure of such information.

 

Our success will depend in part on our ability to obtain and maintain patent protection, preserve trade secrets, prevent third parties from infringing upon our proprietary rights and operate without infringing upon the proprietary rights of others, both in the U.S. and other territories worldwide.

 

Manufacturing and Supply

 

We do not currently own or operate manufacturing facilities for the production of preclinical, clinical or commercial quantities of any of our product candidates. We currently use a number of our suppliers for the raw materials and formulation to meet the preclinical and any clinical requirements of our product candidates. We do not have a long term agreement with any of these parties and we believe alternative sources of supply exist. Notwithstanding the foregoing, if we exercise our option to license doranidazole, Pola Pharma will meet our supply requirements of this product candidate. However, there is a risk that, if supplies are interrupted, it would materially harm our business. We typically order raw materials and services on a purchase order basis and do not enter into long-term dedicated capacity or minimum supply arrangements.

 

We intend to enter into collaborations for the manufacture of our product candidates, with our collaborators assuming responsibility therefor. Manufacturing is subject to extensive regulations that impose various procedural and documentation requirements, which govern record keeping, manufacturing processes and controls, personnel, quality control and quality assurance, among others. Any collaborator or third party contract manufacturer we use would need to be compliant with cGMP. cGMP is a regulatory standard for the production of pharmaceuticals that will be used in humans.

 

Competition

 

The development and commercialization of drugs is highly competitive. We compete with a variety of multinational pharmaceutical companies and specialized biotechnology companies, as well as technology being developed at universities and other research institutions. Our competitors have developed, are developing or will develop product candidates and processes competitive with our product candidates. Competitive therapeutic treatments include those that have already been approved and accepted by the medical community and any new treatments that enter the market. We believe that a significant number of products are currently under development, and may become commercially available in the future, for the treatment of conditions for which we may try to develop product candidates.

 

Many of our competitors have significantly greater financial, technical, manufacturing, marketing, sales and supply resources or experience than we have. If we successfully obtain approval for any product candidate, we will face competition based on many different factors, including the safety and effectiveness of our products, the ease with which our products can be administered and the extent to which patients accept relatively new routes of administration, the timing and scope of regulatory approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Competing products could present superior treatment alternatives, including by being more effective, safer, and less expensive or marketed and sold more effectively than any products we may develop. Competitive products may make any products we develop obsolete or noncompetitive before we recover the expense of developing and commercializing our product candidates. Such competitors could also recruit our employees, which could negatively impact our level of expertise and our ability to execute our business plan.

 

 55 

 

 

Government Regulation and Product Approval

 

Governmental authorities in the U.S., at the federal, state and local level, and other countries extensively regulate, among other things, the research, development, testing, manufacture, labeling, packaging, promotion, storage, advertising, distribution, marketing and export and import of products such as those we are developing. Our product candidates must be approved by the FDA through the NDA process before they may be legally marketed in the U.S. and will be subject to similar requirements in other countries prior to marketing in those countries. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources.

 

U.S. government regulation

 

NDA approval processes

 

In the U.S., the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act (the “FDCA”) and implementing regulations. Failure to comply with the applicable U.S. requirements at any time during the product development or approval process, or after approval, may subject an applicant to administrative or judicial sanctions, any of which could have a material adverse effect on us. These sanctions could include:

 

  · refusal to approve pending applications;

 

  · withdrawal of an approval;

 

  · imposition of a clinical hold;

 

  · warning letters;

 

  · product seizures;

 

  · total or partial suspension of production or distribution; or

 

  · injunctions, fines, disgorgement, or civil or criminal penalties.

 

The process required by the FDA before a drug may be marketed in the U.S. generally involves the following:

 

  · completion of nonclinical laboratory tests, animal studies and formulation studies conducted according to GLPs or other applicable regulations;

 

  · submission to the FDA of an IND, which must become effective before human clinical trials may begin;

 

  · performance of adequate and well-controlled human clinical trials according to GCPs to establish the safety and efficacy of the product candidate for its intended use;

 

  · submission to the FDA of an NDA;

 

  · satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product candidate is produced to assess compliance with cGMPs to assure that the facilities, methods and controls are adequate to preserve the product candidate’s identity, strength, quality and purity; and

 

  · FDA review and approval of the NDA.

 

Once a pharmaceutical candidate is identified for development, it enters the preclinical or nonclinical testing stage. Nonclinical tests include laboratory evaluations of product chemistry, toxicity and formulation, as well as animal studies. An IND sponsor must submit the results of the nonclinical tests, together with manufacturing information and analytical data, to the FDA as part of the IND. Some nonclinical testing may continue even after the IND is submitted. In addition to including the results of the nonclinical studies, the IND will also include a protocol detailing, among other things, the objectives of the clinical trial, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated if the first phase lends itself to an efficacy determination. The IND automatically becomes effective thirty (30) days after receipt by the FDA, unless the FDA, within the thirty (30) day time period, places the IND on clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before clinical trials can begin. A clinical hold may occur at any time during the life of an IND and may affect one or more specific studies or all studies conducted under the IND.

 

 56 

 

 

All clinical trials must be conducted under the supervision of one or more qualified investigators in accordance with GCPs. They must be conducted under protocols detailing the objectives of the trial, dosing procedures, research subject selection and exclusion criteria and the safety and effectiveness criteria to be evaluated. Each protocol must be submitted to the FDA as part of the IND, and progress reports detailing the status of the clinical trials must be submitted to the FDA annually. Sponsors also must timely report to FDA serious and unexpected adverse reactions, any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigation brochure or any findings from other studies or animal or in vitro testing that suggest a significant risk in humans exposed to the drug. An institutional review board (IRB) at each institution participating in the clinical trial must review and approve the protocol before a clinical trial commences at that institution and must also approve the information regarding the trial and the consent form that must be provided to each research subject or the subject’s legal representative, monitor the study until completed and otherwise comply with IRB regulations.

 

Human clinical trials are typically conducted in three sequential phases that may overlap or be combined.

 

  · Phase 1—The product candidate is initially introduced into healthy human subjects and tested for safety, dosage tolerance, absorption, metabolism, distribution and elimination. In the case of some product candidates for severe or life-threatening diseases, such as cancer, especially when the product candidate may be inherently too toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients.

 

  · Phase 2—Clinical trials are performed on a limited patient population intended to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases and to determine dosage tolerance and optimal dosage.
     
  · Phase 3—Clinical trials are undertaken to further evaluate dosage, clinical efficacy and safety in an expanded patient population at geographically dispersed clinical study sites. These studies are intended to establish the overall risk-benefit ratio of the product and provide an adequate basis for product labeling.

 

Human clinical trials are inherently uncertain and Phase 1, Phase 2 and Phase 3 testing may not be successfully completed. The FDA or the sponsor may suspend a clinical trial at any time for a variety of reasons, including a finding that the research subjects or patients are being exposed to an unacceptable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB’s requirements or if the product candidate has been associated with unexpected serious harm to patients.

 

During the development of a new product candidate, sponsors are given opportunities to meet with the FDA at certain points. These points may be prior to the submission of an IND, at the end of Phase 2 and before an NDA is submitted. Meetings at other times may be requested. These meetings can provide an opportunity for the sponsor to share information about the data gathered to date and for the FDA to provide advice on the next phase of development. Sponsors typically use the meeting at the end of Phase 2 to discuss their Phase 2 clinical results and present their plans for the pivotal Phase 3 clinical trial that they believe will support the approval of the new drug. If a Phase 2 clinical trial is the subject of discussion at the end of Phase 2 meeting with the FDA, a sponsor may be able to request a Special Protocol Assessment (“SPA”), the purpose of which is to reach agreement with the FDA on the Phase 3 clinical trial protocol design and analysis that will form the primary basis of an efficacy claim.

 

According to published guidance on the SPA process, a sponsor which meets the prerequisites may make a specific request for a SPA and provide information regarding the design and size of the proposed clinical trial. The FDA is supposed to evaluate the protocol within forty-five (45) days of the request to assess whether the proposed trial is adequate, which evaluation may result in discussions and a request for additional information. An SPA request must be made before the proposed trial begins, and all open issues must be resolved before the trial begins. If a written agreement is reached, it will be documented and made part of the record. The agreement will be binding on the FDA and may not be changed by the sponsor or the FDA after the trial begins except with the written agreement of the sponsor and the FDA or if the FDA determines that a substantial scientific issue essential to determining the safety or efficacy of the product candidate was identified after the testing began.

 

 57 

 

 

Concurrent with clinical trials, sponsors usually complete additional animal safety studies and also develop additional information about the chemistry and physical characteristics of the product candidate and finalize a process for manufacturing commercial quantities of the product candidate in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and the manufacturer must develop methods for testing the quality, purity and potency of the product candidate. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its proposed shelf-life.

 

The results of product development, nonclinical studies and clinical trials, along with descriptions of the manufacturing process, analytical tests and other control mechanisms, proposed labeling and other relevant information are submitted to the FDA as part of an NDA requesting approval to market the product. The submission of an NDA is subject to the payment of user fees, but a waiver of such fees may be obtained under specified circumstances. The FDA reviews all NDAs submitted to ensure that they are sufficiently complete for substantive review before it accepts them for filing. It may request additional information rather than accept an NDA for filing. In this event, the NDA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing.

 

Once the submission is accepted for filing, the FDA begins an in-depth review. NDAs receive either standard or priority review. A drug representing a significant improvement in treatment, prevention or diagnosis of disease may receive priority review. The FDA may refuse to approve an NDA if the applicable regulatory criteria are not satisfied or may require additional clinical or other data. Even if such data are submitted, the FDA may ultimately decide that the NDA does not satisfy the criteria for approval. The FDA reviews an NDA to determine, among other things, whether a product is safe and effective for its intended use and whether its manufacturing is cGMP-compliant. The FDA may refer the NDA to an advisory committee for review and recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendation of an advisory committee, but it generally follows such recommendations. Before approving an NDA, the FDA will inspect the facility or facilities where the product is manufactured and tested.

 

Expedited review and approval

 

The FDA has various programs, including Fast Track, priority review and accelerated approval, which are intended to expedite or simplify the process for reviewing product candidates, or provide for the approval of a product candidate on the basis of a surrogate endpoint. Even if a product candidate qualifies for one or more of these programs, the FDA may later decide that the product candidate no longer meets the conditions for qualification or that the time period for FDA review or approval will be shortened. Generally, product candidates that are eligible for these programs are those for serious or life-threatening conditions, those with the potential to address unmet medical needs and those that offer meaningful benefits over existing treatments. For example, Fast Track is a process designed to facilitate the development and expedite the review of product candidates to treat serious or life-threatening diseases or conditions and fill unmet medical needs. Priority review is designed to give product candidates that offer major advances in treatment or provide a treatment where no adequate therapy exists an initial review within six months as compared to a standard review time of ten (10) months.

 

Although Fast Track and priority review do not affect the standards for approval, the FDA will attempt to facilitate early and frequent meetings with a sponsor of a Fast Track designated product candidate and expedite review of the application for a product candidate designated for priority review. Accelerated approval, which is described in Subpart H of 21 CFR Part 314, provides for an earlier approval for a new product candidate that is intended to treat a serious or life-threatening disease or condition and that fills an unmet medical need based on a surrogate endpoint. A surrogate endpoint is a laboratory measurement or physical sign used as an indirect or substitute measurement representing a clinically meaningful outcome. As a condition of approval, the FDA may require that a sponsor of a product candidate receiving accelerated approval perform post-marketing clinical trials.

 

In the Food and Drug Administration Safety and Innovation Act (“FDASIA”), the U.S. Congress encouraged the FDA to utilize innovative and flexible approaches to the assessment of product candidates under accelerated approval. The law required the FDA to issue related draft guidance within a year after the law’s enactment and also promulgate confirming regulatory changes. In June 2013, the FDA published a draft Guidance for Industry titled “Expedited Programs for Serious Conditions—Drugs and Biologics,” which provides guidance on FDA programs that are intended to facilitate and expedite development and review of new product candidates as well as threshold criteria generally applicable to concluding that a product candidate is a candidate for these expedited development and review programs.

 

 58 

 

 

In addition to the Fast Track, accelerated approval and priority review programs discussed above, the FDA also provided guidance on a new program for Breakthrough Therapy designation. The FDA defines a Breakthrough Therapy as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. A drug designated as a Breakthrough Therapy is eligible for accelerated approval. The FDA must take certain actions, such as holding timely meetings and providing advice, intended to expedite the development and review of an application for approval of a Breakthrough Therapy. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. A request for Breakthrough Therapy designation should be submitted concurrently with, or as an amendment to an IND. FDA has already granted this designation to approximately thirty (30) new product candidates and has begun approving Breakthrough Therapy designated drugs.

 

Patent term restoration and marketing exclusivity

 

Depending upon the timing, duration and specifics of FDA approval of the use of our product candidates, some of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Act. The Hatch-Waxman Act permits a patent restoration term of up to five years as compensation for patent term lost during product development and the FDA regulatory review process. However, patent term restoration cannot extend the remaining term of a patent beyond a total of fourteen (14) years from the product candidate’s approval date. The patent term restoration period is generally one half of the time between the effective date of an IND and the submission date of an NDA, plus the time between the submission date of an NDA and the approval of that application. Only one patent applicable to an approved product candidate is eligible for the extension and the application for extension must be made prior to expiration of the patent. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we intend to apply for restorations of patent term for some of our currently owned or licensed patents to add patent life beyond their current expiration date, depending on the expected length of clinical trials and other factors involved in the submission of the relevant NDA.

 

Market exclusivity provisions under the FDCA also can delay the submission or the approval of certain applications. The FDCA provides a five-year period of non-patent marketing exclusivity within the U.S. to the first applicant to gain approval of an NDA for a new chemical entity. A product candidate is a new chemical entity if the FDA has not previously approved any other new product candidate containing the same active moiety, which is the molecule or ion responsible for the action of the product candidate substance. During the exclusivity period, the FDA may not accept for review an abbreviated new drug application (“ANDA”) or a 505(b)(2) NDA submitted by another company for another version of such product candidate where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement. The FDCA also provides three years of marketing exclusivity for an NDA, 505(b)(2) NDA or supplement to an approved NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example, for new indications, dosages or strengths of an existing product candidate. This three-year exclusivity covers only the conditions associated with the new clinical investigations and does not prohibit the FDA from approving ANDAs for product candidates containing the original active agent. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.

 

 59 

 

 

Orphan drug designation

 

Under the Orphan Drug Act, the FDA may grant orphan drug designation to product candidates intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the U.S. or more than 200,000 individuals in the U.S. and for which there is no reasonable expectation that the cost of developing and making available in the U.S. a product candidate for this type of disease or condition will be recovered from sales in the U.S. for that product candidate. Orphan drug designation must be requested before submitting an NDA. After the FDA grants orphan drug designation, the identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.

 

If a product candidate that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product candidate is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications to market the same product candidate for the same indication, except in very limited circumstances, for seven (7) years. Orphan drug exclusivity, however, could also block the approval of one of our product candidates for seven years if a competitor obtains approval of the same product candidate as defined by the FDA or if our product candidate is determined to be contained within the competitor’s product candidate for the same indication or disease.

 

Pediatric exclusivity and pediatric use

 

Under the Best Pharmaceuticals for Children Act (“BPCA”), certain product candidates may obtain an additional six months of exclusivity if the sponsor submits information requested in writing by the FDA (a “Written Request”) relating to the use of the active moiety of the product candidate in children. The FDA may not issue a Written Request for studies on unapproved or approved indications or where it determines that information relating to the use of a product candidate in a pediatric population, or part of the pediatric population, may not produce health benefits in that population.

 

In addition, the Pediatric Research Equity Act (“PREA”) requires a sponsor to conduct pediatric studies for most product candidates and biologics, for a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration. Under PREA, original NDAs, biologics license application and supplements thereto must contain a pediatric assessment unless the sponsor has received a deferral or waiver. The required assessment must assess the safety and effectiveness of the product candidate for the claimed indications in all relevant pediatric subpopulations and support dosing and administration for each pediatric subpopulation for which the product candidate is safe and effective. The sponsor or FDA may request a deferral of pediatric studies for some or all of the pediatric subpopulations. A deferral may be granted for several reasons, including a finding that the product candidate or biologic is ready for approval for use in adults before pediatric studies are complete or that additional safety or effectiveness data needs to be collected before the pediatric studies begin. After April 2013, the FDA must send a noncompliance letter to any sponsor that fails to submit the required assessment, keep a deferral current or fails to submit a request for approval of a pediatric formulation.

 

Post-approval requirements

 

Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements is not maintained or if problems occur after the product candidate reaches the market. Later discovery of previously unknown problems with a product candidate may result in restrictions on the product candidate or even complete withdrawal of the product candidate from the market. After approval, some types of changes to the approved product candidate, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further FDA review and approval. In addition, the FDA may require testing and surveillance programs to monitor the effect of approved product candidates that have been commercialized, and the FDA has the power to prevent or limit further marketing of a product candidate based on the results of these post-marketing programs.

 

Any product candidates manufactured or distributed by us pursuant to FDA approvals are subject to continuing regulation by the FDA, including, among other things:

 

  · record-keeping requirements;

 

  · reporting of adverse experiences with the product candidate;

 

  · providing the FDA with updated safety and efficacy information;

 

  · drug sampling and distribution requirements;

 

 60 

 

 

  · notifying the FDA and gaining its approval of specified manufacturing or labeling changes; and

 

  · complying with FDA promotion and advertising requirements.

Drug manufacturers and other entities involved in the manufacture and distribution of approved product candidates are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and some state agencies for compliance with cGMP and other laws.

 

Regulation outside of the U.S.

 

In addition to regulations in the U.S., we will be subject to regulations of other countries governing any clinical trials and commercial sales and distribution of our product candidates. Whether or not we obtain FDA approval for a product, we must obtain approval by the comparable regulatory authorities of countries outside of the U.S. before we can commence clinical trials in such countries and approval of the regulators of such countries or economic areas, such as the European Union, before we may market products in those countries or areas. The approval process and requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary greatly from place to place, and the time may be longer or shorter than that required for FDA approval.

 

Under European Union regulatory systems, a company may submit marketing authorization applications either under a centralized or decentralized procedure. The centralized procedure, which is compulsory for medicines produced by biotechnology or those medicines intended to treat AIDS, cancer, neurodegenerative disorders or diabetes and is optional for those medicines which are highly innovative, provides for the grant of a single marketing authorization that is valid for all European Union member states. The decentralized procedure provides for mutual recognition of national approval decisions. Under this procedure, the holder of a national marketing authorization may submit an application to the remaining member states. Within ninety (90) days of receiving the applications and assessments report, each member state must decide whether to recognize approval. If a member state does not recognize the marketing authorization, the disputed points are eventually referred to the European Commission, whose decision is binding on all member states.

 

As in the U.S., we may apply for designation of a product candidate as an orphan drug for the treatment of a specific indication in the European Union before the application for marketing authorization is made. Orphan drugs in Europe enjoy economic and marketing benefits, including up to ten years of market exclusivity for the approved indication unless another applicant can show that its product is safer, more effective or otherwise clinically superior to the orphan-designated product.

 

Reimbursement

 

Sales of our products will depend, in part, on the extent to which the costs of our products will be covered by third-party payors, such as government health programs, commercial insurance and managed healthcare organizations. These third-party payors are increasingly challenging the prices charged for medical products and services. Additionally, the containment of healthcare costs has become a priority of federal and state governments and the prices of drugs have been a focus in this effort. The U.S. government, state legislatures and foreign governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our net revenue and results. If these third-party payors do not consider our products to be cost-effective compared to other therapies, they may not cover our products after approved as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our products on a profitable basis.

 

The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (“MMA”) imposed new requirements for the distribution and pricing of prescription drugs for Medicare beneficiaries. Under Part D, Medicare beneficiaries may enroll in prescription drug plans offered by private entities which will provide coverage of outpatient prescription drugs. Part D plans include both stand-alone prescription drug benefit plans and prescription drug coverage as a supplement to Medicare Advantage plans. Unlike Medicare Part A and B, Part D coverage is not standardized. Part D prescription drug plan sponsors are not required to pay for all covered Part D drugs, and each drug plan can develop its own drug formulary that identifies which drugs it will cover and at what tier or level. However, Part D prescription drug formularies must include drugs within each therapeutic category and class of covered Part D drugs, though not necessarily all the drugs in each category or class. Any formulary used by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic committee. Government payment for some of the costs of prescription drugs may increase demand for our products for which we receive marketing approval. However, any negotiated prices for our products covered by a Part D prescription drug plan will likely be lower than the prices we might otherwise obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries, private payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment that results from the MMA may result in a similar reduction in payments from non-governmental payors.

 

 61 

 

 

The American Recovery and Reinvestment Act of 2009 provides funding for the federal government to compare the effectiveness of different treatments for the same illness. A plan for the research will be developed by the Department of Health and Human Services, the Agency for Healthcare Research and Quality and the National Institutes for Health, and periodic reports on the status of the research and related expenditures will be made to the U.S. Congress. Although the results of the comparative effectiveness studies are not intended to mandate coverage policies for public or private payors, it is not clear what effect, if any, the research will have on the sales of any product, if any such product or the condition that it is intended to treat is the subject of a study. It is also possible that comparative effectiveness research demonstrating benefits in a competitor’s product could adversely affect the sales of our product candidates. If third-party payors do not consider our products to be cost-effective compared to other available therapies, they may not cover our products as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our products on a profitable basis.

 

The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, collectively referred to as the “ACA,” enacted in March 2010, had a significant impact on the health care industry by expanding coverage for the uninsured. With regard to pharmaceutical products, among other things, ACA is expanded and increased industry rebates for drugs covered under Medicaid programs and made changes to the coverage requirements under the Medicare Part D program. The administration and Congress which will take office in January 2017, has pledged to repeal and replace the ACA, largely because of significantly increasing health insurance premiums and decreasing participation by members of the insurance companies. We cannot predict the impact of any repeal, replacement or modifications which may be enacted.

 

In addition, in some non-U.S. jurisdictions, the proposed pricing for a product candidate must be approved before it may be lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the European Union provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A member state may approve a specific price for the medicinal product or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any of our product candidates. Historically, product candidates launched in the European Union do not follow price structures of the U.S. and generally tend to be significantly lower.

 

Environment

 

Our third party manufacturers are subject to inspections by the FDA for compliance with cGMP and other U.S. regulatory requirements, including U.S. federal, state and local regulations regarding environmental protection and hazardous and controlled substance controls, among others. Environmental laws and regulations are complex, change frequently and have tended to become more stringent over time. We have incurred, and may continue to incur, significant expenditures to ensure we are in compliance with these laws and regulations. We would be subject to significant penalties for failure to comply with these laws and regulations.

 

Sales and Marketing

 

Our current focus is on the development of our existing portfolio, the completion of clinical trials and, if and where appropriate, the registration of our product candidates. We currently do not have marketing, sales and distribution capabilities. If we receive marketing and commercialization approval for any of our product candidates, we intend to market the product either directly or through collaborations, strategic alliances and distribution agreements with third parties. The ultimate implementation of our strategy for realizing the financial value of our product candidates is dependent on the results of clinical trials for our product candidates, the availability of funds and the ability to negotiate acceptable commercial terms with third parties.

 

 62 

 

 

Employees

 

As of the date of this prospectus, we had six employees, including certain of our executive officers, four of whom are engaged in research and development and two in administration. We consider our relationship with our employees to be good.

 

Facilities

 

Our corporate headquarters are located in Rockville, Maryland, where we lease shared access to office space and reception services and our research and development activities are performed in approximately 800 square feet of laboratory space and a 400 square office located in Germantown, Maryland. All of such space is leased from a non-affiliated third party pursuant to leases expiring in July 2017, which provide for an aggregate monthly rental of $3,807.

 

We believe that our existing facilities are adequate for our current needs and have sufficient laboratory space to house additional scientists as we grow. When our lease expires, we may exercise our renewal options or look for additional or alternate space for our operations. We believe that suitable additional or alternative space will be available in the future on commercially reasonable terms.

 

Legal Proceedings

 

Currently there are no legal proceedings pending or threatened against us.  

 

 63 

 

 

MANAGEMENT

 

Directors and Executive Officers

 

Our directors and executive officers and their respective ages and titles are as follows:

 

Name   Age   Position(s) and Office(s) Held
         
Anatoly Dritschilo, M.D.   72   Chairman of the Board and Chief Executive Officer
         
Peter Dritschilo, M.D.   47   President and Chief Financial Officer
         
Milton Brown, M.D., Ph.D.   51   Chief Scientific Officer for Chemistry and Director
         
Mira Jung, Ph.D.   67   Chief Scientific Officer for Biology and Director
         
Theodore L. Phillips, Ph.D.   83   Clinical Director
         
Michael J. Starkweather   33   Vice President, Business Development

 

Set forth below is a brief description of the background and business experience of our directors and executive officers.

 

Anatoly Dritschilo, M.D., is a co-founder of the Company and has served as Chairman of the Board and Chief Executive Officer since formation in December 2012. Dr. Dritschilo is a radiation oncologist, who has held leadership positions at Georgetown University Medical School in Washington, D.C. since 1979, including, Department Chair from 1980 to 2016; Chief of Radiation Oncology at MedStar-Georgetown University Hospital from 2005 to 2016; Medical Director of Georgetown University Hospital from 1994 to 1997; and Interim Director of the NCI-funded Lombardi Comprehensive Cancer Center from 2005 to 2007. His pharmaceutical experience includes the design, performance and reporting of clinical trials using radiation and chemotherapy. He was a founding director of Oncomed (Neopharm). His 200+ scientific publications and 12 issued patents have earned him election as a Fellow of the National Academy of Inventors. Dr. Dritschilo holds a BS degree in Chemical Engineering from the University of Pennsylvania and his medical degree from the College of Medicine of New Jersey.

 

Peter Dritschilo has served as our President and Chief Financial Officer since we were formed in December 2012. He has over 15 years of business management experience in medical services and cancer treatment. He has held administrative positions with Medstar-RadAmerica from 2001 to 2005, Georgetown University 2005 to 2006, Prince William Hospital and the Fauquier Hospital 2006 to 20011 and Inova Health System from 2011 to 2016. Mr. Dritschilo graduated from Georgetown University and received his MBA from the George Washington University. His experience in the technical aspects of Radiation Oncology, as well as business management experience in administering free-standing and hospital based clinical departments provides a unique understanding of the roles of cancer radiation sensitizers and normal tissues protectors.

 

Milton Brown, M.D., Ph.D., a co-founder of the Company, has served as our Chief Scientific Officer for Chemistry and as a member of our board of directors since we were formed in December 2012. Since 2012, Dr. Brown has served as Director of the Drug Discovery Center at Georgetown University Medical School and since 2010, he has been the principal investigator of the NIH/NCI funded Chemical Diversity Center. He brings to Shuttle 15 years of experience in drug discovery with over 80 publications and eight issued patents, including discovery of novel HDAC inhibitors. His government committee service includes membership on the NIH Experimental Therapeutics Study Section, the NIH Drug Discovery and Molecular Pharmacology Study Section and scientific counselor to the U.S. Secretary of Health. Dr. Brown holds a Ph.D. in synthetic chemistry from University of Alabama, and an MD from the University of Virginia.

 

 64 

 

  

Mira Jung, Ph.D., a co-founder of the Company, has served as our Chief Scientific officer for Biology and as a member of our board of directors since we were formed in December 2012. Since 2005, Dr. Jung has served as Professor of Radiation Medicine and Microbiology at Georgetown University Medical School, with over 20 years of experience in molecular radiation biology research. She is an expert in mechanisms of radiation resistance and on the roles of HDAC inhibitors in modifying the radiation response. Dr. Jung’s research has been funded by NIH and the DOD for research leading to 90 publications and six issued patents, including the first reports of HCAC inhibitor drug classes modifying cancer cell radiation resistance and protecting normal tissues from radiation damage. Dr. Jung holds an MA degree and a PhD in Microbiology and Molecular Virology from the University of Kansas.

 

Theodore L. Phillips, M.D., has served as Clinical Director since 2013 and has held positions of Chair of the Department of Radiation Oncology (from1978 to 1998) and Associate Director (from 1996 to 1999), of the UCSF Cancer Center at the University of California at San Francisco. He is highly experienced in radiation oncology clinical trials of hypoxic radiation sensitizers. Dr. Phillips serves as the principal investigator for the for the Phase 1 clinical trial of ropidoxuridine being undertaken pursuant to our SBIR contract. He previously served as Associate Director of the Northern California Oncology Group from 1983-1990, president of the American Society of Therapeutic Radiation Oncologists from 1984 to 1985, and is an elected member of the Institute of Medicine of the National Academy of Science. Dr. Phillips holds a BS degree from Dickinson College in Carlisle, Pennsylvania and a MD from the University of Pennsylvania.

 

Michael J. Starkweather joined the Company as its Vice President, Business Development in 2016. He served as an administrative sergeant in the United States Army from 2004 to 2008 and developed his initial business experience in the fitness industry both while on active duty and subsequent thereto. In 2011, he founded CHMS, LLC, a consulting firm focused on building sustainable growth for emerging companies while acquiring private funding and currently serves as its senior partner.

 

Family Relationships

 

Dr. Anatoly Dritschilo and Peter Dritschilo are father and son. Mira Jung and Gene Jung are mother and son. There are no other family relationships among our directors and executive officers.

 

Terms of Office

 

Our directors are appointed for a one-year term to hold office until the next annual meeting of our shareholders and until a successor is appointed and qualified, or until their removal, resignation, or death.  Executive officers serve at the pleasure of the board of directors.

 

Director Independence

 

At present, none of our directors are “independent” as defined under NYSE MKT listing standards and Rule 10A-3(b)(1) under the Exchange Act. In order to list our shares of common stock for trading on NYSE MKT, we will need to expand our board of directors so that at least 50% (assuming we meet the definition of “smaller reporting company”), if not a majority of our directors are “independent.” Accordingly, prior to effectiveness of the registration statement of which this prospectus forms a part, we intend to expand our board of directors to include such number of additional members who meet the independence criteria.to allow us to meet the NYSE MKT listing standards

 

Board Committees

 

General

 

Prior to effectiveness of the registration statement of which this prospectus forms a part, our board of directors will establish three committees, an audit committee, a compensation committee and a nominating and corporate governance committee. The members of each committee will be “independent” as defined under NYSE MKT listing standards and Rule 10A-3(b)(1). Moreover, at least one member of the audit committee will qualify as an “audit committee financial expert” as the term is defined under NYSE MKT listing standards and applicable rules and regulations of the SEC, based on their respective business professional experience in the financial and accounting fields.

 

 65 

 

 

Audit Committee

 

The audit committee will assist our board of directors in its oversight of the Company’s accounting and financial reporting processes and the audits of the company’s financial statements, including (a) the quality and integrity of the Company’s financial statements (b) the company’s compliance with legal and regulatory requirements, (c) the independent auditors’ qualifications and independence and (d) the performance of the Company’s internal audit functions and independent auditors, as well as other matters which may come before it as directed by the board of directors. Further, the audit committee, to the extent it deems necessary or appropriate, among its several other responsibilities, shall:

 

·be responsible for the appointment, compensation, retention, termination and oversight of the work of any independent auditor engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services for the Company;

 

·discuss the annual audited financial statements and the quarterly unaudited financial statements with management and the independent auditor prior to their filing with the SEC in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q;

 

·review with the Company’s management on a periodic basis (i) issues regarding accounting principles and financial statement presentations, including any significant changes in our company’s selection or application of accounting principles; and (ii) the effect of any regulatory and accounting initiatives, as well as off-balance sheet structures, on the financial statements of the company;

 

·monitor the Company’s policies for compliance with federal, state, local and foreign laws and regulations and the Company’s policies on corporate conduct;

 

·maintain open, continuing and direct communication between the board of directors, the audit committee and our independent auditors; and

 

·monitor our compliance with legal and regulatory requirements and shall have the authority to initiate any special investigations of conflicts of interest, and compliance with federal, state and local laws and regulations, including the Foreign Corrupt Practices Act, as may be warranted.

 

Compensation Committee

 

The compensation committee will aid our board of directors in meeting its responsibilities relating to the compensation of the Company’s executive officers and to administer all incentive compensation plans and equity-based plans of the Company, including the plans under which Company securities may be acquired by directors, executive officers, employees and consultants. Further, the compensation committee, to the extent it deems necessary or appropriate, among its several other responsibilities, shall:

 

·review periodically our Company’s philosophy regarding executive compensation to (i) ensure the attraction and retention of corporate officers; (ii) ensure the motivation of corporate officers to achieve the Company’s business objectives; and (iii) align the interests of key management with the long-term interests of the Company’s shareholders;

 

·review and approve corporate goals and objectives relating to chief executive officer compensation and other executive officers of Shuttle;

 

·make recommendations to the board of directors regarding compensation for non-employee directors, and review periodically non-employee director compensation in relation to other comparable companies and in light of such factors as the compensation committee may deem appropriate; and

 

·review periodically reports from management regarding funding the Company’s pension, retirement, long-term disability and other management welfare and benefit plans.

 

 66 

 

  

Nominating and Corporate Governance Committee

 

The nominating and corporate governance committee will recommend to the board of directors individuals qualified to serve as directors and on committees of the board of directors to advise the board of directors with respect to the board of directors composition, procedures and committees to develop and recommend to the board of directors a set of corporate governance principles applicable to the Company; and to oversee the evaluation of the board of directors and Shuttle’s management.

 

Further, the nominating and corporate governance committee, to the extent it deems necessary or appropriate, among its several other responsibilities shall:

 

·recommend to the board of directors and for approval by a majority of independent directors for election by shareholders or appointment by the board of directors as the case may be, pursuant to our bylaws and consistent with the board of director’s evidence for selecting new directors;

 

·review the suitability for continued service as a director of each member of the board of directors when his or her term expires or when he or she has a significant change in status;

 

·review annually the composition of the board of directors and to review periodically the size of the board of directors;

 

·make recommendations on the frequency and structure of board of directors meetings or any other aspect of procedures of the board of directors;

 

·make recommendations regarding the chairmanship and composition of standing committees and monitor their functions;

 

·review annually committee assignments and chairmanships;

 

·recommend the establishment of special committees as may be necessary or desirable from time to time; and

 

·develop and review periodically corporate governance procedures and consider any other corporate governance issue.

 

Code of Ethics

 

We have adopted a code of ethics that applies to all of our executive officers, directors and employees. The code of ethics codifies the business and ethical principles that govern all aspects of our business. This document will be made available in print, free of charge, to any shareholder requesting a copy in writing from our Secretary at our executive offices in Rockville, Maryland. A copy of our code of ethics is available on our website at www.shuttlepharma.com.

 

Board of Directors Role in Risk Oversight

 

Members of the board of directors have periodic meetings with management and the Company’s independent auditors to perform risk oversight with respect to the Company’s internal control processes. The Company believes that the board’s role in risk oversight does not materially affect the leadership structure of the Company.

 

 67 

 

  

EXECUTIVE COMPENSATION

 

Summary Compensation Table

 

The table below summarizes all compensation awarded to, earned by, or paid to our Chief Executive Officer, Chief Financial Officer and our other executive officers for 2015 and 2014.

 

SUMMARY COMPENSATION TABLE

 

Name and
principal
position
  Year  Salary
($)
   Bonus
($)
   Stock
Awards
(#)
   Option
Awards 
(#)
   Non-Equity
Incentive Plan
Compensation
($)
   Nonqualified
Deferred
Compensation
Earnings
($)
   All Other
Compensation
($)
   Total
($)
 
                                    
Anatoly                                           
Dritschilo M.D.,                                           
CEO  2015   18,960    0    0    0    0    0    0    18,960 
   2014   2,084    0    0    0    0    0    0    2,084 
                                            
Peter Dritschilo,                                           
President/CFO  2015   6,015    0    0    0    0    0    0    6,015 
   2014   0    0    0    0    0    0    0    0 
                                            
Milton Brown,                                           
M.D., Ph.D.,                                           
Chief Scientific                                           
Officer-                                           
Chemistry  2015   0    0    0    0    0    0    0    0 
   2014   0    0    0    0    0    0    0    0 
                                            
Mira Jung, Ph.D.,                                           
Chief Scientific                                           
Officer-Biology  2015   0    0    0    0    0    0    0    0 
   2014   0    0    0    0    0    0    0    0 
                                            
Theodore L.                                           
Phillips, Ph.D.,                                           
Clinical Director  2015   79,818    0    0    0    0    0    0    79,818 
   2014   22,997    0    0    0    0    0    0    22,997 

 

Employment Agreements

 

The Company has “at will” employment agreements with two executive officers, Dr. Theodore L. Phillips and Michael Starkweather. Under the employment agreements, Dr. Phillips and Mr. Starkweather devote 51% and 20% of their respective working time to the affairs of the Company, in exchange for which they are compensated at the rates of $92,500 and $20,000 respectively, reflecting the proration of their respective working time. The employment agreements contain confidentiality, intellectual property assignment and non-competition provisions.

 

Outstanding Equity Awards at Fiscal Year-End

 

There are no current outstanding equity awards to our executive officers.  

 

 68 

 

  

Director Compensation

 

It is anticipated that our non-employee directors will be compensated with options to purchase common stock or awards of common stock as determined by the compensation committee. In addition, non-employee directors will also reimbursed for out-of-pocket costs incurred in connection with attending meetings.

 

 69 

 

  

2016 Incentive Stock Plan

 

Our 2016 Incentive Stock Plan provides for equity incentives to be granted to our employees, executive officers or directors or to key advisers or consultants.  Equity incentives may be in the form of stock options with an exercise price not less than the fair market value of the underlying shares as determined pursuant to the 2016 Incentive Stock Plan, restricted stock awards, other stock based awards, or any combination of the foregoing.  The 2016 Incentive Stock Plan is administered by the compensation committee, or alternatively, if there is no compensation committee, the board of directors.  7,500,000 shares of our common stock are reserved for issuance pursuant to the exercise of awards under the 2016 Incentive Stock Plan.  The number of shares so reserved automatically adjusts upward on January 1 of each year, so that the number of shares covered by the 2016 Incentive Stock Plan is equal to 15% of our issued and outstanding common stock. No awards are outstanding as of the date of this prospectus.

 

 

 70 

 

  

PRINCIPAL SHAREHOLDERS

 

The following table sets forth, as of the date of this prospectus, the beneficial ownership of our common stock by each director and executive officer, by each person known by us to beneficially own 5% or more of the our common stock and by directors and executive officers as a group.  Unless otherwise stated, the address of the persons set forth in the table is c/o the Company, 1 Research Court, Suite 450, Rockville, Maryland 20850.

 

Names and addresses  Number of shares of   Percentage of class 
of  common stock   beneficially owned (%) 
beneficial owners  beneficially owned (#)   Before Offering   After Offering(1) 
             
Directors and executive officers:               
                
Anatoly Dritschilo, M.D.   29,250,000(2)   65.0    59.1 
                
Peter Dritschilo   0    0.0    0.0 
                
Milton Brown, M.D., Ph.D.   6,750,000    15.0    13.6 
                
Mira Jung, Ph.D.   6,750,000(3)   15.0    13.6 
                
Theodore L. Phillips, Ph.D.   0    0.0    0.0 
                
Michael J. Starkweather   0    0.0    0.0 
               
All directors and officers as a group (six persons)   42,750,000(2)   100.0    86.4 
                
Other 5% percent beneficial owners:               
                
Joy Dritschilo   29,250,000(2)   65.0    59.1 
                
Gene Jung   2,250,000    5.0    4.5 

 

The persons named above have full voting and investment power with respect to the shares indicated.  Under the rules of the SEC, a person (or group of persons) is deemed to be a “beneficial owner” of a security if he or she, directly or indirectly, has or shares the power to vote or to direct the voting of such security, or the power to dispose of or to direct the disposition of such security.  Accordingly, more than one person may be deemed to be a beneficial owner of the same security.  

 

 

(1)Gives pro forma effect to the sale of all 4,500,000 shares offered hereby and the conversion of $125,250 in principal amount of our outstanding Convertible Notes into 22, 270 shares of our common stock.
(2)Includes 6,750,000 shares of our common stock held of record by Dr. Anatoly Dritschilo and 22,500,000 shares of common stock held of record by Joy Dritschilo, his spouse.
(3)Includes 6,750,000 shares of our common stock held of record by Dr. Mira Jung.

 

 71 

 

  

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

 

Related Party Transactions

 

On August 15, 2016, the Company received a loan from Joy Dritschilo, our principal shareholder in the amount of $50,000. The loan matures on August 14, 2017, bears interest at 5% per annum and requires monthly payments of $4,280.37. As of September 30, 2016, the principal amount of the loan was reduced to $45,928.

 

On November 22, 2013, the Company made a loan to Dr. Milton Brown, Chief Scientific Officer for Chemistry, in the amount of $75,000. The loan is repayable in monthly installments of $2,248 including interest at 5% per annum through December 1, 2016 when the loan will be fully repaid. As of September 30, 2016, the outstanding principal amount of the loan was $4,912. The loan was made to Dr. Milton Brown in connection with his recruitment to serve as Chief Scientific Officer.

 

Review, Approval and Ratification of Related Party Transactions

 

All related party transactions are subject to the review, approval or ratification of our board of directors or an appropriate committee thereof.

 

 72 

 

 

DESCRIPTION OF CAPITAL STOCK

 

Capital Stock

 

Our authorized capital stock consists of 100,000,000 shares of common stock, par value $0.01 and 5,000,000 shares of preferred stock, par value $0.01.

 

Common Stock

 

As of the date of this prospectus, 45,000,000 shares of common stock are issued as outstanding.  The shares of common stock presently outstanding are, and the shares of common stock in this Offering, when issued and paid for as contemplated herein, will be, fully paid and non-assessable.  Each holder of common stock is entitled to one vote for each share owned on all matters voted upon by shareholders, and a majority vote is required for all actions to be taken by shareholders.  In the event we liquidate, dissolve or wind-up our operations, the holders of the common stock are entitled to share equally and ratably in our assets, if any, remaining after the payment of all our debts and liabilities and the liquidation preference of any shares of preferred stock that may then be outstanding.  The common stock has no preemptive rights, no cumulative voting rights, and no redemption, sinking fund, or conversion provisions.

 

Holders of common stock are entitled to receive dividends, if and when declared by the board of directors, out of funds legally available for such purpose, subject to the dividend and liquidation rights of any preferred stock that may then be outstanding. 

 

 73 

 

  

Preferred Stock

 

Our board of directors has the authority, without further action by the shareholders, to issue shares of preferred stock in one or more series and to fix the rights, preferences and the number of shares constituting any series or the designation of such series.  While our Articles of Incorporation and bylaws do not contain any provisions that may delay, defer or prevent a change in control, the issuance of preferred stock may have the effect of delaying or preventing a change in control or make removal of our management more difficult. No shares of preferred stock are outstanding as of the date of this prospectus.

 

Anti-takeover Effect of Certain Provisions of Maryland Law

 

General

 

The business combination provisions and the control share acquisition provisions of the MGCL could delay, defer or prevent a transaction or a change in the control of us that might involve a premium price for holders of our common stock or otherwise be in their best interest.

 

Business Combinations

 

Under the MGCL, “business combinations” between a Maryland corporation and an interested shareholder or an affiliate of an interested shareholder are prohibited for five years after the most recent date on which the interested shareholder becomes an interested shareholder. These business combinations include a merger, consolidation, share exchange, or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities. An interested shareholder is defined as:

 

·any person who beneficially owns 10% or more of the voting power of the outstanding voting stock of the corporation’s shares; or

 

·an affiliate or associate of the corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of 10% or more of the voting power of the then outstanding voting stock of the corporation.

 

A person is not an interested shareholder under the statute if the board of directors approved in advance the transaction by which he otherwise would have become an interested shareholder. However, in approving a transaction, the board of directors may provide that its approval is subject to compliance, at or after the time of approval, with any terms and conditions determined by the board.

 

After the five-year prohibition, any business combination between the Maryland corporation and an interested shareholder generally must be recommended by the board of directors of the corporation and approved by the affirmative vote of at least:

 

·80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation, voting together as a single voting group; and

 

·two-thirds of the votes entitled to be cast by holders of voting stock of the corporation other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected or held by an affiliate or associate of the interested shareholder.

 

These super-majority vote requirements do not apply if, among other conditions, the corporation’s common stockholders receive a minimum price, as defined in the MGCL, for their shares in the form of cash or other consideration in the same form as previously paid by the interested shareholder for its shares.

 

The statute permits various exemptions from its provisions, including business combinations that are exempted by the board of directors before the time that the interested shareholder becomes an interested shareholder.

 

 74 

 

  

Control Share Acquisitions

 

The MGCL provides that control shares of a Maryland corporation acquired in a control share acquisition have no voting rights except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter. Shares owned by the acquiror, by officers or by directors who are employees of the corporation are excluded from shares entitled to vote on the matter. Control shares are voting shares of stock which, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within one of the following ranges of voting power:

 

·one-tenth or more but less than one-third;

 

·one-third or more but less than a majority; or

 

·a majority or more of all voting power.

 

Control shares do not include shares the acquiring person is then entitled to vote as a result of having previously obtained shareholder approval. A control share acquisition means the acquisition of control shares, subject to certain exceptions.

 

A person who has made or proposes to make a control share acquisition may compel the board of directors of the corporation to call a special meeting of shareholders to be held within 50 days of demand to consider the voting rights of the shares. The right to compel the calling of a special meeting is subject to the satisfaction of certain conditions, including an undertaking to pay the expenses of the meeting. If no request for a meeting is made, the corporation may itself present the question at any shareholders meeting.

 

If voting rights are not approved at the meeting or if the acquiring person does not deliver an acquiring person statement as required by the statute, then the corporation may redeem for fair value any or all of the control shares, except those for which voting rights have previously been approved. The right of the corporation to redeem control shares is subject to certain conditions and limitations. Fair value is determined, without regard to the absence of voting rights for the control shares, as of the date of the last control share acquisition by the acquiror or of any meeting of shareholders at which the voting rights of the shares are considered and not approved. If voting rights for control shares are approved at a shareholders meeting and the acquiror becomes entitled to vote a majority of the shares entitled to vote, all other shareholders may exercise appraisal rights. The fair value of the shares as determined for purposes of appraisal rights may not be less than the highest price per share paid by the acquiror in the control share acquisition.

 

The control share acquisition statute does not apply (a) to shares acquired in a merger, consolidation or share exchange if the corporation is a party to the transaction; or (b) to acquisitions approved or exempted by the charter or bylaws of the corporation.

 

NYSE MKT Listing

 

We intend to apply to have the shares of common stock listed on NYSE MKT, subject to our sale of a sufficient number of shares in the Offering to meet the listing requirements of NYSE MKT. There can be no assurance that an application for listing the shares on NYSE MKT or on any other market will be approved.

 

Transfer Agent

 

Following effectiveness of this registration statement of which this prospectus forms a part, we intend to appoint VStock Transfer, LLC, Woodmere, New York, as transfer agent for our common stock.

 

 75 

 

  

SHARES ELIGIBLE FOR FUTURE SALE

 

Prior to this offering, there has been no public market for our common stock, and we cannot assure you that a liquid trading market for our common stock will develop or be sustained after this offering.

 

Commencing ninety (90) days after the date of this prospectus, the 45,000,000 shares of our common stock outstanding as of the date of this prospectus, will be eligible for sale in the public market from time to time thereafter pursuant to Rule 144 under the Securities Act, and in some cases, subject to the volume and other restrictions of Rule 144. In addition, the 22,270 shares of common stock issuable upon conversion of our $120,250 in principal amount of our outstanding Convertible Notes will similarly be eligible for public sale commencing in February 2017. Further, we have 7,500,000 shares reserved for issuance under our 2016 Incentive Stock Plan. The sale of a significant number of shares of our common stock in the public market or the perception that such sales may occur could significantly reduce the market price of our common stock.

 

Rule 144

 

In general, under Rule 144 under the Securities Act, beginning ninety (90) days after the effective date of the registration statement of which this prospectus is a part, a person (or persons whose shares are aggregated) who is not deemed to have been an affiliate of ours at any time during the three months preceding a sale, and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six (6) months (including any period of consecutive ownership of preceding non-affiliated holders) would be entitled to sell those shares, subject only to the availability of current public information about us. A non-affiliated person who has beneficially owned restricted securities within the meaning of Rule 144 for at least one year would be entitled to sell those shares without regard to the provisions of Rule 144.

 

A person (or persons whose shares are aggregated) who is deemed to be an affiliate of ours and who has beneficially owned restricted securities within the meaning of Rule 144 for at least six (6) months would be entitled to sell within any three-month period a number of shares that does not exceed the greater of one percent of the then outstanding shares of our common stock or the average weekly trading volume of our common stock reported through NYSE MKT or such other market on which our shares of common stock are listed for trading during the four calendar weeks preceding such sale. Such sales are also subject to certain manner of sale provisions, notice requirements and the availability of current public information about us.

 

2016 Incentive Stock Plan

 

We intend to file with the SEC a registration statement under the Securities Act covering the shares of common stock that we may issue upon exercise of awards which may be granted under out 2016 Incentive Stock Plan. Such registration statement is expected to be filed and become effective as soon as practicable after the effectiveness of this registration statement. Accordingly, shares registered under such registration statement will be available for sale in the open market following its effective date, subject to Rule 144 volume and manner of sale limitations, if applicable.

 

PLAN OF DISTRIBUTION

 

Terms of the Offering

 

The Offering is a direct public offering being conducted on a “best efforts, self-underwritten” basis, which means (a) no minimum number of shares need be subscribed for in order for the Company to consummate the sale of any of the shares and utilize the proceeds therefrom; and (b) the Company will not use the services of an underwriter and our executive officers and directors will attempt to sell the shares directly to investors. Notwithstanding the foregoing, the Company does not intend to consummate the sale of any shares until it has received subscriptions and payment for at least 1,125,000 shares ($9,000,000) and will maintain subscription proceeds in a segregated account until such time. Thereafter, however, subscription proceeds will be paid directly to the Company and will not be held in a segregated or escrow account. Our executive officers and directors will not receive commissions or any other remuneration from any such sales.

 

 76 

 

  

In offering the shares on our behalf, our executive officers and directors will rely on the “safe harbor” provisions of SEC Rule 3a4-1, promulgated under the Exchange. Generally speaking, Rule 3a4-1 provides an exemption from the broker-dealer registration requirements of the Exchange Act for persons associated with an issuer that participate in the sale of the securities of such issuer.

 

Our executive officers and directors meet the conditions of the Rule 3a4-1 exemption, as: (a) they are not subject to any statutory disqualification, as that term is defined in Section 3(a)(39) of the Exchange Act; (b) they will not be compensated in connection with their participation in the direct public offering or resale offering by the payment of commissions or other remuneration based either directly or indirectly on transactions in our securities; and (c) they will not be associated persons of a broker or dealer at the time of their participation in the direct public offering and resale offering. Further, our officers and directors: (a) at the end of the offerings, will continue to primarily perform substantial duties for the Company or on its behalf otherwise than in connection with transactions in securities; (b) are not, nor have been within the preceding twelve (12) months, a broker or dealer, and they are not, nor have they been within the preceding twelve (12) months, an associated person of a broker or dealer; and (c) they have not participated in another offering of securities pursuant to the Exchange Act Rule 3a4-1 in the past twelve (12) months and they have not and will not participate in selling an offering of securities for any issuer more than once every twelve (12) months other than in reliance on the Exchange Act Rule 3a4-1(a)(4)(i) or (iii).

 

In order to comply with the applicable securities laws of certain states, the securities will be offered or sold in those states only if they have been registered or qualified for sale, an exemption from such registration is available, or if qualification requirement is available and with which the Company has complied. In addition, and without limiting the foregoing, the Company will be subject to applicable provisions, rules and regulations under the Exchange Act with regard to security transactions during the period of time when this Registration Statement is effective.

 

Offering Period and Expiration Date

 

The shares will be offered for sale for a period of one hundred and eighty (180) days from the date of this prospectus, unless extended by our board of directors for period or periods of up to an aggregate of an additional one hundred and eighty (180) days.

 

Procedures for Subscribing

 

If you decide to subscribe for any shares in this Offering, you must:

 

·execute and deliver a Share Purchase Agreement; and

 

·deliver the subscription price to the Company by cashier’s check or wire transfer of immediately available funds.

 

The Share Purchase Agreement requires you to disclose your name, address, social security number, telephone number, email address, number of shares you are purchasing, and the price you are paying for your shares.

 

Acceptance of Subscriptions

 

Upon the Company’s acceptance of a subscription and receipt of full payment, and subject to the timing qualification set forth above, the Company shall countersign the Share Purchase Agreement and issue a stock certificate along with a copy of the Share Purchase Agreement.

 

Right to Reject Subscriptions

 

We have the right to accept or reject subscriptions in whole or in part, for any reason or for no reason. All monies from rejected subscriptions will be returned immediately by us to the subscriber, without interest or deductions. Subscriptions for securities will be accepted or rejected within three (3) business days after we receive them.

 

 77 

 

  

LEGAL MATTERS

 

The validity of the common stock being offered hereby has been passed upon by Gutierrez Bergman Boulris, P.L.L.C., Coral Gables, Florida.

 

EXPERTS

 

The audited financial statements included in this prospectus and elsewhere in the registration have so been included in reliance upon the report of Paritz and Company, P.A., independent registered public accountants, upon the authority of said firm as experts in accounting and auditing in giving said report. 

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed a registration statement on Form S-1 under the Securities Act with the SEC with respect to the shares of our common stock offered through this prospectus.  This prospectus is filed as a part of that registration statement, but does not contain all of the information contained in the registration statement and exhibits.  Statements made in the registration statement are summaries of the material terms of the referenced contracts, agreements or documents of the company.  We refer you to our registration statement and each exhibit attached to it for a more detailed description of matters involving the company.  You may inspect the registration statement, exhibits and schedules filed with the SEC at the SEC’s principal office in Washington, D.C.  Copies of all or any part of the registration statement may be obtained from the Public Reference Section of the SEC, 100 F Street, N.E. Washington, D.C. 20549.  Please Call the Commission at 1-800-SEC-0330 for further information on the operation of the public reference rooms.  The SEC also maintains a web site at http://www.sec.gov that contains reports, proxy Statements and information regarding registrants that files electronically with the SEC.  Our registration statement and the referenced exhibits can also be found on this site.

  

DISCLOSURE OF SEC POSITION ON INDEMNIFICATION

FOR SECURITIES ACT LIABILITIES

 

In accordance with the provisions in our Amended and Restated Articles of Incorporation, we will indemnify an officer, director, or former officer or director, to the full extent permitted by law.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. 

 

 78 

 

  

SHUTTLE PHARMACEUTICALS, INC.

INDEX TO FINANCIAL STATEMENTS

 

  Page
   
Report of Independent Registered Public Accounting Firm F-2
   
Balance Sheets as of December 31, 2015 and 2014 F-3
   
Statements of Operations for the years ended December 31, 2015 and 2014 F-4
   
Statements of Changes in Members’ Equity for the years ended December 31, 2015 and 2014 F-5
   
Statements of Cash Flows for the years ended December 31, 2015 and 2014 F-6
   
Notes to Financial Statements F-7
   
Balance Sheets as of September 30, 2016 and December 31, 2015 (unaudited) F-12
   
Statements of Operations for the nine months ended September 30, 2016 and 2015 (unaudited) F-13
   
Statements of Cash Flows for the nine months ended September 30, 2016 and 2015 (unaudited) F-14
   
Notes to Financial Statements (unaudited) F-15

 

F-1 

 

  

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Members of

Shuttle Pharmaceuticals, LLC.

 

We have audited the accompanying balance sheets of Shuttle Pharmaceuticals, LLC as of December 31,2015 and 2014 and the related statements of operations, changes in members’ equity and cash flows for the years ended December 31, 2015 and 2014. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

 

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Shuttle Pharmaceuticals, LLC as of December 31,2015 and 2014, and the results of its operations and cash flows for the years ended December 31, 2015 and 2014 in conformity with accounting principles generally accepted in the United States of America.

 

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As discussed in Note 2 the Company has losses from operations and has an accumulated deficit of $730,268 at December 31, 2015. The Company currently has limited liquidity, and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. Management plans are also discussed in Note 2.The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

/s/ Paritz & Company, P.A.

 

Hackensack, New Jersey

November 14, 2016

 

F-2 

 

 

Shuttle Pharmaceuticals, LLC.

Balance Sheets

 

   December 31, 
   2015   2014 
Assets          
           
Current Assets          
Cash and Cash Equivalents  $128,837   $106,957 
Contract Receivable   46,648    22,706 
Note Receivable-Related Party   24,728    50,160 
           
Total Current Assets   200,213    179,823 
           
Property and Equipment, net   54,096    72,572 
           
Total Assets  $254,309   $252,395 
           
Liabilities and Members’ Equity          
           
Current Liabilities          
Accrued Expenses   4,577    12,672 
           
Current Liabilities and Total   4,577    12,672 
           
Members’ Equity          
Members’ Contributions   980,000    680,000 
Accumulated Deficit   (730,268)   (440,277)
Total Members’ Equity   249,732    239,723 
           
Total Liabilities and Members’ Equity  $254,309   $252,395 

 

The Accompanying Notes are an Integral Part of the Financial Statements

 

F-3 

 

 

Shuttle Pharmaceuticals, LLC.

Statements of Operations

 

   For the Years ended
December 31,
 
   2015   2014 
Revenue  $-   $- 
Operating expenses          
Research and Development-Net of Contracts   214,519    280,665 
           
General and administrative   77,140    51,258 
Total operating expenses   291,659    331,923 
           
Loss from Operations   (291,659)   (331,923)
           
Other Income          
Interest Income-related party   1,668    3,389 
           
Net loss   (289,991)   (328,534)

 

The Accompanying Notes are an Integral Part of the Financial Statements 

 

F-4 

 

 

Shuttle Pharmaceuticals, LLC.

Statement of Changes in Member Equity

 

   Member Contributions   Accumulated Deficit   Total 
Balance-January 1, 2014  $280,000   $(111,743)  $168,257 
Member Contributions  $400,000         400,000 
Net Loss        (328,534)   (328,534)
Balance December 31, 2014  $680,000   $(440,277)  $239,723 
Member Contributions   300,000         300,000 
Net Loss        (289,991)   (289,991)
Balance-December 31, 2015  $980,000   $(730,268)  $249,732 

 

The Accompanying Notes are an Integral Part of the Financial Statements 

 

F-5 

 

 

Shuttle Pharmaceuticals, LLC.

Statements of Cash Flows

 

   For the Years Ended
December 31,
 
   2015   2014 
Cash flows from operating activities:          
Net Loss  $(289,991)  $(328,534)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   18,476    18,476 
Change in Operating Assets and Liabilities          
Contract Receivable   (23,942)   (22,706)
Accrued Expenses   (8,095)   7,026 
           
Net cash used in operating activities   (303,552)   (325,738)
           
Cash flow from investing activities:          
Repayment of note receivable-related party   25,432    24,839 
Net cash provided by investing activities   25,432    24,839 
           
Cash flow from financing activities          
Member Contributions   300,000    400,000 
Net cash provided by financing activities   300,000    400,000 
           
Net increase in cash and cash equivalents   21,880    99,101 
Cash and cash equivalents at beginning of year   106,957    7,856 
           
Cash and cash equivalents at end of year  $128,837   $106,957 
           
Supplemental Disclosure of Cash Flow Information:          
Cash paid during year for interest  $0   $0 
Cash paid during year for taxes  $0   $0 

 

The Accompanying Notes are an Integral Part of the Financial Statements

 

F-6 

 

 

Shuttle Pharmaceuticals, LLC.

Notes to Financial Statements

 

Note 1

Nature of Organization

 

Operations

 

Shuttle Pharmaceuticals, LLC, was formed in the State of Maryland on December 18, 2012. The Company’s primary purpose is the development and commercialization of unique drugs for the sensitization of cancers and protection of normal tissues, to improve the outcomes of cancer patients receiving radiation therapy. The company has a product (ropidoxuridine) for use with radiation therapy which is the subject of a Small Business Innovation Research (SBIR) contract with the National Cancer Institute (NCI), a unit of the National Institutes of Health. The company also has obtained an option to rights to a product (doranidazole) for use with radiosurgery, developed by Pola Pharma, a Japanese Pharmaceutical company.

 

The Company is in the development stage, requiring substantial capital for research, product development and market development activities. The Company has not marketed a commercial product and the Company’s proposed products will require successful clinical testing, regulatory approval and additional investment prior to commercialization. The future success of the Company is dependent on its ability to raise working capital to develop and eventually to manufacture and market its products. There is no assurance that the Company will be able to secure the necessary financing or regulatory approvals to attain successful future operations. Therefore, the predictability of the Company’s future is uncertain.

 

Note 2

Going Concern

 

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. The Company has losses from operations and has an accumulated deficit of $730,268 as of December 31, 2015. The Company currently has limited liquidity, and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

 

Management will seek potential business opportunities for merger or acquisition of an existing company. Management, while not especially experienced in matters relating to public company management, will rely upon their own efforts and that of its Board of Directors in accomplishing the business purposes of the Company. Management began in the fourth quarter of 2015 to form new capital in the form of an SEC Regulation D, Rule 506 Private Placement in the amount of 105,000,000 offering shares.

 

F-7 

 

 

Note 3

Summary of Significant Accounting Policies

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities of the financial statements, and the reported amounts of revenues and expenses during the reporting period.

 

Development Stage Company

 

The company is considered to be in the development stage as defined in ASC 915 “Development Stage Entities.” The company is devoting substantially all of its efforts to the development of its business plans. The company has elected to adopt Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements; and does not present or disclose inception-to-date information and other remaining disclosure requirements of Topic 915.

 

Cash and cash equivalents

 

The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents.

 

Property and Equipment

 

Property and equipment are stated at cost. Equipment is depreciated using the straight-line method over the estimated useful lives of the assets. Repair and maintenance costs are expensed as incurred.

 

Research and Development Expenses

 

Research and development expenses are charges to expense as incurred. Research and development expenses include, but are not limited to, product development, clinical and regulatory expenses, payroll and other personnel expenses, materials, supplies, and consulting costs.

 

These expenses are assigned to the clinical project to develop ropidoxuridine in combination with radiation therapy. The SBIR contract covers much of the Phase I clinical trial in advanced GI malignancies.

 

The research expenses are assigned to the clinical project to develop ropidoxuridine in combination with radiation therapy as a treatment for cancer. Costs that are not covered by the SBIR contract for performing the Phase I contract to determine commercialization feasibility included partial salary support of personnel and consultant to develop a commercialization plan. Costs that are not covered in the Phase II contract effort include business development and partial salary support. 

 

Research expenses related to new drug discovery include partial support of personnel, space, supplies and legal costs. These are preclinical studies and have led to discovery of the candidate lead ATM/HDACi bifunctional agent, an HDAC6 inhibitor and novel formulations of IUdR and IPdR.

 

F-8 

 

 

The Company has received a contract from the Department of Health and Human Services to assist with the clinical development of IPdR for radiosensitization. The Company recognizes the amounts received in regards to the contract at fair value when there is reasonable assurance that the contract amount will be received and it is probable that all attaching conditions will be complied with. The Company recognizes the amounts received in accordance with the contract as a reduction of research and development expenses over the periods necessary to match the contract on a systematic basis to the costs that it is intended to compensate. The Company recorded on the balance sheet as contract receivable upon meeting the criteria discussed above until cash is received.  During the years ended December 31, 2015 and 2014, the Company recorded $281,913 and $70,699 in accordance with the contract, which have been recorded as a reduction of research and development expense in the accompanying statement of operations.

 

Fair Value of Financial Instruments

 

The carrying amounts of financial instruments such as cash equivalents and accrued expenses approximate the related fair values due to the short-term maturities of these instruments.

 

The fair value of financial assets and liabilities is measured under a three-tier fair value hierarchy as follows: Level 1 fair value is determined from observable, quoted prices in active markets for identical assets or liabilities. Level 2 fair value is determined from quoted prices for similar items in active markets or quoted prices for identical or similar items in markets that are not active. Level 3 fair value is determined using the entity’s own assumptions about the inputs that market participants would use in pricing an asset or liability.

 

Impairment of Long-Lived Assets

 

The Company reviews its long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the asset may not be fully recoverable. Recoverability of assets is measured by a comparison of the carrying amount of an asset to the estimated undiscounted cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge will be recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. There were no impairments of long-lived assets during years presented.

 

Income Taxes

 

No provision for income taxes is made since the Company is treated as a partnership for income tax purposes and the income or loss is passed through to its members.

 

ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions.

 

F-9 

 

 

Recently Issued Accounting Pronouncements

 

On June 10, 2014, FASB issued ASU No. 2014-10, Development Stage Entities. The update removes the definition of a development stage entity from FASB ASC 915 and eliminates the requirement for development stage entities to present inception-to-date information on the statements of operations, cash flows and members’ equity. The Company early adopted this standard for the period covered herein.

 

In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern. The amendments require management to perform interim and annual assessments of an entity’s ability to continue as a going concern and provides guidance on determining when and how to disclose going concern uncertainties in the financial statements. The standard applies to all entities and is effective for annual and interim reporting periods ending after December 15, 2016, with early adoption permitted. The Company is currently evaluating the impact that this new guidance will have on its financial statements.

 

Other than as noted above the Company has not implemented any pronouncements that had material impact on the financial statements and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

 

Note 4

Property and Equipment

 

The equipment is being depreciated on the straight-line bases over the estimated useful lives of the asset of 4-5 years.

 

Property and equipment consisted of the following:

 

   December 31, 
   2015   2014 
Office Furniture and equipment  $6,261    6,261 
Laboratory equipment   86,967    86,967 
           
Less: accumulated depreciation   39,132    20,656 
           
Property and equipment, net  $54,096   $72,572 

 

Depreciation expense of property and equipment for the years ended December 31, 2015 and 2014 was $18,476 and $18,476, respectively.

 

Note 5

Commitments and Contingencies

 

The Company currently has a license agreement which allows for the use of a laboratory facility for a monthly payment of $3,685, which was amended on July 1, 2016 to a monthly amount of $3,879 and expires on June 30, 2017.

 

F-10 

 

 

Note 6

Related Parties

 

The related party receivable represents the remaining balance of a bridge loan provided to a board member in his recruitment to serve as Chief Scientific Officer. The loan is repayable in monthly installments of $2,248 including interest at 5% per annum through December 1, 2016 when the loan will be fully repaid. All amounts due under the loan have been timely paid.

 

Note 7

Subsequent Events

 

Shuttle Pharmaceuticals, LLC applied for two NIH SBIR contracts in response to announcement PHS2016-1. Notifications of contract awards were received on September 19, 2016 for Topic 345 “Predictive biomarkers for prostate cancer sensitivity for radiation late effects” ($ 299,502) and Topic 352 “Cell-based models for prostate cancer health disparity research” ($ 224,687).

 

In August and September 2016, the Company received loans from unrelated parties in the aggregate amount of $120,000. The loans mature two years from the date of issuance, bear interest at 7.5%per annum, and are convertible into the shares of stock at, if at any time prior to the Maturity Date, and if the Company consummates a Sale Event or a Qualified Financing, then, immediately prior to consummation of the Sale Event or the Qualified Financing, the principle amount of and all unpaid accrued interest on this Note shall automatically convert shares at the Conversion Price.

 

On August 15, 2016, the Company received a loan from a related party in the amount of $50,000. The loan matures on August 14, 2017 and bears interest at 5% per annum.

 

On August 12, 2016, the Company filed articles of conversion with the share of Maryland to convert from an LLC to a corporation. In connection with the conversion the Company issued 45,000,000 shares of common stock for the outstanding 100 membership interests prior to the conversion.

 

F-11 

 

 

Shuttle Pharmaceuticals, Inc.

Balance Sheets

(Unaudited)

 

   September 30   December 31 
   2016   2015 
ASSETS          
           
Current assets          
Cash and cash equivalents  $120,091   $128,837 
Contract receivable   79,707    46,648 
Note receivable-related party   4,912    24,728 
Prepaid expenses   7,125    - 
           
Total current assets   211,835    200,213 
           
Property and equipment, net   44,573    54,096 
           
Total Assets  $256,408   $254,309 
           
LIABILITIES AND MEMBERS’ EQUITY          
           
Current liabilities          
Accrued expenses  $68,445   $4,577 
Accrued interest payable   898    - 
Note payable-related party   45,928    - 
           
Total current liabilities  $115,271   $4,577 
           
Long term Liabilities          
Convertible notes payable   120,250    - 
           
Total liabilities   235,521    - 
           
Equity:          
Members equity   -    249,732 
Preferred stock, $0.01 par value, 5,000,000 shares authorized, no shares outstanding as of September 30, 2016   -    - 
Common stock, $0.01 par value, 100,000,000 shares authorized, 45,000,000 shares issued and outstanding as of September 30, 2016   450,000    - 
Additional paid-in capital   550,000    - 
Retained earnings   (979,113)   - 
Total Stockholder’s equity   20,887    - 
Total equity   20,887    249,732 
Total liabilities and equity   256,408    254,309 

 

The Accompanying Notes are an Integral Part of the Financial Statements

 

F-12 

 

 

Shuttle Pharmaceuticals, Inc.

Statements of Operations

(Unaudited)

 

   For nine months ended
September
 
    2016       2015   
Revenue  $-   $- 
Operating expenses          
Research and development-net of contracts   121,705    232,163 
General and administrative   126,477    32,500 
Total operational expenses   248,182    264,663 
           
Loss from operations   (248,182)   (264,663)
           
Other Income (expense)          
Interest Income-related party   443    1,361 
Interest expense   (1,106)   - 
           
Net loss   (248,845)   (263,302)

 

The Accompanying Notes are an Integral Part of the Financial Statements 

 

F-13 

 

 

Shuttle Pharmaceuticals, Inc.

Statements of Cash Flows

(Unaudited)

 

   For the nine months ended 
   Sept 30   Sep 30 
   2016   2015 
Cash flows from operating activities:          
Net Loss  $(248,845)  $(263,303)
Adjustments to reconcile net loss to net cash used in operating activities:          
           
Depreciation   13,856    13,857 
           
Change in operating assets and liabilities          
Contract receivable   (33,059)   22,706 
Prepaid expense   (7,125)   - 
Accrued expenses   9,753    (12,059)
Accounts payable   55,013    - 
Net cash used in operating activities   (210,407)   (238,799)
Cash flow from investing activities:          
Acquisition of property and equipment   (4,333)   - 
Repayment of note receivable-related party   19,816    18,983 
Net of cash provided by investing activities   15,483    18,983 
Cash flows from financing activities:          
Proceeds from convertible note payable   120,250    - 
Capital contributions   20,000    200,000 
Proceeds from note payable-related party   45,928    - 
Net cash provided by financing activities   186,178    200,000 
           
Net (decrease) in cash and cash equivalents   (8,746)   (19,816)
Cash and cash equivalents at beginning of period   128,836    106,957 
           
Cash and cash equivalents at end of period  $120,091   $87,141 
           
Supplemental disclosure of cash flow information:          
Cash paid during period for interest  $0   $0 
Cash paid during period for taxes  $0   $0 

 

The Accompanying Notes are an Integral Part of the Financial Statements

 

F-14 

 

 

Shuttle Pharmaceuticals, Inc.

Notes to Financial Statements

September 30, 2016

(Unaudited)

 

Note 1

Nature of Organization

 

Operations

 

The Company was formed Shuttle Pharmaceuticals, LLC, (“the Company”) was formed in the State of Maryland on December 18, 2012 as a limited liability company. The Company’s primary purpose is the development and commercialization of unique drugs for the sensitization of cancers and protection of normal tissues, to improve the outcomes of cancer patients receiving radiation therapy. The company has a product (ropidoxuridine) for use with radiation therapy which is the subject of a Small Business Innovation Research (SBIR) contract with the National Cancer Institute (NCI), a unit of the National Institutes of Health. The company also has obtained an option to rights to a product (doranidazole) for use with radiosurgery, developed by Pola Pharma, a Japanese Pharmaceutical company.

 

On August 12, 2016, the Company filed articles of conversion with the state of Maryland to convert from an LLC to a corporation. In connection with the conversion the Company issued 45,000,000 shares of common stock for the outstanding 100 membership interest prior to the conversion.

 

The Company is in the development stage, requiring substantial capital for research, product development and market development activities. The Company has not marketed a commercial product and the Company’s proposed products will require successful clinical testing, regulatory approval and additional investment prior to commercialization. The future success of the Company is dependent on its ability to raise working capital to develop and eventually to manufacture and market its products. There is no assurance that the Company will be able to secure the necessary financing or regulatory approvals to attain successful future operations. Therefore, the predictability of the Company’s future is uncertain.

 

Note 2

Going Concern

 

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern. The Company has not generated any revenues since inception, has incurred losses since its inception and has an accumulated deficit of $979,113 at September 30, 2016.  The Company currently has limited liquidity, and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern.

 

Management will seek potential business opportunities for merger or acquisition of an existing company. Management, while not especially experienced in matters relating to public company management, will rely upon their own efforts and that of its Board of Directors in accomplishing the business purposes of the Company. Management began in the fourth quarter of 2015 to form new capital in the form of an SEC Regulation D, Rule 506 Private Placement in the amount of 105,000,000 offering shares.

 

F-15 

 

  

Note 3

Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with Article 10 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company at September 30, 2016 and the results of operations and cash flows for the periods presented. The results of operations for the nine months ended September 30, 2016 are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited financial statements should be read in conjunction with the financial statements and related notes thereto included elsewhere in this filing for the years ended December 31, 2015 and 2014.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities of the financial statements, and the reported amounts of revenues and expenses during the reporting period.

 

Property and Equipment

 

Property and equipment are stated at cost. Equipment is depreciated using the straight-line method over the estimated useful lives of the assets. Repair and maintenance costs are expensed as incurred.

 

Research and Development Expenses

 

Research and development expenses are charges to expense as incurred. Research and development expenses include, but are not limited to, product development, clinical and regulatory expenses, payroll and other personnel expenses, materials, supplies, and consulting costs.

 

F-16 

 

  

These expenses are assigned to the clinical project to develop ropidoxuridine in combination with radiation therapy. The SBIR contract covers much of the Phase I clinical trial in advanced GI malignancies.

 

The research expenses are assigned to the clinical project to develop ropidoxuridine in combination with radiation therapy as a treatment for cancer. Costs that are not covered by the SBIR contract for performing the Phase I contract to determine commercialization feasibility included partial salary support of personnel and consultant to develop a commercialization plan. Costs that are not covered in the Phase II contract effort include business development and partial salary support. 

 

Research expenses related to new drug discovery include partial support of personnel, space, supplies and legal costs. These are preclinical studies and have led to discovery of the candidate lead ATM/HDACi bifunctional agent, an HDAC6 inhibitor and novel formulations of IUdR and IPdR.

 

The Company has received a contract from the Department of Health and Human Services to assist with the clinical development of IPdR for radiosensitization. The Company recognizes the amounts received in regards to the contract at fair value when there is reasonable assurance that the contract amount will be received and it is probable that all attaching conditions will be complied with. The Company recognizes the amounts received in accordance with the contract as a reduction of research and development expenses over the periods necessary to match the contract on a systematic basis to the costs that it is intended to compensate. The Company recorded on the balance sheet as contract receivable upon meeting the criteria discussed above until cash is received.  During the nine months ended September 30, 2016 and 2015, the Company recorded $409,069 and $121,272 in accordance with the contract, which have been recorded as a reduction of research and development expense in the accompanying statement of operations.

 

Cash and cash equivalents

 

The Company considers all short-term highly liquid investments with an original maturity at the date of purchase of three months or less to be cash equivalents.

 

Fair Value of Financial Instruments

 

The carrying amounts of financial instruments such as cash equivalents and accrued expenses approximate the related fair values due to the short-term maturities of these instruments. The Company invests its excess cash in financial instruments which are readily convertible into cash, such as money market funds and U.S. government securities.

 

The fair value of financial assets and liabilities is measured under a three-tier fair value hierarchy as follows: Level 1 fair value is determined from observable, quoted prices in active markets for identical assets or liabilities. Level 2 fair value is determined from quoted prices for similar items in active markets or quoted prices for identical or similar items in markets that are not active. Level 3 fair value is determined using the entity’s own assumptions about the inputs that market participants would use in pricing an asset or liability.

 

F-17 

 

  

Impairment of Long-Lived Assets

 

The Company reviews its long-lived assets for impairment whenever events or changes in business circumstances indicate that the carrying amount of the asset may not be fully recoverable. Recoverability of assets is measured by a comparison of the carrying amount of an asset to the estimated undiscounted cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge will be recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset. There were no impairments of long-lived assets during years presented.

 

Income Taxes

 

No provision for income taxes is made since the Company is treated as a partnership for income tax purposes and the income or loss is passed through to its members.

 

ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions

 

Note 4

Property and Equipment

 

Property and equipment consisted of the following:

 

   December
31, 2015
   September
30, 2016
 
Office Furniture and equipment  $6,261    7,731 
Laboratory equipment   86,967    89,831 
    93,228    97,562 
Less: accumulated depreciation   39,132    52,989 
Property and equipment, net  $54,096    44,573 

 

Depreciation expense of property and equipment for the nine months ended September 30, 2016 and 2015 was $13,856 and $13,857, respectively.

 

The equipment is being depreciated on the straight-line bases over the estimated useful lives of the asset of 4-5 years.

 

F-18 

 

  

 Note 5

Commitments and Contingencies

 

The Company currently has a lease agreement which allows for the use of a laboratory facility for a monthly payment of $3,685, which was amended on July 1, 2016 to a monthly amount of $3,879 and expires on June 30, 2017.

 

Note 6

Note receivable-Related party

 

The related party receivable represents the remaining balance of a bridge loan provided to a board member in his recruitment to serve as Chief Scientific Officer. The loan is repayable in monthly installments of $2,248 including interest at 5% per annum through December 1, 2016 when the loan will be fully repaid. All amounts due under the loan have been timely paid.

 

Note 7

Note payable-Related party

 

On August 15, 2016, the Company received a loan from a related party in the amount of $50,000.  The loan is payable in monthly installments of $4,280 inclusive of interest at 5% per annum until maturity on August 14, 2017. Interest expense incurred on this loan was $208 for the nine months ended September 30, 2016.

 

Note 8

Convertible note payable

 

In August and September 2016, the Company received loans from unrelated parties in the aggregate amount of $120,250. The loans mature two years from the date of issuance, bear interest at 7.5%per annum, and are convertible into the shares of stock at, if at any time prior to the Maturity Date, and if the Company consummates a Sale Event or a Qualified Financing, then, immediately prior to consummation of the Sale Event or the Qualified Financing, the principle amount of and all unpaid accrued interest on this Note shall automatically convert shares at the Conversion Price., which is a 30% discount to the effective per share offering price of the qualified financing.

 

Note 9

Equity

 

In connection with the filing of the articles of conversion referred to in note 1 and the articles of incorporation, the Company is authorized to issue 100,000,000 shares of common stock with a par value of $.01 and 5,000,000 shares of preferred stock with a par value of $.01.

 

On August 12, 2016, in connection with the conversion the Company issued 45,000,000 shares of common stock for the outstanding 100 membership interests of the Company prior to the conversion.

 

The Company has no outstanding shares of preferred stock at September 30, 2016.

 

F-19 

 

  

Note 10

Subsequent Events

 

Shuttle Pharmaceuticals, LLC applied for two NIH SBIR contracts in response to announcement PHS2016-1. Notifications of contract awards were received on September 19, 2016 for Topic 345 “Predictive biomarkers for prostate cancer sensitivity for radiation late effects” ($ 299,502) and Topic 352 “Cell-based models for prostate cancer health disparity research” ($ 224,687).

 

F-20 

 

  

PART II

 

INFORMATION NOT REQUIRED IN THE PROSPECTUS

 

ITEM 13.OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

 

Registration Fees   $ 4,172.40  
Transfer Agent Fees   $ *
Accounting Fees and Expenses   $ *  
Legal Fees and Expenses   $ *  
Miscellaneous Fees and Expenses   $ *  
Total   $ *

 

 

* To be filed by amendment.

 

All amounts are estimates other than the SEC’s registration fee.  

 

ITEM 14.INDEMNIFICATION OF DIRECTORS AND OFFICERS

 

Our Articles of Incorporation and bylaws provide for indemnification of our officers and directors to the fullest extent permitted by the Maryland General Corporation Law.

 

ITEM 15.RECENT SALES OF UNREGISTERED SECURITIES

 

During the past three years, we effected the following transactions in reliance upon exemptions from registration under the Securities Act, as amended:

 

In August 2016, we sold $120,250 in principal amount of our 7.5% Convertible Promissory Notes due August 31. 2018 (the “Convertible Notes”) to 23 investors in a private offering. The Convertible Notes will automatically convert into 22,700 shares of common stock upon the first closing of this the Offering. The Convertible Notes were issued in accordance with the exemption from afforded by Section 4(a) (2) of and Regulation D promulgated under the Securities Act, as amended, as the persons receiving such shares having provided the Company with appropriate investment representations.

 

 II-1 

 

  

ITEM 16.EXHIBITS

 

Exhibit

Number

  Description
     
3.1   Articles of Incorporation*
     
3.2   By-Laws*
     
5.1   Opinion of Gutierrez Bergman Boulris, P.L.L.C.**
     
10.1   Form of Share Purchase Agreement**
     
10.2   2016 Stock Incentive Plan*
     
10.3   Code of Ethics*
     
10.4   Employment Agreement with Theodore L. Phillips, Ph.D.*
     
10.5   Employment Agreement with Michael J. Starkweather*
     
23.1   Consent of Paritz and Company, P.A.*
     
23.2   Consent of Gutierrez Bergman Boulris, P.L.L.C. (Included in Exhibit 5.1)**
     
24    Power of Attorney (included in signature page to this registration statement) 

 

 

*Filed herewith.

** To be filed by amendment.

 

ITEM 17. UNDERTAKINGS

 

The undersigned registrant hereby undertakes:

 

1.            To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement;

 

(a)           to include any prospectus required by Section 10(a) (3) of the Securities Act of 1933;

 

(b)           to reflect in the prospectus any facts or events which, individually or together, represent a fundamental change in the information in the registration statement; and Notwithstanding the forgoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation From the low or high end of the estimated maximum offering range may be reflected in the form of prospects filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in the volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.; and

 

(c)           to include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in the registration statement.

 

2.            That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

 II-2 

 

  

3.            To remove from registration by means of a post-effective amendment any of the securities being registered hereby which remain unsold at the termination of the offering.

  

Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to our directors, officers and controlling persons pursuant to the provisions above, or otherwise, we been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933, and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection with the securities being registered, we will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification is against public policy as expressed in the Securities Act of 1933, and we will be governed by the final adjudication of such issue.

  

Each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B of the Securities Act or other than prospectuses filed in reliance on Rule 430A of the Securities Act, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness.  Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

 II-3 

 

  

SIGNATURES

 

In accordance with the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-1 and authorized this registration statement to be signed on its behalf by the undersigned, in Rockville, Maryland, on December 9, 2016.

 

  SHUTTLE PHARMACEUTICALS, INC.
     
  By: /s/  Anatoly Dritschilo.
    Anatoly Dritschilo, M.D., Chief Executive Officer
    (Principal Executive Officer)

 

POWER OF ATTORNEY

 

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Anatoly Dritschilo, M.D. and Peter Dritschilo, and each of them as his or her true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for each of them and in each name, place and stead, in any and all capacities, to sign any and all pre- or post-effective amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as each might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or his substitute, may lawfully do or cause to be done by virtue hereof.  In accordance with the requirements of the Securities Act of 1933, as amended, this registration statement was signed by the following persons in the capacities and on the dates stated.

 

Signatures   Title(s)   Date
         
By:  /s/  Anatoly Dritschilo   Chairman of the Board and Chief Executive Officer   December 9, 2016
   Anatoly Dritschilo, M.D.   (Principal Executive Officer)    
           
By: /s/  Peter Dritschilo   President and Chief Financial Officer   December 9, 2016
   Peter Dritschilo   (Principal Financial and Accounting Officer)    
           
By: /s/ Milton Brown   Chief Scientific Officer for Chemistry and Director   December 9, 2016
   Milton Brown, M.D., Ph.D.        
           
By: /s/ Mira Jung   Chief Scientific Officer for Biology and Director   December 9, 2016
   Mira Jung        

 

 

EX-3.1 2 s104853_ex3-1.htm EXHIBIT 3.1

 

Exhibit 3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-3.2 3 s104853_ex3-2.htm EXHIBIT 3.2

 

Exhibit 3.2

 

BYLAWS

 

OF

 

Shuttle Pharmaceuticals, Inc.

 

 

ARTICLE I

 

OFFICES

 

Section 1.          Principal Office. The principal office of Shuttle Pharmaceuticals, Inc. (the “Corporation”) in the State of Maryland shall be 1 Research Court, Suite 450, Rockville, Maryland 20850. The name of the resident agent of the Corporation in the State of Maryland is VCorp Services MD, Inc. and the post office address of such resident agent is 836 Park Ave., 2nd Floor, Baltimore, Maryland 21201.

 

Section 2.          Other Offices. The Corporation may also have other offices at such locations both within and without the State of Maryland as the Board of Directors may determine or as the business of the Corporation may require.

 

ARTICLE II

 

MEETINGS OF STOCKHOLDERS

 

Section 1.          Place of Meetings. All meetings of the stockholders of the Corporation shall be held at the principal office of the Corporation or at such other place in the United States as may be designated by the Board of Directors and stated in the notice of the meeting or in a duly executed waiver of notice thereof.

 

Section 2.          Annual Meeting. The annual meeting of stockholders of the Corporation for the election of directors and the transaction of such other business as may properly be brought before such meeting shall be held on a date and at the time as may be set by the Board of Directors. Any business of the Corporation may be transacted at the annual meeting without being specified in the notice thereof, except as otherwise provided by law.

 

Section 3.           Special Meetings. Special meetings of stockholders of the Corporation for any purpose or purposes may be called at any time by the President or the Board of Directors, and shall be called by the Secretary upon the written request of stockholders entitled to cast at least twenty-five percent (25%) of all votes entitled to be east at any such meeting. Such request shall state the purpose or purposes of the meeting and the matters proposed to be acted on thereat. Upon receipt of such request, the Secretary shall inform such stockholders of the reasonably estimated cost of preparing and mailing a notice of the meeting and, upon payment of such costs to the Corporation, the Secretary shall give notice to each stockholder entitled to notice of such meeting. No special meeting need be called upon the request of stockholders entitled to cast less than a majority of all votes entitled to be cast at such a meeting to consider any matter which is substantially the same as a matter voted on at any special meeting of stockholders held during the preceding 12 months.

 

 

 

 

Section 4.          Conduct of Meetings. The Board of Directors of the Corporation may adopt by resolution such rules and regulations for the conduct of the meeting of the stockholders as it shall deem appropriate. At every meeting of the stockholders, the President, or in his or her absence or inability to act, the Vice President, or, in his or her absence or inability to act, the person whom the President or Board of Directors shall appoint, shall act as chairman of, and preside at, the meeting. The secretary or, in his or her absence or inability to act, the person whom the chairman of the meeting shall appoint secretary of the meeting, shall act as secretary of the meeting and keep the minutes thereof. Except to the extent inconsistent with such rules and regulations as adopted by the Board of Directors, the chairman of any meeting of the stockholders shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts as, in the judgment of such chairman, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board of Directors or prescribed by the chairman of the meeting, may include, without limitation, the following: (a) the establishment of an agenda or order of business for the meeting; (b) the determination of when the polls shall open and close for any given matter to be voted on at the meeting; (c) rules and procedures for maintaining order at the meeting and the safety of those present; (d) limitations on attendance at or participation in the meeting to stockholders of record of the corporation, their duly authorized and constituted proxies or such other persons as the chairman of the meeting shall determine; (e) restrictions on entry to the meeting after the time fixed for the commencement thereof; and (f) limitations on the time allotted to questions or comments by participants.

 

Section 5.          Notice of Meetings; Waiver of Notice. Written notice of the time and place of each meeting of stockholders, and the purpose of any special meeting, shall be given to each stockholder entitled to vote at or to notice of such meeting not less than 10 nor more than 90 days before the date of such meeting, either personally delivered to him, left at his residence or usual place of business, or mailed to him, postage prepaid, at his address as it appears on the records of the Corporation. No notice of the time, place, or purpose of any meeting of stockholders need be given to any stockholder entitled to such notice who is present in person or is represented by proxy at the meeting, or who, either before or after the meeting, executes a written waiver of notice which shall be tiled by the Secretary with the records of meetings of stockholders, as provided by these Bylaws.

 

Section 6.          Record Date and Closing of Transfer Books. For the purpose of determining the stockholders entitled to notice of or to vote at any meeting of stockholders, or any adjournment thereof, or entitled to receive dividends or be allotted any other right, or for any other proper purpose, the Board of Directors may fix, in advance, a record date, which shall be not more than 90 days before the date on which the action requiring the determination will be taken, or the Board of Directors may direct that the stock transfer books be closed for a stated period, not to exceed 20 days. In the case of a meeting of stockholders, the record date or the closing of the transfer books shall be at least 10 days before the date of the meeting. Except as otherwise provided by law, the record date may not be prior to the close of business on the day the record date is fixed.

 

 2 

 

 

Section 7.          Quorum. Unless otherwise provided by law or the Articles of Incorporation of the Corporation, the presence in person or by proxy of stockholders entitled to cast a majority of all votes entitled to be cast at a meeting shall constitute a quorum at all meetings of stockholders, the stockholders entitled to cast a majority of the votes so represented may adjourn the meeting from time to time without further notice other than announcement at the meeting to a date not more than 120 days after the original record date. At such adjourned meeting at which a quorum shall be present or represented, any business may be transacted which might have been transacted at the meeting as originally noticed. The stockholders present at a duly organized meeting may continue to transact business until adjournment, notwithstanding any absence or withdrawal of any stockholder or stockholders during the meeting that has or have the effect of reducing the number of stockholders remaining in attendance at the meeting to less than a quorum.

 

Section 8.          Proxies. At all meetings of stockholders of the Corporation, a stockholder may vote either in person or by written proxy signed by the stockholder or by his duly authorized attorney in fact. No proxy shall be valid for more than eleven (11) months after its date, unless the proxy otherwise provides.

 

Section 9.          Voting. At all meetings of stockholders of the Corporation, each outstanding share of Common Stock as of the record date of such meeting shall be entitled to one vote on each matter submitted to a vote. A majority of all the votes cast at a meeting at which a quorum is present is sufficient to approve any matter which properly comes before the meeting unless otherwise provided by law or the Articles of Incorporation of the Corporation. Candidates for election as members of the Board of Directors who receive the highest number of votes at a meeting at which a quorum is present, up to the number of directors to be chosen, shall stand elected, and an absolute majority of the votes cast shall not be a prerequisite to the election of any candidate to the Board of Directors.

 

Section 10.         List of Stockholders. The Secretary of the Corporation shall prepare a list of the stockholders entitled to vote at any meeting of stockholders, arranged in alphabetical order, and indicating the number of shares of stock held by each stockholder as of the record date for such meeting. Such list of stockholders shall be kept at the place of the meeting of stockholders during such meeting.

 

Section 11.         Informal Action. Any action required or permitted to be taken at a meeting of stockholders may be taken without a meeting if the following is filed with the records of stockholder meetings: a written consent which sets forth the action and is signed by each stockholder entitled to vote on the matter. In addition, the holders of common stock of the Corporation entitled to vote generally in the election of directors may take action or consent to any action by delivering a consent in writing or by electronic transmission of the stockholders entitled to cast not less than the minimum number of votes that would be necessary to authorize or take the action at a stockholders meeting if the Corporation gives notice of the action not later than ten (10) days after the effective date of the action to each holder of the class of common stock and to each stockholder who, if the action had been taken at a meeting, would have been entitled to notice of the meeting.

 

 3 

 

 

ARTICLE III

 

BOARD OF DIRECTORS

 

Section 1.          General Powers. The business and affairs of the Corporation shall be managed under the direction of the Board of Directors, which shall have and exercise all powers of the Corporation, except as conferred upon or reserved to the stockholders by law, the Articles of Incorporation of the Corporation or these Bylaws.

 

Section 2.          Number and Term. At any regular meeting or at any special meeting called for that purpose, a majority of the entire Board of Directors may establish, increase or decrease the number of directors, provided that the number thereof shall never be less than one (1) nor more than fifteen (15). Directors shall be elected at the annual meeting of stockholders and shall hold office until the next annual meeting of stockholders and until their respective successors are elected and qualify.

 

Section 3.          Qualifications. Unless otherwise provided by law, the Articles of Incorporation of the Corporation, or these Bylaws, directors need not be stockholders of the Corporation.

 

Section 4.          Regular Meetings. The regular annual meeting of the Board of Directors shall be held without notice immediately after and at the same place as the annual meeting of stockholders. Other regular meetings of the Board of Directors may be held without notice at such time and place as shall from time to time be determined by resolution of Directors.

 

Section 5.          Special Meetings. Special meetings of the Board of Directors may be called by or at the request of the chairman of the board, the president or by a majority of the directors then in office.  Special meetings of the Board of Directors shall be held at any place in or out of the State of Maryland as the Board may from time to time determine by resolution or as shall be specified in any notice or waiver of notice of such meeting.

 

Section 6.          Notice; Waiver of Notice. Written notice of any special meeting of the Board of Directors shall be given to each director at least one day prior thereto either personally or by electronic or facsimile transmission, or at least five days prior thereto by mail, addressed to such director at his address as it appears in the records of the Corporation. Such notice shall be deemed to be delivered when deposited in the United States mail so addressed, with postage thereon prepaid, or when delivered to the telegraph company if sent by telegram. Any director may waive notice of any meeting, either before or after such meeting, by signing a waiver of notice which is filed with the records of the meeting. Attendance of a director at a meeting shall constitute a waiver of notice of such meeting, except where the director attends the meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at nor the purpose of any meeting of the Board of Directors need be specified in the notice or waiver of notice of such meeting.

 

 4 

 

 

Section 7.          Quorum; Manner of Acting. A majority of the entire Board of Directors shall constitute a quorum for transaction of business at any meeting of the Board of Directors. If a quorum is not present at any meeting, the directors present may adjourn the meeting. Notice of any adjourned meeting shall be given in the same manner as prescribed by Section 6 of this Article III. Unless a greater proportion is required by law, the Articles of Incorporation of the Corporation or these Bylaws, the action of a majority of the directors present at a meeting at which a quorum is present shall be the action of the Board of Directors.

 

Section 8.          Action Without a Meeting; Telephone Meeting. Any action required or permitted to be taken at a meeting of the Board of Directors, or any committee thereof, may be taken without a meeting if a consent in writing, setting forth the action so taken, is signed by each member of the Board or committee and filed with the minutes of proceedings of the Board or committee. Members of the Board of Directors, or any committee thereof, may participate in meetings by means of a conference telephone or similar communications equipment by which all persons participating in the meeting can hear each other at the same time. Such participation shall constitute presence in person at the meeting.

 

Section 9.          Resignation and Removal. Any director may resign at any time by giving written notice of such resignation to the President or the Secretary at the principal office of the Corporation. Unless otherwise specified therein, such resignation shall take effect upon receipt thereof. The stockholders of the Corporation may remove any director, with or without cause, by the affirmative vote of a majority of all votes entitled to be cast for the election of directors.

 

Section 10.         Vacancies. The stockholders may elect a successor to fill a vacancy on the Board of Directors which results from the removal of a director. A vacancy occurring on the Board of Directors other than by reason of an increase in the number of directors may be filled by the affirmative vote of a majority of the remaining directors, although less than a quorum. Any directorship to be filled by reason of an increase in the number of directors may be filled by a majority of the entire Board of Directors. A director elected by the Board of Directors to fill a vacancy shall serve until the next annual meeting of stockholders and until his successor is elected and qualifies. A director elected by the stockholders to fill a vacancy which results from the removal of a director shall serve for the balance of the term of the removed director.

 

Section 11.         Presumption of Assent. A director of the Corporation who is present at a meeting of the Board of Directors at which action on any corporate matter is taken shall be assumed to have assented to such action unless he announces his dissent at the meeting and (a) his dissent is entered in the minutes of the meeting, (b) he files his written dissent to such action with the secretary of the meeting before the adjournment thereof, or (c) he forwards his written dissent, by certified mail, return receipt requested, bearing a postmark from the United States Postal Service, to the secretary of the meeting or the Secretary of the Corporation within 24 hours after the meeting is adjourned. Such right to dissent shall not apply to a director who voted in favor of such action or failed to make his dissent known at the meeting.

 

 5 

 

 

Section 12.         Compensation of Directors. The directors may be paid their expenses of attendance at each meeting of the Board of Directors and may be paid a fixed sum for attendance at each meeting of the Board of Directors or a stated salary as director. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefore. Members of special or standing committees may be paid like compensation for attending committee meetings.

 

ARTICLE IV

 

COMMITTEES

 

Section 1.          Appointment. The Board of Directors may appoint from among its members an Audit Committee, Compensation Committee and such other committees composed of two or more directors for the purposes and with the designated powers as the Board may determine, subject to Section 2 of this Article IV. The members of any committee present at any meeting of the committee, whether or not they constitute a quorum, may appoint another director to act in the place of an absent member of the committee. The Board of Directors shall by majority vote appoint a chairman of each such committee. The appointment of any committee pursuant to this Article IV, the delegation of authority thereto, or any action by a committee pursuant to this Article IV shall not constitute, of itself, compliance by any director, not a member of the committee, with the standard of care established by law for the performance of duties of directors.

 

Section 2.          Authority. In accordance with the General Corporation Law of the State of Maryland, no committee shall have the power to amend the By-laws of the Corporation, to declare dividends or distributions on stock, to issue stock (except as permitted by law pursuant to a duly authorized stock option or similar plan), to recommend to the stockholders any action which requires stockholder approval, or to approve any merger or share exchange which does not require stockholder approval.

 

Section 3.          Tenure. Subject to the provisions of Section 8 of this Article IV, each member of any committee shall hold office until the next regular annual meeting of the Board of Directors following his appointment and until his successor is designated by the Board of Directors.

 

Section 4.          Meetings and Notices. Regular meetings of committees of the Board of Directors may be held without notice at such times and places as such committees may determine from time to time by resolution. Special meetings of committees may be called by any member thereof upon not less than one day’s notice stating the place, date, and hour of the meeting, which notice may be written or by telephone or telegram. The notice of a meeting of a committee need not state the business proposed to be transacted at the meeting. Any member of a committee may waive notice of any nesting thereof, either before or after the meeting, by signing a waiver of notice which shall be filed with the records of such meeting, or by attendance at such meeting.

 

 6 

 

 

Section 5.          Quorum. Except as provided otherwise in Section 1 of this Article IV, a majority of the members of a committee shall constitute a quorum for the transaction of business at any meeting thereof. The vote of a majority of the members of a committee present at a meeting at which a quorum is present shall constitute action of the committee.

 

Section 6.          Action Without a Meeting; Telephone Meetings. Any action required or permitted to be taken at a meeting of a committee may be taken without a meeting if a written consent, setting forth the action so taken, is signed by all of the members of the committee and filed with the minutes of proceedings of the committee. Members of the committee may participate in meetings by means of a conference telephone or similar communications equipment by which all persons participating in the meeting can hear each other at the same time. Such participation shall constitute presence in person at the meeting.

 

Section 7.          Vacancies. Any vacancy on a committee may be filled by a resolution adopted by a majority of the Board of Directors.

 

Section 8.          Removal and Resignations. Any member of a committee may be removed at any time, with or without cause, by resolution of the Board of Directors. Any member of a committee may resign from the committee at any time by giving written notice to the President or Secretary of the Corporation otherwise specified therein, such resignation shall take effect upon receipt thereof.

 

Section 9.          Procedure. All committees established by the Board of Directors shall keep correct and complete minutes of their proceedings which minutes shall be recorded in written form but may be maintained in the form of a reproduction, and the Chairman of each committee shall report any actions taken to the Board of Directors at the next meeting thereof held after the committee meeting. The minutes of committee meetings shall be distributed to all members of the Board of Directors.

 

ARTICLE V

 

OFFICERS

 

Section 1.          Positions. The officers of the Corporation shall be a President, a Secretary, and a Treasurer, and such other officers as the Board of Directors may appoint, including a Chairman of the Board, and, at the discretion of the Board of Directors, one or more Vice Presidents, Assistant Secretaries, and Assistant Treasurers, who shall exercise such powers and perform such duties as are provided in these By-laws and as may be determined from time to time by resolution of the Board of Directors. Any two or more offices may be held by the same person, except that (a) one person may not serve concurrently as both President and Vice President, and (b) any person who holds more than one office may not act in more than one capacity to execute, acknowledge, or verify any instrument required by law to be executed, acknowledged or verified by more than one officer.

 

 7 

 

 

Section 2.          President. The President shall be the chief executive officer of the Corporation, shall have general and active supervision over the business and affairs of the Corporation, shall insure that all lawful orders and resolutions of the Board of Directors are carried into effect and, unless otherwise provided by the Board of Directors, shall preside at all meetings of the Board of Directors and of the stockholders. The President shall execute bonds, mortgages, and other contracts requiring a seal, under the seal of the Corporation, except where required or permitted by law to be otherwise signed and executed, and except where the execution thereof shall be expressly delegated by the Board of Directors to some other officer or agent of the Corporation.

 

Section 3.          Vice President. In the absence of the President or in the event of the President’s inability or refusal to act, the Vice President (if any, or in the event there be more than one Vice President, the Vice Presidents in the order designated, or in the absence of any designation, then in the order of their election) shall perform the duties of the President, and when so acting shall have all the powers of, and be subject to all the restrictions upon, the President. The Vice President shall perform such other duties and have such other powers as the Board of Directors may from time to time prescribe.

 

Section 4.          Chairman of the Board. If the directors shall appoint a Chairman of the Board, the Chairman shall, when present, preside at all meetings of the Board of Directors and shall perform such other duties and have such other powers as may be vested in the Chairman by the Board of Directors.

 

Section 5.          Secretary. The Secretary shall attend all meetings of the stockholders and the Board of Directors, shall record or cause to be recorded all the proceedings of the meetings of the stockholders and of the Board of Directors in a book or books to be kept for that purpose, and shall perform like duties for the Executive Committee or other committees, when required. The Secretary shall give, or cause to be given, such notices as are requited to be given in accordance with the provisions of these By-laws or as required by law or the Articles of Incorporation of the Corporation. The Secretary shall have custody of the seal of the Corporation, and shall have the authority to affix the same to any instrument or document the execution of which in the name or on behalf of the Corporation is duly authorized, and when so affixed it may be attested by the signature of the Secretary. The Secretary shall see that the books, records, and other documents required by law (including the stock ledger and the records of the issue, transfer and registration of certificates for shares of Common Stock) are properly kept and filed. The Secretary shall perform all other duties incident to the office of Secretary and such other duties as from time to time may be prescribed by these By-laws or may be assigned to him or her by the Board of Directors or the President.

 

Section 6.          Assistant Secretary. The Assistant Secretary, or if there be more than one, the Assistant Secretaries in the order determined by the Board of Directors (or if there shall have been no such determination, then in the order of their election), shall, in the absence of the Secretary or in the event of the Secretary’s inability or refusal to act, perform the duties and have such other powers as the Board of Directors may from time to time prescribe.

 

 8 

 

 

Section 7.          Treasurer. The Treasurer shall have the custody of the corporate funds and securities, and shall keep full and accurate accounts of receipts and disbursements in books belonging to the Corporation, and shall deposit all monies and valuable effects in the name and to the credit of the Corporation in such depositories as may be designated by the Board of Directors. The Treasurer shall disburse the funds of the Corporation as directed by the Board of Directors, taking proper vouchers for such disbursements, and shall render to the President, and to the Board of Directors at its regular meetings, or when the Board of Directors so requires, an account as to all transactions as Treasurer and of the financial condition of the Corporation. The Treasurer shall also perform all other duties incident to the office of Treasurer and such other duties as from time to time may be assigned to him or her by the Board of Directors or the President, or as may be prescribed by these By-laws. If required by the Board of Directors, the Treasurer shall give the Corporation a bond in such sum and with such surety or sureties as shall be satisfactory to the Board of Directors for the faithful performance of the duties of the Treasurer’s office and for the restoration to the Corporation, in case of the Treasurer’s death, resignation, retirement or removal from office, of all books, papers, vouchers, money and other property of whatever kind, in the Treasurer’s possession or under the Treasurer’s control and belonging to the Corporation.

 

Section 8.          Assistant Treasurer. The Assistant Treasurer, or if there shall be more than one, the Assistant Treasurers in the order determined by the Board of Directors (or if there shall have been no such determination, then in the order of their election), shall, in the absence of the Treasurer or in the event of the Treasurer’s inability or refusal to act, perform the duties and exercise the powers of the Treasurer, and shall perform such other duties and have such other powers as the Board of Directors may from time to time prescribe.

 

Section 9.          Election and Term of Office. The officers of the Corporation shall be elected at the regular annual meeting of the Board of Directors, or as soon thereafter as possible, to hold office until the next regular annual meeting of the Board and until their respective successors are elected and qualified, or until their earlier death, resignation, or removal.

 

Section 10.         Compensation. The compensation of all officers of the Corporation shall be fixed from time to time by the Board of Directors.

 

Section 11.         Resignation and Removal. Any officer may at any time resign in the same manner provided for directors in Section 9 of Article I of these By-laws. Any officer may be removed by the Board of Directors whenever, in its judgment, the best interests of the Corporation will be served thereby, but such removal shall be without prejudice to the contract rights, if any, of the person so removed.

 

Section 12.         Vacancies. A vacancy in any office because of death, resignation, removal, disqualification, or otherwise may be filled by the Board of Directors for the unexpired portion of the term of such office and until a successor is elected and qualifies.

 

Section 13.         Fidelity Bonds. The Corporation may secure the fidelity of any or all of its officers or agents by bond or otherwise.

 

 9 

 

 

ARTICLE VI

 

INDEMNIFICATION

 

The Corporation shall indemnify, to the fullest extent permitted by the General Corporation Law of the State of Maryland, any present or former director, officer, employee, incorporator or agent of the Corporation, or any person who serves or served another corporation, partnership, joint venture, trust, or other enterprise in one of such capacities at the request of the Corporation, who, by reason of such position, was, is, or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative.

 

ARTICLE VII

 

CAPITAL STOCK

 

Section 1.          Stock Certificates. Each stockholder is entitled to a certificate which represents and certifies the shares of Common Stock he holds in the Corporation. A certificate may not be issued until the stock represented by it is fully paid. Certificates representing shares of Common Stock of the Corporation shall be signed by the President, Vice President or the Chairman of the Board, and countersigned by the Secretary, an Assistant Secretary, the Treasurer, or an Assistant Treasurer, and sealed with the Corporate seal or a facsimile thereof. The signatures of such officers upon a stock certificate may be either manual or facsimile. Any stock certificate so signed shall be valid and may be issued whether or not the officer who signed it is still an officer when it is issued. Stock certificates shall be consecutively numbered or otherwise identified, and each such certificate shall state on its face the name of the Corporation, the class of stock and the number of shares it represents, and the name of the stockholder or other person to whom it is issued. The name and address of each stockholder, with the number of shares held and the date of issue, shall be entered on the stock ledger of the Corporation.

 

Section 2.          Transfer of Shares. Transfer of shares of Common Stock of the Corporation shall be made only on its stock ledger, and only upon surrender for cancellation of the certificate for such shares, properly endorsed. Authority for such transfer shall be given only by the holder of record thereof or by his legal representative, who shall furnish proper evidence of such authority, or by his attorney thereunto authorized by power of attorney duly executed and filed with the Corporation. In case of a lost, stolen, or destroyed certificate, a new certificate may be issued upon such conditions and indemnity to the Corporation as the Board of Directors in its discretion may prescribe.

 

Section 3.          Issuance of Shares. The Board of Directors may from time to time authorize the issuance of additional shares of Common Stock or securities convertible into Common Stock. Prior to each such issuance the Board of Directors shall adopt a resolution which authorizes the issuance and sets the minimum price or value of consideration for which such shares of stock or convertible securities are to be issued, or a formula or method pursuant to which the same is to be determined, including a fair description of any consideration other than money and a statement of the actual value of such consideration as then determined by the Board of Directors or a statement that the Board of Directors has determined that the actual value is or will not be less than a certain sum. In the absence of actual fraud in the transaction, any valuation so fixed by the Board of Directors shall be conclusive for all purposes. The actual value of consideration to be received by the Corporation, as determined by the Board of Directors, upon the issuance of additional shares of Common Stock shall be not less than the par value thereof. For the purposes of this Section, the consideration for which Common Stock is issued as a stock dividend shall be deemed to be the par value thereof, and, at the time the dividend is paid, the Corporation shall transfer from surplus to stated capital an amount at least equal to the aggregate par value of the shares to be issued. Unless otherwise required by law, no vote of the stockholders of the Corporation shall be required for the issuance of additional shares of Common Stock or securities convertible into Common Stock.

 

 10 

 

 

Section 4.          Books and Records; Stock Ledgers. The Corporation shall keep correct and complete books and records of its accounts and transactions and minutes of the proceedings of its stockholders and Board of Directors and of any executive or other committee when exercising any of the powers of the Board of Directors. The Corporation shall maintain a stock ledger, containing the names and addresses of the stockholders of the Corporation and the number of shares of stock of each class held by each stockholder, which shall be kept at the principal office of the Corporation, or at such other place as the Board of Directors may determine.

 

Section 5.          Dividends. The Board of Directors may declare dividends on the stock of the Corporation, which may be paid in cash, property, or the Corporation’s stock in accordance with applicable law. No dividends may be declared or paid if the Corporation is insolvent or the payment would cause the Corporation to became insolvent, or if the Corporation’s stated capital is impaired or the payment would impair its stated capital. If a dividend is paid from any source other than earned surplus, the source of the dividend shall be disclosed to the stockholders receiving the dividend not later than the time of payment.

 

Section 6.          Registered Stockholders. The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends, to receive notifications, to vote as such owner, and to exercise the rights and powers of an owner. The Corporation shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as expressly provided by the laws of the State of Maryland.

 

ARTICLE VIII

 

MISCELLANEOUS PROVISIONS

 

Section 1.          Fiscal Year. The fiscal year of the Corporation shall be the calendar year, unless otherwise fixed by resolution of the Board of Directors.

 

Section 2.        Seal. The Corporate seal of the Corporation shall have inscribed thereon the name of the Corporation, the year of its organization, and the words "Corporate Seal" and "Maryland," and shall be in such form as shall be approved from time to time by the Board of Directors. The seal may be used by causing it, or a facsimile thereof, to be impressed, affixed, or otherwise reproduced.

 

 11 

 

 

Section 3.          Control Share Acquisition Act. Notwithstanding any other provision of the Articles of Incorporation or these Bylaws, Title 3, Subtitle 7 of the Maryland General Corporation Law (or any successor statute) shall not apply to any acquisition by any person of shares of stock of the Corporation.  This section may be repealed, in whole or in part, at any time, whether before or after an acquisition of control shares and, upon such repeal, may, to the extent provided by any successor bylaw, apply to any prior or subsequent control share acquisition.

 

Section 4.          Amendments. These Bylaws may be altered, amended, or repealed, and new Bylaws may be adopted, by the vote of a majority of the entire Board of Directors and the power to alter, amend, and repeal these Bylaws, and to adopt new Bylaws, is hereby vested in the Board of Directors.

 

 12 

EX-10.2 4 s104853_ex10-2.htm EXHIBIT 10.2

 

Exhibit 10.2

 

SHUTTLE PHARMACEUTICALS, INC.

 

2016 STOCK INCENTIVE PLAN

 

1.           Purposes of the Plan.         The purposes of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company’s business.

 

2.           Definitions.         The following definitions shall apply as used herein and in the individual Award Agreements except as defined otherwise in an individual Award Agreement. In the event a term is separately defined in an individual Award Agreement, such definition shall supersede the definition contained in this Section 2.

 

(a)          “Administrator” means the Board or any of the Committees appointed to administer the Plan.

 

(b)          “Affiliate” and “Associate” shall have the respective meanings ascribed to such terms in Rule 12b-2 promulgated under the Exchange Act.

 

(c)          “Applicable Laws” means the legal requirements relating to the Plan and the Awards under applicable provisions of federal securities laws, state corporate and securities laws, the Code, the rules of any applicable stock exchange or national market system, and the rules of any non-U.S. jurisdiction applicable to Awards granted to residents therein.

 

(d)          “Assumed” means that pursuant to a Corporate Transaction either (i) the Award is expressly affirmed by the Company or (ii) the contractual obligations represented by the Award are expressly assumed (and not simply by operation of law) by the successor entity or its Parent in connection with the Corporate Transaction with appropriate adjustments to the number and type of securities of the successor entity or its Parent subject to the Award and the exercise or purchase price thereof which at least preserves the compensation element of the Award existing at the time of the Corporate Transaction as determined in accordance with the instruments evidencing the agreement to assume the Award.

 

(e)          “Award” means the grant of an Option, SAR, Dividend Equivalent Right, Restricted Stock, Restricted Stock Unit or other right or benefit under the Plan.

 

(f)          “Award Agreement” means the written agreement evidencing the grant of an Award executed by the Company and the Grantee, including any amendments thereto.

 

(g)          “Board” means the Board of Directors of the Company.

 

(h)          “Cause” means, with respect to the termination by the Company or a Related Entity of the Grantee’s Continuous Service, that such termination is for “Cause” as such term (or word of like import) is expressly defined in a then-effective written agreement between the Grantee and the Company or such Related Entity, or in the absence of such then-effective written agreement and definition, is based on, in the determination of the Administrator, the Grantee’s: (i) performance of any act or failure to perform any act in bad faith and to the detriment of the Company or a Related Entity; (ii) dishonesty, intentional misconduct or material breach of any agreement with the Company or a Related Entity; or (iii) commission of a crime involving dishonesty, breach of trust, or physical or emotional harm to any person; provided, however, that with regard to any agreement that defines “Cause” on the occurrence of or in connection with a Corporate Transaction or a Change in Control, such definition of “Cause” shall not apply until a Corporate Transaction or a Change in Control actually occurs.

 

1 | Page

 

 

(i)          “Change in Control means a change in ownership or control of the Company after the Registration Date effected through either of the following transactions:

 

(i)          the direct or indirect acquisition by any person or related group of persons (other than an acquisition from or by the Company or by a Company-sponsored employee benefit plan or by a person that directly or indirectly controls, is controlled by, or is under common control with, the Company) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities pursuant to a tender or exchange offer made directly to the Company’s shareholders which a majority of the Continuing Directors who are not Affiliates or Associates of the offeror do not recommend such shareholders accept, or

 

(ii)         a change in the composition of the Board over a period of twelve (12) months or less such that a majority of the Board members (rounded up to the next whole number) ceases, by reason of one or more contested elections for Board membership, to be comprised of individuals who are Continuing Directors.

 

(j)          “Code” means the Internal Revenue Code of 1986, as amended.

 

(k)          “Committee” means any committee composed of members of the Board appointed by the Board to administer the Plan.

 

(l)          “Common Stock” means the common stock of the Company.

 

(m)          “Company” means Shuttle Pharmaceuticals, Inc., a Maryland corporation, or any successor entity that adopts the Plan in connection with a Corporate Transaction.

 

(n)          “Consultant” means any person (other than an Employee or a Director, solely with respect to rendering services in such person’s capacity as a Director) who is engaged by the Company or any Related Entity to render consulting or advisory services to the Company or such Related Entity.

 

(o)          “Continuing Directors” means members of the Board who either (i) have been Board members continuously for a period of at least twelve (12) months or (ii) have been Board members for less than twelve (12) months and were elected or nominated for election as Board members by at least a majority of the Board members described in clause (i) who were still in office at the time such election or nomination was approved by the Board.

 

2 | Page

 

 

(p)          “Continuous Service” means that the provision of services to the Company or a Related Entity in any capacity of Employee, Director or Consultant is not interrupted or terminated. In jurisdictions requiring notice in advance of an effective termination as an Employee, Director or Consultant, Continuous Service shall be deemed terminated upon the actual cessation of providing services to the Company or a Related Entity notwithstanding any required notice period that must be fulfilled before a termination as an Employee, Director or Consultant can be effective under Applicable Laws. A Grantee’s Continuous Service shall be deemed to have terminated either upon an actual termination of Continuous Service or upon the entity for which the Grantee provides services ceasing to be a Related Entity. Continuous Service shall not be considered interrupted in the case of (i) any approved leave of absence, (ii) transfers among the Company, any Related Entity, or any successor, in any capacity of Employee, Director or Consultant, or (iii) any change in status as long as the individual remains in the service of the Company or a Related Entity in any capacity of Employee, Director or Consultant (except as otherwise provided in the Award Agreement). Notwithstanding the foregoing, except as otherwise determined by the Administrator, in the event of any spin-off of a Related Entity, service as an Employee, Director or Consultant for such Related Entity following such spin-off shall be deemed to be Continuous Service for purposes of the Plan and any Award under the Plan. An approved leave of absence shall include sick leave, military leave, or any other authorized personal leave. For purposes of each Incentive Stock Option granted under the Plan, if such leave exceeds three months, and reemployment upon expiration of such leave is not guaranteed by statute or contract, then the Incentive Stock Option shall be treated as a Non-Qualified Stock Option on the day three months and one day following the expiration of such three month period.

 

(q)          “Corporate Transaction” means any of the following transactions, provided, however, that the Administrator shall determine under (iv) and (v) whether multiple transactions are related, and its determination shall be final, binding and conclusive:

 

(i)          a merger or consolidation in which the Company is not the surviving entity, except for a transaction the principal purpose of which is to change the state in which the Company is incorporated;

 

(ii)         the sale, transfer or other disposition of all or substantially all of the assets of the Company;

 

(iii)        the complete liquidation or dissolution of the Company;

 

(iv)         any reverse merger or series of related transactions culminating in a reverse merger (including, but not limited to, a tender offer followed by a reverse merger) in which the Company is the surviving entity but (A) the shares of Common Stock outstanding immediately prior to such merger are converted or exchanged by virtue of the merger into other property, whether in the form of securities, cash or otherwise; or (B) in which securities possessing more than forty percent (40%) of the total combined voting power of the Company’s outstanding securities are transferred to a person or persons different from those who held such securities immediately prior to such merger or the initial transaction culminating in such merger, but excluding any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction; or

 

3 | Page

 

 

(v)          acquisition in a single or series of related transactions by any person or related group of persons (other than the Company or by a Company-sponsored employee benefit plan) of beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act) of securities possessing more than fifty percent (50%) of the total combined voting power of the Company’s outstanding securities but excluding any such transaction or series of related transactions that the Administrator determines shall not be a Corporate Transaction.

 

(r)          “Covered Employee” means an Employee who is a “covered employee” under Section 162(m) (3) of the Code.

 

(s)          “Director” means a member of the Board or the board of directors of any Related Entity.

 

(t)          “Disability” means as defined under the long-term disability policy of the Company or the Related Entity to which the Grantee provides services regardless of whether the Grantee is covered by such policy. If the Company or the Related Entity to which the Grantee provides service does not have a long-term disability plan in place, “Disability” means that a Grantee is unable to carry out the responsibilities and functions of the position held by the Grantee by reason of any medically determinable physical or mental impairment for a period of not less than ninety (90) consecutive days. A Grantee will not be considered to have incurred a Disability unless he or she furnishes proof of such impairment sufficient to satisfy the Administrator in its discretion.

 

(u)          “Dividend Equivalent Right” means a right entitling the Grantee to compensation measured by dividends paid with respect to Common Stock.

 

(v)          “Employee” means any person, including an Officer or Director, who is in the employ of the Company or any Related Entity, subject to the control and direction of the Company or any Related Entity as to both the work to be performed and the manner and method of performance. The payment of a Director’s fee by the Company or a Related Entity shall not be sufficient to constitute “employment” by the Company.

 

(w)          “Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

(x)          “Fair Market Value” means, as of any date, the value of Common Stock determined as follows:

 

(i)          If the Common Stock is listed on one or more established stock exchanges or national market systems, including without limitation The NASDAQ Global Select Market, The NASDAQ Global Market, The NASDAQ Capital Market of The NASDAQ Stock Market LLC, the New York Stock Exchange or the NYSE MKT, its Fair Market Value shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on the principal exchange or system on which the Common Stock is listed (as determined by the Administrator) on the date of determination (or, if no closing sales price or closing bid was reported on that date, as applicable, on the last trading date such closing sales price or closing bid was reported), as reported in The Wall Street Journal or such other source as the Administrator deems reliable;

 

4 | Page

 

 

(ii)         If the Common Stock is regularly quoted on an automated quotation system (including the OTC Bulletin Board) or by a recognized securities dealer, its Fair Market Value shall be the closing sales price for such stock as quoted on such system or by such securities dealer on the date of determination or the average of any such prices for such period as determined by the Administrator in good faith not to exceed thirty (30) trading days prior to the date of determination, but if selling prices are not reported, the Fair Market Value of a share of Common Stock shall be the mean between the high bid and low asked prices for the Common Stock on the date of determination (or, if no such prices were reported on that date, on the last date such prices were reported) or the average thereof for such period prior to the date of determination as established by the Administrator above, as reported in The Wall Street Journal or such other source as the Administrator deems reliable; or

 

(iii)        In the absence of an established market for the Common Stock of the type described in (i) and (ii), above, the Fair Market Value thereof shall be determined by the Administrator in good faith.

 

(y)          Good Reasonmeans the occurrence after a Corporate Transaction or Change in Control of any of the following events or conditions unless consented to by the Grantee (and the Grantee shall be deemed to have consented to any such event or condition unless the Grantee provides written notice of the Grantee’s non-acquiescence within thirty (30) days of the effective time of such event or condition):

 

(i)          a change in the Grantee’s responsibilities or duties that represents a material and substantial diminution in the Grantee’s responsibilities or duties as in effect immediately preceding the consummation of a Corporate Transaction or Change in Control;

 

(ii)         a reduction in the Grantee’s base salary to a level below that in effect at any time within six months preceding the consummation of a Corporate Transaction or Change in Control or at any time thereafter; provided that an across-the-board reduction in the salary level of substantially all other individuals in positions similar to the Grantee’s by substantially the same percentage amount shall not constitute such a salary reduction; or

 

(iii)        a requirement that the Grantee to be based at any place outside a 50-mile radius from the Grantee’s job location or residence prior to the Corporate Transaction or Change in Control except for reasonably required travel on business that is not materially greater than such travel requirements prior to the Corporate Transaction or Change in Control.

 

(z)           “Grantee” means an Employee, Director or Consultant who receives an Award under the Plan.

 

(aa)         “Incentive Stock Option” means an Option intended to qualify as an incentive stock option within the meaning of Section 422 of the Code.

 

(bb)        “Non-Qualified Stock Option” means an Option not intended to qualify as an Incentive Stock Option.

 

5 | Page

 

 

(cc)         “Officer” means a person who is an officer of the Company or a Related Entity within the meaning of Section 16 of the Exchange Act and the rules and regulations promulgated thereunder.

 

(dd)        “Option” means an option to purchase Shares pursuant to an Award Agreement granted under the Plan.

 

(ee)         “Parent” means a “parent corporation”, whether now or hereafter existing, as defined in Section 424(e) of the Code.

 

(ff)          “Performance-Based Compensation” means compensation qualifying as “performance-based compensation” under Section 162(m) of the Code.

 

(gg)        “Plan” means this 2016 Stock Incentive Plan.

 

(hh)        “Registration Date” means the first to occur of (i) the closing of the first sale, subsequent to the date this Plan is adopted, to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended, of (A) the Common Stock or (B) the same class of securities of a successor corporation (or its Parent) issued pursuant to a Corporate Transaction in exchange for or in substitution of the Common Stock; (ii) the date the Common Stock is otherwise registered under and the Company becomes subject to the reporting requirements of Sections 13 or 15 (d) or the Exchange Act; and (iii) in the event of a Corporate Transaction, the date of the consummation of the Corporate Transaction if the same class of securities of the successor corporation (or its Parent) issuable in such Corporate Transaction shall have been sold to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended, on or prior to the date of consummation of such Corporate Transaction.

 

(ii)           “Related Entity” means any Parent or Subsidiary of the Company.

 

(jj)           “Replaced” means that pursuant to a Corporate Transaction the Award is replaced with a comparable stock award or a cash incentive program of the Company, the successor entity (if applicable) or Parent of either of them which preserves the compensation element of such Award existing at the time of the Corporate Transaction and provides for subsequent payout in accordance with the same (or a more favorable) vesting schedule applicable to such Award. The determination of Award comparability shall be made by the Administrator and its determination shall be final, binding and conclusive.

 

(kk)         “Restricted Stock” means Shares issued under the Plan to the Grantee for such consideration, if any, and subject to such restrictions on transfer, rights of first refusal, repurchase provisions, forfeiture provisions, and other terms and conditions as established by the Administrator.

 

(ll)           “Restricted Stock Units” means an Award that may be earned in whole or in part upon the passage of time or the attainment of performance criteria established by the Administrator and that may be settled for cash, Shares or other securities or a combination of cash, Shares or other securities as established by the Administrator.

 

6 | Page

 

 

(mm)       “Rule 16b-3” means Rule 16b-3 promulgated under the Exchange Act or any successor thereto.

 

(nn)        “SAR” means a stock appreciation right entitling the Grantee to Shares or cash compensation, as established by the Administrator, measured by appreciation in the value of Common Stock.

 

(oo)        “Share” means a share of the Common Stock.

 

(pp)        “Subsidiary” means a “subsidiary corporation”, whether now or hereafter existing, as defined in Section 424(f) of the Code.

 

3.           Stock Subject to the Plan.

 

(a)          Subject to the provisions of Section 10, below, the maximum aggregate number of Shares that may be issued pursuant to all Awards is 7,500,000 Shares, plus an annual increase to be added on the first day of the calendar year beginning January 1, 2017, equal to 15% of the number of Shares outstanding as of such date or a lesser number of Shares determined by the Administrator. Notwithstanding the foregoing, subject to the provisions of Section 10, below, of the number of Shares specified above, the maximum aggregate number of Shares available for grant of Incentive Stock Options shall be 1,500,000 Shares, plus an annual increase to be added on the first day of the calendar year beginning January 1, 2017, equal to (i) 2% of the number of Shares outstanding as of such date; or (ii) a lesser number of Shares determined by the Administrator. The Shares to be issued pursuant to Awards may be authorized, but unissued or reacquired Common Stock.

 

(b)          Any Shares covered by an Award (or portion of an Award) that is forfeited, canceled or expires (whether voluntarily or involuntarily) shall be deemed not to have been issued for purposes of determining the maximum aggregate number of Shares that may be issued under the Plan. Shares that actually have been issued under the Plan pursuant to an Award shall not be returned to the Plan and shall not become available for future issuance under the Plan, except that if unvested Shares are forfeited, or repurchased by the Company at the lesser of their original purchase price or their Fair Market Value at the time of repurchase, such Shares shall become available for future grant under the Plan

 

(c)          To the extent not prohibited by the listing requirements of The NASDAQ Stock Market LLC (or other established stock exchange or national market system on which the Common Stock is traded) or Applicable Law, any Shares covered by an Award that are surrendered (i) in payment of the Award exercise or purchase price (including pursuant to the “net exercise” of an option pursuant to Section 7(b)(v)) or (ii) in satisfaction of tax withholding obligations incident to the exercise of an Award shall be deemed not to have been issued for purposes of determining the maximum number of Shares that may be issued pursuant to all Awards under the Plan, unless otherwise determined by the Administrator.

 

7 | Page

 

 

4.           Administration of the Plan.

 

(a)          Plan Administrator.

 

(i)          Administration with Respect to Directors and Officers.        With respect to grants of Awards to Directors or Employees who are also Officers or Directors of the Company, the Plan shall be administered by (A) the Board; or (B) a Committee designated by the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws and to permit such grants and related transactions under the Plan to be exempt from Section 16(b) of the Exchange Act in accordance with Rule 16b-3. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board.

 

(ii)         Administration With Respect to Consultants and Other Employees.       With respect to grants of Awards to Employees or Consultants who are neither Directors nor Officers of the Company, the Plan shall be administered by (A) the Board; or (B) a Committee designated by the Board, which Committee shall be constituted in such a manner as to satisfy the Applicable Laws. Once appointed, such Committee shall continue to serve in its designated capacity until otherwise directed by the Board. The Board may authorize one or more Officers to grant such Awards and may limit such authority as the Board determines from time to time.

 

(iii)        Administration With Respect to Covered Employees.        Notwithstanding the foregoing, as of and after the date that the exemption for the Plan under Section 162(m) of the Code expires, as set forth in Section 18, grants of Awards to any Covered Employee intended to qualify as Performance-Based Compensation shall be made only by a Committee (or subcommittee of a Committee) that is comprised solely of two or more Directors eligible to serve on a committee making Awards qualifying as Performance-Based Compensation. In the case of such Awards granted to Covered Employees, references to the “Administrator” or to a “Committee” shall be deemed to be references to such Committee or subcommittee.

 

(iv)         Administration Errors.         In the event an Award is granted in a manner inconsistent with the provisions of this subsection (a), such Award shall be presumptively valid as of its grant date to the extent permitted by the Applicable Laws.

 

(b)          Powers of the Administrator.         Subject to Applicable Laws and the provisions of the Plan (including any other powers given to the Administrator hereunder), and except as otherwise provided by the Board, the Administrator shall have the authority, in its discretion:

 

(i)          to select the Employees, Directors and Consultants to whom Awards may be granted from time to time hereunder;

 

(ii)         to determine whether and to what extent Awards are granted hereunder;

 

8 | Page

 

 

(iii)        to determine the number of Shares or the amount of other consideration to be covered by each Award granted hereunder;

 

(iv)         to approve forms of Award Agreements for use under the Plan;

 

(v)          to determine the terms and conditions of any Award granted hereunder;

 

(vi)         to amend the terms of any outstanding Award granted under the Plan, provided that

 

(A)         any amendment that would adversely affect the Grantee’s rights under an outstanding Award shall not be made without the Grantee’s written consent, provided, however, that an amendment or modification that may cause an Incentive Stock Option to become a Non-Qualified Stock Option shall not be treated as adversely affecting the rights of the Grantee;

 

(B)         the reduction of the exercise price of any Option awarded under the Plan and the base appreciation amount of any SAR awarded under the Plan shall be subject to shareholder approval; and

 

(C)         canceling an Option or SAR at a time when its exercise price or base appreciation amount (as applicable) exceeds the Fair Market Value of the underlying Shares, in exchange for another Option, SAR, Restricted Stock, or other Award or for cash shall be subject to shareholder approval, unless the cancellation and exchange occurs in connection with a Corporate Transaction. Notwithstanding the foregoing, canceling an Option or SAR in exchange for another Option, SAR, Restricted Stock, or other Award or for cash with an exercise price, purchase price or base appreciation amount (as applicable) that is equal to or greater than the exercise price or base appreciation amount (as applicable) of the original Option or SAR shall not be subject to shareholder approval;

 

(vii)        to construe and interpret the terms of the Plan and Awards, including without limitation, any notice of award or Award Agreement, granted pursuant to the Plan;

 

(viii)       to grant Awards to Employees, Directors and Consultants employed outside the United States on such terms and conditions different from those specified in the Plan as may, in the judgment of the Administrator, be necessary or desirable to further the purpose of the Plan; and

 

(ix)          to take such other action, not inconsistent with the terms of the Plan, as the Administrator deems appropriate.

 

The express grant in the Plan of any specific power to the Administrator shall not be construed as limiting any power or authority of the Administrator; provided that the Administrator may not exercise any right or power reserved to the Board. Any decision made, or action taken, by the Administrator or in connection with the administration of this Plan shall be final, conclusive and binding on all persons having an interest in the Plan.

 

9 | Page

 

 

(c)          Indemnification.         In addition to such other rights of indemnification as they may have as members of the Board or as Officers or Employees of the Company or a Related Entity, members of the Board and any Officers or Employees of the Company or a Related Entity to whom authority to act for the Board, the Administrator or the Company is delegated shall be defended and indemnified by the Company to the extent permitted by law on an after-tax basis against all reasonable expenses, including attorneys’ fees, actually and necessarily incurred in connection with the defense of any claim, investigation, action, suit or proceeding, or in connection with any appeal therein, to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan, or any Award granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved by the Company) or paid by them in satisfaction of a judgment in any such claim, investigation, action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such claim, investigation, action, suit or proceeding that such person is liable for gross negligence, bad faith or intentional misconduct; provided, however, that within 30 days after the institution of such claim, investigation, action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at the Company’s expense to defend the same.

 

5.           Eligibility.         Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants. Incentive Stock Options may be granted only to Employees of the Company or a Parent or a Subsidiary of the Company. An Employee, Director or Consultant, who has been granted an Award may, if otherwise eligible, be granted additional Awards. Awards may be granted to such Employees, Directors or Consultants who are residing in non-U.S. jurisdictions as the Administrator may determine from time to time.

 

6.           Terms and Conditions of Awards.

 

(a)          Types of Awards.         The Administrator is authorized under the Plan to award any type of arrangement to an Employee, Director or Consultant that is not inconsistent with the provisions of the Plan and that by its terms involves or might involve the issuance of (i) Shares; (ii) cash; (iii) an Option; (iv) an SAR; or (v) a similar right with a fixed or variable price related to the Fair Market Value of the Shares and with an exercise or conversion privilege related to the passage of time, the occurrence of one or more events, or the satisfaction of performance criteria or other conditions. Such awards include, without limitation, Options, SARs, sales or bonuses of Restricted Stock, Restricted Stock Units or Dividend Equivalent Rights, and an Award may consist of one such security or benefit, or two or more of them in any combination or alternative.

 

(b)          Designation of Award.         Each Award shall be designated in the Award Agreement. In the case of an Option, the Option shall be designated as either an Incentive Stock Option or a Non-Qualified Stock Option. However, notwithstanding such designation, an Option will qualify as an Incentive Stock Option under the Code only to the extent the $100,000 limitation of Section 422(d) of the Code is not exceeded. The $100,000 limitation of Section 422(d) of the Code is calculated based on the aggregate Fair Market Value of the Shares subject to Options designated as Incentive Stock Options that become exercisable for the first time by a Grantee during any calendar year (under all plans of the Company or any Parent or Subsidiary of the Company). For purposes of this calculation, Incentive Stock Options shall be taken into account in the order in which they were granted, and the Fair Market Value of the Shares shall be determined as of the grant date of the relevant Option. In the event that the Code or the regulations promulgated thereunder are amended after the date the Plan becomes effective to provide for a different limit on the Fair Market Value of Shares permitted to be subject to Incentive Stock Options, then such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.

 

10 | Page

 

 

(c)          Conditions of Award.         Subject to the terms of the Plan, the Administrator shall determine the provisions, terms, and conditions of each Award including, but not limited to, the Award vesting schedule, repurchase provisions, rights of first refusal, forfeiture provisions, form of payment (cash, Shares, or other consideration) upon settlement of the Award, payment contingencies, and satisfaction of any performance criteria. The performance criteria established by the Administrator may be based on any one of, or combination of, the following: (i) increase in share price; (ii) earnings per share; (iii) total shareholder return; (iv) operating margin; (v) gross margin; (vi) return on equity; (vii) return on assets; (viii) return on investment; (ix) operating income; (x) net operating income; (xi) pre-tax profit; (xii) cash flow; (xiii) revenue; (xiv) expenses; (xv) earnings before interest, taxes and depreciation; (xvi) economic value added; and (xvii) market share. The performance criteria may be applicable to the Company, Related Entities and/or any individual business units of the Company or any Related Entity. Partial achievement of the specified criteria may result in a payment or vesting corresponding to the degree of achievement as specified in the Award Agreement. In addition, the performance criteria shall be calculated in accordance with generally accepted accounting principles, but excluding the effect (whether positive or negative) of any change in accounting standards and any extraordinary, unusual or nonrecurring item, as determined by the Administrator, occurring after the establishment of the performance criteria applicable to the Award intended to be performance-based compensation. Each such adjustment, if any, shall be made solely for the purpose of providing a consistent basis from period to period for the calculation of performance criteria in order to prevent the dilution or enlargement of the Grantee’s rights with respect to an Award intended to be performance-based compensation.

 

(d)          Acquisitions and Other Transactions.         The Administrator may issue Awards under the Plan in settlement, assumption or substitution for, outstanding awards or obligations to grant future awards in connection with the Company or a Related Entity acquiring another entity, an interest in another entity or an additional interest in a Related Entity whether by merger, stock purchase, asset purchase or other form of transaction.

 

(e)          Deferral of Award Payment.         The Administrator may establish one or more programs under the Plan to permit selected Grantees the opportunity to elect to defer receipt of consideration upon exercise of an Award, satisfaction of performance criteria, or other event that absent the election would entitle the Grantee to payment or receipt of Shares or other consideration under an Award. The Administrator may establish the election procedures, the timing of such elections, the mechanisms for payments of, and accrual of interest or other earnings, if any, on amounts, Shares or other consideration so deferred, and such other terms, conditions, rules and procedures that the Administrator deems advisable for the administration of any such deferral program.

 

11 | Page

 

 

(f)          Separate Programs.         The Administrator may establish one or more separate programs under the Plan for the purpose of issuing particular forms of Awards to one or more classes of Grantees on such terms and conditions as determined by the Administrator from time to time.

 

(g)          Individual Limitations on Awards.

 

(i)          Individual Limit for Options and SARs. Following the date that the exemption from application of Section 162(m) of the Code described in Section 18 (or any exemption having similar effect) ceases to apply to Awards, the maximum number of Shares with respect to which Options and SARs may be granted to any Grantee in any calendar year shall be 100,000 Shares. In connection with a Grantee’s commencement of Continuous Service, a Grantee may be granted Options and SARs for up to an additional 150,000 Shares that shall not count against the limit set forth in the previous sentence. The foregoing limitations shall be adjusted proportionately in connection with any change in the Company’s capitalization pursuant to Section 10, below. To the extent required by Section 162(m) of the Code or the regulations thereunder, in applying the foregoing limitations with respect to a Grantee, if any Option or SAR is canceled, the canceled Option or SAR shall continue to count against the maximum number of Shares with respect to which Options and SARs may be granted to the Grantee. For this purpose, the repricing of an Option (or in the case of a SAR, the base amount on which the stock appreciation is calculated is reduced to reflect a reduction in the Fair Market Value of the Common Stock) shall be treated as the cancellation of the existing Option or SAR and the grant of a new Option or SAR.

 

(ii)         Individual Limit for Restricted Stock and Restricted Stock Units.         Following the date that the exemption from application of Section 162(m) of the Code described in Section 18 (or any exemption having similar effect) ceases to apply to Awards, for awards of Restricted Stock and Restricted Stock Units that are intended to be Performance-Based Compensation, the maximum number of Shares with respect to which such Awards may be granted to any Grantee in any calendar year shall be 250,000 Shares. The foregoing limitation shall be adjusted proportionately in connection with any change in the Company’s capitalization pursuant to Section 10.

 

(h)          Deferral.         If the vesting or receipt of Shares under an Award is deferred to a later date, any amount (whether denominated in Shares or cash) paid in addition to the original number of Shares subject to such Award will not be treated as an increase in the number of Shares subject to the Award if the additional amount is based either on a reasonable rate of interest or on one or more predetermined actual investments such that the amount payable by the Company at the later date will be based on the actual rate of return of a specific investment (including any decrease as well as any increase in the value of an investment).

 

(i)           Early Exercise.         The Award Agreement may, but need not, include a provision whereby the Grantee may elect at any time while an Employee, Director or Consultant to exercise any part or all of the Award prior to full vesting of the Award. Any unvested Shares received pursuant to such exercise may be subject to a repurchase right in favor of the Company or a Related Entity or to any other restriction the Administrator determines to be appropriate.

 

12 | Page

 

 

(j)          Term of Award.         The term of each Award shall be the term stated in the Award Agreement, provided, however, that the term of an Award shall be no more than ten years from the date of grant thereof. However, in the case of an Incentive Stock Option granted to a Grantee who, at the time the Option is granted, owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company, the term of the Incentive Stock Option shall be five (5) years from the date of grant thereof or such shorter term as may be provided in the Award Agreement. Notwithstanding the foregoing, the specified term of any Award shall not include any period for which the Grantee has elected to defer the receipt of the Shares or cash issuable pursuant to the Award.

 

(k)          Transferability of Awards.         Incentive Stock Options may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the Grantee, only by the Grantee. Other Awards shall be transferable (i) by will and by the laws of descent and distribution; and (ii) during the lifetime of the Grantee, to the extent and in the manner authorized by the Administrator but only to the extent such transfers are made to family members, to family trusts, to family controlled entities, to charitable organizations, and pursuant to domestic relations orders or agreements, in all cases without payment for such transfers to the Grantee. Notwithstanding the foregoing, the Grantee may designate one or more beneficiaries of the Grantee’s Award in the event of the Grantee’s death on a beneficiary designation form provided by the Administrator.

 

(l)          Time of Granting Awards.         The date of grant of an Award shall for all purposes be the date on which the Administrator makes the determination to grant such Award, or such other later date as is determined by the Administrator.

 

7.           Award Exercise or Purchase Price, Consideration and Taxes.

 

(a)          Exercise or Purchase Price.         The exercise or purchase price, if any, for an Award shall be as follows:

 

(i)          In the case of an Incentive Stock Option:

 

(A)         granted to an Employee who, at the time of the grant of such Incentive Stock Option owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company or any Parent or Subsidiary of the Company, the per Share exercise price shall be not less than one hundred ten percent (110%) of the Fair Market Value per Share on the date of grant; or

 

(B)         granted to any Employee other than an Employee described in the preceding paragraph, the per Share exercise price shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.

 

(ii)         In the case of a Non-Qualified Stock Option, the per Share exercise price shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.

 

13 | Page

 

 

(iii)        In the case of Awards intended to qualify as Performance-Based Compensation, the exercise or purchase price, if any, shall be not less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.

 

(iv)         In the case of SARs, the base appreciation amount shall not be less than one hundred percent (100%) of the Fair Market Value per Share on the date of grant.

 

(v)          In the case of other Awards, such price as is determined by the Administrator.

 

(vi)         Notwithstanding the foregoing provisions of this Section 7(a), in the case of an Award issued pursuant to Section 6(d), above, the exercise or purchase price for the Award shall be determined in accordance with the provisions of the relevant instrument evidencing the agreement to issue such Award.

 

(b)          Consideration.         Subject to Applicable Laws, the consideration to be paid for the Shares to be issued upon exercise or purchase of an Award including the method of payment shall be determined by the Administrator. In addition to any other types of consideration the Administrator may determine, the Administrator is authorized to accept as consideration for Shares issued under the Plan the following, provided that the portion of the consideration equal to the par value of the Shares must be paid in cash or other legal consideration permitted by the Maryland General Corporation Law:

 

(i)          cash;

 

(ii)         check;

 

(iii)        surrender of Shares, or delivery of a properly executed form of attestation of ownership of Shares as the Administrator may require, that have a Fair Market Value on the date of surrender or attestation equal to the aggregate exercise price of the Shares as to which said Award shall be exercised;

 

(iv)         with respect to Options, if the exercise occurs on or after the Registration Date, payment through a broker-dealer sale and remittance procedure pursuant to which the Grantee (A) shall provide written instructions to a Company designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares; and (B) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to complete the sale transaction;

 

(v)          with respect to Options, payment through a “net exercise” such that, without the payment of any funds, the Grantee may exercise the Option and receive the net number of Shares equal to (A) the number of Shares as to which the Option is being exercised; multiplied by (B) a fraction, the numerator of which is the Fair Market Value per Share (on such date as is determined by the Administrator) less the exercise price per Share, and the denominator of which is such Fair Market Value per Share (the number of net Shares to be received shall be rounded down to the nearest whole number of Shares); or

 

14 | Page

 

 

(vi)         any combination of the foregoing methods of payment.

 

The Administrator may at any time or from time to time, by adoption of or by amendment to the standard forms of Award Agreement described in Section 4(b) (iv), or by other means, grant Awards that do not permit all of the foregoing forms of consideration to be used in payment for the Shares or that otherwise restrict one or more forms of consideration.

 

(c)          Taxes.          No Shares shall be delivered under the Plan to any Grantee or other person until such Grantee or other person has made arrangements acceptable to the Administrator for the satisfaction of any non-U.S., federal, state, or local income and employment tax withholding obligations, including, without limitation, obligations incident to the receipt of Shares. Upon exercise or vesting of an Award the Company shall withhold or collect from the Grantee an amount sufficient to satisfy such tax obligations, including, but not limited to, by surrender of the whole number of Shares covered by the Award sufficient to satisfy the minimum applicable tax withholding obligations incident to the exercise or vesting of an Award (reduced to the lowest whole number of Shares if such number of Shares withheld would result in withholding a fractional Share with any remaining tax withholding settled in cash).

 

8.           Exercise of Award.

 

(a)          Procedure for Exercise; Rights as a Shareholder.

 

(i)          Any Award granted hereunder shall be exercisable at such times and under such conditions as determined by the Administrator under the terms of the Plan and specified in the Award Agreement.

 

(ii)         An Award shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the terms of the Award by the person entitled to exercise the Award and full payment for the Shares with respect to which the Award is exercised has been made, including, to the extent selected, use of the broker-dealer sale and remittance procedure to pay the purchase price as provided in Section 7(b) (iv).

 

(b)          Exercise of Award Following Termination of Continuous Service. In the event of termination of a Grantee’s Continuous Service for any reason other than Disability or death (but not in the event of a Grantee’s change of status from Employee to Consultant or from Consultant to Employee), such Grantee may, but only during the post-termination exercise period (but in no event later than the expiration date of the term of such Award as set forth in the Award Agreement), exercise the portion of the Grantee’s Award that was vested at the date of such termination or such other portion of the Grantee’s Award as may be determined by the Administrator. The Grantee’s Award Agreement may provide that upon the termination of the Grantee’s Continuous Service for Cause, the Grantee’s right to exercise the Award shall terminate concurrently with the termination of Grantee’s Continuous Service. In the event of a Grantee’s change of status from Employee to Consultant, an Employee’s Incentive Stock Option shall convert automatically to a Non-Qualified Stock Option on the day three months and one day following such change of status. To the extent that the Grantee’s Award was unvested at the date of termination, or if the Grantee does not exercise the vested portion of the Grantee’s Award within the post-termination exercise period, the Award shall terminate.

 

15 | Page

 

 

(c)          Disability of Grantee.         In the event of termination of a Grantee’s Continuous Service as a result of his or her Disability, such Grantee may, but only within six months from the date of such termination (or such longer period as specified in the Award Agreement but in no event later than the expiration date of the term of such Award as set forth in the Award Agreement), exercise the portion of the Grantee’s Award that was vested at the date of such termination; provided, however, that if such Disability is not a “disability” as such term is defined in Section 22(e)(3) of the Code, in the case of an Incentive Stock Option such Incentive Stock Option shall automatically convert to a Non-Qualified Stock Option on the day three months and one day following such termination. To the extent that the Grantee’s Award was unvested at the date of termination, or if Grantee does not exercise the vested portion of the Grantee’s Award within the time specified herein, the Award shall terminate.

 

(d)          Death of Grantee.         In the event of a termination of the Grantee’s Continuous Service as a result of his or her death, or in the event of the death of the Grantee during the post-termination exercise period or during the six month period following the Grantee’s termination of Continuous Service as a result of his or her Disability, the Grantee’s estate or a person who acquired the right to exercise the Award by bequest or inheritance may exercise the portion of the Grantee’s Award that was vested as of the date of termination, within six months from the date of death (or such longer period as specified in the Award Agreement but in no event later than the expiration of the term of such Award as set forth in the Award Agreement). To the extent that, at the time of death, the Grantee’s Award was unvested, or if the Grantee’s estate or a person who acquired the right to exercise the Award by bequest or inheritance does not exercise the vested portion of the Grantee’s Award within the time specified herein, the Award shall terminate.

 

(e)          Extension if Exercise Prevented by Law. Notwithstanding the foregoing, if the exercise of an Award within the applicable time periods set forth in this Section 8 is prevented by the provisions of Section 9 below, the Award shall remain exercisable until one month after the date the Grantee is notified by the Company that the Award is exercisable, but in any event no later than the expiration of the term of such Award as set forth in the Award Agreement and only in a manner and to the extent permitted under Code Section 409A.

 

9.           Conditions Upon Issuance of Shares.

 

(a)          If at any time the Administrator determines that the delivery of Shares pursuant to the exercise, vesting or any other provision of an Award is or may be unlawful under Applicable Laws, the vesting or right to exercise an Award or to otherwise receive Shares pursuant to the terms of an Award shall be suspended until the Administrator determines that such delivery is lawful and shall be further subject to the approval of counsel for the Company with respect to such compliance. The Company shall have no obligation to effect any registration or qualification of the Shares under federal or state laws.

 

(b)          As a condition to the exercise of an Award, the Company may require the person exercising such Award to represent and warrant at the time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares if, in the opinion of counsel for the Company, such a representation is required by any Applicable Laws.

 

16 | Page

 

 

10.         Adjustments Upon Changes in Capitalization.         Subject to any required action by the shareholders of the Company and Section 11 hereof, the number of Shares covered by each outstanding Award, and the number of Shares that have been authorized for issuance under the Plan but as to which no Awards have yet been granted or that have been returned to the Plan, the exercise or purchase price of each such outstanding Award, the maximum number of Shares with respect to which Awards may be granted to any Grantee in any calendar year, as well as any other terms that the Administrator determines require adjustment shall be proportionately adjusted for (i) any increase or decrease in the number of issued Shares resulting from a stock split, reverse stock split, stock dividend, recapitalization, combination or reclassification of the Shares, or similar transaction affecting the Shares; (ii) any other increase or decrease in the number of issued Shares effected without receipt of consideration by the Company; or (iii)  any other transaction with respect to Common Stock including a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or other distribution of stock or property), reorganization, liquidation (whether partial or complete) or any similar transaction; provided, however that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.” In the event of any distribution of cash or other assets to shareholders other than a normal cash dividend, the Administrator shall also make such adjustments as provided in this Section 10 or substitute, exchange or grant Awards to effect such adjustments (collectively “adjustments”). Any such adjustments to outstanding Awards will be effected in a manner that precludes the enlargement of rights and benefits under such Awards. In connection with the foregoing adjustments, the Administrator may, in its discretion, prohibit the exercise of Awards or other issuance of Shares, cash or other consideration pursuant to Awards during certain periods of time. Except as the Administrator determines, no issuance by the Company of shares of any class, or securities convertible into shares of any class, shall affect, and no adjustment by reason hereof shall be made with respect to, the number or price of Shares subject to an Award.

 

11.         Corporate Transactions and Changes in Control.

 

(a)          Termination of Award to Extent Not Assumed in Corporate Transaction.         Effective upon the consummation of a Corporate Transaction, all outstanding Awards under the Plan shall terminate. However, all such Awards shall not terminate to the extent they are Assumed in connection with the Corporate Transaction.

 

(b)          Acceleration of Award Upon Corporate Transaction or Change in Control.         The Administrator shall have the authority, exercisable either in advance of any actual or anticipated Corporate Transaction or Change in Control or at the time of an actual Corporate Transaction or Change in Control and exercisable at the time of the grant of an Award under the Plan or any time while an Award remains outstanding, to provide for the full or partial automatic vesting and exercisability of one or more outstanding unvested Awards under the Plan and the release from restrictions on transfer and repurchase or forfeiture rights of such Awards in connection with a Corporate Transaction or Change in Control, on such terms and conditions as the Administrator may specify. The Administrator also shall have the authority to condition any such Award vesting and exercisability or release from such limitations upon the subsequent termination of the Continuous Service of the Grantee within a specified period following the effective date of the Corporate Transaction or Change in Control. The Administrator may provide that any Awards so vested or released from such limitations in connection with a Change in Control, shall remain fully exercisable until the expiration or sooner termination of the Award.

 

17 | Page

 

 

(c)          Effect of Acceleration on Incentive Stock Options.         Any Incentive Stock Option accelerated under this Section 11 in connection with a Corporate Transaction or Change in Control shall remain exercisable as an Incentive Stock Option under the Code only to the extent the $100,000 dollar limitation of Section 422(d) of the Code is not exceeded.

 

12.         Effective Date and Term of Plan.         The Plan shall become effective upon the earlier to occur of its adoption by the Board or its approval by the shareholders of the Company. It shall continue in effect for a term of ten (10) years unless sooner terminated. Subject to Section 17, below, and Applicable Laws, Awards may be granted under the Plan upon its becoming effective.

 

13.         Amendment, Suspension or Termination of the Plan.

 

(a)          The Board may at any time amend, suspend or terminate the Plan; provided, however, that no such amendment shall be made without the approval of the Company’s shareholders to the extent such approval is required by Applicable Laws.

 

(b)          No Award may be granted during any suspension of the Plan or after termination of the Plan.

 

(c)          No suspension or termination of the Plan (including termination of the Plan under Section 11, above) shall adversely affect any rights under Awards already granted to a Grantee.

 

14.         Reservation of Shares.

 

(a)          The Company, during the term of the Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.

 

(b)          The inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.

 

15.         No Effect on Terms of Employment/Consulting Relationship.         The Plan shall not confer upon any Grantee any right with respect to the Grantee’s Continuous Service, nor shall it interfere in any way with his or her right or the right of the Company or any Related Entity to terminate the Grantee’s Continuous Service at any time, with or without cause, including, but not limited to, Cause, and with or without notice. The ability of the Company or any Related Entity to terminate the employment of a Grantee who is employed at will is in no way affected by its determination that the Grantee’s Continuous Service has been terminated for Cause for the purposes of this Plan.

 

18 | Page

 

 

16.         No Effect on Retirement and Other Benefit Plans.         Except as specifically provided in a retirement or other benefit plan of the Company or a Related Entity, Awards shall not be deemed compensation for purposes of computing benefits or contributions under any retirement plan of the Company or a Related Entity, and shall not affect any benefits under any other benefit plan of any kind or any benefit plan subsequently instituted under which the availability or amount of benefits is related to level of compensation. The Plan is not a “Pension Plan” or “Welfare Plan” under the Employee Retirement Income Security Act of 1974, as amended.

 

17.         Shareholder Approval.         The grant of Incentive Stock Options under the Plan shall be subject to approval of the Plan by the shareholders of the Company within twelve (12) months before or after the date the Plan is adopted excluding Incentive Stock Options issued in substitution for outstanding Incentive Stock Options pursuant to Section 424(a) of the Code. Such shareholder approval shall be obtained in the degree and manner required under Applicable Laws. The Administrator may grant Incentive Stock Options under the Plan prior to approval by the shareholders, but until such approval is obtained, no such Incentive Stock Option shall be exercisable. In the event that shareholder approval is not obtained within the twelve (12) month period provided above, all Incentive Stock Options previously granted under the Plan shall be exercisable as Non-Qualified Stock Options.

 

18.         Effect of Section 162(m) of the Code.         Section 162(m) of the Code does not apply to the Plan prior to the Registration Date. Following the Registration Date, the Plan, and all Awards issued thereunder, are intended to be exempt from the application of Section 162(m) of the Code, which restricts under certain circumstances the Federal income tax deduction for compensation paid by a public company to named executives in excess of $1 million per year. The exemption is based on Treasury Regulation Section 1.162-27 (f), in the form existing on the effective date of the Plan, with the understanding that such regulation generally exempts from the application of Section 162(m) of the Code compensation paid pursuant to a plan that existed before a company becomes publicly held. Under such Treasury Regulation, this exemption is available to the Plan for the duration of the period that lasts until the earliest of (a) the expiration of the Plan; (b) the material modification of the Plan; (c) the exhaustion of the maximum number of shares of Common Stock available for Awards under the Plan, as set forth in Section 3(a); (d) the first meeting of shareholders at which Directors are to be elected that occurs after the close of the third calendar year following the calendar year in which the Company first becomes subject to the reporting obligations of Section 13 or 15(d) of the Exchange Act; or (e) such other date required by Section 162(m) of the Code and the rules and regulations promulgated thereunder. To the extent that the Administrator determines as of the date of grant of an Award that (i) the Award is intended to qualify as Performance-Based Compensation; and (ii) the exemption described above is no longer available with respect to such Award, such Award shall not be effective until any shareholder approval required under Section 162(m) of the Code has been obtained.

 

19 | Page

 

 

19.         Unfunded Obligation.         Grantees shall have the status of general unsecured creditors of the Company. Any amounts payable to Grantees pursuant to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of the Employee Retirement Income Security Act of 1974, as amended. Neither the Company nor any Related Entity shall be required to segregate any monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company shall retain at all times beneficial ownership of any investments, including trust investments, which the Company may make to fulfill its payment obligations hereunder. Any investments or the creation or maintenance of any trust or any Grantee account shall not create or constitute a trust or fiduciary relationship between the Administrator, the Company or any Related Entity and a Grantee, or otherwise create any vested or beneficial interest in any Grantee or the Grantee’s creditors in any assets of the Company or a Related Entity. The Grantees shall have no claim against the Company or any Related Entity for any changes in the value of any assets that may be invested or reinvested by the Company with respect to the Plan.

 

20.         Construction.          Captions and titles contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise.

 

21.         Nonexclusivity of the Plan.         Neither the adoption of the Plan by the Board, the submission of the Plan to the shareholders of the Company for approval, nor any provision of the Plan will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of Awards otherwise than under the Plan, and such arrangements may be either generally applicable or applicable only in specific cases.

 

20 | Page

EX-10.3 5 s104853_ex10-3.htm EXHIBIT 10.3

 

Exhibit 10.3

 

CODE OF ETHICAL CONDUCT

 

Shuttle Pharmaceuticals, Inc.

(“Shuttle”)

 

 

To All Shuttle Employees:

 

 

At Shuttle, we are committed to conducting our business with integrity. This Code of Ethical Conduct is a guide for every Company employee in applying legal and ethical practices to their everyday work. The Code describes not only our standards of integrity but also some of the specific principles and areas of the law that are most likely to affect us.

 

There is no quality more important than integrity. This applies to a business just as it does to an individual. Integrity is a core value in our Code of Ethical Conduct.

 

Shuttle is a good corporate citizen not just because we comply with the law, but because our employees are also expected to act according to our ethical principles. We are committed to go beyond mere compliance – beyond simply "doing things right." We aspire to "do the right thing" by being faithful to and executing the principles and guidelines cited in this Code of Ethical Conduct and to act in ways that exceed the minimum standards set by law. Each of us is personally responsible for meeting this obligation.

 

Certain situations may arise that are not covered in our Code of Ethical Conduct. If you have any questions concerning the legality or propriety of an action, or the meaning of the Code, you should contact (1) your immediate supervisor, (2) Shuttle’s Compliance Director, or (3) Dale Bergman of Gutierrez Bergman Boulris, PLLC, our outside counsel, at 100 Almeria Avenue, Suite 340, Coral Gables, Florida 33134, phone: (305) 358-5100, fax: (888) 281-1829, email: dale.bergman@gbbpl.com.

 

Compliance with the law and honesty and integrity in our dealings with others are not to be sacrificed in the name of profits. We do not and will not condone any such action. We will attain our success through compliance with the law, dealings evidencing fairness and integrity, and a commitment to quality. We expect your wholehearted support of these Company values and principles.

 

You will discover that many of the guidelines in this Code of Ethical Conduct are simple common sense and good business practice; others reflect our desire to emphasize integrity and compliance with the law. Our business mission will only be successful if every Shuttle employee follows this Code.

 

/s/ Anatoly Dritschilo, M.D.

 

Anatoly Dritschilo, M.D.

CEO

 

 

 

 

This Code of Ethical Conduct is a summary of Shuttle business practice policies and guidelines, which must be followed as a condition of employment.

 

TABLE OF CONTENTS

 

    Page
I. PURPOSE OF THE CODE OF ETHICAL CONDUCT / POLICY STATEMENT 1
II. GENERAL POLICY REGARDING LAWS AND BUSINESS CONDUCT 1
III. DISCRIMINATION AND HARASSMENT 1
IV. ETHICAL BUSINESS PRACTICES 1
  Accuracy of Books and Records 2
  Fraud and Similar Irregularities 2
V. GIFTS, BUSINESS COURTESIES AND BRIBES 2
VI. CONFLICTS OF INTEREST 3
VII. USE OF SHUTTLE ASSETS AND RESOURCES 4
  Corporate Opportunities 5
VIII. CONFIDENTIAL INFORMATION 5
  Insider Trading 6
IX INTERNATIONAL OPERATIONS 6
  Foreign Corrupt Practices and the OECD Anti-Bribery Convention 6
X IMPLEMENTATION 6
  Scope of Application 6
  Communication Responsibilities 6
  Waiver of the Code of Ethical Conduct 7
  Potential Violations 7
XI. WHISTLE BLOWER POLICY 7
XII. COMPLIANCE PROCEDURES 8
XIII. VIOLATIONS 8

 

 

 

 

I.PURPOSE OF THE CODE OF ETHICAL CONDUCT / POLICY STATEMENT

 

This Code of Ethical Conduct sets forth the standards for business conduct at Shuttle Pharmaceuticals, Inc. and its affiliated companies (“Shuttle”). It is intended to guide each employee in making business decisions to ensure that Shuttle achieves its mission and its commitment to integrity.

 

Shuttle strives to comply with all laws and regulations that are applicable to its business worldwide. Though customs vary country by country and standards may vary by business environment, Shuttle emphasizes good faith efforts to follow the spirit and intent of the law. Good business results do not justify a violation of business ethics, the law, or regulations. Ethical business behavior should exist at a level well above what the law requires. Shuttle’s reputation for integrity is one of its most valued assets, and integrity is expected of everyone.

 

Neither this Code of Ethical Conduct nor any book of rules can provide all the answers. A Shuttle employee must consider each situation carefully to ensure that he or she is acting ethically and in the best interest of the Company. Employees should consider whether their actions would withstand full examination by friends and associates or public disclosure in the press. If questions arise, employees should discuss the circumstances with our Compliance Director or their immediate supervisor.

 

Each employee is responsible for adhering to the Code of Ethical Conduct as a condition of continued employment; however, compliance with the Code of Ethical Conduct shall in no way alter your employment-at-will status. In addition, employees in Finance, Purchasing, or other specialized areas must comply with their own functional policies and requirements.

 

Violations of the Code may result in sanctions imposed by Shuttle up to and including immediate termination of employment. Violations of the Code may also subject the individual employee to civil and criminal sanctions and shall be considered as an act outside of the scope of your employment.

 

II.GENERAL POLICY REGARDING LAWS AND BUSINESS CONDUCT

 

Shuttle operates within the bounds of the laws, rules, and regulations that are relevant to our business. The rule of law is fundamental to civil society, to the democratic process, and to the conduct of business in a dynamic global marketplace. However, today's market demands that companies meet higher standards – simply obeying the law is not enough. To achieve higher standards of behavior, we need to make business decisions that are aligned with our ethical principles.

 

Supervisors must ensure that employees understand the values and are informed of the requirements relating to their jobs. They must also be available to answer employee questions or concerns and to guide them to other Shuttle subject-matter experts when necessary. There are serious consequences for failing to follow these laws, up to and including termination of employment. Laws and regulations are sometimes ambiguous and difficult to interpret. In such situations, contact our Compliance Director for assistance.

 

III.DISCRIMINATION AND HARASSMENT

 

The diversity of the Company’s employees is a tremendous asset. The Company is firmly committed to providing equal opportunity in all aspects of employment and will not tolerate any illegal discrimination or harassment of any kind. Examples include derogatory comments based on racial or ethnic characteristics and unwelcome sexual advances.

 

IV.ETHICAL BUSINESS PRACTICES

 

Our success in the marketplace is based on the quality of our products and services, the value our products and services provide our customers, and the competence and honesty of our product and sales presentations. Shuttle prospers only to the degree that we serve our customers well – and treat them, our suppliers, partners, teammates, and competitors fairly and honestly. When we fail to negotiate, perform, or market in good faith, we seriously damage our reputation and lose the loyalty of our customers.

 

 1 

 

 

Fair competition is the hallmark of our relationships – our business dealings will be frank and respectful, and we strive to generate mutually advantageous, long-term relationships.

 

Accuracy of Books and Records

 

The Company requires honest and accurate recording and reporting of information in order to make responsible business decisions. Many employees regularly use business expense accounts, which must be documented and recorded accurately. If an employee is not sure whether a certain expense is legitimate, the employee should ask his or her supervisor or the Company’s CFO. All of the Company’s books, records, accounts and financial statements must be maintained in reasonable detail, must appropriately reflect the Company’s transactions and must conform both to applicable legal requirements and to the Company’s system of internal controls. Unrecorded or “off the books” funds or assets should not be maintained.

 

Fraud and Similar Irregularities

 

Shuttle prohibits fraud and has established procedures to be followed concerning the recognition, reporting, and investigation of suspected fraud. Fraud includes, but is not limited to

 

·Dishonest or fraudulent acts:

 

·Embezzlement;

 

·Forgery or alteration of negotiable instruments such as Shuttle checks and drafts;

 

·Misappropriation of Shuttle, employee, customer, partner, or supplier assets;

 

·Personal use of cash, securities, supplies, or any other Shuttle assets;

 

·Unauthorized handling and reporting of Shuttle transactions; and

 

·Falsification of Shuttle records or financial statements for personal or other reasons.

 

·Use of illegal, not licensed, software programs.

 

Any employee or agent who suspects that any fraudulent activity may have occurred should report such concern to our Compliance Director, or Dale Bergman of Gutierrez Bergman Boulris, PLLC, our outside counsel, at 100 Almeria Ave., Suite 340, Coral Gables, Florida 33134, phone: (305) 358-5100, fax: (888) 281-1829, email: dale.bergman@gbbpl.com.

 

V.GIFTS, BUSINESS COURTESIES AND BRIBES

 

To maintain trust in our business relationships, we must always act with integrity. We must steer clear of giving or receiving gifts that are intended to influence, or appear to influence, business decisions. When we accept or give such gifts, it can undermine customer relationships, hurt our reputation, and put Shuttle in legal jeopardy.

 

Shuttle recognizes that gifts, gratuities, and other business courtesies may occasionally be appropriate in building and maintaining business relationships with customers, suppliers, and other stakeholders. However, our employees, representatives, and agents must avoid even the perception of favorable treatment or the appearance of impropriety when offering or accepting any item of value in conducting our business.

 

 2 

 

 

When considering whether to accept or offer a gift, gratuity, or other business courtesy, Shuttle employees are expected to use moderation and prudent judgment. Begin by assuring yourself that any offer you would make or courtesy that you would accept would leave you feeling comfortable if known by your manager, coworker, family member, or the public.

 

If you are a buyer, influence buying, or are involved in procurement transactions in any way (e.g., determine specifications, evaluate bids, etc.), you must be especially careful not to create the appearance of special treatment. In other words, you must refrain from accepting gifts or business courtesies that could be perceived as affecting your objectivity or influencing your decisions. If the "right thing to do" is not obvious, seek guidance from your supervisor or the Compliance Director. In addition, each Shuttle employee should promptly advise his or her immediate supervisor upon receipt of any cash gift from a Shuttle supplier or other business partner, or upon the receipt of any gift (other than customary business meals) with a value of more than $100.

 

A number of laws and regulations, including the Anti-Kickback Act and the Foreign Corrupt Practices Act, have been created to ensure that business decisions are free from unfair influence. Bribes and other corrupt offers not only violate Shuttle policy; they are illegal – subjecting both Shuttle and the individual to civil and criminal penalties. When dealing with government customers or officials, whether domestic or international, we must be especially mindful because these laws and regulations have been put in place to protect the public's interests. Any offer of money or gifts intended to influence a business decision should be reported to your the Compliance Director or our outside counsel.

 

VI.CONFLICTS OF INTEREST

 

Integrity in a business relationship means that all participants are working together for the common good, and are not making decisions based on self-interest. When we act with integrity, we earn trust and build long-term customer relationships. When we act, or appear to be acting in our own self-interest, we lose trust and damage our reputation.

 

Except as specifically authorized in this section, Shuttle expects that our business will be conducted free from any actual or potential conflict that might arise when one's loyalty is split between personal interests or friendships and the interests of the company. Judgment can be affected in any transaction or relationship where an individual might find that Shuttle’s interest competes with his or her own. Shuttle wants loyalty to come easily, and we will work together to resolve disclosed conflicts in a mutually satisfactory manner. Our customers and suppliers can expect to be dealt with fairly and impartially, free from any conflicting interests.

 

Except as specifically authorized in this section, Shuttle employees have a duty to avoid financial, business, or other relationships that might interfere with this commitment. Each of us will scrupulously avoid even the appearance of a conflict between personal interests and those of Shuttle in matters of importance to Shuttle’s business, and we expect those with whom we deal to support us in this endeavor.

 

You must disclose any matter that casts doubt on your ability to act objectively and in Shuttle’s best interest. Employees, representatives, and agents of Shuttle who may have an actual or potential conflict should report all pertinent details in writing to their supervisor or the Compliance Director.

 

Any of the following situations could present a conflict of interest and must be disclosed:

 

·Ownership of, or substantial interest in, a company that is a competitor of or does business with Shuttle.

 

·Employment by a competitor or any organization that does business with Shuttle, regardless of the nature of the employment, while also employed by Shuttle.

 

 3 

 

 

·Placement of business with a firm in which an employee or close family members has a substantial ownership or management interest.

 

·Acting independently as a consultant to a Shuttle customer, supplier, or other business partner.

 

·As more fully described in Section IV above, acceptance of anything of value – such as gifts, discounts, or compensation – from an individual or entity that does or seeks to do business with Shuttle.

 

·Employing or discussing employment with current or former government employees, or using them as consultants or subcontractors in violation of relevant law or regulation.

 

·Hiring friends or relatives to work directly for you at Shuttle, especially when you have control or influence over their work assignments, compensation, or promotion opportunities.

 

In certain instances, senior management, the Audit Committee or the Board may determine that notwithstanding an actual or potential conflict of interest, a particular relationship or transaction is in the best interest of Shuttle. Any such relationship or transaction must be approved in advance by senior management of Shuttle not having a direct or indirect interest in the relationship or transaction. If the interested party is an officer or director of the Company, further approval must be obtained from of a majority of the Audit Committee of the Board of Directors of Shuttle or the Board of Directors, provided that only those that do not have a relationship or an interest in the transaction are eligible to cast a vote. In each such case, the full scope of the conflict of interest must be disclosed to senior management and the Audit Committee or the Board, and must also be publicly disclosed to the extent required by applicable securities laws.

 

VII.USE OF SHUTTLE ASSETS AND RESOURCES

 

Effective use of our resources is critical to our bottom line. When we use Shuttle resources wisely, we demonstrate our efficiency. When we waste our resources, we increase costs and reduce productivity.

 

Our employees should demonstrate good judgment and discretion when utilizing Shuttle or customer-owned resources. Such resources include computers, telephones, Internet access, electronic mail (e-mail), voice mail, reproduction equipment, facsimile systems, production and operational materials, vehicles, and other equipment and facilities. Likewise, we will exercise prudence in our expenditures, pursuing best value and return on our investments.

 

Employees must use Shuttle or customer-owned assets first and foremost for business purposes and to advance Shuttle’s strategic objectives. However, occasional limited personal use may occur when it does not compromise Shuttle’s interests. Each of us is responsible for safeguarding these assets – never borrowing or removing them from Shuttle’s premises without proper authorization and always being mindful not to deplete their value, add significant cost for Shuttle, or use them in a manner that adversely affects Shuttle’s reputation.

 

When using Shuttle’s assets for personal reasons, follow these guidelines, unless previously authorized by Shuttle’s senior management to perform any of the following, provided that is lawful:

 

·Do not sell, loan, give away, or dispose of Shuttle materials, designs, ideas, data, or other property without proper authorization. Any improper transfer of Shuttle property, even though it may not be apparent that an employee has personally gained by such action, constitutes unacceptable conduct.

 

·Limit the time spent on personal business to reasonable duration and frequency – always incidental to your workday and never charged to Shuttle or a customer. Private use of computers and telephones must not interfere with or adversely affect your job performance or that of any other person or organizational requirements.

 

 4 

 

 

·Do not use Shuttle assets in support of a personal business, consulting effort, or similar private venture, or to support the business of another company or firm, outside fund raising activity, political activity, or lobbying.

 

·Do not use Shuttle assets to support any illegal or other purpose that could cause embarrassment to Shuttle or otherwise adversely affect its interests.

 

·Do not use Shuttle assets to be disruptive or offensive (e.g., involving sexually explicit materials, or materials that are discriminatory, hateful, or threatening) to others.

 

·When unsure of what constitutes appropriate use of Shuttle assets, talk to your supervisor or the Compliance Director.

 

Corporate Opportunities

 

Employees, officers and directors are prohibited from taking for themselves personally opportunities that are discovered through the use of corporate property, information or position without the consent of the Board of Directors. No employee may use corporate property, information or position for improper personal gain and no employee may compete with the Company directly or indirectly. Employees, officers and directors owe a duty to the Company to advance its legitimate interests when the opportunity to do so arises.

 

VIII.CONFIDENTIAL INFORMATION

 

The protection of the confidential business information and trade secrets of Shuttle and its customers is vital to the interests and the success of Shuttle. Such confidential information includes, but is not limited to, the following examples:

 

·compensation data of other employees
·computer programs and codes
·customer lists
·financial information
·labor relations strategies
·minutes of the Board of Directors or any of its committees
·new materials research
·pending projects and proposals
·proprietary production processes
·research and development strategies
·scientific data
·scientific prototypes
·technological data
·technological prototypes

 

All employees may be required to sign a non-disclosure agreement as a condition of employment. Employees who improperly use or disclose trade secrets or confidential business information will be subject to disciplinary action, up to and including termination of employment, even if they do not actually benefit from the disclosed information.

 

 5 

 

 

Insider Trading

 

Employees who have access to confidential information are not permitted to use or share that information for stock trading purposes or for any other purpose, except the conduct of the Company’s business. All non-public information about the Company should be considered confidential information. To use non-public information for personal financial benefit or to “tip” others who might make an investment decision on the basis of this information is not only unethical, but also illegal. If a question arises, the employee should consult the Company’s Chief Financial Officer.

 

IX.INTERNATIONAL OPERATIONS

 

Success in global business depends on our compliance with country-specific constraints and conditions, and sensitivity to local customs. Laws, regulations, and conventions governing business relationships vary from country to country.

 

However, Shuttle’s obligation to comply with U.S. law and regulation does not end when we or our products exit the United States nor does our commitment to treat our customers, suppliers, and community stakeholders with concern and respect.

 

Foreign Corrupt Practices and the OECD Anti-Bribery Convention

 

Corruption undermines trust, impedes the pursuit of democracy, erodes social and economic development, and destroys the concept of fair play in a competitive global marketplace. In accordance with the U.S. Foreign Corrupt Practices Act (FCPA), the Organization for Economic Cooperation and Development's Anti-Bribery Convention (to which the U.S. is a signatory), and similar laws and regulations of other countries, our employees, agent, and representatives generally may not offer anything of value for the purpose of influencing a government official to make an improper decision in their official capacity. Likewise, we are committed to transparency in our record-keeping, accounting, and other business transactions.

 

X.IMPLEMENTATION

 

Scope of Application

 

The Code of Ethical Conduct applies to all employees of Shuttle. The Code will be circulated annually to each officer, director, and manager, who will be responsible for ensuring that employees under his or her supervision understand and will comply with this Code.

 

Communication Responsibilities

 

Senior management should always be informed of matters that in any way could damage Shuttle’s reputation. Failure to disclose such matters may be interpreted, wrongly, as an indication that Shuttle policies and rules are to be ignored. Accordingly, any employee who discovers events of a questionable, fraudulent, or illegal nature that could potentially violate this Code should promptly discuss them with (1) his or her supervisor, (2) Shuttle’s Compliance Director, or (3) Dale Bergman of Gutierrez Bergman Boulris, PLLC, our outside counsel, at 100 Almeria Avenue, Suite 340, Coral Gables, Florida 33134, phone: (305) 358-5100, fax: (888) 281-1829, email: dale.bergman@gbbpl.com. Likewise, no information may be concealed from internal or independent external auditors. You may report ethical violations in confidence and without fear of retaliation, in particular to the Compliance Director or the outside counsel. If your situation requires that your identity be kept secret, your anonymity will be protected. The Company does not permit retaliation of any kind against employees for good faith reports of ethical violations.

 

 6 

 

 

Waiver of the Code of Ethical Conduct

 

Any waiver of this Code for executive officers or directors may be made only by the Board or a Board committee and will be promptly disclosed to stockholders as required by law or stock exchange regulation.

 

Potential Violations

 

The Compliance Director is responsible for investigating potential violations of the Code of Ethical Conduct. Any substantive instances or matters called to his or her attention will be reported to the Board of Directors. A record of all communications and investigations will be retained on file for five years.

 

XI.WHISTLE BLOWER POLICY

 

a.Reporting of Concerns or Complaints Regarding Accounting, Internal Controls, or Auditing Matters.

 

Taking action to prevent problems is part of the Company's culture.  If you observe possible unethical or illegal conduct, you are encouraged to report your concerns.

 

Employees and others involved with the Company are urged to come forward with any such information, without regard to the identity of position of the suspected offender.

 

Employees and others may choose any of the following modes of communicating suspected violations of law, policy, or other wrongdoing, as well as any concerns regarding questionable accounting or auditing matters (including deficiencies in internal controls):

 

·Report the matter to your supervisor; or

 

·Report the matter to the Company's CEO or CFO; or

 

·Report the matter to the Chairman of the Audit Committee.

 

b.Confidentiality.

 

The Company will treat all communications under this Policy in a confidential manner, except to the extent necessary (a) to conduct a complete and fair investigation, or (b) for reviews of Company operations by the Company's Board of Directors, its Audit Committee, and the Company's independent public accountants.

 

Moreover, if your situation requires that your identity be protected, please submit an anonymous report as set forth in the attached Schedule.  Please be aware that the address identified for the Chairman of the Audit Committee is under the complete control of the Audit Committee Chairman.

 

c.Retaliation.

 

Any individual who in good faith reports a possible violation of the Company's Code of Business Conduct and Ethics, the Code of Ethics for the Chief Executive Officer and Chief Financial Officer, or of law, or any concerns regarding questionable accounting or auditing matters, even if the report is mistaken, or who assists in the investigation of a reported violation, will be protected by the Company.  Retaliation in any form against these individuals will not be tolerated.  Any act of retaliation should be reported immediately and will be disciplined appropriately.

 

 7 

 

 

Specifically, the Company will not discharge, demote, suspend, threaten, harass, or in any other manner discriminate or retaliate against any employee in the terms and conditions of the employee's employment because of any lawful act done by that employee to either (a) provide information, cause information to be provided, or otherwise assist in any investigation regarding any conduct that the employee reasonably believes constitutes a violation of any Company code of conduct, law, rule, or regulation, including any rule or regulation of the Securities and Exchange Commission or any provision of Federal law relating to fraud against shareholders, or (b) file, cause to be filed, testify, participate in, or otherwise assist in a proceeding filed or, to the employee's knowledge, about to be filed relating to an alleged violation of any such law, rule, or regulation.

 

XIICOMPLIANCE PROCEDURES

 

We must all work to ensure prompt and consistent action against violations of this Code. However, in some situations it is difficult to know right from wrong. Since we cannot anticipate every situation that will arise, it is important that we have a way to approach a new question or problem. These are the steps to keep in mind:

 

·Ask yourself: What specifically am I being asked to do? Does it seem unethical or improper? This will enable you to focus on the specific question you are faced with and the alternatives you have. Use your judgment and common sense; if something seems unethical or improper, it probably is.

 

·Discuss the problem with your supervisor. This is the basic guidance for all situations. In many cases, your supervisor will be more knowledgeable about the question and will appreciate being brought into the decision-making process. Remember that it is your supervisor’s responsibility to help solve problems.

 

·Seek help from Company resources. In the rare case where it may not be appropriate to discuss an issue with your supervisor or where you do not feel comfortable approaching your supervisor with your question, discuss it locally with your office manager or island manager. If that also is not appropriate, call the Compliance Director, which will put you in direct contact with the appropriate people at Company headquarters. If you prefer to write, address your concerns to the Company’s Chief Executive Officer or Chief Financial Officer.

 

·You must at all times comply with the Foreign Corrupt Practices Act (“FCPA”) and also any FCPA policy that the Company may have in effect.

 

XIIIVIOLATIONS

 

Any violation of the code of ethical conduct, or by not following the compliance procedures in item XII, will have serious consequences, up to and including termination of employment for cause. Violations of the Code may also subject the individual employee to civil and criminal sanctions and shall be considered as an act outside of the scope of your employment.

 

 8 

EX-10.4 6 s104853_ex10-4.htm EXHIBIT 10.4

 

Exhibit 10.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-10.5 7 s104853_ex10-5.htm EXHIBIT 10.5

 

Exhibit 10.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-23.1 8 s104853_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

 

 

 

 

 

 

Shuttle Pharmaceuticals, Inc.

1 Research Court, Suite 450

Rockville, Maryland 20850

 

 

Gentlemen:

 

We consent to the use in this Registration Statement on Form S-1 of our report dated November 14, 2016 relating to the financial statements of Shuttle Pharmaceuticals, LLC. as of and for the years ended December 31, 2015 and 2014, and to the reference to us under the heading “Experts” in such Registration Statement.

 

 

/s/ Paritz & Company, P.A.

Paritz & Company, P.A.

Hackensack, New Jersey

December 9, 2016

 

 


 

 

 

 

 

 

GRAPHIC 9 pg53img1_s1.jpg GRAPHIC begin 644 pg53img1_s1.jpg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end GRAPHIC 11 pg55img1_s1.jpg GRAPHIC begin 644 pg55img1_s1.jpg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end GRAPHIC 12 image_001.jpg GRAPHIC begin 644 image_001.jpg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pg1img1_ex3-1.jpg GRAPHIC begin 644 pg1img1_ex3-1.jpg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end GRAPHIC 14 pg2img1_ex3-1.jpg GRAPHIC begin 644 pg2img1_ex3-1.jpg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end GRAPHIC 15 pg3img1_ex3-1.jpg GRAPHIC begin 644 pg3img1_ex3-1.jpg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

.=5UUU5%H\Q09\J&EW*D*W@U=0>"P.*-49?%1Q MSH:^JH]'DLCDI2)*("=G;3%A+0S &H,)2B/4"-"%A7&@Z.>+1:KO=J>K%TN9 MA3A1L=L.,%C*VQV5(!$J;0I&F:J6TR1MR73>N/)^,E2 'Q'##Z>@A:V'+<*2 MIMULYHNQTJBN'&XV!G41YBM9="8VJL=F8%:9P1JF1KFI[:.1H&E2D=E11BEPA_A) M>C*94J*5%NSDIWOZJL)^E!YGK[1#%^H90HYPY[5K*^<%5%T^H75*XN[Q5:LZ MMH<:HK5V?U9;@^.<"-&S;'$'!X7$@.5'-^TYAYH=#'O8M:W@=.FY0Y=1V";; M*3G"B4MI'R' M\#H2>F>M8&>2VB*"M.41VRYS3U26),F)E$UQ2=RJ!1&62%JCR\PQ M<)O8I&[-:]>D9U1RH9VBB#M$C&9L>M>HM[V'42SEKF>>6"CMF<<]4E,+1;PL MX$5C2BK(0_3E*".C&9'PDRIT8U3X +$88(2/6C_1*+?J5[=X$DR&O8%+G1E> MY7"(C)WF-C&9'7:0QMG>G)@,,4HUAAC*M; 0N*5W13EU@D7<)>D=4+>0U(7)/)%;6:\$KT38E M*3DG!.T8426$ =Z"'6M!SK2=:H880[OEV.5>,M;M!CZV07G9O7C#.CK)?KMB\;C MT6=48(&"(16LD.DKN)CB3C &!EW-DLDE !.AKR^JGIUV'X4I*L"0@!6PDIOA M?/-C/[K-VJ)TS.Y2S2$IN?)<6H5 MRJ1!.T+-&45#T[>O/LO,GWTFZ4R=[K!]*96]1/1(&D+>6^)7(I8G2A$0'T"( MW0PM+R+QY">2Z[G4-:WI5.WFV;#DUJVM(G..Q6),LHFLL0-C,Z#9*TA+4RU] M!HX%C9$B4#O0"@K>PF:$'?I@96DA,-01;^#(8E&$4)VWJ MFG<.2,+4FBWXI;\OW6S^/$I -/X]7]@SY2?A^,SWB]VM^N_4,<<*CI\]E8VA MTK&M3H[#!*ET:;'"%QQBWO?KO>!PF"$5Q7!4@=(O$8 M3 R'08WB5.+ P,47*<3$8%!YCK(%;I$+8 B'O8M:WO I2FY MTKWISHR!=DH.K9Q=%*0D29PJ^@HI+H7(N8$%NPH,@B8;<2J6!O6+Y+,8Z>XK MP$A&YF(T3F6 \(-'IP;"%]7&/L#NL:7%V9&AS<&!4:N8ESBVHEJQE6GIC49Z MQI5*233VY4<6"_H M(TQA"VQPD1J=TE,29X8GID$VO<4ED;>4>MI'!"H3Z/;G9I>6YK.TGBIR%B5IU 4AX"!%) M#2Q^S18@[V'35;9-1W9#4]BT],(19<"?U3RVI)E!G1ID<:>U,?>%["]ITSRU M&*4#EIN>F]0F-]HQAT<4+7K^F!)!)!"<.P)R2B ;%L>P$E@*#L6]:#L6P@T' M6Q;T'6O7^OIK K]T 7SQ,ZENRK+PF$.9*[>*^61ZXTZR=(H2MC\+M1&ZQ-.L M=7E&[-;O$Q2SV*DKPP9A MVPNIX.T.J-S?HTN M31T2I6W+BC6YS;RA@5$G)1B ,.@N?R*<%\[V*EHRWNB:QAMCHD:%2IKW6G!] MTFIT8V]SF"&+M#TFKQA^BM),+6/&V](%.+WZ,T7K8M!,A?4_,!M-/_1)% M[T\=0K :X%2*XT\ZC!U:(3VY>6SN):V9%+QL.S4[F:%*/7SBWL\6B_U'OVX% M=X?Y6O'9.$KL.(=45NZF,D=F$KVRDDR1)(W>(U\Q*I)+)/#8FM8$LDG<99V! M"24+9(S/3>!/G/'7O-'6B:7+N;;BB%S-<$5L3?*GJ#GK'1@;'" M1M@WAK;POWTRF9P7[0%[$H(2GG&HC-?$I"4;^S B=_\ (=PHH62& NG2D")= MBK]3\=2!K2+WDMS:+_DZ-U*;JW5GHVW9C.ZN(&M:6F%*'F5Q-_L"0'3Z8368S:=V@ZV%'?KQ5R:+&?+*.-GZ)XB M;>T)T*9L<@)]HD0"ME$Z+-T,P+[X#T_T_P!,!@,!@,#^>FO]M?\ 3 _OI_K_ M *X# KRQ\K4='.CIAUJTQ1S*O^>P5MK*4SE1.)XO(<8"SJTC@TQ4N(+I,IA# MG_[8# _ MGIK_ &U@?WTU_M_\/_E_M@?STU_MK >FO]M?],#^X'\]-?[:_P"FL!Z:_P!M M?],#^X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# T"41 X-Y(.E?( M9;733,IO&)\I="3;DGGKF12^K$L.@R*N84B)G$_!&C9JWQ)ULR[WQ^&22[.P M$_XQ.W$ 3G)O::, 0+SUY-X/SC6E6>2E-!F32<@>_P#M##E"DE,E]YH6/9?*CVM/Y5 Z MOB'CI)@%L6)R?9?3 (M>UY.$(4UH17%F+JT4H[28MU(7+&MFD"]$2H8S4R,U M0\%.B40BT11:DXL(G9//#-;T@$&)K:D;FCD,]D4 MC9DE"Q=RIZH[):&J8.S5$UKJW/\ (SVIG&FVF)$7L\\T*4)UA?DM[CL*\[N@ MT:\>9)$"Y_@%7VO/$3]>#"Q7=N+6Q0\HLR'0Q# GMI:&A#:[M-F8MH4MSDO1 M)F5.2H,5'#.V45L-:_4'D:G_ 'EXT/*_7%CUC4S653G*%-60"7U+-)5+8H&1 MVBZ+'(V!!6RN*QTB5N=>O<+4)C)''CW&-N)ZM;UH-O?D'OFR.9/#?9 MEU5!(-1&QXESA5"**RD)*&9NDARA",P RRE998 MQ!%H.P[#[Q;Q*\F'4O4G\)!(F6YXY(8!<*;L))(U[OTA-Y<%^BLRFKO-K8)7 MI7N:L=NI&DU"\-:@\;(8A7CT0E+T$OVA#[+Y;9\_%5%T"VT[#EW%5V=RCX9A MKVDDDE'T 4^*9=)*M9+C(28(5K:O M,EWVKY]EW50N(:%>::BW0IO-I**,="S)99DBL1+TLR4()NC\4/J@*18!U,=] M_3-.5I@[/*V:,.@" G$$PRSR[7_4MFSCD.YZ#J&/=JJK9YA@-+M\:L>9O'.D MFB_4RAS01Z;RBPW2$LDK0:@#I&'9(Z(2FHLYP5E$%(=CT88:4'>SKR+][5A+ MW*DU7-M#VC=3Q8QQHNYHJ-:QV"KAZ0N4L+TUR= MM=E2DUM-3)=(S%XE@-:# C?++UI7W2\&H+H.F:$KF6#O+FJB)S6\+D-C6JL< M$O1(2TH;S:;H8&Y-!*RA\9?W-$A;(S+6M-()3LE>8E&0%.#8PK4/I7J>S.39 MC8'3=&\]]3A5,8='X,KC=SQ*FJ[E-&JU!#SI8VPRR@#-0@=#T MAI81+1*%1XAB(T%N[D\K?0U?QWI/I:+US1$CY9Y=[9;.,I7!%+_.4]_R]0FG M,-KF;V.C?_K$0>&*&642\G;4PJ6YQ"[-GJK,]%D&AU$)\I'9BVQ+##,JC MYH!4]/\ DYB'CPF1\:DUG:GTD/L62PF),LRBJ9T;A,#4")'3$EP5B6&'_E@" M$D*(1;)^V>%F?--6U>V+R]4Q,^@\3FA3=VSQ$D0 E$?:WS2%)*^GZOBN #80JD2@PDS0BQ;#L+:]P7Y)>5N7[ LRK6:JW.7-U7J4(C6B%M#U]S\8Y<];5Q84S2RR"S) M%';*^PH;7S2\D\@11Y?M#Z%G!E=:^6FU[-NVXN:(9*.:Y];4=[CI.G*=>HA% M9^; ;'YFL!ODLOG\\+4&6$H7N4OK.(5])4;FY-HCV!,_M1:?03P*?<2%_NH> MH+SCG5/.7&7.C!5R">WA!;2M^26W<9[H\Q&!UU42N+M3NULE:1M_A\EG\VD[ MQ,T1:4!3PB3H$I1ZD[1H ;T$-/-F]#WGW')?$@&<(*\@4B%W%TK4%XU$ZUA, MK/IM5?/,D1M^.O#D_$G3U@0O<)5(&82^-H5NPK&MT4?;TK5_3$7@;!NXXA-N M;R?&Y3W&#I6_-U5RGNN,0F1UXP5VXDQ-VT\Q:S+7;TIK;!II7IB:&;D\26*W MAH3FDZ>E*HCY#RR"E!"L*)T??O1O']D=4O=95E00..7'S4.E)V0VF;D2"W-N M70+E2\".D-<-3$8RP2--$#?'QM./(6%.![T):H$'ZOP>X\+117LGKNZ*X ML>NJ&(2N-;*>HTWQ M9,?'B32"RCU0PGGC#$_*;4UYJ.Q*4Z9I6N:,[F#1'/>4G&D*$?\ *(D 5:YLN1]!9'A:JGBU MX7<_\@76I[TN1QI*W(:\ZFD.EU8R*QW*RZSFZB+3V'HG6'PQUGKLW15",DHA MM4MZ5P<0.8BBDY(=*J\I_:MJ1'IYG!8=60K4LXCZVZ2IUXA%4R/;-7:OF"QF M^,OT#JB[W.8FQKIQ9*:Y-6&K)@S("6F+/PR]IP.'U#T^@E&'=I>3!74/-'.? M+S+$KMZ%C_ G//6TQFTP8HTXF6&V6R>XM$ K)_*L'H:NW=I C:8R,N53E,;( M'%A[AD]!4XE@\@E*28P>H;9OM M\:(F>Y2)]C1Y!,^C-:NKB>>86W'$_E@I@@ <4 S9H0U6=Y=$]O\ _&CRA\37 M'8$,-LJ@.;8WT(1TC6E2.\=C-WQG%33%M$2IC<$B5P Z/ M):YM1&F 1"UL8L#9UKGYFIGQJ],+7]FJ5ZM.Q>4+.D5M6#7M$MM$%6>H9J8D MJ2!JI= PN+ZO*?(K#0HVT>UJLT[1J<8_81L>R0!I8X)NR[.:^3WCQ)P][6-O M2\_*H-_XLG2! @)NS M@DX&<\Q]#6)R!XR.%*SY:?XBWO%LV3W.1M>LK!WMWH"Q&^HK0N9RC[Q!J>:5 ML,;Y8]2 UF;@2^02!Q;&^.,^QGG& 'HK0 E>KO)CY$^L)-X\HA2*SEZKG3L_ MC";="NITT@<]DZ2.SZD+$9&.?-)*M',@B-B,_;PZ); A3!5-)3@HV:8J-(3F M[";JC[7[7'T7(N#+8G,!?.IHOVU!6X^01JFVQ!!7W@A=5+G;KE8RF+;LA6^, MZV5M4:5QT;D ]2!EE+@A(&6:4/\ >%6(IT??'/GC^YBA?-DF30J0V_W#WO'' M%)!H/';8Z&7Q*&=)=&2K;10%)R@LB&RHS;BA2E2-U=SD+/&6$9JHY008,@>@ MRVD_);Y"^H6_Q]1"#2CG>N9EW3Q?TM8Y\J6U5)GU)6UK\]S4QI%+$3.HGIJ> M2-DO:BTJ8IL-VE3M9ZE2J&)<$!"3 XE?^1+L#R%0^J:2K^:5?SS,W[QQ3SKJ M[YANMT4P;Y_-V2RIG1Q=.QB.3Y=(&Z/U2_.4:5+G=TV2H>!(QE_0,3^T>Q!: MV$= 2/F#_P =.#=!UVFTAEM:>.2'2*$!/5EJ?P=HS:JI)S#T16EGR"21Y5*:40R.&3U. MZJGRO8]3$7@#6FL-21$8ZF-:)8BE2UP<2E1 EGJET$:?072Z \4=-W_.>E9\ MLN/HZN73J%KI,R:-M;V*C:(_'K#H"1PQ^KBX86U.<>> -%BM*: MK?I0,1R4 MM$$_XB"SE)IH@T$^42%.W(W9ZWRJ5LTKWIWY![,H*N;T+0$J"'Z=4[9')%(( M%SK(G%F A_(JS7%2O1&B4B"2>M?2=#_M[&'81IS3&+H1>?7GBZ[&:=ME^]8\ MI]"]1*HDZ)EK756-OU;X?K"CO/LXYQ\9EX=WVM95I5 MG+94RN$2D\W<[SCB]9*9,\MQS^WL+ ZGN4R4-S&/1:,EN1*MD)RM *$4'LJN M]FYH=)53QLL7UVGNJ'1ZW7SF5J%(&QJEQQ2NGY%&Y_J#,25T;6 2PU1\I BS1C4A* &XV.<=\Z6J&47JF4V M4[BZ;F5$]!R12Z2YR;Q/#36;63(*AKS32F*3!CM:,:MV,<5+*F^$:]>J4?>/ M4 .-+$%5Z-G48I/RU>1Z#.3HDB%;634G&=]O+X_N;%'X*U73*4LWI@]KTXK1 MH"BY=9#!!&@TD@9@U"XQN-WKW>@ A#<_@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@:[WSQ^(F'HRU M.GN;;ZLKF&?WXUQU)>[#"X[64TKBSWR(%"2QJ>.$+L:'2)(QV C;CC4JES;S M4XG DW>U !F^XT00&[>'"N]QKGA9"ND^A*XO[G"U+WMZ*=,QD58&V&]R/IF0 MNTKNQJD<;=J^75PNB$LD+L(XMK_$?61@!\8-;",?N#*(3XKP5Y< [OC7770B MF$B%,8F8V\I"G;4 MR,ML+TEP(!KWP/UU2S55FJ$[%ZSH>:06IW*BIQ855/=>1Y\NVJC9*^R".,UC M-IT&7QSS.G:R97T*4UUXRP09LA59// M976UDS$"^@H?0EJB M22TRH2A*$9!@8]$O$=4,(L_^0QJX+D;*.;>DE?8,.Y4)-@1E.0CI!2F.$3.6 M!2KA:J=$L#7(EJE\1QS;K^$(># G:(V H!6!2?JCQPSKGOQLN/&O.JKJ#I^3 MVMV?![P-E,>W4LAH%TQ([ M3)EU9-UA3NP*HCS5%ZJ:9@ZMM1HVY7 *Y9VXX#6R)4:-& QR6&FZ-,.T( 8' M:_AGYGMBU+;MU1:O5T!DEPW%7G0;VW5=>:R%QM@NZKV]J:8C9T6:4C HVGE# M?G)NL=@CUO]15[%;,Z3BO6;G$85:$ M?)CT?O"*/A,N)ED.2R*!2-0P'/*KFB0 MVI8UA+76SRX==R'Z*BYYL^XZZ)1C8YS*X,KA*IW$O<7QL1N[NG1 MNJ-"\NR(D]80=[=@$&%*?$#12F-V#'O\W]3I%%F=@1[N6429ML&!MDC,O^+Z M(-:7=&>>&NB+@3R<5Y=#=HW>_.["E8H?+[(O)M6R2FMD6!$[+4O-/',,$CS7$ MGIUDT&:?M&&)%A1B9"43HL(0!] FBJ/&A0]7P3I^N'&:WY/1[6H6JG8DA(0%UENS$J_>G(7L,%M M_=1#"(2P0@AV_5'"U0=8RFF[)D\@L^KKEY_=9"YU%=E)2Y-";+AY,P;BFB7, M9+DX,LC9':.R9M("2J1KV]45[?79?QB&/8@BY9XNN?"U'()T,EMVU>5Q9,I5 M8=9HJ^GR%N13" 'QZ.#\83OU MOR!6'9L&AD%LU]LR*%5]:$7MZ'2RH)VY5M/H],8JD>6M,H:)>SEC=&Q.Y,'VCP0B4U^=T#V,N8)?T]'^O'D;SB]<&U&SVESU;[O6[^772J2*I6OBZ]K M,1OL/>D2]Z5B-&-:V*#BQ (D98P!%H(]EWB=Y*E\6Y:B9Q5N1XCDI?.UT D M,.M^91>=RPNV?E4W$W6A/VI:3,I>@M][/,<9)H*U(:Y*S3="&$@XT@81M!?" M'PE7;XSO,=:+D&E8(C>E8M$4>KOG[[!FVF+^97MDE5'MD.=7-4PM%3, 9"J5 ML[4C)3_7<1!5J#%1X CT'#'X.N'%,0HR-N(^@U\@Y_C#S 8=;1?1-FL-RNU: M/IYYJRKI?8<3>(^[O5;I"5)B9 S ^NB:D9@R$0$Y1A@1!?.U^1><[LYU4.?S(Y'8JCKM'M:QMS&T1 ;>;$M1M:QJV]VCRZ,*&I,8B4I#RCR!DAWH M?ZBUL*PG>*'EETIVVZDX3WX5#&V[++EMWSA?6@D1"Y<,_:I6$XW9@]B,%O81XQ\44)'SH0_ M(V>3J++K>@9#S)![L<9M)EUSQVH)*>A5+61)8![B)U.=TBML3G(W8_Y71(:7 ML91X1&G[-"L!/AIX9_@57URXQFW'IAI^4VO)(.NR&.'D L0"&,MC^C7:)^-$21\&DZ MPA #00I?7/C'K&1T; M4'/'8\8C/2<9X_EJA!R;8CL_2]IGA=7)&IJ1PTFQ2(VIC"/IS-61;)RF)VY9"].Y3 MF;EK%$Z-5N[G)E:?>U):\:I,(!Z@&B] 4J FADE%^/'B?F>U9Q=]$%,FF3"W*Q+]?R%=MS?4D<3."Y:VPEK>%V]&*4;(0WI#MA#H9>]!#K07- MP*PK>+N5G0^WU#Q1L#?17^H9E=UE2!N-?T=G*HZYHGF/*IB@>5*Y"\*&%Q;4 MPT0S"]B2A3E *V$!8 Z#^.7%G*CQ?:#J5SHF +.B6L]">VW(%2F1%,WJFVG!Z$#)&((@"T,7J&+VEX]>(;KFSW9-H\NTY+Y])VD;# M*9>MAZ!*_P J9C3!F'-LJ<6P*%1)49XA^A@%VU&C Z"$7J$(=:"0%')/,:N@ MDG+"NAJM5L"D+-2,.AT&E+K+5#.P5?&V5&(@:ABQ^[?Z:UZ^W6M?TWK>M?[8'/UZ^FO7^O\ K_ZX# 8# 8# 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# KCUOT;%N3N=;5ON5F)1D0.+ MK5;"SJ1J BE4T6A_'0F'I0(RCU@U4GE"I*CULHL>R@&B-%Z +&+05*<.\)7. M/%JJ[YIMFA*>7H*656FXPZ7Z>'B,HWJ$G&DV7"]G,KBT.NSR%S*XHD"D1FM! M'\)QA8P>H-A1MI\N/2D.KWQ_7I;E:T=(*K[BG22!&1BMC9NTV?72I:^GL"5U M3:D3T[LDN3#/- <:#1:+184^RM"V,\(RPS[I[R&=W\XV-3,2D-*\^L+5TUU7 M8'/M.@D+A8#C)V.',4]:H?#[2FQ+0Z(V=P(DZ%\(JN[?(-R0VYOK*TE M%2+13@QK-F*%"A ;HM0468 S86!GG=5^3KLL/C\Y7C-9KK1K>"LDVZ3O^R$$ M@6U? $JML8EJI!#Z]C,B3O[V_KE+\C+(2+GE( D2SV"-,TG-.P(EZ\[-\AW( MO/G35BSJ(T*[KN_H_:Z]U8)BE1L3A8@7*$R.O7KZ>E!87 M!R!L.]>NO8I+&6&UFGI=8=B\P5I/'EWBK3:,\I&)S)8\M<8QMSDNUO2';J6>>4#V?8 (7OT&ACG?R5]^=)T@[6%7TIY/77,ML MVU(+4/-BBG;&22^Y4M-1%#.):H2R ZZ@H8*X.#$X TD_)D_3+4ZVG,4;-,+U M@;?O(#>=P]*@7QD(FB6Q16SJ=+ M7(!@5VC%>@A3[!\ OD]X U66GY)^V(I4/BYF<77<]JI5Y G%LCTA2/=73,IB M@KM)WN(:9U[28BM0UN!R,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,#5?U[ KHZ;Z=I.AF!KM6J:9K=HE5Q2*^D\"K6>5M*;.$VH8S"(&:R30Q^ M2JBVJ*O\D4&&K6P(4[P) :3H8R0CP-5W.W*/:U(\D>13BAKYYM684M;2:T47 M),RD,AJ6/2(QTDFQP0QOF,)53Y.HA[)(TY!#T!=L)*8)2=0:(DL:LDG01M4O MC"[-Y6UP_P!<410;7++\JAF(62JK M&PR(M:QYKMR7Q4DURGJ0N0REC+CJP*C2#YT M@#\2DSWZP.7Y@.=^A^BYEQ0 M&B:7DUE)*)O9JNN?NB"05W'&Y/'FQT9P;86DV;32-'NDK5EM1IH" %Z3 +V# M9AX-CUK _I/,737,?DUM#MJM*T47_2_5\):HU:$%CCY!XO;U0/#&T10+IO:#CN0HX$T#EB44 M_L%O0%&+3?JFHTWH'Y"0F&GD!JSY8Y([(YI:'RS6CQX29TZ];[-AT5 H:LO"[[+@<6KUU.9W*%P9"-['IL5RB>KOY.]L+&WLNEK2:9])*:8 M=H2DLLDO8 B$$-1MF\C]QOM0>'J*,_(LE7O7#CW&Y;< /\I4FG5[-ADKBR < MPBV6887L6M^T0M>F]A]\!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,#I)))HY#6%VE4N?F>+QEA1'.3Y(I Y(V=D9FY.'W*'!U=7 Y.A;T M2<'[C#31@+ ']=[UK BY7TGSVBK<%QGW=56ZE&XFM(;.33R-+8!^3(-4)SD MI_P!^]!V$B.\WAL>C)MG&G #U$(.MAC%GW54E*(F-TMZQH MA6;/(W<3"T/DX?$4:8%#QI"J<0H#GYV-2LZ \U(B,$7]@\K1H@^P&Q#V$.PY M#S<531ZN-7"]V7!&RI]MS<[@LM7*V,J!F-+NH3)&IS*E>UOX,UO<52PHL@X) M^RS1&!T'>_76!7E_\A_$473LZU\Z8JQ$VR-P<6J-/ 7P2QCD[BU.)S2O1QA\ M0IU+1(SB7%.,K6D1Q_O$'?L]VOUP)OTP)QP& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P&!"?2WI_QRO\ ]=!WK_"=J^NAAT(.]?P5^_00=_H(._\ 76_ZZP/'>3 [ MP\;=05&D8%4BL3AWR-4A3:9>R+C!*D=/=%3R.05]+5[$:G^FWGK%FS?K>T9> MW=J"<$W1BEN(V(-M'F^>)Q?L:6\77"Q-!5/D^ MZ;Y:HJXM+?JGC4RMMO&-5]*7M8C3J59B<3\ 0'?1!X2C=!5!]2M!V'U#5",S MI&0<#]->/B;Q/2EE\:[S;&LMQ 1149952)2V:="&Q\>Y++@_ M(;]<]O:VT'PF@&$HT,QZ266?KQU^!QGWDAV6*W1*X=$)8S&NZ)K$K*'8D9 M837)+I;3U8]%6)'J]5R,IT#X MEJ 3DQ+VQV3$*R=[+,^$\O8RQ"!O>PBWK88$?SE1RRGHY0#G6L;>Z>B#=&6J M,P20DJ)"ULB.&&I#XE] ]\4.#D2KC9R D2)1\_V$PB@[ /7MU@=?%>8J1A$Y MN"RXM#E#//+[( FMJ4$RZ;G.DM)(TX!0 &8JDAY;-^(*=5!:#;<%)MO*,^-- MLH&@AT$!Q_Q@<*12/O$5C5!MS"P/\RB]B/#0HU>?%9@><1-@*= MR)E4.1II*O0]'?+[!B%L99>P!,5H<>\TW.Q6)&K+J6/R5FMN1Q.6VVD M<]D,%9D$?B3A*EC$ZM:YYVQ-#6G))*/-&3_9 ,0!#UH6!#DA\7_",KBE<0:1 M<_M#M#JA1.2"L8TJF-DB9X0G=WU;)'$4?0@F8"4*I2\N!INU&M?.$/M+"/11 M98 A+M%\;:UQA\FQ#6J,C+5 M(7(@Y.>@95SN$HM2: 8!EDB%O6];UK U1QOJ;R(ROI3J/F*.,_(#W.N9ZJIR MR"QCC-O,359SI;#0].Q$(;G)79R\,+$C-8C$@'944O*$,XLT:4L 1@P,UXU\ MDD=M*?7=2O25ATA7UWQCKBVJ*J6OV5Y$RNLSB4+/:6Z/'!;GQ\=%:V0N;S^0 M2%"T-/IS-2B^J1OV[UL+S1[JGG.66FJI*.7'!7BUDBJ1H!PE&]$C=U#E#@DB MES6W;WH*1V=8KH[7Y)*E-.4(?07S ![!^T)_P&!%MO794]!1,J>7//(_6\,- M?6:-?R>4*]H&0AZD"KZ;0E6N&RQIT!:M3^WYCQ%D%ZUO9@PAUZX$%$>0/C=; M4@;Q:[YB3Y6IMAFU&D=X^G?Y [N5I%:--_QVT0QF9UTV>)D:C)$K*;DK<:I. M0Z^T D^]&X'6H/(]PPXLD#D!/3=7D-UGQR02N @B=#0ICG1A M4N* M1OXQ&Z%^F!:# 8$47!>%5T)&44MMF7HHFT.S^UQ-@+&DPA%O0:]>O?)+7\-H&M9QSU8:-R6 MW7?,.H1%8R:K;#L=!4*I9-&Z.V:X2N!,[&0YD6=!4!YI:.'N^T#PL1L+S\W-]X-E8I$U^V)$+5EXGEZ5,,\B,#JU7V8.JF$-<%1Y3/ M/MLA@/RY:,M(B"J]0E$%Z#O6PGK Z.32)LB$I.%Z ++&/>@[#2JS^6R.3Y=PS>:%U,J M?F*\E'9*&SF.90A[=9DL/HI@$IK]3%G%(V?DGL;[K0%NV^/MSD<>H.VB">8< MD4E;"[$A\EO&$=KFK[8';9S] [@9IC*(4[PZ!6-,EAD,KI0)%84W?XY&HFYR M>)Q"#..@IG5SOS"\)2UK:YMZLK>P&IU28X(M?T$'?Z"UH6MZT&68'\WOT_P#GOTP*(PWR M5<=3FZ%-$M%IB0R\:B>I(N^R2,2:,UG9*NJ0*16FFJZTWMJ10*P#*XVB/T\? MC5YX4FR#?78M%CV$.&R^3KC!Y,G98K/>&$4#KMYN$S^5UG9T7W-J@8!(27*T MZH ]1!&9:T% J7@*+7, 5X3=^HP!$5L)@@C1-YF/'>LCJ21)+M=U6G5,,Z/L MB2I+@62*4J 1(B9!;8NU)8*<-_7J&PT91 4PAEJ%B8\@H8QDF>T):!Y(N2W2 MNZPL6%3E^M NY1RHFMH%5T!FLZMR2*H!HW=B)/\ %C(R'S5G45YL@8'K2](E M"@-]A0]_*:2 P(\FOEWX/A3-6+R*UGV7ZN&)NLUKYJKRL+*G#\]L3!)5,.D& MA,[#%E2QO>H]*$*A"X-B@)3D@.3F?.06$/NV&8[\EG,1\V=($R*;-E3LE)ND MJ.N<8JF:.T5L20<\M GBX877,K+;2V&5S&%%E&D*$11X=B5)S2BQ#$#>!3ZI M_)/'NEUGCGL)78]KC2( M@"\2QL,(-5. S"-;V41[]A=>/^1GEN367'*U;9++_2=2B80:M;(55Q-D],6M M.8&F4J9-#*NM@3+N&SR2IOQZPI,E;E)XG%0A4$H_L&E;#@=+1_DUY3Z(FU=P M6L':SG!7:JB>ML&D;Y2EJ1."/,BK74B/ET/U.)+%6N-)IDW-<65KMM9J@"W2 M0(1"+",7LP-@.M^NO7 _N!4_M_IY%Q[S'9U\#92Y5((V@;66OH6(XTDQ+N@=RLOC\G)=HJ[D MEW)ML7-+NJHQ$&)K96.P0I&AR955/,1S;(6 -70%>XKFI0M?D7JG5)$1!NE9 MQYQ@@P_QM>6F!SSFFFVOJR4V.Q7$3R[-.A9Q<=E5V5":YLF,5I(3T-BOT =V MU.WII1_$$ZY($\3>UEHU&_4"4Q0< P 0O!R1Y+N9.T; FM75 XR@J;PB',=B MK&>2-S($+I 9$M"W-<2N]##1[*&(TD,*D_F>J:%T5?-JS&A;PB%A\RK:C'=//$HW7S59\:BMXB; M?\<3MN4ZF2F)2&-/!3RE^7ZZ_P"VC-,V4>26,.M""/Y=YV*W@<5@\[F/&_94 M8AEE3>M(;7S[(8%%V$F>!LV&BF#2]0@#U+D ),D(*+$1\1 _F&(9)F]%EGE; M$$K(O,M0Q->W(\3.KKA@%T4Q>D+YO=N:7]OBRRT9);UFG*2ZVCD6[6-+FX,,95M@-ZWXXW'MGG MN#DY ^I[P#,*$,,2MSRVV*^R_P 61G-5*25ZKWNMS62YS,?3X,BE;JPQ]O*SM9H2.KDD5QN1 M',&F.QHS(FMG--0*M[9]#'O0#=%;"9L 9&U7[8OD[C4^J^NHS9G)EU\>=QUS M';83 NT+4J9([$C5SLZ.JETKED>&.UV]Y; *D1\-&K2MJI7HHTYSV24#Y@QV M[D%S^-RH%73JFY)I+DK+V,2VND%M:W7Z>1-QY=ONV8_$PQ202:1-"9+&)!#W MUX%+6MW3-XSXXC.,C_SK6TOWB#>F2<2H)*4)S2SR#RP'$'DC":2<2:'0RS2C M ;$ PLP M;"+6]ZWK?KK ^F!A]A/"^/0.:/S7'U\KO3T>:98^#@EBJFA;7+1<]R]&M52F!J(:A6 M&2:+2.NS22"E@U(!I%0S]_"9ZEBUL)QP&!0KINB^JK'OBE;!I6V*XB5=0& W M6PR.*S-IDYS^AL.P8>JCL*M:#K6$P3.KD4/$=L@*=[3K$)2-2JV62(\X)A0> M>OL1YZMY,EG(RWLZJ]=>\STIS63![TB?.=HV:A% [GEW;EO>,6STI,H=))RZ M2>PT]K3BI7>XW2;BIB;,+?*S%KS+82;*U;#H0O\ [BL,)ULLS19Q8=!8*H%3 M-8'_ )&[NTD12SX76KC33M.FFL+%03:!C1RLJIF9*LF&H"\KD_XY4M=S5AR9 M5\(?<(>S2_07IO0=WX;J_CTWY:\M2>6M<@L(:"WK4KAI;7V;RA:NW#Z_C#E( M87$V=X>9%L;%MO?CMG$JRSR#M'[ 8:=OXP;"$2>37DB&4IXLXQUK%I?9@;4F M4;XK:8BI#95AI$-8Q(VJHJSRN.,2,J7F('84WD^G%]M[%DM&.-J6Z1'G2:@JF0LX'EU-7V )\:E& ME,UTX*D.][!IQ;RP[]"!'$&!1_P@\O5_>7)K1W*5RUWE2QIC\!21IECT<'() XK1?A88T%"2D; (LCV M!$;Z>HQ"V&K?L^45Q67F%Z5IQFQ"#U5[1IBD\V?)BP5ZI5K'A]BXGJ)25YI9 XMLB E*;I4X2%,F>3I1[VPP]"5 M]@I$>(S1._B"8&MYII#J!,SSU"X<47JO63/S>Q[L0I-H^JD)8:(9)='WD+^X M/9%GZ.(5$D(#C"B"M&:]1>WWZT(6!,? _'=NT+>4:K>><--)T@I2X+EGK9W- M(;G=7.LG^$68_2I5^9JBH"I8]+&&YY+&I8!J6%C;6U&G("K./.$8+X3@]%^ MP*0]_P 4LR?T2W06KJ75W:ZO5P4:]/["5)H'&4K1#JZMV&6;*'14.?OS$V/! MRMIAYB!*@ ,7V%2P'RB+(T89H-.LWY![Y;+FZ;F4!YU"? ;3\BL-Z"+31BX* ME@ML/=2QVFGZ!&/E4V(>^GFTM+9!(2-!?5Q $DDVRO1A"%2$T:LP(?'A/A[M M.E;PX=?+7YT3,L6YE:O("V2^1,=KUA+4SL=T1*_YO72UJT=)44I>E*L:83\Z#N2<6+QETI1K&78LOY$NB02]UI92^LT7#9,'LV&+*YF M)[%()&XM<=;YQ#VI?M8U:7'$IC0C4 $8$6P ,"D >.NJ_LMD^24Z8DD5[>5J MN^W; KI3:L +CG/M6U09'VH@IV7HU)J:3V-8K5'].*X$?+=" K3@$&'[T1\Y MH>@' 8'!<[F/ MD+NFGW+Q;0N;\YQ/47X?E73S7-YS7EUP$U%(HM9<==&IAEI$8D;4C=]K7Q:[ MF'[1D[^TI BD]M$:(L 1]"?&QV+"914-TNW-7,M\&%17IB"6/S/>-CM@V6 M,MMJ=$SSH&NY?"IV574X94,@(U/OQ,A2$(#"S_Q_H6H-), 86'H@Y^A3Q7-) MU?")#&*OA<@C<-9F]^B=*L1T:J>//6DP3G5IK]D4[^RAC*->:8!-\F@F&!U\ M@@AV+8=!,&!QEB8*Q(I2#&,L"I.>G&,K>M& ">4,H0R]BT(.AAT/UUZZWKU_ MTP//767CR[8%RRY>.B?-/-D:H2,Q;H^#QWJ1([/D^N:5P^V#I0JC#>PP!='6 M-%5;ZN=)0$R1+].KD4>W(OJD)OD-TH"'\>^&.[++15!+9K#:6BMF_H%I]'N>T1_N,V4< /C7'CTZLH#H"I>VH6UUY8]H.3[UXXWMSVX62XQB-Q MMLZBL,FQF5'4-@+(HZ(#%L(5M*%,\?;0ITSF/1QZ<(1C]VP[GG[@'I^F>G.% M[26QRK%L3K"*]G.M[;8IXJ;TL.F?85I/=J&Q:MF,R':42N/UN>-*V@4J!-^W M !FS=!)T#V;".:[\>7:C#U#$K?EL-HE_$.;7*86T.C.P.E9)!)7M:VS-2Z#1?94%DEI"B- MG"-.'\(9[3'CFZ;BT'YEY3L=HJ=UH;A7HYSZ-IV\XK-GEDMBWB8JY2F6U/73 MC$-QY035"YQELT.+E;F0ZN*12U( IDR;U4"-+"0:EX=Z[BB7@)ND1=$HD] ] M2=.]*7.:WRR2R'V-MW/%A.$>A,#TYP%N*F!_<#71Y4:$G'0/'LJ:JS:U,EL.K)O6/04.A"0192FQ'>CILT6". MODBDPLW:1RE[:SJ$2(P(1;TN,)UO6P[%K KE-*GM[K'H"GN]^8'2J#8XJXUN M'F^6US=1]D067Q673Y:"0EI5Z1OA+FX-CO$I4F(0/"%P1I5)!91VP $,1?M" MI:3PI7D_P#E"F)W8=2%U]5O!EX\?V](8XZ34V5B?+;E!DK:YE6[2JBC>VN2* M*.T?93!$N2Q")868J*V$OV%C,#83P)R?UC1[W^:Z2F/+Q26,5NCJ^-1OEJG4 M4%)L79*MJ5'6G6!#(54R)(9BTR1J:-I&4C2A2>8$XT9?Q!M/P& W^NMZ M_P!\#5%UKXZI/875-7^0'F&?Q6ONM*AB;A#4C/:; ZR:EK1CBMKD3*4US9/' M'!JET<<4;7*UI1+FWFJ/9K97O2F;*#O _/3/!E_=SN.L&R%TH>$6BUPC%S.F3HMZ F3 .#L\84_L M7PMVU;=0]C$3>_J^!?W7##S572N0,T(EO^-(-5W-.X7I@;$;8Y2Q7*9!+)(* M(!.5N2M3OV",]F@#_<8(*_\ FMXV57,JD:V0O<;6,.=]FS@CDK-4[>K:K&8IT[H%#A'PM+W*E'\? M6-T?1";27$S:[Y=F[4C3:,T$.@P9+X07<*6WE:KK%Q)ELK[09N[Z>?6BHD"9 MNIV[F]TDJET(51UVG3VEGL/D32\I$BA*>:B4AVV$F 4!]Q@!!^;:\&I=ITI) M("?TN>UV=9G9CEVW;EJ?XF3*FV0V,H9'AE:XS%*^+G:-'$H)>'7;DJP^O;+D-O M>1=;W,5<;Y\$$(@J.++P)W1,-I1)R M)+(].)!@7'7H9O9&P_'_ .W?N_0.N\A5(NO8,4@?'Z:+O(X?.[#K>R+@L18W M+2H5$ZOJB>LTU=8X6Y?!I(_SNQ5K 6S(FLDX(TJ96ONT&F07A^FA'(=6L$KE (15DZJ>4M\VY\B.LQ;;$C,2 M>I?L-=W#7R%W/0,C^D5J#2_EV.]E$IBI;-'^?(PHA*RUN]$)CTXQDZUH[V@"Q6 P M&!12R>.9C(K^G70M8])32IY!9580NI9K"3(- K#K1^C$)6S!P;5ZR,RMOVH_ MD^E$R4E!6 5@ %&(P@9)@3/4 4BFGA"@+]5_(E0Q'H6=U_#^.I#JR(,!M@5? MNKG*;E62E7+I!8LQ7."/6EA;TY&D@_%$EDI$R=. L O;_0+#,/C0;6SR)B\C M3I>$E=K%.BKC!ED$3P:'LT2<(JIC(HPWIURU($Q\/>6I(6F]J[Y=#-+2%E#! M[/7U# JX\2Z:D';H]HHKJVYJKI;J:<+IM9=3-3# 7A8UGOH32I4DKZRWYF73 M&)'2%"J.1B5[&J4IT@B]$[">26HT$W]T^/&'=LQ@T,XX!>@"%Z;WO869B]12J(IW!-!690]87U(Y"FFLCD$UC$SDM>0$J00:8R9L+0N3QM,T(T+ M5+TY:A$E.3I7$H0" D? $7U]A+ %6(+X;)W5U%V!S;7'D0Z%B%.VNLFCM8L; M;JUHG\F_O-D!++GZU)+OX4&61\B2D$Z*$0B6$@(*$,!>]!&+6PD=U\3PR^L7 M_KJ"]+2&%S)TJ!LH-KAQ]/5?+:_8ZG9V5F9$$="P/R09;HI))9"A_.IV(&][ M]FRMEZT' O;RKS>EYAK9VAAE@R^VI;,+"F]K63:,Z U)Y+.Y_/77\@\O2MM8 M$;>P,J5.C(2H4B)"G)2IDB0L Z]-^H66P& P& P& P& P& P& P& P& P& MP& P& P& P& P-3\Q\S''E>.UNM4Y07S%P4!-8K +N>%])2U0PU=(INK/2Q, M$L=&L#@0G;W\*8PY,J(^SQ1@6P*95D_1=HES7949GI4O%'@PUF8+>(: MS^R!,4$POT.$(>@X$[U5U+3=SV_T#1T D)SK/^97V)1NU4!J3:1,@=9BP;D+ M<4TGG&:-=TZ0@ TZL\LO1)*TL9'N$, O0*13;R^4[#[LZ+H%!SMUQ/[!Y:95 M$LME'7U=0!]*1P<@;1L$X8$JFUFQ\D4=4I7Y(I!]9&)8%*;\IA @'L(=K1UA$H\Z.K'(D")X6J([+XS)9C%'QJ=2PQE MV ;HDE42F,:S_G,*#LD1H9]>7E"Y4H3D*N.UY._2"05#;88?JO6Z'H65PG M4 /W4?4U.W#S-$NMVF1%Q:E997G^3A2";J&ED%%XP0F4*744N,3.CDU,ZZ/B M2'$KRM*C=)CR1E[%L0=ZP*'M_E[ALCK:6='PCDOK>=AL&+;' M@F..2IM=WR)5>]V SVM)(*WFHS=J7HEJT2DT4:(\LLLDTP <%P\O\7<>@9)S M#5O+UVVK;D=@R2VMIFN7T#%X8NJ![@L8G<8L0B?2^VFF-DMSL@EJ0!Q!AH3T M81;,%H0=;] ZZY_,A$Z4JBM;=DW+%^(V:P;FG?.RR.OZ^KXQ-(7=4-?W*.I8 MB_QY=-CS%2"0JFHX\EU0&*D)"(.CC!^@P:&$S=*>1I1S)8@Z]E',]I2]65ST MJOXY; I#!7LWX4LJBU<[@Z9E-=TCLND"BSIRSLY1Q)8THPK!*]CT029O05=: M?-BJD$[OVJX]PCT0_P!F\LL#G*+]A+)-Z,>'6%,;.O3('10TC:I^M2SM:UB5 M:VI1,PUBP.]""64:((M!"R=1>3J+VOV5:'&W^$Y[#WVH(>?9TULZ22>OB:]; MZJ4QUBD48G(C 2#3Z61)TTK:]!1F) *D 5(QK-$Z(-UH.%7_ )/2KS_R=,N: M>3N@^@^?ZH>7-@<[TA(ZX:6FPG./B-#)"J,A\RF<=E%LE,_LUZ&)"TY:L7J6 M1LP[XRC0F29^0V@8+PVG[^?MRYOIIQ@S+,VAC<6,INL)Q62-:0SL,)_CQZ[: M9+,%\@4@0;(,5:(*/]VQG:*"(S0=STMVK#.?N0'/M!BBSI<]6MD9A\ZV5!G^ M+HEJ^"S$]K)229J6OSDC:7$I,6\IS!)RCA'FA%O16ABUZ;"3>5+_ $O4O/%5 M]$-\0=(&RVU%D\S8(T_.;8YO*&/.1APF8]V4LXSFPE8O;P 4")*,-^#1F@"% ML81:T%2*P\F3#;;='+"A=#6,^4!-[^:^=H==+-*:Q=4ZB5/%F%58W2B50$B6 M@G$,@:]^]XTZI2F,6F$#3&"1@*5 ,T&SO?KK6_3TWOTWZ:WOTUO?^GKOTWZ: M_P#EO T\1#RS+9G+>VH*V\CVB3)^#8VZ2.X$2J?5J%&[A:U"P\;9"'@MT,:7 M-Q51=I6NY(%9R+W)D^B]^U08 K QZIO-=4%]AZAE/2'4G\243&P(-$I5%8Y!:7;TC<2O/16M:KL'EKD<3.;]AT4O",K9AOR%B*+&4,.@KM6/DC(LB5T_&Q,S>4UY!I+-(4,1D.ES_ !)@>)/$C!FA/&9&7]Q; MU+JPC&> (][2FE;V/6M_UU@9S@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,#R*T[S;5WDD[H\P]*+>D'5AIB97=SU,I)'J>=X,K<;F8ZZ:G M!,>%!*EJ5[6%1B,2@G298:W%G)M+3R?FW\A9&!PT37#(Q_Y"%B0FL>A$7.S) M6?'<<@D7D;.&)2EH)25;44&3O=;/R.5 <(Z+48AS K<5):SVGHC671HO:(O> ML#%/#SVY1_(_.'E+M"<6W$']\CU_22?0Y*ZO#2@>K>4/#8Z-<#=FMK;=I0'( M[)EJ8)03D10$A(CA[#\90/T"'Z0GMI^+SR:4)>76$BJME8^Z:U=E5\OM=6FY M6HA?%5AR-1(TEWO*8;2UG1J-J[ 6(2VXM(!R0)FA&KT2I-%HT8@XM[AN2Q_) MYY>TO!MI(&:S7.B$[>1'((R0R2+;R+9FNM&:\*FCJUY",IMG92=,\.&SFS>W MDQ+[G-@VHK9E;^G4S%<5&3A=('24,8Y37E^0. MVWJ0O[MI&J01!TFUA;4(G88"TVA."1+[$QHMEDAK[L"@[TIOQZ=:5'T<8YR9 MGY.MJ5-Q0QM0$)BMA*QJ"R9I0?,?DQA IZ[)Z^?WI7,ZBK)O+(FMOL\"&R@D*ZMS'E8M;P MFG)1!-+1[/'[2C0ZT&T.FYW7?2O M(E;Q#HRXR) SD2MR2-D*1*'(Q(2I);A?$2,XL\9I.@UC>/M N8?.9Y'9DNC, MH98+<;0\L=6S5?$GI!";#DD)D$1.G3=$Y:7%6&+O;BSJ&9>-0648V)), MRD29H7JF)^9EJ1>4E5#-*VE/U[1;+$' F#Q"].Q7C+B0GF+J*!W%4=[4=.+9 M0@K!74=B2*56NEF3&D@..-*3J"31!F MG;L)LOR-6-#^3:7JULB%6U'43[;=GL/24*MBM*W>[,M>+#A<)A[(^P.-.+,M ML>@$,Q7/ZK2)8O0I) 8G*V$\9!YB8->U7/M[R?P:=?<0VM4]^,5P\[@W ZSV MB@-E*#[KB)]H-[M%4D-.!$S-26/)G5.K:CDR01I(V$HD[U+(&(8 V9<6=9N] M1<5>/[FZ$5-:,@Z%<6JDJAFD8FE(7S%(;5C< Y$58TBL&<'UR5'V4I@CQ*D* M/>E)A:AQ&3K?N*T;O0:GX304_@5G\_\ 5GC;6W?2O0=R7;!B^J?'T\PNR(K6 MT=2.KRYZG;PM/>X@0SL]'(MIW4]N6O0%J4A"HT-H/+5H]I AZ=>.NSF+L'=^ MDME56A4;E0-V/5,/K!;#*4PR)S4-C*ROB*0Z:BC#]M2=X1/ 32DAI@SP)A$G M"W[%!>!YX>8F.P&.Y_\ R#)H_P!?]"MT/6UHZTR+GO:O[$-I+KB%2!]JVW*QK2P+5AR-4KET1D X].10"-/[O$ M7]-IH4)Q@4I=%#-^(8#!$G ,P-MSIWTT?=J <-YSZ4E[!<:XA:&_2\PU26,I2:8KTG^P,Q048((Q;%O8PBWK?KK> M\#CAA<. 2]@]VM^W>]^G]<# MD*XM&5^TVU\<8ENT2W=>K-/5JSBT*%,C3 V/XD:!*0F("60266$,]P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P&!TRV11]M,.*<7UF0&I]$[4%K7-$E,(TH",9&S@'GEB*T< L M6P>[6O=H.]Z]?3>!R#G=I3(2W-0Z-Q#:<$H93@.GG*1! G))>FTTT\8Q!" !)8%(AFB&(6M:T' M6][WO6!R44CCSDH"D;GYF7JA &8%,B=$*I0(!7I\@PDD'F&; 7[M>[?IZ:]? MUP. HG$*1R)-$%F93587(]&B$J*T::$ MK8"]F!]V]>[7J'[532'(3TZ9;+(TD4JW%"T)4ZI]:TYZEV=#BD[8UIRC50## MG%Q4'@+((#K9IPQA" .][UK Y3E)HVS*B43Q(&1J6J$BE>G2.3J@0JCT*,P@ MI6L)3JE!1IJ1*:J*"88'6P $8'0MZV+7J'$89K#95I/N,2V,R/2MN*>$NV%^ M:GC2EH/V6$ET3[;U:CYFXX1P-!/#ZE"V/7H+]=8&(O\ >E(Q21&Q"4W'5<;E MA)R%,=%W^PHDSR(I0Z%D&MA!K(XNZ9R+.<2E10B ;*T(X)@=@UO0M>H=2DZ3 MYU7E.)Z&_*56DLZ 3J[G)+3@RDIK; +4;8-Q<3"7T8$* #DXIT^SC=A+T>>6 M7Z^X8=;#/8;/H+8K8>]5]-8E.F9*N-;%+M#9&SR=L3N1)*=2B<:3.L29T[6_K M6MCG:V&G+%CDE0JU&_KE*1;)UL9^BQA%WBQYVKWO.K.M=2EW$7Q4^=IP^SJ3 MY?)E G)?61%:2)ZE0H3+HVO2K"8;#9PSN3*2QAPN*N# M*.O[M;R^1*0P:*1^#P+H.K6ZK%<09&5FDM1RV/R:3SQ(YUD,IH&CAZ;9B$HD MX"/XBSBO<0,K9?IK00#0DE6\R7+_ .0-UA64Q #8]XV^$N9.I/'.R6-=\,9 M[7NGK!%.IO;][R)1N06V&=N,DDT>3NDXE.>EJN*SK63NB M9&UK)3$=R6M95.3X*N>!$#<&M*_-*YJ<#T7RZ)-").88#>PA] O7PA6-;[LR M7=#NE/P3EVY')YN[FMHI2*QVOX,>LK:"S>+R-G!(DD,7.#18,SCFV,Y9MZ:C M=)1MKO[!E["44/04CZ5@4)<__(HXG,71*.J#';F^32IW-&SH-&N\DCK-=B9B M?'@E@UH*J\^0&"MEY?^2"WML+B;3\@ ^\L8?4.PUZRCQDTK,>.A<4/T\MQ=6Z^4 M.$KE$S4., 56O-'!VF[I8KE_)Y>LKQ0G5'KY>Y_:/6DHR'([X &I$6(X)H8 M>+Q3UR.41N-2JC908\LI9+8I M$N$=L3=&&)DX7)4662$HP( !\^4?']6_(MH7E;<(LVYYC) M>BG,$AM%%83[#UD==I86[.+L&6(66*P:))VI[T8\*R?4G82-D'[#LKU" 00Z MZ@O'%2?/UD=%V0T2BS+ /ZM$]J;TA]H.4.DT$FKF]OSP]&.BJ.HX2S@(/2)Y M"O;P$@,TD,0JS G$FF>TT(8-!?%-157L;S75:VQU% :%D+HYO#USS$;N=F.M M%2QZ7B7NY:1S0-Q-I,;8Y[]A*A&WR-*E.3@^,0-Z$9[PR-X\8M".W03KU$GF MU_1FZU[ DAB&6PNVG2)[8*_;6= QM<":6UG1)VX<<0(&TOT^V6J6'G^IYYYI MWH/0=//_ !.\IVC5ZBI)X?<$BC+K=KWT5*%ZRU7_ %*9K;[VSIF#%9H6QHA3FR6(\LT=9F)N"Y!/C_\71: UKV5\_-+?R)"D)P5FE9@ M1_MWH(0BN+>*KFB'+^C79DD5\EN_63 [1V^G57H(!H(#->T+/\L\NUCQ[4C;1].FRX%=L;H[ND?:9?*7" M6JVI^^XMC2X.?JJ3-!KH,Y7HC8A:"H4G#UO\ ?Z:"Q> P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P-$G0ODXZ?JKLCHGEV%5/S^_-]&\[OW4"63S&9SN-&O\ XXS M-CZOBJTQ&TN2!HEAJ)6:$E5O0T C@ "+0-#V((=*C\O]G6'9OCH9*GJ>N4L$ M\@#&K7HQ3][EH)O5[G#) XL-BHEZ=C0Z8I,W!5M9Q3.K),3;4##[SB@ WK6! M;JXNO.@X%;_94#C4.IIPCG-')[#TU%W!\<9N2]RG;T.;"W%7\E 4) W_ $5 M8]_]RGV9[AJT/[-:"?ZA3Y)Y<+S@%'\5]57?4%/GT5U_+V.%#9*NE,U/N"N5 M\G,7%M+J1'WYH/;+!;T86L\:PE&-(HT+9)9>AC-!@2'TEY%>I:>ZNZ$YUB%; M<\O#73G*,H[ 8I++)-8;6ODL$BX1EK(6XHFUN5)6V8C4HU6BSRAGHS"@%BV$ M&S! +#!V[S+R2ZF3ABO>:Z=9E/3':+,MDBZ/6.YO9E>4M#F)UFD9D4W>W*,I M N9>GNCE%H_"2,]A>9>SNRU6194:<7 MQH1)CWE.G8DA0W4D)0#@Z$8 (MY\\H'8'2"?HIOA5;87%[ M;=LSRO96M:[M&QZ,VU.:I"0>O;=F:$+0]H51@RO7UWZ^WU]<#NL!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M!@,!@,!@,#S;6;R,;T)YJ)7+[PY)LF>R1;UH)GOUH1IA89S M-8[;%I1[R)=0@Y\NZ(ZNCCR-R@C#3W7W"W15,4CP_P!85%QS8$IO7FQ\;Z[Z)YDN M)A"Y;G?_ ':IV4W1446=Y>Y1W[2AODNVD3G]!UJ53 MU-Y:T-Q7WP'>COSA*N9(I3[6Y6W6R(V/QNQAJSI6H=Y]*-!9+K'C>R*=['Y>[^Y2K%LG3!14'54U:/.L52)6MX14X MM,>2#WJ@(L4ZQN+G2UM:I8Y!"S#.2)3C?C- TX0]:"OKUSGU/?W9]\^3B+T M[.:07U#RK.8!R+6UHH(Z"X+"NU-6'!"U-B(K9ZUQM;$ M,6M?K@8:AMFJW16D0-MF5^XKEXA!0HT,RCBM6L$#0A#"D3IW(PY0( 0;WO0- M;]-:W_M@=W$IG#Y^Q)I1!)7&IK&5AZ]*DD42?6N2,2I4U+U+4Z)DSNS*EC>> M>VNB(Y,H $S8B5!0RQZT,(M:#)MZWO6];]=8'TP&!$UPWQ2_/L M=;I;>%I06J(V\2!KBC.\3R2-<;1.\F>C=DM3 U&.2@C;B[KAA%LM.3H9NP!$ M+T]H1;T';6E;=84A#EEAW!/HG6<%;W!E:ETNFSX@CL?1N,C=T3 Q(U+HY')T MA)SH\N)"NO3U]=>GIZ^OK^GI_7U]?Z>GI@1Q5UPU5=T?7R MRG[$AUG1=KDK]#ETC@S^W25C(D\76;;Y"R?E6H]2A-7-"W7QGA ,7L%^GK@2 M1@10UWM3#Y;\CY_9;1@SM=T/BJ2;RRJVV2-BZQA4E"UKVF V()7P&!4V>]X<6U;,'2 6-U/0\*F#$)62_,!S%Q@ C$!&V-:,T\W>M;WH -[] M-X'5UK8\)N"O(1:U;/Z:5U[9$489O"),B)6)T<@BLG;$SPPO*4AQ3(UY*=Q; M599H G%%FA"/6A!#OUU@9M@,"):MO6J+K6V>WU?,$LM5TQ9TAIJS"TC>\H@Q M:S8HG;E4AB9YSLVH"'!8U$.J?9AJ,2A+ZF>W1NQ:%K02U@4^NSO/EKGFQV.J MK5LG;),7<^"IUR5LB\LE*"&;M.1J8;5QMB.T79'AO@9%D3!(8ULHG,Q-I>8_+'!M3QR4$'*M#3G:0*3]IE))I)GM,*&$(6'P& P.J?'UCC#0XR&2O+5' MF!H2F+G9\?'%&TM#6B)U[CECBY+SDZ)$E*U^HC#1A '7]=X':X# 8# 8# 8# M AYAN%*_W98-)EU_:C8HKV'PF7'V2]09S;:CE6YHH>RM1N$SP[_[;(Y/&2V@ M!CJE*UK:4*PK7J(6C- "8$-,>(18_>47O]N!:+ 8%#N<.[F7 MI^QWJ.5W1USBJ(A9:C5%>FCT,/64M,7VF["4UE,F(A8T2QPE,=]8$QW3TI&J1LSF6L7Z*RUZ7=0VB_51%G]B*9AQ^*O[%7,L MLO9\N-7NZ%R*2.C/#E927Z296,1X=_)HL.O=L+'8# P2:V= JZ6P1MFTG;H\ MOLZ;HJX@*-;L\2B4S=Q:'I_21UL*3DGC&L,98XN4[V+02BR4PQ#$'6OU#.\! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"*;NI*M>BJ MRD=.V_']RRMY>-E_E$8$YNK6D?TC$_-Q0._>,7Z#:C[(GASG#%S51S!,T M!<&>(KIFC7+%_5'.K&;I\5&W*"+J\>4SR-?5,;:9 M(_6M,$]\$3ZO Z7J3FUBCY[:H^;9A/PIQ","W?D(Z!Z-Y\9^:5G.J2EW5XN3 MJ2L.=W]LN=KFQ[8!/; G) SOS2\PE_;E;,:P.#;LQ2$U"Y:5$&>T 2AA]P@H M$5Y,^S*_L5@I"ZJLHI3:4.\D7/O&UJN%:D3-1$[ J;IJM))8T!M<2V9/+W M )/'6MG :Y-[P-X 85[P^B87J(L._E?=_=3_ "A;"*5'QX5+U'D9Z"X9BS3; M$4N!&A?6N T_JX85-C76(3YS4HW!B:6MQ3/Y049I:XS:<:8*36C 8%7YEY)_ M+=6D7[.MF50?B&0USX_KA@577&VQ6&WHU.%J$2-'7K].7&JGU_L)2D(7P%CG M"8)1"D@U0L-4^[:;8M$$&A*DG\H?5\;K]7W$@1TQ(N42^[M\=.7.RB+OS)<< M7@0+9_PNCMA99XI>H1DVJX30\E4IC2IDTW)F4\G6C-*!#-"&/VOY=K_Y8N[K M]HZ(!"VEIJN#=-6%4=#22D)S7TKF\,K"1((SS_.J>NL,\D$-O.*6;I<)9-"0 MHVYSBP4Y@B21 *. 6$@-G8'EMB]-2,Z3\UH;#?)%#:GGM=VW#D-)KIL)CE$H MB*6\-PKE:!=&3IYMA%5T(D0W2+*"7M.H>SME$.*8@SV%*0V3^.WI=YZIY_7S M^0S2(SIZC=IV+63@\1J"R>JGL@<&=RV\AMM"IY@Y.[[6%M)D9I8GUE&H&0G4 M&:&G]$YI6L#39V\YRZ&^6"^+ M=TA5Q454WB'M:ZW#GV0U6QNC-,J>8;$3#E MU).*^4/+XTEODZG<82.1TG_'[V2C()1;;S=$A.V%@XAV)V[6TNYVC4NE-"V1 M!>SN*+;Z'IN5,58K&6/49;E5P)FMG=5!;8].V<^SJ:+@LD3($*L9S:]C$F"< M8<']X!A=SQ:WAUGTQRQ!>ANIB*@0BNN*PRQZQ9ZOC4QBKFP1:0Q\DUP9YNW2 MI]D2=8M"ZE;5-ZU"HT4K;U0!#**%K0<"BW>_?77?'O4%K50ID,,# +=Y??K, MX27$4\;+WV0])P65U^T.O.\K1H)JW+)/N:_DPI6PU.4D6:_D?R:]WX[W##77 MV)W?,>^O&Y9\T3DL6X_7"+QRM-@,ZV*&,0X?VZ]]*)S;GAKR&E];K*,5R0Q M+"8\B/0LY_QB"K$O.&2$80!R9:U]\_7\L"PS2#N'-70'F([=YG=*/%6/XR71 M^1.*FTK"16HEMDN5'Z-TVKZ] C"P@84Z;:-29[CQ': 8 -F7E\E<]@'C>ZRL M"NIT]P%\@]5/["LJJVRR'R1P6,73(IW'ZT M&D"ZL[.*2;:4C8P+)2M3KU1Z1&8J^I]L_P!Q86.=_(GY"^D[(EKAR1JF*Y9. M5JQY9LRY(5;4-/LT(M"#L'KK>@U?>.ZK>5[M\+5/,EE)XG+*DN+GQVEW24NF M!C:!4[V5)T3PX7Q8DVEKPF)4DSEGG!SHH&^*Q_<1FIBS@G>A0!X%.;![>ZIB M=<]TWASQ=,>;:A\4DY@-*LW.DPBL(FQ'4E>1&%5XH>YM/;8-+33YFF%@H9&K MW&SV ](C5'HTH=IU)AI^AABLD[+\GDQ1^4Z[()T97]6U;PH^R-T:J;EO.D:? MI^:QN'-;-;K5"#I88Z(4[4_0I\=$Z,U4N1. SE0E9QQ8B@$(L#B6;Y'O(%Q? M6CM8UGVW5_3"6[/'A$^OZG2/-3M%:'T7/W"T:'K1VC;@1"5I.K!@B=LO*ZZ[-I[IMVK.GBY9$ M#@6Q"JFGE=S"&15L:8$NB\E7.;! M(885URGLFRHSQI<_99YE.4!2K#(V!#^=0)82.VQW B-KAEH2NBDRQ GTQG+Y M_*G$?M"E"$CY#0Q6N[@O2Q[C[XZ(2=#3IOE$3\07+]_(XDZ,E1S^NV9QM2J+ M)NE_@C/%)!"5.D$81N#>:-(!0("D]0O$-?I<@*2H]!+U$];=>]022#4A!;_1 M\V.$,\0?/_6D?/C]:TZN_P N7):['\HW!U;Y57+JQLM/UP:VIFY6V19L;MZ, M7"V%0GT$A. *V-'D6\@70#(FM",]!D\^$SGQ'3CO-I@+!558RULB4_H";R:" M2ABC^[#CR]WD,/NM7'RGG2I7]E6Q(E84Z0>7K>GRI( MNG%G\_U%/I@N0H26Q&MDTL@;$^/:Q*W)_1.A(5.2TPP))>M%EZ%[0ZT'6M:# M1J]]4]MRBG.HXW5,IG=EV-4GE]LOGJ1LT&<* JZXY[S='XHXV"L@'.*B119M MCYEFML?VF-']LMT?E*1M<%!2@ /U3AMK\9MV'WYQS7$X$67+(X7$K2AC*2G96JR(4SH4C4]F(P_66N"0U47^T_6!H8Z$M MBQN1NG_/3TY7LWGL@F=1Q'B!%'FB9+6^85NQ)KJ:4Z(B9R*&CC0E#DV\];>% MKG'4VUA+>G*$,*PL_P!1&["6>L^H.I.9HGV)4%0=:V#;;6U^.8OR!U?TL_$5 M-)YU7[HBE,9A1MHY#VM2]RNUW\PN"]KJ.'NKQ;%BU5-]RA "P>CY)5B.F88AHIBY\:9",I MT85SFL9U*I"2D(^L+M85)'=)*[8' M-;.D-4\KR&IK(;&^-1=>QQMD9GI(YZ;T19JP_0R0F:"V/8E"NBR+4[V]8_\ M+K_\![QU+,)O;EROEP%0GHV.M<9=6*;12*GJG@B*+V2!FJTR-(V-9BG;>4!1 M\9QX##S Q6(]*U]_QYZ:OA-U5?D>C+APSSXE<*,K_O1EMB]4'2,\D:&.=#W* MD8T%IV41"HR\HI S-CU+Y:F+5Q4Q4L6)&Q.-.2 08C%>Q'R+41WS!G6^HDZU M;77?W"*MPA%+],3IWC^N;K"P7=KG2^ R]8R@;W&1*7!B8CUHG M!42O!N?(D@/N1&(J(7_87 M4$-8YS/&2'W7.X7)H>V2J.D/.UB%'5:J:+GN7S:H8L-<8TL;XYNKRL5E(AEC M7J-$A%@:D?(K:^HE9WFR8XCT9.FB1Q[QY\TSZ*1EGOB3('.M[A1RFU]$M];L MB"3IUT)7/Y*2-'+VMM 5^2&ZE?*6,*X !A93QT2K^-=[SNNRKRL6=);>\>/) M71DLB=D6\YV. V^']2_);$DT6;']V<.?P9@D'$<+L:8R2(Q256#<#VLW))I8]>\S.;A"JP.>6$VZWFGFX^T9- M*8Z\?$NAD>:%;=^0=@*2PDE[V&J7G2Y>;^AC?'3%.@.M[61Z!XV>FF/K9 M$#I*YZI=5ZRH'B%OD-U+=J)9'U2J0-#4ID:O[19@E[D2U?"N.5)D@R-A(L-N MB\(!R;XH?)94ZNPNA9/)(3+N%+*@ [-E(FV>N\X63"JN6IG)(F.2"CAEAQBP M&%O0O[C]/\@L+<3-F&%C+)$ /4ARK2:GG+G.G*1<)<^3]ZKJ"L[')9S)'=[? M'B82[90E\ODREQD;B[O0BGN3+%:@@D]2=M*G, 0$6P%AP/+=?%U49 ZM[A@; M@]G(6.:>;X\BT5K!9CU':38A$Y#-6F@WUWC"UE>FUAV2N? M9&UJ$A*TH&E 2PPJGYD3'^+*.ZRIF0RNV)AXQO(3:3'22\?(99<*.YR\4/5#%M+!XY!?(9>+7U-9<51V.@1Q2,*8W<;? M7#7;S>CW(Q%IGN+"CQ9!IR%(F=R#2!?M^01@@L1Q7:M;J%O%L>BYSFPP-E\Z MG6":EVB0H+$;W113,GH&UTU;K43//@&/J%@2N4]0,H-%E)TR$TP@I4 M68<, MP/1YY*9ZXU?P3UA/V=?9[6[Q:EI>Y-+G3+F8R68WN>DFB6];%7LE(O4,JE*K M. ,]842:COQB594%>\>5'*:>6S5V07A#(-WEQ;5)ZQDT6>D2Z2(BSRA[+(+]=ZP-@N P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P&!2*B>$J^Y\N3J"\8=:5YOVTM4@BKC$"=PA&Z,FX3'E6VEJ(-5JDA+<666:4<,L)F@@^N_$I15:QW ME&'LEQ]0+XAQQ:4AMVI8J]6;'%+$MD\F5N1[@EFR%% &\,C8BTLA=T9"<.TP MBD+TM(T9L!@-%AF7*OBVY>X\LIULNIS[=7G!-F^JY@E@6M)9I5E#-]CNY;U- MFJC*^<# ,,"3R%0264>H"!0X"2!VGTHT28: P,3\I5$W9T5"N9X/3U?R.7(H MIUM4=QV4_P -MM@I^:0N#UF-(>5M.,@0S!^FP M@&&7&^+/D]TI9=34I0V?,3WJYF7HR0W0^6O,DW0S_?D=1D-3);BRX(VX1^2H M)5 MDO[4DMV:0M# )9)7)&[OJO\ D(I#&$AI*L#@)3]@:Y48/8AGC%@5=H#QKFV9 M?/<-G=CU-,&**6SV#'+NKBN".B%TFJ.T8I 6",-U?N-I4W#G4N%JW>/R:&Z= M]DNA2G[.EJ8@_1H4 <"Y?_XPN3Q7'(;_] -AJ M-0DO-WIXL06%QL0*AO(/&,X0VPU:2!:-&):'2G0?1H\8'(+>^.KFZPZ6S5D7 M%WH2T5W/[*G$PK*#D]*??+NPFO80\/1[/"T\Y2.JI.<4A"46G)4F:3A*V+8L M# 8SX>N*(?7XZ\CS+<2)&F>("Z1B5&]!W(XV'7:.KY0&;02*UC/'.8K)'7D) MC\N#MQ T-)Z5$D:0JX8'2.16/V.G0[JF54;!%#E<=EOKM2-138TXV40.AG=ZDB] MQJ5J> &Z)-.:#"%VTI12?Y_@+ 7H+4_-9)2DI(WU9'G M9"O+OA^ M5]()NK9!2J-SMXM4P/#B>HDDL%"I1,(GLK<6L.:5OI[U!9G8<>V2$:5X1$DIGZVE MIRV?J .$^CRU1J@!B=0!.R-N/:W1&(PH1:A,:-*H%LHXH0#B#=!,+$$80BT%,6;Q8 MN0_XHD#J>\4&5S#('E[N2['%]D5&A7)G55 GES'8@#5#/Q9+:PG2_FR+NDIIZ%PVN8(Y.TDL!V E@=>*QK(1$I(W M.,N4M4_8HR:( 4J>0$.@ %$$%>FRTY 2PV$:UZ?IK]-:_36M?Z8%%#O&?PX< M^O#U_@1G(12.?_Y3D< 1RVQ$%+R.PA&E*#Y7(J%0R]/2;ZZ+51 #U.U; [ [R;^//C:QK7=KKF-'LKK8,C=:Y?)0/'/2%2T)'V"UJ0K]=<,TYLB'//01XYE.+?C4CA[*R$MKW (XXV08 3+6 M;PO"8NVR-C>U-A:@[?M(WLL!FPDQ%XUN'4<"?ZR4<^1B00J5HH*T2EJFCU,Y MZIDDF8U[&T2 M8H:-]7$_>#2GV'&:$'8S7QR\06"QU;&Y1SC %#+2T;6PFLT;46\ M1C^,P)S^3\I76E,7=696[UNZ?*+[4=7F*F53H6_D2BP.[D/ O&,K>U4C?^;: MJ7O2VLD]+*%W\;(2#W4*5L1,I-9%%(AIDZ>"Z:6XE.)K+ !&,HO01%[UZ^H3 MO6\$K.F8G%:=K)DC\&B<693D\-@+*86E2,T=1*P?*2R-(SQG)V5N5.("]!+U M\"?Y0%A]NM@#@5Y6^/+B1Q#, K.:*L-_GUBI+=F(],6RCI!:*$,A DL%<>2H M+.W+R2Y8Y TO (*G9:PP.Q;#O6M!8VL*KKBEH0RUM4T)C=>0..@5!98I%&M, MT,R#:]8H<5YQ21* 1*G!Q5FJ%!P_<:>>:,PP0ABWO80K'^0>14-G6;;,>I6 MKA6E8I4@8+?E29M2+WJ8$2] #<@8YZ P]22[)W=I7!T-*M*[T"'18_38 M8ZR^/+A^.5I-*;8>7J>:*NL51&U$\A"")(DS%+M0X.@1-(_IB_:)R:XT7K84 M*,P0DB4(A:++#H8M;#-FSCGEEG.K)0W4+61!]+P=[K6I311E"H,KF!R1*I0/ M\5AXE0#ML3.\(%9B=041[/E3B^(7J#T#H.9'.1>5X>FKA)%><:0CA5/*Q.%4 MF,M7PQN5URX&FI#U;A"UZ5F*71Q>Y'H2AK#DIA1JP8-"/$9OUWL.!7G+W(D0 M=;@>*OHB@F-UME4M8+R50^OX,G,G"@20HIUCEA%MC;\;F6>F5:&K;U@=EFC/ M$::6(9HAB#+*XYKYTIQVV_5%0-*56^;:UC)MYKBJX+!W;;*XKD[HX-&W&,,3 M6LVUKG-&2H.3^_XC3R@&"#L80[T&16#3506V9&SK5JFMK-.ASD-XB)M@P:,3 M,R*NY@DPC'6-F2-KSTNRC=[*!ZB_:'T"/RJ7Y-J"01B>)ZFYXK M"5MRQUIY"^$".0 MDCV!4H-#L1(-^GJ /H&52J)Q6=QQXA\WC4?F42D2$ULD$6E3,W2&./K:HUK1 M[>\,CNF6-CFA.UK7O*/*&6+_ %UO Q%;25,N3O$9 XU'6*]^K](UH($]K8#% M53O"4+&J"N9$<1_EW]C9GJ9^[^OZX$'="\C4]T'2 M]F4VYLI$ )LJOG>N#9Y6S8QQF?Q=E=6HUGU_&GXEK,,2$D-YHDXT@PC2*40S M$II8B#3 ;"LG*GC<)I*7M=C7?>KIU%.8E7\BJJOS':EZ2IB%PN RXMC22MM* MAE21%F#*'&3MD7;DRT][6N*?1:<7U4R7YC?>'9^2"C.:951D=E%SWH1QPP57 M<%3V4TWA'"ZX9AHI?#P.T/KV./J:>Q:31.5,9H9:8E3-:Y"J)T/X_8#00;#L M)1Y?X?K+GA!:3DX2%^O"P+X.B"FX+&LMG@J0XB/N+C#&]3IT86)PT5L",TQ,4G-T'T+WOTP.T%!82-U7OHX=%1O;J)&-T M>!1YH$ZN0FY2B6-XE[AM)M6L$@5MR_7U$$H&M^N@A] _2A"B6&)#5: M-*J-;U/W4!BA.4>8B6? >E^VD&: 0DRGZRHPOY >T?QF"#Z^@MZV'4N42BKP MX$.SO&8^ZNJ9 M:DSFY,S0>,!Y(1:+- ,6A:W MK>\"G,CX0@TOZ#HXM=405Z)&GDD?025*:V*')K,6H$[F28D,."H ,O06"6,;$M1:; M%[.T*VX2LE9IO6-Z,]%M>0NTZD*M)#B1D;5DN8-*0#]OO"?KY-;]_P"N!$U" MW;0=]QJ3S/GB;0N?Q5ML&4Q&5O\ !OB&VZLB.F)"):WN*DE,F M?4)AQ(5)O M]S8M^W7O%Z?H$X8'\] Z]?TUK7]=_IK7]/\ 7?\ Z8%4H5W-QQ8]@!K"!]*4 MW+;"-?ET5;HPQS9E7N;Y(6O:S\PRQC9*@1$I7LNVT_:XMM,5;1?$+9_Q^F!: MW6PBUOTWH6M;V'?IO6]:WK?H+6_3_76_TW@/T_I^GZ_IK7^_I_\ U],#^X# M_FM:UZ^FM:]=[WOTU_7>_P"N]_[[W@5=H_M3EOI&=3VLJ4N*-SJ>5FD1NDLC M"1,]M3D5'G!Q6M#?+V #^U-)4S@R]T;S4Y+ZS"7LYIVM!"IWL8/<%H\!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<9:L2MR-4X+CRDJ)"F/6+%)PM ) M3I4Q0SU!YH]_H$LDDO8A;_TUK U31+S-\;2$RSE+^.V*WC=;T6NZ932Z>UPX MH6FP*)2SXFL$D^@S4SJGN8G?G)PH B;VIR:VUZ5_( T"390PCV%?>@O-TU5Q M2]A2F&\JW^VW96-QT'6DYI^ZHDAAIT0CE^O:+4*L5Q>V63.["_LDN8?E3M2= MI<%:XM]/3IG E&7\Q@ RA)Y$8)44U\DEV.:;MRT&R@B^97>V.:'6L(FC,YG: MWZLY N=WNMD"V5-RI^8'-F9OSDI/+5*$A)@2C4.U)8SC<#\=M^1ZF'3GZ^HU M\?6T'CC-S-S9?C[>O-)L!+FM=LO3$V3-U5-K4Z&S@LQNE"I0UB-<];+$W;9A M';TK]IH!;#Z3+RU3*M^M>OZ-70Q-OU^&3DDJ'(RRJ71NKJOPQX4SEJDG8- :8^&62"*QT2XS0]B] M%3@E+]@!>@MB]H=AYQ."^D;#CK!RW>TP>^U+UZC[ K*X/J\>'6E")#!;$0L% M@BFS[U*VHK L3<2H"!P!J<4\2;D?VH_]D9I) &]1O8% PO6N\T5,JV6EE%9\ MX=:7-+;K<;ZBK;6->5]#E5BPZRN:%28JY*NF\?>+":!-)K=B2T[HVB6)BU D#DG*.4%$."/ M9GQG "8,(3 [UH0M:]=AJ(O/S)5#0)79ITVI"Z$0N&9I5D?MI"Z*JNC3I)XE M<1SVF@]F50AD-@H!3:*NQ[:G$45L21><2K]Q9 QD'E@"OO9G;4SE-JYI4CDL:2V4!Z11EZ$>G.M":'Z6@G/- MW5[T\VU7V?##$YS$H%1/\@BM@OYZF&#=9#1ZLQ0T+U,.%Q>23&1*1(H_$V%XDSZL 0 M>J&D9V)O4.CFI F3%FJ5 B$248M%EA$,>]>@=;WO6L#4U'/+M'T$-.MN\^7[ MUHZBY'0 .DJAMU86Q3Z/6+"'B5,T5@4*<2HBH.W"+QL\^5LI[!%%!JI0K*= MZ&>4,E0$L.GGWF"1T?!K^5]%2-:P)2U (7JE O!Z"V'5J_+C;>G^O*[:O&/UDYV];']@J>0U5#:ZL)?4+[&G!TER L\3:-0<>G(,*$(,4;O-(DLF<T\@DQJL"NHG54,MZ*] &&J=IBD(58%A!^PZ$OS4 MB?Y'6,*P$ M@;6I$00BOG_N\1L;&D6"!I4N&9Z)PM;#?*\M>SJ>/ MF?)EFUNQ]44W;MQF-Q$Z:6Y-*3@CC(K+9D-D.#]$HK()"S65*:K"QG_PVC[9=&$;5#W92\#> M'L__ +@IJVF$ >P[^AO*4CN]ZB%>?X'>8C=KGV5:7(D^J!58T;>GZK14O G2 MP;!MB1.+>UEH%D/2M+>1IN*)UH;D)Q2:+,",P998;7E*]T0CG.E[3OJRE#BE@%/0.3V M+,#FAO.=G;3!$VE4\.(&QL(V$QX.AF"UH0@A]1:#5&?Y4+SAZF MGRK5Y%C,;_Y175*IY5*)KHG:QI=%2L^L*L5S^3RZTITRKF.(MT?:G1 M.LT5^0/4E)@B#@=FR>8_IJX(A0K_ ,\\30A_-O[CZPNJFEPL?HO44:8CJDI[ MN$7+$GI"VUL[/#H!G//0_AU2?10W,;F5LPI* A3[ _=0]SP[J+L/DVYH=QJ) M5<5R>+NU;TY\GKQ>ZYL>RFL4CCXY?SV^0PEF*@:!.^V&G0$D2=4<>:$@ 3_A M(#[R0AU)WFINNNM=8NUO\V5B^1'F%W8:U=7^E;-L5X2K.I;!>$$6@7(;0LFU M0QI%85@L\B5"%+)$RB_",Z#V#(*5'FD$'!)C+Y1>O_QY]:3+AU;!NA[!O&O: M,YD?ID*U*]YZMYTG,;E\ZDLK,\C[58\.K^ SXKR)V4IET5JIP]I&]X. M9I$%<%S"%4G3GE&+1EC**V'V!"Y?;W1ED M@H% Z#IB:26I_)?3G"L33NU@R^'I9'&+IC:1\CTO=UFX^_EH9&W*75.2N"7K M20HHLTTHL\6P$X'TA'E#Z?L$E3S^WTU3#'V*I[LM3AY))@R*;R#F1D65'56K MHEMK+-'HXW9+TF3PP!Q#>P!^BH"E25M9T4IC;LW+VQ,M-&HTI/.(5&)]%E".#T5;T,1>]:] &"!O6M[U[P@' ML/\ MZ@]^@[_ /3U_P#A@>1V[;$Z3NRJ+EDMV2BL[)A( %+G(D\]88-6<#9)&@O?+_)7U%"6*54 MZ\1&LGOJ(CNC_B6S.-K%8E[Z_HX\Y_ W-*R4-R M=S4$BV8H*$6:1L-F/#UN=!V_3KFY=/5<35-MQ2Q9G"EC826UM7\NBC2L(606 MQS82@FM@KJV436)N252NBI[U%F-8YSIRBP6=*IS27LP39&_F.0)UV_C/T'43GN;RR22QCZ69WCDN@;7A/C M8FW6-LLW\857:S-%M57<4C@4QB#'(6&?+V=.->*,E(])S3UNF<*M3I0$Y:0 M( Z5/Y-/(_UDH9W7AF)UV6;7''W*70-B06:M53%(YS/+SCRRK6]@9QHT+PRMST>4J--VK+*T$GU"1I3WYY!$Q'?-YM%F<7(* X[A3/+65 MD6LKFH-IM8^^,T.F,W;BCW%!H 9:,.PH](23"@#"G/2 M_6G3-]\/>56H+["7-D%5T/PO:$'+L.G8Y45DL8[DLT1@-Z"JN_(IY(E%7]NQ:*'-$DO+B:,B)_S^F\9=@N%!-B5D=8Z\6>CC?5+:XA!('9)9C9SZT+E9:QW'M $T#&J-#L M(@^X86PYAZIZ\<_(6IY^Z3L)_@FGUUZ*71BG)-SNU-M6V?5M8KR66J)QS9T3 M$'%[(>I&OCYA;].&=]6G*42PTQ.F)1%E!($&UOK.]!\Q2&?\AI,L$A*7&I= ,.T2;LH&]BT 6]>FPU)53?W9"V M:4-64[Z/8YO&/(WQM:W0%76A$*_@#!,^5[7BL2@DN616!-!21UC,^J)NCUB$ M%MAL@+G_$;7%?7 M!(ZMC]E]E/94N*C[!#WHQT5PBKWR8Q]>;_*&5UT(*,A X(!)]^Y(,#H(\PH9 MZ9.( :H^6;PZAY<>EUM0BSXH#FBP_/1T!RQ8?.Q=9H%DCEIEX3HYM%/QV>N> M-KFM;"W!J($VMR!(D($7\GV3%.QA+ %S.'^R/(7T1;E"=&OME\\HN0>B;0MB MN'^G);/*Z;I%"G*/JID#<:TJRUJUH6$?WTCHE3"$-.:# M]Y9H0BU^NL#RT\MAM?F(7CKI>VHS770WC^=;5C:+QP]R5&2FBEQP:Q[A@ECI M:Q1WK63P,LI6%UCLN=4CJ<03[#5A9)JT:P[1I(0YE"7#U'4O,G/$38NFK5G, MQO'M[OQOD;3%*UJQ^Z&GK94EJW2-U5P%]G$?W4,'B1\M;R7Z;/4K&!(TMBG2 M1I,3[^!,:'#Y][2Z'M*1,OI:%,<8CU9ODPY[M>/1H MUQ2-BU&Y.07>RV5:@)4["N 8F/;R@-YB8I2H+,"]_CAZ8[JO>6<_6C<\HI)7 M0/2G. I^*."L6N%D\06ZE3LK\#_!L0@\69'Y/6Z2-NPD[\VR1P?W9K6E%FB6 MA^41.!L=[OZ'?^3.-^D^DXK&6^92:EZCET\8(R['K$[2[/#.WC,;R'4UO -= M^,+5#"8H"3[#!D@$$(R][]X0U:M]J=?_ ,@B]!2;J(VPX=VIX^; Z1KVYFZ! M5SNX1&A$U.JUN4IFYRT,G6S@;0K#0&^H/W:]OZ?K@ M>2^->!#M":,;PR7#;_-T//G/++O34\F4(%;UD62_7#'+9AMV0Z]Y?-)X)L<+ M!EEC6-$TYL@^Z("9E8DI;:WIS?[9I ;*IYQ5Y)NDN7'&*]*7]S(JOQFL3F2; M5K%(U74N[KN3H9XHV=P'N"#4LQ2V)P)#/&Y0WN]75:"KGMNVVR?[R84/F M3>[NANRQ.!ZM*'X"_>;[C1A"J9GA_M>$^,2Y.'ZJN&%K+>NJ6,Z&0W5.DLG2 MMR.F(#)6=OJFNP(F-(N>G%%$*8A;1&OJ"&2G&)0O4?)L1N]&A,$WIF=\<=27 M)Y*;$G$:D%%SGE6GZXZJJJ%U!8-D6.NFE7"<8S'EM(,L?4+EJF&.+E-/G7I5 MR1S(7E%/S9S@ZOR^,RV,O]PSN82F+L=DG&++(KSG9)+I M+_QKII_/4ITJMI1P&N7(*HME$63^(7O*TD9>C]G;$&R>QR;!4025)ZI4PU%8 MY[,K*ARNPT+VY0A,^& ]B0^3-T;7M3ZN:2M[V(PI*I3G&>GMT8#U]V@TM0'Q M9]"T?'^,K$J>\:G "I.60828F]=8$KTKXUK2JF\^>+S<+S@H%/.KKDO)("JGIF M'9=M=@_ATU@*X,:EL,397T-A[/$65&RH3D#FI-^HH/6*#357J4&X/ U7=*>* M>FNH>S8/U38STL5Q5LIQWJRTZ._% -B=RN#>9(!U++I:L^\66H65,9-GE2WD M*$BH&E^T2@L10DN]&A#%8^)274S0'$-!P'H!H-;.6>N$W55DR:7UR\R.0WDX ML#P_%PV/C7CL%,JB![%"7DEJ$JT8N+'IL2?&02F+VFVGXDNC:T#1:!OZN MJU3'Z9[TM?N12T"Y^DN@S1TMW4@2/<"U1MRM,V6F-S'=T[BDK M89M<-=08R=."A(TIE3"0Z609\VJTR3.,OL4>-H3@IUNFN1-:IH<-I% BS@D*M)%@_C'L M!' MZ;]-^GI@:(@^%2U[&YT?>2>FN_K1MKGV&5JFK;F"%Q.OX]5YU9;C:MM/K:;V MNYM3FY*+WE=;)XTUE-9:_P"FWD^U28$@)QA!B8,AN_Q'7ITW5-L-E\=:0J4W MG,^9(_R! +%:: 5M,-KBG3GV&26VWX$,.M->_/UNW*]0Q.8O>#7L"!N(!I.C M;RRAFZ,##.C(%UFU>1;QK0VB'5V:I/5?'=YUA:713[S5:OTV%)U/TU" M90 .C-ADO/'BW=^8^@N;YM6UYZ-H/G'D>8T!P KQ1OA3M>N'"KTE@=QN4^K^NZFZ@ MH$Z!L= 06%_FJBZ5;4J=](/EA;N[R938RAY;T;DZR5>>O6KSD))184X!*-GA ME]3>'><14[D9IMWIF,W;7O-O,EV\D2:'NG/K/%%MBTG<[%N(JXFFE,;FR5T9 M$T?B;.S)TYBS3L<-40M4F#$)8$"<,KK'Q0V/&TM/L%G]3I[3BW'USY3]C,]OM#(V#Q8SV M+,G+K/&^R9E'3^4./[8Y-KJ0,55L*62@,M!E:F$%O!>ELK!G/=G'(NUZ]JR!:M%95 M6JOZ#JCH).\-\0;YB>\/%1.JI]8(^>C<79J)1MJUW-*&I. (9HBBMEA]OOV+ M04DN'PY#MAZZL>==.O4=,ZCZQYYZP6$@J1B=0P=_YN*+)AL/;Q&RQ'^;9'33 M2U;7GG:*4&?2,^/X_LB^,.>T>)J>Q:VCK.8NW;+0Q='V#*NUV^J6ZE*:.;55 MDSDQ,=CZ4QAC"@N.UG"(Q.93"-1\RRCFB.M2=289IW M6(8ULTSXR%6@FAM_P-34&\6+,S@AM>V9=;Q;G,=8=!63TM6] .L 88^4GLB< MSF73]A!84\;'90Y6+&JXD4ZNK8L<;5YAY'6RN$ M5_K7/D$MQB)B)]<5&U]3\MMY"LA$7;&F,?B\N2F[F M*@:QW X'#;AMVE/P:,,#L 2-S/XX.F;JBU*SR][KNCGE9S18%N,O+FTT%H&* MWHJY0QAD]"UG/G%S1F?A'!C1GN[0S&"(6;&J&#:4+#T/X;F MWGY-%&V)]87 ZL=;\FW;RK6#!(8=6RYLA[??V3QM5AP6^IT+I&H79 M!BE]@$<$T.&U>%NM3N=V7DJP.E.@ M[#YP88?+F))5QR>J(6D7S*5G$NQ5O2:306NV&:32S(Q+RMO;7%>7^2,,& MI+4A&(.P[M\\-]9S.M$,;L?J3L"R;BB\MJJ8UAU%+[*8%=VT^XTP>^F05-7" ME)#D<0:$@29.XA=!'-:A4]#5?*M./,*($4%J^,^(&3C=7>KLW7C>=V/W0]CI M[8L!VN=\B;GO4ZVQHV-W?&)OB4/B+ZOPP5P7,'&?1[JOK1AEDDZ-JCJJ:KSY)64G1S.Z M:?8VUKC4L=FB3U@Z-R(]6X)#EJLE !(EWI0%&444A3)4Y(9:\^(*GG<-HO*> M]>DXQ9E@=4NW8T9MJ%RV(Q&:5#$GEM%%6UK:;0ZI9["8+]F/2D5O\ ;;ETAO:+6C93(V,- MG+&J=HXRFV:9= M5\+L:):0*[ />FFR7&XWLV46W/[B4/;>X22Q9_8,J);W-8N5. $K&E(),42 M L18@V%X&KZ<^)?G.;2V:2@F>]$0Q%/+L:NB'V"PRU"T5>?Y?:%Z9X)F2.*O M,^(RU@Q"$9L)H= +V61K1.@^=E>(CDZWR^BO\B*K:D;ATA8L1MI^D M!L\)0RBN+&@ASAN*2NG),UL2)\@S@T(7#:( ?G5$B0DE$B ((-8%P^:^9:LY M2KL=<56GDRA*Y/:B63"73N6OT^L2Q9NO;6II=9S8$VDRQ<]264NC>QI"33S! MA+ 2F**)+*)+ 6$-=GE\XZN?KI#R\16]< M>'539$[F%@0^.WV=S3:H7!WKI MSB<%D4 M@V-RUI;$K"X.ZL;HD.1"/6@&0 L6BOL!$$-T!X98K/Z18V;MA=<" M^70ZU76PN=&\KIB;S:X.38<[L\59GRK&/IM@*A;Y,&V;*HR:X.1)")*W(-.& MTJ (=D:5F!>%!XJ^.&-_>)%%8I8<-5O'/KCRYM+$[HM9E;&JCWE:2[O<-9$* M>6[+;-OD@ 8]6ULJFB9(#K:A3 K]@$:"0;<"24I)2?6O@*++"$PI/&[ MR*1'.IXHAV4%G*O:*/TXFCO&W9+&VHQBBR"(LBQ\,;JX;HFR:3I&M. MPEMY3>F0(RR @ D3Z+",VGP\>/EJ:INS#I=\>4=GQ**PVSQ2"Y;L>5=E-T+D M!DGCKA/URRPQK)?(4#N( @KUPSU(22"B B"0#1>!LI;$!+4VM[6G,5G$-J%( M@(.7JU"]<:2C(+3EF+%RLPU4M5F +ULPTT0C#![V(6][WO>!36YO'QS!T#/+ M5L6V8Q+Y4_7116^;Y\C':-CML97U-IZ*DA#$WQ1JDZ*/LJQ'(B?OD+4B$\[LF!I:ZL*33.RK+LERFT?3B,^8Z M3#L"620#J^N) PD*7 P.U1J8L!/OT5ZAV$HP#BCENJU= +:[IV,Q(_EN*SN$ M4)MK,=?;7,4LP*8,W96<*MP4_.F?MI"]C&I^8XO]VBQ@T89H8=57?#/-E6VX M&[8A#WXJ;(%-AKHH4]V'84IB5=N-O.FGNV7*M(1)9.[1. +K+=PA4/)C6D3; M5#UZ?M"(01!:EX9VF0M#HP/S8@>F-\;ES.],SJD(<&MV:7-,:B<6QR0*BS4J MU O1GC*.),"(LPL>PBUO6]ZP*'55XP.,Z79IHRP"O)4V@FL)/K#;NMMZW'>3 MPBJSU^G,-6U)*G*;*9#3U=IU^M&%M,94M:70@A]P1: #00M%15"U1S57#/45 M)QI#*)$WL)2P>C3D#*9+'M]6M30$W6Q%HB#2TA(A"V66'8Q M>H8WT+RGSYU8TPYDZ!K-HL9#7LO2SR$"7KWUG<8O+4:-4@)>F=YC3LRO",\2 M)8868 )_PG!WK1@!>T/H$.C\;'%)C.*/CI0H3*+H$OJO3;_/[2TE+Z)+,-.U M;9 -3?7UY<-0<(T9I?M+,-]!B!L80[T'<5KX\.**?O61=+UISG7T0N^4NDG? M7:=MB=S$HT^S06MRQ]:&56Y*8U''R0 ]Q:I8W(DJDTDTTK8_C-,",+?.S4W/ MK4YLCPC)<&EY;UC4Z(% ?>G7-S@F,2+49X=;UL1*E,<( M>OZA%O IC3/C@X MLY]=H2[U)2"",&5HM=76N6M5,K'E46@+R]HU+>YOL+ADPF+_ !&+R!2@6GD? M?0H2%@"5!H &A":9H08:\^)OQTR!Y6R!YY1KAP=W&Q)%:BU8>;)_^YFM.,7,N@:9%1AQ@C$@A#'O89!$O&+P1!=5&"* 6B"=%A:R01]BEC"]Q:4,[9(HU)6AR8)"P/2).YL[XQO", MYO=FAV;EA9R1>VN2!082>2: 19I0Q!%K>M[U@4ZB_CCXLA<&GU;Q:C6IFAUF M0E!6HG)6::6QLJIO:PB-'Z$>@Q:V% MBZ8I>M.>JTB]/4]&_P"'UM"D9K=%(L!Y?WQ*PMIJDY7IM;UDE=7ET);4QJ@6 MDZ?Y]DIBO0LH("PA!H)1P& P& P& P& P& P& P& P& P& P& P& P& P&!P MG+;CIN7[:-(A.WTE7XL+D(\#<)Q^ SZ(5XTH#%(46U/M^7981&:+]?;K>_3 MUB>-3R4-'=L,O@$VB,>IJX>9K6E596_!$,P52>/H$<>4K4C?/F64O4=AYZZ( M2$;.N$6<-&6%/]801CWO7KL(MXC\OE;]-P/K>_+75U90'-5#]%GTC6]E2F=J MT"B>-9B%H5L,C?TTB:69O:50H5?Q@EL4:<0_'H: PH M19^BS->W ZN,^1/A2:5_8MK1+K.AY'6E1%1T^SYVS6+'E\5@94M<1-$8%)WI M.K&A:=OSF'9"31HP[.,_0.MX$$4[WKMMD??KGU=.*6KZH^7KX@\,KB=L&WUL M0/-<673U>6?!/SACTYNJN2V"^ G9*<"5I3!^TJ%HE(0=O8!#";B?([P@9 *_ MM(_JZDVN!6D.;$0*0/\ -6V-E2%=6JS#E E&@;,"/6P%" , 0DJK?(_PK M=+G8;1674-3R=95D:>IK-A@?A-+>W0>-G'II#.VUW?4S8TRB"L:E,,M6]-1Z MUK3F:]HSP[WK6PE#G?K#GOJ]FDC_ ,^V2W6*V0]T;V64"2-$E8EK$YNS0ED# M2EQ0C4%'EB$4: 0@A**^4+Q_P VLB,U#%>IZP>K M)E\_=ZMC\32+'73@KL!F4G(CHNH,.:BD36X.2U.80U[5FD%O)Y0RT E(P"#H M,YCG>7)\3N!PJ8"8PP^>V!"6E M.)2[,3*N7NJ K6]G$!]@]!#J(=Y$>-+ WSYN'W&#\FWG'C LT6S :$&;T-V3S[V(Q6:/DVX8K9#C $K*@<'],R MR-3&&5^F\5%)82I5!6IXZ*0MAZ,P!YY:%3K>M ,($:2=K?M"B?CF\K-67[&: MPI6_KI@!G:,B'?1THCT9BC_#H&I/JJW[$CHF"/NCG^2C:*1H*_C:9UVQFO*M MZ T:^Z?H0=B-V%B&ORQ0!I>"HX^RZ MGIL]L"&-W(P1Z1J"D"Y5&5+H20J. #8M^[6\#CLOEIX&E59O%KPB\!V!&F9] M6=,YPZ.S)"FNPWS3!7T>AR^9OK6QP]Z2K%[DF0F-J$)X *%!9@@A MV';6#Y3N$ZS*K%?);T;U$=M>!Q2U&&9QB+S2906/U?.WA1&X;8UD3.+1YVC= M80N22A(:UI5[\I;R1.!1A MA&69H(:S.W?*]:##T_%,B4B$%^ M63RY\A%\\TW?]A2*7P1%:\&03U9$Q5C9TCD< B^C&]#))U-D+##EBF.U!''A M?H@4S6%D1E8$.S4JPXO6Q:"1VCRB\%2&]X]S3'>CH?(;FE;M&6..Q1B0R5V( M>'&815PFL; AD2!C/C*A*ZQINVI+4A6;3>AQ(-F:&<6'88O;/84;JOMQ174E MZ,B;+7U=<EN5OG[$T+T&XHV1PQ6C,8TH%"]2J M#\@"Q:"/V!D_.ODZXMZJLF.U+25KJ)--YA4R>ZX@A7PJ;QENED"$J);W99%W M^1Q]K8I"Z1-S.TD>D*-0H4>\#4CG#HB$L$Q-00!-4-YIG MRX%C.:?)QSM:""OX'*K(-56RY4I(;'.ER*J+8A]07@54A);5_88K7WFW\=%KD&:K6X)--WL]3"T,9A<V"YSM>\M[.TUM"B(@*13MS0&,"LQU*;4YXF=.5LU;\ /UP,T=/+KPJW5 M/7]R);,DTDBUD(+5=F-JB%5V5*9TUM5&K#FVX'&8P!FBZN6PI'73J3M(YC=$ MB7XE6]%A]XM^F!?JMK&@]OU_#+3K22MDQK^PHTS3"&REF/\ L-C]'']"2XM3 MDD,WH(]%J4AX=[ ,(3"Q>H1A"(.]:#-L!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@<52:I/;$[D T.@!2F &$4+^;^IFAEZ49X'Q M5>T?@[EY>H#TU"W2,0FMO\IU]SU&:Y20>+6%SA"9W*@5V\V*Q.,5$W:1R !J M5I:7$M;]4XS98B R&O>0NCSYYPPS6QQ5<;W%:_\ *1V'>=E.=E-U+60L(J:X MF]8= I;-'B)2Q3'UHE$BDR,]Z 0C)3&+&XY0G),*3 WL+86IQU7\S\FT:J;G M2:U:@YNO2)1.T_('SK!FUA-;6]YXGF4;F:_ZV5ZU3*:T=<\U$SQVNEL M^I%++95_%(_-4LYY8G[$Q4Q MY7.B>F[ /M:R:7LQU(IRW8>I'%)4\2AIF)X[ E**1.243P).@ =]],8>2 WX M0BP,QI/E#N?G"_8!TFJYSG,W@=>=]^0Z9.]&PJ?UK_+)'678X8TBJSH&--;M M8I,*6.T(3I5K8YM2Q6S."%O6C,+]P!*A[#:7XM*@NBE^4K"A5MTZHJ2=.W0? M3%ALD"D3G6;TVCC]KV,_V%$RMN=5O+VS*V\"22 0J]J!%K J$YP= VG"G&,/ M/E'_ !S][Z55JXS;Q[NL>?K4JI1TU4,)HQU_S._)Y#%834C1'IZY/ M%5TY%DGSC1A3D&NZV0#"I5[T+8UF@WN^*SG3HKG59TNPVMNPC:9<'ZG4/-9U M\KJID'1Y$2B=9D,,BC]F3*IG!Z;9;&X6I*0LT95.2X]U$B0'", 64,GWA0>7 M<43J[.C?)_MF6,2H_+(23PIB6Q M9L*LK0P["$(?=H 9W4'#'3[# *2XR?*831N*TCY+)'UZIZQ:9G$VN-NU5,]O MRZ[8PI@C$RS%VLHNXI]J5 BCLD= M+,(8([2_02ON+QQPI&K1LOS=%VH\,$JMB'29S.?O8RP6.HX\Y,30E&%$C6BE M:M0KV((!;$&W::VV'->:)C73I87J6E$Z6O/65T=IG)W 3 M?\.@(Y=83XN/6B#L8]D+#-BV:+>]B#69(N9.X;E9* M7Q=@M"FUQW1%P7? F*IV.*P=P22X]&CI:"DQT4G,5R5:SJ0JU9):9$880;LX M-N_CWK>>T/P/S)7=C5H.)6S5W/<"A$V@;4OC3BX'2>O8L5'QMB%]1R)R8''3 MFXA[:?:^\9D0D'-$^KA91]U>0!WN1\C]H46 MN>J\C/56K/9X+-FA4BL06G9V8 VH6L4E) *5!1+4?L 3#1$$F!%-.>-'IVI. M5K.J1+XS:T;.BHYRGT9S&HZ9B70$;<5E\AL]E,KV#O%51*239.@K]H>R%NGZ M8B>BFDT"=!\:).HN.E]^M-1N MS><6U0UR3SN-3F/R-K@\C6(Y%#]IG).H7*TRU+]/6BA#)">G" .N?&'Y K#B M$IJV%\R5,AA3_P +PJJ*YBG/%QLU/5954RB-@3":GU]:1;V-#8'1@XRS.2-# M%"G4>XQMX4*W-1],T>QZ"V*7E7MJV^C>SY%,>77*GV&]O%*FXH@4F=K8J281 M@-IQMJEBM*O?38I*CY,VQA]42H"4D\MI/,*/3F;- K83-A#*+@WM-I%QY<% MB^.Z@>GE;1QE6'%MI\UV'><71J:G<*362INA=TJINJ:%T'E<:F[/)SS7N/ID M+PXJP MYH,LRJ8EP7T529$Q9Y_645D+Q:]RN"&1,\=6I9=*&IR#%67_ !FB2Z4[(]B= M=(OD#HPK2D1(0QQ_R'U]6W0'C&,G%#PF"U5QOP-,:#LR8-D\@KFYN5LSUOBB M99_&T3#ZO+W&4JRL23S_ +!2305#[\X-FC"IT$)VZMY@Z'NOR.<]VS'ZT0:H MFL^<.B*3D=DCL.,$.9+ITHQ-K"8^HZ]6$EO+NCKXIA&-6FTI3#6[6)]IS1>P M\ 0I!S]X_P#M8MB\=]0VC4+%7S9XG7NW7Z*73%;HCR[?4CBGASM&ZE:J_BQ+ M:J=()&IT:XIC9-_* I]I2$IJ0LH\M0(0 [R!\0^0JH^./'(\0NKZD<.MN KP ML=^?*J>[,;MPJ[*SM9+8C',E3;/VIO:&>&R4YDL4XU&6I0]EF MAU-T^.CLB5WI2G7DMY@XLZAD$CK^;U7X; M*2I/-(XF?%"&5.Y3.A4O[BH-5DIM%&?& -P'*<5Z'IQW9>>913M$1?G^MJ,B MBQ@L^DRRZ_C+U<#]+I*JE5<0BARQNI\(@$(8=I]EKU3@:C'FRY%3E15]6;]:ID4J6($Y)[NY&&JSA^\T6 M]!&<8+6M",'L03/@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,# 7NTJ]CE@0:JWR6-+;8EEMTL=H)$E!P].\E;8*F;5@0MLZ5R5JLNS$"EQKR(L=76I-W*;$H M1G@<2(P*$0N1)7IR:PI]C5)"#!JDQ0RS#2P@,+$((V3>3/B!95TMN-->C:?! MX%9+14$S,+B4_'*(S94@7B:F.(O, #%-SQ$YN[F48G3>]MT6<>486 6Q%CT$ M,-2>6_@-:Y/[21=;K]^(R9EALQ)-IV\$X(7*9$^'1ED8YFH/K@M/$U[E(4QJ M(L+@--K:DH9?KH0=ZT$UU#W+S->UOS>A:PG+R_VW6GY/5APU76UG1U9"3&AP M_%+").NDL.:&AG4"3[ MZ'4-&YZ^G6S8C W3* 1!97%C-ZB90!X8?Y0SV&QN2J+%LIL*4>6#2L")3[!;V5O6!]JRZ[HFV[*5T[$Y!*D= MG(X1_D@4+G56VG6#VJ@OY@A@W)FPBR(9%0.[8%X4 ($)*([81[WZZUK6]Z#$ MK,[LYYJ*_P""\P3AXF#?==GN<905U$DM>S!R*FB62C5EC?6%^0M)T?4L$9&@ M.T[J!*@?0V4+W!W[=^@8WS7Y$>=.LK'MNJZ;%9#E+:-^^59I$@K:315)''!" M_.,;TSC/>TR4:QY6NC.L"G3$@,,, E,%Z:T'7J$V]:UO>]ZUK6O7>]_IK6M?UWO?^FM8'CT\A]D7KKH*!^7 M""QF?JJ,YTZ CM55K*FJ0P\R#R6B8PZN4.LMT)C7YP$[VX6I:9CZUE*MH2FA M4Q[0F?.(1A8P!<;R$6BZVIW%X<+3Y=?:[DLCF,>Z,F=2J)HL.50A^-=:_C"M MM9W]1&G0M6B_,Z :W?*2>+:-?OU%HSX1EB#'O!Y$ZKLJP>W9E>)!)O:;U?:& M8WS0$EAS:RPZII+#IQ)WV'2VN(ZH5NZ9U/;Y:XJ1DO?K]QJ4! 62((#PJ5H8 M%X?H;#+0[H\R4/F[&T3*'2*V2PNK*ZE%N#4Z%)KSN=Q1C-![M@-^!7($C48I AV2+0@N/P@WZ;WZ8&PCQ"6]RFQ>)&O6N?S*JXU&HFPV?%>A M625*F=A&E?5LKDI'J-N:,KV&E&J5Q1Q)1>C!; # KU)GRJ( M_P">SA8$'=HZQ5>P\%JV>'E#7::FYDBY0: 5(YRHAS87"/2&1,]-R&6O3O M$%S8[+B'I@C^YB0C4GBV5H*P@T&]>SVC$&R[CY^B$,NTZ(=$6'7%U=DV;8O0 M$FJ&PH*X()0J5\WN4?K!ZW(4,::7>2;H"O7%/#FMI_%GJMIECPV:,*//,6;V M(*0>1*3,B;SH^*M"L=4"/;)&WU8X#5KR4Y2,+VMGA"/[&SU6B4XCQ-_Z;V L M0_<'U$/7LT ,9[FK2_.1?*-#+BY+0.IZOR25[+:"=6Q*L4-\8CMYA84C<@LI M^TG+. :J=7@UO3!TXR!Y5'&'&JWN1.@SERTT0A;-5*#!;W^N!+& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P.N>&AKD#0Z,+X@2NK*]MRYH=VM<2!0BE6)#AEF M%K>A %O6_P"N!7W7''*6JF+H?_CO3^Z6)?P2HFJQP./C@:>2%;ULM[3QD:(3 M4G<@;U^AH"@BUZ[_ %_7?J&,G\"\3J?X9\_*U$#W72$IL@(O\;1@(H8WD2!S MEA2.,""WA$R)RY,\JU^@I]EZ^VH,-_\ >+>]A)Z+F^@FRVGB^FVFZW;KJD+< MH:7VU$,194<\>6U6B1-JI$Z29.D+=5R=0@;4Y0PF&"T(! -;_P#:'T#J*AY1 MYHH!\>9-2-$575$AD3=II?WJ PMCC#D\MH5H7$*)S5M21,!P5''O*2NT3;M5\WTBJMT]>%U/LA3640/F M!SL 0!@=S7PUI&N&[ ,+"/2K8]GZ&'0O?[OUP.6KY,Y;<9%+9>Z/ M7\CFJMA3R]29^^J0B_+/+DZ,JM6N7;2)BR_D&/8O:#6O],#L3^8>;%38S MLBGGVDCV2/*WA>PLIM5P8QG9ETA+;B7Y26A(!4:66$P\*8K0] M[T /H'>0NAZ.K=X'(:[IFJ8$_F(SFXQ\A==Q"+/ V]0,HT] -S8V="M$C/,( M (96Q^P0@!WO6]ZU@?.4T#1,Y?SY7-:5J682A2%$%3))37$.D#^H"W%@*;PG M/#LS*W$T* HL(2=",WHH(=:#Z:U@2.N96=T4-*IS:6QQ5,*_;JQJ5R!*K4,S MH)"L;!.3264 M(P0L"S$N\DW9"WOZH>5'B\*AY6K.]N*H+UL_3.SZE9G60\^29WKE4^2BL/O2 MR801B<&1OD,46;T<^I?R:8*PXHP0]DE; $6IO-!V?-?%!T#V8T-->Q.U^8^G M8Q7+9-4E9/ZJCNF:U>)"S18+K'V65/1+^SD'#E0%*@]OW5]6/#/T*TV]0B_JCJJFDM3PUI=&VLH&[5^^V&&OGQG+_- MHHZ6RW:@;!>B-QK*L1T MY7L"9([7$B?=ESY[YXD^G2/O9">"$+B0FIY,H>W!T:4QQZ8Q.NT!.:&L2M.Q M.]Y'2?FRFTEZR/7/OCXG=MU]1Y[32%+LJ=M6(9$G/7$)@[&7O>EJ3U#9+?'EF2U-Y M4>>N/C&XQ)SY)S'RGK2MXQM),CI754U8HW*JNJTF3' &C2J(W'7%O$ZD$G%G M@42M'\P= 3#UL.A[/ZGZRI;RX^/;F^K+1#8K*=1?G9=*Z^4&%,S4@2;+ M)6%Z$J,&4(9H4L5:=E\ =>PZD+"D%;QV+O]47FRR%[< M8@0N>XQ)F1^0%(URA.L,&4T+$WJK;B3RQ%$*/JZ"P](7]UC?D)ZFL:@_(=;] MGU+17.]@AN*9SX;'*:)1.59L;B<^Q&1)W,YE7QGR3V;-+@65^9=79-.+(KSZ76T&K.2S.:52*( MPM/*QT-SSXUNSNZ>EKBD/ M2%EPOJ&4\A4/7[_&XA#X(&20(MK9X](70F!1EKG\PQ5[#RF_P"N MF^ TW1FPOG!J2\KTZXG8>@HEWF_+^N+?KIFLLJGG> 4>1SHQI+#,:90" P91 MNOBYE%W>-Q);]=L>ESTZ% 7ZW]DH].+U &M"R.V^@6+RO=><@V'Y$.C*KK9E MGE.0_FJ.US$>=G68NUA]!22K&]%$]CFM1NA#G":V360J7G[$82OTS-?H)2:H M_4T/3Y0U>]!IN4X56725N#>.ARX KBEAW75I3,V+%LE]Z]"FG<4(=8D%A0O MD&TZH(%#,-,6JUO0R# ZW[@\MD![![WL#Q+3R_FGLNX2.GDWD00\S5])%43J M7^)N;6YSB.5;'8Y(&XNJ#BRF-:*6[<%RYN)4K2G-,2$(=$:.)V$]\I^4N[NG MY/QWR?:5@V-S[V=1W6Z:BNRH(@:XCLV]H@Q5=:[LNE0%9T3?6J.%AG5;MR=[ M*2"1[T-<:%$:,A-\KS2(M=C-W.,DNPQMZSLVH&-I>K*AT M!0-B8V.Q^.J9.SND3BVIJ]*S-&N2P1)H]-^D28P!RO0M!AO(4BN#NM@*F-!> M3N43[FMBO!R>CY0PM5M7[>%+80N61 MTI+]LA[M , MQK1YD#_(9)(%+@8DVE=M(TA(DVOCV/8]!"+>Q7KMOG[Q;67VPT]RW,_O"RD> M(+DJ@AP(K]M?J^M>2OB%DNIK=?X[7[''IS4\[9++1FIFEV3K!HUR$(M"]"2A MB";_ !*SN?\ 24K1W=&^M^C;6:X#&8+"^J8%=DZ#Y^NR)VQ,(W(MQ*R6>]: A+G(TDK&KCQ;8H9C)<8S-[H M8G^(LLY,M-2FA'KY@[#3O&?(!W35=%V1X\^MK/NM-U5.62KKQX?ZPCT^719R MMIELI^K4]OK0F8!"RFR,E>@D[J6E$K&8$A:2>VJ@EF)4F]A;V0O]^3CS^V%P M(FZ\ZSAO/!O.P)(R,45O69)76-3$%#Q5V1RAO>5:Q8O5*4TB6#<1I50SD*E2 M(6CB1E"$7L+Z>!GN>W^KZ:OBG;]>':?VMQQ;Z^GW*ZG),2F-MN,F.,E319[> M@)R@$!FC<3&%!+GO0AB/*$E4#%LTXS>!J$Z,[V2TMTGYIJNN?M'JF O]>ELN M^"XW'+2N4#&RV6^U[('T^+I547^VQ$(#IB]-9B='(C@H2T) P%;T408'027Y M-+C[4KKQO^)^V+/M"XJDZBL",-:K9Z4@2UM+>L.FN$[/ZM89Q-*6MWG:DN M>.B[5FL^G5=3BFNAYI#&6:QM5>C\J=8-:4YB)"T"UE=1*5J%Y$D)3*PB+T#8 M5B\\96R]"/FJO_$*)M#GF12L MAZB-M192%6[F@+ Q+?IB,4)$IFR K$X:[H!:-Q.G_CW]?](N%ZW\JOBO^U&Z M-PVU3;WMW^8,$<*=J6CH8\C5,]:-JZXF%'/Y'(U47== M*+!3*@!1'$(35*,\K9'HI%L 4CYH>6^QNN.T^4K0+Z1FK18O=\HXLIZV-]*7 MQ"8+R=5LD2WXX*V5ED39.QMZR:/QL$;2XI%G!*H2OBENV28<2 'H:%S/)5S] MUO0_6=1WAQ1<+^NN[G+A>$7/=->[E4[T9URS\Z36,5A*EZFORG9SCKZL+B#J M6:YI#M&J51&B@I_E< D#&$[<-UORIY?_ //73C.W3&$1>7=*<^6#:4&0RN9D MFOKM#>?8^ZSZA'U>4]-)((&?]9$E>)LV*N6/**!]YWF#9.7UW2286'H'\A'2VN5.5+%LIL=HTT3Y[$Q574!TOD;3$XY_EZUGA)!X M$M?'][&!M;(]&79XT\NQYGKHAH;51OIO1>]8&F7QS>2ZRR?#_P!;S28RAKM_ MI_QV-5VQ24R1XDADD06.JC"1_DE:3UPE %*X^2LLA)"81I< )05X6PS8=!WO M8M!#/$T*Y5?_ !>,_9_D$Z/F\'O;M9_LJ/OO8JN[;(;99!)&ZR*<((4Q0R1Q M=TU&*83M3%"OU:=$(F\XX&VY5HX)A*3 @KO=U9Z]O/PA!@$ELB_X+:=$&5A< M(^?G.9P^1=J5?74?@#"S-FV$V9Q99*396W&*3VXE>Y?*/:S^RH'ZE;$$^7US MI";"\135:<)L*9Q$CI:P>!YM5,10V79$V#QVKLJQZYHU]9ZRD$JL!ZF84(F* M1JR7EL/7%(CGM,LT LK02BTH0'6%T7D1TIQ+XNNWFF<2SK;DWNR&R:M+L<'I MS$VWSR,NCED'G/JY<4[!/D>R-1IG(ODV/_ ,MF-6S2N+*.MTF>2Q[>5UUOR,%C.8)-: "5B)MD;J%<27LK0B D MIBB2B2@!** '0>KOG>D&'F^FH12,6D$MD\:@"5U;(^ZSAY.D,F"S+7]V>6QH M6O*G7V5R:.HW(#DV, MU.$@18;7N4>5^G*C4>-^#3Z"58?7W-W#=DT-><@36 H?U:F=S4NH$J-BBD5/ MB+>2^L 2Z>*&K7*3RBQ%N8R0D"^'Y# K?7'B!E')L_\ *DX\R-4%55/VCS>& M'TC6:N1+HIJO;$?VZPFJ815>J.:7Q&WPA&ME8'!I.3@V E,9IO\ @*"F <,( M$:_!Q<%J>&ZG.);3=Z_K'JKG"S)M9E13UH>ULV@8WMUETF>TR9[5)F9M7$,D MH8Y+]-9K2)4>B4)"CP@."'9(PV]U#)/)E)MTI'[8JGG>GTT40H5U_3QOL]VM MM3:BEH:1MYD6JV'MT/@9=?"F+N,#@>\.:Q>%F)+$F)0KMCT<$-757^/_ +VC M_/GF=A\BJRET4X\AUASN[&)BZ=P"G=$CDD3&*E2)48W $+T ;H&@B#4-T7X0^A;LX9KG\6) M.S^1<[IN7]&V!,7SJ&S7JJHI,9Y+I,^RJ2PIK.83HEIQ5-J&/)TIB1@;G4CZ M9&CER@"46C@L7,>/_*%:?9OCLZ_E\ YA4RKDBA'6'V:V26\Y20TSVT)S'I4Q MS:0LZN+TLY*F$H._H*DX@H5)7VU/MT7HDD0MALWY#BG;:VU>@;J[#% (,WV MAK.*TSS_ %7:4JLZ)5G'8)_-C)'(7IU?8?"VE9-YZXR1,:H6($97R)$A!!H M_7+]0H54OCTZJ\>G4?7UR<0-%)7'4?9;HBE"JK[=L"75C):3L\+C)WC4D*E2 M2&64"PJX)>9>XGGMWJWNOQ*"R21"^'Y!!4*0^ >ZV#QGV5Q[7=BTW(^A.HN@ M8_=O1%S2E7,H? X\&*JU3^QQR QQHBTN>WYL;W$OZA.U/XTS8W)0J%K00@3A M#;\W<:/M>\8W'7-4UC3$UU3()R15K91RFQ3GO\ @1[I MZ-,,2Z7B+3QM(I=#T^BC]_,8)9@1OXPO'O*N#N7H;$Y1#*-D'4=85Q.JK9K$ M@\WL--%+,B3[/72UF=)-G%]@Y;I&!G39W,"HV0SO'X\K0C$GN">8DT%)Z5\* M=L2#ASK?@_K5^J J+75?$FZAJ:VJ5D4LDTA@5I3!V"Y::WF,SJOXDF5M44&R M)BA*4RHLQW;G-6FV!(+T.P+]BPHFV^*OKI MB[X[2['Z3=H@Z5U7ECVY=[ JKA\J&>06 M527KC-[D >XH1V(RSU5-[A,:D86*RXY:CU$5<754FH&H5F/,03(DBO2K1?TU MAPS2_>2$)P;(N@/&37MI=X\G>02#A8836K& M@1[VIG45='Q+I$N4A#\S6 :8TP(24P0A)?7%"=0V'U-E2L5V MQNUJ;N8J<**ZO2,VFV0E&ACCR"(&*"&X]I4Q@TXAS5M[M^/,-]0(E(##BA!" M/CX\=S[PXB[%LEA;ZD8+9ZGGB^>LM*UJMD33S54R6,-T@1UA F!Q.BK;)5*$ MU0\F'OCL6QI= VH$4@;2B4X '!'GB5X$ZI\=/,E_TQ+I!SU,9I-)S)KAJ^21 M-ZLO;".PIA$DC6M8K$1OL20JD,387F-M@4ZMJ *5U,9!0C1WZJZ!>+CL_J%B>KC%%GA5+K$D4HF$S98T20R(S;"G.UO&I'^,)O>%6HKG>":T1W#=)D-E2Z.2 M@->.J=Z/>X[%@/B5S;W^5N;(WG*=J59I!&S%00!'[BM@#F]:\!7;TKXOHMP& MUV=5L.EPH33%=3^Q%T6ECY&U<;J,;"MVLB#&2^-;HWO+\Z0YM%ZK#U)*8@Q2 M7[31_$8$,/YRX&[ JB5X>1:-4AT)1,2HCN:O+-K]AI4RL;%5QVIBI:J=&.'O+,"M0:1ZA"22 NYT5XO ]0\MHC[8^5FZ1'4A1!B;T\'NRV'3MCB9/VVPYPU[7 E.<$W6B-:V%;YUXIN MQG#RC6!Y):RZ9Y_@S[*HVLK.-QM_I>=S,V)5ZIA#77R=Z,**LR-H7VQ&QJ; MKBAF&%-0U^M!,3#3^XL0;'O'OP57'CWHU35$,D#Q8$MF$O>K-N2W),C1M\DM M6T)-\.WV5+VQ ,U"Q(-A3@*1-I S"49 ?3WF&C--,#7R@\+KS/;4[^F?2EM5 M=8\!\@RW8)_7$:IY^8'2NPP$)_\ @695O8ZZS'!T;IC#% 4ZEU)/0'(7-25Z MA^(KU)$$6V#X*^@[4YFYHY6GWD7+DD"Y.L)!8=2R)?RNB,GQ2EA1&((E&I&] M[O;Z#W%HBD4GE(B]HRU>R3 E'*#2R20@"SM@^+*[;E-M?5E]ELL=;IW!)\R0 MUCYVYN34.SUW9EH6A5EES>]U*9#<D5K1K &?($030 MS8OQL6<^=)QOKRS>D8)/N@J@HV74WS[,0D"!-('6*L"M&K$2:8VF-Z@L0%1*SV)PN+57B4 M@L9Z%HWI6ZKFF'1DZY^?Z.EB6.V MP6LER]LG=7$2=F=E$&?(XHG#AIM-T]A;'AX9Q.PT1@OKDJ5)A1(2R/86$(;X,\>QG#LKZ4EH;_F5T+>H[+47+8)< MNA4%B^DUFN8U/YU^910QO;2TCI;)66G/XA!)!!I?)YA'7&(K9.\KWQE42=N?VV,NIZ5 >D5@" MB^49A0 F#,$(*FU%XB835'8?2W51=VRJ3QOK@B7M%[S%&SPSZZ M_#XUVI)8Z/K5IXFKD^ C M:,:C2@PH@O97H46#W"V(/@_^(Z6S".VP1->Z;JEQ6!QR&LD.CD:#/G@MV?+7 M24F$J171RJ_2!RBLU9438D72=AEL,?8G)81)@')E(#HNX*W@#F26#T-0JR-[ M3#*T>?L80;;'C3AET]OU-W;.+LMO=C<_+FHJD(0PI:Z::ZB$5VA,2S2+/B4V M$KY3,@SHYQ<#3UJET*5(?N: DV4$DO V5X# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$,WE?M:\ZQ1 MGF-GK9$G;)%-(Q7<<0Q&#S2QI/(9M,E8T,:CK'$*_89+)W5P=%18@@T0D&$. M@[V/80ZWO I@@\N_$SK\ VV1W$I2J+(E],Z1#UG.3"[%$KVXX]*:$>@CUL(P"", A $$6PEG 8&*SJ8-=>PF M7SU[2O2UFA,8?98[(XVR.4ED*MMCS6J=EJ9CCS.G5.KX[GID@@ITB8LP]0=L M( !V(6M8%=V?LZG)!QH#NQE(G3G1AE-+KX++10YP4SX< ;&52_KSP0HD8W$3 MLE:T9I@TNA>\.@;]=_IO L1!)DR6-!X;84:&I-CD[BD>F3 8L3B2*S&23M"- M[:AJD@]B&E4C0KB]C+WO>P"]=;_I@95@,!@,"@LM\B50QGI4GF9KK^\;">6R MPH!5-E696M>AF-3TQ85J,&I)7T;M!^;7G;\QF/S884(Y40V*D#5]@K;@>E"9 MK>!=9]F42C#C%6B1R9A87:BI7-)&@CQDN<6LUQ:P)X= M$0+MKWE9\N_IMY)AOL'[?;L);P/R,6P@&((!&""$0@E@V#0C-ZUO>@!V8( - M"%O]->[>M>O]=ZP( Y=Z+B75](Q2]80Q2J,QV6.$U:26&;)F=))FMR@,[DM> M/Z5S)C[U(6;U"_Q53LH:=:>681L _76Q;UH+ X%%.H>X$_/<[9JJA%#7%TO: M9L&*N*65[2[>SKY-$Z1*G+37CI/R6]X-!2,+6%0Z+R4JLP 0A( MWL00'5'E+=;MFM5I:SX\*Y16 MUS'6]>LY]K1OH^XKDI#_ "W%)'&MP2 3RCHI-Y'-8X\ &O-D;R^$K($X(0A1 MHA-Y9J8WY5A8PEE&A=K;FVZ1@<=N"'3>;HO9:[:LC2,S1P]%E; J^3X!Z-,% MH(?07[A;]-?K@<[ U^R;N9V>KTL^@>9>>YITU*:$(8P7W(F2;5]6\%KN2RAL MT^QVM44CGSN@#,;-7L'HL/0(R@H&THX@*YAC] MONV%B%"U&D]OVU:9+[];V#[!Y1'NUHPHK>P_(,/NUHT\ ?T__D,.OZ[U@?D* M]",\"4"U(-29I0(M.%22(\84AVTZH0"=#V8+28_7L,WK7[!_IOTW^F!\0/#0 M8N-:RW1N,WUU?VIN9F=MT(0-N#JYJU9*)O0Z&#>OE.& OUUO7K^F M!&,YZ4I:O7^D8O(9['M/G14E/C-1(D3PTJ?Y<:CC#G+W!Y0'[7E)C8V@9&SW M&+0#&4)0J2IR_>>K3EF!UM?W/)!1.T9ET-$8;STPP6U)E$X\^NMPPZ51B65H MT+F]'#+2I0K4P_3?H,HP0=_Z;P*_/-S M2^-=&O4(E*.HXSSXP<_F68Y6<]VRR-U@(IV3.D[&J:':N5_TS66MD,7.TJ'( MS3Q)A+S IM_&+6O>$M0ZV*LL16XH*_LNOYTN:$Z)6[(H=,H[)U;6E]8$6]']9T3R@WUTONV;MD4%:]DQFJH&WJ%K M:0XOLGDJTE,)042XKV\HF/1E$8)>\N!@PIFQ 6(TT6O4 1A!_+_=D>(0C-A:Q%>M*.5DN--M]N5JMMMH3%K'.LDLWC9\\0I30&F@.4Q,MR$^% M T42(8O4CU #T$+TUO6]A"'?'7#?PORC:73[G#5,^35N7%M:BY+HI8$RX^53 M*/P\A0[R-*PR<4<8VPQ^TI5K1(5(2221?LWO>L"K:/R+S&H0S*7]90JK6[FY MOYO=.EJ_Z^H.>/DSI>?M[>[L#4&H2"Y1'&7\=:;F*1)A,1.W0W4HT=K2,@LP ML\HD+,R:S(.U220QF7$C$S*T+<-_,TL" M>L(.1Z&0,TDQ8G-)+&,8-ZP.C@?D Y,L>^.A.<8S<43,LSF!F2OMOHG!W;6M MK8$ 5"Q')S2W5:L*3J05XO3DII$/]I30I6IBSQ:&;Z:"Q=9VO6-SQ8F;U'8, M,LR'J%JQM*D\%DC3*6,3BW&:*<&\3DS*UB4M>B,%K1I(A:,+]=>X.O76!CUL M="T/0P(^.[;FJ^HP2M<)MC0K(G4:AFGY<#9034[5N0.2#[HB!*"]&;+]P2]F M!T+>O<'U#7QV7WC/(M>="@5 M^J3R;U;//&FC\BS^RK&UH9ZR6/U@5DP&FNHL^TTW%+DR!8;)E-C> MQH;P*22##Q*DY@@Z"9K>!TW'/DIA]I\;U#U;UY**+Y9-O606(1 H>]V.6V%$ MM4%DSW&5+.K=9KMC,?):W&QI6I+8N]LL9D?6'. MS'(I(@A;K'F)UN* HG=];+'3 6P!>T-RA^ KP[I1U#24E@<:DM7WG1[^LMIUDD H9V5SYG6PZR+::$+WLF&LJUE<#5,E6H7 M%C4:7HVS9RXHE*?Z T(O?H%2^:?)! '+A_G'IOLNPZ?IB9W?#Y!*S&)@4OB= MI5I6%_<4KDKBD:G%LTC M8RPB$$((\DWD(@?$'-5AV$PSRFU-X%UB^SZF*YL&0K](K!"T% .*/"CBPC'@ MUHEM@/S&O3Q?25P8H*[MCRC=9 ^7,Q,7SJ9(4QEK6E( & MS"S/B+-$$-@,&G4,LV'QVP*[E#%-H/+VI*^1:6QAS2/,?D#,M!\B1S:'5":< MC7H5(/U 86(01:_IO A]GZXYI?[J7<[-%SPA9="!4]-PX$%R$4Y+GB,MZ-VE M,?8UAY)3/(I-$FQ>2H=VQ I4N#429H2LDG7KO05=KSOF)H4G3UQ=!S.(U7S[ M#NGY7SM0:UQ0.HI#,-T\Q)6*TI#]9 F7.\C+66:S23ZX$B+>D32R&J31;3A$ M?H+_ ,"GT(M*&QNQ*VEL=GD#F+4E?8K,(D[H7Z.2%G6!]Z9Q:'=M.4(ER4W6 MMZ]Q8]ZT+6P[]-ZWK09=@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,#BJD*)=];[J-*L^FJ*7)/M)RE'U5I&AZ(6)OE /X%1.C!>PP/H,/N MWZ;_ %P-$_B=DK+'>>_)K*59+*[BK[R9=_3@:%P4)-$I%,==VU];U2D\P!^V MG?J@V(M3[="*UK8P_P#MP-._/G3G4',M'^.*S*@OFV+0V=QU6C->2RE"L3,#,U.;D_G&>FRRTZ4XS0:7*@\ACYT7%J MCB'3G:TBJQ@I_P :$ZNR&S*&7.Y5>JZ-ZUCDDL>$O1DULAI6,ILU>*SA,?;5 M!D2&=\;DO>MK%2'>Q$)B@C>O+^AT^X,;*,OWI!RHFMZE\*,.LSG-ACMV"J'5 M[7_.&RV6*QSE@VUR:#;>/B[G$4,1,ARC\H@*_(KA'(]J5!8TX7>H667%;W5K MW&:\ZKO V#\X>-_@[L&K.>ZKL9BU!+"LF/5DI;5M<+FPMI=UBBO)_P#ATI+P MW)S-?:6.6CC![WH@ 0KWSK>/1$TJ2QK.1>6R!$R*^^'K)$LACC)+IGI-$6K& MV!A"^W-?X&F)THP:#TQ>.JT]W7PYS!:0G"TGE+-;#WF9N M#'H+,]N;L50"""Z!N=O>Y.5<$LK" M%-C^S5(JD%?-ZI4WR%C8&Z32Z2!$V@.T80X.S<8I:]B/2J#2<#6Q";=.JBT* MFZ=IGH2:.BN[/.WUASJJJM';GK0LQJ:Q)?9@GK:>KT)I#"Y/RF1C97 I[/"H M<$ZDU, L\M.843@3+XM;^?+OZ3YTM62=_E2.];$8+Q8.G.*VILNR1R,$T1E. M3Z\!LR"RNQ76N>>&^BWY G;&=X9(^P-SHF^N@"!6'R9L MNZRJ#0L75/*Z283>M;&75>JW7TUNJ)U[.DB8W9M0>>G$$N=&V0;0SAYMJ3KKMV[YI M_@'QR\YJ((KE?0DF=[$KJUHN1*X^\$-%I<4O44DRFFWI*?H"/24;26^IG C:7LTE06$([MQSDB.5>3M1#NZ^A&KK"C^_(>T]2#@2DI!1X%(V9J5P)C E,D9Y9'Y,!GJI M5DE!O6\*$PBLP\?4"'%9"T2$#%;?3S.\#9UQ"X#:Z*>DK3DJ9"K&0,82CU,= MD*!<5KU]#4BPDX.]EF %L-:??> M2=&^]F.T"0WD5XBHO871S0FMN:1-=$;]?D(F*^BI/&VB>(H_#UZ:FC]*SVAJ M*3)$"3Y'7ZQ)OPJ]!3/D%?7M9\&^%245Y,C(2^6!Y9FAGM04>L60,J>5,K=. M+C90-TZ8B9"2UKT2:(J6$LPM%X3)P M$IUQBO8S@R3PC.L/GERUI/F'IB\9K00WKRBCZ,M2#1>/7&BDK.XO4NZ M/YSM.8/"]Q4\H:M:I%ENJZT4RM>7+)12 M[=M&Z(4AQ.E"8EM'HY.9];03A!['T, AK9 T]8(8\WD0!+%M0DB+: 8-K!%- M->V73'\9I@S1H?Q6_@WH0M[V#]-[P/&USTP\H6/4WC$Y<=&A]@ZN/>0_JR*] M6P:/L%ET^L!+3(#>\7;XZ]/K*V1T1<>>&>2Q!@<]M*PM*6B=4R)481]GVB") MYANO(155"4=-[3FE8^/6#]N>1>!*E4CHN8])5/!R$%EPTSE-CFT4=U(70R/+ M8.[OJV(/0Q*2T)YWV499AX-*"0]>' R%I:^-^>FN/2.\9?&FNO4#9%93TDR_ MQV[9!$VY6M1Q9VGC.)(@5)%JV/D)C$NU)!2TUOV08I %0,W6!JTX\N"'^/"^ M?(?4?8I+Y7#[;W6EF]9U9=1T*L:4PV\JCLIM8U+.T,TQ9(P\I%,TJH"#\,J8 M3#=. 3-A"D*.*V#>!%70SW65F]D&F(,?1 MTHGJY:?:5AUHSHC':N["L>HR5+E#UKFV(WY&IG(.+"K0%Z,#K(U2%>/EAM,:XY8Y2W]_4SYD[I3QISCY%JJH]6?)41 MNF2'3%HL"3*4KM7\?I#4:6E;4-NSP">'4[80DJEHU&MA+M*QUQD(> X4CJ&< MQSRDU)V@_2SOR?N--39HD*SG1YEEJ+N@W*T+K<8R?$;1JNT(">T(F%*I=G08A(0$E# 'XPBUEY%JRNN)N:YVP<=VH.W+%[6D,.N.8/]%WQ:"&J:6@5WV_ M8U;++'Y,VG1+K2JMMABUI_#,Y:%(V:/5$B/4B"48B4!F_/->#A(N,'VW.2.A MIK!>9/)!V8RBW*N,I4IDC/5-NP&:RBC'6.U0TQ)X31&NP6>](7$"%DT8Q1AX M) =H28TH&BP_-459/H9&H>.9\TV?)N1XIYSNKK-NZI5O/]A2)6MJ>>1)7K'E7,DX M\TKM9'.-3/\ 0MBO**K^8G&GW2,V3+7:%/$8&FJ*C9]T,[,CS^%=P-Q2UN;= M*C&_91)A>@W8^'J .]:4#>\975S):O8CNW.KI'748>8?)(!'O\722R53E!'& MN(9)65A/C$"6LI@=I49"_C :-.(00X$ M4^-/G!?1W1_CO]O*\YJ)[CWBI9-C.V-LI MFX4%@X'O9]MN1^5'CBZJ@FYM9C6SD%*PU+6;A-7>NEZ=Y2IXTDB0*U?D#F,E M>:C<1O"37QF!,(4 "2^<^,;/8NC&.K;UY Z3G]K4SW39O3==]6?YP40WC@4? ML>PWJPGFYV=LCZT2]LLE=%WTIG/A)#.J+=G+W 6*4R0LXTD-\_=,EL.*\R3U MRK/FYOZW?E+A!V-VH%R1M#FFG<%D,[C;+89(6=^4HV5Z5M4)7+EB=,K.*3#/ M(!LX6B@CP-%5#\5V='I#W%'>,Z+OZAN++PX&M)H;N9NK4A:>-,W@D!3'JFC.SKXKJ[(]$>!^J:[W8 M?&7'S,TQ>)16I&T-O///:D);]'.FIR^2U\E;"J@)C)L,1AT%$VJW$"TI>L&8 M>'1906>ZIYBZ7MIS[O# ..[L1JK.E7CQZA:6=&ZQ2NC;/@%,0JLT=U\[H+9; MY+(0I+A42=K4J1H3BW%,>>V[4F&FJ!)]'!M<\6=?NC&BZ'M)9RMT#RT5>4XB M4R33@LAAS4 +F85HDH8 B;C'DWJ3G.Z?%HU6S 9L]-?-?!UJ47 M:ED0Q-7KW FF?VY-:_>(572K87H4T-9ZXCT2&B<'MN;"TWV4B88E!J50IV$- MRO9+3*Y%R9TI%H)#WZ?368T?9L)BD0C)K$0\OH\QIR2%S MN Y08H6$A+3%F"#[QZ" 0::8!P)=]?=+3>9?Q>4./#,FB\/[^D?.QB2+.4P7 M]X,-=.T%/IUF85,K.;W%,8]H4TX/T)0G:=RA"T$E*#2RQF!"H%7\C=Q0CDKQ M^U<+CZY4DZIBLNQ*PM%\K*Q:+@5N,KC<=@(Y1 X@"RY-/U;:T<^3M*O+62Q: MP ,E):AE*2D;)*&J*5A9_AGC*Z6/J7DM\Z*Y%_$5Q5/B.6JRN1;U =75+]*5#.WVGY9SU#[XB\\G4U)5P M^&O5S.+]*VNL^7Y1&&Q$K>'1H!I]6&-Y!!YFCPZ*/#-Z5Y(Z:11,F-VQP58 MW.*>%=TXB1N*I9S7,"5]WQQ_F DB.,'N%GK0!9YNPOZ?ZRI86G+)V2(A6$ = M!%L(Z>N//(-!*$ZAJE)Q],[Z=NV?&YRG2;5*E-D4VTNW-EDT?2ZZK9;4DO+E MDV^9TBP)#]B2MBMD4KBE2U65H8"SC33DX>HOF*,RB%YM1 MVXUCYFZWIZ9O'E,Z:ZAHRSN?K0I,RXZ,9IW#B_XG:)4>E-E((?9D.L548XLK MY&E[BG/3HW/8?8,)03,#>KPW#[6@'(U P^\8M 85;C%7K6EGT5K!B8XQ"&60 M&&J52E(SQ^,:_C32;L!X1K"6_8D(%PCO@$(KV"V&E.AZE\B%*P1)2R[Q^5'/ M+)Y#F'4]KTMV/(;-@CF98ZJVGVQ7XM+3<<7AU+VBYK-0SE,W.3M*#VYKT6G4 MFK0FC"028%@"N3+YY>L;QKW/%:YE_0\7YZY?M+GZ^JLAC_"29>WV5;S5$Y?( M[YB3+.Y+&8C('.56+'EZ"1;_ #A)X$CD68F :4 X&PNOXQ^>;!YBY)C=968R MM40DBNQ;LL8BN6)X0O[-54IH]B#.:]HVC:663-^JRI:P MJQ?.7(R13YW@\*C,.4RIT!HPPQWE"YE;F\QU4EZ&,6S5(A[#[A;]=>N][#Z/ MU?TA>J:O)I)8=5]OH8LY)YW5&.+SQ$Q.JM'LI++H*]*TSHF0K%*$WT+7( M3 B&#>MA'O6M;P/@+GVA3&E@83:2J,UCBJ]P=8PSG5Q#C6N..;NN YNKDQ(# M&825I7N;D6%0H.3A+,./#H8][%K6\#F.5&TH\I(\@=Z>JUU0Q%(J;XHC(>_38MX$'G59XT/XBV\WJ(+Q+_ IR<9.Y,U(G,E(Z9%SNC7"2S)Q:H",G MX%#FC<&O9+D<2FV<48F^,X6ME^T(7=:&QJ96EK9V) @:F-I;D38S-;4F3HFM MM:D"8I*W(&U&D 6E2($:0H!9)180EEEAT$.M:UK6!#$GBO,M;SX%XS./T9 K M.>$BAA*MR3ML#B\W=$:-M6+%;25.74E"]K"4S,0>8:3I4+04A8]BU\81>@9U M%JLJZ$O#O)(37,!B3_(]&"?WZ+1"/,+P_:/6&N1NW=T:6Y(M=-'.!XU OF,, M]QPQ#W^[>]X';R:$0N:::-3&(QB6:C[JG?F'4F8&I^TR/B/U^H\M&G1(J_&N MJ7W;^-03[#@>O[1:P,&)Y[H)/IK"GH^GR L;PHD+*$FM(65IG?U@FT:M\:] M90Z;WA4-F1[,4E>PX>TA.Q"W\0/:'-=&^E*623RWG=NK&JD9J51(+,LM:AB\ M+*4)$QIBM2\3:7&$MWV2BCSQ&".6J!?W![WZ^X7ZA0KOYMIWISEFL9\K[/IZ MC^6DUG5)=$IMQX;X).H%9D7ALN9Y9$(XSRV1RMKB+8WO\I:DH#SMEN@%B;9J M79'H,6]!>%MK#GIU@\1&TUU3;A6[-HF=0/Z$0A2F%-'Y,L+P1+XGHAN&QMPE MY1^E05Z3V;,T/Y/?OU]<#KZ_)YJN-$_676;?3-D()(_N3))9Y$FJ'R5/(Y'! MGTIKM[HYOG M%EN4<$O/C$.G-:7'S1&MS.XJG14V"&TEI#"]A$'02 $'00@U@3F MWUU7S2TQ]A:H)#6QBB2XQSBK*WQAD1M,9T5FOT<$Q M#K:HEJ(LIZCE+^%D,$CTL&(2C246RO?\>]AP/HO>87" ,R1T=8 MO$"Y(_(XY'TR]K&@2B4GEG$Z3F@./V5LTP!J?7L%H6]Z$#]N_P!/TP/F&/L( M %E@9&@!92C:LH 6U&$!:K82P[4EAT3H(%&PD@U[]>@O0&OU_36!S2T*(E2> ML*1I2EBG00J51:)*E3IA*3 MA*%(B""B=J#Q_P#O//V6$.S3A_ZB%ZBW_O@?I0G3JR3$RH@E2G.#L!I"@H!Q M)H-_U"848$0!AWZ?TWK>L"H=Q=L\0T=-]UA>/0M'5Q-6)E;7Y1')W*&%G-CK M4[G$)6,;@:0I6$@V806,L A!"WI)Q2DDI0G, <0>46<2 M<6+0RS2C0:&686,/KH0!@%K>MZ_3>MX'X+2)"C!&E)4Y9HAG&"-+)+ 8(Q1\ M>U Q#"'0MC/V2#W[]?47LUZ^OIK _JA,G5E;(5)R%)(A %LE046<5L18PF%B MV68$0-B+,#H0=^GZ;UK>OUP/O@0K(.BJ6BMXP'FR0SYL:[PM*+R*9U_7RA([ M_DY1&8D6I-D;HW+2VXQE]C04C,&:68I =H(?70-ZWK>PPJ^NR^;>8I+7\.O" MQA0F46J:XIJW9 PZ?2==-E[2 )KBTQPJ'1:0:]K/@ULW1>RPB M%H(Y9O)'Q9)7&",;#=J)P?K*NX_F^*L.HC/F]_%=B5C:Y,L@+XRO$40.43>D MD;>4[@+\J4C+$D'LP AA /VA(O)G*\6Y%KR45]%YW9-DZF=KV)Z/K#5\.,; RF0L,/E4V&P)G9>0UIG1T:X>T/3JC92ERHL!ZP9.DR;Y M[-& ._7 ASG3R(\G]23=76-6SY\2V:FC!$X35O9M;V132$MW-889'G>4/0&!B>) M.][:F- >Y.&VJ.1]$XOKXO"D3#V6E1ISE)XM: 6 0MZUL,)I>]JTOVK:LN&N M7W[D+N>)HIM7)KNG,87F01MP1 OE"#?KK0 M=A3EKLEV0)#8<>8)Q&&M>]S%B*9[%B;G")64IA4Q?H4X*E4==P 7)VQS<(^: MJ;CQ:]BYN.(4E^I9H=X$H8# 8# J%T_VY2?'\FH-@O#^9L37T79:2H85.VN+ M'O<#9+ =?K:C[%.GM&IVHC I*,\041HTYI)GUSA#$ )0Q:#G=B]GTCPS5C7; M-Y+9-IFD<[BU8Q".PF-JY=-)I/9B7IE2N/2=.@;IJ M8\2)*Y$MRKXTK8E6.(]I3-!3;W[=""W/-W3E'=@N/GR>(;!@"YT=6 ;HF M0NS.O:9&PGA3/L:D+!($#6_1Z1,J@80*4:Q,2>5L0=[#Z"#O85*?O+'R9&+> M)JZ0#MQIC"BX3N>R.C5E22POEPZ\DQQK:JJXNZ_K[CPI*DDA!C.:/V_1 ZE& M)]J/4LS80L.3V)3ZOK4?%2$BPEEUI*W6N4^1FFRZT\=?1?._+"J J;JK\V-0:BF6*32/NLZ@<2>7Q"1&;=6C M2R-8NL1M6Z \Z2+W) T9'R_6$ (>@A$J N1I%I01A*6)B%181ZUH80*"@&@ M"/0=B#H>@C_7TWO7K@V(U3@O5&:%LM,B1 M$#4JE ] "(>P$D%B%OTUO?IK]-8%%>0.V9%UD].*@/,5NU=4[[7$5N&D;SDB MV+/M%16R(A)8#.&1')(?,&5PCTE87 M (Q(G9F=$XTJY"H^(91NBSR#-Z]P!!&'?ZAWK>M;P/*-5.S$',5S>#YZ:7=O MZ#)[G0T2ADIXC%KT_P#-ME2ETZ-0],IWU9(#USC(8WSU"W$ U(?K'(W,EM#\ M&MFZ#@;='?K?H9+9MN47P]RG#K>@7$3_ $G3-DQJ56L564QE:J:C$6J&X ]YA)0 M8;8OE0\@E;T+V5TH[\Y .@ T$&]&A?OF+K;II^Z[LGC?K"IZLBTO:Z*CO2U6612 M,@F+M IA7+W,QPEZB[FDG36W.Z:8P9^5)4RA20(29>'8E&B$83"B=AJT\@-< M3NG>NNLNL+*YJCGDEY!GU6U]5]BQ:(O,>>.DN PPB$%R!R<(/&79$H4,##(D MLG#*S3F0U"[ &>G7J#"]$DJ%()T@A)NX$<4T2>;0Y24E+ M<1D;0M8]E*""E&Q[+."'<5;Y'[3Z9KF!,;'!Z15SI@YFZKF_?=5R@B;%%5O/ MZ>,<:F:*IC)B%W,H,YEGD0\BMCV?,4')_--=3J+\N2.JH)T0U*I=72Z,V)-I M57L)L.WR8W;+Y=< 6U1%JM9)9L+"Z"CE;_Z:^BTM(#'>V*SK2R> M;H]8=4O:Y F$]+F,^N;1D:A.G]XBB3#5&PA#LX8L"I/5EZLOD0[3\8]TL*I? M(>,V#M*D*CJZ/*Q-_P#&;&N=\JU^O"XYH\H_IC5O":KTB:/P\@(5.TA;XG>2 M_080'!&%TN8N3.8+>\G'FJB=H<^4Y/6!0_\ )IX4$KKN+/7T5EDT<_O$^<6= M2N;#EC&YR]Y4"6KU*,P@]2LW\XQ[-UH>@DCP"2B>NO+M_P '>Y4_S6IZ0[2Z M I3FY_E+Z=)9 "E8&YM"-B8%3XN4G.SDBCSD>J(2C5@ 8$GT+#ZE +T$.^_\ M@AG:73QT.QKHUM[B:U]&\F*VTU0BL[V\AB2K7/F3=3>/Y9RM,W"(2FO9R9*[-K>\ M4?WWV,ERQ'-QI&&5MJ%1[@N 48DQAI(0 3E!&(>@L95/8O9G2]L7M9E%R7EI MHYHYN[--Y:G-0V>GDK19+K7L$TUH;<=#,U_/7-!=3MI,LO-/WAS8XT55[PTI'.#6Y9S6KE3DW0 M.RCW%\C[:QP4;(E7N:M>H.&6G-;2M?'L0M# %\3 M[0Z0M&<.BN&8^LT\MZ2Z^KGHJ$6^]O#W64YD'&(G>;R^K'9 M; UR&02FAY'-)%L@MJ;ESD*1J>'5-43-6_FVO:R95TPI=%[9:,4:8-/DK\I15;$&&OR!/#\ M:U/0&PHXR4MR5.63K6_7?]LD+40?O[M68]?P*O8S/JWE].W9T3USSHR3!%1J MK_!T'?*:@5P2:KM5Y9*ZP8I9-U2IM409.&=^QJU&0K4JE"VNA1H?<(*G6IT; MV),>)>,_(#U:*J[HCQG6G&EOTS4'/E3.4>M)E=HB[6F78C8F=9-)W@ER<;#; M6M#\9!)N@$F[."$6B=!*-#TC\;65([IYQK2YY+8$%L@RW6@=DLCW6S:H;X8U M127J37>+PYJ/7#_)OBB%LR@IM6N:LE$I<%Z8XX:-%[])"0\]7F!F5U=4W+/& M?G*-W&^I/&:BB5M5O+ZDA3I.8H^]QMKY&I\^0V7N\:<2Q,6ZWHE*:@WH[0]I MW&5'!-)&(H(,"_/0'D#GS!27CZ\B-;6"R1GBFV954C/UI%I/$V-^40:O;K/; M$*"RBI6U&+'&+N%83?861^*^XK2 2K3=Z(VK( +005).R?(A-'OG.L:EF[[ 9[ M$X?.'.;H8H^MLGE3'LI:,2=<%B*^=" H:HD*XT.JC?DPZWM6)=$2=@L]G@)Z M?PG4GY!(*W?XW@ST165WO#;(E>);%4BP7^G[&=&IQ2'#CL%^@N3-:O6@-P@ M@_&[#LH)H Y:_O;M6\Y_>"OBVZJ!H;G/CJM>3I26F[#>4\:=)G65A5C'[7?+ M.N]2\5M8,ZU&91%W+3,A6L[W'U:54G$I."K.4 UH)LJ#NGJ*WVJ7]EZZ7Y_@ MM&53U]:O.TZY6>(ZC>&N6QJ$$)X/!&:N+4#%V*S!WQ;D\$4Y-(3S%+*)(YIB M=(A#)/*$3VUW)*:Z\8O39MT-\KC'D=MJ5U-,*'15?7@FN@AV4PV(^5Q)8 M!)&:+)YM(P<[IX<(4B(D"]0%\ D.V:)#[A;*#IN9NW.ZF2%\%] W9T0S7S#. MDA]HLMB4^Q4]5D(-(%SS6M[6'#G&-RUD3,Z]',%@JD+1KD:D\#?[U.PZT'8- MF"#^%GJ*VNEB[A*P..0"H%KI1*4PUBK@QFC++ M/U#4P(Q@9G +^M=S#G%&8>$\(ABT,+U^68<]W)/&PGI]97".Y#N_HQNNC+3( M>5D,TX%T'?07$Q_0Q=:W2I4S@0F["9I <6/1XR/>+V[]-A4_IJ&63"Y!XC%W M1+77K5T_9OE5;)7GFJ/($!BG9Z\) M"8)2TT1@!"$$3?_BE,.,72-P==!H#4C[= M5]<=^F\?77S6HK#K:9J6KN, D]?WX^0N R MM).&5FAZYYL&9($)J$Q!OW$+!'E!3D@VG!H06B\X(RR_$QW<(W?H7_@MXT+] M^B]BT)W9@^P(Q>NM"'O?IK]-_KO^F\#4(]N5H5AY%O$%9W3-GT-T8VO%:S"& MTA&Z%2O-0672;/.:F2/3W:EH0M1,;.4VQ4,1A[*:6-S"X-"0)HSE!B?>]%E[ M#&>&NX+>E74-*.UD]9F2FJ>M.7.N9D;'9_?#"]AEKY#)4@5UU-&JC!LB=AY7 M(4QY4K1L\<;9"]KUZ!N4FKA?(6(8PQ3EZ.L9M]^ %9*KOLN$Q>8^.>>&M;>C MN%PA<,8)U&8M7S'&APQ 6K1-)3].EK^6E=41OW"9$(E,F/3FE:$28$F1NYK] MM*"^'6H7/M#H1N67MUGW]3%W3:$V>T,%J6!'*MEUQ$0]0_R!&S*3TKM'TC"W M$IP)R2$J4I0#19 !:2C*#D\WVMT4S.GCSMA#WE<-O%2SR*],<06+ + M&,R> M/3:J('(.@4$*4KXJC8D^I+8("XTSJW"1J5/WDY"U" CXB!DAV'ZIF[;YE[5X MS[11=@W5,[OZJZ)OBC>YZ$76@8VHH3'E;39&K-5P^GDCH2=12GE0R-I1MCJT M)DAB,HU,K6&&:4@T:%>RK4E\7X0YAZIE'D;Z%DS+?'6*#D3I^8V;84BF%85[ M6M>6?>ZUH3.I=*2**RAG7.VXXS-4CDC)*$RA]9G(PTI6!.<3O0;V_'?TW4D9 MK2"TK/>YX1T1,[ N*[HCSE*G-J>H+JSHC72QI/<(=3[K.9A-'Z]X;59SN)E1 MS +JX[>=)OB^RL4)S3S0Q_R^TU4W4:#E'DVTII'(;^'VA1,71,Q-ME]*L_3$3_Y5V^T)'Q]5*WMN@M2U$SI"7D0O39C MK(#]%ED@WL ;A:FZ0Y[KGS6^2^2SZ\JBAD?3ZH MBU3@[$%'+V\J0M^S2 ;$<#[R?U#ZG%^X)!\,$;)?9;Y'NH8)"7:#\Y]7]?JK M!YU*>6-VB9LUB+)#VYEDUILT7=T:(]OB=BS,Q8X-Q_Q@^V 0]^P&@!U@1_V5 MV!PWU+:Z'DB6W]0\3YXYLNUAGG6![_8478978=KUC)4DE@7-],0)$Z_Y%G3N M?9@4ZV8.+0V;*+TD"U(E2AP5+"4@67EMAQ])YQ:3A*9YBJE\=?'#="-S9E,N M:&Z3-.CKWK"3-&TL6/$)V>%;LCCBHP*< 2S (TRA5^XI.9Z!42[^\>*>L.TZ MGI*6WO3\4IGBSJ1B?3(:X.CLKNGH?LV(K%T0K*)536D<95K\IK.J9_(CS75R M_<:^/Z,"0E(-M(/6'A1=G*(L'F:A.!XXE+C?9D/\W<@FUCU4I4+'^=HXO ND M9A>LJOV2LQ*1Q&U5P75DL9UI+P9H;*LT:0 A0::;LO0;5Z6FL5?_ #[]D,[, M_P 9=)5!I@'MC;Y0VFGIC-!/2IEZ80 MPZ"<7L0;:*4O:I>BX6=8E*S5MGT,3RN9PR9SATP:-E.:-"J M^9FD;.H3B'\?Q&^S0RA#+$$8@R&T'YDB]:V!(Y*[MD?C['"Y.ZO3X\KDS:TM M+8B95JA8X.+@L,)2HT:4@&QF&&"" =;WO>!Y?;BF4,>O_%18344K;1E)^<* M)A(SD)@%:HF3.KT-.<"6[8YS7:4\M^W(]!I2]/A'8$_@#<]3,]\3R=_B,A;W M"5F-^T"E)MPTH^1"/9(RPW<>'%LJYO@E\J:%Z2L?HZC7ZQ&.10A2\5G**[I6 ML75YCYBN6UK0.IJ_2*0+F%I6#3G/"("HYO9G0_:4D6C]*B20T2.#U5S%;?5U M^AZ;LYNDO/GFFYYK?GIT4]264F2#)P/O6E]4DH[Q@*Y7<&XI&K&Z'\D]86](%$VN%->#Q#Y1& M+5;(DEZ*NN/N4:JIB:E$S9F8ZLV1F3@7QZ/HD:_;D$?V![#-^/JGY@EL;\1: M236?,9!KL3FWJJ&==%NW2EI)EEA$UU'F27M$/D1 )\W#C":(6BSJ]$)T($&U M)Q)Y:C:KY5'RA"$!LAEL+G?QD?\ ([HB5UAR>.INS:@C5GS!IDMN1B(7S$+Q MD+349%BJ(;-H-(V:VV/G5,5_%Y2JT8 A>$!R0HI0=LT >C*TAZ&CG&CD;5\OM"+,;1T+)WB/1 Q,S3E^B*=TDR-%/Y(Q(=.I"49ZART> MH*T:6%=[R0AJNIT/,$CE#%ND)\9,^/Y1XG9_*N^6-7+96^4ZQVPR#@*NOYU9 M"^2/AQ46Z/D+BE?QNQ8 (Y.>G;0*U@1!& W W!>&-HKQI\8W')E=)HZG3NU* M0ETF0HZ8G, ILL3$@0S\U[VG,,V7*"9$@.(<2S?:>2I)$68$(@[#H-G^ P& MP& P& P& P& P& P& P& P& P& P& P& P&!5D/&]$ [ 'W(",GAZ -IHRC3 MWW[18VD^(B?DKX4X";#$PQE2A*!+M"!:4<7O;<:80( M;UL(51N;Q*4E976]VWJ%;QG^5BZFB5%[-KQJ1 >SA M+HNKG Z^4RDHA\.B6G33*8_)25>P>PO2? JYW-XVYQ$O'QUMSERL=?\ TG9' M9?0<=M%Q061/*NT5#IN_V1';$L2;?RA:SUNDCD46IH;HL18QN1A*X:0" MN1!3U@P]!&)6AB\*:J_8%J1CF]FBM%!$= M@^&WD>62&FY1 WJ_><7BFJA8N?TJWFJZ)'5"^PZ1C:E*I::RM)Y0%+GZ4L! MB30B.+5)'$T*DSWJ1""1LD+!\]\%4]S)?-UWU5T@L5"NO*+5E#'^LUCK& U+ M%V"G(ZCB-<)81&&B(M#HU&1J,)-HBS%+BM&84>;LS8QBT/0ZIQ&%C(IDX7ASBA,25G1(4IC\C96<@:<2Q:$D]$L* Y.:M1 MH.A&ZT *GG^$OC\^&\QQ0J2]"LKGRQ W.GHI8T,MU57=G3ZBGAQ>5[A1MKS" MO6:+*Y-6IX'U0F^!(!N7A3FF:"KT,Y0,T,JD?AHX9?+,9+":HC/H R)X#!:Q MG-,UM9\MA='77"JN;T;76[%=M?M2T!%AH8@WH"B2RE*@)2\L&@N 5FM[UL)8 MJKQR4A4EYLE[,\ONV1N,*=K@?ZLKF9V2>]U-3SW?+LYN=HN%:Q$MK0GLI4A( MZK'->S-BC:G8@'!-:4FM"]A8@#"K,D\4W*+[ >7ZQ M:06S7L,XZ?%TKH%JK2UI1#-PZ8+EZUQ'+C%;8=I6ZR$@UU6@+.4#&$)*Y0#8 M=A-%K .?BSY]<["OBR@6)U&ROW3CPV.E[IXOT?8T7;K$2LJ8YM9XVXZ87% Y M-<7:F%2:V)T;P>+: M@[A@C#6=W.=F%0AADS=,-,-?6&_0%*]2!C6(G..+))^",*&^ C3PWE+4!1V] ME$+ !-]NQA#O00),_%!S%82'I9',)%?KR=UT75B>]WF2B*)5E!"$T(O;K Y+UXE>(Y%T4GZ>>:_E"NQ!N$*D$C9 MR[)G#?6EA32O?JFQ2P+.K1L>D40L2;(ER!.K.7.Z97M:L(">I"<9[A"#I[)\ M;$=6@IENIBQK5K8,$[)6]:2*8K+TN)^E:8=*I8G]X%!B]0+X2S-@3: M( $H)89E,^ >79C3]64H7!7.&1JBW\F74G)*]F4NB%GU5- !<@JIK$+1;7G4 MY*E;W^96"=EJM:K->3%9PU^U(S!"V$V4I0M6<\5BVU#4,;W$X4VFOBX1);J[ MN3ZZOLHNM>@8YS[RW3'+K M=-FJEV.2,""QIHZ6/-"9!8]CV&8^SU^]NY#+SU5BRN5+"'Z1#+ ->>287M88 M6$9ON&'6\"HK5X=^!V">,MDQ^L)E'95%[2EEO0\^/79<[$VP>53I,\ ER>!L M;3.T;-!V*0.+ZH7JDC20C"T753-7$B15_S3:) M5STC&@7#=1B2"V0F=#GI%($IQ]AFK74#:YJSS4B)P-5H$NU)VB2 !.-T()CH M3F"D^844Y:J.BBZ$,EBSE_LF2QT,QF\@C0)G*7):\2-VC4V2$EO;HX& MGJ4K*0@1FF[T+97J$/H'!J7E&D*-CEN16KH_)HPU7I,Y?8MFF?Y-M!Z>7V=3 MQ 4W2N6(9)()BZR*,/CJE3E?WVI4B&284685L!A8!:"-89X[>.H#S7.>/X]3 MI ^;K'<'5UEU5R&9V',65>N>U3N,.9D[R:X!8U&PG M-_UC0 &$.S>_%?X^I))Z.F#]R[7CL_\ .468H34BI<*0*$['$HL,)L9CSXV& M/0FR?-4=.#[T)4@)= I1[V(OV[WOU#/>9./HAS5975UG1M404Y=4W'_E:11] MDU($<5:%*5N&WIUQ37()+*![F3^-4<>]KDAB%O5""F*3($A28(1!C=@>-/AZ MSYE-9[,*"CZF0V>^(Y%;.F:03:)L%PNC<-"8B'<41B+[AMV!WM9W-M63.TZT:D[+#Y*\QTDXI&V(!(Q,R5 MS8"QE1J2AC0D!6VG;FC6":=A_P"SV1Z[]0_";Q_<9HNEP]@HN>:^0]&Z+4^M MD(D*Q(H-<5B?Z:B2GQY.M+B*B:&(O4G\X- )WT4(0-*=!$+6P^L'X*Y'K:9R MB?P6F&6-2>5KYV['J6YZE@&Z,O5HH--EE/U:1\Q_,C]2R"?H0Z+>%\72M"QQ MUK7S&#WK _L1X&XY@8*0+B'/T"8B^;G>2R&C"T:5PV76LAF+@L=95((Z6/W#WH8M;#J(/P;P70?JM;+VD+BN>7:SDT5;PR90_.J%(V M.TC+4"+$G129V;D19"MR(+*7*BM;"::/0QZ$'T:N,N3F*TY%=S+SK3[5:\L0 MR!OD4X;X*PI'IU+EQ2A-+U2@9*,"?3O+TBHPAV7@+"M4&2LH14//HK+06S(8S%XXS 3IW)O#\CZYQ5U?-*SJTDKHC3A!N M0-(TSDA*T9LDP&S#!;"Z,^I^GKK@J&"6A7\(MBNOG8'E)&9TRMDXBZQ0Q#)6 M1]R.0OQ3FA=!I!@"84:;HWW^OKO8O=OU#%:RY4YAI5\.DU/66A&[1]C;U^T0"U1H=%?)\>@F"UZ>F]X$>*./^#H"6L6K^ M:N58D7+7J0I%BUTJBJVC3^^V<(EODK=M4O9"=KULX]"TRA,$0MK@Z"5L M>@ M<"0'>C>7(9"X=_(*CH>+5W01;O(X")Z@T!98;3))Y"H;Z^1,:]L3,M?%&)E! MPE:E)M('8!"V8+TWO Z^(XXY1'\LO@C_%:CKQK61O]A&J-2C!M7^FQ[%^F!\WZE^0H,?63G)ZLYSAJB$S!6X4X MO?(76T=,BD^<6=,:N6UNH7-R/;-+US##B1FF-FRUAB1K"(6]EIM; 'T6Q7D> MIY4\W:Y1_G:MIK;Y.T+_ &PO;:WA\DLY.)N"K$D=9PI);W*8E#:4031 -4J- M"3DZ%O6P UO02694-3FPIPK8RL*\'7;M\WY2!"A<;W#'+[ @#4;7Q?;;^$5[ M.&4'8]F$"]VPZWO]=:P(JG_(E%V3*.=Y%(H79*.95'#65JC[-#V64I& MO33%G4;>B92W LJ"DC..:4*54E;2E9NCSTYYJ=().$\/41BDD6L;E(HQ'GYQ MC#AIVC2]Z96UT6QYTULO>G)C5+DQY[2X:V2#^\G$69^S7Z_IK X4KK^!3Q*E M0SF$1&9HD2@U8B1RN-LTB2I%:@H9!ZI*G>$2PE.H.),$ 8P:T(01;UO?IO>! M7E;(>%&NURXLXOG);=>3>\I-$QQ:YT\DM=#(0-Y2I!HMH//+EZ9Y U 83Z% MA/TGT$0?V:UO MD$(0!" 0@ .@A '6@A"$.O300AUZ:T'6OZ:U@1>*CJ4& M]ZDPJ?JT4DTZ?G-2 5?Q/;WIZ^W]_P#,:=MM'W_RGWO[WV/D^7Y?W^[W?K@= M/:3MSY3:9PZ$N$VJ:[+C);8W.%QS=-&&)6S%O2PF+-#>9-G0DEG M)THU\PU6B0AW\GMV&0)J8IY%( 2U'5%:I)46Y&O):8><[ >2 MFL+B%R..-$,1^C/E$(6][%Z[W@923$8FFDJR:)XQ'B)BXMQ+.X2PEE;2I*N: M4XP&)VM8^@3!=%3<086$0"!FB*"(.MZ#K>M8'*;X^PM*MU7M3(T-B]]6_DGM M:WMJ-$K>'':9,CVO=5*8DLYP6[1HR2OE.$,SXR@!]?:$.M!%D5NGG]594[DIW ,N2+#5>T_QG#7A&(> MQ#WO 6YT10=&JH>T75;==UJOLAQ.8X(T3B3-+(OF[J4I:T)[5&6UP4%JG]:! M4^(RQDIP&CT)27K>OWZP(&@WD:\>EERQOK2!]?V6A##'->O M2[&)0C2MQCB7LY>6, O[(=;-V+6]:#O>!=HM(C"(1I29,$1P/:,PLDK0C2Q: M#^T0PA]1@%H.OTWO>M^FL"%+EZ2YXYJ(AV[TN&MJ;33Y^W%X-_/9.SQ0F42' MT),&SL.G$],%>O#I27L19?KO7R!]?ZZP)GVVMVPB!M BV 0O>(.TI'M$/]VO M<(/Q^FQ>@]_K_7]=_P"^!^MH$.PB!M$DV 0A#$#:8G81#&'8!"$'V>FQ" +> MM[_KO6_3 _/XUOUL M($7N+_ /I[^J1ZE_NV/]F_9ZA_>+>_T_UWZX$96];] M*\_PKP2JX(6\M3,"03=W:X\R&2![/VE9FE(7,_U"G(*T,\W> MM^T._3?H&!2?LSDV%TW&NAI=T;34;HR9+$K;%+7>; CB""R)R6&K2"&UGD"A M>! O '68&70@NKS8_N7G3TM\8]08Z M+B1Z7;DHY*6I_!',8T'H;]OYMD"*]!>[TP/U6M@5_:L%C5BU7)6&95[+F_3Q M%93%U)*V/OK8<<:6%Q:EB?6B%20XXH?M,!ZA'Z>NM[U^N!G. P& P& P& P& M P& P& P& P& P& P& P& P& P(XN"PC*EJJQ+/*A\IL =?PV0R_4)A)36?+ M91I@;%#D)ECQ3TYLS4-T6A3[ 5H]427Z[_47^FP\[X/+K;RWH_@&TED#OW=- M](<&W/;$CY/K&JD%@3&46='76&.<>E<*,*0)Y&IBPV->I$E>'!T;F?\ '%?. M<%/LX6AA?6Y/-3QK3T+J6<;/GMAH;3HUDZ94M$!;(J=)*YH-]"4!)8\Z9)7, M8HJ&1M;\Z8+4S?EWP\U$HV2B,**V9L+\SGHF"P[F][ZE:TI))X,:P$RA.X1UK7KFA.I&AQY 0$Z$(0@^W>!K29O./S>_QR)O M:*ENEV=?8S<[RRK&"Q(I75/G6G5T>A2:9OMMU_(;9),QU[*J=@=WWI%953<-Z!G#O7,4CPE--U+-;'=: MB2R*;QV32R/29V61^PF)>D>4; C>#6M*WJ59V]$!*$<'65GW+5M'Q[MBPYU9 M'4]J*F[O]\Y_@5,69"8RGGH;DE$9@ZN'J-V4E+$J-"E'+GDOD] VGY/GWM657"T%QGI&A*_H?GJYYU3BR71"96C6$E MFZRIXG+XX\L=--T/2IT@EX7I2[$MB2.(BUC@KVH^<9H7 A7G,YGL2%4M)()4 M_04]D=UW-;?.[+ Z_C]?RYS;[HIJ%-T]D,1U)D=C$021HI#'W4D]C=&IS6-Z MX@6S33$P CV$.N8?+V[6E8G!T6J?G:3E-_4%Q]#U!;C+.)!"$=@U%-N<&*6: ML"M],B2:)V[ M022=1.MXE ZU1-PW!?)YDK.2MJZ2R!\7-D;@D%:@IC#W9^][ M"'84K9O+36\NJ6L99!:DF\KM^W.H95Q_#*/226#[-<[?KXES=+ :NKV6KV*7KJ(LF,SV16'>M;-M:6 M5-Z;KDI2](AVD#LH(^JB^J,:DH.N=_-M M"'!L6.M04(QV.C6,[!"(RB44^Z+7I%*EJ\MD]&]GO%.1FD2&3FU)R-3W2;#;+K*6LV;/ MG^>UB]=61J^(IUVM1]H=(_''8DU%H*U<0M2Z,.,)*,+",)MZ8[)+HZRJMH6N M:CE?0W0]N,$YG,PJ3,^^K:XJZP\AEB677/1%Q4Y"Z>XLNJP:Z1V7#G:&\A()M'IXSV@.)FS M&5M:61I5KVTI% 6^,IE)J\XM0,("BB-;V%J;D\RM4U;8LOC,=I:TKNA&:U@8DS<*79#HW0;_%NU>AW*\('/*UE=Z2*R+4G$WJV M]V%.^(G&YX:JJA8Y$0^#,\E2FJ]1_P# HFL3/LE*0/9R7[)9P17%?+Y''>84 MR]2F@I?"^6NEKIFG.7/O2*J;Q%V!,+EB,IE,0;6N6UZAV%57D2LA^B2I'''5 M4YG[4*0Z^XG0D# ?L($DWG,G<:KPZY5/CDZ"W4(+J*Y^)F9UCU$G,46LDO*2 M4L^PY,R_G#5;BZD.#4C^D8S7OEE56#RA9=4= M?M/35;\KQ?G:73*(K664SFYHL^3^M) 9<\7"_1%NA"J!QQ8O$!!@J:/M&W^?N M?%S#*;LA)UOMUJ7I#F61JWF(50JV.C>;HI9_2W/LG:8"M\M=?456"BB>H P%\CCS$;K!#HXU3_;= 4CA M+X3&90T&:7D:$<&4B]=FE-R?10L"_KGY>F9K?)!8"BAW\/&<+Z_6\2S?I<,P M(.>HY:J-V!$%$W5TZ1&C'=/2C;9"A.P+'I2YIUQ2@\*DIO.2>AP@C1N\SLR% M*VY5(.-WF/T@1Y"'/QVR^V0W=$7IS8+2%(4L9C#\UU\V1LQRDC YN2CW+1@5 MD 1%"!LLQ5ZC^,+:^6^8,\&X9M"1RVIYU;]?MKQ7KA/V*N+F,HF6,L?:)['7 MI+)TDY2%*'?:%LDC:@ L1(2CE2Q(<8#0! ]^!5KI'S$S[G.Z^LH&Y<=*Y-6' M&"6CI7<=EH+TCR20"K&]G,+-&)?%*['"E1CTZE+30C,:ANA!@$X#!&'%CT MPVA=57!):9Y5O:]:^9663R.M::FUEQYGDCX=%F=P%&HPMD.OO.P620&I/B1I M1&@*VC'\YH DBV5HS9H \Y$>Z,ZBA?:="]&[JC_.%V33PJF]!6/6#=T*Z1.N MY2I_R5 BU5DMR:31DB!U_*W&!1I,-4U,,<+ :O."E$I/+*VNP+TNOFL4RI'" MU7-?)-E='K5'*5+=569%X4?-E,GC*&[5K<"/U3" 1RI)X+,M7DJV04P M/N]WCB66G/%L&%6*L4B;]I@%0+2!UE::1,1T<3L^G%O;/J*ORIR\9NPH20OO MP_W5>?3=DRJOK7XYLZDF1MJ^+VE%[D5L-H(*LDALH5I!*JJVJM:K*J?2['AB M%W3:5#3)5;8Y[3JU"0W1!9?O#\7KW9:B#IVP>2^5*G!4AAU45^>Q1B7JE5GS<*(TX"IR*2-+63M.([Y_LZT4%+YK(*9\K5 MQ^-=MMVLE#USET5Q'U5?JFF9LJ%\[#/BU_/,69GD]QCJY-O7D8G/9_BE0P^I)3N# MW*^1^=>/2GZ!KN!T+7#Q5L"YFY'E"1A7SF4&V=9K1:*Q+';'D$,:(E' MY@E@46J70?N/#_-#429R<5Y1"79QINMB"SC/W7WA:W0G:5,T9S=SL[-7&=A. M4-?7>5W!8()'-RI'1RNT*BTQ1UIK<*^/Q:5N=]?:-VD$O %.6> DU5L*5 M7EWK/^^?'?T88WTY6;I "/%I8=XWXTJ");)'^N>E'QUF#! *C9VP0FW05$+, MK*0.K@J.T8K(/;TV_80$6O>'*N/RBW]Q94_.L:KNOZ>F$)KCBKDFSGJ(.1-D M36V+,C,L8FV,3%T(65D6JBW-$/KPE G]D@G1 V]^6K-$(0[V2;[0FFY/)9WE M6KGVS.2:/YH_POP]TA2M=2UEU*K/DEMV77UKH*U7F-L/ UM+STSBQMJ@!(4ZA. M/:K97J<4'U,"&J&PO)MU#4705!TFG@G.7/\ 0T_KSD=95<[N2'6NAK*U@6"S MQX^X('![GCL(5.@FHWN,.9X3RS"#"31E?(3L>B MS1ZV&AOBJP3.^M>.WCJW8-%E[YX\?\EROL>+R:-I%PFJW>41[YKH5E:M'M2Y MC VS)VDITH&$!X##RF7X]AV6 6QA<:NNZNO)XCEO7;2'G5PX]C5T=,U)*:/6 MN2MDN^$QGG)ML!C;YDW6,<\;8);:=D6/!!#'$?Q0"44><$@R51I^CS0AT=7= MD]VJE/"D[D4OYGGT%\E,!GIM?1UAA4F;$'-]N**-E%\U$RJI8BFQ[I<< *9X M\>U2D*K:*QU^H^?- M#)72)=7]TODJ1O;DBM<]QD1QCI D@FH:<28]8>("802=&"&(-J/CPZ$O2XVS MINLNCU==2*V>4>EY50+U8M6H5+!$[,:DT2AM@QF6:ARIT?QPI[_ SHA&XMFG M%:%.L2F:]^A>X.@T'=1U8W\RH>NW>PZ\KWK;Q:]!=D2>YKKZ1IS<=UUEQ5T" M"WH\AD"=V+=BY"BF$1JFD\"_NC<323/:86(&A!BES^0#H"_P#B;J?I^KU= M!V-SQ7E?\.IX.U6QSPNL&.3.[94I@TLZ)0O*,B3*&HDB#+9HRMX1#+4$1E]3 M+ G&;,1_($+B$=?=;WO?W3S;0EK\!8U(5(\N2><5EW_6_:E-$ORVS>'.6 MH5?4LB+ 86G!9_-:B_93!>CH>X_#_P!ZK6)H8^)7)+K8!E )0*/781[*]0Q) MOLD74'F#\TCI:H*'5&O5GG,CLA2K=RFY;?F" MHYO-$$LTAECR/0=&Z/ , 6-\;=1T%:/'ODTB_040@SS5#IY!O($AGYLM:VG; M\6C M-"$':^6-E9W2L^1UCFU('%2R^2#A58TGJTA"@]M4+;UC[,M/0FFEC$E-5M+D MH3&"#Z>\DX8-^NA;U@:P;^[X\A=/WCWP[H[UJITJWBCJ[C>+M-5F4"00=95: M=6JVI!J!/,Z3R=S>8T9#FF2EG#=RRA*%SHD"=[TB08D(@L[SSU]UAT!8[QTL MLZ.HNI.;*][PM'CJ<\M3*)M(%"R&Q5Y<*UA,D8;4* JL!TOZ<6*:WJ4;2(MO M9#$*D1>B1?!LT\-\NG%O%M-H*Y&+:PPXI)K2DG>U1J?W:4%IM:'ZGF$; +WZ M#Z[#Z;]?3TP-'?G"C+S,&+@UCIM^:FSLA-V[7\KY%:Y86(VO'Z=PF-R:42PB MQ=G#_'I(P@AS:>?H[99JL2T)"9.'6U)A@ CKQCP**7)X\)4\1&F8)*.O8K]=IIET50'A,XA@"N.T%#2GGJA=.T-PQY;:5867=?#[GIF;F44Q.7:!.\E@HC5KD9_%W56T"T O:E3I*K*/3A.."2$T87\P& P& MP& P& P& P& P& P& P& P& P& P& P&!C,UCXY;#9;%2U04)DFC+]'P+1E; M4 1C>6I6W!5"("84(X*<2GW[!H8=BUKT]=>OK@:->=_&KUM6\[X4L*>R_GA6 MOY#XBNWCAT9XLXV/HB5)9&U1A#5DR1*G.,"$F4C.B*?^0)QZT!.!28))L_98 M0#"*:4\3?:O,:3GI]J^P^0K2ES#RZQ\R7C%NBH7-9S72$5>6)8,WK&T:@=2& MM&[**)^ -U-@4K-GSCB;<[M,N:9+83]SI)*<2 M3R4-**'LCS*GJNED,_EKRPP5H&WQQN5.2O:PQ$UH]E)B]_$0#VA#@:V9YXX. METD>\>LWJ"6\O*;OY#YYWS3:,&N>"2.7<[6K '*,P5*YJ6 A*VCFL8?FN6UZ MB7HE0 %&FEF#*,$ 'O <&']!>+;I:[RJN;W:?\Z.S%FA M4?$$.R0>HPB:>^'[KZT7>YKMF%X!:)0O,"'[7TDX69UXX>GI1/.+[5L MOH&CG"7\S=+2SH60QBOZ$'759F-DOKI+5:FK*Q8V.2@>&E"VQ[:MQ_//ZQ[< M5SNHU[RBD99:8 8/5GBGZ$K,FF9BSWU4C7;-7]V].]C+=ZKZ>R&MWIMZBC+S M%9)"CF$ZP(\Y*9'$&I^4%M3SLTDG0?3WHO49^S@OAY!>5K9ZXJZOH'55PQJK M112XX=9$UCT_@;C9%6W5$8JF=Q&U':T.:)="%TCK][>5:-6O;A+])5VD02CR MQ@W^T//OVOQ_B@\N[RN[KM9U#3W']OI6KF9U>(&B;8[&3D7 M/%@.-D5\FD\TD^RV]4RKV1N*;4!J9:8M#Z$F!:CDOD'JN<5Y3UCT18E=<]2G ME>O1Q5A71,%?2L0L#_+'"ZKD U_LB R==/#I O>YY,U=F/K MDS3EO8!-94PM)W*1L"! C(1,25N1%GZ,).4G!D_*/!-Y\V7U75J*+Z@4FA*+ MBZB>3[6KTBJW%"ND#ES@CEC?7,\@4N,F9JB*I5QE=MF&FF@*4!!H MC903%T'R99DOZFI'L2@[1C4#M.K:SLNDY7%K%C4@EU<636%A*6J1(T;@@C,K MB+NTO\/G#"E<4JDL\T!Y>S"3 :]0C"%7:?\ %Q/**,\><=@-QP;<#XSG5G7! M8(GROY,MF5NVI>;'9[-;:E@6%S\MC@<17#L]2H:$0TKD>WB) PY0'6_4+J] M\\JJNTN6+$Y\;)HDKQ^DZR$2",S%PC267-C+)Z]G4-Z>+;I2_&[O]'+>A*&0KN[N?*'I=_>8W1$S93H MP]4P#ZY\U-0&W ZEO8Y(E?G@O2;+:8X06J&[()$8 MDV<:>5O:H"8X@-BO6?+-8]E\YV3S+;@7K4%LED2-BQS87 *.4,#FSN2!]C20!-3M&N]V1V3<6\U],/?4E&U0=6QQ5FD2G3U(IC7%?SZPA2L;$_5 M]54]EZUS2;2,R-R-^MN>'&0KKMLU[\CT/O=% M**4YUM62)&%BD_2RZ_)J_26#1MWGSA^*@BR1+CA[,<4 %B$DI,4(2GW#,"XU M@>*RV;+CY X M4HH-CD_D,=KTVK8S6E;1W4]VJA,;AL+5G$MJYR6O3B%>+2[9@3O0(0CRU/"Y M/IQ>=JW%&NO0QHB;]I4QV]%VQZHF+2Z41NPJK6MA!,->+ 7R-.^/U8,D>1' MC[*2%"E1+5&S5'V Z$ 8?$WPU6\FKY;2;%UZQ(J:1^0YK[G@;(ZT20\2R$$- M4VDUIBA(Y0EL)D+E+B^3]\3_ '%JM* @MN0Z+3$$F&C%@2:=XC'<4SM"O"^A MQF<&W1U$E[$L?F)PKHE;+G6S_P"6-<]?ZX26SN4%IR:)FD\9$CNZ-AS(>Z#V M3]4I:4288,08\/P]3);6CG72_J!J)T[>2Y-Y*#GMNI(LL2*7I5J*1EU\D@8_8'W[", 4)MGQ.6'<+UW; M)I!UNC;9#WC3M-4M-U;'SZW%(H5':DW]02V,M[C:KE]MQE#(M7I3=J3-A2B5 M -*UL1 =##9A+Z9E'>H);9D786J/N:E3(H4HA[[,66- M+Q2-F9EBK:LU64C&)400,6@:V((=;P-;U?\ BEGL/EL4GC[URHF\JA/CZE/C M\CBIPHB-LC>5"WI__*L4R<6UCG"8*YPB;>G2HRD81E;6:3?(H5#$8/6!AM>^ M&>3U"BIY34'=]WU3-8YS_$N6^@)U"X=#S'7H.F:X6KRJQ D33)7,"*>LJ"1- MS-:$4C:!*# %>TT"8L8=:P-IMK4$U6?S-.>912V6,S)-*<=Z:W.#W$Z23EN; M'2)F1'^3'/+V:<>^2PA*9]D2M8,P:A9KY3??L0O4*HQ+@2<.MJP"S.E>GWWH M?_#-.V-4%.(?\4PVL7MC#;+,AB4_L6<2N/+W51/;"?86UD(-B+3-+(2:(]44 MV@..U\85#@?@V105AY_8$79]R#*HNG[PYJ)D@!D%I@R^)>$>K&=OKR-RF]K+E4'9^'#>"KB MB"./0N+IKUJ5H>) \5RN>WI WJY##7ROE$AV,DQI5%&+34*41YFR_M$JPM9Q M/PM+>51:=+0ZXO;K64L<*!5%/((W' A3266KS6E % MSDSR@YKR[9+* MKBQ)^R0GE'G"38PHBTQ5,;A)I/(90Y,A\\<)<\.439SS30N):8 M(D'H62 )Y^AA+W5'+P>H$U*(55H2VMT=,7S6W0"4F)L\1 MU(]IF):K(TI/2#,&/8@L1">5)5PBV]I]*4R?K8.=-I M)!VXJ(Q%DC,B31*-LT>6HH0,"0]4N,- OVB+--]% QF##%.??'V%ZXJZ-IFY MVM91$C[MLRW+EO:(TQ*TRYQK5/=KVC/=JMCM8DR6#0-5T18,=B-F,3&SV"50[2FCU*S> M<(FR'(DDA>H&P$;(_'#+ PN)HMJ52(Q1L1@PE&2>(JFIA772E8RGH/K=^8.L MI)64KN9:Y63 U$A>'JJ&IH9(RK;'H54_::5*ILC#,4X* >Y6MVS)!C.^31PS M@Z";>%CF";2&;NO^5NL8?'+-GT%MRQZO@5YJ(K5TVN*!N,?>4MLO$211P19$ MZ?WN-IUSF>B.2)SUV_L%D$G%D#)#8?TA1$9Z>HNS^?9K(9M%X=;<56PN5O%= M/::.3 ,;=1E >VUJ>EC8\D(2WUM":A5;VG,$-&I- '81"T,(455>'_FITD9# MM(K"Z2E486G<\K)[5$FMDIVJBV7/EZ-0R-5$ZV)$3HSK2Q:V @3?XK9*=0AE26A6UU?U22L'$YM/ MTC2." (7!O0E 3)3B2/>6(*D]+^,I9.=(\K!SQRET@RVY)W60]"3V M)6O%XJP()@D:4M=S%$Q2"5NDH9WJ>C=41QSJWZ) T%HMF;+4^\D-H-!\[U9S M5$':&U6SN*%-)YA(K%FS_(7]ZETRG]BR\\I5*IY.);(UKB^224OYY -GJ3S= M^@"P%EA 4 A7-Q\9_)SB^OB_<:GJ6)3&UW*\;&IQ/;UFF49:-KN\@#*G"8 M6)4BZ4+89)C5@?.2>,/C65=/*.MG.LUI-HNJJ M(O4L:F>72=AK"P9E7KH2\0"P;&J]GN\"*)#XX>6G[D<7#J:.3&)G+,-T8,LO M8 XL;\3G!<2N^=] ,5&HDLZL(^8N3NVFR66+*Z:Y+8K0\,%@3.*5:L>CZ^BT MSF3*_+$JYR1MQ2D1"@P !%A,,T,)SYUXPY[Y9&>JJ&)O*-V-B+!7260S&=3B MR9&S5G$EKFX1&LHX^V!(9(Y1RO8NI=SQ(VA"80C ,6AC ,S6AZ#('+E2B'BY M)C?SI"U2^U9_59M(R]_4S&=&MSU59PQ&F0TZ'BDW\+(;MJ#!G:&2W%J-'FFF M:,T,TP0@CQ]\?W),@6<\N"FJSVQ9RA%BH5SNHBEA6A"3*LC!:)K;#&J/[A\T M8]&EK6MF3)51BO[!RM*7\)PS"Q#"((R3>)S@E.QOL4'2SPXPJ62QQG\R*<5^^6@X0V:.3RM+":L&Z(5>E8PAV;H>PZ] SZ<<35S,> MIN8.D$K6TQ)9RS"I?$845$CY)'W-4RR%A61ANKU2@:7M%"P56U(G,:\2#;:- M48Y(4 0G%I"CDYX2/T=R/0/6C=#&B_8:Z39LKV3$3.((4<_L:%)6B7(S$IS9 M)?A@4MC '![9%",!K>I5:/-;S?<--LH0Q[$$)/\ XO.()2CN%%)*B>GLKH"1 MP277*:I=84CK)0L5P!T?G$RRMKQFQ0]<+:,!1A91>@$A]NPD$Z+#,&+ MQY<81R_".H6J@HD"^B -)G^15JR1NSFI>&1@,B[;,7!O=7M:PN=B$,!YJ84E M4)#7\T!YVS%@A'&[&&#H_'-047L[EF65S#&>#QKEB6WK9,,1HWBTRB'2EJV<8$E>VJTRH!9HP:'[1 MBUL((DOC5XIE<#JZM7*F-HX?3)\\5UXBC-C6Q#7-H6VBK(7V.O6 M.,X<$X5#HI>%B\]:HV(PT8AC&(02/->+.79_55;TH_T]'$M;TVM9G*HV2(JG MROUU7.+ C/;FQPKZ40-VCK.3FFMZY.8J(/-+/V8 P>A!,%4U37%'5 MW$ZGJ.'LL"KF#M13+%HI'T^T[8U("AF&CT'WC-4*UBM4<8>I4GF&J5:DTPXX MPPT8QB"0L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@8E/G:3,,'E[Y# M&%'*I:S1IZ=8W&5[@L:4V]N4*VUD4.;>TORY !U5%!(^8E$K,+V/U"49O M7MV&G+G?RUV+9*W@AYN+EYFK"L_(@*91ZGY-#KG56)*(/9,2;GEZ#"K6A3U5 MU=B:271IC3@+3@UK70E,<4 HT =CWL(;,&'KWE.4M]C.TZ-M+G[HN+]0K9==T6M B0JX%+.:8<3+']B,)8RE413(BB5Z7[1REQV>6 M 1NQ$E 68<&QFO[!@]K0N.6-6DL8)W I@V$O44F,5=$CU')&SJ=BTF=65W0 MF'(G)N4^S>RSBAB+,#^H=[UO6\#)'%Q0-#>N=G5:D;6MK1JG%R<5Z@I(A0($ M1 U*Q:L5'B 0F2)4Y0C##!BT [WO>M:P-;'CT\D<1[BK2]IT\Q,RFG:BK* MD;1(XC)'AL4O2.IE[*EL&I+/=T:):K5-B";UBZ$*Q[&UB56 @1A97NP+* MQGM;D:91&$3Z*](TT_0NRK#1U) ),VS^/*6>7VFO()4)*X85@5OQN$X.*/#_ M /:P>JW0M[#LO0M;UH.MC?=G&TOEUFP..=,4VYRVG&F22"RF<$X94YL6CT,# MK^9R)2I5J$Z);'X8=O9+PN2FGI&M2$1"HPHX(@:#'XAY%^$Y^V6"\PGK&C)4 MUU3"6:R+(7,4^9')/"H$_:*VBETA&F4&:;V$C1Y?W5 _0#;\H/M[(]X?4),0 M]8\UN$RF, 3W;7899 :N8KMES8KD:)O*9Z?DJ8"MFLX;HO&F:%<&4IS2Q#8V<8A-4IBBEI!>S2!&%^@MA8; U!]$]ZVPP]^LO!-1.U!UA- M7.@FNZH0^=*-%A&M5_2E9)),TJ:@K9PBKU'$#&8VM3"%4L>!">E19@S"B&I3 MM.;Z!.33Y!:NJFFJ'D7<4@BW,5XVG6YLVE51+P2IT5PXUA"05.%ZH@EC5/;/ M!8RL4!T:].Q")$ K?O,,![1^T)8L3NSCRIIK&J]L3HJKXO+):GBBMH0K9"2< MA)1STT9,"6R!_0@51Z(HIX<6(#&<[*D13P,.PHQ';UO6!\GCO'C^/W6@YV>+ M^@:&X7.7(*^21,Q4O&3NPG5O4NC;7RB3E(#(@BGRY D&84R'KRW0?[0Z(]PP M:$&.1/R0\*3FR8W3\3ZBJ=[LN73:95M'H>D?Q:='"?0%6:@DT0W\Z8I,D?R% M9 P)$QYA1CG[-[1:4:UO>!4;K+R@1BNNI.1>>:&M.KIH^V!UXQ)S<$*=W*,T24<3\1P;D\#2/=7;' M3=?>0*X.7UUU\FTU2$#Y!'V$BMFU:4L5V6Q^-I9P&"N<-DZD/0T#8GS;<-.H MU/V1TVF[BJ+F#H8%"-,??\ QZR+IVQGRNRW[;,D ML.,7$G@2E_C4SD$G/2@JQ]B@-.Z5,K1@6-X%6RU*H[97OP+A51WGQ]=KY,HU M6M^P5[?J_A(+-ES6XGN,35--9F:&,%E:#,6Y@"X5T,D.C-/J79[5LD8#/L>P MP A!&3-Y4."WN 6=915_M+7&: M]P"9.Z@D#2^($*IK<"U!1A)XBS BV%D.>^FZ%ZNA+C8_.MG1NV8,TRETA+A) MHL8L-;$\I94C8O4INQ@T(H0#P["(6MX$[8'G'M3R5]@5R_ M^2Q$X7-PI#?^"C\U$UE'K6KR;Q5SZ/3+:N0V\X11L<]=(@5M$Q;V9R3M) F] MH=BUCDI(,V20 WX@!L+UY3N9837-'O\ ?+X^UC8]IM5Y7L=D[H-N.>GS\>D"82/8Q!]@_:$(W-Y&IGS!:OD;D5 MFE(K2I#F/G'FFZZ=B5809U)E"YPN,=OM1C+*)6B2K:'5^@B(1LB-3(&EJ M0J?D,)U[-B/#OFWR(01MO:83:QNBDL J2O.#(3?UO='QG;:#'C5X2OXQ1MMF MC6W?X$O[3])X4O2/*U3-HE1Q6]8%D[-\ MC/)54L$0DC]/I!($,VI4OI!H35K6%GVF\HJ ,(2':N.3L->Q"1O$0KW0EY16 MW)S)2$_8%LKU^0!@0A'DN\N/ D+LZNZ?=;M5+IW;#154@KU!&ZTM24-/R*?9RW:K25!\V@JADBT((0F:HN[>9+RLTJI*[G;@X M2]S8I?*8:)XADSBT:M",P&2DQ&9R&HIA)6)JC%J,LN MR1:,V%O\#21YC>U.H.&C.7+,H,YHE$,>K!E.KUJE; DTB>)#4=;1%?:MDR*) MR43@W'L;^PP"+N6RR-CWH_6_>#7N*%O0=/Y2/*%*Z*YRHR2\;.<)?+%Z,0P2 MQF&4RU$B?6Z"T')7^"L>IZ=#3WYD-=)#+)#8K.S,2%2<20L5GJ]?)H20S8 S M%/-.VIAWW=/(L<[+AK%'*]YDI2?:0[ZKCHGY=A $T02_P !=KV5>MJ=<\G=#L$.;.CN+I[&HQ+Y36R9 MW;Z\M:$SUG/D$!L6/Q]XCUVDW MU@&$B-T: -8/)]@=U5IVY:'%O0E\1/L!D!R^P]&ME\(JE42@SNL:GMIE2=J4O3<,Y20[?51F[V(18]"*#IN)+\[PZ2YE[,*U/:B?.E* M\[SO/FJ&3EXAIT6K"O()!G^!1Q?)F6"M W5XE8X.TN;J[-#4[.IBEV5A)2KG M310A&:"K7:UYRD]1]'K:J8:O5)[1Z;E14$;*FL M&'0!2?#W!3#1J4\@*^N!,HVW&!TKWL"DC8 MWS=;G6LMJ]"(KLE;+ MRI!>CJ8Z5D-1PF,/L/=YVZ/M<.4=E];0#<1B4N8H],6HAX;2BQHU1J09R14K M'O99I86%\5ESW)?_ !)6UF7_ "HF;6TNF=[1F6R5/%6R$$.)U?7S94!;?BB; M020C8BTK/&DY.D^_D.!HOT.,--]Y@PV(8# U]^0*H[HGE>'V!6'6-N$XDD?IUNAA+[:,E1PHERKTMXELO8I2!ECD2U"O#Q_^0AN\DO40I_*>(O\NR2(29%3[['T%B:;_ 'WI8R_03:$H6!3E%'[*"VW'G<-8 M]FEW$CA$;G$*EE#6(96EE12;IXVH&C>A(]KVYUC,M@TDF4!G,5>$H#-IG)H= M5B<8R3 [WK8=>H95V=U=$>).=9WTQ8$,GTX@M;_A%,L;*V1QQPDR!G>'QO81 MOH44GDL50*&YJ5.10U 0*1*-%[]0%C]-^@:T+ \XT.K:-0XR8\K7+!;3ES9: MU@E4G;$JK*I9L71]9NS+*Z#9XRNG MU0U^.,-%/S]TK^PVMY=9;)$[8J1-:YIVI1.B<8TSPF6(Q(@G:/$(D'.OEFGZ,LZPX_7+H&8:! M(J5BD'VRUY9Q!! 2S WG8&GZOO+M#Y#T0T458]%3:FDLM?>H&>'2*5R^'KY< M8;/K^G+8YAMGL>OK50YL7HXH6C#/88$<>/CR32+NV4. 4E M+Q2)5T9 7V8(93&+J16++(%*6"QC(2JI'H:O PF+.5-W*)F,(>@MPE+FD-2; M."2I.VG-%H-G4P?SHI$I3*4["^2I1&HX]OY$7C"0*^2R0YG;%3B4PQY",TD" MU\>!IM)TA.Q@T8H, '8M>OK@:O\ A7R;']=7;*:&DU90B$3-AH.$7^(RM[H2 MW(W1E+*I*LBKY4=GG!A4''#KH@#J6G+=VQ,%T1DF&F%_;]Y/H,-K#@A(@\O M_C'\@DVYFB?6E6]Q6A,K*:J\A=E]DT-;$CEDGM1VGE",-HR>E917T?ESV M9:X0FQ(>C1MH E%FJM/01[* '>A"#HN".P>N*FAOD#N?HYJF-ZWLP=LU[3[K M&YU;3G"J2Y<@D^A,9LB2*)6\/)DJBE+4O2!,J5?G'%"V*3QF)"2=A,]Q?L"S M17FXLB40GGEYJ3C=JMJ67]TI?W*;$SQKI.,MT7<+.I5LO+4Y0CT+ONCH5RM*:GIX% MY*G]=T&NZ@EC-7K>T1F0M-4'-J4F'60ZCCZM0B"\",<4XQ:*"FV$_85CYZZ' ME?*-@^8F;1Z)JK;4MG?E$QY5'Y-:ZR)UG4BRSZBK+5@R676E8A3@IC]/UDY. MBI2N>$[2(T]&04(EN)!O19 33&_,C9MA1GDLVJN38W8,YZOO;J>AXK'B+]4Q MN/&+>;#'(6K/C4F?Z?3KI#4DB;VT2M6O4MK8Y-H-Z+ @5F"#K82I6/DPM>\F MZK:LC_*\?:.F+.GG8< E=:RV^!H:L@C7QO*&R"6<[JK@C-:2![>U,ADLK:$+ M,F01S8C!JS3CSDY"?Y3 DKPJ$F$^,'E(!Z?:15N.3L2U,)<>Z"3K=VW/_M)Q M.BK8E+G]8[6R]*#/WFA!H6]:]?30;2\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@819;V7&Z]FS\:QRV3%M<7>E8H] VE2^S1ZT6WG_ /VV+,Z-2B5. M+ZK]?8F* <2(1N]?W ?^[0:+?&QX[XO5?'%'WS8]$6S(.R:?J&W4T#JF_;(L M-Z_JQQG;>K(3&.C.G+-VE6[,"=ZB$+8:"7+&[6;Y3%JQ@<:AS_J6$PVNQZ*( M:7Z3'O,G=%J8YX&>!*8 PL+9]E\$7C+G'QM13BOG*0TH^USS9<%IVP^,=:(H M'5QUN3.JJNVJJBZ_P1K&-R=[L#4JZ(R1.2:!2 MS3;//T4/]0],W+=E2&W*# MK2>RVD9ISC*GB/$%26DYZT(&5_KY];1F-SHR 3-2I8V*&0*M*(QM4D&>Q2@& M29L!8A"+ %7/)V&U)O1D=YJJZ VK($_6%AQ:B[@G>PY:-2( P)1@&%,X-RWT%Q=Y0X185+Q2W.C*'Z)H:. M5/TY,GA-3$-;JI3U<[-D7Y_E9.X\EK!OF[Y#8P6I1/("VU8\FLIFCR_D$ !& M!\*H\;5VUWV-><89'%+'^(6J=63V=S7I.L2%',7671=:R&J)E%5;>G4'OI47 MJQ6X.LG:C0 ()1J7M*!+H9A!NR@I)S/Q_?=?\]IZ.FWC*DS;='+=$=-5";T6 MMOQRL6(6>9<%4R2&$G@K,10A)#HZ_/,7F+Q)7IL M&MA2\\QR+1*DR?3H2+W>\U1HH(.G/$?DAZB@D5IEQYF<:!4Q#Q6U]R\7,9G: MT!6LLUL2F+IJ.PW2)2G=6D+%HK07KKB1 MW!Q77=W=>MOBDA\ 1^PS7M,![@Z%[1A]=^T8? M7TWK_3>!IR\BU .72\ID5;W?PY)^J^;2ZVBKQ4>6)5'RR5Q:PY.F7I3/F0JB1^X :T5OCS[;KQ^YOG%O6M0[&M2 4Z;'_ ,A"MMY!2I:(CT-&A&:+1(8JV^//MIPH=%P!-Z_97IN0 M^1Y+UV9VV9)H>;%)/4J.ZA7/OLB14U*6592<>998]>=)O\@C8C'8-CYV3,U"YP=4BP)!DZ9 MTI1B4" PXTT0C0%@-T0#U"&*1KB[R#14CF7FA9RS$;#A/(ODT/Z]4=2O%U01 M$BNZN)?8MC3A:ZH*]4_3F;;9C2598SEY2P\M+IQ:2?C$L*-T'0>IO TUS7@0 MWH/R=WCHYV=)7MP8(Q[U4DA_HPRA42&H7E.F2K8$-8I;*(+)K%<26H&=6UR?V[T R6Y9#[S# *OLE5XJ;&X,8X*VVY WA=8EI7,]Q';C)T\ MK0:+:(_457(8\:I1%N:C;JI^Z>44D +6A'!LJB-FV31TIXXYT)YR0+VFRJP0 M)[4ED/L2+;?J9E4+KY*4YN:B3<,WW+[=\F,ML#QSU5=Q7:,[AFJ=?+6MFD2TU6QR,5>EJDV5.SP4@E M\[B+I\PE#X0"/D*U8=!)*T(H_P!XPA"=W>+;R.N%.Q/G-*AKR_F1F\=T9YR: M[3#T)**04-EU(Q3-5-7VW1)(VZV5T-%RDSV0@AL>=W+4/1FA^VN0D'&G&@"R M%I<1=QW9&.^F-TJV#P9\Z.\?&)B7<].C2Z-;Q"V1\)P!!!-N9_(W8-Z7I*G M-39>,@>U[LYN"?:F,-9H(V1_)S!KC"T10 G(#0)MJ@"3F&!^8+Q#VE!V:ED M:,K]Y64YX89=Q$L7G7)'$"J17M+B(H-.V1T6H\O$1&&V[ X^\)1B=.M^( @!*?*7C#NGGF]X J7RV**:EA'BQ M:N%BIQ'WU?J>AL@RR'.QWF6LL.=8R)J:X>RJ'T]&SEFN*M0$E*G^8O>MBUH( MLXSXGZ.X4A9\C?N:/'5$Y;S+2C]"(ET8CDTS3S+H]>-H96M!(IP])ZM4.E#L M[FE;BU$I5)29&YNJ]*$@HC:<7V,#?!2\JG,WJB 2RS8237%@OT9;5\QA"1W_ M #R"//YA7M<4C6\B2H%#DSF'@V:C-/3)50DIA?SD$'?(2 *M=6T-:]VWQQLX M,C3#GNAJNFMO/O03!*Y4N;3)3'["HR>4TUM+5%4T7>4OYC [(M%TO2 QZBYC8MD2!B04GQ!0]PFW33 ME4,BI/6DE5 D:F4J59KF *8PH*E408)0J(;TR70;#-T;W9 .\.@>OJUHOF^4 M(;BYOJ"FD;1,NE9FPO1$MJ]:^OA4D<%39SL\)4<76*)6>@.0)P#/.^@4MT87 MLX24H+"\,<9R:@)9TGT;=C_%)7U'V+/F2>VXK@K%03][ M/ORO>6F)FL@V6V+T);T)M6S[8NF\+H:'V_+O[)NKHRE$;W9$],K)O9[ MI>8^I4!L)P1UXBD %L32MQQA:)$2,*\S0"Q*2-"V,(0G"_&_U;:/*=\<@WXS M FFB*W> M>;4713+8\PE+&M>"[%D%),\7LV_':TI.P'@3I([,5ZZ/1"7.34@- DLY2F3 MGCT (Q@"&TLKY/C+^;V?-[ ?+\7N^/Y/;KW_ !^[]WL]WKZ>OZ^F!^\"'N@X M?,K#HNWJ_KXR,DS.=UU+H9'U,R4NJ2,)%LI9%C%M:\GLB!S=M)41"\9OM((& M,8P:#^W6]BT&L87C_P"DRO#:F\<""<4LFMU+2K=0.K'&*;'5VHAJ-P3(5DA& MA$P_R,E^U>/;UY;;IHFKM;<<51QQ/-%C$9)4T? M,22-D?OMG,1+HRFN0!A:-E>P*HG>OD]WN_3TV%:[FX4Z,=;RH_J'FOJ6,4K= MD"YV3J(B&IS$9/&79EFBI2M2F%OAWJ5LHHWWZ M;L\(NNCQ;6K>5QU#9-@=%Q&5N-)3/GR75MP!\8MZ-C4*;P[IJ%0SHZ)=WWOVA4D MY34XY/M>,#7T8T+F"S::G$#=+$ X3-DU:N#+;%==JL#!TQ!.J[PZ.@%D?\>DHH>:P]-D- [YJ.P84.R5+E*(?+71 MB2*$ 4KLW&M6B1:",XTP)Y(6,2^.3H$?2]8=.2GJIBL*;PKEN^*0D)TRJYW. M$^SF^G7^5.TE92FBQ&MOBM:PV2MS>F8XRG)^1*QDF)S5QZLS:[ Q[D?Q4V)R MW-.++$)Z0:)/+.9N;9SR58QA]7'Z:K6I1TL[=G01%&D9\V&IKJ71IP%I(L?9/XM^BZ&L('2<3ON*6PYTOT'U+U9%:\;N>&D%Q MW&7>$*G#HRWGA[ MK2FYI6,OE#-/N<9GSITRMM?BKI7GZ54K1\SALF7S*,5QT1:ES.U7JUH;0JW14#4J-=4;, MUJZ\I5.\,+A^2F86>4( W#=3:U0UJ:VI\=C"T+:D$X#TA-.6:&2$@="^)-YO MUAZ=9W/IE:UE]'\I0JR/GU*A+W$A\E"MSTXL^AD M%_07A**4!-3 /&&W:$-?;HZ Y2NM-:NXNVIE:B0H#XZ0VQJ3JAI]$(CQ?;]A@A;"#X]A /+GCF M7T3T,1TW8MVH;AM=+1AM%K)8R4S&:;D=CMZJ0L#\JG=\OD5D3L?<]A@#&4R= M*O<"R )0C4&@*V<>(>@V$63"DUDUU/JZ6N3@S(Y]"I3"E;NTC"4ZM2:5,:]B M/M@+<$)2_9I(MZWK1@=;W@:SN./&+)>4+;K>TUW6$OLU/6_,C9RFVU\ M&GZGKN%?XUBSTVOD- WD1EL/>&MP2N:92X.ZC:M0J>798(_9R8C6T8PVP* G MC3G@3' 3J1DFA3GF$_8+(/$ 6BCAD?(3\X"S-Z%L'O#[M:]/77KZX&HF*>'R MG-P[B./7#-%]M/G$UA63.F&2%1-K@Q=G)+"E3S/BX7/65J<7,D^(L%@*&IY MA+.VE5*V1/HTKXQFA$$+2[PP3J1@O%U([-7ERZWNU8'W(@5+J"A;C$&&SH82 M9'BF"409QD[BR63!D\-"E"@;UVB-)WIO(<#3#_41&!F4.\0,FC5EU!8+SV', M)N"GNW[$[;;D,EJ& $.4EEEL1=&P3Z,O+M%5,71HT;NK5NZDD]*A"!'I4E+) M("%(/[(9D94SIU?Y,89=DTYAL:HHOPLVVQ VJVI^='T[+TL_R11"UU8&PEF: MI(L7OEX(2MHW_2?17H<$S988#8WAP=9S++\FS7U@]Q-_N#MFK> MY8T,FF8M(&N!6+4\:E;GD7;MCV@12_0U\](HV&45)6Z-ZEDWZ)B0HI8A4DF+2,@S2->08 M(0 I4":0C0-Z%*4(PTT MT80 '>][P(E;+WT\WJWTVU5;:3A&G6F4ER-O0*1D:SJ(7$+I 6R(X(FEP'K M;@;/5*0T+D!'I#[!-PM&Z,WK GO 8# ^)R=.HT7I002?HHXM05HXH!NBE!(O M>2>7H81>PXH?ZA%KT$'?ZZW@?; 8# 8# 8# 8# 8# 8'X^(O9FCME@V<$ B@ MF^P/R!+&((Q%Z'Z>[0!"!K>]>OIO>M?[8'[P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P M& P& P& P& P& P& P& P& P& P& P&!4CO>R;>=R'CSO:_+WCO0S?Q,Z=8+1S#_("[B6*6-/FJ,WU=RVV!J%FZ9M.V5KB+C('J8S2-PV.$II)^*4NJTUB6#"H/'\._BV&76G2,-ISM MKI'D*U?)1W;!Z K'Q[)>@(A)+ ZP>&]^/L9-93RL9$3$_(TL?5R9GC+>>4,I M@3%*EKTL)WLPTSXPDX$>NUX6[9-9=M[[HZ6M2@NT*,X5Y'GG'S)%+*EM8KBI M,_U,US13)8W#(\]-C795WVG>8TK$^HE!;JI*VL+0)TY'ZE@"1U#Q+95U+Y ; M7MB_NP8W,^3?'CS?T(\59070DW6AI6GNA@)@3D[[C*M9#WY8G.&QF) MF]$V*E83#4Y.C2P:#7 ^6\DNJ@?(-44@N$BUV@WQIT/T16<$AMD7I/8<.\H( MIT;9$P3.UA/R\^;SR,L$AT;+QI"TT: X>XO2#1S:(T ;6)99 M:IG;C,J7Z+=+D>1H%;;^0:C'-N3*4YB4W0/8()C\=5I5QS[=W)TQ%TQ=RZO; M=\.TEZ=ZM_IOTP.K_ ,-5!^#2QG_%5;_QM$XGNZ*/_P &C'X-([*B/JJ71*T_B_H) MW%0F_MF'@+T:,O\ ;L6]?I@4ZBO!9"/N^X>UK!GT5LA)8]6P6K8I43C3$>2H MZV1UL_B?XE)&V;N,BD3JXR1,:75U83PG%J GLS@N2'JVL[1Y0!Z$0, O>'6_7UUK>!S$ ML7C*(YP4(HZQ)#W90X*W4]*T-ZA[%H ?0.,DA4-0%Z*0Q*,HB@Q\N)!+2,+4G+#%21'#*C.@$I !U'RAJ#-A1 M>GU@[&+>@?KOU#DML6C+.I M:(XQ-2PMJ;6$M6VM#>A4@8V8)P&AF >E3E&A M:FH"@S29/K?PD:&+0 A]V_4.0W,+&T$K$[2S-360XN*MW<"&YN1HB5SLX'?8 M7NBPM,24!4XK3_WG'CT(PP?ZB%O?ZX'*.0(%!!R90B2'IE)!R90G.3$FD'IE M 1@4)SBA@$6:0> P6A@%K81:%O6];]=X'T3)DZ).G1HTY"1(D(*3)4J8HLA. MF3D%A*(3IR"@A*)()*#H( !UH(0ZUK6O3 ^^ P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P. Z.C8R M-RUW>G% T-+:F-6.+HZ*TZ!N0)" [&Q#&((0Z_7>\#''F MPX)'X,XV:\2^.HJ\:6%1*'":#=D9D;(CR5.)6<[Z=B#349Z'ZX?<$98AZ,_3 M0?7>]:V&J:Z_(<\V/X^+(Z-YE HB,N0VFAIA(N?"$+@)A<%\\8(X&0M9KDG) M;%@7B.2%$K2'&D# C&NUHTO8TX_0,\\>,\ZU:I?@DPBP@]YH1EA17IRQ)!T_P 0T3*[ MR8#FEJ@?8,0KCL>+L#BLB;>8FBDX>JLE0FGYU@UZEB42)R;U8-:'\Q0#-F!" M'96M@"SO),"C-'7%U-P(]-^UE2.:!#=M(161FFN:%93]F)!1JQH@WB6&L M<4G"0Q/LL7]P.EVQ"V,0A&;" #N>XK"[D[1\?4;C++%JJZBY\0750K0%V*1I MFR?Q-J10QZ9&4A04N4B*(D;0B=S1&F"$G F$,(!A,$((40X69VKFZ3<1= P. MR7IY=>@;6FG,_3U8N#ZW%#;)>I7G(&#\>P G<7=#&U^DBP]6>8KV7LPDP!@ M J=E[#UAX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# ZYQ>&AGTE$[.C!M#XYO5)TCS345ODJ0J'. M21-"FE8=:"$2:;,6A,H$7Z!"$1(@"#KVBU@6)<&IJ=/HB= M&UO<=M:\AV;1+T:=7^.=$H#0)G-%M069]1>F+/'H!Q?M,!H8M:WKUW@:A.?J MQ2]+<6=.QZ5J6]"GZ)Z.Z8;)-:UT\BW1 W5E8)%05KK' M26+'#8R%KU5,E8U3?+XZWGIVY::K5JSB$X"DYHR2/:<:9L>AA#@0ZR^*7F5A MZEWU*BW,/S)4K/L-OKX;JEW!6VPU+B)W-E*@@"(6]:V%.J)\C'-?0ECMM5PU?.V&6R-A7 M2:$DV' GV#(K!8VXU0!4X0E8]E%!?"@D)33PZ"$ ADE&;UK>RS @"]N!Y\/( M-4\8Z"\C]449:+C(D4\0G3LDN6D)%3EFK75PMSF]ZU"9$Y.WWE*IWC1RIT31E M4M$W>C_8B*,'K>S-[P.!Y+8W>4FMOE8RNZ=-N"OHBBO>1 M3]L=G$J*UXVJ72NS( MA)VSW&OY=42U8X5?IMGCVP1EE@S<\L8966H(7.LD=;#!^,D;"F&E:/B1%JB5 M"5:)3L'QIC?C]P>I,8-& &7OUUH81 WO7IZ^@M;#OT]=;UZ^F\#5YS%XI:/Y MVFL3M%SF%B6K8L(6/BZ)JY,\?CH7%E3R>^Z$HC4(;O@AL]*2)2##CB$R-UC)CHB/3:4^A8P'%^AA8-&%;,"$Z(Z)M)T[0ZIY?N$3+[(FBB]IT M.H:6HIK$NJ1[ 4VKTRXS2Q6:[+VAX4I@&J!;T(2@9_["R]%EA#5A9;5+$?,7 ME'XQ?':0K'/G^=%="P!6M7KE3E*J>F$F0V@!C6B,*5#7MZ(EM/ ('NV 9RG0 M-[*++U[0OW?O8E TC7//-Y./.TXMYR0U$CLBMI3!8"U.C/5\-=VN,L3^);8A MXRF>%;-;'\HC1 !; HV$)>_CT((]!LYC+^@E<;CTI:Q@-;)*QM+^W& .)4 , M0/"!.XI!@/3C,3G@&G4AWH8!" +7ZAWO6];P-37ELYWM.=12H.D.?V=Q=;FY MHF'\D2HXZDVJDSA%E*AO<3SFI*7HP]U/CKXSIE/U2RC31ICE.RP[WZA$$'^- MG4GLON?J+I*&57.JKI2QX)'_ .3-\_9E;&<$ M&O3WCT(>_P#7>][P,TP& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P&!Y$YK=G_ _R>=$6B6I4MZ4 MJVD^I57Z3XG#5A5#:R9#*)+MI5F&"+2REB=E"1Y3DJ#BP"WZDAV#T$'8;6.U M['9*=N3B;R&Q 9KS6+@$RHK6D+<6:>UFTS:Z1._1B1+AI"CC]%L"\Y2M3@$' M>C56RB?< 0_000T2 MY()<2B/5)T:X]"D"I,* XPSX2]B_:+ X<\X_P#(I%J6G_!=6MM;SOF"627Z M,'N"634A+-J_JIUD"1W,A;LQ+#2%"LMA$3O0AHTAX_A$,*;>Q# $D-Z]70S= M<5G7=>B7Z=10."Q&&"= I_IA/M['M?I)\I_U=+-H?D^/WC]GN]ONWZ>N M!G6 P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P& P& P& P& P& P& P& P& P& P-0<;Y)?9%Y+>II[:=,1&;4)95/PTEFF M,TCS6[EE2,#+'(ZLC\0-6C5*T3D)(@6[<3BRBO[04_M-T/6M""TW+O'#?0-' MS'G>;S0R^*J=Y9(U43C4_8$JM%&*Z>BT&TE=+$B]8[)'I WKDYZGY/802(U0 M+8""_3 G&H>>*.H)$O04S5D+KDEU,V8ZFQIE3(U[IOYC#P 2G,-% M\)9IPP$A] EZ"'6M:"91B4.!7]Q8>4(P/OV4$S11OL"5IS+4,$C4BF#D 8VZ-1]S?7#1 M0=B,$F;"]';#KT]?3U"(6]?^F_\ ; @7H[L*J>5N5$E3RL@ MT642YW9D$V5H6]G=EC,C4$*QM6W9U3)S3BM&;+&I +8?C]PPASZ0ZVJF]IO/ MJK8TLYA-NU@VQY_FU5VA#'6%S-KBDO$M#$)FC+4A5,<@B4G,;5):5>VKEA/S MICB3=EG%#+"%GL!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#6'Y3)1'X_6_,J5Z<8J MB/=.Y^3SDFI"N;TB\I(RVDU.CNZQX*U8F-VI;$96@K#B@FZ(;SS]F:" 6QA" MZW0I)1M'V\6,6@[4UQ*TX][WK7H7MG6A]=^N]>@=;-_7?_QP-9_E3ET-@?AG MNDF72:/QL,@YRB<*C('UV1-8I#*G-I8 M,;9 *SBC'-[6@1FF%IB-#.V4289 M[?86,00N)S]RTS0:[;;ZS<;>G%O3F_H57,3:1OHXHEA=>5#"1OS_ N"5XV1 M!E:$JIG+<)@L6&N2XQ_4-$_9772""]UR=X66E)*S>JF\A?# MT$4,EA2&6+7IHI"00R(I[KDM5QEB9VZ,UYSE8[0Z)PO+B]J7DJ1OA"PHK2-2 M4@",-D7FAN:*T=2/+LILJT2ZPI=][WYMA%\_G("_3=_<:/HE78LU5&25>? (&)K $MX*3_ :.V4#1J4LI0<&K M;Q&32>WC?_-+Y;_D!O62]>4E6-N1/M#C,-%63%U;7:+NG3DRW?74MD$E=:W( M1P^5)"P0%6SL$>*/)$G3MIQZ79_R!ZQ-?TU_Z:P/[@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,#B*F] NV5M:B2+-D;$(C:I,2HV2(7M]PBMF@'LO8O9KUWKT]?37^V!T,QC+ M?,(Z\QEST?\ 1D#6L9%>R0[%L*5P!H!XMZ]=:_\ :#^N_P#^^!]6R+LR*/-$ M;-0IW!M9$:- D*]>OZX&1 L 2R MPA 6 (0 .@@ .M!"$(0ZT$(0AUZ:UK]-:P.(:V-QYQB@YO1''G%D%''FI M"##C2DQVE"8LPP9>QC+3J-:][T >O=KTW^N!2[M'AB']H$TZX.EQWU0T_ MH.;N\_JNS: F#!'I-'GV0Q9RA+_M6S3>(S^ 2$ERBCPK1!$XLRD]&6J-VE,( M$:9L021S7R[#N:F-Z*;)98-IV%,P1[=EW5;CPTOMHV:IB;<)(C(;FI F(3_MT7O?J+86-)1I$YRE00E3$*%HRS%AY)!19RL90-%%# M4F@"$9XRR]>T.Q;WO0?TU^F!R GRAPHIC 16 pg4img1_ex3-1.jpg GRAPHIC begin 644 pg4img1_ex3-1.jpg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�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�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pg5img1_ex3-1.jpg GRAPHIC begin 644 pg5img1_ex3-1.jpg M_]C_X0 817AI9@ 24DJ @ /_L !%$=6-K>0 ! 0 !D M #_X0,9:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B \ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835 @0V]R92 U+C8M8S$Q,2 W.2XQ-3@S,C4L(#(P,34O,#DO,3 M M,#$Z,3 Z,C @(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO M+W=W=RYW,RYO7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I$ M;V-U;65N=$E$/2)X;7 N9&ED.D4P-D0T0D8U0D4T-3$Q139!1$,P.#1&,D)$ M,T)#,S!%(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.D4P-D0T0D8T0D4T M-3$Q139!1$,P.#1&,D)$,T)#,S!%(B!X;7 Z0W)E871O'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9, M !_]L A ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# M P/_P 1" 0E S0# 1$ A$! Q$!_\0 B ! (" P$! 0$ <( M!@D$!0H# @$+ 0$ $ !@, 00! P($ P5HKE[= JTCBN22(]I:EKX[G)R!%)TKK)SFS)&51Y=XVB2_HT3208C S$+B%INU*A&40>I"^W M+71['T[6!TV1QIY@,OBX^GT".LDDEGT'9)#E<]>1;2M #4ZA:NTG4F)DI_P @[#%?'5VVV=N M1,\<=')"MTBD:)BE#0REKT*M8D M(*5$'Z$4(8/0>PMI7MOU+;B=U5U1:-=6]:WK6\" .Y.L6#D#GFT+5_.U&*PXM7LQFU?5U:M MG(:U!9:N%-GY=UC\>4;1/#V[O(T6O8F3(D)XE"TT@@8R G?. (SI7LYXGRNO M)G8+YR] *1D7%M4]"S!\W>J/4_BEEV.L8#CFQ;$Y B82V>E4C0^%EHY$O,). M6N1Q1'Q%[WZ""Q-K=!PJ*UD[R2#6-1KI-GZKIE/Z7;)U;D:AT+L/>.7;4N:Q*>IVP^C*7K2T$=?/UB1Z.J#U\\8FI::WQ-OE;LA?'M 0\. M/TR!A+,&,ST!OU'OTP)Y6="4&W2!/$W"\*@0RI7+3X"EC2RRX6FD"F=I?QWV MH4G9CGH#B=+4WYA)\C:$O:P'VB?4O7R@]P4G[D\A;'S!8//=.P*2\]R>V[=O MZF:MF->SVV!L,]@D"M:5H&$%DHX P-3N^/+:F*,,!\BDQO()-/3&>IY8A T& MPJ9SZ"UPTE/]A32)0-B/S31:WH(=[P(=WV)R=IU@;)_N6HC;M:/V/XY0!M:$"4S?29U6,1@HP +WO\ M,!&^-RA$5LGWZ.6$&$E^XT @Z".JX\A7(UHSOI>!1NZ8.0KY->VYAN)_?91' M6*+-"Q2G3Z=5")Y!$W5MKSJI(/"G:N'VA623R*Y*HB!X.@Y\*OXVZP]]F#<1/VV'+"O0Y]L\R M&A6"86T.]!4K@A]WO"'98PU^S[R+VG9W>,KXSXE>^597(.>$M>O=\1BY9?)& MB:67M\ERQMM6 4>NC*@]N;)+1\+()$-F-O]+<]< M_'QE+>-V5=4JJ9*S44536%-H_%%#\%M;P@>YPB4.40:UB!4\%J M$RZ0MR4:A*6,.A&$:T9K^P0=[#-RNG^=3I/;\**NZL3)=S_'ARV[XT&9,FWN MJ8N6W'.YDAGC=]S[4:9RFQ.,\2A4$LH)8-[WO7I@2G$)=%Y_%(W.82_-4JAT MQ8VN3163,:PEP99!'GM$2XL[TTKTXAD+6US0*"SB#0;V PL>A:WO6]8%?I;V MWR/!)/:,*EW1-4,!N4-XC%B M@H")"TR:@+* MM6)UBY6O$CV%6WL[VG;3YO4+PM7C!N!Q@2TVC1BT' M85YL#R\<$5_'J,EQUWM\FC%_3E\@<0=8BQR1\,:W&+-VUDJ,E3,F9_W!'U4< M5JFY*K:ST@7H!KJF'I&(C9II815Q7Y-X/8$]GO.O3EUT\T]4F=8]!4]6]8PU MN?68+K#JU?%:"(E@2N&W94V.3TT,:Y4GT\JDJURV2=L@H02]A"%H#O)?P4EG M%F5PMZFJEOE]/L\J?;";W)X4MJ)F;8,>E2S,:-_7(D\=DBJ**UA9+BF:U:U2 MC.]Q9I81@&$(2;SGV3R_UR7+SN:[JAEQ%0'42_>1L/5*U1<='.6+81&U(%CLA XB6-Q6_\ 7*+WK>M!'<$\J_CVM!2] MHZYZA@DX51RN9U;3N1%T$N>AIJ^K,_9$\D!6D$;.^]J,Z]#5"5/\JWZPP'A) M$2,!@@G: ]>$GY5\<0IFQ#M45HTX.Q:P(^?O)9Q''(K84 MY<+U9C8A4EJPVEK0D+=')JZ-D"L&P4Z55#6Z1GH(V?\ 5:I 0X)1)W0&C&P8 M5B?>E'H<7L0?>0^0_DYJO0',Y]K_ (RT'.P$=*-[V;#9KU&394RTVK MM0#0"L]VT>RZ H#&ANX',8AEI]EA/- 7L*=^.7R@02X&.J:"Z%MK3WV+,99T M"P&&I*FE,'@,J55C:]H-C4PL4D3LAE:))8&M(@G<=L93PIUR.R')[-=)@^%PRM8%"(\X3:T;3GBQ"L7MT*K.!LQ*EWEDF4I4 M)IWQ%@"G3DE#.4FDD &8$-+7(?>-EV77U-K[YZQG];3.T?)_;=0U>CD'*#:C M5WA4U;NQD1;N?7IN9V4:.EUJY>#9SD[.IB)]0.:96G $Y*4$[8;-FKR/\NO< M0ETR2/%B)D< Z,A/*DU8WNH;(C,SCUV6 \QEBC<64PN2QQHDJT"A7,$!ABA& MF4EEICOGWOX@B'H(1@7>-/U16%NV#-;^L_J%0]=MVC1E:0N+\]R%AM=)/BB$ M3DW0+I"H:)IEFJ4Q'TFW1.%I(])"ZR>:D3?AB&APJV-JSE;EL2@1*)&:4 M$U28I,"7L+-NGFJXA(9*A=8LLNNTG*]*OEMHUK#ZEHRP;!F#XE@,P' YO#3& MAA:U!;?/X?*$BQ.ZMYYP -@$)IRHXDDQ*8H"(^W_ "U4TT\J2=[YGGMJ/%I3 M3E%;TK$)=4%1BLXJD(&\,YZJ$S>^R5S:[-571^3.Z4YM"-<0:M3FIU)P2?:F M$/ E.A?)'2T%IOEN"W/9T_M:U'CF7F.P;>MV+U1*I7#XZLO)NCD=@DJMJ2P- MD\+X]*].5+R=72:RK?=75*V/$NC%=0V M/QEB4=M.4<<6&317R\\832PH!!(_(I\I;+"F$0K!#:2JNWYKJ>/W'/ M8\WR2)4S+I8YA2',5C.R=W2I-IA)1I$SJH"@4*2EFA$A"RO5G95%\7QROY;? M3K*F./659<..4<@K,#\*0I0? ML)6PJRQ>8'DV2Q)&ZL;-?BVQEU\F0&>,,MR$(^WD,_-I252&NC M(]$-/M8K98@F<&E[XYNY!3#/&L^&+=A:RPJCU!7QF%>\L?NT$8,V)6=,^B.GI"-O$0B,VH5*7%;\18= M", 6$+T<6^2KG?N.3V57]8@ED7LJIFF)R.8P&< B(GI/%YR4J41:0H5\%E\V MCBY(K3$ TK("MTL;%)NDRLDE0$980@&TNYZ]YJZ<[=F=FS+KV21+GJA*-F$N MH]LIA@<:EAD)D;Z\(AW?4[\CT@E$RTX+0KRY(J5*_J-Y#,IT$.])-^T+,M5G.;C7K(1*O4 !B("6<4(08IUYY,Z0XWFP(3-87<5@FQR!H[?NQ\J*%%31FYVI M=PD@HBW6E;>@.R)U1L;F^D*0I$36E@Q)/Y9N>G'H-MHU MF@]VNL?66_7W/JV_ 0IO;J::;NMN#MMAU?7ZA2\2%NGBP^9QEV(&2X)6(YL3 MJ#0$J%!0AA]0IUVMY3&ZS>+>N7GE!TZ"J68PBD+ZM&E.C4,)A7\:6*AY\F\8 MKJ>?MB3O'[T_#'[E4G"ETWNS8Q2+:8H2Q-HDOXCAA?3B;O2MNBUS11)B*WV* M[H?S]5=LO K=K205X"U(7)4*1A56O7*E_3HCY=$5$N)&06((-EF M %L-BV P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& M P&!1WR.BTCX_L:1J$"IQ98!*Z,M:8%HTFUYR*O:COZKK.L=[$BUZC5IX[ H MDXKSBPZ$,9*86@A$+>@[#7K:,(A\M\YW*%O-E"2Y]A3;RI813Q?C+03M(JL= M[4F2R+N%1.CE;[;'E;(<]-$'CZPE&[&*1_B@&$IOF("H#K86D\>('U\N_P G M-DMS\C>*9G7;!S;5X41*O24R15A2U6UA=#LWK#3M(5K<;9,64M@AI2=%[<&= M6/9QVQ_Z8;2,!@,#0WVK5[C&?+-R%TV?0,YG-;MG(O5\(F-BUK3KG9Z^/3\A M(Q/,$_<8' TP5EQ9=95%<0UOSKSE= M-4])37@CR#5? M!JZ:=H* MWRZE+_K1CDO\U<,W[T$R7CX7:*Y+HL,1JV/V6_]ZTZ-XBXCJ^!1Z MH-QV*&0ZS>:8"K8W>@>C98N7M;S2E?GV5L4CW)DCHC&#T), 8H]3$V@G6\N/ MW2;0KO\ F27B:W4%V2KR*4_67-,N=8=&HXWR5:F@\0GQ+U83PJ2.:A*F+;0PE.N1G:T/ MWJ0K/K:"+1PM8&D[R6<5W]JY^PX)S/Q/<[# CZ6YR)YT9N58E6C;14U:*MG# MGI@MVOB,Q@]AJWDAC@T,:49SFN6$N*P*GW:^R$^6W1_44[C_?49BO M#-X_DYUV;S%W:;LY1!*[U?5&QF-T,NEO/['.V*3#< 7LX8SREQL*S6JUK@:Y;/&)@B M;C?]V0YVL:3FPJ,O$^4HF$(&IR(V>O8LW2A\BC/5MTQ.R)C,OC<5S>)M"CA47<411B48E:A0N+2 M@#L)X]Z"+>3(-.&[RT>1NV'_ )YL.&UU;\$YK2U7;\H@Y;0Q2)UJ:(ND8LEO M;G33D<:CVY.L@3GIA&)2C'0LD\SY!!)T' K-Y:N?^B[FZ8=/V1RU/[.KU]\? M-XU)&K)I0ROT,RD%E35S=3%]0VW.)W*F5?7U*%-92)XVDCZ0YUE;B'3<,X:4 M1Z404Q1+WD'GFH4\BJFN4$T6VU!*W75[,HU#G5D MG"I4Y 03@Q@?U2]2K3F";VSXS=^QN3I]A/O2U*(+3ZFX4CE5ST-;69V1S[_L MT\@]).8XV=<0>=(+6C%=CPNG#1'WIZ4P.?,S4A,C!CAM8,04\I3!*&>0']0W M7TCTRJDW3U]=YI4C/SO#ZX>:]L!0MB[C7EFP21)E#8E%&4D;5'G0S;$I M;M)D[:X:+5'IBAFZ+* #6A!1+R7< 7M=_1-%75R.K9(#)K3BTSX^[9G!P&;: ME7Q]821.[NCT0VN:M)^:F,24-*M RF$@4JB#WH Q VG('K0:Y;!\4O833PET M)5*R'.M]62U6=2/-W+$642R *7!EX9YZZ)_EIG=ULAECZP-:118C.,('%N4* MCE@MM+829K00C"2'>]6\,=JS_ISJ*WJ6Y?DB6N1W/XV^F:NK%59-:5M'[7%R M=#G-ALZK?DB%BJ38#.#E,V*.:EXTOU##6 [8%11@40S@L.12E_)B^8^H:P\= M\JJYQ'Y&#^@[&H,ZYT$MZ!>F:<\^V313M=-VRJPIBLB#;)C9)+$BI4WH'55] M!@3%FG&FJ!#+("-7;DWL.3M\"-2!"_/_C?Z;@E3RJD[7\?#%,K$IB/ M=F,L$ZY.Z0-E!UF1JY879,58!4K4#G:+/'X-<%F.\_)V]+'9,P,93*D4&G>Y MR.* 6'H,\;582BF^&.7ZRG]3ETS9$!IJ#P2PX9HV&K% 9;"&< L2-0=_JRGVYW;TR.2+T:UN6S!^D0#)6[258<269^-]OUP M^W&?('1/,S/XEY=>M*--9Q[BBM>^))U'9,DM&LB8]6L:O1=*%["V*=-SVXCD M:](BV0Y.:A.+ZB-* 0=G&#UL(0L+XG^;:_*Z ZE< NGF:0HVH M0IBP+8^Z*SBBB0)BE.S1@("F?9/ ?D7FK;U_4=6U)1UH1[K)=PS:CS;ZFVDE M5)(_/.;(E5T5L>)$UH*$K-J@RY^K#3D@4DFI$*)M7?'L SP!("%DJ.YV\EE) M6;+JO44UR78O/I\5YL[HZ(1??)'8W8%O6]I#=<6DQ"* MON@G.:O,5=(^80V(#GUT:5%J*B%:,!98]!91F %O[1( AL0\A///2$WM3BCJ M;EQJB]@V+Q_:LZ?G:D)S-15]'+1@%M0-17\R+;)<8T/K?'IVP-X]#:U2M*:G M 4H4Z%H6Q: ,->3)Q-Y%0,G,Y,GK&KPN4/\ ,#..YK5;XM?Q[JT'5#,'A^D* M4M6KDD.9E3Q)HFX3M0G0)$Y(PGIF4!@_KF* @"%T5/CKE2?R?*NFV&0(D'+, MW;(Q?%K58,9.C)%VK5K&[575T[1IR2@KB6M'6\G/<%NOE"G.>FM$:86<,(-D MA4!QX*[T1/0>GX'%*M:;WJ/R7="]>5M1,JM]B]5WC':. MM+0R1!=-7RJ;PN=RYYK- MML"L65Q6!E\3;+1C+'(9E6+HJ$L3JOR[* EW+1I3TZ8X(U'M&&HGG+Q*]KT] M;?.3J]I.6D%84QY#[;['-::]LBU-_@8/-_IZE^L+BD=?QWA^PJ+N;J-/TLW77>->.TPZQH[4 MF?DDHM&#PTU='G1/,1J5[=I/&7%;)$.F#9_V0IS=%!2X$G^;"?FU]5'&CNS/ M-7MTV3^1CD]RA:&WI,;%H,ZNS7(7S82Y(Z(4CF\H6 DY62%6L2(U8T/S%FB+ M%K7MV%=;/\9W8-AV+8/16VWFD4]OSJ>)V+=7.;G8]J-]'/M'U11[M5%-QB93 M*(0-CDMHOS%+G8V5OZ(QK:6V1&;+;CQ?6 (8PJST!03I3' 7/?BRFDY9R_(: MTWPHM;A)3R[&;"5')DV[Z>G5-:SJN<(RE8JB88S%IY(?RZ10Z_5;6A%K1*E8 M83OU"T/:/B(Z+MX;14]*SBCW?EI@XL+YKKZM;S.M HJFI^R(5Z4JV8]&Z_5H MV"RYK+?SJ +HL3$7%B MED_&XG.S>0\^WZ("RR/9\NPDALI\=O+73E%&2Z5=)"Y"B#P^12+0I)6W&5)- M-:P9V4Q1<[J5-M3Z4+6)KEL@GLJ"Y?'IL(TF86A/H6B"3#CAF!"!.PN#^M>A M;F[R<(8NH1@J[JOABO\ DN&O8-60_&+?VB"TR08A&#/.T4'7])\3]D [*=NK>([ MWJJ"&7W3S-0W2<2Z"A[[8\8962$?G%%=VC53"TKFX:J5QX4B6E&,*I8@9%II MXE"C9NS3@;"E\Y\4O>TFZ9'=;G;_ "W:KI%NJ^Y9M8UKQ!V;NFI74)$,9X#6=EUS53"L1C1L"$W4E= MG$\X]6D":9L06IM7GWR(4S/-]'U";S)#=:2Q('*7 M,9\'8XD2I7PZ2K8N% D/^VF,;"5NU2L7Q)C3,#=A6[M+7^O($^S^.$PZ=O4+ MBSM-8BG5EN">+2UR8T*R21PA>4:>4M)9'DXY,$X(QA,"5H6A;UOUP,TP& P& M P& P& P& P& P& P& P& P& P& P& P& P/X(00!$,8@A $.Q"$+>@A"$.O M40A"WZ:T'6M?KO XC>X('9$EI9Z54G&80H) M,U^NA %L.]?TW@CZFN"R[WJ.!O;FY3GFV31B(6VV+XS(F$AB?IA' M2MB3-ZY\;&])(4RMC,"=I4@$H2[T+7M,WZZP)TP/F<<4G*-//, 2006,XXTP M6@%E%%AV,PPP8MZ" !WO>]_IK6L"G7/'>?./4LV<(+3CW-7E>3 D]J1]\? M:NL2'0RP:S52=7#2)Y6TQE4;:(_.(R;)$1B8*A">;[_T,#H10@CV&7=/]>4? MQ_7Q%GW8]R!OB!T[BU;G+8C"Y78"EKEDS,+*CJ-]0PQI>E3 E7FGD@"I6A(( M^1207[]C/*",+-X# J7>O9U245,6ZKSVBT+7L5_.(/.65I>&UU:%GRHG! M1Z#O\ 77H,L6MB M#O8C2=?P"GT]$PE$]1BMFZ+NL,8FIME 0MK+9XS%H^C+0M;6B 8 M8>9\90/49ZM:L/,4*E)HAJ%:HXP\X9AI@QB#.,7P&[^0( M-AV+6M[]-!-?KK_/ 8#UU_7U_3_/ 8# @Z].A:XY^KZR[!F*IS>PU37+E;$I M@\$0@EEEB@34<>G6R1L@Z)2!X5M!!R4X(U@@EHRM$&B,. $HP00R:F;9A]\U M'65VU^>N40:VH)%;%B)SJA,:W,<=F#*C?FG\BW&B&-$N"B7 T<5[A: 9K>M" M%K6M["2\!Z^G]U*S4QPR1 $808(L6]A%O6P[G Z2/R:.2QO$[Q:0,DE:@.#JTC M%T8G)4S/C:):W'J4VE[,\(3TBHGW?(G4DC*,T$8!!T'=X&(SF?PF MLHVIF%ARIBA<61KF1L5/\DV^-Q] -8K,+*^X]2!V2HDI6M^\]2 MH++!K8A:UL-?/+2OD.<=V^0"35ASHX5]U+6;S4-<=!7-*&9 F<[.2/4,.=8< M9#C@2%Z4HHM^!8$VSAA2M6W/V)CC2SMEEC"&QMLCL?9ES^ZM#(TM;E*W).\R MAQ;V](C6R)W2-#;'TKH^*DY19SJX)F)F1HBSCQ#, E2E%:WH!8 Z#NN_P!1:U^N!0_G M_N4SH6 478D6YPNU,SW!;MS5#*@Z#!G7^!G*FI'8$5<9#;2E!+=I4\<>W^ & MH2#VD3I[%JLDO>A!%HP025)>H$RK^+5]$P-VZ2B\QZ*/Y_L>7UD]-9['2>V0 M4E;YM.I:<:$X;JPP>3QW\2X 1:'HE:?H(S0>P6MA:K 8'5O;(S25F=XY(VEM M?H_(&Q>R/K&\HDSFT/+.ZI34+FTNC:M+.1N#]8' M70^'1"NXNR0J!1>.PB&1AO*:X[%(HS-T=C3 UI_7X&]G9&E.D;&Q"3[M^THD ML ^N_36!DN!UK@\L[0) !U=6UL&ZN!#2U@<%R5$)R=5(1C3-B *DTK:QP4 M*%L!)?N,'H.]ZUOTW@<=UDD=8@!,>W]E9RQK4C: QU=4+> ;BO"(:% $2L\D M(EJP -[**U_>9K6]AUOTP.TH5;FZKD;8VH"#%2YP<%)*)"C3$AV,U0K M5J1ED)R"@:]1#&+00Z_7>\#I$DVAB]P3-*"71A:Z+6LI\1MJ1_:E+@K93BQ& MDO"9&2K&H/:S2@[$%0 .RA!UO>A>F!1&*]^M,@[WM'CY=&(HRP&ON;(IT U7 MV*SV!R9I?^YYVD@6X^6SI4H44?TV/.U:<8E+B)0:K:TIKG6RX#<#M:;(4?9+O?RU]0ML?)9UP&YN1FEKV<2-(6E M5KQJE ->@O<>64$+SR"VZJB4QB]=RJS:^C-@3!SV1_T;'#B9/\9*F92A404C;T9!A9ZY6,LH._7>O0(TA?72.P+=CY\8D- M#&\N._)R#H!RL%PN2.(K:CY4W$LZ5_K32LX+16FX6K,/4OZ@\M.0Z%[2; M%[@^@@D\GKSD97J5+R>FN=SRH C8E6,0-Z$'6M^HP:$'%7]-\Y-5K-U%.=\T\W70[IT: MEJJI=8\12V XEN):4YM BB9[L![4*'-,M*.3$@)V:H)'HPL(@>HL#,[ M6KJ MF;FQWM2R(#6;2]O":/,SI8$PCT,;G=_6$J%"1C;%LC<6U,O>%2=*:,M,4(9P MP%C$$.]!WO08B/I/GH(+(%_.U-E"IYU3,-K:5V9#D@*S?5SE^%;FJPA'.X=P MY8XO/_2$%K]$#.4?Z9>A#_MP*2<"^11MZ:';\!O%ZH6K;^KKJB\N?8Y5D4M! M.M=[!8JD5H0$3")QZ7#99J_)UA)RG1IQ#>$D>D8S= *U[BRPNL#IWFPQ;.VP MKH.D#G.KD#LZ66VD6M!#G&O&U@4#2/B^;H2GX:N*(V966(I48N 0!.;K8![" M+],#F5KT70%RKS6FI;NJ>RWI/'FF6+&*#6%%)._MT9?4R%8SOKHQ,[JK=VMK M+(F\9@S6X M.04YJO;>A<).YM:16NTE(&;LHL8C/C (7IZ:WO PM]ZIY@BY U4FZ/H6.I2F M.,R0SHGLCHHB2=L(9+TK:S0TOL(\A3AR;8-*2V!S/G6RVRA(&XKBJP M2!C3">)%9UW29HL MM0-'9459VQF:DR>-(E+:CVF7KC2PZ^+0@!A%%=6N[5Y-^E8=(KRF4%Y^Z,ZD MY9T_]=QI,4% M!Z0_(M<]B\\<+=6794;6X.MEUQ2A_5=L]2BY99#K,XLM< MJRGL$"D.CMA,TRB;$TZ98E=Z.0&M1C*,("]_3,$0/?Q'!+#8;X3&%*V>+GBA MV(>'IW'(^?:Y=!ENSP:[(V7?[?2)#6>.@-]?Q+*4>E$9I( 6P%GC'Z>FO0(0 MT8]4E,[5S7YJFMDNV0JK30>4OG[2=FF5M)W@R M+M.N35T(F'X&6KE#5'D"1 MV,4(T+BX$[0@0,I27>]IT8P8$K]3]9=#\[6E>W-K9V6\JJ=;^W.,*>E=T7C8 MC2P2>J*\N3G"66).6%5;5:Q"//,#9))/HTF(4NY>TCDR$'" D4%".$:4&]#Q MTKIVKIZPD]@=00/JUR;+WL5(S3.N%CO(8O HJI*8'>/4TGG[XK7N5EJ:[0N> MB#7M0>>K/V;HE488K(/'L*-\=S2%T=Y6_*;!+[?F6N+5Z%F]#69SR.Q75O9U M]NT7'JC(C*D%6O;TK &2,T.FJ%Q+6-2 T8FY2,P8R0;V9O0IS.ZVURM%47%*R50J MDY?)Y3-V6JWC1TS(69&,M,04?I2([WFA$48NZ9Q7D_QIV"_ M>0#H*S9IW% 7E[F2"T.HA5!SZAE=$4J\*7W]X='P1,"U:4:(2ZNX/S;0PB7. M\ZDCTG'HGI_QBW1T-U!+%ECV?XZ^O(\]RU1;;I&74N9P M7IDN 1T]IT<R^*JH^ MA^J;>9*:NFLO(._3&VT=J2NLYA;EM4A$-YWO M1 R4)>0SV-UB9$6D\FA)Y[VO?THT9CPU,IP1GA0'*-Z#>+XJ[BL"[O&WRQ;, M\ERFV;)?JD__ #@E:]:TA=)C(8VZO<=^5ZQ[V&DVINGK9FD5\==VL_2=O+^UK@\B$AY]Z^Y7-N-_>H4&*0B&&S'PT-,JG= %=&S?J>].@Y)) MI=?U8?BYY:FIG 8[&J^Z+L1GAYB)@(*$FU-BXXUI_F>#3/NJT*H!0M?6+2@* M"O'9EOOJ_L'MZK[ZZ7M3EV%5-PD@MSBA/7EQRFAF*P7P;%+5=R6FZR)H/86V MR9Q6Z(3 M)97TOM"707^0;>G<.MYJDZ=F@:N5((RJ9OV_!43DX0\I-MN*>W#\D6A*5@,- M &*&=-6YRK32:-.*%*P1 M4=45.!X )O9$*??X\GY=$!4)SE1H9O>M^.T0Y,M.9T;YA+*NO]VW?P$]1X^L M91:4=)H-KLF9.<'FT:/M^R[5N1YDRA0I>6,QVWIL-, M)&6C*3D%A!LLH(<#RA4M9%D:HWA>SHSY">A;+M^>MO:S)U=6$PZBE,EVDI:J MJKO5,\6@)E1+])JEF-0ND083T#RI^H8-\=B-"$<(PH 0R6A)D^J. MJNM9KS_WZ%7[*!05NL2(0%X6TE4>K%87EA>Z1CDML+9X'CZ:IO,?U M#*4G7+AB <48&/.5L3>1S+F&,3[M^X(_RVI\KW6_,\'NQ-T78L69K3Y'C54? MN&'QM]M1(Z$:GZ]OLQ>Y15#-%PAJ]_"-.0[;)+(5:#$I1>UP;F-24I=G<\W@ M/!D;X5T!:5$2B][.+NZ8 MQ\-DMD((DADH0,#G5K,4!R^)4 ;J@7H7;9B@2HE8$(EI#1T:\15%]-$UW@*D074LPD*D.]!%LTW NG6MJ1F[>]K,<)YVY:=1=303M*,K*NHB MNX[-)YNXN=70MI(JD$";$TZ>H'(Z$EU6.YZR9&(&L93/H"AT6*2M@)4C#;CY MBK-E]/\ (39/6P5C%U8SW]18>H1U&M?VJQ@\P+)PE2VMJ./<70J7YE3F)S4@ M750E.0G;91+"@*2AF!]0UF2:]N?-MYVT.83-NKEE M,D-%-;[5U4([.,6L-HQ[EQDN%T* [[=3BR@2 TU*):8G)$06%>F01T_F7,%< M32[9XV\[2#S"]4U/S2%'?-XM$AMGBR2UDJ1,Z"*3>)2A3(9I6":[TQ3.UOKF MM]R0Y6G3-[@4688/08[4M]QZ*O5(5ET?<=G/?CUK[NGR55])I2"P;Q6"@+W$ M'1)KCZ!79:S&ZNUCR:-NT=2WN SD9QYYXF[98@R[DEVJE:7XB(0 MDL.P6.)K^V/)W 5L51SFTXZ1,82\OMVNU=ML^8%"U*=+&]_<7I@T4Z.Q!RD: MA8$&U83A&ZT$$*RZ*J?S:3.&2^*JFNQHEXV4A805LQ/M6/1H3DC3.LH55>2UMTF0^8F+>5P M\KH%8E"_PRQ)9SP;:DDU,9,0W">=QYSY%%RVWM)27U-41E)I*$)0MN1GR* Z M;G!3S]!FWAB_*[EUA*;2+\N/4%1'3I?+[QFZ\KEI3,KK(71I[(DJY^;"82LB M4JA*LQ0M("8>3GE:^;!KVR9#1;KQ=UI24V=X+5L_M=LD$NDAL?50JMG^-U\PR94I7R),O<2 MVX"Y*!*8)2<#1H=",] T(\]T]S W3_@)A[3A5ZBBTX\5]VNEEQ9W9KYW9+G: MD,Z"E,>B7Y"%5\:X2HM7$XXD/11*2ICD^P_$AYS8'Q%Y'D?8L!EUK=#QOQ6\N)2'O=:W8]:=^TXC4S_ M N72B,F-S8Z0V8W?')VNB"3]RQW9QA:56886H]ISP<,/671""-W3QW3[//X M\HEL7L;GN!LTWC%DQIU(4R!O?8"UMTF:)G&)D@2/&CG#1QY2PA>G":/8A>_6 M_7UV'DT_VJ=\\M2UEN^IJ"!*&CQ"7%/N?Z 1_L5H067UK0U_RB0C;3SGPH\Q MS?8+2]?68R)R-$"$5\YR_P"(!9Z=6,D.19'#M-U!:G0M 632CM9J.L?"4*,, M[NGI&>2:.R3MN1SZ5S=P?8I^THBMCBZQ%\XL).M;CD8CAMX50 EF@V4;L(2K M;'.O1%F3^?*J+HR]X)9=K^ :&T,IG+C5=GU>-UZ6CTC@[^]U)*+&5,#8C9[% M7U5##&4.U"XHH0_B0;4!&+0=!Q^CZ;0VCQ-*P*OJ/GAQL>9\!-UW,BFLY M3%'.82BB[#B2^0H(ESK#U;TZ"9896^W<3G8?XYF_*&ITJ,!J]0,.R W/>.:G M6RDNHO)]%X10THHVGG>]J6D=5DFUNYP"LI4!]A%IE)VXV.M PJP^+.B))V-67F%9>BKQZ>BO/#I*X3;E M.*+ID^VJ9-_0!Z@9VH.U5S(F4"5D^T?IG2,H"3R$Y9(C2PWA^:RFIO??C'ZH MK>LZ]<[0L5?&8@\PR',#-I_DS@YQFR(>_KC(NV!*.5JG]/'V]8(@M-K:H[^X MHK0A#T'8:).I.=TEZOWD5F<8D#MR;.H])XY=+7(WE$MAE M7L9<+VFA3^SJ9&TJ'@I('2@",I4/[!:@7RB5&Z7EX].MJ\8*Z+LR=N]#V,97L0(8D5%@EQ-U#'#8FB5D&#_ M '40M.V% :GT!5HT?H5O0A:UL-%/057O5D7-=DQK/B3H&)1:>>!.VZ0*+5\M MRV/%R.]I!)D3S!ZW6,+/$SR@6&C;T!(@$'F#4D" 25["AI_3 P.$\C,K9>?+ M;K*?'98VH- _",]1&WMJ>33'=G=.DSHLSKT3.XH4+$XAE5S&@(5&2(U?.9C [7IJY:RM5ZT2MT].Q:UM(2HD@R0A%HHH 6;K7FNZJY[>@YM8:7E5EW-\9Z Y=7PFI:E986W=*U)V2G:$LXKBX*X-VH3IX^K5J#Y M&-/_ 'I ICOA+#>?Y&N2&OMWC6[.>U DJ*32*,B?JOD2A$4K41&VH<:"25U) M4 A@$>C4))(W$E&G$;"?I(>< &]>_P#4-"E:>/?M>S>E*-MF^X TQ*"=\)Z\ MM[R+5TA0JC":\E7&,M;)[0T!=ET;-1(USC9"5*SHWA0N/S%?([;6"5IB230NSP M?S*^U)T1XW9 Q<;S6BDT(\:D]J'HN7G02(1Q.7NE#RX. MM;2-P3J3-K= +=DPMF%C5B 6$U>6"E;(MFU^5U<7YGMZX8LP0_IR//=C\^/\ M":[?@[U9D"98>R0@E1:$IC4/A5?V*6>?M\DX"U[R@3M^DZ'ZNU)QAH:R*%XQ MFI3)$S[<\=TT<95$_">5S(9J.K5TDD?4?*,7PJPFA'\9@DIH>H"#0N-UO"H?7D M-;2F:(0.+L$,BK.0(8R6J.1=I2,C(W%#,$(P1:)L0E%:V+>Q;T']=^N!E. P M& P& P& P& P& P& P& P& P& P& P& P& P&!5.'\,<;U_-I[8\,YDI2.SF MT4+W8H 0%N&M:T?HS0=:T'6C\ M?_$1L"@-7&\I4,=7M6JG957L1.K6,<4%(74Q[D:5J3&-XOC:Y,[&[/U(4#)W"M'>,H:I>[$A,(/41-S:U!HHD MP1->\H0B2$)EAHA(FPD7U]G>@@$['K6]!CTB\?O$TN*MXF3'-B='10>F,,UO91APMZ_K@6F<4,<2QM\"''B@..;90OEG/\ 2G--EMMAHVF1 MR:P7BN*NF*&=-[ D.VQ/K]*EK,XIY.C9$(S/J*5)YX$Q6Q?&((=[P.8V\\A:]<"989"897,89X37L1C$$AD>3"1L$1AC"U1>,,:09YJD:5G8&1 M(A:FQ,-2>,S8"2@!V,8A>GKO>\",;Y@?,\JBX'KIZ%T7)(9&CM*RG6^(Y 7F M,L"@P)A85!2VP$:EK:SS F"#H>A $+0MZ]?UW@9))Z2I6=P9KK695'5TRK5G M"W;9(!)X#$Y#!FL#47H#3^+BKJTK&!$%N*_1-\1 =$A_0'IK ^A-,5(BDR&= M-565FVSYG:V]G89N1 8P"3LKMA5OBCA2'\CLLL7/*R!VK<+R3TY&:]G1J&X9VYV.\PD3F ME=)0_G1EHDSXL^F28YB !*(HK8-B*^08668Z!HB,2"9RV-4I4D>E5C)3T5A2 M9CK>'-,@GB)4?]E2DF;R@9D[C*$JA1_J&%KC#P#'_=O6]_K@<]YI:G)&UQIC MD-35F_,D,DB690]G>8'%G1KBDO0GFJ44JC3>N:CTC%)$:D\9A2Y* I46,8A! M'K>][P,>4\S\X+&R-,JOGZDE3-#%\T>_7U$+>PRO4,;9D'/*>XI0CCZ&FB+_-CZ&0S5.S)(25;YD75FG(&U[E!:(L,S&P MJCE1A)"A7_TXQ&"" 6]BWK827'XQ&HFB,;8M'F.--QRDQ::@C[2@9D1JPX!9 M9RLQ*W)TQ U)I9( B,V'8Q:!K6]_IK ZB7US7M@?AMSV"0R;_MQR \Q[T\CXS=>GZ"P,'GK9SHJL""EV>W4LIM22M[] M#JT!/$4'/G[\U*" OLGBT'U("AR)S;CT[/I8O1(/>4("71IH-Z+T+09HFK2M MD:I,M1U_"$JU$VFLR-6FBC"0J2,YY"E*>U)CRD 32&TY,L.+&0'>BA%FC#L/ MH(6MAUJ2FJ@0,VXXAJJMD<>V^.,FVQ)(-&$[-N2.^Q[=I!MK):P(OSCIL8MJ M%?L^<_UW[QB]<#,7Y(ZJV!Y01UV3QY\5-#BC8GQ0U@>4K&['HCB6QU.91JD! M;J0V+! .$EV>2$\(-E[�O=H*K\C<9UAR50\/I%H W6 9&V62,3O84HB,21 M2^;()7)WB5O*:4#96M*C6HCW!Z,+^O[?AV066$01;#L6PEVS7*A*EJ5^=[<, MJR TC$D>G"0'38B,LE=,J;:X)Q1BM,Z%$L1)BAU4!^$&@?(R.HK$G2%H1;)"6 S0-%;]FM>W],"J'37$4/Z;+AC Y6M<= M35DUO$E76I4=*R5H@<$Z(9Y6!#MZBMRI4S"ID=&U5HHT!Q M6E*%<4>E/T6<6$8?<'?H(.MZ_76L#'#ZUK=2!V+4P"$'@?QHS7TL^*L)H'HQ MO%L;>8[!,0"TXC0C%O9.SO?LK>_4/I@=P1%(LG6G"J2-0/\$Y8PDZ_P#P<#NCBB%!1J=064>0>6,D\@X #"CB M30[ 84:4/0@&%F %O0@[UO6];]-X'$:VEJ9&Y(SLK8WM#0@("F0-;6C3(&Y$ MG!Z^PA(B2%E)DY ?7] @#H.O\L#G>P.M^N@A]=:T'U]->OIK?KK7KZ?TUO\ M7 B>#7K3MFSNUJRK^PXQ+YY1SFP,MNQEA7!7KZ_>90C7.#$T239(=IT+JN1- MIQND_OV<6 'J8$/N#ZA+/J'_ #U_X8#TU_EK_A@?SU#Z^O\ ;Z^GIZ_IZ^G^ M7K_E@0@P=)4;*;WG',L=L1F=[UK6',L_G=>(B7,QTB\3D:LM$R.KHM^AIE*$ MXJ#0Z 1I2)3[1:'LO0-^[ FE2K2(B3%*Q2G2)R_;\JA2<602#WC"4#Y#31 + M#[QB"'7KO]=[UK B:(WU5L[MVX*+BTC-<[,H9)7JRTV+\*^I4T:!:3*OD4*) MT^K6U.Q.ZMS8V\2D92)2H&E+&7\VBQ##K PI5RC4B[JII[*6!EBB[F*K'&F& M9<9+WC<4;:Z=G,E\FMZP.?ZZ_SU_QP.,N7H6M&J<7-8D;F]"08J6KUR@E(C1IB0[&\"!:]ZBIRT[PNWGF$/KHZV9SNEA)]LMY\9D#2U1T^P4 MKDX1AO3/;NWH6]^5K&UK&H%M -2064,'J9[A;#H+">OK_3 8#UP& ]=?YX#U MU_G_ $_K@?SUU_7UUZ8']P.O:W9J?$)#HRN;>\-BG9VDSBUK$S@A4;3GFI3] M$*TAAR=[PDO/\]U+6#S"P;*V68,+!>NOZ^OZ?YX# U_S#R,U)$;*Z MOI\NK.DI?9?(=&X8AC0.J M0)_QJ"-BWLHT(@[WOTP(PC=TI)'=ME4?JN+<8UU;1J%RDRR)!"#4%/39'-2U M@B&VOY\4N5(Y!((^>@,*=4!A292C%[1>T90P&"#'(=TS!YITGLK$D#J^L:)%"Y'%;7'(T\:<(4]DO"M8]:3.,3<$BW1J1+HA4F$ .S/3UP M+%8'Y$+0="W^N_;K>]Z#KW"WZ:]?30=?KO>_\-8&NKF-AXPZMMF0^0BOZ(1N$)E+,&,JGQQ;F78528](!9M,G=C$(A)SM@ M+$(G V+X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# \Z4J\P'2:"; M=IQ1)4]'P.4+A6M')T2^L+0"0+2.)6%7EZHB%V@+HH> MX:CH]IA*_E+&,6@SBS_,C+:80H7V95A WI%+N ^5^GH(PL$@=FYX,N_I^S(] M4D?J^3.BP;JC:8"DD;[]\;R8E(4%-A)GH2>:$.C KGY7EG::OFR%-_3-SM/[F0K5)')L?Y%84RK\Z,35 (US=K2XE M-Z&;("&Y7A_HNX+OWTI [\CE=L=L\T= N--R5=4JV1+*[D21?7T!M2..$?\ MW<41)2S&^/V(G;U@E0"_L*T9AY8"BS0E%A37R87_ &O8R'L#C&BV^F -]:\% M6#>?24N'H$BFNRWCOJ MG99&9ZM@=6[HQ<]U6UP]6Y$2),Z,;C8+>4]73B)RF%3264$@KUR=9'4T7YZ@,$U(XH] M-<9@2:!\>'A4H2IDP##"4SB(W] CCFCNKLN!0*!,OD&FJ6H><(LR<)1?C2Q)-$)>*:/\H7I[^KMCDT\J5.]127:C3H^-,@ M=SB$DJ3&;;2"D(@Z;U8CM&DA&?F7NVV.K.0>V4K$&KX?0W(UT\S0"7Q"31-7 M-[0LRP9*KHJR#I;'9<%Z:&BJFF#FV@W(VW8&UU5O027 1XT0!E%8&Q2.=F]0 M!\BSIS+/"XA4%,Y MT@3NSIU+>QMAXB%!J@!NMA9OR0]&V?S;35?/53KXRQR*RKZK"G5\I>XXNL.0 M12.3I6XD/#Y6%.,BQ-)KLM0@M$ MFC3>6H&I-,&H4%Z1IE P!J$8_)'Y-+)4A(E;C&XQ,WLB)_FF%H)$JCY M/Y<:1\ =K2@U&'X=A;7CWL;R,=-635MJ'TE!6_E-^L>Y*AL\A(ZP!(DAZ:M' MI_@""S(S.%=JJK-F,F6VM"E*,YB40AD1[:78G90QG)MJ3PN[Y(NA;BY8Y3DE MW46T0&13R-V#2K 1&[(*>MQR0-ED6_"JS7M6E["X(%C&XG;F !$KQ!5%)-@V M,:8_6OCV&J"VO)?W142[K"*:NAMMF-^[)VU5F[ E9=2IF6&.:5J_.C5)S M32BBBL").GO*)V+&ZE@$UJR401C3V=!NT>AX*5&*-4W5=2ZD:=DP&;GA1*:S M;YXG:8W7$N8OF?9;8!@2FIM;OKITY7W!"T8$2M]D=;W7Y!ZAZ5Y;%SM6U_V_ MX,J4Z"M VR8?)I+"7LM;;A4E>(BT(XZ],#R8KD3DF0LY#FO7F#:F?0A ^8TH MD.!EQ7?+FVRJ:^3ACJ2*M5E/W@@@U\O$(7?>96-SG:;H62-1!+V^C;DD@=(N MA6)@:2*3="--9RBM%'?&(!N!M;\?5E^1J<265&=B0*$?Q')JS@%AU59\4!6C M,/\ >D@) =-*]1,=?W1;FWRNDJ58G6QE\5C3KU231H5VM'?%H0;';"!)C8%- M2X4^((S,1Q.0ABLC=63]RMC!(MM*O3*\KX[^1:/SJ-LX\3"*PN:S8'%D9,^D3&G>7X1;RX+&EM+. B2&[%L MT@-^',D@O*44!4S]TS#8S7]_.$-;-VU$(8_(Y-%6>;$:&E=PL+RWJW!&>VK3 M2/LEE@4*=)M'?#LXW9>S!!HECGD \DXG647?+C.;!6>J%[3Y6J5A,4-50RE9BZ6G" M'H#G+J:L^QH-"I_.X7$)E7#TW*25;!]M6TO R4RT(2AEEBP)(K3JOL\VX[31 M6J7YF:$< M9,97-O4 +&-0N4B, $=I^[_)M&:G#9/Z -46J[4,?8G:,< MZ4GL+,M PB?6B9FER?VM.2\F(1+CU81G[V$O-72OE8*L;FCG M.<.-&U58UO\ 2W3U?Q%I@J ]$T,5S>353%7"4%-<,LF0U\QK9&2P'))*R12<.T;2G M.Y3*H$I5H7]J8GX\S28>SC25110=^\01>[8>;3CKJWJ1H@WCWYS6=+B>;-[M MO7M&=22\+:B3,^.\(KVAK%FY+W6M>(U8@L/SH:P+_JZU45L',3G97/?3%Z\P3&51EG6Q]DGBZFI:)F;ITF85.CD MS$KE# K1J5B)(I5I$RP1H2S Z_T2@UW]"=@]66!:'DZ#0]MLM"LWBWJMBDC/ M U\*BLY_W&SUXK'=W+'NT%4@0G/K!4Y$99CX\B0QXQM<35ZDY<8Y^A):30=U MQWTKW/V'U1+%K/=-?UQSA X#Q3T&?4[]1;0]SJ4POJBF'6F=*W:8"4V3>0I"4!4'B:PO\ +J%I$<;6 M5Q-B#PG>/]H>2:].@[EFM0S;GF&4;0'9S-2DV@UD6W7L.9X_44 M<<8@T2I-+HJ]5$YV6\S^S29$WGL\N:7MD4HWI$G-1G"&1LPH! M^S"]A&$.\#1[9_2WD]76A0'(;%T.ROUC7MS"C[4;[-(65KR:+:YW211H;:,@ M\BDE5WE'9I%ZN=69>_O*,:!(]/R1X"401]JC"?9\O9WZ<+2P,R1NTH"J5GE%: M*V'?P[" YI8_1E[TUU)SK=5_]/,T=H[LSQ:,;H7VMB+(C]K M.,,9WM@61]KD*T$GC[7LW:AA4FITKELX) T80N#U3W5UASE9/E$:HO>Q3G": M^M?QC536,LD;'!G4WGF&=-,IB"U[/3IT;*0C=E#:F6%')721Z5-ICD'7R!,T M2(C81IVEU-UKSV?WCS=6_5%O*VGG>T/&/)JPN)Y4PU^N!$S=5STF*6A74EEB MB(F-$ECJP/\ ZHW_ "(252;W_7]QB+T*P-R7 ,GM9NOGR$\]6)>LYO\ 8.?; MQK$FN)9: (8;8+2P6S2,2LMWC#PY0>.1%G<&QEDCNI*;]:;D^R" [*UKT#Z! M"F?>:5TBGEDYIM6.2ZP)#+ZPX2[/NJ"TNGLDE#'I38$(1P=ABT.CD*7&?] 6US-6$!LH'D=ONPFGHSQBJ+ M5Z/=XY/&N^G2IKF53JE8Y Y#4Q8ULD=C-HB$1J$]>>8:^?^JSXI;?,=Z5;;O*$ JCL>;V9'U,?+KQ,\S^E_Y\?Y M,@L2?5;.7A9MM>G12L_$-4J4#.1C3DA#[@EFX;<5-,*X"7'$Z0PMSKP#N^2JOELD$),E5HBS7TKYM'*2_? MH(A+N^_J5B=HV6R]D]"29-R-YK8IQ96\,L2W=S"(O](SRR84URM%M?=G0]/6 M)S2NMJREEQ;K+;]/8;%*10TE^XE50QC-6KEQX/L! $ M>\@2FZWDOQA2.9]P7_;Z3NFGO(+$;SC,AO9]T!*77,1DTVK8$ 2Q5R:%D+D\ M"=& 212^I5 7LXTT1 C"R-A3DAM>_P#C[&Q11XFN65,8>C7=0I;)JHEY1TT7 M3(;/-#9])!/3;[%J]:&)[4 V2NVT$@3%)Q+-F_'LP\9QH:[>I[YLV42GS4RJ M0],V]15]\1J:OWQO64+MYYAD2W%PUXS3B"O956I75+'KB?K_ )P!:U."9T3N MPQDJ"$:0A.:(OWA*_%S?')GYJ;>E4Z>98TW4XTD37_,SQSY0&%(BC3"C-!.?G^1Q)-SQR7*YW*GV& MPV.>0GE&NH!+'@:[:=*SJ#DHBQ@6&"#/Z2NU[M/LV>HYUY*YC35^UWY-9 MXR)..C8I<,FEM@U"5,%<5KZKXO!17*""R2AY7528#VK>T,.V*-';4.2M;\)& MC!!N9\O5MV_1OCOZ,LJCQ/Z&:LC'&4:Z2132OK/LVS8A''NJK_AFW=Y>&.%-ZUD$X M+EQ[6 !0"6@\Q.$DT_6S0C'J/H2TN26WRO4K1W3]MV#8M&<><#.K&-_M24VW M8L. X3)^K#IZXV!&[.CZ=$9H1$7EI M^0RQ^'NEI3+8DOYD\8QRFQ&:?2^[I]%:3<[FE#'T'(HRM>Y07/$9\;B$U(6/ MGP.21QR.%T9*K?HFKH M!'K82N:.WJ)&GRK]X43=4]D=P29Q&WQJ#P*-.7,U'7#T*JDY$SB5=266NKN3 MHE<\ &\?4TF.&8049[ A:N+0A4/Y=/;^9^K*V5H8]Y#_ "*R,RHI_P!23:JT M744+8U!JJ''"Z=CKHO=&.QXA"E3+*(MMU4:;Y*JT!2H&<,L0AAZIN()\FM/C MGERQDCI8+XFFM!U5(R7FV%+2NLQU Z0MG4_D)XX,21 T.4J6;'\BU4G)*+4G MB$;H.O?O6!:3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# U@L7BII7 M4CFSM9UK7_>T=D\3Z,@,>@=KS=E@P=!X4>.SVB6,-AO5^76T2WG&/&,DYF="M?=3&B,,$,PTTP8@[AV\/?.DDA[/&)?;?6D MY=6BRZCL_P#D*=WVZS2?KG&AE3FXU#&CW.2L[FT(89"79Y4K"4*!"C$J5G;, M5F*!>GH%S*'Y@A?/LNZ!FT7E5AR9[Z4M4=Q6#NG/&=SYU+:*FYI+);RK&QGRJ'*C)X_ MT9;L@K/5H5"YF.)XX#8[8@ M:I*QI5+LH&5[B"S_ /4V 9@RM!+T'VIWQK4# M15TTK>5?R*XDDCH3F)EY#@D><+ VX0LRE6$\]>W,TD:!LX%TA<2GDX*_2@]7 MO059)0@ "$L -!)S)Q#SW#WGJV6U]%UE>3SL\?SWM/HNY"%)WE:&,J8J2O8] MR E^9(X>0A7*%&@)D6B#'!2:J,+&>/8\" G/Q+* IE?SI M9C7=X3V-S,="NJM4K'>L!?N?:H)H:,6!6U_6; ;&E5(%;=3!518DOB[ZVN4JAVU#R<845 MO9"A#OV 1G)R@!+T&?R'Q><@2:(WG7[C#Y@7 ^BH#456V;#6ZS)TVQ]57M#I MD2"IHG&TB-[*,AK5#6U%]8@+6-(,TH\[YA&"-&+81C9WADX?MM_F;]+6:Y"_ MY1CL 8;B9(Y?]M1:.W,KJI*R(ZWE]I-3#*$)S&M M9E#)^QM3VQM\CC\N@KTQ/R!4!GDBY,,&C]E&DJ1!&'?Z>@5=J/Q0<=TA**6E ML"9;8)<^>YE8<^J1-([ZN"8LL3E=LHSD5DNQ+%*9@[M2Q1-2E1PG 2@HP2@X M\PT6_D%[M!F%9>-/DBF[:=;AK&(3B'.SS/G2U5T%9[EMTBEC+,>=J3'*=!I3 M>W M&V$WU@!MC<%M2)67('(N7+1:4MJ\]%#-H$AB/6UB=8N*4 ] DC%H.,Z^*[D* M9?1D\NB]J.5I%V)!+?3W(^7M:KI?C'-J[C3M&8*2FN34S4S #1"FB1+R4;>6 MO&W%G*33P@$:+Y,"L%[>/J=0VG%'"/)-)Q*4\E]6.D\#UE8M\]"V),IO51DZ M>&)2^3NNHI,A255+98M!MQ=2Q?D2=CD.DQYWMT 0QA=&X_&UR=>\BALIL&&2 MX3Q"J264L!,HBBY:@*-/3*]#"=L/M'[@; MV'88D#Q6\F(Q5ZHCZ:[(9NA3 M-4B2,#0^3-S:28\L:2!IOQ@B1(0DJ5&OB]3S-B#K7KQ ^7(_*I398&JTX[-FN< :93)EY[@:B$M$F*5GFC* 7L MXWWAL"K>MX73\!BM95PP)HW"82SIF2.,20P\X*5$E"(7JU;,8_()+WI:'7==5UKHUXFE/JE M\ED9,HK68N]70UW;X$58%>B))*V:M3+AB7(RE19H@A* 2%R5GC%Y!=^<9MRE M)89,)C2T\LISN!R9)C:ED25^9[*>)+N9N,OA\U=9,HE\/>%,O./8K)1:+U$6Y 22U:>UBPAO(+T426 GU+V'!=_&)Q6]7Z^]**:@&FLJ629C MG-OC25):L4&^ON/-]X,7B M621N*Q==3RM,D@UM2R\H8[M%FVRSS&*6?8*PM=8DECD[;IRGF;)NP5 1B>DR M5<4D<##SC32MG&C,V'133Q,^/2>)ZK3/7-$20AIF+JX-!3XF\S&$.!,%<3G! M6[0N1NL0D;*Z36,O;@[*52Y*\G+@+%*@XT[WC/.V8&P5H:6I@:FQB8FU S,C M*WHFEG:&M(0@;&IJ;4Q:-O;6Y"E+*3(D"%(2 HDHL(2RRPZ"'6M:UK I.A\: MO$C8TQ]E;J,0(DU\EDKZ M\OC\N='Y^?7Y^=%"M6M7*E"I0<:(0S-X%?;D\?G'M_3V16=:]*M,CG$SB#37 M\Z?$4EG,3_D*#L2LU:TQ.Q6V&RB/M%@Q]$:<((4KRG7$[)W\.P[*UH&@D2#< MJ<^UG=5@=#P&M&F*7!:<8C$-G\M9W!^3%R2,PIM:&>(M*J-Z=A1-,3&VEB2I MD0TZ DU.G+V6 6@F&:&&57C1U3])5A):9NZ'(I_64NVT;D<4<%;LWI7$; ^- MLE9S!+6->UNJ8UN?6=,I+&2>6+1A(?U]/76PIR+Q&^/ QGGC +G1")CM)IB3 M%8K4*R+BV@FK+!#B%$.:Y&FW87Q.B".GIP#3%&Z$ M>OIO>]^H9T5XT>$2[ MA@O0 ^:*]67-7#;&6R+6&YA>W>0 ##4>T,5='\YT>%9$SD[ GT#ZKP\EN#L4 M8229I1\A)(@!8N\Z)J;I6KY/2UXPU%8-7S,I 1*(@Y+79 @>2&UR1NZ,A6H9 M'!KT>A!WL.PKY9_C=X=NJI:HHVVN6U*$B(@D]*8O,(4$IRBS0# 46$(?J8^-_AVP) M3,)C,N<8&_O<\IQJY^DX5FWT+&LIEA(:R(_7J&*)W@F*L+%'OPJ4QOTWHDIJ M!02$\@99WJ/88FD\4OCM0P2;5LCY/K!/$+'C4,B,Z1%$/87.3LE?2,4MB '6 M3?F?W08T3(V]XG346,AFE+TID)CHYO+PPI!Z3MYJH\W;> MF 62G^(HHL 0FNM^>Z.IZ561.*MJF#0&8W$\))!:LGB\?0-+[83V@$X#1.LN MI37J]V+))<5D1>EZ0]Q#(&#>A "+7H+6MX&+5OR[S)3]@R2R* MKI&IZ\LJ8H5:212F(0]@8)&ZM:]U_-.*,:EO2$'DMKB^!^XI**T E0KU\IFA M&?W8$IV!7\&M6%R2NK,B,=GL"F#6>R2J'RUH1/TT8-^T8="UZ"UK>@J_&^%^!*\-=HQ'.6N9(V=8:1K&\QP%85^6.9-L!&C/ M:BU;,L:Q[>FF*'_7. 7LHQ.E-T49L(1Z +02.BY[Y3FLT@-]-=-T3)YW"VLM MOK6VVJ#P=U?H\SHTI#,D31.8H6XY0D1-:-N E2Z3'Z"D*+V45[ ^X.!P>L8: M9=5&VQS5&[(@]?6'?=63N 1]7+48I&H(8Y&S'1Z8/K9"4$IB3Y(3F9@=CA%B M(5@)2JA$F'^\H(BC AKFKF;E_EVHJKY&?FKFEPLB24Y'H1+FUOKFO8&\]&MU M:1\IN?9,[URH4O#S,4!8=FJENE1KH @Q0:,8]>\6!S;ZX;8)]!D<4YKG!'#[ M\I>XRGFUA<\U=6[1+9O53$R/[ JJ!>I-94Q2*.JT#YH2)27H9[,H3%'(]%F! MT+03NDYAYX2U[556+Z:KF3P6D6)BCM4LDXB3+.@PAOC;6WLS48QJY5R5T M*0-:<)BW1GVSQEZ&88,?J+ Z!)1/'4I7SB+(:;YID;H"5M\MLF-I:\JYW7@G M PNBEJDTX9BFA0H#+!@=5IB=:O+^YO2DX0!^A@][#,UO.G/CC,'BPW"B:;7S M^1(75LD$Y6UA"54P?6U^:!L#XWO$F/8QO3FA>6$8D2LD\\9:A)O9)FA%[]N! MCAE(QBUK6!@%LQ+EYN?XC;-Y1:ATDI:I)%HS MK*M-A@!4A;9<[/1)$+8(A,)6DTYHY$XR$TL+8E1* J35@M?"'9F]8''@\5Y3 M>+?W.]X@ZC9;4EL)8Z[5VQ&GN0-Y1QK3/9 QI3)>TNCRUI0"&0X' M%FJ""P^H1!#KT#)ED@H:Z5T\IMP>*FMEQA9S#_)M6+5L1G:J+*52C;K&OWS" ME!CH8S'G*VO[*+[Z8L6S$_R%_P!P/70=*X5@25BCY%!059V@CUHT?N#.PU55X)T5: * MW@0++(9P1XFQ P^/!G1+ 6#99;&5+=-VG\MG+!OVZ3:4:)UK]-!P,X.))4DF MIU!12A.H*,)/(.+ :2<2:#8#2C2AZ$ PHP MZ$'>MZWK?IO BYLH>CF5J4,+ M-3-4M+&K0C:U;,V5W$$#4J;#%*M88W*&Y*SE(SD(U:\\W9(@;+V8<8+>O<,6 M]A(*-B9&]O9VE SM2%KCQ*-.P-J-O2)F]C3MZ3;>WD,Z,DD"=L)0H-[()"2$ M 2B=^P.M!_3 X7[:B2%:Z/\ ^WXZC<7!,H"]/6FEM(6KD8RROM!=''2<)ZI, M,I,#Y-&C$'82P^OZ!UZ!%=('%I MTF9TRZ% -8E!8G]0H&N3A%O6U8S!&A^00M["138? $3>F =%(@D:F$\]Y1@, M86NQ?I@89%TW/UVU[^XH:CJ&V*KL MH7Y?;U'4#3F->WE.4?DXD3PD,U\VQ'[+4EB_70P[] ["34724 MT:B&*8T[5V%=1&W6Q&H:FQ*Y6:,N#,UK5OPGJ0C3JM$A>[HWHV(7-DCS6$2)J5JU;@YKD+<@1)33CC@Z#K0@I M#)_+[0$&JM]L"9US=35+8#U%#.0+>I9L8(I*+,JNYYZ A5%&YY)C\Q71F3,4 MB;5J4YN7L+BZ$K!+"B0^TW1P20M9R1UQ&^M(_:"M!75DT_-J6MF04S:566R@ M8$4TB$O9&MDD*;:DR*2"51IQ:G^,R1 X(E*)P4%&D*-?KZZ_4(%E/D\JV)] MLE(.%56Y^&>^EV+D)/;)Y4!:(R?>\@8$LA3,[-#GV%(4S@F)629N85 M+*0J-$7HX?QC%H(CK_S/TC/[!K")AHKHZ'PRT^F+'Y :+FFL>KYNK=LZ$KY6 M\("J_>36FQ7R3(EDK6M&R$"@3=I&)0:$L1NMA,]@334'DAB5O%)6])2MIQ>> M)>SI!Q-,:P?G*ME$VA,[BL/43N0SAR2L,W=VUQKIJBR4Q>-4C4GJC$(?L%$& M%[#O82EU'V&DH*6U;2]?UF_= =-WBFFKG5%%Q>21F&*':.5PT >YO,9;.YBJ M2Q:!Q%E3G$)BU2P0S%SDK(2IB31B,V4&OMO\GLMZ:N?C&JZ>I^UH+5O4$:ZR M:;0D\B7Q>&V)")K0K,ZPB?P5I*&Y*'./2FGY\:4L4.A(_P#K@A(TWE*PB4"3 MA"GBP\HKDBYQY3@'5;/T))'RT8AUG-B^NYRGCL@KN2DT#++3G,Q8EKDADBFP MU;Q$:UCX=!W^!"0;]?1"81OQ[]H9]!O_ )$/*DV8+XDR*J+D<6FDZ>-Z$V.$ M+JIL0][IHN4MT0-?G_4;L,Q)64M;7-W1GKXX^')W1*A6%&Z :/1Q)(;9N:.E M"^B*?67([U+:E!,I+Q( (V.[V1%&9 XPQN3)GE@L4@M"X.C:*,2J+N!"XH8% M)FTP]G)CMZ.3FAT&OE=Y'%?1E0VJ@C5 ='U#7=SM86@P:\M&$ MQ:K/#O8O<&Q5!Y1H1)NUY=Q] JFE(''[P%",P)G[J\A#5Q MA)Z$KI#4SS;5E]#O$Q0PAD-G,.J&'_5@+*F>W]&HM&R5""%"GCJ6N((8(WH_ M3B^J1# 3[= V+85AM/SB416%@,<%54[;Z]0T%4_J^VX[]I-ECT4\W2T,[LR0 M]54>GU?-[#FD$(?$YDQ1,I)H(^FV(?S*3 _!@1ATYY32IC17:3*YQ;^92, MU,F#)[9\V]&\WO4.JY-5%MV>""5K0L@O%X12=@7RNNFRX8=')#%&]E;9*L22 MKH6>M48?$;O(@,Q?JD0*-*3#AJ!"3!"VE%^1=MO_ *GL?GJ$4U(%T1KB:S>N M7VV$$\@SHX1F605B;WPU59E/%+4]B5M!9P!8,B+/JHI0F>CBPAV!/LT&L"2^ MB^PW2J;<@W.-.4O(.A^AYO7DTN+4 ;I(AKV/1JJ(.8!J62B36*_M3HPMJ^2S M!6E8V-O^,1BU><(1QB5,4,_ U2W]W)9/94K\7T:H&OK88Z:ZKEU\O-CQ@J[W M'FZQW.7-DXY]GDP@R)SED%U!)BV!- M*M$?4&(M7OXM!7SL7LJV^AN#>O3E','0G-D,=>$9EU+0U[;L,I:6M&W6%J'1-*@V[$1B%2E.L:1/2E5M.ZK49HD834_ MH?L)XOVQY-4-*V=:L.KY3:T@KN&OU*GRS/>8),W&!!K8PU@W5U/UM>U8T=< MUB1QE5S:J?/C$*.KJ&49ZQZ*+I#&GVE7.2_@8'"7Z).<@84A*1^>CU0 M5QRPT:E*@T6$@0;(%OF93VMXD;7E>)[ M;>[6.FU=TS)9])80DA+JWD&E-L2-7%NZKXS"RT@-J]ABK/YB^FIW+^<*BK/Q MRS%?=7059VM.DD.LJUBZ8(8S*5LINA4X=!:LFOX^^FUXL8E/Y1E=%")*O6+2@90;-^R.HY%SDP5)'ZVKDBVKXZ)MAHI:E:]<) =%(ZIDRYB?97(9 M9-)20SOI[+!:]AL97N[H80E/5FD)OB(+V89K80UPS3R^W?&03:JV+D./3'JB MJ>Q:OX^LBOB+N-B]=A=;\9'%XH:T(1-Y77+8ZR&%V%MO,(-*5MK:H;32#-C$ M:1LL\87CZ4ZNNKECQQV%US9%-Q$5ZU-1R2PI]3;=/3CH2@F:4EN*E32VSE(T MN2IR8&90I/4IQ 3_ #+"20D^\L8_E"&O4GS(WO7ZVXH??W*478;5_@_EVYN7 MH#6MI#EX+-+ZAG;+246CMA29>RM;1"U;9<+XFVN-)^<*=H/%\.EIA'RGA"?< MODM[WJCGCMJEI/%J5IOKCGUIYSG?\I5')IC(J\?>>NB;"05B3+:J3S!A2R5) M:47G9@FM80ZDE(2DA@UA!NS@$D&AOIORUK+HGE&S;D;J]_F:VJQIEYF@*Y@9 M#PG3SV<1^,B7JF:,I1%/LA):G!W)'LDOV*UH4O\ ;K1AO]0U/TIY4K\MC?)4 MBCS)RO:-67[UHRIE)QR),C1M:0Z[Z$GR M*JIFVW[6-&5LG5J:_#'Y+(96XQ)&]6_5HV98Z #LDW>S=ATG) /9H JTZ]%6 MO-NS/%/Y$+B;:6=&Z=\?^0F]X! *FCJYNE$5KB+42XV'&ZWFMONLCD@)X\BC MBQ-]D1#6UI&1^4N111"DO>C1!G3#Y-O+ZV9WW_ "GQM7/.;G"=2:-UHD6=N*9RQQ[=GM;M*I!*'EFI MF1UZO)6+T1K8=)/]/1:-N /Y=!45IL_IKB_JSS76A$X1%.E+[(.\4S"6/5>188EZUG2/XE3T: H?V4I1A@B0WR\ ]# M.O4'.;9;#K9E.V_M;.K*8&FPJ19Y;%HK((U&IH[M,84/<&G2E=*:^GX6 A.% M^8U2A3^/;JPB,AK'GR^Y(GYK>Z"FS M';<97PN[XS&*,MRM9Q-YDZP.]J[D-<'F/CK(&(A JBCBH3C"4<7H/R!:07D> M[0H5NZDIR<,_*R^:TIJ"G"2IZFHMQ5A3 2 %T8\M<_>%'K0/L&+#AF&['_K",&(1G]V][ MV%);AF?1]2>3CRRVAR(DYRB3M3W$O-ML6;JW(1+'H-B B;%:\],;VP->OL/& MADDD;B%*-0].9KD81I.E"%.:#>]DAE]9>4+R"=E@<[3XOY]KU57]63>AVN?0 M2?3.JVY&XPN<57#[-MAREG5]=&TWS-$9[9H%*NO*P<[;=5Y*JQ):UH%[8K?D< M:8V96)*A J3%JG(:8!YQ2;9Q@0KJ=?'<5$V3R[6=VS^AK"_DWN>;\WN[C%8L M>5))30SM24PN"HK%E*-L>FAOJ^ZRE$$4I'-M3HUK(L0J@')RRQ:"8(*UZ[A\ MA$PGE84I IES,R2B8=\=I<3/T\EE/3EX)2L5&0YVLV#VHSL#3:K0D%)D$2:5 M*%6TG;V@AE#-1LFM*.1NR(LD!(CU,*E;B75 3E:3[" M]KV)U4!"3K1:?XPJE![_ +KYDYB;*]Y;=X1!5$S[S\JB8N'1JMTM@W"YLE3V M[:$BCC)1M7K366MB(FR.19 IV5;+&MXE:9^?3@.B4S[:!5]3$$K:L:.?7Q M\M5/4\PBKBWG$*81!':3H2$[L$>S2B#4P#-F"-6F[V&9![\\FMGJJSY_HV$L MBCH:>T'8O<3.\R&)5NW*-4=)[HD43Y?J>=1J<6+7473*5\,_'*9N[L2U0](M M*"2DB !OSJMAZ"Z+E,_FU-UC++6CD:A]H/T(CKA8L5ATG1S.*QR P& P& P& P& P& P& P/YO>M:WO>]:UK7KO>_P!-:UK^ MN][_ ,-:P/-90%"3GN5/T'"8Q,Z&6V5&+58F M*+ *8VN"H(K)7H*(PEW3N6U21J^5$$"D.]J#0Q^O_'U>'!=Y0/R4]4W515B- M/.$.ZL?NF+"@]9627>-R,5KI7J2HIT\'%J)"&3RN-NJE*R-4:1I6UE964D6T M8]B.$2 ,WYG\>+]9'(_=LOYJG\QYD?\ M*4S5KX\FLBC:]J?Z;Y)/GCI8$8B MC;&71N03*!PNU9Q,Y@^E)BQ)79&T2)"<7LA006 L(X0^$WK55#;\KY39W&== MQ2R)WQ[=L4:*CJ6T69I)M/E5V9%1;2\)G::+5:9@G*9H/5/CV<8\/CL].)BL M02=!$6:%B.H/%%T;T]'NDY\]VY3<9Z*Z6EW)Z)Z1)&VPGBE813G)4R/L&+QV M,@5GI):KG$RF!PU#FXG%E(BDYVR24NA@VH-"7(AX]NO:FZFLR:4]U!3[%RW> MU_.O2-DP*9T$W3Z[X=,I@)NQV%I4H MW-\@,UALB<&UP)2GIU983PF%&:]@@&!KLLOQ==06,@=)FOL?F0JX;6[KH3L> M[FY/ YVFIX*'FAACL;KN#P%E4.+K(U+Q)$L;*52%W>5!^CE9@MIDQ6@AW@7A MX?Y1N7FRS^YYG9T^@DU8NJ.H'OH2#H(PBE0'^%(7IC;HK^TY*[2%88D=$[7' M8LT%H](TY!9 @G@UZE?"$L-=5I^(CKN9]$V!>3#U!01KN=V#!NJJGL*S:'DE M@W;&VN).K9J/4:YRT<^:FQDIVK(X%<2QLS"G0E.RE1\C@,&Q"$$/U"?$]UK" MX92D25730"YNK7R@3?R+S-8CB-G_ )>1IGY\V_-L C1:)];0MR]/N0OI2@9H MC25.Q(M:]H J"S@E7B"N*_Z9\A71'DGA=>7E7O""/U3J)!>#2 M2M8K=M./5K(4+>ZE!10-H8(R%Z5 V8M.TY%DB$3KW;"X'77'4]M*ZN?NN><) MW$*YZDYU332'L:JS6.0RFI;$J2T$J=%.8!8*>8G;ZWLN?_ ,C6 MAMDB".?,W\69QO+N[HM(J^?J*-YI@)H>8(^SK$MO&GW%151R_G/ M7?+3(J"@=<6O67*\(5TZ3]]&R62Q+F%A#T1)/W !]G+14;>[*01QM9U+7L"C M2<]4J4DIRT&! -G^#.^+*C\#@ZCK^KDD2B_#D9XY/VY\R!E*B+:BZXTA9.:0 M8WFT!LU.OUFQHA EE2] (:]>-$/98B]'%_5"Q*KQ7=!SVX*LN*\NI*7GLZJ> M[8%<,2M2)5!NCC0[-WH8 M= "4N(_&K,>8>BY3TG.[7K&33:6TNAJ6=;IBCD](I;VDI;D5.)"@C[3&B92#"E1PU&CQ& 0'77YXV;BD5^=0W+S9TC&JH9.Y*?::6Z M>KFPJI56(Q#)986[0%JMVLU3).(0J:[/:XHYC0@)=1'W! ;1C"JG$G*E4-FV9!RSY$.;I1?]>K1=V6A9ME()*WTBZID%4FW$%F M13EJ&PN%K.ATS"0V,A6VHX:Q"-(L%LTW1X-!*T&.-OC"Z)KVV'"RZ#[UD],H M[AK.@(#U%$F^GXS*T4Q>*(K^*U>DL&DW"3/RM33,L?X3&]I-F* 2$M.([1@@ MG[*)T4&;P'QMSYM[8A78MG7Q#9O)*U?+S''7Z,48WUS:+&.Q*\IUM6 _$^L?2.:A2A1F'*O0D0# G3HOCV:V!T34?75!7$GIR_:O@< MRIYT_=T3=+(JFR:AFIHGD^*S*!MP98U22>575A2^QE4CI^/1MO8DK6S M"-<7\25-LXW81GG"%@=E6OAW;T49H^C^@KQ'T5RKRPVVJS\]U1(*Z1QN8I&N MSH>]5VWI+2LMNDRP M.G[R.VE+*;?H)_!U5-3U45&YJLVZ=H:R@#5;3JPR6 MS$D&BS?9;Y'$)B",O\Y(84*>8NC&VJ"RS$C(Z/P5!J8D8 [ 0,(=A#Z>F@U" M+? _QZLA<>A@]OYA$>[%!U,F<50C%*P$.)>UQR3E]&+\@4-'1K=#UHF1*@V, MT"4DU0>46 U4=H09#T'XE7?H8[O@J1=72QG9>]#*.*DK4W5-!3C:T:^?WEL6 MP9OBCF:L H=AB:&WZ2HY>$8CA&;/]-"UH.!D<0\74W@?1#G><+[TZ7A$?LF1 M0.QNB:8A:2!M4!NVW8C'V1@?YQL;JR2!SK9!9!,<2?FFMA&G 82$1!1Y9?P_ M"$<.?AJ&)7^-BW75D0^M6WR$)_(?$*R15K7#DUQ6Q]2%YE#A$P2%T3GRE]8' M!W>-C]Z]4?H@)(-%$AWZBV'P=/##IQD=R6DV]A6_ K_GW4+QU96MU5E%8K$W MNF9K*X856TXBR-@4J'QCGL F,!0(D*QN=P"T(U)H[8A>\9>!.<'\;4LBO3G, MG34C[(N>UY'SG55DUBK26;%:W>WJSR[=>%DAGCK(IHW,3.ZLJ,]X"VZ;&Q 4 M!$S(FDE,ET$!A^S LYUUR5%NM(?!FU?+Y55]C4_94>N6D+@@NFDR6UE9\6)7 M)6U[2H7U"Y,+B,O?(>!H_L '5.N^<9!AYHRSB#"- *"&62+Q-U M?:U67K#NC;JNR^[+Z'KBIZNG-[R-PB$8FS)%:1DAG(0C' :G7H'07+FW.XI]S$[*_3PE;>S7)FMAO0+ MFE+3"*L%#*(^Q-3,US@MQ2@5@/2MQ*8L[7H$G0/[<"E*OQ(U4YQJ2_;OOHE/ M=4HZ,A'42OI2/O-<1*U4=I5]6Q]01]8@;8W6[;60$1E<+UK>NT8P&G.!JXY4 MI,,4["8$,6+\)'+J.",<49+/ZBC4LAG0MD]+UQ=<>NI>VW17MC6\SM3%9.V* M:EM&S%[7-$3,0-Q"Y$K5"A3[S?F#LP81!,"/Q:4:UV%!;/9[+Z';9?7U!6GS MRS/ [0"_.J^,W6]266VA,)"\RM@?GA\LJ63F3#>S74\_>B5Z5/\ "260 1(@ MLOSWR;4'-/,D3Y&@*%]=:8AT3?X.W-,V>SY&[+(O)5KRM=VEV>=EHSUA!^GU M02'T"#8"-A!KT]NMX%+Z:\-?+E#S6KYW7M@]1I72BV"SHK1+:\W[))!&*7C% ML,#FP26.UU&75$>SLS&F+<0J4:0PH].6K2)AF -"2$&!+"3QB9JYF-35G!V&6+6ZI=5_.H[N*2&.2&N1$J&-X2* M6#12;U]"A")3$ ,V,!!00A72H/#1P[2-O^>O*.NJTW(D$G?JGJ$N0*G<%;5]-7%I1@>T[=HM8Y M)DA))BGXP>W82'8_A_XTMQWLAZL9ILZ6+K3JFE*JDRAVM64J7 D/.X0:J"QV M20#.W)V>V8G_ *N_S92[WK!*E E19VSS-B#H"O#AS02JE\F2D#N. MPCU0M+%R\1XA*E)9>MA"2442 +BU)RY3U(V;>]P5\SO;=/>E9(P2ZXG-PEDD M>D,ED47:3&%DF2A-))*"/0OC#O013*KX]5)UH]5_((+&;.CKG65O3&^8JEH8:;Q05&Y)IY&[>D%\0_P"&SK3)B4&M>7&'*I=+H- 29B7"HDJECD:% M8Y$H4)*=:J(*&:6+X]:P.D(IRDE[E&;((?AF/M-.M,7@ M%AQ -!L,\BM5N<1Z OB-/\9BMD/6Y%)XL%^9[$1NKA&!O7M4)6U2::A1C#K1 M)0 _I@2^W>/3DI!R6@X=/J[3]S*U*$ZELKF52>5R<#>8BFP;$0@22!\>5TD( M(0RP/V"BPJ_C 6(1'I\ A%[#[=(^/_EKJ^30&;7# G!!Z'H?G,JSW>@VZYJA3V]%60I[>:E M33B*)YNQL);>>O\ NJHB!Q+=4B-$SHMJ3M?#KZR/V&F: 4,L0@Y]>]!\_P!P MNJ^/53=].VD]MK8)X=&.O;*A4W=4#.%Q,9QNB]LC;TYJTK8%V*$EV>8 )6E( M=E>[WZV' R.R+5K&FXX&7VS84*K.*C=&YC*D,[DS-%&4YZ=S=IVEF3N#VL1) M3W5S.#L"=, 0CCA:WH =^F\#"&;J'G"15M-+C8;VJ5XJ>NGF01Z=V2VSZ,K( M1$GV++2VZ0-#])B'$;0W.#8N.+*&48;H>QFEZ#H7R ]P=&D[&Y065U'K;#T? M2J2M)9)@PF/31UL>*LK$Z379FRC(:2K>'-#H$M2"T+:AL,T!:F" 0C2@!"+> M@DZK+@E\%D#;)H\L7,;DI:'=(G=6E0J1FJ&YR1 MF$FAT/U",&_^SU# ;,ZOYKIFP(355K7A6U?V+8REJ1PJ'RJ4-S2]/ZI^/&TX9JND4/Z2J:2L-UV0OI^IWAFE:)TGK MHW8=^[6MZ_7 KSU+W XQQFHZ3^J5Y%Z)2NJ=X?GV*@GTU;(C)X M\S$M;PT C<]9CG=*<+3F2<5],_1Q98_4OWA/"KOSD)+;=B45NZF97;%5M#^\ M32'-3!,WI8DW%6%/*)+'F1,,>5!6*XVRJ'"0$$:$(:+6@#]H5#K MSR71;I>0<3V!1-R43!:@M=OZ#F-TT]<#B<#J-YAE;0V4*(XJK"!,"M<+X6=X MBZUQ?#S-C"4B(" G9Q@#R-A>"(=I\I3V*51.(=?5=2")WG,G6NZC>T#V 22> M3IB2O"U]B;%HPLL\U]8TD>7&+4XP ,2!1G?+H'QB] _%%]J\K]+RZ:P.B[KB M%B2^OR4ZZ1L+4)S1K1,BH_:1-*XW^9;FTJ;P<];_ -.!]9!.#,)1O16E/R;T M'86BP*H3KN?D6L[SCW-,\OZOHQ>,H''D[57[DY'A<0KY>L)00YG>'$E*:Q1M M^F:H\(69O<525:[:]PDA1P0BWH,,2^2O@I?:[!1C?U73[C;DGM*1TJT0)ND@ M'!^,M&*"T4\1!<2C)/)9EOW-_52&K1ITKBN]4J0T]1K96!5_J'R:P^'=3Y)HE836O:J]8IQ"5[:5MX:S37 M1S3%K"=FI4X="$,-P6!HUMSRF+>7>?>\+]L2R*'OU/5?48K,))P+]<1SN\;-KJ03N MV+2I2YX?(Y*!72EATY )O5XGB%IVA W2%+-85-7Z3&MKVSV&B=DJ8U*M-)5M MQ1!^]!$9Z8&7= =JRA!'L,6E/ER M\;,)LA?4DM[ J2/V T3X=8O#(YKGA.0RS0I(G6'MST^B9]QUH0)0J0%'.2E6 M4V$J_5,-0%0$16@RAE\GG \E@[]94?;MC/" 8@K-A+'L(5%\D'DJ'6'.U^R7C2U8"X7;RC MT-SQ5G045F%?R9X415%;5CLL3&PDI7D<50EKGM&YB4)'9/\ E4!B5,>$G_5$ M6>2%W7CR%\<,-SJ>?G*[&H%J(I>.O%S*DC$[-D665^@G M_P"SFL]PTR'.@'3:<&MZ(]1!T(**$^5JN.EZ^HN6\[WI%.?#IOW\S\\MIUXU ME.GY#T%!8M-'9EDL8JO2.,IR2Y!:# !&I0K!J$VHT:?HET-3'A&2(+NMWD;X MQ=H7[J71!LDW1Q -DFZ %L=;]?UU@47Z7[SK/F>_. M7>=Y3&;$>I7U#(Y,RM#W%X'.)$Q0YLC\5?W@+RM51V)/Y$A<5;ZV)D(FI$,2 MQ"E5"0(X85(\=OD5:Y@I5))ID9Q0IF?#XC'-KPMZI<2Y*4^]' *, , Q!=BJO(%R!=UJH*4JZYF^ M56*]-L\>8RUDQ2?-;--6:L'\$6G[Q )J]Q1L@]@-,6D _JJE+*Y+R FZ%[1" MT$6]!<0XXI.4:>>:60006,XXXX82RB2BP[&8::8/80%EE@#O8A;WK6M:]=X& MBX/DQ9[)\@%,M]5WI)$G&Z+EWI&\+=1R.@7N*1"1L=.Z0HVBZH1<$PBZ5VG5 M7."B0K2A&L&Q) K(T7L)II:WVF!)-R^;'D^ 4-=%L0A':LVEE95]%; CU=.= M-VM$7*7Q>U6YV%2=GB,>8>2>TT-83XWEI/W>85^/0B4%!.T$XY.2<$]R3R:\ MTU@@BA-T.\I@4BW7%=6'@)*GC $]0)GZ1K!)F[< M@ WG*2 ?;$66D]3]!L+3J"%9!"I*<4I3*22U"=008 X@\@X 3"3B3BQ"+-*- M+%H01!WL(M;]=;],"B-R>2GDRB)Q*81/YG("RZY>J^CEP3N/0B42BKJ0?K3< M -T$:+DL-C;EL;KYP>QG%'"+7' $C2GDGJOA*-+&(/C"_)=RE873KYR)$Y#. MW*YXW8,CK%]1BJJP4D1:I=&80HL-6C6SM6P$11.EQNDEE$C>51:)I8F%E1G.#JZN*LW>BR$:%$ MG&8,6_Z!#_G@:%H3Y78X]=T7!/I!/[E@G"4"\]*S0CC6K7E,-GD<=#R$&UVP&*#@BT!"4'11A@2Q=?FVJ6O:"=[;AM!]#O, MU8;IHZFY+3]A5TXUQ,(0*_?Q[O7LVF) QOH4T9F,/5"5,9:/:M>XN!B= 80F M..%LH)]7^7#CQINB.TB[N]B,ST]6+$:6=I:\UX\,\#@MXSQJ9W6(TQ.7ES&E MW!U8)0X^GUEK6@-4(RAJRM#3;*-,"U]QS M=RK.IK*L1GC+E,G6#P:42MNBK/IO$Y/ZQA9ECF0V) NKLPMXC%)B;6MZ,6)] M;#ZZT/0O3 \PG%OD^659&Z'Z>ZMGG>EA2GL/GFT)PEYZC5-#N"HI+,(1*'6P MWFQ>:AQ:2.3U#HXQ0\[4;)CAR9$4LCC:[,=P, M=8RN\6[FEFZ1>H8TMW/Y]\.#7M8*N!RT^5:D0%C<\$*612Y_A]L)3ZB4(]+A M#)%O B)7YP.6TCJVM?\ #O8RG3G>DVYA)7).>W Y,7T7"Q.G_P#!,:7]PA># MK%DY3:$UN;R4IH]%JB=K-H_]7107=XZ[$@79T F,RA\4GU8HXQ!K;:X.L5UTPL,SG*^6OS&0@AI;Z<0D4J2?G$ M08I+V,.@;V+00;*_*;5<:5]?QP-76BOG_'=LT=4G^6'6-(MI(3'BD>G)&TF,"!5H*+[(! MDG )"8^?^]Z\KBJ&UA@T8[ OZ^;W[(Z[@<&HNZ':OBKM,F-93:1O]NH?S!D@ M15S!*2IYG**)1>Y;_P!(C,2IBBCU!OMV%;U_D/GLD[:Y2O.I:,Z]G;7<_COO M&=RGCHMW(9W:/O41NV(1Q._[B$OET>JEFED>41IY3*7!2K3J7!$H2E)='*51 M"88;]:*N*)]"4Q5EY07:G41MJ Q:P6 A<)&)R0M\I9TKL6U.P6]6N1$O30)2 M)*L*+.-"2J),![M^WUP*E]A>0Z&\D6!#ZLW4EG738$GJJR[S41*LC820^HZJ MJ10QIIH[,+;,Y3&55@2XK;Z :*.,05SPM*(.&$G00>NPAR4>7>KH96=NV=)Z M.NUG04CU;4W+LZ85I$')D)8[L105VK^SVE*.7:3.43@SY3Y&(7([?5T\T4]?BBNW?HY_XI(Z0BC2Q*(LBZ(:8\\K9.T)6$EV M4V(UQ>%KV=4W*I:H9@L29W(]NC3"=;/P-?\ XA/(++Q5?S-SY?C%T!8;S=%G M=306NNLIJMCTGB4SF]93ZTI8JK"0.1DN5V,"2L$$C9X?R2ID1LJ@U((A&9LL MO^T/1<,8"P#,,&$LLL(AC&,6@@ .MB$,8A;T$(0AUZ[WO\ 36L#S\R+MZ;] M&=Q>.N8U76MRQCF%UMKKR*0:STEGL"&(=9)(3S_:&G5*&GFZ2)CS&0$T@A"N M'NTCT64K"0<>#2$)@!'!F_./D3IZI>>^7)@@K'K4RGNI.O[0H8RR.C; C.FR*LK3HBL: 4^0G5*PJ]FNYVUNJ? MHR/-P;)8+"0R^GH?(%)SA"7AXKPD^)NSSH?W-)U@=$$!&'YPGBM_.17-JSD4 M?A/-MP2B)R>*W))*CE\8>(:^K9B.EF"4R-Q1SJ+D.!!M+)9ZW18>XRN?%GU5 M@C@!6B;Q_P!NP_E/^<6 RAK13.^^;+7YGJ^7\C33L>IIS)Y#$9R.RZVK #*" MQ$R>-0XXUUBCB0JD*0+!IUVG%(2S@"+ G$826:%<5/D(G]-=F]!]5]$4=>E) M5!%?%LU7TCI8=PCME+/BE%Y0]BB$N;X"T+?V'5MD)D#T4RR @@(](?41ZA6> M3H1XPW/<;=.R3JB!2"=OE8,\!:DC\VIH1(X9:#;=%9VO#W>)1^1I)Q7]DLT9 MBK:[H4;LZK&1P2;3!5-SJTJ"3M:W[?4.D[R[+1<0U1"+*5PINFQL]NNNZ3;2 M)%8K'4D*CSI8ACL!'*9[94D;79EAT1;!-.P'JSR!@T<>4#>PZ'[M!ICL'N#I M"*=V\\7K%>>;A$ZVUX[>D9W9_&;YTA'&.'(W&C+=:6YML1"^RMU_AX"4V,)3 M5B!]:4J8YZ:'!*=L(PB'Z!8RU?/+5%8P*NK:641-$U93.D*'O:I5*(C&SU*DX8S3E"@YF1&''FFF"$88 M::8+8A"%O>][WZ[WZX&78# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# _ MF_7>MZUOTWZ;]-^GKZ;_ ,-^G^/I@>4&C.:^A1H.<^8[5Y3N(B].3?)#9'5] MI=>JHNE54_:U*/\ (IY+9N_,-@@4Z=K0EM_0"6)H@=$D:=:L+$4 #AHM,E^/ M V&>#?DG_;MRTJ>;(YD0T3T"\VI?9+PZO\(A[%9CO5LLMQXGU>-;D_L!B]S4 MQE+'')O 0WJ5.M(%"01/PE[)UZAG'G!J&R[ZX,D-2U!3DKNNP));5'.K/'8F MVL"Y0THH19\;G,E?EY\B=V=&W) 16/+4@# &"-./5EI]!]IPQ:#5O8''/3\. MZKZ6L2I^2)8YTG&?(OQYV VT^R(ZZ8HKT!4]>T.;7LM*@>E;FA:FN9UE82;35UGT)Y/.(KX8Z2=8?7Y MDE9*[YLBY+1?URSB/_O%8TM!ML;>ST:5MT,YR?"$0S%9>M&%@P-@=.\C=,6^ M^=V-,9GO3'C=99+WR]776DW@314(5MRUL\TE7M:N"<<7=DLT3-#**40$UV3F MC"A6B$L+&<5L8C #!)'0_6E1]&=;TTOX;:NYZ3[&EW/4W@705CV!7Y++$)- M3E0U_ 5KWTR@4%1^2;6,$I@9O-;#?(*ANE@L.IF*!2NFW>719Z^FRHIA8+<_%S%G^,PI>D"A)2HP M$#.,/'_YQAW2#EZVY0C;5SSPG8 FLCSK3#KQ?'Y+%J:"J,YL,BZXE+,C&U1. M5"9448\O:4\IKT(:LXUO,]I6S"RM##(G:E.G4D-O">1;CJVE1T(\X\,[9C=: M$F59'IA9=$,+!#6)\E5>(5D\3LBAV6+F!4H C6*D*D\*D(A:UL1VRPZ!34?: MKRJM"0O/"]JQ45I>9[G[KQ.Q-\^I>3.4?HBG(I5KI+9<]G-4_P!-PWQQU67P MI6Y&>J,4NKEM,2,S2?Y3@_%&4!W=$^S6]]FG'T]:X8X>3NT;OG4YB5Q5P5ST MRU=)H#:T?@,WK:EDLTCQZV7.I4X2K)E+W!C,D:T2<2'6_E%I*$,]H*L>Q#[J M\.*&P.+9]7+-QX@ZEK2TY^7,JOD,:!'OX?'3T"G:@Q*\M\@1-L\>$JAR1M_P MG*BD1P!B*&8=K0 S.)^*6ZD\T[BK@Q[BT1YZ$CZ5E/CP/2N>W$NL[7[=@2MG MMR2.; !.H<8Y_%+@-S;&7981!*;9(5'HW%N67"PYC,HS5]((D:4YZ-:W31 CW16! MK9$.CQ&CP/337M,4A0;V+:% M\:=+?KJR=[W\2@L8?\,#S">13C[M:V>M>D)O$.3[.L^!.MG<"RFOE]/WW7-/ MU]8\*I.2-$CFBBX(V\3*/3.\#S9]-\7=;VCR]Y M@:V@?-[BBE7677M8671K$IL&DVHF7PV/(:$:I/,'!6GL(QIC0U2^HG)Q&G<3 M2'%0%Q3BV5L\2@!(>BZ*G+5,8CBAR:5K XGL30,S:A1M-]G?JL"C M/5G#/D?"])#P7(^;T;O9U5,R>V=\OR.(+YJ@,"V2)Q#7OY--%!F(AO(4V MAA4 T((1Z&$(4QZ$Y#\E70(_)F[CX97Q%?V=:G $TA++KHF@WHV,(N6%$;<9 M0E?G$V7,;:M$ZM+28 !J,PT)+F,M.$)Q/RJR@FI_XT[U.[D4W&3S$\N<-;?) MA&^GDLB:.G*PA-2O%($P9;63(#U#T=7B MYX2K$[[U_P \%K([4*MHBRH MIVV3)'IM>W-0$LT UD6]I@RA&I@X%7>5^$^ MJN=;>BL2L#BOG&=1"AKZN2\(?W7.>AWU2E40=]>YS+V9/&^?3'0S=?W@N2RS M;4;)5!7XEK3Z/4&%J]@#M0&[SA_HZ3]8UE.38[H4_P!!?>@YM)[!CJ^?,5>B0Q&?438]6:DA;J^D+ K$S"YRTD]0F2)U2 MXTL/H42/U$( :]H-P;UVR1[GU,MJZ'I%<,\FO6W4)6_&6 M!P3R!>P[4RV:,'\T;,5I##2QG_@A:TH]5!6P!TWC'\7MZ\D6S3@Y]SCQG#]T M"T65$W?KB 2">2NXNB8@[-JJ-PI UUZ]!0,E*/#J4H ZREQVL=?R TX4J=,G M^8X[0;W^@:P.NVAKMIA.]:C9]NU%9-8$2+:4:W3"=/H:]10MZVB*4(S%>FL; MMH_X@FE",^/VZ&'>_=H//>X<3^46PFVB8S**;Y&@"SG[@/K+BUOL-BM-1,$< MZ>+.I^,1"N)P;7+M4B-J8(>ID%?-H#V)68[E)@.*PPP.P! 4((!AGA[[P.CG M512R"T=6+I?7C@@G+I1AO1T_N20R"X*QE3&YK)%+)!+H"$2%OMQ TG$ *1F[ M01-N&D(2@-VGV (3O*_'7WA(^C[7O23->Y$_8+548I^R7NXR&S/\ :=(: M[AB.M#U48/NP\[UQ^-3KEX.\ MH-!Q1MI6;T+Y-K2B]G(;1DDO>(N^\[JE:1@:;'V^U\EC;HNL!_;V^+)%47-0 M.9"7;F028M"44(X&@NCX]>0+?YAOKOV1SIK8"JQO6W*OE-(.9,VXK0O,1G$MD/_KY<^039!8\?0+ZS_#LZ^T5 M+(0G4IU -DQY(;\Y C%( $EA7A'X9N]E5?\ 72X4=Y>@LNN==P=SIH<'Q2?.$BA8K=9((U4:I=CBPDIPD[,- %X*S\;?: M<*ZHN*VW=B\<(R@97YC2O$5 M5%1U>YK$"A&I6!=OA)/*VB&$H<2^._HZANK6WH"6BY^I6-K8%;;5=U=\N36V ME59](65.9FV/,.LYTI.9Q>-0*FI)%F5$9MP4LAZ\3LO.WK0""/0(0V[70Q3" M45%9L8K\J-G3:2P24QV+AF#@YM47 ]/C,L:T2A^7,S6].I+8E-5Z--TG3&FF M!![ ^W8O>$--_.GBYORCI-XEP*K%J)[C'CEK'H"!39X3ES(A[M$5Q-!$8;3H MM'#&T*&-?C&DK[)YBMT5Z^P'X@%# +Y0!BY7B9Z#65ZJXZ?K8JE5QCOMY3V" MQR],1,C^CXW&RK>5W:EHXI [H7"'/2IQG1NAGS%:Z&J2$"A0GVV*1B*4%!EJ M3QI]8 9XBC6712AID>\K#QB%L0R-?#\17P["YO#')5GPL7U5SW$.KN<+IYRG2=*=& M[@KV10Q0>K3B5 :')Q0C%'I(20 PD8UT6D)25R3>@P[TH2@WK>O3 U+T5X4& MJG+=XFNDZUCW^7T5 I$;U'LS;T2EZNO6QRRX*$4F\]>2&VN[EI=*=(4O/8]6,H?*P%"^N5)*VZJDLN$2:1*W)Y2G*2"]-K@B5ISB2"O8(/O M'LX 3>H\?G91?0E/= J>GJLL&8U1R[T75"V0V! ['2N$ZMGH=_43%Q?US1$K M(:T,8J2%OJ%J1,<<1*1B;6E*,))NE&R320O_ ,2\Z+N2.4**YLJ/TM*9E+L^'HM>U3H&]#5&[,V#8_[?=[ A2CR;>.RT>\ MG>'HH_,*49HB/F!K1>]B"O\ TIXH>MK47=+Q*LNL*ACE/=*V;SC>,F)L2DI),+2# M9'/T:JB*%MBB5M]C-#,;$YF&J$3LX* (0.NUH=D$FD%&G&B"JX[:8F[FBVN@9#UG.*P.ITO]^BM^5?^MRZN(_,E,E=$C+S[.)V02N=$("-O MVF[Y$1"\LXX]P.")N6_%ETG0[5P=&Y%=E(O3+R9TGTOT)-U;' IR4YSXV^VF M>-:2-Q\:-/5"6[%LM(((=_&< X-[#@@1NJ!XE4C6$C3JDYH=;UO99Q!@@BU_EO T4\_\ B8Z/H.P^7&IL[)B4@YEX MKN:RI_SW6[W0)!UCI(#:\.E\8?:TE5@-\^:&M4GCB:9+$C4M):OE"4?L\W6] ME$)@!-T2\5Y/_MTV7P#;%SZL J62RS)Q K;98(LB;M5Y4O-L-H/8W:3&3&1NARDS3L;IT=OEWL8"S"SPKK7 MGB$NB!E4S3Y'9#4JXZYEZO+Z,HJCEO/S*ZRY+$SUK1S.P!QTR0*49SD[G:=!EJUJC_2(3EE MA!@3#UM0TNZ+K5HKZ+S*OXT@!-V5]G,;MJGD%[55;$&0-SVD=:NL*NE\IAGY M*./2]Q2+OF(<2%"96VD#!O?IO U<5UX89K5IT*0P_JAB;H?".1^I^5FZ(E46 MX$MQC?U3,9)8SX[;V3VU*1N5\P45S>\JW#G*)2I60CY[<@+(BLKU?)ITXO-3Q28Z0(%4L:6- M6G4OKLCT>)P*3C$CP+:2'Q<]&3)B[E:)KVG#Y4M[@H:KZ*E3\IY=3LZZ*HJT M9W6*$RM&CC]T-S8Y/+M%)4\E")"4D2%+5"91H BTPDYX;A8(Q.L7A$/C3Z[( MGYZCT786-V>VUI-86]X<6IK2H%CFB9#W5\.:$JX\@1H$PEBH1(1:!LTST]VP MRO 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# KAR[TQ$NK MJ[?;)AD9F<2:V"T[4J1 PL1B=22 P&]Z]0& T+7IO6MX'*P& P& P& P& P& P& P& M P/F<22H)-3J"BSR#RQDGD' ":2<2:'8#"C2QZ$ PLP MZ$'>MZWK?IO _B= M.0D()2I224R9,26G3ITY8"2$Y!( EDDDDEA"64246'00A#K6@ZUK6M>F!]]X'A&8/(Y83/;-KV;S+?[D_6A:]6^1]?!Z\LRWIA*;0E5AP9^C**@ MT=RU2Y/.Z%A-CP^/-CZ.O8A&&PES4Q]K3BU'TM$>1K8Y*ZUZ$=>1H'Y9:UB4RMN8659V^?(MS[: M56%N\]I]MGLP>U#?9=+0V11U.!2YR(U>:RR!Q6-Q*L _D*T&#U[2E\[L M.#'P(V*+Y,K0RU@=H<8TN>GMQ)6NGV5R4XE<$@:0H(1W7M_,Z!'Q=4DNZ$G+ M;?/.GGBF-6BB5]EU);:DWFNN4X7=X(2CFAD'7-12%N4CTL7-)Z0E>@MKX\+8I62,JVV^C^\NFS+E4\OT3*^?YI);#I= MTK2, K::3-WDS]+W^+MR MJ0*Y4\3/6I8OD9?T1%+1N/_6?9+'HW^[6\"QV MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P&!':&H:G;'1$^-M7UVWO3=)'Z9-[PAA4:2.B"7RE.)') MY4B<"&PM6EDDC2#$4O7 &%4L+WL)HQAWZ8',8ZQK6,,C_&HW7L'CTW%_:D#>G0O"YX*!H*HY0688H#K6C-BUK ^*VJ*N@['_P!0!] ^!-;5TG5DKT\!A1"Y,K O3K28LQE*TZXM.!(6L)4@0A.*5@2E MA*T8'>AZ+#H.M^FM:P.Q2PZ(H71T>T45CB-Z?'-&]O3NE8VQ.Z/#RWMH&9 [ M.C@4E K<'-"T%!2DJ#1C-*3!T4$6@:T' XZR"0=P0IFM?#8HN;$3XDDZ-N61 MUH4H4DD;SPJ4$A3)#D8TY#XB4@T82K '2@L>M""/6]>N!VA4>8" MX"6-H) MTGGJFH!3:B+"V*5/R?94MX0$ZTC/4?*/WC+]HA^[?KO?KO Z=\@T;?&67,HD M0F<,W:')FD#M&#S8S)%!#HC4HCU:>1L@D3RB=B"U8QIU91P5"C"QA'K6\ M#K:JJR"4G7L6JNLF$J-0:&MXFU@9BU2Y=M,2YJ5CBX+E[BL.4*% M!YIAQYYHQC%L0M[P)!P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/D2>2H!\JFTH#L9&U!01;,)^8 =[![M:]VM>NO7 _*98C6?/]16F M5?54&)%7UCRC_K*R?3YDI_Q"%\*@KW:]P!>@@^OZZP.3@,!@,!@,#BIUR)68 MJ)2K$JDY"=]=:4G4%'&(U&P!,T0J 6,0DYWQBT+VCUH7IO6_3TP"U>,LHOW&"T'7KO7KO>M8'( ,!@ F%B",L80 MC , M" , M:$$01!WL(@B#OUUO7Z;U@?K 8# 8# 8# 8# CNQ;#"AZ3I"/>>;[!>T.]: MW@?FS;@JJEV9HD5NV-"JS8G^4L4(8W>\3&4*1)(Y%FM4[JDA*Y_?% M(! 2I"MB//$'?M#OTWZ!G:]@A#K>]_I@835UL5E=T'9K,IV?Q&SZ\D7WOP,V@K^VR>+O' MXU>I:G#\:]M"A4WK/I.2(X@WXS!>PTH0=^F];U@2#@1;5-W5!>;=)WBG+)AM MFM,+FCW74J3I03[MB*$/VB]!:WK0 M2E@1L;<54D6JEHPZQ885,"4:=SH\4YEB3 MB5A*V2$[7LV+U_3 DG B=YO:G(]<,-Y]>[(B;;=EA1>03:%5@J=B 3&1Q**C M"4_R%N9];VH&UMQFQ:$:+00CV6;[/=\1GL#D+[KJ1KMEBH=PL6(I;HDT673A MAJ\UZ1_O=TAC:H4)%\K31[1FW'<=2K$IA UFP:3Z/#\?N]_H'82A@,!@=<\/ M#3'FAU?W]S0,K$QMJYX>GEU5D-[6TM+8F-6N+FY+U1A25$@0(R!FG'&""666 M#8A;UK6]X$ D3*[Z5I$Q0E*IJ."> 1(C2Q%BUOW8$NX# 8# 8# M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%#O(3 M-;(9JEKBJZD=9#%YUU!T%5/.":>Q50G2/]<1*9K'22VI-VA2>E6#2.[54L*? M2T*DD'V$*X\E46( B?>$*6=%>5%;RRNO*(T]S:7:]/\ #7=S3JE0SEGP%+32!FB"=*WE<^I3R M>S>@5ZA]!)R MDB5(6[EJ#R2@"6*= #:A@,!@>??N?J7H@Z\?(=S-(D5,#/@U&F)W*-I4A (E*Y'84@: ME!1(EKB).W..C50_F",K0;(N%.UKLZ=E5P0>Z.5)G12VMBHN\QRPBVVT@U-8 M;/+OR(@L#$ZW)4](S;]^PL2'1+RFTQC1>X6C25&RQ T(*>=#>6WJ"G+V[*K6 M&\$HK6@G#317-F7),&3HAC;I2KHR<1U[E.YG%H0Y09/MRDI3 UC5B:=+!?4 MC4 ,.,V,D>P^+SYP#6)?U;+3>2Y*_<\5<(]ZR%BY>DG/E@ M5/14>L")76O*N1JK4^!V:2%HE!4"DMCTO6#VX="4^2Z:V!"!$%E7J :6I7'1 M "PFA&5*=<@X&!(ZJY_XO>Y]T &@*:Z+ZTK6KIYT_;,.=7V1M2I+74LW]K078E7F#L^OYGU>MG7&#VRT+QU& M*_G=R6:"UFTN51^-6I3H;.K]@_CI^B4>5KK/=71S;6IV92EGQQTU2(9ZH\&@ MBV&$OWF1Z0BM/7'8SGP')W157C;2$PC#T2^VQ7M42V+WA.F>O4L01SB[J K% M*3;2-CI[%: 1:'[(#R3- MAWEH>3V\J>U6=+V'S&V1OKZR93?:%LAZ1\M*Q:L55M0Y3(L-NN.G5#4%@7,_ MPJR"Y,A1LQ8HJD$F6Z5[<3DA:77SA$>'>P] M NM[]=ZW_AZ?X;U@>?F[[9GT93^@(135[57!85)+$M]XN>:*GJX(FOY MEL%WBUKQ?3.P.:6 SB"1)I2D,K066G(VN).VI4@WHL\07-\8_,E<;V,2@BT39+);8%) M*BMN8*X>XQF;6C!$#\B<7!9$%.V%4K^=K+/(/(&?H+01_P E_;SP_7Q4P>5J M7<+^B_'M7=U41"&"UI8XLD_IZ0OJ..S6OIH\[B0#H_<@E"1:-&1:];A62<:RGT"5S M]?R"*/L47/4*31>Q4A.^,DX(MG@V$+K=$6D]4E1%R7!'H0ILAZJZM9E/FV!I M'UEBY\J4Q5A6O0&?]QR)2D8V(E5I'O1JM2/19!6A#]!;UH.P\ZK%YU.D1\P= M;6WNI^<;'F_,4XXW#MRA#W;$1JN5USUD%(B"-B%+FUSDTADL*DXQ-_Y!.,B/ MNR4S\B@/4IBR@+ L@X^5GJ*O9ITISM;U,\^MG5<8OSE*DN>(M$+!FCC5#A_N M^87IXAR)G8%QK3!"XXX;<1($38L=C4NDJ5&08H(,$&4^'9GE[%T%Y@6 MV?DPTJ;![N0K9297A+PCA+@].]+P5W6/,>:W]ZD;RR)WL2[2HU"H7*3$JDTP MOW[#H.!KS\F%J]*V<=Y\:4LN:P*1<[T!R;S^ZQ"!$QF0I5T<+)@,BC) MQTF6-94P(<@^LD<5))OWQMK=I"2B+*&'86#'Y6>HN58O8U,VG3E)3&Q8CS)Q MO8O*C163Y.@I) U=&VHCYYC#9=+K*-I$VGF'/RQL5N06;ZQ2X C2TH@Z%\Q( M;AN+;:ZTM%NMXGJNCVRJC8=9![#4TR9TAL61W-7P&Y/H!>I=?'MYLB3M"8]6=L!>RAC"+ZZ\D_E%LM M#S3+$]9\21J+]"='WAQ>VD'.MN/"XFVJV-M@Y'E_;YYH MGE:+7SB.3 5$!3A)-<^2+K6XD?)W+\;W1L,Z\OF8]HQZ7W4]P^4O])L<:XBM M*0UO))#%JL*FC%)WB4V>N:$WU6DY\*3M24Y2J$I.V26G&'*YG\G745\7IS_2 MMBMCSYF@-E3_(6I-7""R/@^\B73'9TIOBN>H;'A#W9M,5[3HK)J172#GSC=M%7H[N4 M_0V] ))!762R8FPJT;S&YITP2] -(6JW\Q*I(0=L'R!T7<7DFZ_Y)NOM&B%# MU7:B9'TQ5]Y>.0E-2,C?3+55O5A"KZE#D\V32)V0$IE*#ZNRVT!R M\PG7MV1H*(]@=979W;SQ5E^PN70QPI3?7WBFB]*-+Y"TI#=&NN7 (YA?9[FZ MM)R>6N<.B3U,&5F6(MJ1C^T2O)3G@^+>QA8^\^S.O4G-D^;;>78_+Y M2?+3^-366P8"Z0O MMKFATHE+636R/D*/.M[JN9-$Y,LHUX<7YY>C)5"5("F]$B;6E*UDE$C 8>,1 M^!>#RX.EL)[O\448K^YYE6+#8O>L4BLI:HPWQ=4E=E+?!IC*6)[L?-\^YS M,J)C.%(AW;6%4ER>Q4-F$NR)[C\@;EZE,H1HDR8"(Y06<8KV=L\7H%H.%^H^ M[>K)_2_21TTJB/A8A-Z@F#]6*F11E7&Y!-V:H8?3[I#(V@G[E:C&E@ M>ULK;I.J&4-"K.4) Z^+X4P9SW/#[;EODAXD9J$M6'TG9\KY;[=B_P#)4E@Z M.Q'.,QK\OSLY*G.'Q(^2,2=XEZ->45M'^4 >SIBAJ#32SC-%DC"K% =S=K]< MF\0\W1V]X32%S6KQ7=/3]HW@74\2?C9[*8/:SW2,#B4*@4G+<(JA;-O+>*02 M@I,5M:6@)**2F)@G"&$(>0=IR65] ^+7LRVX=%G.?M/C\\H#S:A3"T; 2HE' M.A30FF;E7HCE1BAH(E#Y6:WZ.C1CV6VNII6P $:+VAU&NE;]BU@\9>1JY[#9 M[S=7_P 5W>_6,A+EA1 M[>:J"/WJQIB0Z5;W5Y;8OS+;71;%4!7V5T M.G::P54^ZVE++^I?G> 25GY^GM@2]4F@K1V#03Z?*[+(YBB# ;^)!*8ZI0.@ MUJ-6O4_.:DVC"&T#R>=86ARKQFS6=5;M$4EA6#9] TTAGZ] !WC4*U= M\66U,CB8! ]"CB%T.6MR5>8%&,W1>U/O*",L8:@^X[7Z".J/S3\(SVY[@GT6 MYKY.@_0-E MA?UP[&&[JD6R.<\^/]@L F6/DR+2R0WM9;1&A>A<1I\I9&)%9:V M3; MJ31JOVL!9!("MJE&FE+HDLX\P6S3 \Z8/('Y%8]2W8*93T;+D\Q@/C:AO<$2 ML:;5I3"M;(WUPL]T:54IJR%M4?1&UK2EP0/X1Q]GE1*R4LA8"U:DLD\P:<07 M6J*;^16[)QV)S S]HO\ JSW/A_E7K"B;/%5=9L&Z]MNU$LK5.M?-[2&*;8SJ MG?5<>3(C@*!NCBE",PX*[1GR$;"TWBPZCO3N)]%>DBD]@-%4UASM5=#3V R1 MK@J)HD_;C8N=G3I&4IAQ^,H7,H4# G:VG11:LM!L]>?H"4L1/Z!@74M\='VW MV!UQSO3W:D!XK4\;$*#)&6+NS)9[E.%RJ3SJD8CF]:0I>M+5"D00DDX%:+\Z!FE8RGREV54EZI*AD5A]">+V+L=B1B"BGDA ME*&S^>*M1CB]1LCTE6Q]LF]BI%WU&5PD.@,[;M1\RTPH -F!#IBNM/("X0#I>JY[7L+L/G)P[S,H*IJ^BSP2UTL Z .517A+JED,J"Z2I M(UM)RU6B* WICO:,:D(1_+^_.AD@.<[G7]GV4\\Z>:9 G=K4K-'>3&'\2W.+(Z$)6IP3G&(DRO1@2]!N@\FE\V15C7 MR94=<2]YJ8WKKK6O.=)=>;*WLZESJN&2%GDL@=SHRX20E9'&.?S0V/DLK*K6 MI5H"#5AIA1 U("-Z#499G2/D19+(M;CR%==.S&^4;Y(^0.?8?T'(:UK>5RV? M5#V-!WZ9)XW:"8V$M$5=)/3P49.RE+0C;A.@5)12P/IH"@8>ENDHC8T"JF$0 MZV[3-NZQHZSA;93:ZB(L\$4SA:2I4;(>E<2CYQ[*S+!H!%%G 3"^,PTL1FM: M]^]:"4\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@4R[LJB?V?236[5$Q-LXR['H$)4I?Z@G#7)'B'(G=Q3*4S( M\3>#A=F5&K%LDHM2X T<:6G$:/0>;+HFBNM[,\A?071T:IGIZ*3QZD]6._-$ M0E'#]<]"4=+ 06GV,JIY+8ENO%I0&-U*[1BP%KB8>F=BE:B*J=:/T P&!J]Z5\:1/0%V7%<;9T58U>)^@^5W' MDJWZ^!&(3-(H]5\,4B.9%D7-D+4ME=9WUU@^KFR-QMD?;F51A$GB<5B MR906C;FB/PME8FE8^.BM88/4OD:\H2 4 MNNSG+FJ]*TYVJ"=24=#@(*Z!A47KN2PFQ(Y4EKS@U(3$W!N6N!J?\LA:WA,K M;UHC"=;W\1Q87<:O$K1GR]RQZ72>1RJH.Y8/4E>R>IBFMACK964HP""+WGQ#2Z=\^VS0]Q]_]-7*"S*Q M2T2URZ\#[0Z-HBU6BA87SK*VK$7^\Z*6)8DVM:D>T8G X3+:9D)*) M&WPYBK&)$0"%*&"82)8FC+H'!E?V.#RQM M[3[ 8^O(7+':4_[T]SIH=K:>$LCCK;%I' CHNL9@5HUUBN9V5&$IC1-2=,4> MGT>9LXXP\9H?V\/#T@O:'LU3S#L#H%YI,V&0Z-6)74Y;*WM)1/I,PV!(+#E= MLM\RL"+/5J=O"IY_U>ILFTIE M/JOG]V?N_G^,SIZ:']RK.%J(VW)7>*QU4UIBQM%>IW8D)+(UJCE"M*G2B/.$ M$Y48#05XL#QJ2V<2#O5Z([#M"/$=\QR)PJ;MJ.M:>7!K^%1-K61%-'86K71< M9Z@M;7#NO835*_2A7\2O[6C-+"RS@AG<[D=EM":GU=*ODX5 MH6*)2=_BBF-*8<$_:>+($3,U.J:-G@( Q;V&I-E\#,;88L7 M%T'<_5Q*4?*:_BA:$M)304!G-YK\C4MM>-K2.N#4C$D0Q?2Q"H5)O8N<5RS; MDH.&H+"'860F_)#]R+(%_;'/;'>'7W1\"Y>K7D>.4A(;"J* L]@U3&9XQKRE M:AX250SI$$T8]'*'0Q4$U,G5[)&5LL 1:]H8' ^$+DBGCDNVH*Q;4W*W4'3- MI6#=\C%1=I"B(:HFMGVX5*4;*AMM%&9,L6,L#@B5"T+S6QM"-:O:S/I ^F'AZD0I?"(L[5K,N?#1F5#.Z=<837,;7PF30\"E447O9J MM&H)6GA/(-]P=A"Q''W!-9\9R*\YG#;(O.SIGT9+&6;VI)[HGJ25*WN4,;(4 MPDO:=L8X]%8ZA=5R$D(52H"+[*@("RQ&?"226 (AZ0\3/._2\XZ9GTDGW0$% M<^N:FA-07^<99;[_),2@DLOB<03M0D"1PFK:G ME7J%.U:PA-H1: Y$$PWWAEM=^*7FRKT%0-T4E-[$IZ3Z*F?540 MM)4M+579 M8*<:672:1IC&K2-Z1NZ=>Y@V@&6%$4%Z7Z++!H[7L#])?%+S,V11@C[(_P!Y ML<@A5\6+T96MI-MLO&K5JVQ;@,/';15?R]4E5#8X?97W56WAE$2PVXAS.Q2UQ=JR"4VDS/ M)$MESE;6G([]R&KU!QCE[]:%L(0AUH,,JWQ"OU>//0;)NJ:ZM^L* M[:#+\L!R9(=&;U*6N*.1&)](EZ-.>G"6, MC#%V_P ME<'H8=5D$.C=J.4UE+!F%HE9OR:"/8"_:$\\8>./GWAM9+'ZM'BY;'GDQC<-@;C:'0]NRV[K'; MZRKPA45!:HCTO1863G'/M,659]0W- M.Z\CTGL^A5$L5U%,'1.8?&9QT_4U%.?EM;.:*HX5=\DZ*CL2BLYFL! AMR12N3S4N4_EH"^QA\ M,-C4AEB@]G+VI^-O^%-HO7_3$["&+3SQ/\764MFBZ7Q*S5XK*NI@Z#L=*FO^ M\6MMG%K1%"K00R3O;6US](WE*X>4,_AUZO M9=TJY\_QE5E[/;?#K/E&B_P!P MR8M(^60XD/ W<7V!')G *I&,;BO%\7N<%NSPG?HGE>ANK8]$XS?$")FK= YN MSV/"E1+Y)8K((G-6(M4G0/L>E4.>(_)FA0)&N.3G@(5@*5)C1E'!,+%L.!7] M/XNN)DA*8A/5LC**3='I>MQ:U<]WB&MZ$;P(BFJPW8T=BB-=U3.0@++1HE0C M6U(7[@E)P:&/0@D:N^"N1ZGO.8](U_2T?CMQ3M^?)8_28EQD:Q 5+I0D$WRN M81Z(.+TLAD0ETK;QB3NCHTMZ)>X)Q"*/-,+$(.PRJ=\B<^V5;R*^YE!5#G<+ M1!'.M8]/TTPG+,^16'/25^1O39$A,DD;DL7/>"9$HVJ5H"DZQ086F,,-$-&D M$2$;+?'-QNH@E75RV4\5#X]2B28-M4JZ[FMB5S,((RV&8K-L".L%@P>6L,\2 MQF=#7G;>&W;D)"X['O9Y0]ZUO09JT<2:6X%#3F?D-"UM1LT00[T& 53XTN%:1F**>U M=S;!(I)FM+.&QD4IQOR]MCS#91"I/.HI&HX[O+A&X["Y*6N.^PRHDA#7L1@A M!3A%OUP,:B?B@\=$&C%EPR)\E52R1JWPE)K":T;>YA"^,Q+@@=]1,I4)T$N9 M8,:[MA"LYB0&I6<]47HTQ,,S^[ D&PO'QQI:RUK<;$H:+2Q:TUI'*;)4.CA) MQ#7U7$35Q\=@,A^!^)#*HPV'.:D84KGI66,1YFQZ%[Q>H3_:--51=E:OU.6U M7L2L*K).V)V=]@4I94;I&7!N1FIU"!.-L/+V05MN4I"34HR] ,3'% ,*$ 8 MBT$!J?'UQFMJB0T@KH"&*:NE[DUNLPBYQKZ9J8*6-O4M#(3+GD3QN02AK9FE M88D2(5ZM0B3)A?$64$O6@Z"QR>LZ_35NGIXN'Q\=6IH637)<"4MJ=9%Q04AE M#'"XH>TJPGIE3)^"!I((@W0P#(_M%ZZWO I(3XDO&PG0'MI/&]+EI5<15P%7 ML+"ITJ5PQY].GED MB*58O31MD,?W\TI$D :9LM*47\@AF[,&(.KNSB?DCI"9PZQ+YYVJ:V)O M * MBTGFT.:GIV0(RU7WBVE2I4$[V\L1:WU."WKM*46C1"'HKW"%O88Y)O'[QA-" M[I*F'.U=RHOH=Z8I'6*=)D,%CL(BD3,#%4WXEF M8*T,5**];R(UL6XR=J$K5QRIK--1F'(5AHE)0P'[V9@6(MZF*GOV#.E9W77< M1M" O(TYSA%9HR(GUH,5HQ[-0.)"=:49M$[-I^_E2JR-EJ4INM&%& 'K0M!# M"GA+D%9"&"N%= P)5"HU,C+':F%0B6'$;L@;60REV.Z*3%HE[_8:%K2E$I'U M>:I=482@;(4%[ '>@MI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@, M"FS;Y".*WATF[.W]'UJ-77,2D4]EYZET4H6E!"HG*$4(D,J0ORY&F8Y Q-LR MN.L;^KQ@MBG9FSV!74HVZ!8)8PC M/&V.(V-X<(\\$E_:)3*2E#6^M2E(>686 91Y P"UK8=X&L3L;R85M_!/3\7Y M*O(AHZ=KWGF]KLJ^1.E+S>55U)F[G?9H[(70B62*/-536,A;7)O.93%;>[.2 M5&XFZ$(I3\6R!AF]">6CC6N+6Z-5.48E$40LR62MS>U M.,LBB54V'H)O%'&>C-;$:F+JGU ?DF>G?B:Q+I\>=GD MALVH>C*!J:QF:74[(B9NT?R=,(.U&P[=;VI'V)W:G^2--@MBA$I/;% 3DY@P MI]?+O1A06_YEN>W)_P!O^1JJ9M.TDAK:A7_FAJJ.*((BSQ\$026-3HYO+2G- MZ+(.D,J=5CV:'>U"A6)* H(0D$%?W^H09U[WT5Q]Y ^=(1;5W,,7YJM#FR\I M,^5HWUHY3&Q%-I023P0J(O3:?#V^56$\I']C?'0M.VH&THD'X=8><8<$._K! M+\A\MO D>K2OK=_G4N20&RX:]V/'W>"P"RIRH;ZYBSZ;&)9/9FS16).KS HK M%9 G-1KU3RG1:(5$&%>@C"Q!T%Z";.KT^M 7(5,XZ950X1_)0;!"YIOVIN Z M8MR;/1/#9C.Y-T3(KCIALL2^5$7O.NZ&?XZV5M9,0W$I'/G"/*&YWG Y)#DSU&6!\B M3L;^Y%Y($2$)AIF]@#K;#\E[+SX=Y*[K5VA(^F(IST^<]L$6Y6BU& M3^O)W0LKG,4,9AL<\FD@@B8Y?'K*E98'+;N84L3,A.MD[U\YY"8T/[ O(#+8 M]WIU"AO>U 0'C>"\%4'UJT,%F5XAKM\I=SL)^6L$A9I4N7L#18:QV,,9A: U M.A6G#2]7]4E-LS10-A:UF\IO%#Y#)Y,4UH/:0VMYC :]D]?N]7V@S7#J:G,I:2QBO4D%KF4H8#*X(O0H)"@D\$>I2N:5QKJ$2\\]((P M>]!$ (0*O*S1K#UQTIS5.F.;UY%.6*LCU@VE>,QALN9J\8E#JGD[PNT[/"IC M+;&:*"86A"!C=3U'LE3JX?3:BU(R=B&%CN>.W*.Z8EDHKZ"F6!&[&B$5B]@. M]>VM6,WJV8#K>442(X\!1'M-$'31;RC<=2ZY&>ET$\?VUPE#G/H]"K$E,"EL1IF=RZJF M3)#!68HTYP+"8$@O:P37WF65RFRH&=/I+18AK A3""R3QY6N5F%;VB@=";A2*."!M!7 M08#:AE@#$9TC>C62,$P@@9(%4\%*!E_:;A-Y9A:Q",!Y0A ,![@[_P#]T#D@ M-SM5*'2R3D.CG9TOB*-/+#O\ 48=;"K5A^5CDFH55OH;7<;0KU72-Y5[S MU-2'ZH9RI$.P+4:58I*8XB&N1.I8M)5)6P%E"&H, 0(.'$O M+5QO,ZZ>YVUR&Q4;ZQ7@BYK/I)]J:;%A-\L MI:TU35D^AT897QRB\P7A1_\ IB,WW&O6C2]M^E6M[V$+-\O=25+U[6)MKTZN M?S6)!,9A7DC9)A&7>%3:&3R!/)S%+(=,X@_$)GB.2)G6E:V8F4 "/11I8_Z# MU@:;NU/)M:\DAOENH^E(1>E!6%PM44:EL/OIDC,3?E#K(OK*):XJG!OE*=TC M$8ATG8T9&V@X_9SDXL@G!<440:002,+DUWY;.2E5?V*Z6%*;&KU_H>NJEF%@ M-UIU'/())I@T6PM#$X#+*QC;NQI'>Q6.PYJ5I"UJ6Q,,I2H5$>F@EFA%@6:Y M+[7I7LIIGY]6'25IE-2R5OA]KUU-V25V94T@;&UZ+;G![CSB2X-2G1 MA"QK<%Z$[V&! =L18]:#!Y7Y#Z/B5J]04HN8K/,LGDV@5_2MB,0HDD:T\AJQ M&C4JR7:NGE^>VEGE9B\2%00#>CB$Y*@@0%!I.]@]P0K)/,3RO%D(7QQC%_G1 M*,U]6=E7U,FZH'5?'^4X_<+*\2]%B)7[A3NJML0"TK7 M3IA -$%-G/OY?R_W)Y.;3LFY+5O?D6B^9>1+>:JVBI\$D9U?'71(%Y:MSK&. M$BAHGF'D1YV1NJMR&J6&[1GA 8I/&!,0$+K7=Y;:!Y_%?I\]K3H$QFYXB_/4 M]ETACL$87UJ>J]Z65N3; 9W&PIIF%QW'D#PSJD+I]].A5)UQ7PEDG#&7[P@[ MH'S.L<'I7J*3U-SA>#C<_-3K5":0U?;D78J^<4\&NIQ"A@%[J6)7.")&Z5.\ MF!$04!* #WIP,*3JDB,.SCR E^1>7RBH98)D#G%.]&PM/'[$YYJ"U)O(XA!4 MD.IFUNF6TESKN#3Q019*EZ6+$8%));LN843TTH#3@:VK'H6A8$837SDT5"TE MT.)G+7=+^T<[S*U(5=+\QT*WBCE>KZD)0KGU8_2)SG+:R%)'1D7A<418#QJM MH?0T\DCY2=&!?ND>QJVO^T9%5U?LDZ3O%VFHTT<60$EEOMM4>:6: 6PCCI'R%5QSK/956">JKQO.=5U2#E MT9:C#1\5CCX;65/H5ZQL1223*Y?,(4A5N,C5-#A^,:&PUP=U93:I,"FT67H0 M@@1#YEN?)1<%;T]5U+=67.MM>K*EN^%3.JZB12:$KJBMQ^9XPCL1H3;Y++.CM3T#$9)+I=U%7\<6]!T-''&<< MG:8 3=@.?;!:T;.1.%4B5)DB&GY2^"3,LA,+T:>).Y *+#[C/<$*QV?YIZ[J MJW;1K>1"R/0ENJ>!J;2.8TD:GR]X.F1C@MC3@=)VU0F M3ITPUY[:N*4B*)]VB]AFIGEGBI";M%N4\Y7&FLGCWH"HN>-5"7-)[Y ME[7$*B?*_3!DXVQ/&YN<\%+$9ZQ0#Y$6C!ZUL11@0AV)_EEK5%/XND<*6MDB M@IAU$KXM8NG4:ROGR *^CT;THC&XZ7&V&7N4V-@:F6H53.3)0(Q(QN20X&RP MD@T>(*T.G,,;U7\]17!>O\W>9+J+CN+3213U/)Y# OO61)%$36R17*W M#BXQ)B9V!6'X&X/HC)(T$LG0=ZU@9XL\U#!J,UZX1_DF\)E,+([7N;A1B@,< ME%3:(JEOWJ;H/GN[H79\Q@R:?QV8\[(I8URZMV8YLBI"!Z$_!7 M"+$4W_1)*&-1[\"2ZW\R [%Z,?>=T-M;:CMQ)PDC@%(X%;+,-$0$>_:$6P3S=V;,:.J7J%TX(E<#Y MRM.^J7I5/9TJO6)"2MS9;4X?ZV<;*"D8X>[IM1FOIM'3&]S*<534?\JI*+7H M!0$6!M@Y;Z-?NC_Y[<%E8&P**5-T7:-%064[E9$F0W TU:Z@CKQ8C.24R,XV M1L,DY"QMVF$)7H*MO/T!0:$.A[#13YB.LIW>-$VQ"JVK!U9J6Y^\@7*U"3.^ M!6\[0U_D5DI;%@JF?QJ-5>Q1X)\I@;0.6I6)>J<'U*$U8H&>0A/+3 /T$J*? M('3?'<_\KUPH*.L$E]@O8G-M56O);$OYZ>8 N=K&B3/'V"TG(&HY+&7G6AXD MQFZ.4:;D[TY'*#_:>B(WM,2 )AL[S!32MVNAT!_.%8J)_?\ #^B9E7B)WZZB M,;J>R2:2FK5&8;'*B31A4BT7@9',_+TX MPYALZY!\OOKGRYSU=U?<[]&6VBL]E,EU=V5(4T8)LQ6RUB1&5)PKT=T03P3>?EYO*'P!5;,9#U%PH.1QQTMAZ:?QZ M+H*J(4V.DGA[B\M,Y1"()G$^(5!:"0-Z'Z9YNR3BPD$DC#M>Y_+-T%7$7[4B M-#5+"XO/N2^HN3J'#1)GL(7%*UJD2X\XE" M!8ZM[0]LZIH3FA M5*!*"#QI0B&$+S<1=J6%TM/>F*8NJ@%//=R\T2&N_P!PQQ/.FRQHZ]PBZ(RO MG-8/#=)FUM:21OH(TDV0\IBBST:=P (*=4H!Z_&$==2=[W)7W0DNYSY>H:(W MC-Z1YXWU1?"6<64NKH6JV5/#JSQR"U0%FB,V.D5L2HR/+S""W,IM:4X $:&I M&(_VEAK=N*VK&\E777CTC;%6\-E7$O1O*MFWZUP6P+)LN O8&IS*K.*3R=3M MCAT6&F*M^GD$ MM:UU1S>/E_3$E=DK8:SN8#=JMC3A ,P-SU=/MV2&DF!_L2 0RN[\<(6MJ M-W""K_;Q 5#CV%3G8LN_F+"4>&/)]8G3%PU%55N4?$*V#TCQVQ]E4<\P"R%E@:!!RGEGB,LCEFI MW&+QE/'Y**0.P538%K/=D^V_^Q2:6I"(&!*7DE[QG_%""N1PF"5J\@FL=N.2 M+9A<,X>X?"TR^JXJW2!FK%A2Q".2V72.R[/.<3--A)*+ZB5&V+5*DS0"O3 I M(Y^8WI^51Q9+Z?XYKTR+%>.*#^1-(]V5?)[4$Z%K"%ZFQ8J:VQ>"OKD!V8UC M*N:FG6B]Z7JRBU)XDJ4W^P):'2" M8QD$*ECY&&)XDL.+O76]^F_TWK]/76\#QI.'C"[>M.&6W#ZMHJ;T!#RZVA$]1T%T-9U:S:G2;IC M73$9N1YH+EJ<1EUFEMP3F6RV%D5N3RS.2MK2$2,3>7H6_@&I+"Y)W&O5#VJI M6:LOC8HZEF<':G+70ED53$;E@DSL)Q24A&9\SS.AX[Q$_P#-SG8L\BQU M:/SEQL_1]Y<:7_S^-KI0Z=DASL>C^8LYR&>/9YX]B.&&B"-^.[R$-L&O*&5]1( MZ=B%W\Z=1UE.^>9'TO7DQYI8+5OUW;X5"9KRLC,1SZQZ,A<9BSDNDTM:?N)2 MG+ZX&]&G4#T3K RGH7A[R,6FD_!Q#F:KTSK(/%W1O&EFSN86)31K9)Y7!+%B MEAV4FC4>2)78+2\.#0V.+7#GA4WB1,;TH3K?C3%%!-*#%$_CX\A?\7=EU]'N M68U $/2'2')EXPA4O[0W9%@1K^!3:I?'8Z<6)-&B1/+Y+7HJLU!:MW"H5Z32 M)>G+1(#FDH:PD-T?+U.7O ^\/(5;D_KE#':GZ)5\^.M62EMG\011>FF<8=96S%Q]V:$Z.,D)EI"EX1FIT@E(TI1 MQQGP* U!?^RYTI5UEP>TW'GGD;N=!:\"F;#>%'VI8U*4+9QPDY.A##[Q"#@>>%9X> M^PIGRQ:$ ;>2N$^=[=70BG*?_.0.<2![EU\J*ZNRM++D]R3*VED87KX9$WAF MJQ,4ABNF]8N7NCD:M7*$H4B=*(+%] >,GM2YEOD=?&R+4\Q+>H.G>&.D*G;7 M.VG)0 Q)RZ="TLOA,O7HJ]'J/.CXECYI[>K(*<$WKOV&:!OT$()(O+@7L2V& MSRU/B:M*CC4G[7KSD4^MF-HO9[?B'2P^?$:(N8('=Z=:WBVX@A?R4H$S8H $ M98!)PFF!)V:/9883T;XW.Y^T9+VL\V*STU1B3J7B#GFI6=H:;=D=MLS->7/U MRHKE:$\B(.@,+4+XJ]EJE3*-Y!LQ:A]3CP)U 3@AV'6,GC6[1B_\0WO5G,OC MJY^N*B;@I:8)*'J]UF!4-N]LA%?V/!)E)+%O$R I9(T+2B[-/419G_#.A;2I M1_:4K%B@8=X&Q;QB\[],T(L[1?.D855<)7=(=82[I:,--86D^V@G;-6,PL2& M1QQT<7NOH$87IE<8V68F/ 4/[0%8P[+)T2'Y0I/V[XL^G.F+[\BY4.=JU8J= M[BYKYP86>P7B5OJ2306VN7GM4^QB&N\!;6!6"40VP7()07%P_(I--J0SY2TZ ML\D)!@72YJYMZ5=>U#>U>CXI5U3/+5Q9#^3$E MN+&='>>K&*6$:NG3 G3J8[%@QEV0/),:U%BSS=#5HS%/W-@",'P[]X:U*>\1 M70T'>+HHY\K;A[56V%8W0E"D;.W[?#G92K_3XB2?C,#J+G\6'%9!^==J8"QDH.?+,,M.63F86ENKB9!+39TM0I6QCB MOX_Z4;)&8J$O4G&&@V%[.CO&[(+I\A'/75[!,$\4JH$:96WL"KBCDY:>ZEE' M2#^1>9R'-(F90"DZ6.6,XC.9^H[GJTJ1];4WN=S5!/9E"8@P:B2J.2-_8'8A63&GM:ZE!0[ M5%J-D@V1HC VA^1OGVUNE^69!7E'.,-06TRV)2=M0(NPCG))#7B04G<$)M=) M'']P:$ZUP:T4A_:.TFU)9!_PB-T+8-AUOT#0YVG#^N:(9+CZ:Z81\I0ZP.C_ M ")^+J74E!V2X9,=!DKC33RV1PZ%SZ7R6#QUQ+2-:-K3&KWM @.T,O[2H*$D M@D(!A;>?>/3L>9W&_=XQQ@H.O^I6_L6E+PBM' FKJ[P21TS5-)R"AG^&RZWB M*^2*T%CV$Q3MX7G.I#"H3)RR$*7V;&7M0$/JX>.GJV*KCTC5/(EQB-K1IG(99181@3_ M #'A>/QJ<\] \Z,G6K;?;%7#2=F0II++-^MM4%6,8S1;"/UV8%..P/'+TG<-E^3-GK2.4@KJ#R(\[45"SI5 M*[/G43F4$N>IMJXHFDKI'6:"29&]1))&EY3B:0F6)S5@VLI+[0_9.,T$1]/> M(3JCJBR+WG;G,J$K18_\W<>UA5(]K)+9[2LL_E^P&FV5;I/(X]P!@1GUI*WM M:Y,PDVMG+-)B"5!I!H#S4H0VG^/N@;@H^ R@^YJXY"I:2S1:Q*]U#QA6A4+K M&,FLR-NCQ7?1B(D!J%PO;E23'HI2_P!+KG5&VN!RA"=/HPV&_54_&E-; MECF3LPL2C^X*X7/XN;_6+O(_7E&6+50.?_)BB:G2=(K+7S1!-:"L1RCFX+8T MHKMLCD8?F&P65^BZ5&H1M:Y:P[3JD@$VU'UPZ'@839'A]NR?K/(3$$UI5Q': MPZPXVY^YGK9T.72J13%BDO-K"SL,4EL[CO[18&%(V2]*D.TO):W$\3<+T&4! M4(X>BPP2T_%KY$[MK_K!DLJS.)E6\JE81B1@ 0B;)+!H&$K^J:0Y M+JRJ=IE]AO1K$IYIF[1-7!/90EL.)2;C4V4_>*,$TD#<2BPI] -+]3M["OU_ M^'?R(=%V38UGV/=?#LCFMAVGSA<*.;N%86QJ358.@5K8 (BD16RC'$X@?R!+ >8&=^'SDK7*/' ML;0O3!.8_/[.=G";21KM$9)UCQ:')#C(S1U824P C#4HJLI5F8V@*,P6Q)#R MCP[" 0A T&.] \%=!NG8UE=8%H5.2V$6O M#BX@]M WJ0,I3B- :TK3D"<9 ]G!6:%[R# ZOD?Q?2+D#I>E;-AEIQN15!3_ M +$N'2HH]QA[)L)Y+CDZ5VBNLHV2D2,U@(5O0BNG9XL2J9<\2&=Q1\F#:8RU?/V&S"6="V,,DBZI,X M/$CB3>2-2,\P!2(2C6BMF"+& -:E]^)7IB]"^W]KK]HUB4]E75RK;I^TU;62 MK1P37+H6H#6S)T"BR_KNILM!&6_2I4'20TOW':W\H0I@$!>&7>.B)S#R$UUW MBKF*Y$8P5@BCMBU D2G#AMF6A!CG$FE;3>BU2TY.8Y54U3!] W@,3C-)5B0* M2C2S$HOD"LL2\1DFCCO&JD5W9%W#BJO.WQ=XUO6*:OWUNN:/3XI^?YPW54KL M\$[.8G&L$-A2,YQVH&R_F#4Q?U!': 9LPL,1?O%)U!)*D4-"CIVGF2[(EY(W M3R-5!-F:DI(J@K3,)&[O[X]0.! MU=,>&*XX"KK5VG'94?F3K5/D"EO?+!]'G=.RH7F73UD<&J<19Y*36D4/$?:>W2EYC$^N6R.6337<_0/93)*_X#0+VG MX>ET[SNQJ^'$G.QW(E:- K>#@-3D8L!\*8X6CB#3@%FZ#":;\,-OT]9==VFT M]O(G"051.^H9+$]OG+T!?'-]0]+FGEO3Q9,V%+&V;SNTD;=\"8<@6KC1:1$Z M1IB$Y&Q_('XO>A)KR7XQZ^\8[=4EH]].UV1:R.;(%.(97L5K^*5\\/25WDU: M32\-_NY6CA,9A+JI L%(2AG;&0&JG!0+?ZC/4CWO]=[P-7'0_AOE% MQN_0+/!>V;$J2D.B;XA_4DKID=3P.QTS1?L6>8L]*I-')A)UZ=W:HF_KX@B5 M*&4DDKT6D%C^T)/HQ*:&:O\ XM+5/E'2D[AW;S1A"[KX*6MTJ1WI/_ M '5R-'6EB)[A,N&MB:+JI;4SF_75.4DT?I12E7O>G6-<\/\ %?K;31]8SA5K M6_W_ "&GJ=!"7H+&6GXHV.TT]GUJNZ+LUBY=NLRA%=K\^,D8@)!/ MJA'6+MF_<*%+;+-!V4J 3\B,((:RISREA2$*WZ(S!; ,\6P MA"TF\)S]/V'K,NQ>V[#ETUZU=N;[(EDL'3M:,[!@UK^%:4 MWQ6M\I[G[/?Y_P!'W_#:I3.T M'-ZD)C@-A!A?1GC]>+3Z$_P!S MU&='S;E^VI547^WZY7.+PV(SMLM&GRW5<\M2/3?*=$&P^Q(FN=%0F:1)#C!( M]';":D4!"'6@Q*#^+J+U5?W+%PU3>%@P>'\AT:5SM6=0%,,1D#0]5DYC1JIT MEGTQD:!SF$@?)FY-2-3M82>BV@-3^I -;,'O86.[2X^C/95:Q6(N,XEU5SNK MK.B%W4I;4'VA/D-96[ C%@XO*BF9W*4,,G;RR7%0G6-JXL1"I,>,.A%&:+- M%+WGP_QJ7-J9\FG1MC/-WOO8E.]KVQ,>QX&Y# T>MOBJ:>:9'6EV1KJOKZ3P?E%TN^3U! M0L;B\ G)[5"[J/5.DUI]@1LU=*IE,F20/2HO9PU6E[WM*F*)2*T?L$:(((\= MOC")N'DKEL/<:N\I(AIVLKUK9DY1O"OHC7S=6#A<)+C!IP).YM$>;[!DS*FA MIAB>+*U3H88B2J]'EF?. OX0MU$_$3%X[%4C&[=-WC.'RON;9_RASA,IBVUH MZO7/51V6%,WRDZ. W#@)IA8*F*(B&,M]>]*SRFDG1("];$8,899S3XM(SSG= M% 747T#:4ZA&Z,"2.O?'=!>NK4K"W7.V+7J>55]7%O4TZGUHJB>]S2IKM;6]MG M,04[F<9E9,56+BVX( O+,6A>2TYQQ(5(0B#LL*P0[PQQZ&UR]UXBZ[Z#5)7' MC'?!K2N41^DO_P W^?35KRZ'M*9'JL]_=D&G!Z,T2X'FC.)2;V3_ '>H1@#" MSN1I7)+6X9X9DG.$PL'GOQZ+:ENB/=WVB]U]HN5C@,0D[1$Z?C4+:&M$[JWP M;^F94[UL&BT.FQI -G M.PI&?)'5K;/C@J-$J@ ,+ 9ZZP,I9+5KR26 M-.ZE896UNUB5BRPN03^+HC##U\3:[$_<6X68\B 7M,D42 F*+C22-F?/H@D) MH@!+-*$,(IMV\;$KVPH1$(7SI8=PQN2P2Y95(+#B#]"6R-PJ15DPH'2*UZ\[ MDCTW#+D=J.:HQO;C3A)D*8XD0CCO:$SXPQ?A;KEC[>Y;K#IIIB*^MTMDHY0N MU!GU[;'IXCQ$:G$GA(]KW%M+3HU %9\8,.T, -%Z]^P:V+V^[86K<7QE9R5Z MAV>&MK3M;6I>W,]Q<$B(EN940##%CNO-4G% 2-:0LH0C5!FPE%Z#O8A:UK>! M6%EZ@'9AW+4KY[KY9>%#=%'S!4^WBQ25HCK)5D68HFY/49E"^-R0M%(96CFD M@;_Q9!2(L)B<0OF,]0;#H86I*6HSU"E(2K3'*T7P_<2E'E&*$GV ;,(^R0 > MS"/G+UL0/?K7NU^NO76!_"ER(\W:Y-S41]IT7HFU-\@"OL+U1",CY3/7XR_F4&%E_(/ MTWZ:]?7?^&!3;K3K9=S[(J&JVOH5&[.O'I*;/\1K*%2NQ2:OBVTD.@[_ #^5 MO\DF0(S-ES2C3M+#]5"$II5:6.:L@C8B0B$: .WB/6*(BO>=5M_PA=SA>W1[ MBLAL2YXF#^U2:2%6@W1Z7295#?W3$"G-@-;U#-"U:I,ZG?63B(,(": E2;I- MH.7QCU(5UM2#1;2V%ZJY[<9K<,,5UZME3=*G1L45#;4SJAQ5#=6]$VIEY:Y? M#C#_ '$$B)+^70-&&:#[Q!9QOD+ [.#TTM3XSN;K&U*9'(FQO6J.N$@8T$@?2U9S(Q M+'9 E>7DI!HL2XUJ;#U %K@6B"<#9PB0#T7H>O=Z>NL#\D2B,J7IRC::1,2B M1,Q*10\,)#NWFO34G7DFJ$)[DUEJ!+D)*T@@8R1&EA"8 MAWO6M[P.M)L&! M*8RIFB>;Q ^'(B%"I9+"9*S&QE(F2;,TJ4*7T"T3600FV4+1@QFZ"#V[]=Z] M-X&$/O0U*QNRZKIYXL>,)K)NUKE#W5T4+<2E3A+V:'(DR]_=6[:7YB MR5.K M+T6<8,!:@S>RRMC'K8=!(##-8=*ELB;(O+8S)'*(.PV"6-["_-3PMB[Z6#1I MC+(DC>J4'LCL66+0A)E(2CM!WZ[#Z8'X=)Q"V21,,/>)?%VF72LM<9%HLYO[ M2@D>HY-6*>0IXJPDQ!J5*BR(_(K! MVW2%)$Y>\-C:L<4;>:A.5*&]*(X)?L$ 6PL91=VQ>\*X@\W:U[&B>Y)6];V# M)X0DD;<]/,!W9,*:)LUL\A GTF6I!_C78(B#5"9+]HG6C0 T$6L"08E.(5/F MXUX@DPBTU:"%BMN.=(E(&F1MQ+@@/,2KD!JYG5K$Q:Q&J)&6:5L6AEF!V$6M M;UO6!KN7]_SFU>AK@YVXGHA@Z&<.;Q!9>@K0G=N'4S4\(LE8C<%;=3T>?4-; MV>\3:PR-(-:="R4"9 T_.7HY2(S1I9839SEV&TVQ0ZJZ;OB1')ZMBM"RJBF$ M/MNZ_/3CEYPV=@<"9 M9=J$ BM^U02<#9>QZWH6PL\]6# ([ M]'4BG$08OR:4"YMT\R9F:]N"(P](E+6(?NK2/MI3%+@06$POW V8>6'6_48= M;".I8'F>XG6.P>E+&;H:5 M<>F)]R87N+-$'?J' SQNL>N7.1/\+9I["7&6Q DDR51-ME+"LD<73FD[-3F/ M["F7&.;(280'8@;4%%!V#7KK]-8&-[OZB@-K\\&W74@&B+"2 DSJ*QX:%MC@ MUS@L:407Y=MYTE:!+'1O/3%:4"+V8H(,+#ZC +6@C&8]K\QPFR:,JATN"#*9 MCT1^6/K-,U2R+KD#BSM+.K=M2)8Y_FBTB5A>3$GT6L\(C-NCD:%.E":/0_8' MTJ&^7M56\]G_ $@MHRIDD6N*R(0W/$7N5CE<#%#&"7J&&".D@FCD%B0LDSD# M=HD;BT* $'MZTS:<0/?KTP)C56]4R%E8I(NM"NT<=E#:N>8R_*IK&D[+(FAK M;#WIS=6)T.D<06$KQIY*JVE1G&_&B$>/XRAB]/0(MZ#-\!@,!@ M,!@?,XDE0#XCRBCR]B+'LLXL)@/>48$TH?L'H0?<6: (@[_KH6M;U^NL#Z8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&/RQ0^I8O)%,73%+)*G87@^/(S] $2K M?2FU28T)CM&')@;*/< EA%K9A>MZW^H@_P!=!XH^-KEJ-UZ0\2,ZLE^F'^Y% ML.[Y:O(J_2YLMC[@.THD\2I^P)!*(\9&WHMH- )64H.&>C0* MW9. U26:>$L 2CS*[LR"*> UHIV%/U>WW#:HZN8'8N64[:$-B:NZG3GQ;#H< M^6$(IKC;6I991=1AK:=(%7VM+U:10'T4@+]X D#FJ&%JHUXR&5%"Y1#.UN?[ M6N(ORAKI-!+!;G(^C4$4M!'?R[H2:MI88_9""8IU:$J#J'%2\&KAK2MM @)R MU9>PP/Q^(:[KNW?"._5DQ2B,3J>3_P AC5T8_EQZR@.;M%9(.4;J6)VF]2!A M2E-C6)TVW'-#(L-T4A4F@/*#H9PC3 VG]]J6N+>2[G68]DUZX6)X\GOEVSJX M8S#H-++8K"#=.NTL1/"EZM*O62+3!,1()-!VY*UQ=UTD+4$GC4@)-#_JX&N: MAJ&/;;2\$]=]3URZ32U(@+L)QF\0LRIIK9TDBW/EB*)^?RDDL^5OL/?FEG9H M"YM:4A*U/3CM7&UJXDT9:?T,, &WWRDLNTQD7"%F.1EEI32$ST),JULDTH)F!I1K^IGQ M,1XYK5H:K+ BG1EC]Q^1HI^MS=<6RRS!' 9Y_.BZGELL7.3#H;71KJ;8D4

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

*P1K6UH5M_N( 4G,*"G(..+)^,!QNAAG[E MXK>#7=:QKG"D%)ZN,4<9S8P;!;=W)RVFAE,?4Q575R1*FLDE,5$W%D4FE*2/ M9ZJC!;.-$,__ %,#]R'Q6<"2P=??N?GIK?T]85C$*6B38[3FTE['_$T!?54F MAU>RA@43@QDG\48'Q8,\A(_IW,KUT (M" 66$ 9M!_'AQI7-F.5NQ&CF5#-W M1WLB0&&+Y'.)#%6Y]N!%MKL]YCM=R24.U=Q1UG#0,:%P4-C4D-/0&F)=B^N8 M,L08Y6'B]\?=,26*S*K^4*EA\HA)\^-C#VW,ZHU/:NJLM:E(=R53[16%X*RUMJ13;"< MY$2\Y,L/<6H"MQ=EB]Y0I(ZX*3#VA.D4IR&QH@)Q?K@27SEPYR-R*K?'' MFR@*[J%TDS*P1U_=XJT" ].S)&4I25H;5CPO/7.9JES*YKITL3N9:J0.,92-B**KI>TI')/'IJ MKB1+,E$T&.Z1:)J.( :DV2;KWX'$)\+-,((Y@J@J(L5CJ;@9XZ!AV%J M;[66)$*%38R=+I1[ S4U*VD@VY;]5>O9ZZ'K8A;V'0-GBW\=;,D,2-7&7/K? MHY9+UQRU)7C*2\FG3U*:@EY9K\ G3V8C?&]08F-3[4;3A3FC* )8Q!V$G2_ MB#D.?TE$.;IQSG4LMHBOQHS8/54AA[6[0Z)&-^E8$0H\U+"CBVG:8I><6#X= M@]"C1%_^3?MP.ND'!'%DKG%<61).7J4>IQ4###XM5\A<($QJ%D#C=?GGJ8.P MQDL:7ZC6TQ-0J,,0$%EZ+3#%Z@UK>M>@6!GB"N).S&UU9J2%OS!8J==&C8/- MRF1R:IPE-2C,6L01-3Q(&AR:%B5_=FOXP!2J5@3STX "6((0 M!UH)R88A$XK&&Z$QB,1Z.PQH:P,;3$F)F;FF,M;(63M.6SMS"@3)VM$U%I][ M+"G**"2$']N@^GZ8&(UA2%+4DC=6ZF*AJ^HV]]4I5CVAK" 12 HWA6B($F1J MG5+%&EI(<%*1,/990S@C$6#>PAWK6_3 Z^.<]4##FJ=,41HZGXJQVA\^K,9H MY6<+8VJQ/M%KRE7[Z;FQE2I)=]DIT5!,_( 4>\*DW6_71@_4,=<.2^57:%L- M;NG,W/KE7<5N\#(]<]T'J50^=:H^H-3>O6EN8(#,=5I"]2J#L30B&V-++#Y#^%_+QEI M;&XP2=.F1'$$DD"V6 (0[WK Q@WD7D\]HE; ?S#SR!H6) M]3%K496SMEI5983B]!,#H6@SY\86.3M*]@DK,TR%B="-IG-E?&Y&[-+BFV(( M]IU[:O)4(U9&Q@UOV& $'UUK?I@8/ :4IJJ5CZXU=4E95LX2E6:ODRZ P**P MY9(EQYFCCEKZICK4W'.ZLXT.A",4",&(6O7>_7 XZFB*/611+ UE-52K@R%P M4.Z*&*:\B)\41NJMPT[*G-+'36<3.G<%+KK2DPX!.C!J/]3>]C_7 REY@4&D M21K02"%Q-]0L9?PLJ)YCC.YI&B4Y8/:5H&O:6'7] Z] M BF))N5Y_++<:X,EH&:3ALD*9!>R"*IJ\D,J0RK>B2DB.V$S26K=B)![8T6$ MLMWUI1_Z>'6M?Z&O:$O*X;$'",&0A?%8VNA9KPE"!K>SS-_P#WQ>H:6M&\&GE"(/,=$R%(02X&'$CV >S@CV(.]ZW^F\#$YY8%-\VUDY36P)'" M*=J>&$$?>>'4UMBL38P.+@6D1IB2RP)DA2AS=EX"B""0;-4*3M $0QZUL/S M6#S2MI1QDNBHE%>S.-S\HJ4LED0PAC<4TG]4ZUI"\%2!O)$:M6$$'*48QC,V M<3ZG$#]N_># QVVY=S30T3DD\NUZIJJ8;*UI;=*9+8!L0BS1+G4XA>X)VET6 M/.DI%9"92:2D%]A2=[#-@ +>A8&=D5E5XF=&TIJ]@?X EP_/(&LJ)1\+2 M0ZG$@!^82H M^DA+B80$(?L!!HW8=:U[O36!JN!X;X <\V0T/?3%]26B;=M" M=6I8E#O[!0#HAE#K8TG%,Y4R+K>64R?>R=A<)'O0M?5D:=<0CUI.0I*#K0L# M:@&IZM 6,H%:P )1CB0\&%AAT=T QW2A."F=1@TW>T;DG"I,T _?^J#1@O06 MO=OU#O44/B3::D.;XM'$!R!P _:$3^@V-7[7COXME<2GAF;?PC;]!I=B#SE1+HV(_K?70.) M*I288$\H(#0F&"%H7J+>]AC5FN%41&,O-E6Z9!V:*P5B=U[S,IP2SEML9CYY M O0SW9V*$%"A7$E@+.+"+6E&_:#81[V$.!Q:>NVH^@H2EL>DK%B5H0=6X.; M07)8<\)7AN)>654)$\LJX2<>S6UZ:58-EJ4:@)2D@?IH8 ^NO4)1P& P& P& M P& P& P& P& P& P& P& P& P& P&!73KJXI#SYR_?EW1.*N4UDM755,YHR M1UJ3)59RIQ9&54J3+5B98X-A9K&R##]YRT [Y_QZ8_9(#3O84,-&7"_:LJI" MMX?,K&D/;?85O]/4/7?44[YYV@KN=/5#1UK:SDEO=&P5U6V"RHVKG.T9"]H_ MVO%$(S' .VXT+8W"#LXLD+U.OF:Y9,M&CJQK2$='7ON_JUA-PPR:4W24FE41 M2UE-9LTP$,R>!*-M? M2.&+VI^0#"4'21V/6%N8P-YA %A@"MA^G+S:4,QT1/[WD5!]3Q9!4'2#)S+< M\$E->1Z.S^GY;*T#6Y1&4V$UNLR2MS-!7].^H0:6A5'&(SU91:HHG8P[V&QR MF^B(G=\RO>(1)DDA95 V015LAEZK3"KA,HE0HPR2MR1PI]9'UUVZ'QE'($R9 MW)/)2GMR\6TQH/E 8$ 13T/VU$Z+M.)4+&ZQLV_;ZF%:SFY4-25&"$ZD2"K* M]/0H'Z7.JZ?3&$L*8"YZ<26]J1 5&+W5;L9:0HB(R%#63^4SLC]*4:A@>Z7FYBXE_$>F6J%*D MHG;.F<"M#.V$&^.3RG16!43R[3/4Y/2 GR81+I]>V]0)&D/&,O1>@F*)>>SF"8(9BXM-.]'.J6 M.47(.BV/<4B\&G!LNK2+K!!?CP%1.P'3<*DK1']A>U+/(_Q#D2T;$;LG9H!$ MZ#8OQSU>C[&JP5NL]*7C2T97+6S<13WG$VR).L\B[W%8_+&6?1%.UOT@3N4. M=D4@"40IV: 8CTYP=@U[?U"'[P\B\/I^W9[4,=H3HJ]G*FVZH76])#2\/CTB M9:F2WC(B&*OT[JB=98QR>5/"M&:)V6(F!O=%"!F+$K.T$O6_0*#TQW3,^;I/ MY+6.81^^NE=5[Y'(M5%1I5>[,B]267('WH@B^]1:NT4MI%K5N#V!T+&>=XYS MS?6Y6X0 O?T9?\ 7'+%'V3T';B]>VUW5<%!(5"="A:V1J)$ M UT>WIU6$(T:<(@[/4G@!ZZ]?7 U[6)Y?Z)AW3C]4# MHGJE3)Y'0TND6HLIL6//+%9CS%-I8,[A&&0-RA82\H E[]B,\7H#8; N>+E= M;ZK9'8SK35K47^3W9?M.V%4(7_\ (-H>Q'VRV:#T#=4S M PUO;%GU4;%OP:Q59\>J!NS*;\P]Y?#E>QKC?*Y;(98ZF&FPZVYG7= MEQYM-DA$T1TS')#+) B>HP4@0*X"OE\?BRU7%RUJHX3J4 %&D"@S1&!C:[%@YC8 M)-)HZL**6LIYY 1['HW6]!?22-2A]CK\R)'5>Q*GEE=&I,^-8@@W&':.)WO]-& UZX'G)=^6WIW\EYG$A?5/9C=!TOC$16RVRM+U1? M(Y,@Z#3V^*L=7:7I381Z\K=?6IX^I%V8 MQ7;%N@>H8$B\FD6Y_E-ZR"T8M(Y1"/Y!KSG^*UZ^ZA+X^Z?'9%.GJ5_DPLL? M3@2,J8[90A:,#H(@V'1#S!5_/^G6>BH-S]>4VKQ\O69\YI[[AL5?9+%&JP8* MZ CKS))*D;(X:RLM/GRHM0WII'M[-%L:0PTY&01[3!!L!ZR:@O/,70"/[SZU M'E4_83HWNL8D;]$I U.[%%W)\9'1GDD8<6I]:%[<[MQ!Q9J=06+U![1>H-B# ML/*S6'7TJ@V_"38]/W;VHV/G3ZW4_M;"/8)YIIA9D,HYYC7!=P-TIZQ-;_9J:P']VN6.;:40= =#-=#/W3$NB<@L0-5QYEJIJ?#HDPHV^1BBDR-> M[ L&8D#;6EN"D)2E" (]:K3$>@A!JLO3HIV\E]L>-6,0&F6:=\H=#UST?94G MB$VOB7U4L?9I7\6;J\L>O[#8(9%'=2![Y_=)8J$@2J]&IG.2?64%'H (@J3 MWZGU#7S500*.??W,^5@PU>EKQ<)WDTK<9@Y0^/QTEE^9RE[:N)FKC(SFQ#H9 MJ\E1IQ/4^INA_*+UP/,Y7'/Y+%X/F/N^G;?O2K>M*^YVEEWMUQDWQW,57"0OS+5*AKD;D_J_N*RSW=:E1 M%IR@&%F@.,"Q O,)T2'4 @ZKQXSMFO6UHE*+CKNNM3UQLA&^<]LD6BKPQV4N M6456MKR2/+I9*9>FCQ2!:U%%(7 HX:M442 .QAGS;Y3NA["4O+'2G!$LF-D4 MSSM4=W=343+[(-KB\*SF5MO;HF9Z&A$1>*]5-\[L 408%DA3*5BYD:SV[:8 MSB%"@).@K.Y>7/HJ@;>\DCQTC ZZ=*[Y[G'*]2TA4D/EA[1+P6?T5%!OE=Q) M<\N$..3/BB1E/'VIHZ&+?AC86-J[PY M70\_3-YC$2Z!"K@M@5)T#*R8,RSN#2M\JQD?CE<;F2U*UKVQ8SI30GJ?F"9M M.4(P0=C/O+3TS4EOP*@;@XM@53W%83"QO\'A\SZ;**:K<,>K9QH]"DR:1*V-U>61<>!5I&E >H]NAANXL)^>XM IK)XTR(I+(H[$Y$^L M4=Q_$/V^W8>?*IO+YW/ M<+KS9%&/AVD6*6=G6N63R3RX(3G8OEIL*I+1G$> ML6O:YC5?6-PFV]><0O?S3AUE5N31YW$V5'1$W:D9(&P[&(L(;M86NE2Z$1-RG[,V1N;K(JPKIK'V1R,?&9@E2AH2J)(S-#P-, MD->&QK=QG$)U.R2Q*"BPCV .Q>W0>:6;7Y;/8%S>(KL"95'2L-HMY[DN1+1; MH0[21TZ*8H2TU7>K(D528HXC]JB:[2;*_&[+D:#VG-9B1O)'\PQF"+";X)Y? M>G%D,UU)/>+'E#PZ[T/<%XH[49U2=L>XIF!\4O,O5AG6[-:&OZAZ MIG9DXFMS6$Z&G&F+./"'UM_R0>1RE>3IGV)(N:>37VGRN8ZAZ1@DC8;IEF_F M5V%(HP5(Z@=;2\-6\_'0]X)_.(<04XQY"Q!7L[< MK.]-'&(50P!L"XDZ&[;MR M$OMK6!-[.KT^.OZ0]MF8F^-Z.-3F /;2OG*]@1UY:;-Z2KZ2>.EAH"WT54IK M@[VJ.J9K\T5<7_\ <2=X1OKVS(I 8VRZ+*U]?E*H^9^88R34IKT PHO:T@DL MTL\-UL37H$[XU(W=,O#'G5G0H$A1\NOMI<<5]R)?<3?8A!K)45G M-*WZ?7#:SZ_7('FSDDD#(HPV/)EY,J9C'=CU)5/&DDUXZ+NY^1VF?%8/;+8?;T-O $4E<#G)>H*#H) M8O>,P+%5;Y&?(OTO:,DN&@ZKJY)R+$K]9:,D\0#J"+D7MT3,^:UU,N* MJZZ[1PVM:WL&(V FGE779(X4AEYCU(I&[,JB./+6RJT^VX!0AI2DZ0>U2E08 MJ$$)@ZQZ$N(KJOF;B.B)6TU%,;Z@5V6W([ME%;:LA!'(E3B2.)4T5A16F[*@GE;G? M+%D-[=694VJ]WZ!H1#-@,-[L; [3)*J?8LE:R![3L"Q47I.ZJ3# *@[2E"&' MJ[C,)CE50,^-5E#HI&$#83)'MNC,;:6V(QM1)GY5_3/,-POO-]E4BJJ>2'L#GR< M]5WK M (1,] S6"C.[8N N=3ZSVRU(S-)&X27;BP-:9 M@5L:5.F"C$):H,W[0LQQIVYT'/NXW[FWH&3.$5D(H]T!(4]0S&E PU@D$;AU MI-3;5ME\PW?$ 2B*W/ 1P)1[9 4Z.B1Q0KEA7M"8,HXL 6T\@?4,\HE=R/4- M6.37%K"[$Z>B_/S78CW'TDK;ZX8U,=D4NE$F2QE:ZM21\DAC?'@HFPA0(Q(% M0K^4X!@2M$FAI>ZQN+IF^Z5ZKY4O*=QXZJHNZXZD MDM1+I3%EBQWC[?-X0H&=@3ID'[CF#J4)6M-]!F&&C_N&+TUO MD/ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%9^RZ^M2V^4^@*FI/4(U M9MJ59+*TC2BQG!Y:X:WAGS:;$WMW=UD?;7=WT-FCKNK5I2BDX]'K"2BA[ 6, M0PAJ>A7C9Z^YRG%+7ASM*.>G"S-<7PKA;H.LYJ^V0R4DJA]4I/I5-<=;.#7% M7N;;D,= 4(3@P. - 6:7' )1ND^:9R3,:QD=0\Y<-.?) M91I1TS2V++Y3,["U=$^L73,LV4V#",)@#-?#@;$NZZ M0MKH_DN[J3HNV5M(VK/XGIIB%BHE;FW?BU93HWKU;6M=6+VR)H:92V(SVM6L M;1EN"5,L&:0+Y :UL-#SEX2>R 1"?P&*V5PW"X)9]H<;6^ZPJOJEMJ ,L(D? M)*Q">WLD3._=4O/?T4K2-!('1V=P&.SJN4&KS1$FZ$4H"8[_ *<#RI O)>1V M&UOU^U7Y0KK>2:K@7.T$MFT+58I*^U?^T(3!WX"-A$A8DS>A@;48W/7RIT*% MU$$L7QE!*'L-NO!O/JOF7DZF*MD(0*+)(AS1);J?Q"V#+,G*!3:!/+N7*HF^)72$.9#XPR6#RDL0]E!3'$.J%0,@9B880'8$#5IXL M;4YML;C6R^?[8JMY>N=J,O>H;#!<M5GNL>BDU;) M/.TO748E,-D\8@PSY*8FBS8QM%A.AX'%6-4>H6-S=OZI8-J-8'=U;XV^\V_F M^4\HW3VM6,XIB*T7.N<:(CS!2SJRB=(5+(FMK6/R[HDY)+FHJZKQ<,IH9 M&P2!MVZ@)7*U*DY.4+0;>.>:_EU3T54=6SJ3LDUE5<5]%X*ZRV.QY9%&F1_M M-I3,2%W(CR]]DJEJ/6MR D:@O[IP/L[,$7["]A+"&MVY/&[>:KKZS^BN4NLG M'FR*]9Q"(P_L)B31;4HF2LRNB$C7%Y_ST]*5J=GKRSW*(A/93W1Q2N1;<69] MQ,08?H "PKM;?AVZ E3M?LM@G3E8I'.YNXZ_Z^'6-@TV[3&C'YJB,1_81U<7 M+%'*;N+C9J0AO3I'TD99[4E5OR?>SB %_5,1!BTJ\,G2K_1$BYUDG07*]V5? M(9[?\I#&[CY07)P1YYZ#G33/E=RPUXA=F('^%W#5SZK?ML!+2I1-!J)Q*1J? M4).C\"LL254]!KGL?QA M=(W?!+K+N3JNNY)<5E\5,/"T=GC/1\@9XRSUPLDNY-:EBRV)*+<K>YM69 E*&C2&7H5KKTZM%$&>.9GJYVN8)6:64-)'9Q6."U"Y1U2N$2J M&E"IUH6S,")JS\8'856U#8_-[7Y%7&2,-(MO"N-$^ M/Q1K]U)B*9?3B;A1)*F6T>VZ8S5UJ'G5ZXE5\ZJQ#/'^6]'$BA*0V&@*-3)=BT+U#=1@:_ MV+CJ?)_(@_=VR&VHRY(5M!KN:6*J&JNE[6)HK<$M:K$9WE=-%$YANZZW[F>%9% I',B( MRFLG(ER9X0RMCQ9"Q(\QM:;"XEH\3A\AOM0N(?46EQ7U SKGSQCW-SI<[L=! M^YK'1\>O%VOO1ZKEE'!6=$XZLZ1OQ\L>(RGN=2]N/W M)U!YA!RG1P;.[I@;O:51V36C%*2X0Z3^%2*&IY:8PE2?4?!)&Q0T*W(# >XM M)#F<0C5F?&6-06#Y/3>][UK8=AI^2^&5Z>Z/Y"Y4M?KAZGW+O(,VKB;1VL6B MD8E#9%8BBJ-*A0ULG=BAE,A= ($YJPS2G\8E;Q*BC!@%OU^,989NT^)A>@DS MS!%_2\G?N+G'JY!VBWN%T2>O'-5 M=H/;J].+U.)^[U=%\S:_WV4/T&BD"5(I383='RI2B3M;_SCT*AIZ04#*)8-)'1L:R)%!9F;MV9W(DW7M-$,I60K($$L 1+5?C#*I*R MN+Y)5U[.C%6O&$(LN&L%@N18434\7Z.A:"".$ZG M5/JFIL:))!9_'7./!@#UIZ S)E19XFS:9(X!&?I(9[_8$,#E_AZCZBT(U:M2 M=B=;4K)G.J&VC>BY QS-EE3EHB%*@U"8:H6B6@6@4A+)#ZV'X<(M=<#N%KN[J&ZI MU;W0""BHU;=Z-T6J"-25ZK[G1P%(JWK]@CNX(\QZ,,HYN$J0.ZDL!SDZ.H-^ M]0!'L*0 3YT-XXHQT_*'E7;-YW$]UO)SZ+<9#3>RH"=#P/\ 0SR>_,LJ@SLO MARV8U)*I@N4B+?7"*N#0H6(]:) (KTV,07UGD963*#RV'MTD=((^EE M;,D9G%XCIKLWGH O#:CDC<\L2Q<@^?Y"P+4JE.,8=:,+&'UUL-9U7^*2$U7- M^0YTS]"7@XN'%O/U@\X52WN+?4H6MQ@U@M*IE6*Y@6BKA,J>'MK2E-8R# &D M$B.9R!F%"^55H\(#H.KD"2+\US+D*2.["^58RNMF<[R>9., M]:JXF?U:NV@ W1*2.9FTY[:2@5K$FM)UAJ@'KZAF)G']BSWH[BFEY_0?[DYL M\;7X";UQV):%B0%XL*ZY,CI?4+CD.:JMA,=8!1HF.2I8E6O*QM;UO6];UO7KK>M_IO6];_3>MZP-0=>^%CEVM;!KV;,%C M=*[8*9OJ1=!TC4:NV@G5'4B(;:M05B.F$]U5'<+I5%KV#52@@HI?!;.E$(;V@N2LB\X MU M$IT9Q*DXPU.,D0O700E.O!;P?-"Y8UH$EX5O"YHU4\C?ZWJV\)K#H M>Z M()2(JUG*MB(4JANLW8VI)]?2U<BPN ON:"7HOXH.56!_(4ON[*L^ MOF>;6Y8L*HNUY+:VB=5E9/+FUNZRKJK0R9 MS4,\$@PW!D1F#3HDP%*G:4K[)YWL#Z!+G6?'5.=H0Z#PZWAS=O#6EH12X8%* M*VF[U7LVB<[B&UA3:[,DH8#BG! (]O(10RC@EF@" UGBBY%6 MM,^8Q);H3-UF] Q_J:9!0]!7"C7.=]14X*E@L4IY(EX'IN=V]6G2G: G4%$# M/0)#!@$-,4((9[6/C=Y$I^^)+T; Z\>6VQ)1,)-8RI$NL6PWVNVJR9F0I2RJ MR(Q5CW)W"O8Q/GQ(X+"3G9"VD+0D+E)19@"SS B"8.J.8ZV["I24<_V^LFI% M<38YI_=:*"3%V@[J_-C4YIG,<>7O+,86M,8'<:8)2Q/K>OF*W^@@CT$80K'+ M?%1RA/E/3JZ<$6=+%W7%7Q*G;?/>;(>34Q\%KMM845:(XXS)P)X\QN]=*F " M]I<])#'(M>I4FG'G:/&'81('P@<3J$$Z0OSKTW+!6IJJAVJXR/J*XU3K9BVF M!*E4!=)LN1R5 :\.3&\&)UR8W^SZ"A F BTE3%[3B";IMXN>3K':.H6.90H2N\R=WES2)'5[,.6C3%FA3Z5J3S M0@T,T>]A\[^Y6I[I)57+Q8K;)$4RJ&0N4GJZQZ^FLJK6RH$Z/C0>P2$,:G<( M=661H&R2LJC:9R1:/VC7E +T<6/99>PA 4H\7_(TGB] P\J-V#$63F21N\XI M\%?7#9T&7,5C/ZA6L?+/=72.2= Y2JRG=8YK3E+XYFJW XUP5"$;O:@SW!?A M>U(W1I6LBX)BAO<6Y2U+ #.-^4]&K3#2* B4:%H[Y#"3-ZV/0O=Z[]?7UP-6 M*OPJ\".=<.-6O4'L^01E?%(+7I"J17[<[]*&"LJW?U4MB-6Q.7.TU5R*)ULA MEJD+H:RMZE.A5KDR8P\LSZQ.@!EMG^)#BRY)C8M@V/';5D,RM(^J5DFD0K\N M-N/FNGA# M(X13+]'9$S6NEO"-/J*Y+J&YQ6TTR!K:QS&/GJK!4!1/#@W->B%AH@F#6$'J M"CMC*/, (,_?_&#P_)>H".PG6D&P5X:>&^3NCFED$J0PZ4S%G( 0QS>8UFC> MR:]E/0-35[H^"+[*/BFNN?#JW#,%, %-$MHQ18P:FJ&.E2Y?&-KDKD M<7IX;XL>!Q4$_P#F(1"T<9[2_P"[ HKVQY,)O'^B:OXNXDDO/3IT)8U82.VF MR47.O^'*C6UO;B]'?75[/U\(7'B M'D=XW6UR[S";=3F@A,]0:#CN'E+\HM!-,+Z\Y@L6UG6CH+>]92NVF8MS,7 MP1CE+=K/O#]%PB:1A'%$#];%W5W1#=9]G)WD^EZ.,L ]PT M?;5PEQX]&]JH9&DC68'25.I1B6+3B"A*2 "$9H*YO_DOM'DBH>@+:[GC%;R> M!P)[I-@YUM/E=KG#G!^H%%M1Q]<2Q,QS^MD[7$UC8Y,)@%PC',]K;P"#K:T_ M9R;9P7;L#R(<6U4OKEML;H&&Q!3:D7A\UB9CJ2_:;B8C8"I(AA4FF+TF9U#- M7##*%JP)*)7(E#4G4& -" >]DF^P.YLKO'D&H+5B])6/?<(C%F3!?$&IHCR@ MUS6D)G2P5&DL!;9-(6MN71B%+YP=O7X3659V&N\DDSXITF;FQ"6,!0=C%H(SE" MI4I-+(3)R0&*%2DTLDD S3 $&H/ESRHMDI-[JLWHRQZH:N<*0ZBC5 <^RR% MUW:\:G4PG\ALU N?TC5I&@:4JE0L0KC-(RR :V$+?NOD MZX19JKA=T+.BHJ=7M@?OO]L.3.RS.1/1VJM3B56>)VAD=C+K-8R77!.@[?AN M;>D T?(5I5LK9I7O# ZQ[B@T@NOLF3R/J'GIQYCHBG>?+*;6=F;I@PS>HH]/ M(&_3Z03JZ)1)VE%&W!OGC6:D4,*9J/--3(DWQJ2"U9F]&!_"O,1XV?PBE^7] M2Q)A2H5#.0Y(9-&K"C<@:"Y'IG.C3B\QAZB"&0M#))4$@1K6]>I2E(EB [:H MHT1!9I@ S-A\HG"$HJFUKI8.A(VY0&EIFT5U/U0&>6)9 @GB7Y?:+VA$5D^8;DR$L?)8D4XIIN1/8\=%]R5KF41D:YFA5;@EL@8T"(;/)$T0>YA#VT#U-:\CMD*FZ@3"2M\VKBW)4Y-T)M2H9:[K!D)5\?:E";2IH.UIP- :$&@L9Y5NYU/!'*K MW9\9;CG&SY1((M :Q^Y!97,X>U2"42AB9%LCFPXX)"E;6F.,SH>K()5+T8W1 M<42C3_*:;[,"$Z>\B<,YP3H*J[\[)JBQK1EDG99#"YW!J$M"I&V'TS:!:(BF MUG3C4M;WB-T+,):^ 5)B"WQ2T%# :E#O0A"$<(+:-_DBXM=^D2>16:[FIVZ' M%-'2OEMP*%Y%9HN[79)WEM4SAQ=VR%1:'PF:65.Y:='&@V12I1'X/7S#))0XML1 MC:V9.EL MIJ^2[0"89,PIXO$'(3F6XIEHU&R"O02K&I*,WLL98 M3 B#H)XIBXH)?M2U_=U;+G)=7EGQ-JFT/XHXK8V])0K6UP5L,E0M;TU MZ5)!Z-"%006+98M#UK81:WL*--OD[YFO-PMNGN;;B0[O>/519=B5HMFE7SP, M L-LKI0XLCW,:PJOYI MY3EW4UJ'KK:MKDNL.F+".K.H;,D;3'8-*&]B;9#;TJ:(I%7@=:56FFKJ)#]] MUVF3DF!V'8MZ"(6!8IW\E/([3=#'11]!=:[^A*L MYXIY]O2SWQ4UU\Q)V 8ECQ,K(W)3G)>^2J1/B) B(]@? MB"Y$C6P22F&))(B4&$K6%2G,)6%%'Z"4(( MQHWR65A7?/\ 85JVK?%D=2N>0B+4"XLC-=[Q/H/E_0TH>2Z(<6%MOY1 &-,^6 M@W4$,"&+,5HRR,MZO1RE(QI@H?849\)P_9O6!LII#R T5T$Z\V,U>(I^I7=2 MT3+NCJ^TNCS<%.QU;#GB-,"ITGRIM?G1-&5SJ[RM(G1)]"4",.V,HS91A8@8 M&1]-=H5ORZ]0B*2*'6M9DUGL9LVDKE((ZD;8 M^RDO:,@ MGB/6K51:9,4<<+0,"=JNM:&7+4\!NNOEJUY@%FP..61#EXVIP1. M+G%98QI)$QJ1,JQ.2Z)5BIL6EBVF,*">$8O9L/N_3 U)LWGSX<=H(YV2JCG3 M$8AI#LV1:-R"8T6\1EBL"=.D[=J]+@4*DSHZ$Q59)6]Z8U1KAM8N0H&U*08- M4I)&686$))C/F>Y"GT]E+0";RU.@'_ AD5B>6WG" )'J0$PZ[9M ZWB]8 M2SHBP(="6M1'>8T-QL;#)(&WW(4]2=D>$S\#F-(+9B_1&O;H M04\HBWM (8% M\C*EU<&\O:H:AS67L8 F/O#S Q;FB.=,1&JZIL6>7?0,?Y]=7,] MXCK,CJEG0]-.:)HKB7.KT?,VEW>H\E<56T:PA"1]G3E["/["MF*2@_3EWG0] M$];=TRRX[;ZNB2>DN6Z/M:=4/94:BHZ4A\?I+=M M"B2ZHNVDK3K2%PFU Q*[8JSQMQE]1V*:L31"Q8\6RR*1;3-K@M0&DFHG'Z+F MD,] G)P#]X0!B'#F'HLJHF)GHJ7&SAH54 MO+8LX0F^I:;!F5S:I7%+5>(HLET+E)R%+)(E]X,I:-N!8S4/QEGC+"MGE=[M M72VE^C(M2SOT+3%O\+]N<=5O.%,.ER>*)[/9;ME$55IT#,KB$J,%)8Y+(4_& ME_0=1-YB==LKY0 ]-[T$EWOYHIHTIC8%3/)MKL'1<+ZTYNH2Y*5Q2 M(WX\FJ(?)XFGC]G+HO.-V:RM2M TK4KUIL9UIH5+D8$D "U 3Y)?,)$(I*NH M(^Y8^L9[$'!-&J=ELDO\ ,Z%10CH_FB+);N>*C>+82W"Q+UCP*&1\3 MQ.(BRH*C(4MBYM8PZ4#_ !QR!2!5];7L*"%THQY0(Y-F"MD\3YMOASN&R[\O MKG!#2"I54;/(6"Q^;&Y\>K4(D4VK>>;&OBL6U+(*Q@P4 M*FIWP^-6%7TY/DBCQ#XP]NDAAR",B7#*;71Q MT4%Z&G'L*MX;HEH,)"M,2*Q&K#"B@E>@A# $<1'R$R272Q97P>8II'IXX M\5.W8]?L,BL&#D)Y6LQW0QUT%(5Z UH>B_R#,[M*X"P)I/I MLG @[7EV>Y=642G5#<671?DAWRO3/75M5["9+%R9%7==WDO=$<,C$5+5IAK; M=LHY-''9<-M:TA"8*%M,V)6!082F,"AD-[JF?'7:/E>MR0U9=]R\T-=E<2R* MS)7(K>:4[ARM"[Y%6]DO\ ^=5MR)_GY@U#$R!3DM"=$(L8@Z++#H/1 MWO9'8RB/5XU;DLLDS5'612^F(8JU$FEZ=7)P2)MZ M(!H80BV+6]BT'UW@:@(]YM6IYKQIG ^;75R+L>R*TK.AW>N+7:K$;L86FVDT$7SZ#N!>8>>NA',C##O'I MT8\VOT\U7OJ*5M*9!$*K/0S'GU,K<9C%M.=CEQY>O;US(6F<6YZ,;4C8X(UH M/K#./+4$$A$$$\B=7]JDX/<8G2*33A "&9-WG"TM8ZS9G'D.QH#=$_G MUPUN&(W9+RJ)JY=)JDBC=+4C? +LLN&-#5.7:VT3RE+B3=ML0+5IVSBU(4HB M@_*&[VO9*Y3. P>8/,6=H,\2N(1J2NT)?A%B?(>Y/K*B=%T6>A%! 4)VCZI4 M-(IV$.@[.)%Z:UK R_ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8&OCR MLQ&>V+X[.NJRJV!2NS+&M"EY=7,*AT,;TKB\N4P3X]'[G+HVA>6GR/TS:\,NR1QV$*9-+9TWM%@UZGFJ6RRF51'W_ &8Y MC">2G*,4C4 42(,X#R_T*+JWG"'P?DNRZ*A-?\ BOOOCM')6V3.4\IZH[(M MEJ3O]6QM/:#A(5TP>V^$MQ)2![?R&\TLEX!\"<:DDDDP(4A2<-W0Y\(WO%&/ MQ87Q771QG%*CE:02JP+T?K@53N;G/L/.A)/-=>N\]?8M&*U#)8HHDKNO6)X^ M7&?F*(:RSQG'BP-M+;S.@=.RO&2:_<+/O\5P;C*T6^TWM;5E<#KFO;MMJ'U4 MVMS?8R AX,*7RYM8ZW>FMS4 1.12M<#-F:T6$+<)EYE/!=MT/#>(N6KJYFNB3/KU2_[1%,7>"PV M*()9"S(]/C'230=Z61?\A]P* I2>HL MZJD=N$M'4M**V>O'URD5"BKV?+'!5&FZS9)%HT?)&F=HV-2C!M4 \X\L)1>P MB,]V@T'OOC\OMEY:[G8^9^=^BX=S4IO[C:[N3.-[*FS&19+>^5%:R&<=&'0" M+KY7*T,1@TF+ 2!FC[@YHSUQR#:H1A>_C >$S2>BNO=;\GU=2?B*Q+5:_+'% M6.;U,]J)'6AC50TQ>:I/@)E4=02@ZS-.$29Z>7IF]T;E4?(>4VC!*2T0##=^ MS04.Q^8K8M_E5#Q%4_653W4Y\JV_5W2=K/K*=3-5VO2%-U-6TN=;?:7= M:\VJ^)H6_5^)XB*=$2%S.5;]A.TQ9YBA,&(V^:QE4I1N+VGTVF%B. M^D (0VM>6VC>A+BHRF9/S9%6VSYUS;U72'3CA1KN[)&5!>,9J5UQI7)A:FQR)9SD2OZ*,8! MB"'7UOZ#O6O^^N?"J(NFR/(;U937)T@+(EDLY.15@*JZ*>HB% Y/*"J+C?XE M%"T&E>CE09 :6[/XW8*9%ZDIQEEA9KJ+COO:2=)]MS^M^85;[!+IM[QKS)(^ MQZ>T"QSEZC/,L6<$-M'4H38#J^-,$L)*^KP:9'EV+;U*!. P](9I1HOU#!.= MN1?(+SZS4T^@XT>) YU%Y9[NZ$+@3UT%#9,Z2.M>CJ6EU=-$S<+9=5[^[KD= M4.LD)W('9R1J75U'LQ402;LL6S Y-&^)_H6%3&PJC4\4T-&Y<@LOHB20#R6+ M[WFCHL2P"Y4?B[*NGB^/4G7/$5 W51<^L%FN2L)$1(7Q[J^&0F/2F,0R.NJUY20A^U M!$IA99HMN(5Z\_YDY)*<)QX6V\S]07WT+Q^"D.>*7D-OS.66W3TF7[:I57<3 M:XI'JMLN*6*[+7A9/I=&!+%#PFCXD:!.B I$)2/W'"(+#[Q!0JZN-^QD:_RM MUM!.5T=S0;RG-\'D<)L:7VS!$ J)ELBKUJK^3QZ\(O(Y,YN&F:E%AAKRS'Q/ M;_HX24"9*4 ("=EA>?Q_\]7-4_6G?$SM.D2X##+"#R;'JHG@)+"I&FM4//M- MN-1R&P=MK,_.3_$5LB,((4)4:Q*F&4W&%!,W]G1X<#IO*;SGT===B\IR:FZG M77- X25><2R7\12?B7MGAXL,8O.A7\IUM1T>U#Y&Y M&WIG&=L0F5KEA+ D1*!"",U)]LH1@C"RA^T.AMRLED\JCQ2\A(IDS<\^56GH M)$>9;'I-D?VFQIH#D:Q:XD567R^RIU@ZU=&4T&4UE AS=M,7B5%(%Y25+LK[ MJ@H0P]2!M1L;?2)M%0M0LAD80U2.I(DK;CCCU\384T0W#6%2A/-4 4G+&)O M4(H8C=#$,K6]BUO]<#1GQQSUY!ZQYZ;^6;EY4HW]H\H3T!==4 M5;%*O2S]AZ+I5_;GA[FMP0WMZK20\T\Q"J64FR^BGJ\6"_*J7]"SR;M4@-?N44?Y5WFE'5LD9V\\3NU. M!Y99ZHY.264HT1I6 +2]349T5!.[*8\@7/M=$=$ 9>?I9R;9M!%2Z-5U*4D7 ME$R88BS :$ 0:( >)+LMC14A;C]%:PZT(HJU M[J9Z[XDZVL1#-S8]S!;3?"T+ MBQ%C"X_/O%/5D"[FXIMR34O0E>TY1O*%]5?,45&OK+%H3")E>L_4V>@@]=5B MG9$*U=$ZZ @1L:AZ.,+6/Z\XYT,)+]PP["D;AXG>T7.N%,P<*,YPGEEU/Y)> MI>JH'0-T3Q),J>ONC^KDQ39*8E-ST\>-:X?-8D2E2J&]0>G<2@G%&##H O:$ MP)AN7QM=CSBJ.?8>&C>:XW-82VW=,8!,^0;(=^3W7A^YI]*V!77R2"/3:PJ2 M+JIYOBS<47,$:]H XOZY*,X&]ZTG+$&^755SYPY9.I.9V BG%F.-$*JPDMGG MQ\B-M\HF:Z!&Q9RFI\8:33T[,E='6[CYAKKC M^7]SH:IIFC?#W2UIJB;9@%CR6RW"]Q/]:*82^291'VV#1%]KJO(U%@*%JIG4 M_FE;RX?4+^#19&Q""8O#+SS$HVRWSTE#W.9R&I+-M6PHMQ,HFGVFTN*<8&S1 M;8;,TPF*GHFP4=AZ+ZMMRB)-5Y M% S*NHC6UWU])H'T&MFJ.*Q*76>FC9+)=*1C@+:)?:"^,MC$H1D1]R7HVXI: M>G7@V%0F <4%RN!ZEN3G_B?G.D;N/A+M;-/5,PUP\GP9:Y#B2\F%)S6");3N M#DW$+MJ3HJWH-+SOK>S:[YAE@V#VZV&F=3XB^O';@^DJO<))S4=U3S?VQ8W5 M,!2273_-N;9^QV=,IC(9)#[2CJNOVDU9\S;8C@0 I,TZ3DC2%")V4(WW$AW' M07BYZ\O*KZ]BK_7G QBDY?;\T>8A6J68=/6Y /()7U7,G0M MV7FCDB.X8/8T=K]KK*U+#C,2:8_*8M9H[$9$9SBA)<'%E4M+J: >U)^R]G## MK+,\/G2,_7>1J",KO1,$IGH[E7F[G3G(Q+*IP]RN-E\A*V#53"L=K.@:!K0M MLN:FTTEX&WJEIK>()>TX%'N%[0PZR/$!WQ?Z/MR?W%:7*#1FE2M4W,DT*L&E)+_*P'TB.RLHY.57;I:[@ M=M8VC>%:M:W-R,7S%#$,LL/W8OCC[7Z8B-Z3'H:>\PL_0TXXJ=^#:W'7S9/W M*NF6!S>2M[U:=S2YT=VIJDZJ>2S\< 36Q-R9*ULY?O3FJ5GRB. 'RF7)O?=' M67TCVI!I_1JBZ99Q;0W--916"5-9UJ",L2KYFT.13B?$5SU'2SV*>K'UU0"& MI<4R6/IS$RY8J^NG5F:#<:6VW5+>_ [I]\.'5-CL'9;A:_4U,OMC]7VGR)T*-0UTM)D4+8K>YA7(7+<=4-Z6? M-;P*JWA*QH6E. !YCP%* :LY0)1O99@3'=/BSOZ](/:=D2F^:D;>T+)OSER\ MD,D15*O>.>H8BY)6.1E65:XA&:?L:NJE9:DE<-30V/SE)'U5/3*'1] RA;/IB4E-[<6>H-5J#U 1!:1[ M\=O6CHX3 M (5OUD@.TYU,A^2XU 66+(SWEU4%K"PC.$I5 ,$3O83?F"E/<_%EYU2\<[QY M=:-A)(Q).W^O.R9!TC07,MWSXBB99;S6WEQ."OD4I6S1VR4)RE$U6$MCXD=$ M"3:=.,M6G.%Z!&&WSQ+,=TPOE2V;S"#S%WEKHZ:6;:4 2CW&!$=I^,2V[$?/)TN0W_6\ M<:?)'"87 G5#NE9*Z.%8M,(BQU7#6FFN/FL!ZF$) M+2B[Q%G2)3AB_-HMEO"H)AAXDY_RDZ]-AB5:>+VRJ0G/,\GJCI1I3(.>.<^A MZ:4"F=5K'^33F;=+RM1:$^LPU>TV)'8U&"$%M)D#DV-21I%LEN*.0'*CPC(. M3AQ**\7-H5 [^-=2Y]%0J4-/CV9KI9_J)*:D;&XVONYF-WC3LZK5A]S/;9'' M=*UN #MF@0*0C6Z-$ )1!OUPA=;L?G6T.BXW73'7%KPR!(8K/=2.P(+:E/-M MY4]>,,-CKTS*JYLN!+I)$5"QG X.1#FE/3.!)R5P1$G!]1E@V$*!QCQ"3RH8 MASPT<[=@2*IY75M)VYSM9$G<*OC]@H)94%S3TNT'B+U=')*^#)J+4#F6O;$Q MB4/0&MJ(3)%!:P)0Q&AB]=^'B^*424DX4CY!)E6\\BW.,[5%#M+J^2NE7^8S>&P;GQ*2PP]L<)0ONDA1.9BZ11I;B'9\6E@. M7KRU"S90!'Z++#K%HCZ/+?7]M?=6?%Y;GMZDJ"JZZA==HY%(U9Z]_ M?D\-CK='BGEX5J3U)QKBY ;]''>HQ!",>]!_MUK6!)V P& P& P& P& P& P M& P& P& P& P& P& P& P& P(ENVW$](P%3/E-?6K9X$[Y%6 N'TS"54_G2Q M3+)&V1I*M2Q]*I1:TSM![H%4Y+#3BB$* HT\P6@@W@2UK_N]/^S?^'_9^GKK M 8# XRQ0)(C5*P)E*T:9,>H C1A*&K5B)*$8%,D">]5E-GJ#O05J=C>'Y ML" ]>RB,+^-49Z!'[=[]=;P+68%3X[UQ$9'V?8O$Y,*G;=.:WHV(7PNFSJC9 MT\#D,9F4F4Q9"ABZDAX4O2]>@]>N_ M7TUZ_KOT_KZ:_P ?3 _OK_A_CO _GN#Z>[UU[=>OZ^NO3]/Z_K_3],#^X'\V M+0?3UWK7KOTUZ[UKUW_EKU_QP*7=5]>N//9])W=]FSNVMZ$A,6_(D+<5H!FW%W6ITON)T8(X 6,,:HG=E7 MH$=BUL0XQ2PHNQN60;LRK-@+5)A[4%$K"- M^T0O;H6!HUYI\BW%//J"?FP?Q^6+R#04=Z64<=KVC$L#9^B2Y:DC1\7 ML4BL9Z\3X#,BD,@)3%/QJ!8S)_LD% /+ ,(0AZ#O<']?[M?IZ^OZ_P!/3^OK M_EZ?X_Y8%4.U>MX?Q3SY)+ZEL?>9D6@?(;"XK#X\2-+'$_0RD*71AWL-$$)0PR;G>ZIW:\57J;BHR3H#-&I2M!"(86)]X?_P + M7_'^G_?_ )?K@<4]Q;TIZ)*I7(TZER.-3-R<]222>X*"$YRP\A$48,)BLXE( MG,-& O0A!+ (6]:#K>\"J/;G63;Q?SY-[Y601UM'<)0D.ZJ!QV2Q>.2)8PZ= MFMG>)$G')UR72EFBYSTF.<=I"E:HI.9[BR#1>@!!;GM]X C]/7U] M/<'0O3U_3U]/7 UVV;Y#&V,6S?U.U/S];O04HY4B,=FG0?[&VRV*B MG$=:XNVS^;1E^LB2.,4(-5:3-*0TC1F@)OGVJ,T3H+'5#U!4ER%5@WL,@*;9 MY:7/\,Z6;*S=!!_>++5LW*9 -;O("$7VF]O$%U?BD/MV?ZGJ2S?AT8 HP00S M5FC-*O=BO5GQZ/U@\6RTMXJ[D5A,K5%7"PVQJ2J=+10=ZE:$@Z1HD"=7K1NV MT\\)8#->[X];_7 A3KKK9IY;HL5YMD-4W&T)K5JJKW-NB4H86X#.;95KQNIE M;ZX.RO:PCZ\/>9&$2Q*24G)6"1G:*&,.@F;*'[=[]HO0.2,8"PB&8(( !"(0ABWH M(0A#KU$(0M^F@A#K7KO>_P!-:P*44#V.CNZ\.OJH5PYMAT=Y:7U7^/L8%A1V M6,%EQ:SXF_RY'-DQS(5ILBS2C0LNP"(/6*#P;T,1WP[U[-!:I98,";XXCF*^ M;Q!#$'#:<*"5+)(S)HVN$K$("4*-].6@:U(E(P;T7H!HMCWK>M>OI@0^EMBT M5O3Z:JT-7Q]PH);0:>T$M](+-CRAT%/U,U$PI:^_C )6I"H9U\:_]3)?B!FM MV]Z^#8OE%H.@E9'9U:N!#RJ06%!ER:."4@D*A'+&!20Q#1EGFJP/)Q+@,MK$ ME*3&",T?L&P!+%L7IH._0.S032'.PG8#7+(TYC84Z98^ ;WUK6B94BQ)M>D5 M.P4RHW;!-+#. UZA9 MGY[?&\T:17_>H&VIP&$ !\AFS?\ 3#9-@:JGOR(3:5=56%1/.%2P"WX+SG8% M,P;I^;.=UQ^'R6(H[/(/=IM-(#&#D#@URB+\_P <&D42H2YQ;%.UBH2-*4:: M0/8@O>AO7GF:P%[FS;<=,RVK4JU5%I)+D-A0A^@"=Q,/"TK8X^/Y#NKCI*TQ M2HTF-1J#=&;,'\8@>N_3 S2"3&OIO'BG2L95#9?%&]8OC9#C!'QD?X\B<(TJ M,9G1@*5Q]4K;4RQ@7)!I%"70@C2FE;*&$(@[#H,9LV^Z,I43("Y+GJBI1R4: MLN.!LVQ(A A/XT&TP5P&4,J>&K;J)$):3HW1'R?'LX&A>GO#ZAU)O3'.!#4M M?3N@*3*8VV=E58(M"+Y]!$'T]0J;X\/(=7?<5+5=*')XK"%7S.8K.YF^4'%[(03.21R+0FSW MNM12?28Y&R2,4<=%3>F.(4JFY)H?V]:#H6@[W@;&<"AEN=Z4LFJSKE7SE<%$ MW#?/+5/V38K]5A-@H',QK: HP\02OE$;ZZP+!O/7W+\=NUJYO?+WK-KO5[6MK6UU M3+%;N\LZN0M#*%O$9_IOCJQ(35B9$,051Z8/R +$ 0=[#[T]UGS9T#)93#J5 MN>"V5)X4B(!49/Y#N(%5?3:U2^H*@!7E;KHBW3V5*I4E1-T14S\PLJ M#;?M+-$*6]+,##=:;% R]$+?3?PC'[1>@3A2U]4OT;#C;"H>SH9;4&)?WJ+& M2R!OB.0L&I#'5 4CXTAOUWK>!@7078O-?+"B-I+ MZM)L@"N5MLF?FA*WEGX[-.JMOD M%@I97+8-#W!EF4=AKDKD[/&F\+D[D_FWXEM3%(A'FGKU)?Q%* @,!L+RR'K? MG>'VC'*4E-IL+99LD=(S'$S-I"_GM2&631L5N\*B,DE:9J4Q&%2^>MZ XZ/L M[RX(71[+!_T)"C?IZAC%=]V\EVQ=3QSQ7MSL)N4:$6?HL01:T%MM;UO^F!5^]^T.8N9GMN MCMY6PTP)U<(_^\#BE;-*7A)'(5^=21?]]3MTCC$\M==0/]R+BD'YQ^.;6G[8 M_B^Q[];#H(CE_E*\?\#FTLKF5].05KF4$G4+K>9,^D4K7ZC4ML+6]Q!(\.39 M'5K2B:G47M )T&?IJ2FFE%J%)0S2PC"HWEG\G!/+=6RR)XB<:X($C\N$I/;PB&2C$8D,+\CU?\ ,2)]@]V\-4ZR65JP+6IN>+H!)5PM.[A+6-N0/;5$ MFA$2@9VTD#0[KW+:-Z4JQ*6]*XH41YA@7%I?R0\;6K7=DREDZ+B+[_MZCD46 M7RYK6>2Q,R-*9"C$4U.A3.^L#2I?$,P=$IA;0-E+7IW,\THE$(\9Q 3 L%17 M3%(=*()@OIF;@E)E>RDZ$S]C<(]*X7,(-+"4:=QVP3&#SMBC,RC#D:WJRE!0 M%J CYR# F%^X&];P.XNJ^JIYYBK9,K5NL8UUA3,I/Z1CC=PM- MN>.BI2N+_AJ:ESA7=-'W!"*A?XVM3K6-;:(_VVX/;H8L;DD>0GMYC2>:J,-2 MA'LH+JS/R:<3P5G@,D=KE YQFQJ;_P!Q+/(X?"+#G+0RT()4G;"[AG1\/BCV M; *^,?%A+=MP> (RBUPQ%&>S91^R@Q:5^6OQ\PB]UO-LJZ(9F.VF=:Z(9(SN MD3G[>Q14QKB:F<#522;+HJFAC8U+HNC-5I%HE^T:HLL6RS18',:_*GQ&[H)B MI36=(TKK#HK YP*'/526Y')W+8A;,I;H344AKJ&R&$-;_8#=:LL>$B!AVU$* MAK#U(-;"7KW;"%HZ"Z&JWI>$+9]4[L[.+0S2Z3U])VZ11>20R3Q"P(0X;:)G M")3&96UM#RT2.+.X1)5A(RM@"<#>@#&'^[88/TOV-2/)H8,5;*Z9G.]BFRT< M4C%>5S-[0EB]EKYB#)[#EAD:@;&^NZ:)0*/FEJW9>,K1*0HXOU]=CUK BN4^ M3KB:(&P\QUN0!S!+JUK^XU,W:8=.GB UY5EM +%54[N.8M\;/8J>CUC&FA+: M3I(A:WZZ_3 ^N P& P& P& P& P& P& P& P& P& P& P& P& P-4'G M"+E9/BWZND,$91]JE\ MU:5ONZA)^9W/T\[E7I+V6\*Z@@+;+@U7!J*K6AVC#ENTWZC65[%)%L96'*0Q] MT=%YI!1*S\:%9H-TW@A MQ2)$C=G=W5Q)[:SCEAPCS3=F:"::(X!@0A#7F]-$IURHWALV 1?;/)+HFX6Z\K'" M;L"I$2XEJ0K"7=&+L2N=BR*5S,J^*IXV\>$R9IM(VZ\K M G$P>F=JALPO&<\D&5B9'('3D,$-W7D6E(WL3R-8L0&(BTY!8C?:$RND0<+W M:/-#T=R!.;UFEGT5;48E7(;]!;HNAZ7,-(WK!V@71RVLXI*9(0G<-R&/&R/9 M:=1))(6N7-"6:EQ=*98;J4!R:$\CTUC-,4N)^_A#T>>(J5JYOX MZ.8I0LKV85>-VB;^I)B4YECM.7XE(*=2GZKR"52%$W21W8I*1Z.+48Y$@7Z; M%*<)^S!ZV:,-?/D0'3IGD,:FWR*H%0>)'7B&>MG-TH/;YH&)QCI-1)SW.X#M M2.%@VHC]S'UHP-0XH>;O2\(RA :!:6FB",*U\QLT6:,+\:QFJ$"44 M@TS",;/>%,$S1@AA1Y^YWB=B\1]X].\QINE9+*HEW[;L%?%L3DUGR1\8/'^O MMB+2BR&2M*OG4H0PRPV1ZBCX?EW+;/-J-<*5YQLKK-,R75-+" M?'R[T[4^2EMN"=TM<\R"-E4IWQI3L:W200$9QI: M@^O;1ZT)%0 .(I'9%$6K;\QC%$0RIJ86)A,MG5/''6LXC*E$C22H^>%D.*;\ MR[@WM>G7C++*V'M$8G),\,C,[H]*0HW5J;W))I8C5-ZO29IN'.[N:X#%6VHNF*(JJ MT+#B_9\-4([J+7R/3\^OEK,L3*AU8V"T0YO$W MHG1R5H?QXC$J0DT16@:V$12B!7,\QYIF/B8GRF@[BCU=I[ZJJ\H9-U#.V<]DQW;S,YY&8VTNT@F\K:D2 MM$[$H2TPW-0N6 T<&XGQ O[*. 7/$IS4TEKGL-JM60N/6LPD4=G(T]_3-8Z. M&X_=\-LB61=B1RJN)@RFZ,86=*:+<41?^FC()V7[S@SGS%MMDN?&*LN"PB?V M7$$5ST6[]$U[5YBT,WFO,3/9#*YW=&VE.S%*)*Z)G.*I1 7(FLHY:M;_ )R? MC&2,X.P\]EOP9(^'=]$VEG&'M846U/M#O;(H:N(12$5=*$(Z\A,4D_2 M]VWO2KMU_P F(KLYHLQQ<:@'%+8B,GX]K"K(])^=ZTL MJ1D)2C4IN!+]3QIG9[3L>5*J M#B&4)__C]K(&_-W)$P); MHE 2HZY3Z)5>FCRYE3K7]&XMQ6RFY<;I>E-T0%&*SDW.UBL5J/\ ;W*(JYF; MMX>UG.U*5-#.3>@W%)>-Q-,2!+'FP(N_RZL(DA5V:TDNI!&R&HAW4'-WWU9S MXM2$%FG!*DOYI69'8*4Y.2]M,5'+5;<@/9Q#* (1(0Q*=\PW>YU3W5$V3BSJB:J;+ MM?QX]"P5V<.-&FI6Y[;*>=(U'KO30JHXDVIF*N7@+(Y'(T<20[Z111Z$5Q&*VC\4B@:>JJP) MZ:E:!LND#K9,6NXP]P7.D-5P9V82M- AC+9T[5[30DB* MWO8>Q; \@EI\V]$3-W\TK;1_+-HI%MF=*\]VW!&]_I%SKF.=(<^5RX5\5TA4 M\"F4Q865K/-LMUB9YZEL+%\LH2@]Y1*T*C^X,6[1YCD=O,OD9M_GK@"_HY2E MS\]"6K2^/BAM2""R*)T-K1_56%*24 MUA1ZHT8>K+G&K:EJ2H(A'J6IN/T-#'=K02\5:L$.;8*)E>Y*V(5[MJ11]L0- MQ9,NV;L);F8<5I28J+%\N]CUO T0>:6F;6F]Y0Z84#15L6I; .X^F?M2XM>A,);50_^H($269H*FV_1 MO4\'0T4\6>T@>W60PQ%(9"SR M.*N*4UB(]%ZE.=M4>,E&%4K)"U5%,]C5_9-F5O:I0D!&8E"-O& M[RA:56./B%E4AXZFE861"UO>SYT[-!59%84XQ]LN$J6%5AJQ'1"I1+1DNYS@ MA"C:1:/5-9)0 C2IBR@^@>FFSV6322M;#CL*="6.9/T&EK+$GI2882G9Y,Z, M#@A870\XI,L-*);W4\HT0@DFB"$&]Z +?]NP\Q-&TSU Q<:H:1E_C"DT?OZA M/'[T;R#)>B%LCKMWD%ADS5J61:!Q+G-+O3*TGB?YRH-J>ZY=ZBC2R6VS 7O3_ #FM M^G'Z26 4[GP"LE3(L4Q=A8B!_F71U":H-,+,+"4%J8O0W8;SU3';;K7C2^(( MK>[]A\ZNFHNE))6TCY@FS55]'_M&,]-P&>LTQ=+(H?JHI*C!'DJ)G*7M1ORE M --^@ _00M5XB.?.DJGN9X>)U2]IUQ0Z#FY)#H*R=,EU\_W)SS+W"PVV2NG, M%/6S$9M()%:_,3,26JCQ<<;'EYW'FB4 89M&9,]0MT>]Z&0W()DPLREL,&> :;857M/#LH0\# M3OW]PQV#V23U!9< Y4>ZHD4U\?5.) ML\'HZ.1M0D;%2AQ1K7)0OWLE)\0?9@>C^G80P5_7,1CT>@3)6J7[Q,MRVN>K_B=\-UPNL4I+FJ MQ8_$Z\8)ZD>.= S!A>)B@J);!C5D-"Q(0"-,/)3C4DIA"VD"8Y-R-TY*N&?* M37@>/G!JOCJ+I>^9I3R(^<<[G.CQ7MV2F'.3:M<9LELD2)B3,:.%DG.R)4I+ M.^0*8*8M5LO8B@_MX<5](SCJVVGPW@2C;U@'1\OYQM1BM^X+R%%6?G*206OZ M^B!2@E7=[I U4%VNCK@SFC.$N5:*VLTE $P 8=ROS'VKR_<)=T17F MQ[K2LF>%=:6/://U[]+TW/Z#BEKR$3])H?(^3;<.D=A6[3BJX'$9!JY>' MW7PYR8[A7MWK.U;B+HNH 2B!SGC)CJ M2*R.*7]%:=)=Y\UV@^S)W9K_ &-S3MTCM&/M;4OUN(,0U!L:(UM+DG5G&E ;2QB^ )@#2 M@VK>,SFZ1T.Q6]()!QQ1/%'\H.T#7IZRJFQ7JVYLZ*HW&E*1[D%LV >;^U5R MP;PZ&DLZ%I+-"@0EB^PK5&&A^(,]\CU$RWHFE8E7,?IIONEE';,8D,W:DEKN M5*6C"XZQ-4A4);*H"QD"]M2L5W0^1F(3F73@<2W*=".)4')P&?8*#77RKQAW M;4-L\[3BS('"K%;*0Y8[4K 5/+S,IZLB5>[?+RBR9E6@,C3"YK0Q]FSA*3MAL @7CVZ+FM M?>3&!S^O(32J[KSF2A*>J:9H+(9IT],;O4O,:>C5C'+%C!$6@Y)%=R1#M<2: MD)W\Z!>HU]9,=Z $$4,WC]ZADM *8-.O';P+7\A31&E85.B:9LMTB,]O);%[ M)A[\[V1%;ABL-ATJHY]JYACBEXC*8YP?M*)>H3JE(]D)Q%C#:YXX*4Z/H6D9 MG">DY>;,'=3>-HR.KSWZ1HY]9C13#RZ)C((S7):*)G9 6A9Q!)1YBYX,*./& M2:00-0?\&A:"&_)]R)9?6/\ $K="84;*DD#3U/;]?UR?1TNVX- (J)1)ZY88*K+>&LQ 0):ME>54C312-IY"N)-3KGXAB:RGE80?H 3B% M3H6E"N4$G!*#H01F;"+0=>NOTU@&V&Q!F:U[&T12-M3*Z_/^49VUC:T+6Y?: M("E4_?;TJ4I(L^PF#HLSY "]Y>M!WZZ_3 [0AI:DH5(4S8WIPK"B"%@2$28D M*HA,F"B3$J=%EAT>4G1@T4 (O70"M:#KT#KTP/UMM;!)4S<) A$B1;0C1H=I M4^TJ3;::4F+$1L(=?$(L.P^FPZ] YV!"54='4C>4GMZ'5+8 MC'.Y%0DX%6MO(&/2TT,'GI2<2I3%'1883!U(<%+>R-YRU*W$J%!#4 MC7N!OS+UI100E$C$(9@=:U^N!T44Z5HJ<6RXT7$K+CS[;316L=N%Q@Z$2P3N MEK*6')$\;F0_D2%I!L[P>N*"2()HA[V/]0Z]-^@<:'=/T1/[QLKFV'V$W/EV M4^PLDFLJ")FY\*71-ED:HY&R*G!P5-9#*8-P.3BV HE2:;[/0>PZ ((MA/> MP& P/S[@_P"?_AO _6!^?>'_ #_\-_\ + ^"A:C2!+&K5)TH#E"=(2-2<60 MU6K. G2)2Q&B $:A4>8$!8->HAC%H(=;WO6L"'*1Z,I?HYLG3S2LY0SMKK6R MY/3\U7-Z!Y0D,MC0P#>.3QH0GAN;MK3VC\H2$PY/HU-L8MA"8(01:T$U>\/^ M?_AO_E@1->=XUISA5'I.6+X21[ $>QB] !%O02L4>4<46<4/0RCBP&ECUK?H,LP.A@%KUUK?H( M(M;P/W[P_P"?_AO_ )8$ 3/J"EH%?],\OR25')KMOQGG4BK6'IV5Z6?E8]6[ M(J?9<]KGE.A&R-")N3)?C#I0H :<>: !8!>N]Z"P.!_-[UK^N!B,^G,=K."3 M6QY:J-116OXG(IM)EA"8Y8>EC\6:%CX\*"$9 1'JSR6]"8(!1>MC,%K00ZWO M>L#C5I8<:MFN*_M6''+3XA9L(BE@Q4]R;U34XG1N9L2"1L9R]K6EEK&U:8V. M16S4YP0FDCWL M:%K>L#-O>'_/\ \-_\L",;HIZM>A:IGM)6_&R)C6-G1MPB M4VC"E4X(27IA1I8+9;8N=XXGEK3ICD9:- ].;$;^69PJENVY0)8U&;T4(S9@0;#[]!'ZAT$ MY:%K?]/7_AO_ )8$'T%?+!T-$)!,XY#;-A+='[)L6LAM]JPI=!'YT<:TE*^( MNTB:&9Q--6*8@\N3::8V+1Z+VK3:T9[ >OI@3A[M?]O_ W_ ,L![M?T_7U_ M[M_\L#H395&2)*BAATA92I>Y,KC)&^+&.:,$B6QYH6MS:ZOJ5F$=IQ/9VUP= MTA!ZD)>R2CE)0!"T(8=;#OO=K_M_7_LW_P L"IE']B5]>U[]0U-RA[=1$? E M>J3DC/,#H9H [V+01;S3T%">J:&J[HBND,E;(/;462RV-M\P;4K3)T3>J/4) MPIGQM0N#NC1.!1R86AEEJ3@AW_\ >W@3EZZ_[?\ AO\ Y8'Q$I3@UK8SR0ZV M;HC6Q& #K9^]^W1.M[WK6SM[_3V_^;U_PP/I\A>AA+V,.C!Z$( -[UH8P@]N MA["'?H(6@;%KU]/Z>NL#^&FE$%B-., 24#7J,PT82RP:_IZB&+>@AUZ_Y[P* MI]<=81KE.&0-T41Q98%A7+:D0HVD*T;'IICJBP;5G0E>V!G529[%^*B\>3I& M\]4XNIX#BT:4D0M%&F"+*&%:.B_)+).7.-F#L"VN-KV9$W[O)A]DU)I\K,^> M5@8X2Y5!F*2.2I-*5$4+91X%2) M42(E026+V[$%PU)C8J3[2K!H5*1R :BVG4[(.3. #@#+/2?$;[BE8#2_<$9? MH+0M>NMZP->-K^0-+".@I%S127.UG=)3&G6BII#T"WUBOAS&NJ>$W*YJF:!N MT<8)>ZLAEH*49;>:O=T+287^): ?-LPT[_I<#8J4K2G@V:2I(.+"/XQ&%&EF M%A,]=:]@A@%L(1^HM?IO?K^N!_-K4>O9K:I-KY?7XO4XO_4]#-%;^/\ N_OW MHT6@[]/7T%OT_K@?TM6E.,-**4$&FD"]IQ11H##"1>OI[30 WL18O7_ 6M;P M*G1KJK]P=IV#QX;6SLU"A5"Q&^FJU#9-'7!@FK)*I>OA VEHCS6:K>FI4QOS M,M)4C<1)1B$0$111A1@3<");*\@R"-=*67R[5E#V5>=@475T;N*[QQA\KZ)) M89#)?HU1'"XZ1/I/'UMB2)R;D2D[ZC8 1) P%DG*"S3RP["4Z)[:IB^ T"TL MZITC5A=#_ K+GC5&FIRY_&JUDL.'(&C_ -:;F5V) M4&/+TA;D[HQG.90CT)AH5?IOTT7Z_P! M9&W]))F)E?$H=D >F5I>P(CC"A* MTB=X0DKDY2D)0QA"8$L[V[WK>P[WK?IO>L#O(4WM# O"UK M'(Q@>)>S-DR60N/O+Y'6Z8V,@BJI6;'F0:K7Y9X"G3:+.V9HDP-5_*W?=^VE M;W#+.#IRO+FK^_+8[1IVR8X*A3J=N&+J:=KA;9D$U841>%OWJ]MVNS DLTH; MDQ"EC5;/3'D"_P!?6!0]%,>S^I>K/%)8,>NNC8CUE,*:\G,>07V54!TM@JJ! MUK;_ .T(T:= M.\5^X[.$>9/9[_F+1)S%9J@";9@]@V$H5/U3VUT=U_PU*I! MO))* MUXJZ_DMVD%.NL?72F12P]C:XLFV:25HXQ01ZAE=0]Q=L]IH>8Z0KWHN M%\[72_>-P7;[_: H!7STQW-;2FR7.OV&L%;%)D[NW1:L&#<;4K90I-V%?U)VUY..V?\ ?^'^'8XTQEDBC8Z6VW:E<+"W(W.' [G-^F(?OG><^*_I^YV:LYK6;6RPNL9!S>17 MSW%'59)HH6\6W.1J&Z8+3'LM*,9QZ1*,2-$6(.M!#!9OUOU/T+S1Y1Z-N*;. MTMARSQ.0#J&-([TK^M6211^6SEO>C)B?'F*HD92QEJZ5EHONPY#)RC9,C3A1 M*5PR@B$(P-RU#^F_)71@M:W_ '>&>$>N]^FQ;U_/D4WK0MZ_KO7KO_CO U]= M5-W3!'E2\D%C\P='(^=YA27CBHFW7,UTK6(V(R64E@Z^T9(@@2ONV]9#9-LP6U*;Y[CO/+MR*NGE9V9,*Z M88.;7%D5%6MHVJY2&OG:O)O?,OD=A++"6-D)-8Y(T@"B6&IRT&@(P%C#AQCK#M.&(.))R1U4MMEI\C/''4%XOQ1E=05 MZC//MRU11S7>D?>Z@T&*QYQ2U0W 6%Q=4R2$3F(:GT4?8 H.WZAT=*SKR12] MJX]BLN\BSFF'VGX\9OTO+)>UT95C@YT\YU.14\@:RJO<0L@"OS,H8[>+1R)> M[-KSL0VXT:)*2>:28F"O\8\DG>O93%0E:5G?-I+7AL6 MG/4UGK*XIKS].G.4(,B:>OA,:JMVFOQVW7RN5/QD[W-44C.9DZ(Q+IM<"$A(T_\ >3\AAF@!(L%[4[@4TQ5'D'.Z!>Y9 M)9QY&#N.[/X6U!8PEK.)5V]7<[U.SP:*MR2/G6HP73#D92:2J'=Q5KEBY H^ MN) K6LT\>:TE8]N-4%*G M6R#V5V*3BU9-?1ECU=8')$SLYN=/WS!FZ:R*-4M5E>5? M'Z#<9C%+9FC*@3N),B,?UIK[H0E)A*)"$8" [GG"P'*:]9^%;K2SNT)'>8[^ MIWK^R[*;)[):Q::ZI.>J>?$ZI^CU?1M@8HVOKV/L*A2M9EI+@H6%''-0#-F% MF>H1!Z2[PER:6@S(IS 2B[)4R*QYEX.+MZ2L8N,J:_=R0 MWY6<3A=+UZ[:X7%W M.5=K6M-GWH_PB3OLTQ1-6FIUA-275 ]U^5&)%6;1J%)DB=N,89A+X%6C'XPJINOH.4CJ4M&?-36 M_-O4%I5-*@L'\V4H\(8T[-BAK;%8%20U.K-*3Z.,3FZ#MX?TQ?%A=,:'9=^W MNR5'?UF]&5CS);]!S^+N%%RY&W4/.#8K2,NJA2PM]EO))=,%I/Q]6O7O1T@N*_GGQ/],W):]*JY*RR%@G%B5_ M6D>KHCOD M.KZ=1*XJEY9;G-''[4WU',.;#[)O&'1J[^PY8[2ZN( CJ-K9H_/QM"2#[;UZ M5([FD&%!^LWG>P-EWCB2PV/>3;R5QR)=).O2C:JI_B)^897+++:K0EK6SFL% ML:5QA1)&TP)+BWM"]:!>7\90 $%/9(1^HS-"&&N?KGNVV8OW2KF,,ZLEC)$J ME\FM"\MR>-R2V(?6<"8*ID+=$P6U6V^;B#WDZSHZC/TJ>G*T7Y0QG-X5!*-$ M X@"C90?-CMR\:RF7/EVM_>71-MHS_-_9W#2:(S:VH<\5=*>E9U,.@K&\I MEAQBUJ'F-Q$JH/S:BSE#&TYE;M/.T9CFYZ<0@,5G 4$ M%A#T#]HW,CH+N/QT2*576KJ*I;/6=,5K;1,GL']IU#)2FBF5\NK@B2$OB]+% MFV3HID7L;B1O!IA3D-O=DQJ$\LTLE06&(\ MM]ERZY$W&5"]:=>3.K>:CHQY#(^YWR9T+NJ)U=%J\_WP9 JJ89O=Z5U8WTQV MA=5OA+P0A3K$H'I26G.5!6E%B(&%;*ZZ=/+H/@#F%;W*Q.A"N@+)C:QR=;7J.2P_>Y]64+9$R]/'WU8I8W$YY%I6AVI&BV(+:" MO:RB>IN07:QNRK"O.)O:7QVUV5-*5M"44!;D(L&=)71]94@-[+^J!",L8=K.>H$T1Y3C9MK=6VK85'L7FOZ(H&Z7Y'T2 M>VTRY]12OU=J-LJA6FN*(RF]G<3TY#VP%'LJ404PMA- 28'$JM8FG, M(\5%=2'O>TU\>OCHOL6$O*&&=CM3U)4W/&ZLMG^(ZUE,IB$@9.3*(;NPIV>WU(\>0U@C%AV=>4WK^L M9ZGYUL)PB]36*[6/5[JBNFT[<@T;D+*=7\((=B1.Q"C[KD:864EVL#KHMTF4 M<\Q7J"M[6/L#NVT? ]!3*><%=J2T]RLOIV'N]@P^WF1GBR5_+BDKL"%QB/:= MCHX-$<4)]1?DOJ"7C,5;#!VKHU/7//KK8G/'<'1/0-0VRR@$J0G*WSXD9!"5++:I]4+\EX_E%TZU2H*-$H3&!5[G:QH-0%0 M^,6SZ:G5QO%E]!<'=X,%GP6H[?=YE+)FAJVL9$Z5LGJJGY+*7J.Q2QHU9,3, M(85C>SI6W2M(K)/">H%O6PIFW7$-IY][5C4;Z%F;D&U_%Y4-B4XR5U,>DC%Z MR[:ZM ]J7A>+1>AL:6WKY/V]:*FBN/)FR.+G=2)H"@--0B]0NST3S]3=-SOG M2%7E:?0M1\$WIRZ.VX;=[HHLGIJ.J>Z;+ SN4RD3DD=U$I?83;>X.D3'PUU& MD,.2.!Q_T?88:>'05:+' 5 M?.[38W-FFC4UJ2UT$\9WA.X7+&G)L2*=FF'A<%"<)?\ 8&ZORI*8]JYN&FOI MF-.3YX]'Z:6I'NC]@'*'*#BM%\B"!/SJ&YXY%4X#PUHW2,AQ4!<5YYC.C=OJ MB5DAV$@\ :%[#K"M'&"\-AO=N^.>45^_.S]&]V'8G/L+A M:.$,S\\2@E+$[GKR;R);'2&%J>5#5N]!=2]"[(J[DQ1QY=\TIJZ.J/XUGMD\(A4:U4DMYBIF$6 M659Z"*V>"NZWCY3&_2RZHM02)[7339:1S94Y!298:>8Y!),+"\R;ACC5D\G+ MCS72;=::-94G#:&[J(;U]R72JCAW4HKF?;7A;NW2=[EZQA=EL<8#6A;MM6G: M0_4T4:>G4""(T(4@I^ V?**3O>=/%6HZ3 M-A<9P;8L[&QDF7?=$L>E,C<(2[,JMP?#0$_+H:0&B@;#:)XN'#E]=Y$'R3!C'E BW,\LZKM*;.\CZ"X.[6I:,UB1S5V+4$,MY^CW3:B0PY MPD""I)(DA\)=(I-!1>1H?Q:MJ$J"X&I5).OE-(")*6$4.L8ZAD]TT-T=->5G M9I[HO;PW62WQ&P(E09G[>C_=P59;E7BF42P++]*H[-8*X1"*$=)#&I&T#5EM MZ109H8R@!@4:@]DSMLYE=_&+!+*J#JJ"<$=(Q[O0;O#9W2:V2W"HI-MC]?L% MP+I(VM".<=*.O0#LJ?X\Y*C5KF D0'(Q62W&@-$$;V9!:9??'WU*?SCPOV94 MEY33B&KZ3Z-0R6L;:BL.E-VQ:PH$%&TM%9#:EPK[O23NK4\.3I.&U*=LMET) M0O<-G+1E8&RSQV= -G+%:=3/'3_.?0H^O&)T8)_<%D5_1MR6-OJVN']6S)J1 M>J35'M2I*G;8'#ITVLQL( >A.C 4J@1A._C6&EAZ*42K2U&D6A(4IM*TI"K2 M983M.K3Z4% -T0J(%O8B%)6A^T8-[]0BUO7^&!RL!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@0=T-SM5W4=;FU3;[:^N42')H=,B/VQ,)5 M Y VRB R1ME\1?&>5PIW8I(T.#+(FE.I*,3*BQ>\O6M^NM[UL*X/OC"XTD<, MB<+=*[DNOV?:4PNI#.&NV+5C]M.UHV*5M)8LRE=N1^9-=BRUWG[5O2!X&XN2 MC2YO++3&:V266 (8_P#^TUPVA8ZR8XE6-SBJ5O//[^XT:QH' M/EZ.O43I$^,/FZC=J21BKWG]7(C:CCZ696$C_9[7,"-HYC$4KJFEA;TM@$M;MZ M2.3 J4G,ZQ$ "IF!R).G M>]"ES0\/Y,E*?I'%'X19>SV=>I4->_A!K1&M:WK83))/&[Q!+K#=;.D7.\'< MI*^5"AHEY2"T[)X>ZU>TQQ7#62..$!2.2>$JAQ^(+C6MN6#0;7-R 7PICB@Z M#K08RS>*CQW1^EYOSXT\EU.GJ:QES6Z3".'M:YR6NKDPIAI(VO!*G5Q72YN5 M18DTS\4)*O)_&".-$E^(1QNQA,'.'%/+G(RF9K.=*?CE7K;#U&]318S'O"M7 M(M1)H+9&#;BJ>')Q/.,1H@"$(SW?(>H.-/-$,XTP8@PU7XZN,5]AR2UEE'M2 MF=RMSM-\=WDZ53\9 7^[HXNB-L2)E8]RS]O1F1SJ-.1Z-/U@/@)R#FJ)G%U=");6E?M[R_SR1LD6KR>)7Y%,80V,$AECHR! MBLC1R=<4J0C3C3&%G^WV>@"_8&'-?AL\9;(CD;>TAZ2!T3@6FA/(W.]=6P@O*& MUPG9K7;*CC]$(9EJ12]>N(J.*EM@&"#_ %'20+6HQK;A-"#.0;SM!/<]KT1#YE9A;5'V%=)UPWI&9)&"*O:>21R/3=K:G9 R M3Z/LSXE+4D(7M,X) #!K_3]/TP/Q/N!>,[1Z B/4]@\Y5E+.@8+IE_:]GNS+ MLU]0&QOY_P!N*U! %!;2[.$>^??T5*Q,H4(_87\(P?$5[ [9EXBY*CG23YU^ MQT!7#7TM)&X]L>K@2,@2Y2L)5HD[:N5:W\NVY,\N+:E F4N!*I3^XLTX8 M!C"(,6AGCOXKKL%D$PGGR&1M-;,+F%<31&W'R " R V"MH2C/D,Z M6(HQ2]@"D(IC7S0C6RI0E2LCZ*4K?EWH'SA^0'L,!\!'QAU;]XJO'C*H/3-: MRODZJI3!>>S';=.1V2HW:0(X0D?7DV0/#*C,=W58KCQJ!M2XQ4V_(+? MH1K7Z8%I;=H*F+ZJEWHZWJWBTZJ5[1-;>O@;L@T6Q:2L:E(L8PH"D D9S./-/&;(AJ/D"CVR,6VI@ZR?M#1$4[.0]* MZV"5J#JDIC8-(HCRB/&%?*4-M&C$,\PTTS8S3C1C#G+_ !EO%4'\F4N M17<@LEGMY[BK9%BF9O<[%C^E &22+!-!J%4:8UIE9R'15&?%9=-D7MV3*))!()3R+S^_/BD+(A)2%!4_+H" MN"#7V!F[U@8&U^,W@./2%^F<;X\YQ:)H_N$O>E4C%4T5 M<3]O2.7:\XZY_A'/=: M%B%%H@![6''"2D-R1QD$L?7*4RQP;8ZBW^%B;(X2)Y5&(V9N 4VM241:5,6$ MDH.L"-6[QJ\ ,Z4:)JXYYW0IC=3<)Q2>KXN7H_\ D@UK,G(E @M_O4F20#*F M)4"'L0OJE[3AV$@8RQ!V;=X\.&&A0C5MG)//Z%2WP9_K) >GK*,%FHZYE2)[ M;I)!4HM-_J1$GQ!)7 E2WA]$II:PT.P>@]X'Y=_'?PR_(X"W._)U#+VZKF 4 M3K]M.KM@_'1>)B>7.1_M1N0 1@2?M<,A>52\+<8 Q&!:=L\)>C=:%H,]A_(' M+E?6F[W?!N?JBB5OOSA)'=YLA@@S"V2]R=IB(H4K=%3TE1%JS'&1[)!I:?[O ME4!!H(Q;#K6L#CP3C+DJKY EEE<\S4/!Y0B>Y7)$4ABU5PQE>D<@G):_8(6MAR8!Q_P K57%9]!JVYPH^#0VU3E1U MF1:+UC#V=AL 2PLTI0"8MB-H*22(@99Y@=%*@FE@T8+VAU[M^H9;5G/5$4>: MO/INFJPJHYU9V"/.9M>0>.1 ;@QQ8*T,<:5@F)N0B4H6;;FIVG+'ZA+$>8+6 MO<,6]ACTHY-Y?FLCE4OE_.U(R>53DV+'3.2O]80UU?I4;"75.^1(R0.RUF.7 M.QD>=T9*A+L\P>RC22]Z_P#('T#[#Y3Y>-2EH3N;:#-1DO*F1E(QT]7@TA4A M6@3EK'TI...[* \JRT9(356M:/,T4#0A;T$/H'(2B*=6W9X_@/T#1I7O% M[=Z]=X&)%30],E+F5<_N;.M*J^$%JVERE7ZRAP;5(&/1R%=)-__ M +^:4(!BS_\ +;'@<3_;%S7^V&^$_P"WJCOV8TOYDK:XC_$T"_;#;*3DQ"(V M2-[#^ _%(W\U&E+)$L+*"H$46$.Q^T.M:#MG&@:(>&.+1EWI2I'6-P94T?6#+:G543MP9Q&&B3&!V:+>@E?F+ABI.<6B2'&M42G]@3B6N,TEDV/JV MN(,WDN;DPQ>+F,T!@D)CS;&J^B)#!#&PCZ:4)JE:8FTH7JEBH0C]A99/4E4I M"HF0EK*O4Q$"6ZR2CP@#H81:UKT#MDD2BC>B>6U!&(\B;I$D0%@1 M( F!0HP@2$E!"E1!-'HHO6O87H6_;K7KO XNHG%M+'!QU&H_IP=DRE&ZKM,S M=I8YI%F];5I7!3I-\RU,JV'7R ,$((_3^[6\ CBL7;E*1:WQM@0K$"<:1"K1 ML[$HXI0 M5HXH!NBU! ]&$'EZ&$6@'$F:T( M>@@[UZZWZX :9.:<0H,3D&*$OR_6/&46 M,Y/\X= .^ T0=C*^8&M:%[=Z]VM>F\#[8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8 M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# I#Y'^G) M9QGQ-?W3T';8T]2FH(LWR%G8Y<\!+^V6 MI%]3U^;9)^@;)&&J[GGR]]'R[J7Q_P!%V-!:&LM@[HY_!<3K_MZ0SM'.N;7% M6P:DB1+9K>_3>>(5L63) ?"FPU]2+S.]LFPFMT3:=C_KNCREVF&62$KX]Z5&A:Z%^2?JBMNY>#^7+2EG/W0D M6[@J-FG[N17D*DM;V[SPZKJ^534*B3-B>7SV-.\+>1B+"A-4_26GDDG"WHL( M &'ARN9.[^M_*C;?5)/)UF5_RG2_(MB K^/N#]6J.ZY;T;(CETH"A6RXN1*H MNCK*O5B&, %LAJ^5Z_Z[U^V6(KV8%:77S!]S7=XU+@Z^H*%5A7/1?#UQR2N^ MN*=?HTYSVM97%4"4@EPF%?KP.J24-JJ'GK"%9B;\B:4!.F<-GF'%Z3#T%\*[ M[6O?IG7BO1<_VK$ O?2=+2:[^J-#JE&\MC!6,7CL=0R"6-R,R4[4P5ZW=0A1 M%E),7KTQIJ]6<<2JVW^F@H16_EN[<8^?O,I94X..6,M0U02CK)3#T MG;FHI>:VMXF]O!HDS7N+ +WEA8SF[N?J2^J1N6 M8TWU+3?1E6Q+D:9W.3THBJ&+P>X*6Z/85#'*FOG>YZ"3SU2S'M3O""'7Z[@0 MW(MC+3F>BLPTHLY0%2H1YN>N2_'ARS<8H]!;2[*\@_24UI2C8NKCI,.I&IR( MO*&R!;6'IFY:"3R%,%:L1J0%.+P<>>N0&,2KS"7[7]7>,5'T+T&= MS^Q=!KDBV+1V/Q0H\E6_.82G9V.0A( MUHA+\YJPL/0MQK,[FMKE]CDMMV15TRGLB56&E8;FH$AG/KJ90S4KD""KK/A[ M6H>IPUI#WJ%!;G ]O6'J=)EXC2#RM: (O \H4-\QW>C=R3TQTQ)NU:>66WSO MU0LI:O>8IM2U6E#Z1B9"Z*-!FVM#""(Y9J:2-_Y]2L.5M9GX_7U- &$K7KHP M+\>1/R%=DU%9GBW>8=T(W\AUGWM'8Z.YHS:]45+)$_-)P4=9+I1(U$DF:- J MUIG(L,X*].[+ )R!MP=Z$3H8P!#OKRZP\B%/^+CHGM*/=41JQ&-"#GRZ.5+F M74#5\4DTSJ^Q5C5$)[6=G56C/D$693FIZ>27)O=T1QAZDHTL.A^S1I00W:<' MS6R;(XSYDLNWYIJP[+LVF()94OE1<;8X@G6.D_8TLNVA1QV.)T[2WH6).\ 0 M$^P/O.*3!-,WLP8][#7+U[YB&+F?R6'S'0%IUZK,YRI1K5(KUL*6L32^U M<[,+>SN)SK!'IAF*8],Y[^HH;U"76A&G!$, PE#A?HGLGJ:TZG>ZT[JCG0U4 MQ..U@K[1AP:5HF,%UPY7KS3))S&4U66?"BEP9E(:[ME*F1O;4I0I#V_8RTZC M2@1"T&PU\53Y*?*&_P#)O?76Z/H>(3EQ\?\ TZ9!UE22BBJZ0Q.WZ<8W!<%<@5DH2BTI@1D:"/WEAZ'HST-:G;OCSBW07$ZUDK2U M[WKI@=ZU^?^ONL/*'VMT_15:7B\HE]G1:1M"&N&J3QAY.0ID,?(-<4J$D2DY.,[9)8 M6-\/WD;M+KYVZMYPZ,1QY3T3QG:[M7LLG<*:A,L.LV-%2N81)EE"1EULPIA? MBW"$*@+TX!!3F[,+.(+* (1)05)\F_0WD.XQL'DH*3KL\IO[![=>ZD5Q*.5% M3"UHJVDG6;I$EW;Y( M/'75= NDD[I>5JZSNMII1RZP$\)J0XI1S+(#DTRBEAR=G75:G:XS>L%;"%R! M2K;0"9C$)0!;2C,WL6!DL-[ZEU]^=>;^\9Q;/'<[J61V-*6F)_Q(XL*2 MQHK#9TYJH:SR=+693R7&=[CS:L5)1';4!.5F@+/ 5L !3GD_M3L+HFY+SY@ MDOD@Z98>A4G3MLF3U.H:RK(BC1O"E MF,(5^Q4'1",7ZC 'J+ZGZCD'%W!=B]06RP-[_/J@I=G?I1&H^L.6L3Q:Z](S M1U.S(W0MN9CQQA=8;P24-9I(E$! (1WPE[U\>@UZ<_5WY+.I^&6KJXKNF35C MU/?]FVS+FY2N>CGL]Q2N A# MT$T)0BS@KI5/5'2GDE\D=^<-'7=9_,-$\60$DJ>.-#.S/$+LN>WX^[1J&/CD M\6.X1R0&,$((EBIR-*0-2=!]M,21LX1FC! "%="?)IUT_4]Y3>6IU;,KB_2O MCYGC4II7H.'HH;#)A8D277,74<4+M:#/L5?V%\:F[\VU+WA2B;R O")<5O6T MQPBS3@[R@O+MT?+O'E<-'2Z=/R+R6UG@JA&EACCG>OD-L;PM\A=8U-UC?2WKR M[[3FC8X*4J"O5S"MCND5S$O# FA#)68$@R&J.4N2L0J-DJ5R!P/5'%F; ;\0 M PGK7S27G;/BMYUL#DZSG*O>AF6LVBXNI)LD+;3W^*MU36/$:)<63JO> .A#+T%H#.L>H;[Z0\8_C8A-WV'6##+7YUMEPE! .D*'FZ"$NMCJF1HMI(T 7R5H MTD8'02=2\$]< MU_)7-JD5M,$U2,DT;ZZ=IBB(*7/ZQ4I4+FE,%2ET-0H2+6LTS9I3>,T/3OY. MI+TW2?C5LYXY&+L637%"X= $(71I,43"WPP)*]QQOM&3LS@\!\DLAM&&\;^0WL*LT)U-1E!-J[OJQ%;]?5 M'2L"P_#TCM?R^7WY#)C>EZ7I6-3\Z7T917.-2<_V]-*:20!;$U4 MJ*-LB2N5?.#"ML65KBDR([VO1RYL^?9Y>D8"-%@P-;35YV>RT7C=DU;H7AM? MNK&GKM-Q$Q]+/Y2)O<0PZ01U\<8]:;PB,UMB5VN4&/*D!RP82$"?U)<30&G? M($0>B%!XOI?"DO/[M7?:W7ZZ906Y*PL:_P VTNAK*FD1Z.8&5:F'9+)(8BI= M%+/$5#^5\BEN)82VQN*/ @\LTD6Q!#S,\C>0QSYXL'MWGJ8V1:,NG][]F/? M&]&V;TI=-ZNW//.M/I9+-FE[DLNF0YJ!8ED3,AVFVG*;EJ&0*AA(./V+;KK-9#:$B@^Y4G1%2>ZK*?90ND2 MB.PI"%*$U.UH@(F1(04:#1Z,]AV$PV+3J)TZ9D\:TE4R% MA,9J;E,D7SQ-8.D(F\YQDP$PMIUPC3PZ$D( ,/2CR'-NHY]3#<_]ATI$:#NW M]Q2A$YP2#6 VV/'!1U,[';BKXD?6PY60F/?/SM<<]3=F'<6L7/7/Z6YX[2UW[N.T?S%C5?"FA>PMOXA .OR6^>2%L M4.Z^5-_VM#'L@2 HD/L-'O9GM"$X^5[DF=6]XV+"Y-XWY2B"R36X?#4C;$8\ MYT]4,7J%0QNS%*AS->%3 MJM+%;CWPM+7=MDV9(8PG=XL<&2F" \L>UZGX40=C3:-/V D+8^*;QJNO&O,% MMP;H9WC5D6OUC.YG:?1K,Q$GFULB76"U;:'2NHZ6K 0<[,2-J/.*4JQE$?;- M4F!"6$H!>]AC7AU\83UX[H71O%6PR M/*%J!(ICG[H6/BN1/3>4<-+MT7Z&+T. 9O I7S?P%Y+.>3?)%+X5#J,;YMUI MU;7'0%>LLDM@UXAKO7C7;$N?[+IZTM(X0>805-:YE1S:882D<$@]GFZ$'7L M(8=<=XC+KKBV._+KY-IB-\WLG27%"SGB%<^QR\&O\&ZW1;B]"CL"RU3BGBVV MNMX%5J4 G!O0-YYRMS4Z/$G+0@5"0:"/&KPK]H'^-WC6MPRVNXCVIX]^AYI< M5%)%DO5RZH9DPO\ .V^:IHPZO(H^F4Q@)1R1/M/KZ"HL@U",L6M%+-F$A?"[ M.#>B_(#VKQ=>74<"KZBZ3XP1&6*5#XM8P+4F%L7:X/\ $W_3$-47&8^TQNL( M^YPQ$?I29HUS7!+V#1:?9OO(#\3[Q9//9W"%U\]=4P>OZPNQTZ-Z9O*B9Y!7 M9-+45;O=KVM);,ASPTN6FU"Y-Z!R02$#/*&S8!:6%EFG%BV9]4PD,8*X2Z83 MUOS?35E-7"GW]4BD$M<[%MBVF>NFR6.#S%Z MZ2S5S&X12G&&$K&@1IRUKT- E L0@4:)+T4/2D+B]0<4>3[K^R_&79UU\]\X/COQ.^:D=XMP[X2KF#H!P6 MN< 42%,S,#I6*I QMS\B@NQ'%.&U)0CUXP?'HHL.QA)-\\:>16WN(.FN-X93 MM&U;3LAJZA*+Y>Z/+*D96EL:4P3]-A MI 5*4\L98C!A/-;5MY0H_5?!'/R2J:RJB \UDUE_N!F<4Z.$]2>X&6BX'M/% M:WAS>77;.2RQ*T9DRH"I"8X&#&6VFC)" P'R[,#7MT-X.;_Z=XXGTLLUTFB_ MR.SNZG2VEX5/4;HKYQ(F3H^)&L,W9X>"))XU&B&JHD:6.H4J)N+<$)#X#NE8&OV,F(/;(]++*;) MB M#F]R,^5&14K86LTHH\@U>+9JH>B=[,#^=E\K=?='>(%LXXC%652TW_)H!554 M2UOD5GIW:#0YLK=8QB6S9BE@H64H=7)U30X@;>66@3*6\]PT+9FQ)M[&$:\U M\H=ZTG(J"9:PH:@>8HJ!GH'_ 'L3V*W0&=R2_@PLFL8_'X07: M2[91<@?5)HW$Y(/V;]HBA&J HS37B=\F;'S/WOR6I8.G;F;G^'< ML\^T]SM 1&&1*G8#'X,U+#TY"56[B9T8"W%_<"4W^@!TD3J(]Q^G6JJ>HQRV%,<7ADZ>'.91ID;'6+/48L:0( M5<):F5>JG>X> *Y"G6?90+5PQB$<47[AAWL \>UW\)=O=.=6\:,D&MFJ.P&D M*^P.=9A/%M1**[N!.\K9&GG,5D:6,RN-/L(<75U<]JD)R%.YMWY46D@SR@;* MV$U>+/QNK^%&6]K%M2:LME=0]7V:[6K>LLBR$2.#M:]8_25\;(;7P5[4U/@H MZUJ92K..4*BDXUBH_8_KD 6#01EY:?'WTKW387$[]2S]1T>C'*UT(;T?P6? M)9XT/\M?6A[C*M%%6LGQ)J/[2:4?*ZJ=@/ M,&,OVH@! /WAPY5X^NIY'YCZP\CY2OG]%4=9U$OIQ)6P9Q/ 3]>V/$0FJ%?) M!J"*BU&B%I$HFYP@(]GFZ-1)PBVH 8/XBPIWS!XC>Z.;'>])LHCW!]NV9/.I M7#KVDIA-;5Z&9@T+;CHU3J.K%NT$1I-J'8" R.3Q0G,2FG-J!286$PY,/020 MDANH>N-T=U\#D\7]0RU]L99,:28(!<,_2O[BY/CU/243LZNT1RU=$;(2*I[%%.IZ6 M.-!:4[\)/'G\Q/:[V#[_ ,RI,#9"(6DHO0\(P@&Q/ \:W\K=H\Q<\3RMX:5V MSTMNU9;.YI'I"O7US44>?&R;U[5,28H\H0I78<,L7RE$D;"&00/Q?V,;UAT?Y [OL:L)[U?8]4+:@H MAC8(K+F:E*,CAD%3P_2SX5\B7S.1O3T':H*X_P"8C1:9:I"G 2@6P!R;O\ M$RFZ3X9YCH:V9C!B.I>2&&K]4YTA%8(:6V,DIJ4]C*:0'QARL=?%#IFU-:^ MM9TQR]8C51'3RQZ?&V0)6LU M:JG?X?0QOG* R.OH$Z*7)P XRVV)R9)I/('J4V!(" %MA(!^Q.B;4Y?R#5J/ M:<4&+\&>..[>6>U.X.M;*N2KYJC[(?$\A5P2#U_*6$^*.#7)7ES8@D2!^F+J M U&C97<:=2 20P:M1O1H1D!!\8PZ*)>+NV^5^E^F;\X+ON#UG'.P0*%]KU%; M]9.4UC$"L(]>[N9%K5*LB,LAQVE[:X2)>>6PNA)J$P2H8!*0E_$$D,9,\!'( MKAP2;Q,^OTV<7Q=8:F^'GHTC;>CLESZ*6M![.MLW\6:%>Q(V16W'_1,CQ?HC M$V!"7LW[>M+M!:VG^;^]$:VIV[H+MZ-2J%TNK*-+2TU26ZTF709S(3]:+N%^ MRE\G$S1HVSX-^YX8HNWM9#JHT$S:PL&MDB#76R__ !^6M13G==/67T>P6&W] MI6*&\&QY'SZ%E<:(O0$C>WHF=0DS=P.Q[NV$H'\]!^-4&D;-(_0U0, S2C M MS67CEZB@=&\IT8L\B]B'-O+%UP>=))A"ZV70676W3L/2N))U VVIU;DA;Y

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end GRAPHIC 18 pg6img1_ex3-1.jpg GRAPHIC begin 644 pg6img1_ex3-1.jpg M_]C_X0 817AI9@ 24DJ @ /_L !%$=6-K>0 ! 0 !D M #_X0,9:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@ M8F5G:6X](N^[OR(@:60](EG)E4WI.5&-Z:V,Y9"(_/B \ M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)! M9&]B92!835 @0V]R92 U+C8M8S$Q,2 W.2XQ-3@S,C4L(#(P,34O,#DO,3 M M,#$Z,3 Z,C @(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO M+W=W=RYW,RYO7!E+U)E&UL M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(B!X;7!-33I$ M;V-U;65N=$E$/2)X;7 N9&ED.D5!14-!0T(U0D4T-3$Q138Y134V1CA%,#1$ M130V,S$V(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED.D5!14-!0T(T0D4T M-3$Q138Y134V1CA%,#1$130V,S$V(B!X;7 Z0W)E871O'!A8VME="!E;F0](G(B/S[_[@ .061O8F4 9, M !_]L A ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$! 0$! 0(! 0(" @$" @,# M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# M P/_P 1" 0E S0# 1$ A$! Q$!_\0 @@ ! (# ,! 0 <( M!08) P0* @$! 0 0 & P !! (! P($! ,%"0(# M! 4&!P !" D1$A,4(146,2(742-!D20887$R"C,E&8&AT4)#)B?PL<%BX7*R M$0$ _]H # ,! (1 Q$ /P#[^,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@ M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#\;'Z M;WKT_IO_ %__ ,8'[U^=:W_K@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#\;! MK?Y_/_\ '_V8'[U^/Q@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,! M@,!@,!@,!@,!@,!@,!@>,>]ZW^-[_I_^.!_0;]=?G_7_ /# _> P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P&!XA_U_\ LU__ #W@?H']/_M__IK _> P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& MP& P& P& P& P& P& P&!BUN]_?:M:WOTV:I]=:WOTWZ$?CUU_Q_.!D@_P!- M_P#^P_\ _L6!^L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@@&AYFTRG=9U;>C[2LK:N9K;M6K&5Y>K-K*NK?5%@;I!+(.7&G0A7O2<" U4 MV*BDZHX17Y#I5@,!@,"+KOM)#1]-VG]8%1W;R)0)CX%BOD,<:AN4NJY-% M8-/1PS21##H6RC=DF&E;,+WOT%[1"#ZZ_&]Z_.!Y,!@,! M@,!@0UT5<:/GBA;COEQC#W,VRFZUF5F.D6C9[2E?7MKA3$MD#DB:SWQT @B2J.GYE:,NH9J)YUL!MKZ[>7VKH51=2)_BDDK*! MR9V,C9J6E'IV;%H%3G+535(?N)5J0H:%60G,$5O80C$6%P,#5)X_/46@\RD\ M;B3C/I%'(I(7UA@K.M0-SM-'IH:%C@UQ-K<'0PIL0N,B7)P(R#E PD%&'!$9 MO0=;W@0I)>@'^#\JJ^CYM3,P8I2R5"*T9/0FI#"#)ZR.+?%Q2F2P$#\X/S1" M7&0QQ(E5!-,+7!(/VE'LG8][ $02%3%JM5R5!3EN(T8X^FN2LX-93-'G%8F/ MW'F")&84(18Q M WL.]AWK>!E_QK M6!STC7=TAG,@ZDBD$YDLF4R7F/H*F*56,C?*8.>LGT7M\J"/.KKCIR!R<6U) M!(W")M_(#23U&W UM1F>XH@_>R0!T!"Y-PUYK4!>B&Z$)BUIS:%40)>2C.,$ M44K-1Z,VH+3&F@V$)FPZ"(6MZUOUU@?E$ZM;DF-6-SDWKT9!RA.C&(M62:>088460J(K,XRR@BS+;$W:Z[;9V!0Z"4%25O:Y6_MZ';JAULE[.]/A9C=;/]2W4WW:]J??H<+U_ <"L%K=7M+5 M$.@2><6%LZAO3GE;%&29T7#IS&8V\M$@EQK4I3-\EDDB4$L;!MJC+B8[+"]B M/5 3)A%A)$H$ K86C5R!A0.2%F7/;0B=W/7JVM2MR1)G)PUZB#ZH4)QP%2O7 MN +7^V$7YUO_ $P/(>],R506D5.S8F5&K$[>4F/7I25!C@L*$H2(2R3#0F#6 M*B ;&65K7O]AUO6O7 R>!J2N?01OF+57:^:Q)%8#ZT*Y R057(V=-,7AA M0'?67O;5&#E@'MP:$2C_ &SE)) R2Q_VB%K?XP/813.'N3XOC#=*XTODK4:> M0Z1Y$^M:I\;3TJ5J7*B5[20J,7HS4R)]0G&!,+#L!2P@>_0)I>Q!X)M/H+6K M ?*[&FD2@$73*$B13))M(V>*L"=4O/"F0ICWA]6(&XI0M4C"64 1FA&#WH(= M;WOTP-?'=5-EJIJA,MJLRUM;,I$DL5&.>18*J QU2BTYIGZ:IQ.NC8LRJ&W> ME %2[1! R-_)H6P_G @&GNE)?*)[T@CN!@J2L*GKV:5\AH:QFR\(5+]6W7L^ MB9#NSS.1HD2TG<$5/KMH>FM&J]HER4P(B!'Z!LT8643V77"R.R&7I+ A*J)Q M%<^-DLE">5L1\=C#E&#QII*WR%[+7B;65='E)0BUQ2DTHQ(,.PFZ!O6]8')R MK_(U?%UI)VYUK6O.;JWP/R5L')1YX^@XX)FE7.KE%(C(C[5KZ9'KVR,SJV%A MCU7AYCS/%$]AQ$Z2NK M_'-$"D+&VL1;P)T7/#$%27M:F**&JLG7_ZH/<&1E-@0.#J( MVDFLVB,/53)]2Q:()I3)&:/J)5)EWKM%'8V2[+4ACX^J]:W\21+HU09Z?V@W M@:4X=$\^M.G+;K>M.-FF:5K(&\;<+.A*/35.&]*>N7PQRVI>R](96A1)C#CF MXWV+"BBQ#$7H(=[T&S5Q:E8W%&P3*I;$A%G1(Q8I;@2>OY4QS!@VX(]%[5H? MVS N<$.EB;1P-F%;'[P:&'>]:UO7J'IVO-DT7+2+%36>H6B;U1IA.E)P0Z'@E_,; 6J ]'O?*LEK61O7('25 M4Q?3Q:1+J9"P1BV)[&X-+99"3XH_IG9>B@+L^')%B]02%&!6VJRRPG; #8PZ M*-G=W&KW4$MOUBZ8IQ_IR"R!?$I38#!-FA\8FN5MX_C,B^AM)ZQ4ODBS>P[1 M($Q9RIQ"86)*6<$P&Q!.U:6C7%S0QGL6IIS%K&@C^6:8S2R&O:"0,3AI.<-, MI+(<6XX]/L](I+$4<5O>C"3 [ ,(1:WK J;VWVD#ELRCJQ@L,3VCTOU58O\ MBKGJM'!Y.C4:7/25,4Y2N<6%*$S:\K(W6]=L1VESH>F1JUIWJ6G3DB,-]Y8: MM$+O[5@O3$#J;I:N:-,I6>5)8DUUT!39EEIV"'V!7_\ '5JFNINDF1:YOCB5 MSC:]PTC9@OQ@8%9Y%."F\N2'+.R. M:B2XJ #_P!6_3 V MV8=K69.E%HP MY61L:<@.];,&'UP/+.NT.1JPDC+#K#Z8HR%RN2-L.>8[')'9\/:GI^:+#=A, M<%SVF[[EYO659=_,@*/M_G"9W ]5;))(K%U(LTIF]]B;:TNZB(%0"#GA M<6Z3FJ-&C)J+9X](;G;'F8-*)95C#+3D">,/<^).4!%%FE M^.T6_SZ!3CNOR(L=)4\P3KGJT:+DGMJ= M.3+UNMFIH^THHXL3]'&TA-MS>?F3.IZI0@(*2F;.)%\I.]A:AA[LXSE5;RJX M(KT_2$HK"$R%MB,HF\:L2./[ TRUZVE QQ0Q8T+EFE$F?3%I($#>3HQ6M,- M @LP0M:V$&S;RO\ $$3DG-T6;KGC\R6=16,\UG W2*J$JY@C3Q'$IO\ (EUD M.BY6U)H40P/9B1J5(EHRG4+DM+)^MKV'C)"'O'OY/(C?14MJ+I>Y>;8IU>Q] M.W[14:JN'/@X:^3ICJ>7+V)BD#%7\REDAE!RE]0MIYW^RH4$F_$+1?\ > P( M0N(=W]Q6EGLNK)=TW3[;-8(GEJF4-+K+V]J(0%U^UJWFP@IWEQ$E8G<^O&U" M89("D2E0:Q^F@K@IQB"$02G3/2//_121\7T+=%97(BC.V,,B5UK-&"9)F(R2 MMFGIA)=CF% P& P& P& P& P& P& P& P& P& P/G2Z?Z-K[H MOR*^,>;<9]*UWTA)*8ZFMJE;OY59?T\Q(JR,K8'-8I>'2;TD;$B*55S/JB;0 M@8T;@^*RVP\AZ$2VDG&JSP*P[@4CT73O1B>SU5.2\,O(IJY)]S_8Y@6:0,VH M[;58+$J"<13?[]J:_P!H)D5+2@[6(_L(3O=_M'#]-^@3;@,!@0+U3!G^S^8. MCZTBA)2F4V'0MP0:-)SQB+(/?Y;7LB8&8DXP #!EE&N+@6$0M!%O6M^NM;_I M@?/47GG)*F-77S";4B$B@,PK!U^ACZ[I7S$$MUS7G"NLZEEG.DV\? MM1QCI^T_VDLNB95DA<27RNJG(EQC5*E4FF#O^K$P?24M[8V&F%A3IDYIAF!^ M+*=;(EIW44XO5?8<)\S%7]6\]!Y8AD&=I*W2E^H=8]56AB#+558Q>4*(5/Z9 MD",V7:ESD6EVAEJ.>2"NT$M:P1MPE2R*R:&.,';7U%H2U(K(3,J!2G($4F)-!@?;YK>A: MT(.]""+6MA%K>MZWK>O76];U^-ZWK ^)N#69"4_9+=:EG6Y8T%C$DZ2\EM%= M$M4@4V^FL)MA$@K&?&0U5>5XL;'"&-I8U+U%VLVMXRT(TR>+,19:TI>I4#4& MIPV/A)AJ!WG7B:KK_)<]?V'MOQ_]-53UNS2&VI<_ML[<8FG*;(1%'%KD3LM# M#9= Y:)Y1,7Z\IO4I](QA+^0831C#I#XH^?K%:+C5UG;"94J8?$Z==O+%42Y M6.1H7&X93>\J;[1,N9_3*%BMI='$5 +XTF%L9YYI3D]N(_0(1E"P.HODK>&U MB\>G;CB[*P(D>N6;R1?.,!IFA*W6NI U-J8!9!9IIARUQ6E$EA"'>]C,UK ^ MPC,/C!4]1 M!,5'-2896EQJK9>A!'ZDZV$:5N/GJ^9M<=<<8-MFN*U=X(>AX/8AL\9;+ADI MF'5,;FD$^VMF+?+R=.3Q=[-)!E#>7E*:X[VO5$D@5#$3O6@_)'0,1M@^&)8H MNM!WABS_ -NY/J.M)XU7UMMC*^]$U\QLRMFAFI$?&TAKA8D-DZ%6F,4(COF MO'M'L\PP>R<#6)).ZJDE60. =VLMQ2: ?_1=IPGAEK<8S:JZ,J^L U^_LEXI M8PVQ%B$\./2:24-3406JLK)-EMNI+4CS.NWVGH-9:!%VR;CSG1;X MKE9Q%O-*]PDQ-%ZD2A#S2NC)"5 3:BGHHE,)V(!\;Z=O99"KU0>I>@BCH2,H MI6U>3^QK]4V6[]1U;R9PT]UX4UBN,$0)["8:A)B]AO%;QIG(!%7^6%6V>TLQ MI*8"DH):P9/Q!">J&,/J*Y]ZWI_H*5V16$(D+L[6+2;+53A9:-QATGC*#::V M887+HC((PYOC0VM5O>M@UL04W\S"YP;N9ZJ6O#59 M3U0:7JZC%?8+;6*1_6KC^4D*N0+[1',$\6)/D!U:IE25M-?RDP?50W ,),]2 MC# [#AVG::7:H5Y"%?.D7L"/T^W^4+QIVE1Q4-A%EQ.+'PIR/II+)E\!9XQ' M6)$]U6W1UHDPPH1)U+>@;RP'F@#O:0W89^VW!'7WDNMZXXM$;6N=H675TBWV MNX-52VI&>XN?VZ/Z656-VTXO:B M'7?04/&(ETL![C>EKE)&!0!&Z!WZ&FA"[MWI8U$*C[U7T2Q35!QG:W8GCG5\ MX1%CK"Q&^+D6U%K0KJ9=0.--P)&P_P#[/TVBC\*3KUC@G;&]IV^I'(LO8MEA M$:&N]YJXS %'E'IASY_M!^LNSNY...GJ)W"J#GTK9RV1)&>?&V9W]&I=#HDZ MQY(XL+K%)(@]A$E]5K6U=-?_N 8DMHB;QV=SR^Z9G% M1N<-/D\<7IVTREJ3?NGEK3S4X@ECWH)7[- MBS[.K1\IAMH5_/Y%TG<3!S)(_$;:,7I:RULD:FIK9&99#FZEITD9S5%7R>*6 MJJ)73!*)N3_6^0L(11=E35V-]\JK\XU/,95UO$KJX%44++XS2=QN MDP.O=CC%;AN"<4G(&V,A0*UKO:##*5"Q7HX@Y,=HLT 3 :-3*2RE"J%Z"#H3XC>7:TC-\^0J\GKG=ZK^SU77#G*=D,>HT1!%TK3-I$H1%EC)(&<6#>DN]!U+[:Y>B/9W*M MW\U3-*B-0VC!'IE9G%8E2*11J9%)A+85+4.U:58%*X1F4)DJPHX /E!LK?MW MK>_7 ^9.%\V>1:RYO55A6A1[;6C?Y#JSCO 783"BK$;M(JZKGG9*T 7]%V4^ M(DA)I[W?Z2/S-L:#7'6D;C:'EA4C\K\=8N9;66)+#\C' M UE4H0T1,[V3MS).(*,3FC)3C,"K+ M8&YV34LFA-V=*M]<<8VG(N-H-Y0.6.@+'IB"4)/(\RVG3C'S[NN9M(X% %$8 M962Y66%]#,C?(%K(SZ5#=CT85R@@]",L_8>JVP[2\]V=HAP[TK7C%OSJ/VZM_\ <%1RTXM.X_RY9$:>6KEB-ND?7/$K;7H,53+XC4[C MMV6F'_$)&BT:EZT6\U/ MMJ&7!/[=FRVD((R6'U%%T#_5#55,"L8\C2<\AP]INVME2^PHU%LTD.JO;7-G M7\%YNALNG5LV%Y$'FG.O^-[T01AEY^J>'6/#(%3EK)7RR7> ,]& M8XL)P0B-4?2(. 23Z&G"P.*MZP-1(K,F5@WYQ%>R6M[B\]E"63&X'8U3MJ*6 MV96[[04GCTLCC##A.2HV7K9"NB9(E2%.K F6"4)@".4'Z-3%A]&/C)J=P@MB M=Y3Z*4-(^:>=+JOZ&S&BJLE<4;J]=E9C54$1C-E6:CKI$ *J"QRQ9.VE'H6] M8!(K!I,,1J-(8(0!!B_([6MZ#Z5\>/2\'JMRZ&I3G.S[0U=M+1>.,TIG20JU MX *"QJXX?'7QU:D6[ MA01V5^H SMFJAZ?3?]_/.*G@RWK8KJ^_(QSWT_&;/@@:XE=L3>DFLE7. 0VH(Z-SDD'<'1BC;C+(U M\7U5:G:X]226(8RQF@V,6PU/F_B[K'A?<-D5D\DV%T97-K\8]24A_A>L5E?V M$\&M?$4=SZILF;,D>GU)$=#-5R22Y8G7ZJ0R*1%/FF5E9UC< MR;7 :AE?.D 6D-3DDA,$%?.4>3NOVTAZ8Y=QCT3'Y!//%#T=R,U&O^N?HE2% M*7,]O,DD*B&U;&6";EOL9J&5+E"(AN=7$2][?%ZHY6K$:0$2DH+,V#R!UIT# M-.1G-FY_LFIVK_Z1'0/$LYFLQ>ZN:W>H[>LV'-<1BB^2L\?LQRDRF,I%T3,5 M&GM8%BHA*Z)]_!HX2DD@,A#N9.DK(;.0PR'A^05,]\+<&WWS3;R=PH4BL(B= ^P:?K Q%+\Y]/MLKC8GA0C&*=-[\UJXTC5Z+3[."E&6G'@4'#X] M^U&GB>RJQM6 K>@K=;KOY=YSJ #.XUD4Y.G"/'O02.S89(+ D$NF#,WNR:<1 MPYT&J:]^Q48M_7EGI-:"882&A=:^-7LRP+B[,M>K*-5JX>H\@/'W0$!JEKMI M@J%TZ JZHJ*DE5SA1#IM!YPS.]7R&/2)[_9-)ZI4T+A:$(TL19NOC&$G,'#? M2=6R_CNZ:8XMF$"B];]ZVCT!/:7<.GVRVK[6QJQ>=2JM=['M.QK)M1QAKI*Y M?,0>]8V,KJK E;$Y1IYRY4<9HH,;3W*O5L2A-6N7_9I89TV;_-E/NS))^S>Z M-9'1FYTEVI"S^G6BFKABU/PF$VLQHPPE8ZN M,D@R-0Q?MGB1P94XML"-HSB;CU XXX.?ZQ0(E*K^)0,LK8] ]GH+ MDGUU_KK_ )ZP'KK_ %U_SP'KK_77_/6!K#)"H5&761/TEA6CQ^TU2,T8?>+TW^=X&2:&)C8"UI3"S-+*4Y MNC@^.);0W(VXMP>G8_:IU>%H$9)(5;HY*1;,4*#-"-.,W[ABWO\ .!E?77^N MO^>!_<"+!W;5!5TDNO]=?\ /6!KR2)1)O?W.6((S'44I>B$Z9YDJ1F; M4S^[)D@0@2IW-Y)3 <5Y"8 -:+ :8,(-:UK6M8'/!JJBBO'9/>T>W+IZ0=FV M"]-V+7LTG)=D-$020^MY(UHB:WAR**N,7BA$M5!6-*I U@ L/5[%]RGKRI"4A:SG0QN A)? )DHW ;2,W:PM&6Y!!M2)N$<;LT)>A_'L0O M=K7KOUP/9VB0"T((DB381C^4>MD$[T,ST%KY!:V#T$/T'O\ ._S^=_ZX'M>N MO]=>G_# \>R"1:&$1)6PF"$(S6RP;T,0P?&(0];UZ"$(O^W>]_U#^/Z8$=6I M6:&T*UG-NMAIG-?.4$Y!XRDZA)I">I+(JV<453%*)W5F*A-FP-*-7-IDW+6%- 5SNIVA>PD.VU:EZ M2! O2)P%B]!"(-#I*$HL&O: L _G?M" (=?D6Q[_&M:U^1[WO\ \]^N!7_H M;IZ@.6(RTS&_9\W05F=%KFD8]C9)%*'EP.9&%RDT@4M4:A[+(I,J;X[&6E2O MO1*0F _X>@OSK6_76!MN@ T+8] #H>PA!L>@ZT+8 [%L( M=B]/780[%OTU_37KO _(RBC!%C,++&,K>Q%"& (A%BWKTV(L6];V#>]?\=8$ M(4ITI1W1@[*)IBP&RSD21 ]M:^&6)'@)SG6-.[>_M;4M J3%*2S M &EEC3' %H11@]?G VR-5- HE/9]9[*S' GEF)XR@F$D7O#V\+5K/#27(J*Q MYN+=W%:ECT:8AO:X].W-Q:5$!6O5*/BV>H.,&&FSGIFBJYN>IN=IS/4+#<-\ M)9*IJ>$*V>1*#IL1$D![G)0H'9(SJHZF-:FY.,TPI4K(,V7KU"$7KKU"=PA" M#7H$(0Z_&O0.M:U^-:#K\:]-?@.M:_\ +6!! MYO7D 7-SZ4JEL;C?[#;ZL:'O]5N,G*VPMJ4&&HMK0K=$E;,T3LO>A;#R2'I. MDXI?%?\ ,DAG!#7>-J1A_F-?08]DDHC)/'8LG<5<@7() 2RFQ4!K4E:5!AJ8 MU<6JT6#W:+WH0-B"\LU%*;QM8J8?X[A"<+A+G*%0F2SYQC[*'WB M6R)R8XFWNCL3'F1#E+J>:+:QJ^>NJ.TT< M,8K)#6%BPF95A/'2MI2W-[O&K"CK#.61D.D\-?&QU3GD+FX2HKXC0B'L&A:] M0NY@5,Z5[6HOE)PBS'9ZN;N4GF$:L";LT/K.N9G:@S0\ MN39%8PDP& ",.PZ#;,#^;UH6MA%K6] M;UO6];UZZWK?XWK>M_C>MZP.-U2<0^-B@.V&.G:^JRQ$%O@KIYZJ@,+>9U;T MDY\KQK:+"9HN\R&!PR231=6[+,U4[?$R[X2&Y0>C. %47M+OX?>%U>@>UJFY M[G\(I]P8+3M:Z["87:9QRFZ.K]SL:P=U['ER=MDEBNS>F.;VIBAK(O5%IQ*% M:PDU6J'I.C*4J-Z*P(F.1<1^26')*HCT2:E+T\:96M2M;2%Z\MO2&# 4(\K0O;Z>[6!M M%?S5FLJ!0BQHYI8&/3^(QN:L(7%.%(X!9I4S(GUKTO2@-/"F6:0KP?*7H8] M'ZZ]V_3UP-NP*HEZ M)$A='76F57^W+VG$<,I1O6M^\H'X]0LV^.)[.R/#NF:'.0*6MK<'%.PLFD&W ME[/1)#5)30T:=%S6V;@UJ3VO%$A:(V9'HBDJ)M6&%EL>IVX+GQM M5M*-R#LX9&TZ=6,T"11Z:ULO01A;O 8%?I1RU1B]^[_9)]@8?L3J2%<6 MN!DOZZP(ROFR)'3].6+9T1JN:7?)X5&%[ZQ5)78$HYM8#FET#26 M-QS2X0$@7!<8/6M",]0@#K8O3?IZ;#0NF^F6GESF2P.GI;7=@RA@K6$@G4H@ M\0(C1LW0M)9*<]V^8E[D;,QZW'23A&+M@6F; 429LH)V]!"() L>S'.%TK+K M$$1CA+BM1MQC\[CT%.2$1WILP7H'W M[] B"0F%R.>6-E>%+6O8U#JTMSD>RNH %NC0WC-V4<$( MMZT8#>M;WK ]Q:L2MR-6X+3@IT:!*>L5GCT+8"$J4H9YYPM!T(6PEE V+?IK M>_36!0OD?N1VZQDJL]LYIN* TC+(079W/O0LA+;'"O[I@(G]1'0K5B=NWIUJ MZ4NHBBW-J9'@/W7!A/ M_P!G?J1H-ZO'L6.T9TARAS>]5W-WETZRD4WCD4GZ M!3$T4$C2^"PYVF3F@>C720I9"M>E")M!\*5(@,",L[WZ-V(&RMAX.(.QV/MR MLY]9;#7DKK)- KUM6B5T8^8SIW MFF3-E8V$S4EXM;587A\AC.O:WH+^.R&Y@S?37D0[0Y\ZI>42:Q$UEU)3_4?('.,HCL!KZMQ50^LMRM<:1S_5WV,^ MI$=C0KI5Y=)EIS9F*%A8JR*4[WL*HNG*;+>N1[ MHZ?JV,Q)FYR8B9?8"JF'RNIG&M-:QZ=9ZQI=.M8K79NTC,0J59SD<5_O:$8$ M:0.C'C]ZEF7:\JLKH:*3%R67F_HI(Q-Y4FU MN*JY:UQ9>VK52DA*^M+D$O16P;+T%%KC[MZS,C7D3\[PN-*GY',:@C$[9T9EAHSVV4-#I M54BD1:(1GQ.!#P%,H&(SVG$;(#\]3V]V)^4I=WR52!LU*)+%BDD0#K3.H%%@1.<)G\@ MF2FKTZT:0\1RA"!M)$06 (V7^6GIJ3^0:YK9!$;CM*6&-#&VN+:R\Z0]%]MT;3U:=F4+'UL*V@*!HTS8>[Y$[]O*O MJ/\ +)QI=>&UJR0^%N1;5,8Z M9(&H2=J(/.:=+$Z@9_P!%L)E[.[4ZEIJ*>6]-6-SIV%^YDHKA:SN;FTR'UDN M505;:X'%CGK6J*D,=6ZEK#*75E!L1[MH\:$:KV)SB-!#O U'H_J[R$0%Z\C5 MD1[IB+1>ON%$/(UAQRLC*6KUY_R*9:E:Q653JI)7)E*58YMT7*J'K]!-8I5\X5'L%IP:O M)/%H;5D$;(*B/<;>3-\OE31#"UND\94+#-K7TM:84L7IPU'_ +S?(M(6*&1M M/T@HHN:E^6MRX(>!6U6G-UGR%-"+&I:/V!$RK'A8 @]-:#YS+5\ M@?3$?[M01.#7>D?:/.\EU/\ &SLW?QJK6JH8HRRJKVXR95"XJ)%!TO0,NZ%0 MS72ES&[,B\Z&M:94WI#U SCSB4X15SUW3W@)JYCNF4= OUXQ6S_(]TER(_TV MYU'1T%"X5#4K%=(D,N726'Q A\23YH5UI^T/&A4E(348/J?5,-T)0<&4I2YK M-Z1MCP?]>VCT.W6>GZ M[K!VU43&PU8@@U+2-WH*V2&B$1*2ML3B,^<'.LF] M/J/O9+XN=E2UU!\Q(0#" )H=$_)QTA;]53KG&K*&M^1PV?V''>C)NLK6O(=5 M#S8ECL53UNF?4SJ";WLS/%45C74 KN&3*2QMFL6NY6VHSK00 M/@BW1.L3.Q*( 0D-Y", U!NPK=QGTGU-6G-'%%/U3T?&(B\]@]F=T-+I*K<7 M5E"T$;3TM9$I$V5E5DA-HFR6"-2.ZWUW": #NP/B8@Q*% S)VTDP !="K[X M\C\]Z\YJX^DG>%3Z>'VBND9+B M[;(&U.DF$W9 O+Z\QJ0G &TRF$HC$:/6@HG%29I.J+,T,HP@.5E7S^]:,Z0\ MEEV5==CA%(MKS4NWN&SMAN-ZHZN9J[ODH?(\KL!D<@QB:%:1;: M'1N)3G( F#"=LX7M"WG,O9O6M_W*RV2X=(\M5]2K!W==_-UC4K)[%CB:6N3* MRO4LK2IZBC,#448<\=12 M2DZVCL1;G"&2B',&X_'XP8^R9$D(0&+R=ED@-"3L\)P1A6_5]ZV,U^-SJN[& M1LMZ[J.J#S0/;B=$VUH:T%KNO/38RP>/R*.HHV7N/)=V"1'"DY1K3HU"(U:+ M:;>P"U@5PDW35GL,_P#&1W^_7Z\=+V=87#_D8Z,3U4S.+25749LLFC 2)FKZ MGX2D9RCVA/'#%FHTJ+7+7-Q6#8Q&>FS!J-C"0'GJKR QCB&R.GTWD,JI]:YI MPD;T# D$4EU?6Q9"RYXS-*_26--TK6'F& ,]2TBRMTM&P/4>(.;TMB9T\UT(5:_,SC8+FU @-OSRF M7AD:5-Q\:1\AJ>DY34C UJQ? =L\W1@"SR@Z1^37K";T3P\PW!2DG1-QMJV' MSK7&[L VE:;:OKV]IS&(R]W40VOI1[9?+?R].KYGEEU70$8XKNZIIM*GEA,E9">UIF:AE5!VM(&&*- I7I M2]QC]VUDG; K 0N;O<;\&M:P.Y75]?[0^.'HF.-]@V6E<&KEJR'@BQVV7#;K M,6J8U7KQ(F\Q9,FI(D4*=*-(@HSQ: $9J 8B_=H0O?@I^K@UBS*>[8#PT^ \:G.]U1E[M%_015GL^R):W2-5<-\(C2 MX@4TV1_$7>(!1*(B$U.D3Z&I$$(M_+\8=Z>_7_3MXDNK)(XRQLEXGGA>RG-1 M-6QOW&VJ7*7BG' [^1-30K,-&RI)*I5:/3)!B&,C1X"O40M?D.8BCB:X8C2, MI\D%F=#0<-E\S>*^55CQJ7S##SX'%H#$V6G%4S;IN]N4X?;(.D\P(&R'02S*ICD74M$.8TCX=)"(@I=A)'Q:+X7%0K(,+2B"88O)OD[5XLLHW MKAXZCN%%XG>I)Q&["CISU6T1Z#D4$L."#BSLVU$V.6R5;/,D[(M/+Z[\ M8QE.'QZ &!5.-=9V/*.(K8Z*8?+,Y2"VI/X^+/GKI0<*>U[M8[%?$*:([*9 M58TF_>%J2^7#:YD SXF2Q,S:S-3ZC$2>G._8G#-,"ZB@]7 M/55O-I)$,)3Q^*P8I\(F#+&&\(SUA@5[@OV/X=!=;QVVG1$YZ_XRG<9[,<.B MK7N;QGV*Y6,TS^WC9S-";,5651LPDYJ2*JI$M9ZN5'JDKX09$F-N:DJ!.P&& M;3;T2,S02EY)(;0]B=QTN1%.JU_"_D(J+GETM.E[YD+W#4=0V/5ZV>O3$KHN MP(W+94UBF[89+6\UQ<$*1* P#4>>(1IVMZ**#G-$+2C%GW-XD^I+V_7T"^#L M#R1P:2CKFUYS4_)MA656B^7O$?LRN7\^8MS$QBZ LIW7BV E1LV7(UZU.H$J M1DED8&2I3JJY)A#N)+_JOH*Q+ \@=Q=-7Y6O7O*RJQ9BZQ\&HY7][&FPS= N M3Z17]:PWGU2SL9K:X)&5.-:(8/E<#CU!@Q!&=?7A0MF\,V;=LG[6O6Z.E9SX M[>J(CV?RK.[$5/D!2W0FA;FH/G=LP2?.1T5Y]*K^1N((U#"D!+0T.BU4B0(- M&KA#":'3[PR=*%SY_DM27]9JU-U9':8I9QKZH66TG=ZH-VY('6\-W65F4+$_ MM$1YZ>%QH#29JYJ"%,@1R !Z8PQ,A^!*6$1>5"QC(5VPSN>[G:9VW,\+Y;8G M#E^-WA9]!=/5.X3^_'IDC-Z*SWIIL62[@#K3\Z=8RAN\"FDF:1AKN8 M1ET"J5@4/AZ,Y64UH$Q_V$XB1%:#7N8NPX\5Y!.7IL+IJ60JL'VV?(/ [Y8N M@K?G,EN-V:X>R28<7UTFM4(F6D8L(AR;4ZJ&1AC9$YD>CS9]E8YJ1"%[ MGQ MC;E/D.'_ +=J$H+*BASH17_9S:VH%+L% O<"TM9/L!;Q%)75,SK!*'22(!HT MI0TY!ZH_6]%D_P#Y=!>/S8IHC)"O&G7LHFB"'ZF'DVYX"-1N=*Z_D&F-"T3H MAZ7QV1,S@W29F<$YKFE2D+T!I)R5>N2AT<2,TL>!Q*D_0<91ADO+RWK)^:Z9 MJ[R6]AU96#Q9W6%DI*C7UC&Z-BTZ96&^[4A$D.Z#F26 3MU6:@T>:WM,JDCR M(P@YQ*TE" P)CKNW[2A_*'BR\H4*D-V]3N54-,[Y2ZWKIBM"RY)N6ND^;)I7 M-0.$IACH_J&@+U"[+DS8B5N2DC]CI,\I#CC%(TZ?80]"^H X4#8M3\9]@=UW M-RI"VOC*"R&M;I@=C?,+S?$G0CA")6_2N0N3#*4_/ZI.XR5HC3@AVC;S0[&6BT(K00 MQDME[9!V6EQP7OFY+/\ &/..B[#67-T!_B^VY#6]4VV?6S9JM:R;#TK_ +L5 MXHQQDZLY6LV!]/9622EA*-WK>OA(#:2(Y"WSHODFDK(Z]ZYEO/#AP7V=+@S" M?V#%:KG.23R33&0.7%[M'YK+BYM(2IZ7+F& NS-("G28MKHDEK7,F=T M0B*4&_9*7D*"_78M"_.!\Z=5VT;_ -I_(U[U!=?75T6PZ<)=2I_(I%J?OFV9 MG-F>$L52[B->/@D+ZHGD9I6SVB>%M9,==2FLD8BRE"\2=:4G.-T&IM-\5W#> M7_)] *VZ$<(NFF?(G-5F4>DIQ_Z>B+0GO!&Y6"38)2"8S-X3R>R[3XBVE"T@&D$06%F?(O(Z$L2!]T-74%G25\MUFXXYWEGC1 WCL=L8)E M5SO3<<5R^:4]'$B;]7,93.+C6/**;F*2%J]!&OJ@4"3)"3#"P^@7R%/:$?B; MZ2DR&6R6(CUR&_/\1DD6E$FKV2@DO\"*7P9(VNS&N8I&G5OLCVB1_K_<$3A] MG:(THP)PRA!\^=XHZNO:X>BQ3.T)=(V1H\#=:= 0_4:O*VHG#WGHN*QA6:Q2 M5MBT?F[/&E#TQI6IHOE]=8'S:\ MVM_+W,]?^";J1I1*X95\S8;[J[LZ=18R=O;"XVA+J!;XRWP:Z8NC"_FAVY39 MJ5E:;#&XDH*HD!NM!!H A!H''ESPL4A\/[0^SQ>E)K?R5=]IDK;8CE)$3K Z MF>F"616F4JTF=B+=X[$!)7)N9VH*C9:,CI>66C#&^5 MOG/MF)[?J=8N$< 48L!&PO4>1/A023"_M[1HWPTTL@WWD:5DIS]@V:G*$ *_ M6AXX.3KBM686U-H7(SW2SB827V96Y MD.M4]HN2+5O#+1>5M_W*Y2Z;QVI7P$@@B)_DSE,UCBM,8EJ=,62=L7SE(T2= M*6,"XLR9/) MB28Y)HRH8R%('))HM8:IV:,P8OG/T8$<33PX<#6!*)#,)764S=GR3N%;2!U5 M*;IN$_8YO586)+&K.*&IFQYX+84LL=3-KA*-CV^KVX1Q)JK>E!^S \KWQS:G M(W/-B0[Q8:K>,6W9UZJ+BEZWJ^6VY:,2>*OY^BKBJ>VVO&(](KD*Y&VMZZ2R)Y='"1R MR2*T32D1($IK[)WA6JT4 &_C ;H A#$'8Q!H4N\?_(,ZMR0WC)Z9;5]C3)W@ M#].EJ>43MIC-AO56*DJZNW6R*Z9I2WUQ8BZ(+$)!J(Q[:5XBS$Y6_7>RP>T) M.J+F6D*(E]T3RJ85N*RSH:;ZL>XW;^2RY\%-9N$"LG4A4HY(_O#>TJ])E@B? M:WDI"OKEDE>SXR" EAI-F\0\Q7%9!ZU><)\J53/JCL^OZJ+CDYHB MF]<^5,]DS.PUH8?36CE*G^!)6MTEJYF<6D2I3LT0UJ=2I$:64/9NQ$$[+#9T M_(/,Z:J;3HP%-0TZG[LETXG=IUPM2*7&)S&560]ADDU='!J7JE)! 7U]#I2- M.GT2E*-UK919>M>F!%QOCAXQ4TY/*#64^:XU?:&X@783.Z65;;H_2YMKXI&1 M!8X]3UPGBFP54.AY" LMM9-NFFA$7[PE)@A-,T,,->WC X*Z4?T\LO3GB-3V M1)H"RUFI?'"33UK7N\(C S#HZU2I2PRUI%+3X^8:(:-UP12A*J:WIA31Q 6!U1B3NAQ24L!R@P ?3 P\'\3'CNK>4,\QA?,4 M297V/S5OLIE%J16 X-3;8K2F3)&R?)8XZR]='"YJA ET,IU^I]X!YAQVC?E/ M.&8'N,G+-USGL]/TATI/:AFE?4,;8Z;C"OX'7SZQ2B"%6TUQUFEDQM:5/LD= MTDCFB*/,I[.WA;$B1&!*L4*!?[Q@2R0DJ@N0(E0E\]:W\R/&U,AZTF$'E$H8 MVYK4,S"T;@+ XLK8K-)5/K\<]3!W$\J-N+H$2%.>G*1D%(B/K",/#1IMXN^ M;'LN77%-^7JZD-DSF4M$XDLH6:?@*%=.= MHQ^7-462MKDTSYZ,5F.4N2ID0B&\+LK6+#5&S=D;T%7OYPZT<$(]!N?1'%O+ M'6;E73OT=24,MMQJAU<'>!*92G6F;93WP!WH-(KSQT\.U.[5T^UYSA7,6>J=>'U_J]S0IW(U=7;K*7 ]VDBN M)J%KFJ,80OZQ0/:PLC8"E)?H68$100@T&'=?&)P$^5O9E1.G*U5*JZM^QS[= MGT:VUK2B'.QSQJC RIJ7$.!3K$5J,3@J^H6SGH$Z+2Q3H@LO2D_1@2S#^.N6 MH#+*TGL#HRNH?+J?@&JMJ^0Q9B(8UT+K@:EY'J5*;>A% MJE)NSC=#-_OP-TO#GRC^EH857=_U5![@@Q#XVR4B*S^/H)&RD2!H"H VO!*) MP*-+*<$92PX 3 ^@OC.&#?J$8M;""U7CCX97,[]'E?,-5J&&4SAMLR1LAC(8 M)I>[#9DYB1HFSFW_ &OJ*Y0UI3?B3K1@VH)+ 6$ M!++T$-Z;N+N3&F]U74# M;SM4:+H9::H4JKC(A+*"?GK5C4!C6.1D@^M]S;JL: _7.5^OV32Q#T,>_>/W M!GK-Y@Y_MZRZPN2T:W8IA8],)I*CJR4O2IVV="/YF6@3R-2QH2G(AH(=G0AN M))^X).-845[BRC ,,",(%6^,?Q^@I]JIA5S'62&K8E)7>P&1 3IX:G*-2YX M:T;9)IDV3I*\I9JT/\@:&THEU7E.99[B2#>E0S=;%ZA+C?QCRJU32I[$9Z)K MUHF%%P>&=F"U_XZK]0@?FU;#XJ@;S4[6VQYU029:6M3!)^)<$T/SZ,V M43L 17$?'!X\*;L1+=L2Y3Y_@<_;I:XRMIF1$/9&X3%+I2!I:#G"/$J__D\> M6*34) $92(E.!,J--&E 6M(QJ0 ,$5L18-A#V)1PSPY.'VKVV4T9 M53](*9A[2R5PS+ B&NC]<1]X4'-4<.9BW( G^O$,A/$9INH5%22>0-TKD\%/B#>;ZT:8P"%(( M*!K2G1>Z@7PY.>A,"T' M;=E(U8_9^#%8OF'H1NM#T$_3B!06S8RX0NR87$[!ASOM+MUB5\A0OC.+",/H(.MZ#$GU)5*FN04\IK*OCZC+9TL= M+JTZ&1PRN01]",DQ$Q A VW<9"S)!IR]EI=)?@!L ?0.O36!K;[SESU*8"PU M1)Z'IF1U;%?B_C%;/M7PAW@,<^#1NB?T,.<&-1'6?X='#]OUTQ?M]XO3^N\# M(ZHFD SI@M --U5JRXHRI8Y%K$U7D1U.HU'D2%:V(V%@ENFC]^S,J1M<5"#RQ.L?W$B3P^K8-&9"0X2LH@B4+R7IE8D3 MD6LDA"4H"\T)NAK %AT=L>@Z] R=D432%QE;(MZFZJM0C:9,BV39%>1&<%;1 MHEAC@C2;+D[0Z VF2+SAGE%^GL+.%L8=:%O>\#1[@F?)-0,UQ!8I9 ZQ0HY.M<(9!$;>^$C7S-6LCD?(1O!"(XQU,62<\Y M& EP*2*-#4[,5;'HL?J9ZZWZ[P-&H^0\XV]#8E=7/BFIYO"'=L7M<+L>MD<; M7-2EH;71>TN36QOS,FU\:%$\(U)!R2S-Q"^82Q"L1JR&X)J<2MUDT@:2U(3P)P&JU",L M[9FA$@,WH-F@+Y3=S1.O;V'+TJ@Q <(U(4+8BM@%L10-^OJ'7H&-(K:NTH2@)H#"TX"'LN3$@(BS& M2$F2%?@J0%!+0AT6]E:_]*O7H>'_ (#P-E(:VQ*C+;TS<@3("C?G*0D(TY*, ML_[7WOF+3%EA) ;]W?S>[0=;^7^__P!7YP,/*_X8@;1RR;_QE&T09VMB;"S5)Y; M]X'L^W6_ZZUO_A_37_\ '_' T"UH.KLJLYY7B"4N4'4SB*/D5#+69O9G1U8" MWYO/;5#DWM\A0N3(J6$IU _8%2G-*]V_78=^F!&_)W-<+X^YVJGFFNWN62&$ M5!&@Q6,NTX7-CE)SVL"]:X$DN*YH:61$>%(-<(HCVIPB 0 1"&+6QB"P_IK M_37_ "P/1-:FLYQ2.YS:@-=D"94C0NAJ-.8XHD:X1 UJ5(M$7M2F3+!)2MF@ M ((3-EAV+6_;KT"/KEN>J>?:Y?[;NVP>F]:$'\;]!: MT(.]AW_X;P/Z+80!$(6PA $.Q"$+>@A"'6O46Q;WZ:T'6OZX%;J:[!Y:Z$E< MC@U(7M6=G2Z+(#GI]C\/DB%T<2&5,^K(LH?TQ)(M:=F)/(VXY 8N2;/2 5E_ M%LS0_36PW.=7[2=:V#6=46#9"A[>4[RD,=2'>FU MVF%L.">J]-ZT45OW;_&!Y:7OBE^B8DKG=$69#+8A*"2/!+> P& P& P& P& P& P& P& P M& P& P& P& P& P&!\ZOD1[#Z3=H[YAZ#'"EM95IS7QU"9S7=QUA9;TWVD%_ ML%FF#JSR0XB*)TD@2-LB=8X=QJ5R6:Q(XHQN6JE" MI.G'\Q^PF!V3L+=<*]MO78*>WFZ64+.:.E5/29A95@GI/*7&OY\TRAI/=6B2 MUE-Y1!*Z5R9$D,1*$3D0-K3J&]81Z##LLTDP85_N_P M<I1-*:B2A>G;7.2@.3(PNY@TA.C M#23-!"#VWSO:D0N#[=+&[]DS+@Q(E)MJHU3HKZ.C+6ZN2*.-R<+@4U*X M^IVW%EN#L)<2C;=J-"")4$ _0)?COEN131A:H3%^>9,+KM^ZYL[B]#SL4B$:!*4E,/%KT#],/EZC3E M**<@+O0,RCU@3;NV3^/RUXR?-(NN_P ,V^QQL^:-$@TY)$^TT_@DLB!/WD:I M)I(H!H82S20C]=:#2V7R_P \GSA3T5JSB6<2:>7/=G77/#$POUN0:'H&&S.4 M%*G3J;)5SJW;>$D/D#0V*W$UN+QT+*;K M:"Q&F>C4'5"*Z8S-I2Z'3A!87,KGJ(V/'XL\-,+=D#A&8NJ-VXL2K12,^3J! MDD*MLY)9HC GGQV^2V3]\S&9IV^CV"%5S&HZ_KUK^@MM/);"K6=-%C+X>@I> M_:FO:MX49W5<$?DS5#U/(W M/? ;IU;-6YE>5>[,>$A,KDB!WD2%N4054F=I.S&P!0W-C$%Y:FXQ(L,6J%QA MXB4:8)"Y\[UL::7]5?/'1%#L%*R_H+G)3TM22Z(6P"T&ESCS(YMB67UY,CU< M,@HF:RHRV2-M7B*:]/+8I3&G[+5Z^OO8PSW3';L]Y\Z>K.@]4NQ.4/N>A;SG ME;71*++'$8DJNNE8H^SM73$K*!#WS44;W:&M&G']\:>:641H[04IHR?8,.+O M5'E6?^XO&+-U=3UNDB+Y8?%_1=]6^NB]Y2!!,^87FC;29(9 F1,;&XJQ/4KD M<\F6B!$I/LLFA(B5(A[.3A$$T)]MCLRP)3R#V9SIU[Q>F(649PM3'0+Y (9U M"[,HK8IR2">&Z1)7>:H)]Z8*PW0PFG!=-[[8NQ MHE[-RO6O,CE;I#M<(H_.5@;B0MCL@KRH$TH9G(BR)K$ZB#^]7. M,@?&5,H,&61HX]4,P.@YM4!UYG8_($_P#("760-[JI MT;M0B*&G*")2&T4OY.)M9%CK;?[-L!M 26X&GIDFSR3U&M "8?)5V](>%ZUJB=-,>@^F:Q M;E8*OE5JVRY2MLIZEFIV9GUX)EMD'P5CD4L):GE8R :$QY"7:=*M6E'*1:*! ML(PY!6;V+T?5/94QZRA- UH_35X\.B3H"WZX4=*%2NLX[#Z>Z*L92)]@%DQ- MI?&2;JW^%%ATWE-+8D3*U*TLQ6H(^N/YPL[T7YJ7NJ'VH72-4_%FZNIY2/-% M[D)+-E+P19ULM'1;XR(U4-IEBA34_,[:KJ!C> *I%()$H3,VEAQ"$@(QG -$ M%&^[T"[Z/_N/PJ1R0$7B35PM.HPK(DLN( SSE16#8;(M,QB-^3_2+4MK@ :E M$GT40WFA8'[C"U$[T%7J/*.<)6M4[2+'QO7$)$E=+'(D], MM:UH)$F5)1)PF $2?M5H8=>@MB_.PX86R5<<J"8$[X@ MZG\0];=*7Y/+-A'0'+\LIQ#'XG!YW!+"! [=B4&>@RK2PF3U0O56_$H>Z.EC M5DX$D@5+VY.)H>4RC[*7102Q V$#]2>36\:TORR*HYEY)F?3[;SJOJY!>2&' M1RT'J7R%VLMK3R=9$ZO=(;!I'7K!)8'!'- \*=2MS;@.GV])$H0;+$HP(4>O M+=UBPVG?:)=R#6 J4Y=Z]J+FNXY6FO%Y%.!M%\N=J) E*,"A*T:,(UV!5VT^T[)EU)>07?:U21*_(13GE/YZYTB]<5_9L MCK1MKLE,]5$0P2>-3)+$B96[HFR9FM[T-*JU\ZM8XKDPQ@1A![@\_D>MGIJP MN<_/C"[+E$+3U=0J:G(S4K=$7"8-4@C(WQBJ:?1YU$[#5(TZ2V^X79C[5]$C#-ITH2M" I&%&O)'T;*>Q&+F:U8 M3"J[+YBJ?S 4)0\0G#D]O9UP2>:0&S1Q2=31F;&PPR&I:Q>Y:A4LZ5(J&:YG ME(-. M% -*)"'83RHW?8=3<_P"!4_+QUY;75W1U(6TKS91%0QNT&+QB M@<*BN273"S'ES?4;7?2],EK^U(^2K3-A[*JL-V/>ECTG,4ORY0J-$:H#K>R] MA'O@MYNBZ+EVH>OYG7=7INCK5KZ:-LCN:'!DP+&LJ/3&R!RR4FW@\.ZTXN?3 M,4YCFC4[F?M08G1! 20(DO9H!AAXSY;+UD79Z#EL%-TX1NP;9ZPI:NT14\D+ MR\Q"04! 39G7LHMV=1-!)Z[(26T%$::IC39LL3[$866:'H29SCMN4*C ZJW"S_MM[.D2UA.$)NOHH MVTU6\(R]@&H-T8(:)9+X)4\V"9!G&4N*K8SUCTTQB1)FD1PQF&J"FXLX MT8S3#!;"L4A\J-^J&%TZCKFL:]D7(T7[Q:.&))!W-)+DMYA3ZM1JIB2WZ&7) MG(R$LS:DL1W+3HXXH:S-&MWL4&.I:@_20L)^X>Z<[KZ2OOH)JLUBY*C%%P5KK;B>OGJ.28=>NR!%S- M7+*Q*259,WDY*UNP'?F::[BE2V_5MJQP)?,TMNXY#/:WL.<+W"FK(ADNAJAJ-0F MCD2!Z:SRUI"E.+0B<#"17R-^0BTYG2M>P:$3KH3HCG&JJYF5)L[FCA2ZRT[7T-;L6K1?>3-':VU-(SU 2AC]HR0YS13RD=1S&&] I8A.^9)R]U%X MHH7W+#K*AT0F;["Y[9;;(9LWS9*86=)^*D2*NS2?UWP(7-G<7(PKYSPHM M[&&+9FY1W;Y.FM#/GBNI?5]Q>%*M[):XU(*K9YC%&YANNUHT?*FQJ1O+DG5K M"G=_:T[B ]<,X8" 1B*V .QB"E?$[A*ZWY0\9%PR!NY[M1QM7RNS2G7*97% MSPS3JWX#JQKLL1N7OM86(6]I')CD3LU&=!26LXC&:XKFP) RUTVM#B[G <97HC:MX/0:.-1;*/V$EOB9I(!:'B]Y1Z&6\\ M:8PIK:/KKF=J7E=&DRF.A+ M.V:4B3.QBQ&66N* ?H*@5#VOT3&*DY5[$@DJ@JOG3H'O%7R8;PU!:BC$=::J MKN7VQ/ZM@SM%),U($$_9[>:71B!*92G=P'HW+3@,DE"UZ!H0PO/X\+6[;NZS M+_4W-?U'S:L.=.C^E.8WJ(Q2F%$1L23O4#D$4-K^C94+1=-7$6VZS M=P:)%"^PCBD[G8-)U2[1$20,_;@;K5'2G6/4D+D_5Z+H.D%_*LY>^SZ)LWE)^:8N@=ZA#!8O/6*E6J, MRX3"9(K%NJ1/3$E5R9L7+"VU0UO)7Z]+["A&C"$_"_;W2M8Q_P 5M,R^Q6N> MT!U'P?:LHB%%TR3*%CV_$2F,302%Q4+30(OV@DQ:1 M*0$8=C#H7WW:?9#/VGP7SKS3?47IB*]1L'3K3,7)[I5@M5;'':IJ\;Y>V31( M6]2>/#7&$_N"R$R )I!!:H 3U'VR=B3:#DR^>2SOJ3PF51$NX=,UL/4:KF*"QJN(D8UQ'R*.4/@ZF'5U&GPR+NL M@7[G:IU,7M:60*UJ/0SE0#-"*3 #@:=??1_DKK1-Y%3TW6D'0&^/FEN0+11- M)%'0=>XV?-9'4&I%9T6EQJ@0RT5[^,"NG*SE%L0BXYDZUKQA8-96P96$J=7Y%#Z(5W7#7&Q8Y%X6M;!.T8EB;: M!*TI?B9GA*:44M)VI"!>6';#RN3R?U9P+T%9E:/;"RRB",#)(2=2>"1:QF%W M1%2ED1K69QC$R1N+">!46L]Y9YI!VTYQ0!Z +T]NPYG]?](]]5U-?*M,J[ZJ M8HM6/"$0H*]X7 %E%05]=)&DE%?OY1D3@QRMBCA^ 1EAMHOK_">J>?+9C]C1!XK M>DC0QJ P2BF^T6*-0^;QNJV.SVR*DSIS(7*=.#XX?:4E%&'&"&,>S U*AN@9 M]TG;?B"G_2[(ES'Y$_);648EC8S0Z/K526N8-.HI7('E)'&=D8S6HAJ:P M?>-3)P'J-ZT/7KO^@=+/!>463SIU.446 HHKR2]REE%%@T LLHNW% %E@#K M00 $/IK6M>FM:],#M5@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@< MI>FO&S,;^L3KV21GIUUJ6&=GSXH@JV.R]W0@@QL[1D2N,REU?6X;8- M;&9XK0FHC$J@L>S1F['H6BM%AHUM>(I'>"RSUE@=&RLD^P^?^7JD:UD(A**) MN4"L+D>5JY]55SL!XY4\(EZ_4U=ERE:SKTRE,8F4!3E'D^S9@POUSA3UW58C ME2B^.HI3T]*9 I:2FMX=JZ@E3L,486@A7\;:SPNO4Y+0:Z.+@XGGKG(\1BE2 M *Q1! MH23>4MRZ1O, C[,F4 :F$T132B4JAJ#4ZLP1ORAY(EX>WN-K82J7]6N,D%#_ M "*.GD>,4KZ1BJ-U>[-?T9:"00\]8W2Q.A;(PZIA';V-(D)-*,/W[=>P "PA M[J;Q!N9'TIKKJR2HNA89V#9W8U27NP5-%&5RADHO P@JZ*XDD.T_JX_/ZSL! MI2$(SD9VT2@@I.5[3A;!^0R,H\/[,]Q%E=V/HF90WIU#V@K[O=NB&J"Q=T;G MN\UZ8DBYWAS9$FR KB6Y*WE*-^AR0"M08H-,-]X;%3GBE'4L[K"Q# MNK[( MT/M @DD/0K?Q#QVFFGF)!5'4E[1!QY@M'HRPH[(]LE/O#Q(V;J)6D=[/@+L M4X5\-F3LQS\BT>C5@2#7IB#CB=&;%\!J<)HY@\?1M ]#R;I6:7[,KWL=VI!I MY];Y#+(7!(K*72!M,S'-B7BW)/#6]O/N"QTZLI,A2OBPA$-,V$;*^$9IQQXP M]^_O'VR] ]%O5TOMPS>.0>Q.49;R#=M,,#)$QM-J5I)'24O2,[^9NC>ND\*= M65TERDW1S7LH\[0"P?* &S0F!A^9O'@.D[#JJS;6Z%L#I:5<[U'):&YV<)W& M8=&E5>5C*UL?-=A2!3%D9(Y[8REFBCZH/#7Z#?A(*T0DT0'ED_B MVC;M;1MTP_J'I^G9K-:HK:GNA#:DE$+C*#H>-5>VD,+"Z2Q,NA3R9 I<;&BQ MMXG6'&1]8G(,V)*,@W7R8&KG>(V$_IKT:$/1=WM_^?.KJHZ]E"X+=5"]6SV% M3+@RNL+8F$QV@"\0XJ%=$6(2S2_:YP5Z:0^]5[E*P1X7@ZUYG9.NJ$D]#2:< MSBO$$D=8(^ZFU<*FENF#*\5[.8W8#$M:37MJ?&D&_P!]&$_R .3'!$5L6M:U MOTWH*A6%XMVFSH]UTP2OJ2^E9G:L(IJ"W(_$L])(WP;93C,&/)CX\8DJHAM: MSYBRG*DSKK:8P&BU0MI=)A!"+0;)#_'"DKFYI/=$3ZJZM:4]C.DL:=&)N/@2J7?=0PM'!)-$;'8 MIK']1YYB-I5Y:$2G$"G$;"2 "E.4L;AFI5A8323"]^[W!0N%^%*EZXA<@KN! M7M>D:A67H M #A>H0^FM:P.?3/X@J&=JW;*MO>Q;8Z,BT1YD>.1:P33T^#1H-74S($431O! M<63UI"X:C4SQ9J"LXOY"XEK7(O\ 7E!+&$/R:&%D>4.-CN8/G/=^ENE>C%R: M(M%=Q,^]YPSNJ"%0%C-+4-[$T1Z&QJ&QUT>-J"@[4/[JE<)"H* D:WX _'L M(MN?QK12T^@9[T+$ND^I.?GZZ(;$J_ON,4?8##&HS;L8@Z4]MC07$QXB$@D, M+D3>RK#T('F.+FEU+3'"T4>6+>Q;",Y5XDHC*@=(@-Z:OYK+Z@Z2ISIN?DMR M6HS2$4LHU4W+(3'&(#M6SF85%QJHPP&+OL#4."T;&3LQ5OYUGV QUP>&^HK7 M6=) 2WWT! HIU!?-9]+SJ QQ763G%VFY*U=6%](ED8,EU<2&1(12)UBK:-:E M.7GHPE)ME$%%%F"U@;%T;XG81T6Y]9#<.D>A8#$>T6JOF^\*XAHJE/AKNJ@$ M9C413/C7_+*ODDD9WAR9(@W@,&0X@+)$4/90 ?*+6!^ >)J&)K1DUGLG5/6T M*-MJ'UQ&ND(I7%@QN QKH)XK&/HHNR3N1_QV')7JNIFX,;2C2K5D)61LPPA/ MLLO96C3?>&GOWA2H5U?I7^GO3IJ%U=)>H8OV*CHF+3""E5C$[[8),5*%\KBQ M3Q7+Q*6Q*_K20A-0ZAZ"+07,[LY@<^KZ"502(RC4'M6$SBO[MI M"9'G*R6V.W+3\G13.!J'[: E0M%&'-Q;]M[I\)9AX6]8<,H.S0@U@1RCY0DE MM6^X]@26P[RYZNB<TJE1 MCB8VJG1F96(MS !S5J#@G'$B4?[WL$,00 UH*11;P[\UPB;P2?Q&R^F6)[JR MXKBNVL4Y-M)5[/ Y9?QCF9;R1E:WB)N1"MGFHG4>E&W#[J\O0=:)5%Z$9\@> M+7C>AO-\7I"S^?U5VVY:O"-.W/&.5JHEUIPI@CLP'8K>XK'*!S61&5\EVH(D MZ\*-&!>I. -&2E(]# Z"8(89+EZH;IHNM^O>K5O,,0CW676(]#6. P>'22VG52TQ1W?7(]O5R&0.:8I.D)5O*LM,!0(H SPL?PQS$LY M5HK40E#DPR"W+&G]@WQ?\LC")0W1V57E<,C52V?.,?1*]!4IXVV*E)34U!-" M6;^K;D^S A,V/6!")/B:Y/23ITD;?JT6^O7[H)NZID/.2:?GBYX?>@&I1^S1 MV*X0-4W*7 )_\B*(=C&LAR)8SW-(0>8B%LO6L"QO,/)4%Y3U067L/^R#6M^@=:T$ =)>* M_F7J*UIO<4X>KUB,KLVLX_55EIJCNN95G'[#CD/<%[C"SIFSQU226_JXF>Z' MZ2DGB$VFA,_ZI*HV$.PA;*<\_P .L2C%?/LF?[*50Y>R,; ND)5CRLNSEB-@ M[05L509SBRAG):JS4?I/KIP *6) ^]7I0I M$8>,,=5WBTY.IQUK%Z@*2X&UPJ&V;#O"$G.-\VU(=IK/MAD*CED2=X%()6Y# MDI\P8PG)UA3AM20,*M2(( C4&B$'N5KXP>4:D%2880V6BW(>>K6G-V5:TJ;J MLYQ:6BS+* YE3B3.R%;)3BY4HD!+\XEFEN?VR@%.2LLL( 'C#L+ 7QR_6G1# MI6C_ #9QLI@DM0/$B?:_D]6VI/JID3&X2N/'Q60;VZP)^8U+BF/OFZLK#9K4@;78$9F\= MY@CO'; ZMML6*66S4-$DB5/&XRVH!2(:%*[,ZI&!:2[!+TYAYV(!:UR&;(HZQ MV.\I'E"ZV-%(,GDI<)B4_6)WT_VO#@QSYXG_'K)(+6M M;O'-$74Q*G5TW<*P2E26PD+O"CK)=S7^=$,!+:Z@C/[G^-0)P:SI0N#2K,+"YDMI:I.(>S"1EF?WX&TQVJPQR9ZB44@5K67^Q7H4I"A<4(99H]@,&'8?HKQ"\"H;0M&Y6*F5 M<7L6W S(^2OL7L"P6,EI?K""XD3.:0-F124MCKV>/Z!W5I#7EF3(G ")6>06 M: HXP(@VRK/&-R13$FYFEM=QNPV-VY"ATQK^B"S+GM=T:(M#I\O>7"5,2YB= M)X6[$4L40[KA774:($I33 MQ,\ 6#':RB=O"R32YLEYJ26$'SW^03%<-\ M5'/0EYYSWH*T8]GAT/0:+%^#YZT7M441(44M"/'UR>]Q"U>8Z?@C+,CK@.N1 MMA4SB3F?:,SDKPO;5<5:G&;+WA-]71JU"1>.OC>8*YTKF%,HIF.S*?C5#3LB;2N=S9!):NA1S,LA4?7-TME M#T@ JA[DQ$+6QQ*++"8'!(A6\8Y_:T$5A%FQ&Y MV0C MJ5GA,]?'\V8"?)(_1)M2?"V;7J%!+>6<>%.64$\[0PR1*6T8@=&NSKU;.EYTI,E]@:?W^\&HC2 B?G2;^5[D"1R.9]C;SBD MZDE*@05(_'1QO+O\P[DU/C>Q= 0&$U= M=)CA8MK*#;)@-=(VIOAL:E!HIS\JY$SH64@G8O4)RDK9H3QFA4*-&A8:3TI6 M4QIY;03_ !K:BHW&%I:[60]"]2%D*-A*-O3M),="[L;LW2 E!MK2@3&>Q6$9 MQ'N+,$((QZ$%<'+QL\0/-,U9SXZ\_P <7T_2,B72FIH%)9S=]P3>:09\0B-E!" (86"^+K@^LI#54EKWGUDARZD)I M);'JI&P2JP&]AA<^F!Z4V2RYLC9,LTPC>G=.C+1FF')S0[;@Z1Z#I+_LX%B: M#YII'E^.2>(T1!2(!')E.I#9DF:TKW)GLIVGDM$F,DTF.-D[T]J2G%\.2%F* M=E# TW6S-A]XA"V$Z8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%1 M+%[3YPB-DJN>UEULD5NQT?XC6C4G41"82ABB]IVPU#651&)8]M;47"FJ42PL MXE6VLCD\MJUT($#XO0)P!["CWC;\GE;7)4E6UWTETI63YV(^-]TODCC[5$U= M?)5C%5\]GJ%1]T40@;N_*+.K*850ACB]I=V5*]3-\&XL=@J0!9FY#ZA^@-2/9@/? M\02G9'E1X>K%BKN2N=O'RMELVIMWZQ+*NA$YM3]11!3@0T+;GFY$ CT@4P.L MVIX/VC6.SL!(F2JR3B3-A,(."6$F$=YL*U:QD(IQ%7QD(.-1+60Q>2J$0,!>Q#UH.PUEX\D/(#%:#'4 M[A9RPI[>95 H JDG\(G.JWB5D6FP!E%:UE/[*-CQ<*@ECSAD,+-0,CJM2N(A M'DE&%%FG% &$'>37JF<\ER;A.:MELL]=5#->M&>L^@&-3$2I3(9M 7F$2J0) M4L6"4RO;XG7(WJ+E)A$-A7[!>)R+)3Z$;L&L"3&GRD\9R.HX]<<3GLLF+3)I M9-(*VP6)U/9[_L"$Q<\B6MRZ>5[B)#7\+M%KL>43.$S2I/\^Z>(!4UIS74.I$#XOC*FU;+2Q^(K5=

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�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end GRAPHIC 19 pg7img1_ex3-1.jpg GRAPHIC begin 644 pg7img1_ex3-1.jpg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�@]#-Y,.(GZOH!:Z&[TQ-;V:YVRSQ&9O$$LZ.L9SC1;([2. MV"7]1((6V"AA4+96!<>I.>0MY!FD9P21F#+$'01HO\OO###7-AV=,9Y8->L5 M7J*],E;18=&W+"9H3&;;<%[;5MB(H5(80ADBVLY\0J%Z- M.E;#]EEF&?(<2$P,=F'E[X/AZ.A7/=K/TN:NF8--; IAQKJK+-GY)O M?VPA'%XLXNJ:7%/A8VW3,8G"Y%+RQ%'DD^T6]!2[M#R?)IXF\=\(Y:GE[0N$ M=Z2&5R!==U-T Z6/;$?KROVQ<6JBL$A\AB4M;D]A*Y^%,D?TZAE;G6WJY)Z93\]S."5'?,VI ATD4UCD# M?V-O>(5,;&B$23A2N::/G'E.+RA4@1E:.&!+H.6E\Y7CR7H(H\ML_M%SCTV6 M0)HC,I;>>[L71-UDED-D@1*H^>[F=HY56GZEK- M3.*@]+9])FW,[,B]A;)E"B#BSUR5L4@5!4$GHQ&:4)S@$!)/E]Z,M;E"*\9W M-7=IRJ"Q@SN.D:QN2(QR<V*LJJ[!,>!REG4M!D7D4S5NJ)MCAH6U.PC3K5 M*E7Z:T:8$C00S>)^7WD.8M41<6XJ[6]9)^BFOE!UC,BI"=1Z6UI?C_IO,CD! MMB/NR%*M@*J2)G#Y4*I9K2(\*<\.C=&E[+P+MUQ?4)M=7=*"$IY(Y+:&LI[J M6;D'L"E 6JG#!&V"5+VR*KUAA+9)2M-DF1@^8@_XRU1@DYNRSBS #Y];%\M M5FW%'N%^D:N2771];//DZFO*]G4\A@:&<2&Z:MCZ:5"3A"RHXC(I2X37:F'! M2G-T:5"TAV3Y!9UEVE3T8I-3 BX_:<<66(+(A)IT*92=KM*#?NAN:[KJ"JJKZMKQPFE;1V-J+BY\>[6C\-,G$5; MY,DFY"^OY&G.\3 M>%SVV.A)K4-E=74"\'R;!OT(/V6&#PGS'Q98X=7V+;E$W!1G-G.%?\]OI$BL M*+,*"TELSO)$C=F>*RJ$M]@NZJ-KI2WS%@_"D&)P%) Z6G/2QNUHHG0>U+YW M./G&+KI(QP;H25GL_0\%YB?(]!(E6]A+VVSK19%#W6H4\@@ELR.OY.P3GZ*I M&@4LCTYF;7)3"CBBO4O8PO?*^T*MK?DEP[(MV.6A3E?,\:_/O,'LN%#C]Q-+ M@>^_M=HA2V!DN"\09M(I*:G0H$8%0RU!RLG?RZ+'L>@J?97EL@=-0/H-[M;G M+H*!VASK6L+NV4T4[D5@MG#Q2=A2XZ&QNS6%ZC]BO,(6MC8[%?"_MY;B8],J MG6RA)#O4L9@6!Y9[NAW3UH7#3(ZJMBDK.J"/5G/U<*N%%$6V0R"KK@;7)P@, MZ1ML5ELJ.9=. F544L:W/ZCHVFZ++4DEFC$66$=65Y(6V(]22KE>O^=K@NV5 MUV\TM'++>8"O@ 0MUOMM5.L%=%42>)2BF[C7K8E^GN0RM*\WT+"'R*_8F*>I)4^)Y,U+9H\R(J/ MM9E0Q9IT*1/;F)L2N:O>OQ2<_P"4LK02^7Y<8W,6B$QBD>:[BM3IF56!?%62 M#F52[0."RBK9SS3'FI\MY%8=V!>K1=-&L%<5ZP4_(G5/%D M-LKS9 \ +=/4@D]E+VM.4@0%[-"&,WAV%T+S7Y-)_.6NG^C+BBJOQNDC:%GW1L5I6@JIZ5! HLJP28#H M^0+F=(>B(2-:<>A+=K1%HQA! .UX12'8_;G4TDF]@O\ S0X\!<37Y6D<_>4A MDS1,'JV)99T4AZ>KX Z.BAFA4FLQQ2-#.6D3D(@*5V_M*=Z",T[01;%>\YYR MUT]Y)[RZVK.=5TA:JBX,W#:557^5<;,V6%<#I:\=BD-A;@I0-#3!T\O?#_\ MZX%O;MMS48R+E7O6AVGV<$U&^;"1;3;1L/$]@6')T/3<(YG7$5U92!5"94\V MK#WB2U=):;G]@P.MDEEHG]QCZUN4T>5;=8/W0L'\N[DJ%L*9O:VM*:M<%R@6M; MV$A(D(&8/>M;] AW@?-Y->E+-O+R!>*CH@53JJGIJY6SJ)/S;(?[PO"F87?% M76AG]]A\0MFK-1L,.JE196_HOC.Y)E+TL0H1Z"J5I3R]$8&/<\>2ZR:[YHX' MJ_CSB$N72?J]_P"NHW7T#L7KB22#<,FM$3F:N4T:)=9=C11>^/+4I&:!>8X! M4C*3%"-2HDQX2R/<$U5OYM)Q8=D%NR#DV:J>5F6UK!JBP[D98_<#LMAB*IX& MZ.MA78[(85S"9HV6$O:8@@*Q2D)T9\( [67>1+R%/G&EB]3Q3 ME:HX164GXOL3JFF;@,MPV8 @2=C!N1Q2(6Y7YS$Q.:BP9A59GY5N R&.C,C> M=!1N"@) ##-AF*GN'M/\(QTW2<*Y_LJ^N<^*Z:Z7ZY?+8FLH01J6N,[C3LH: MZ[J];#&I(X-<[E9$*='50[/+84U(0*$@=)# *-#*##XGY5>M^BK2Y?0\E-7R,6]VW:=O,,X8:,AC!"X\-S.JAG7V!&^GZ*F )LO8AUG?U/HRX\J4>\HH>]B '01#WQY:[GXUZ,?8076-4K:J@[QS@C M4,SPNFLAMZW8Y=\G'&I5-XBZP03A Z3;*W<#R4R=).RDQLE4DFZ0&>@BM;#J M;P\M'7E17-W1"T?(=/2&M^$'JHY!8V^5R2G+G6$G1![BL2!62M$KGH MHV?M:J;5#@E2)C"#"-*31B+V(*H>7WIFTNH*:L[==0:K 03FRE5MI.T MI?E%QR2^XG9]=?NB1UX"/5GD")+)T4>&];NKK M)]Y8A50I('%&*97#TAT%6_,E,-,O^>H1&^>/R1 M2#L3K&@Y]0G#3_5LT]LJ3S,QV?J;5IY%]FB9I.+#IQ* M4\NS.D&2FC:%*F2)-&*G#WA=#G_KOHF3T'P55//T*L!\^\E1UU2<^/',T0Z2J-]5$O$F=IK===-5G7 U,-V(YNQ5[73?0$7> MB HE:UN=BI8X!,*(V5O9))@1$C\BGE-DI'?=E0NCZ FE2\9VS?U"D,< 1S^3 MVG)YO#UD 0127M$,&M(62:'5U''-RD,/JV1] M=4;+K D=S4?>PF6T72*L4[I**RVMB38XEBT27IVVR*AGKH\S*JK.0.Z]<%Q: M5BI26$'Q&IC34XP#$&LBJ?++UY8W:6J>1--$KZYLPSN2,5NA:XA/7Z'P.2\M MQET>*Z7K>FF*2#K^]%HE+; MM$-=OU-6[3; <&^SCNQ>JIWSLDEW75*--47RC>)TA6U[$W9F5I7UB8GMQ3P= M_3:3S"8-+ YS:/D)E)R QZ5EH%)PBQ'^T/KH-//*GD7[>Z@E/.CC$;!YK-17 MI7G8^O+XF2G.*]&UDKST2CZ(# M F%[+#%X7Y!O)5OFKE&][3F/);2W]JS*K6NM&*L*GM:QKPCT=5Q25NTQ+BM+ MII&G-N.:2=>VMAI:-"J3)(P@4JE"Q2>0F^; [ZJ?(GY!^EX+PNHK9?SE5#]U M#SGUU,9H\3BK)W*#6"8\MV$S1)3-HRQ(K%9TRIJF+4ZIS$3$I- %$H-4&'+U M("R4X@CJJO(EU79CKR7V+(;#;6.M#/$_UAU%:G/#%$@&,$YG/.%A1%CG*I(^ M&OR0YI76$(E(8S*#B5@8PG J3@*4[6FG!#OM>4WR#T'0,EZ-Z$I6-2*O+:IV MM9K1J?(]Y#F:^9U$+3L)]I+B:4N-H0VK&:H$E^58:]W5$;HAS;6JE!-^DYAHF M",S.UI+&8K-CSBCKFKGI[,&8NC90PN+QK:-5[DQNL#4FNH#M&"^-ONG@Q'SC M>]PD1'JEG<.0)*[ KE&LMBE'GH./7>Y?FC5$O_%L 8T[19[*.$)M3I!D.C>) M,B$6:800&UKGV 7(V^4SM:VG^F'.-TO:7./)K1#+6>4[$ YVF=?(I0\G269U5&N%H]"F M&V%D=JMV8WVWXK:+S99+1$@OLJ(DNI&9'GTEM1K#4B8L"Y.,H1Q2<&C]AH2= M&7M;CR%>,B'0&B'6+]@M'27D1O")U,Y/U/RA:FH*T$_YIX(71Y78R"#!T2T6 M6@;U)096QK6I>."6]QQSJA59SI M26GR.WM=L%B4V4/-=-D,MEWBTE=G67209J-M:C525B2+=I/:6H3!$4&/=.>F7FIMB"RH+>M6J[ MXCT"NYTL(F:J(SR3:$7=W^R]\\)&AR M1/H3H>]7^O:(C,Z@2^R^4+$J)\A%V5W2L?DL5I%TC3U*V"[X>N)02FY[G_+- MYR:.N9ZHNWVM*3=M,I MSY#1T"98D:L5&/"I[2E$NB9U@?UTR)9\:G6W<)NB=!*/P.(Q<2^1>%+>9Z$! MSW7DPAO.OE$7]DJ.N0W'7(UM@59/YI8,OE('.M7YG0RQ-9J-!9"E"YF!) G$ M>@3F-^S-!+-)"Y/F@DQ\5>O&([1>/$SJUD'D?J9SK*ME3TPQ)+/W5!!K%VXQ M\R$*FP7@3NBI>F47DXB521IRLF2=! M]!S.7>/@=IP<),9K._(7!82XRF(6ZH&@JYOOE0\U\G>'\XDS:!S;% 4NE9AY M(PJ SZ4>+7I5]XZ<9'7FZNI+O#_KQFGD#IMJ0JTDA@]"RNWGA$RR^K5TT4M3 MDGEH$4 6*E;DO2MX4BQ]*+"G*$G**-&' 8O!FZ-C=VU5(["VZU18-(2Z.\D+ M9D].+XMK^[^C*]C;3U'9$R3("4BU>HEL\JYA<"E!@E1WQ.3GH)?N.-^<(6E? M 7?=M<5W52#MPYR#3UIV%'*)IYTF\6N]6^S^T4E0VDPS]ULM^LAU9WY9$J?< M&2!)4;5#M?D70MZ=QN!NDQ9 R!A:'O3CSKF][]KFS:.H9'6]E.%14K$]]*0# MIHB$#KO3;8:B47+2_2M>KD:ILZ6I;\'HD$=+;V(PT+D:K,.+ 6:5LH+K^1WE MF^+R,Y=N[F%Y@O\ ??CF\0W-"H!:0CT-=VHA>(TYP670Q_DB%"ZN<05J(R^* M!H7(A*H&0H#Z>T.Q:-+"GQW-_DHBO4=&>0%97//=C6 GB]XTG:')E=3PV$,D M J>WITP3B*26&VS*F1I9)W8;%((^6JFCJN:TAKJ2,0$"0\PLKT"+Z/\ &/U# MRS9WCKG,'B%96&DYY>^\+4NYE061^PV1HG7:11(45?U2D70US-4PBL24I"4* MM2$@Q864(T!!6S-$EAAU$<#>0"J73Q,.C6>V+S^Q<.T3,0PPT=EL3*.#*C8 M"N_Y'6W.G84=/[SY@E+4QM+!,TM;1YX9GAMG#:J)CI2QC1F+VM(WJU ->I0"!; M,#&8CXXO(+6,1JSF)A/YBL+GSG;R"0SKBH;8E\TGS!<+Y 0VI*+3>X=-V)% MY"U@FC.XR!84J>B5AOY0"P!0" !^4XL-EGDMYS >GZZ#5[UW5 M]/4_377DJ[G7L,.ZJ\HLJB;I1-3U =8-CE0V^N:ZF:FOFB'US82*$-9[I9** M>HTB[;N>TLR56YNOT@ -2%>\8;J>(J 9JRKB5N()!:)[_702TH"BBP@*+ (:=:W\3G8=?(>9X$9-^ M:WVO.9_)W,.V6)Y ^6@SS63UG-)'/'USC+NV;@3NQ(YT1^_3 D%$J-MX/I!" M-49\VQDAV$M\5O7CO(VBY&)UX_/MBM^VNN^C8/7UKI9O;%'6%5'8QS&;,8#9 M1*JMX^_16;0O<91B;'1K3N11INQBWHCTU[@VF*>5'ZVN$)7R5T&ZUZAD-I5- M/H!.W.AH@H@E%T MT,;8,6D*8&)O1-2@UX6*%"L0B$H,#\=1>/GR"WE:O0=B5_9/-]4-=RQ#C:). M$0132YMII]#^>7*=/=GU#/GZ-P2+R6,U[:+C:+@1]Q@5A<1-C2F2F@!I>J$G M"$8%XB.VX/)JD9F^4<-L-259Y(T/D":&BN(S;%?ELH":^00<^H(Q7J=K>(^W MQXE.G]B51MUT>$16U)XE!B@91063Z[\4US].63V5IMN2L(74W2ROFRYX:X+X M7(9/9$!Z2YB:H['H6F>F10ZI*_EM,/#;']J'-.I"8M4FJMD:* 65\IH=1-/' M1W9<=7TE#[,M+B2(N%9]A4YU L8*,HJ80* HT]$G!4,K4U$$O)3O(Y+:*Y2> MI?5J_:4AJT @A"28 (QB#9OW+R='^W>7;/YLD,F<867.DK"N8Y@V)"W(^+S& M%R=FF\*?3V2&+$ CB-+$FC"=&E;'HP(:W.D/%YT5UQ&;UEMW MVO0)O15C\U1?DVOY%#8)9K+64&K@J?H+1L"9/,:63YQ=I1/Y/-FU*>WE:/3- M[2F1ED>BCY3C!A;'G?C*V:P[BZ"Z_L2R:\DR>[* Y^ILJ(PV'R./J6EUIE(X M"<)$:N>I0^DB0/CD_+=E)0A&843HC0C=B"9\@0ST!XUK)Z [FKOIE_GM*((5 M5-ST;;%UK8-T:[N;K:=37H M:BL),ZOZ=T&ZZ B6Q[;)M!]7WB+4&G ,1AFCWXC[M@ZJ"7;S/UNTU]V*U="= M'7S9-F2ZH$LBJ2QS>J2XTBLB(?VF_(,Z-MPQGJJP+,C5H1RY(:XQ&8, MK'"H'7SG$438TQ\DA4-]IKINZ!G#ZRS=P5KEI#DR@(7$B(3BV'11@SPCZ5^%F670NF(133M75BW :N-NCD:D3JI4GG#$7L" * )9E'C>ZGL!BI-597D5D]@V;4'150WOJ5O] Q9-"EZ* MDVQZ;8K#H]5S'/&IJBCA(Q29Q4R60&+')S>#U!80_63I4Q!097=GC)=+]Z?A M%[V)T%^TE-?&@APITRH716@.4,*@Q%](M-LHWY-#]H4KJKPT-U7S7E-U!V5T1**V MX@ELPD/+]0OC%3GX& -,K9GEC_:CO)DE?DS&;MK>UN@4@5#DL-6?1*V42:0( M?RA#]4OX<$-).W%KI'^K;07AXILF][%AB)=7]7@)F ^CGH;G:+!)S267[)+< MZ(%BI$08E&6>D+/"84()I>A;#+V+P[5!&[5GCJT7KT6CY:LZ:RRT)UPHDG0& MSF^06--3#E$B<%21G1MTOU"71P/VM4Q?3C^&5K=!$H+-)#HC0H1<,;>(G)4-=(A1_;ZZR!MCTG=F]K< MWYQG##'V[P\12+QZMO[?]9]-PBU(G1AW+=@76D75L_3&Y>; MAN9ZULK&7L\I@+S"VI1"$9VT<:>FQN2NK.GV/^H>,7NT$_55XUJ4I>?Q&6UW M++-C<5KKE99QU7=4-KM'$\+BM0.BYI?7@\MWU&!V,XSAQE32%RV['ONQEGCV M$!>@?I@=]S_P+":*N!%?#G.J5 M[LEC@,\8D\%53RC LY56V 7&7B(NB@Y\BJ9E* 2F-6B;-CV([ZWS[T;H.ZGG MB:KFPB>L1/?0-_"=>U$5+1N\7[:BKU#N=!J)*,00V/PTY36QA3"ZK64)*=R= M50')2K,"8?H)9IOJ ,9MWPM<\VZYVCM3=O54$A5SV;%+OL>IJ[L>'LE9O]W1 M99&W+=L 8G.MWMIA"0C82_8%Z.I>2ZHZ\K9GKFT_ MW.A,B$SB]F5Q/H6^CCMB5C:$*--.BMAPM^^NL2II$T#4&Z]BM*L0J2SAEJ$Y MI8MAP*@2/Q)U-+:VM:$OU[]%#EG0EQP>\>B;A:W2IFVP;GF%8_ACJW:7\C^T MBJ$QV"P1='4)[V!E;:32(VB9L;X_NCNG5@T(C3DYG[$G$G^).6$,HO M#CSZQPOG%@AEQ]0US.^7H _4Y7EZUQ9<=A5Q.-(2)R&.!IHM(8>G M5.6QI3MM!3PD.) H*6A5>\\8=]_[/W*#;8A4YA#U?-7,;Q7< JZV*HK.YI/$ M:RO^*5@UELL.*NQ A]9/+7(AJ+$G<59+JB/?2#CBW,2L!YX3 D&/^,OGN*P^ M^H3'9+>+*T]$7>P]&S-2U6T^MKRP7%'9BV3=#,*]=D)*=7"E!KPQ-Y9Q*47U MS4C>01L'L!O0@G7FGE*M^76>?I882BVYP?9-M6-9C0,T>3GD1QA1(@EM[U*IO4*U1)@PZ*WZIA&$ M##/';Q*\=/G*U-\@N;'8AM:<\R\$[HZ2)+,D[1;%6RHEY=GM.ZQ"RV92WR%N M,3*'M066#8QEA)$#7M]Q1(P!;BHZ#BO.]1KJQI@;R0<(R6R(N26)+)38DED= MBRT]8[N\VGDME;B]222N[Y(U6U2XTTX7NUO8"P +T 0^=?B_P 7O;%7;J"N MG%#;'-S?'I&YE],VY&>\WJ?5__W"_3AHH_GAFAZ!#"A6?))$9O[[N)J< MHD:,U4@^VJV%6(-M*GQ+\! M H V.A9R?0BBPCT, AT&&5_X6^ X#5\NI@VNYO8%9R=ADL6:8A:=NV1/&>L M(W+WAJD,C:J91N\B$150W9]84*H]:S!2N1QJ,G1B@8 ^W86 YAX&I3D^=SRS M8!);RF,]LJ(PN#S"3W1>%AV\XN4>KX]W-B*4.YF\N)"0;*G>C4Q B@!^%+K1 M9>@:$;\@7:P& P& P& P& P& P& P& P& P& P& P& P& P& P&!PW!7^/0+ ME_U5B[Z2-2K^DWD_97K/K$C.^JA3[&7H]8H]GL*![@^X>]:]=>N! ?*O2D.Z MYH^+7Q X]-8G'90ZS=C!&[$:FYDF;([U].I)7Z7MVBES//IO!_VA<\>1QR2.R2(/9[6AF[ M*F1N+D6MADP1@ K;50ME#-*%O6P:T'0A!TG1W'_+_7;"U1OIBC*YN=J85(U; M!J;1],X.,?/.,3&JAL+X7\#VR:7"1E:4A2J"@J0 T W0P?RX'857OGBH)"1R M73,>AUF5H2Q="?()&P.(0$B.TN5#2 MGG; ((1&8$E2BR8#"7R"QF62YAC\BLV0*8K7S&Y.!"=VF$@1,KE(UK6P(!"^ MRX'HF-G4JCM@#L!117J/>O4/J&8_.1\_UOF*^S\7S_7^0'S_ ;'LO1WQ>OR M?%LS7M]WIZ>OZ?QP,*L^RX-3-YI-)(N"H,2LL;CK>>YN MS@80D)4+%6TZ-.+822"S#SA^@"P#&((=A6>LNQVNS.J+.YS2054UQR$T-3'0 M80BN[%6P9X"]PYTDD:C4N50]_ 8E4! M=XRM=$3@;'W@!J(@>E"41)VA$@W[O4 =Z#.Q+$8#PI1JDP%(]AT!.(\H)X]C M",8=!*V+1@MB 6+>O37ZZ#O?^&\#TENC8:6I.*<4!A*+8@K#2U:<9:00?7W! M4C"9L)&P^F_70MZ]/3 _'YAH^K]W\JV_2^0)/V_O)OJ_*+6MA*^Q\OQ?(+0M M>@?7UWZX'N,<6\G8-'+D96S %C+T8I)+V8 W8M%#!H0]>\!FP[]N]?IOTWZ8 M''_.,ORHR/S#7\SC\_X\G\@D^5=]4Q.4I^F7\WO5?7-5E!'[-"]@C0:WZ;%K MU"-;COFI:$JBPKLM2<,,7K>KX\XR68R!4XH]E-Z)O(,-TC*+T?H2IYL"66":PV5HEKE%I;&9*W-JQ4,01E#UL(M:WKTP.](6(U(S"TRI,H M,)T6(T!!Y1HRM' T83LP)8A;!HTO?N#Z^GNU^NOTP.3@5YZRNQYYLYKNSH%C MA:*PU5,5Y)+,6PU=*#(8!]88:@-?9*F2R$$>E.D;H7'T2DQ( :(9:A4 LD8R M0F;. %4:C[4Z3FZ3EN>S3D:-QRBNEXJGFZZSX7T"*;JJ+B+K4JRUV"4W!'7V MHJ]0-,;6ITY;6H6I7124C<5!8!>\(P;$%]FFUJN?U,:1L5DP%Z63-,YK(>E: M9C'7%3+$;*8H*>5<:(1N)QKZF:34AH5)B71H2!%CT/8=AWZ!^V2T:RDRF2HX MW8L$D"N&?-J8)6271]V4Q3:8:DM1J2D('!0:Q? -&<$?VM%>W90];]/:+T#$ MM75SO(VYN?M6U2[\TI9$D;VEYU/(.Z-R:6F)CE"!$W./Y4],3(AH]&#)+*'I M3LKW"#KV^N\".;?[>Y=I*)0::S*XX*>PV5:43IV$*8[*8Z^@?YQ+) SL 4:5 M0C==H@((U^:*6O*H9H26MO"(X\0=;!H86"G,XBU;0N4V'-7I!'H;"HZ\2N3O M[DI(2-[2PL2 YS9'*] M(\96+''!YK>PE/0+>BL&NI<9-2(W#:9O*.2PIG:B[ FT6*42 HYL.+(2 U]( M1)H@!5'!M&D][TG!T29RFEOU?$V];&P3)"MD,\B[.E6Q U2C1ERE(>X.I!2F M.&JW%.4%:#8DPC#P!T/8AAUL,]D4ECL1CSQ+96_,\:BT>:UCX_21^RIO/3I5\V-9CVY*U,6$ MZ:>4Y#[ QZ#];\NV=.&RM*VZ)I2?6 ]1A5-&>&0Z MRXA)9&ZQ-"X*VI;(&]J9W=6J6-:5P0'EC-+"+0=E#WO] [WH-?MC^5.",_D+ MYXY8K>T^]!"S*?R@^/!6@=7-+VASF>WL5>CM1X5E6='!$ML"+B=A,+V(,RE7??&4(J^M[HE'2M2-57W C/!CEC^2O@>HU_X MNQ>N:)C*_<JK1Y1=)3^$DM.4JRW;/IV]EFM==LK$\M[C)=H#9(L*);]_C MH(A ]J'#1OXP*50 H)XE.ADA"8N<>N^=^M&Z9.5 6.CG@:[D!46G;?MCD\8? M8D_*DNW%O0OT=F#(P/S=MV:M@6HQF)]%JT1I9Y0AE& &((WNWR0<*\XR:00N M[>H:FKV61/<=U*(X\2$)SS'=RL:O\'IZ;FTE R'S%+"Y*F+C\Z4+&A0M/$G32Q4C31LP"$47"$9>Q+]:-+V( M(_N[R(Q'F28=YVW,KY8[=J3F.KZ54J>:*[J"4:LBI[#G*>1"CRB46HD(7LKP MP70J 3\:M264W,"8I.<:866;LQ6'.J3S"B^FD[-.X@VQ/DM-U19=D3R M"V3!XO &\\38M,C;J":0&.*--!<;6&+BI(=M,S+QZ)2HAJ5)^BP!.#!Y..,7 MR)6O,E5IN,*;Z5B,/L&?M%HUS9-53)# ;&4B0UO,VJ#V%%8Y+I#';#<-!2LR MA$B/TN5FED U\Q@ ;"O'C,[*M3JZ^_(FR3*2OKI6]-6_53/2\6F=0G4Q85;Q MR:5\LDC]!K BKNS,\LU*&)[+VG.&YA,,,"4$TK>BC=:T$XVAY%()5G<=><3O M-:6@:NE]5R2U)';9<.EHZ]A3(VN#"WLSBM=D<97LRF&F&KUX7V0G+T35( M"UQFA*0>P,IHSR*\R]!6PWTS"'V6-LQE< 7VS5!DWA#[#&&]*K;'M2P+K&I9 M[>B2$L]BJ=8G";\I'L.&A/)6!*$E- =L(&\IG4TNJQ9&R4K8G8P:6.RE6)+Z"$(O8 Y, M8\Q7),XJULG$*17#*+)=;+DU-$H4EK0EG.D\SA3U6CVO:TL=5Q:( MI3G96M7N*9L^F4+1:D9^PD""Z/+/4E-]E4I%>@*%D2F35Q+C7I&A5N+0XQ]Y M;W>-O"R/R)A?6)V)3N#0],CRWG)U!!H?4(P>NMB#O6]A0^6^:WCV$69.JWD3 M%T&@)JV_4/-]GV".DI-NO:_L5^:$KA#021UV,+JG:IZX&GMS,(I$:J6JDHS MD:2&)U)X=\Q^7OGIW@CXO94+Z KWF$SFZ3U@E;[]>[DMN.DR^L8VW MQ-#R@E)^2FF2]+V5='05G6AUYU/6%%-R&L"'RYIM7U0.:=R+4.<1@D>C# M$PI81#325#RI5%H4Z,]2$K8O>,LO8;M>:>D:@ZXI2$=!T3*-2^L+ 1KE3 [C M0+6E: YJ=%K&\M;JT.1*=P:W9G>6U0F4$&@UL)A6]AV(&PB$%+O_ '=>6T<4 M+F$CCU\0YM*ZS3<3/J22U"\)W:'= +4T=/11Z9($*Q>*/LJ\V3IR$SH:+Z2D MT!GQ#C"-)EWG7,Z[2YY@D+N/I6&_MVU.P:;=::C]'1USJ7IFP>?Z_$[3 M)F46H]E_=0FP4T)8VC\6X% 6NAWUE0"_B/$4&OQW\O%O6RM\6W2L4BW0%>5K M6?SW Z[33ASO>(PF*2M?6!,+;/Q+G(Y3)42EE1$+AMJ]"@1O UQ9Q MGU4VSPAM'AGEPYWLR)TTX5A ;ZL"SKPE=Q0:+\^,D!:T-P,$KY^5H$=SME@I MI'*F2$08B!&N:?2A6O>RT:D9Q9:4P\T80;#M*M\K?/ET3#G2"US#[@>9%TU! MK[E,&1KXQ'XX;'I7S2,U);M/V&C?Y8WN<1LV.NX2T7PF)S&TP\\ M+/A]Q@0 MB2O_ "N+.@K?X&9>>J*G#M3G6C7T2_S653=+$V:60Y#0SV77[^V-;2791*0M M=%)RN3+'I0+\@2]HB%C&"1A;#WQN MWH10 [.+*&&$./8[]9?C OJ/5:_7XLE_/OC?9;"F?9R::(TB4CHXJAXW9*6" MLMDM#Z;(YE:C2D2L_:A3\ 0F6M/+G"X; Y\7=YNW,4GF/0L%L&0-U5('Z+0^(O3R\LDO?+27(D)+&\C2NQ@G0DX\H@ M.CM%A$?<'D.?Y!R+W_3#N M:P"\E)+T1;/*2M)4QK4!2:7HP?J [ Q?R?=N2]-P]U?2M#QV['*S:)Y&K"PK MGOFO)^@K9)1[C9$>1/,*(%)E$A;9A,I,Z,;>H='1M:BQF 9SB]F&#&I"5L)# M=O-M1=$CA-7RR.S6S5M>13FB(WK/V&50 Z0,MD7-%(XH(01ZO7^4-UB6ZKC8 M7I&ME:MD2*"60*\.CAC/ <46%Z>6^\-]36S;M;,G-%^5ZQ4O-+*K.66I/D<$ M! 16763]'V9V@K5B5\$M+-2@4(0$IAEF* G_TM!?W 8# 8# 8# M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# ^8[RFJJN6'O=Q6:H>D7.CI9=F%5C%K9#)7@: MB10U0C,C)#)^>$J%O01%IA[T!7Z!'_+L/TF<^99AR;TO;CSVYOR:7W6]ZS4QBU-I<84,\(C-!,*F849#)91W/79U^=D2OQ[2SD.W8SR'>EH1VSH M3;,NO=5<12 N1L)5<1]+.7)_:JK4)"JT4O+,:M-:#MF!(%\NQ##9%Q+'*3A7 ME)MT+@TV*SV?9_#W'4_J97=30^MMMS)$%FM=ON>3S@IM1I883/P[+8BY.6$M M.%,[#V6 HLX9H=AG?EP8Z!9^@/%Y<5\1(:Z,PGIJ>LLDFB.&S>4JH]$7NBK! M7(6I8; FEV>TK8\6BTQHS1.@?\PJ3%;WH199OH&J*K/WY/GFG'A>W6=%/,K% M_*4!LN^0+DUF@=7;FI;.G0^9FD(529L@YW(J:@DZ),W-WN$RHU)!9Q6@N:S? MSAOM\RE6GV_XR.Q(FVP9PL61)JB>95$HLT-BIY>5,IB!J:1,RUG:D83#USHU MGM_V"2] ,]1EZW[!>GI@?.IT09QS?(NG%3-&'.-L\#\,=2-7.L(?XA;=21QA MNU!,K>?V9.RQ-IB30WK9RR.4YCZV.[+;S]D ? J6\L!1YAH F)QF,"LHCH5X M2V1?P%,]\#'/#5=MDUM'IO*[303@N5_M:P7MHC$@TV('&!_\ K&I3*=Z"E]_\O5]T)W3Y6GNKXO,7 M'IVM^;ZAG/)KVROEE0QJ0=4PJ#V!J5OD1?ONLT!>)S'E 1Z@"9(\!) M& (#U&!0B 1#E#?'ENN\)'Y!8,C>:!HJC^HW]\HH@B T7;;;=M:/,:8Y;3R& MKZMCK>O M5<2M:5\-U'*I54=C7S*8U7,7@'5T5H"U:WLH,0JN:Q%(J9VXIH;CD;4_:<#F M(91IGH<&QWGCA3FB7=OT[5MG\Z]*/%61;Q\5T&&I^F$EAR1418T O>2R6"I[ M;G\1**JXNRF:EE#7]-D4+M&-[.H-:E1'V?M)L#%JYXFMBH9[UE51]$6!,^?_ M !O._3W1G$[-#7!UC$NO5^[(J->=$ZPA-@@/:U)"VD=?GT@%K::8N2.JQN_3 M1R)-H\-=2'GF<6%0/8$'@'.-RNAEW^+.N%]31(OC^PZHK9IO2D["52-[AT ? M)Q']RFP;&A4<< F)YK,%YDKF#H:L&W'&EC(2@#8K.H7+'B66 /B^E+KJRP;M M\&9U>UL>S4U9])"U8M'X_65@GP]F5&-A*TYM5' & PO^LH) MV8$=.=2Q.6.Q]F\T\J612W.4>\.]TT[U)6JOF6UHH\S6[9&VM3;3U1*(PJ@[ M-(;@MZ/3 H"\<@1(W88$Q C3U8?LA& )MXDCK?R+U10,YA?/MU1JO77PCQR8 MW^G8Z7MQPD4RZ"@K\AFRZ-NY[VV%D.EZK6)KEZ*.SEB41>:,261M25W3L\LC:P0U;!(VXI7HE M:C-WLQ,H ,L6_4.\"J/DO_(J/']V&R,<>E,MDDRY]LRO8G%X7%GV9R603"Q( MRN@\29VV/QQ Y.BG[\C?TQ9QWQ?72$"&H4#*3E&F #37QE"Z=K1RYI;D'.OD M3MB]6;FF%ZH_T8OYDJ.!RR$11[Z =AH+C9'."/Y*=57YC2ACT0$M2. MRHTE&0ET6,LXL*R\@>>!*,Y6I#HFGFZ5W7QD]5]SAX MQNA:)ZEKWAMJYNZ&G-AO+G0K;9PX!:-8SF?5) '1"X*2K^GUXK6%_.%*%A)9 M:- M,)$M.&M 1L(@ZTI?FU;S.BN%HX5ZLK<0"DWU:RN$:A\B>7EO2;1"1(D[H) M#HP8-$%?*6'U:W0K)>^@]A\NG(_-]RTS'?$/-;FXOMR64W3E$=-4KTG5 MA-)J9/,J^O>P#2/P=NR:H!LI[S-FE[AS5ID#(T!3@8!,I$3[@AWLLT,>YJ\= ML\1W=XN(3UCRE+K2J2*5YW(U2UJE%,F3"!T=75VV H=^5:@GKN4VK42+<-:@ M+5X4JHXX40/<@E&"2B 5H(?0CY2HG8,F\?W04)IZC$/0,N>(FPLC/4R@*Q06 MO;@2N.[7O"!B;W9B5RUR@[4G,=T;(%8G"[J4!:0S8RS1EC#Y?R^9[L0_A3HU%,;EYY@,AF,GI^"LZ9OOAXES1!U"5AACR_LJ94B-8&U M(686T'DM:O6M_*# D.P.39_IC[MD%>^/:X292\>6'F6U^8DB"B'F$+!TI#7Z M.N,OTK8_>B^XIP1#("E,K<%^QV606 MDI4JD222K'*3,T77V$U"W]@*ES1(&I8I&F$2F]PPSFEJ6ZO:9-XLHA,?&_=, M;:^$Z0['ICH4;>93$C@M@R&T:72Q5HFD&=%UB-I4^26;(-B=7#:HDC87!U/) M$,XTA4, 9OQ;P=9-/QWPY;M;A!U<7VBH;VY'>GQ;8*0?!QIYLM4#^V[W*=+) MS]:7&/1B$(B%*7[RM.28'9GQ^W8-!#-;\2]5PJ)\QS.3>..S;*@4$KCL+F2P MN;V'HJ.43:\;BMW]+22\X%+X^]0&V&V)2NKW.$2TN-O32L>=^PQ.I]Z,99:8 MXT)X>^'[Q9$UPPN/<#)H8WH?"_/N8JE;*QED1L& 0.\)W8-GRXNIJ_F]HSA% M8CBK*C]F(D;H]FIR&\]:B6A*,^F!/[@R4?-_41#2[1Z;\'2^[8%8;&(DM1/#=\"0DF?)L!6RBPA57IQ//''R2=T0^ XOI"WNKB(9/QZ&G$H&64&>6YX[.M[!Y@\NE>H>8&45F=8]J);RY\<7BP*6 M"L<*U>IM7:MW2NCX7)U@X@XM['71QRI$:;[% 74HHL1HPJ- "0^C.*.R)[9' MEAD\$YK3F,O6'#M"\R46D56I4#(%5*(6BR(*J0#M&F&B7. MHO%$T\36&ZR6Z&&0D\^6-"9+-9(UK71!&FA4OL]'*C"FDD.V@!2="%P.,, M4#VE]AX8>;XW.W; JYTG31QOQ7RGTK3LJYNGD)-99\Y6U(.GII0-D(IHM0/] MH/!:\NIJA>FM&86W,:Q(\*QN1Q1BA0C+3ZV(-J7 E1=31WH[NOH7I"F*\I$C MJ-ZY[E$-AL(L=LL)P9]UY5JB$OK5,7%H96QN<9,F- 0)4YDBTG6'"$ D&R20 M'G!CO8O'O2UQ=D1*SJL6UN71]C\5WOQ;?PI/(W)KF$68[<>T3T@G\1CZ>(O: M.:*XV-ZG+,K&(R6 MHI4\2=PZ#?)C$V:IHZ_N;0[1*,?VSBS+7$>TN5MHE#J<>^*]:*, 04+8@N%Y M!^>K9O6+VQJPY&\1)DEC) ]2%NDT622-H9)'^'>W9 MID0MI%"A&0?GWM2O?R4VN$MF@[?12B-G%1V M2Z:JY2*']XD!$%0IQ! #2,D+FJ,UL1J1+LT.KM+Q6]Q3RP.JK!9K)YB9FWHC ML&B^BG>I'IUN%WA%AU[4U:N];KZBM*1L,8A\I1-;IO3>[B_%A-)6GA,2*-!3 MEZ&<'2T'XJ?(!S!$U,]TST?82>UT[ V)&Q M@DKM!W:#3/W ;TC?[DI3>F2E&J%6@F!&$>-/B"[>A]8P"3#2B]E**P%-=*'9V?&ZEH.37U5QLUX<5"]/$X,PZU^14,$71FE MHB7!PW^16J^R<(DTS9)@ R)G\;EUQ&8>)]\ M9)G6LD2\/_WID'1#W*GB6)9=;UC]&1 +1;4TB0F^(*F]0M<)@^/+]H3B-")4 M:<60+1 1",+"M]">*;M6HY-P*P.\ZY:>*8X#Z$O:RX&4U.=N([,E\#N=-/4H MVN5+EL051D""VWH;GI?)^4Y5U4V MSQ:JJR>.K;)*CZAFD3F\@;XN27,XX,VPVYPC1Y1"Y0!"W$%N =[2G_4V!6&T MOMBA;&Z2I(=55S+ZXC>G:7QA7/F&WZS16S6-J5@C/4:FE336**E3>K+:)BA. M"'2] I3.+>>26&.YUX&XR9*ZZK.T9P*9.,1DL2AKC/5I MJI6F94B]Y+2IBC1% V=[@Z* ^+WM&M:-GG+K%WDR.?.K#4%S4YSA7SK2A*%: MT,%PHGB,)!W])F64I'&SD]30R1K0QQ(TZCY/Y4*52J^4A,%*((R@WAXZBINH M+_H&F>C:%BM*]3\WM%2VW5JJH+#'"HQ;YD!5UM/K\IAH0VFF)A+O9+)LA<[M M1FE*16\:$>,7M"46 ):N_P 1MA]2N 4UZWK!TL=%PK6W,2936%=2F/RV*W35 MEG,-NP^^(TYNUBN2,;O\ J!YO MGHJL91TKT!S!"^.X_-(W44RVQYK*4FG%0J-= MTS>D/*)()2[3:-":&(7KX>NCK&#U,AK+KF!5?$>YJ%K*N^GX$ZTDY3MI5695 M\#8( CG]7/9]AL3M%$4E96HTI6F5@7#(*-U[-F& +,+"3(9XLNE:?NR1R:B> M[%56TI=394KCT? FVEF1VF3Y9E;U_':^D4^I28R&3/1-/N%GM<;*$L_Y9S_' MB'_3T?LHG8 V"\DF@CV$80P?F?ENMN7* M>*IR&C>)2UJY7-; F$FG8VEUE%@6%8TM (]ZT M,/H+6M[_ %_7 ]GP$_-]GX2OL?%\'S_&#YOAV/1FR?E]/?\ %L>O=[?7T]?U MP(DLN_J:IV3U/"[.L*/PV57I,]U[4;$[FJ N$\F>DGWA,#&40G/^16!+Z"$( MS990?<'6Q:V(.MA,& P&!#9G0-0%WTEYBW,T8KS5UFMN($!+0NQBXJMT$@01 M8Z3JG$" 3*E3&/[B6G**,4A4'"T/8"]A ,6@F3 8%?*JZKY[NVQK6J*KK/9) M99M'+DK;;,(3I7END,'5KECBA0!>$+RV-P]$KU#2?\!Q7RDG !HP A%C (0= MF9TE1I=^D0LLAZ/L9#4]3C10F7/ MC"\SUR#H:"/NDJ9V99&HRM6$Z&:2!Q5)AGE$FC*T,))NP!8O \>FO]O^N_\ MC@/;K_;_ *[_ .. ]NO]O^N_^.!7CI#E>F.LHO#X==S&^R!@@=CQ6VHNE8IO M-(.>@G\(-4J8F_F+H4_,*Y:8Q+%(E!!)YAA 5 0&>SW@#O0=3T5UO47+CU1+ M':FIJ4KZ*N"-497:R-0E_DC(&?2U04F8T4ID"!-MCBB9:89O90EB@LU0 HX1 M!9H2#MEA9[ \>GK_ /OWK_RP&M:U_#_\N!YP/'I_O_UWK_RP(IO*U4U&5'/[ M>60>Q;(1U['5U:6)Q<"M$8]N1*<0CMD -",110_;H0 MM:#L*\7[W'"Z.@5+3*XNN( MG0.T8J8DMI(Y%D*]8@1G.:\\00Z^0T.@ ]PO06]:#L,_8'! M8[,3*Z.+,NCC@Y-+N:SS!$&C3'G)Q& MWLLP8-Z%L*D<\,E<619MU=#+N1G"AKO:;*G-#J['L.%L;39EN5]!#6)(R3MH MDR$*A<[57+RTQ)C.':HTK923U] BUL(0N7[ _P"7_CO_ (X'ZP(:7V1.$M]1 MZIDE+S!QKUUK)\G3Q?Q3O&B()&I*V2! S-E9+&92X%RI?*']$K,7DFIDQB0I M,G%\HPBV'6PF7 BRY+IK*@(*MLBVI4EB,01.D?8]N!Z9>XJECY*WUNC,;96E MH:4J]X>7=Y?75.G(3)2#CAB,]?;[="WH*]T/V2CN/H;K;G=]KQ96,AY2F4 B MRIW?9Q#'A-9"&S8ZMET0DD<:6A9MY:4#A'"DYWQKB@&:/4"3_J:G.T$+>F22 M/$OQ$6-?F4J3JFXUX2QPQT0@?E+20>%* MN_3 [G>]:UO>]ZUK6M[WO>_36M:_7>][W^FM:U@:]>QNZV^A.>C;[HY/570+ M(PW-4]86.L06^RHF.NV:QYVP05QDZY:P(Y*6ZND;<),BV8T#-;S-D'B/&> ! M(@C"Y)MLU:FC+Q-E-EU^1"X^XK&=]EQ\RCA489'9O6:;US6[OXW$+4VN*)?O MX#2#C0&EG?R"#H7Z8'&'=%.ELS-(AVQ6@(_(FUS>8^^CG<6"S/K0R)E:UY=6 M9SVZZ1.;:T(V\\U4>0,92;9(W1> MV)/^XV5-$&-:Y1QJDI:]-)CG +4OCZ8AUTD.<0&?2 XIE*71FS4YH0A(H^C. M>RV)ME!E[4T",O*QR;F>1#L^$!8G5P9R2U#NA;7<3YIO7+&H@T U)11@AD % MK8]!UO6\"461\9),SMLAC;PUR!@>49#BSOC(X)'9G=6]47HU*O;7- CD3F2RL"JPIG'8:G>W=0!W\8E<6FS,FD<,DC!+H\M,5E(WZ,/#<_,RLU K/0+BTSHU*5:$\Q$N3& M$&Z 9O99Q8@"]!!WK01PY]%T"S6PU4,[W9539=CXE+6L]2+Y]%TEC.:4X@U4 M0:BAI[F!_4:4)2!FEZ"1O9A0!##K8=;W@86U]J66+WZ#JXKY'N8HMSS3 M]I]-=!453DVEM#T1;=@Q%UG#2T+8PIN>.1U4W")BJYV<94C85\A>A$(AG!.W M\ -C&8( ##-!82%=:\P61,)Q :_Z J*9R^M(DVSR?,D:GL<>#XE#771XDDE? M#D*\Y&B: A3[$><(SVI0C+V=\>C2MC")FKR5<#/#'-Y(FZVH]*R5RZLC/,G! M[F[;'"VA7)S328L:$N0C:SW-KE1A ]-2Y&!0B?7DUWLR7!%ZZL-GJ9[::4*'/Y(98T@.5!9(TF2(_KMQ 79,W*U*5Q5*D[4K M(1G;(5&"![=AL=C\D9Y1&V:7,BH2MA?V9"_M:O:94G,/:W%&6O2'#1*"2EJ< MT:8T.Q$F%A- +U"(.A:WK UR43Y:./[SB=ZV$DG(X-7U)70=3 );-6]T;$MB MN@]($3(XP1!^,VYNZV52(U8@;6,HHV0'[1;,VC TO6PO#3%YU%T1!R+(I.? MQZQX4>ZN[")\CRD9H$+_ !]8-N?H\\(E)29R8Y R+B]E*T*PDA6F,_0PL.]Z MP*QWMW'!X!T(S\6Q!R1D=.V315BV?7)\MC$T7UJQ/328B9*Z+G2Z/MA>U#!* M)&H5B5C1KBA(4C2=H\9!BE'\H0SXU_(_6O5=%4RUV1=E3.76JVA45Q75 HHH M+:"(X@ X"1/3Q]$T]4@:4#9M2FVH3#6#5(RC@&'@+"/6\"XE']B-=@(G)ZO"YS(5(0=+3ES=F9RIYJ%%0$!B#7' M_E>GQ6L$N$/:%(J 6$-6#WCY4F!;VC=++8/,KG4O!G<$9YX>:224^[,,EOJ$ M3B65JSH1J;)<[$EQ,"=VQKM1M"E,3)Q;$L >:K]"@!3##HG3O/R?1JK>I^J) M'>%#JZ[XB\B N8IM2K%2;5&U5SUZR6/64!E_I.I+-GU="70@B7%J&T+=IQ6* M%!ZS0AB %$44&/R'O;R*U*1VS*&C,>;FURM&=5( MQQ&\SGYED:57L54,DG6#*9U7V270[>]JU.P"U\86PMRTO(C6#MWERG6M^R"R M+"YUYGKWLOGJ\Y% JF<+ E+*^'V*PS3GRU(ZV0EKA;LK=W"$+U,8=&MF3+R! M%E:4B/T6$E2$9S#R2V[?'/4^Z/Y?O:2P:MYFGX_-KFI,+2D(Q& #$TMR6[<50\[H.E'6 M3RA\IW_N"X#2321,OV#)I\U1.&M#LZ0^.3=XI1D;(/+Y9'G20[+6KVI)I/ZE M^@A# 0,W8?2_9/Y+^W4^_"O2R-O'[+E/XF1-Q2$]P8'+\&N^@]("'1*M;3EC M4J]AY0%!)Q AEZT8 8/4.P^="GNU.D; K'Q=V6V])2I>[=#^/OLQ]MEG6Q:M M1-C[=//U9MJUEMS\,9#$Z\E[;[ 6+@#((.*85Q"0G7U/;[]F!4^NO*%VO2E= MP:]K#NESZ,%=OASLSL ,'75Y%F6*5]J)"G)+( 4'?= 7'$3:(:W20II5ZT,T/RZ,#*; G7?M2\N=,N# M?Y $2MP6U9RM<5%(8_*PG5.5.P5]8]V3'H:6,SA*52VV)^UL31+) E?94\O[ M6A=4<:3HV;6HTV.9380,DHK0TR0O?L#O^70?,_U+;,BY#\H'0GDUBS),'*I: M=N*C>..OV1M]ZT^855:_/E6.T2=H7%$YFU3M(*PM)0A/$(S9&EFWA*21\NM* M=DA'K%)+,>PH M2^SZQZCZ'F4;.Z(L!RIFV&:;R9"S.+&PM\N3'))4HCR%MG'L'QEVKS],UW4O1W5=7WO4E\6I=Y$.?E?7=MJ:SKKL'QI5WKH*SU+/.;2I M*KNM6(]WO]X9'ENCC:T,[>1ME^LT>K>$F/Z6C,(]#@EB"%U_$6RL,<[2\RK% M&)W(+*8D'1G/>FV:2N:F6)(7E,JH)&L_^HS0\Y2J?]-AQPT1)IIAIH"$P"AC M&,L0MA,WE-?TS!=7B3/-3MS@<9Y'8> +:M3I%YPT9],7 V+W1 V*30&JUS$! MS I3B("8H)5A)$2 9_Q%C#3!Q[UM?]Y];\W0\GMNS7BJ^JUOD/B,FE\SNJ&1 M*:RF/LFWABIV6U_RR4D5*>7WJ!S0U*CBFBW,UWD(T"PT21.0683@8K&_(AV? M0ZJEY5::Z\Y['>%9/=G#/?I3O9KH%#:M_P!J/LX1<@5[9M6WFZ%-BZS9=,GM3(7M5.' M_9C_ "5K_++%;@>J:(RYN9C6W;&<:/\ 'HR?>,8_<,0?-I9O45]KZD[TZ23= M,V5$.UN9?)DP5%57-*2=B88@ZT\"SZWA%;T-NEG TN.2EDO&(/"M[.>1H5[P MI5$#/)5 ().*P+^^--9:-I=K^0]VF/6=[V7$N7>GYK4]>U7(9U&'ZNRXI9\( M@DS4[>&YJC2!Q/,3(6$S\@V0L[V[)5K8T.K2 >STZD\DTL@T&A[#OVX&O MM4_];5Y1_5EV<\=5W_T;6WC1[X#+(,;*)NJD9/0?+K5!Z_DG3U(2J6HB"S+= MU5+L\NI2!U5''?4,:%!1>_4P0 AO8\=[W:-A4*XWU:JZ2EKNEK.GU\0&%21: MZ*!UC2DS9]5W;M\RWIZK?-5,^;:VYQEU^/$O:Y M/4;S>^XY*ZU=*Z5DK7&8$OE9JQO(WF2;6$,#<@$:W&( E[+-"O\ 1_7'44A3 MSV_X]WTYS+M=C@':37-?'[&H!;4JL@B=LK#99L543>,N\T>*FB\#HQR8FU=' MWMH@[0C6 2T'F+%:[6\">'>\>7Y?X^NIK*Y@\B76#[9*#QTPJ=69'AWS9;B MDK?H*+2IH>VF2R>RGY6L<:QONR)ZYFQT^'M3NW)7MG*/ E;=EEE'A"UTP!0L M]\M%>"DUCOI!/_M&*K8;+ 9>I;2BYI,F;YA&EWY=M6L=CM[8G3DUQ'"GU:24 M(*)R*!MW<"50PA4A"B','8IKE3'B_:.W^C+48.+[#YXZG)GM]_WBL>**E'7[ M'=,O(@[)<=\1.6H)BW*8_3VAJ&9J#K)9(ZFM1B)*C5D($*\P)!"70MFX$A+0VP^+O/5=](VG>TNZ8Y- MM^9L_/,<9[BGLF9JWBUA5%'6>TGB*5RX2S]I.[TWD-\A,;"S@'@:W5@("@*( M.3! ()NKNC:4ZRL6U:6XML=T>^9NC_%\VR&WGMIGTTE#/7?7JF9@!SE94DDK MA.WF6QN[U#>>^K'UE*4D+#0,Q9[J XPXDS85L&[6A=?CI[3ZNZ)1692-J65<^*9Q-!QQI3;-$=IP,3+T6P'IS]E MB#,>TK%8W?N:EIQ"K2CU\,DHC/CE0IJ(06%/*]OZ()IK9B5[@UY<5R=F+D\6 ML6,2[^<-B,Y;?H\]F1B^U\9(REA88JJMQH:EQ\6E4HG$RX !YL.C]=.29MG] M@S$I)5KQ$V1)SVHL&7"=SGX_F@5ZD*A."_3FI8?8Q!(4F"+"-.(.@*8&:2SB MEX!(9S0\\INU(NQ%DM+"Z19S3/[_P [&]"/+2P- MS^I-&A;4*DQ,WN!2-6::8&XSP8OBT7-_0E>JWF8+6JJ.X>GX?6['-U\M<72+ MTL&;[658VLZJ;F'OZF'',QIIK8>,X\LX C-A,%O0O0*V=YI(.F\KH4T]W/05 M9-_$[TJAM33(KMD454N[)*B7^*$J382?M(Q2O4=C3D-%M$)*Y*M%?&7LPPTH M PC;Q8;A\#Z6\?B-H43AJEMR>)14X7DF>%=I+TTDO%OF=2N+<;/"Y*:L8VF? MI6./2?28"CZRH*5*>46'XPE@P-A7FQ@T.E'(T)E4WK-59<>J/J[E6SI(E:H$ MZV*]QZ ,-U1,FTWU"P,#8[/QR$NM5CH2XA2DBV:@.-+%H01;U@:0^IJ9A5\6 M?Y>.D2: N!ZDS2=X^A\9O&ZBNEDE;38C/&8>DEI58Q1"QHSOWS%$[:G2K3"4 M9JII(]Y ADE&G &&;0NGG.1^02Q7?I.F.X;(Z[3=J1OH3D^R*W96B%45..>A MNC;JO5+_ 'L\U@LE57UA4M=JE"&2Q-<^)4SAO8D*9M-%&4&*=25.EKB[>D:]YIXDL8 M//BKISQNSQ$]5MR3/G^*5.355F25X8U$EE4)L5B5/6V9O1KR? MMDZ.-_YC>RS YLQX^J6TMK>YKV=^D:\/DEB2NLC(2YP M:[WN:Q%R<'UPK2N'?3VTD'-Z@],*3"2JEFT.RD03S ^BGF6]8LMMNZ>-8GS5 M/^?XQR8RUXR5\N<8]'6NJIW6[JBM^JO&DT4H M^ 1"T$-9GF(@=J3#ICCE9&N=K8F<&35YTE$'2]Z"K=EN*X8G(;!B[4B!4S) M'):N[SY#M%VYS:XK;3/N/3:KX8TQD3N M:F3HU22MJI-+W,A( M/IYF,E5*W1:(.OZBM68+?KO>]X'RU=7<_=2+.X9 M!8#%Q%?VHW7/E$YZZ:0_V)AL!>ZTM2HXTTLS+-+PD,[D;^)#V"'\0O4O\ '%-G*8Z\K?05@6R-[YY2I7-G MY:FYL\98*[V O5-AVCJZ8"9['%R5C/\ E(T!D4@ G!]8T6PRQ'SM>T440R:Q M7B+K0WGJBO(SW3-'>@:_ ?5%H'4MT\CC(:BM6EH\IE+?I:Y2"0'(;A=FF,OJMP;4JA0@C3E+2T1*T8%*HPL*_\YT3V/5-*076]CQ#FJK8+S*_<]_<\.] ML\36+*ESA5*V-0&\I.^,:G9$V*C,Y5*I%$[&' E@W!X3-SLJ2D28A4$K2[[' MUPZ.T^.^H+KY2ON/Q+Q5R*J+F,Y^J;G9]>[1Z46W;.+0D3!;-9RQ:WTJVS^W M7ZO8_1<#CL;/ RH$B5VJV(1>7/?(=BL4TL.O$#2DGJ8+$\N,>6"0,IJM(2V*3VXXH9Y1& MDXS0^HBN)))9A!HS)YA 7FK9*]M92]WKV1.T;?7V)J3A#]&EV=H@ZOD96+BB MM!$9M$L4$A$+VZ&+>M[P/F*;.,>]JWDKFZ,?-"::M_/'F-LOOUG('8]> 2]" MTU=2241\YLJ5N]ZV?$G<77G5!MP5[5C^O8%TNB4-:Z]BD,)M8CY4Z?Y^LI1&I75S*[0AQL9_ MJR71MW,8[2D#"R25$N% S4VTPMFE&"-]I@=Z_E&&H)'XX.O913_C,IA!2LPI M]QAO#O=W/5]3U ZUDC1U38G0\%U7L+>I43&IT!9)6U8N8BEKB:TE.)@&PXG8 M2QGZVF &Q[Q.JPDT4C H\JKUTM^IVYB7C1FE M80&B,$GT+0 MH9:X3V\XU84RG=E)9U-W38!K9Q!'[UX^>.W_G4OE!QH^-?V&2S!RL%JA*)8_-8 MX[.769.L^52Z*R1L=DDJBLA!*'Q6<2J;EJ8U,2H&F*V!,+96!#;=X>_',SN+ M.O9^;69G(8+1072SL+1-+*;(D@M!KCZ&,MLQ(B2&9$1P+LA;F\L98OK>FE8C M%.];/,,,$&RG>R% 3B=[)/!K8DZ@K?L-#K8BP[&2<#^;7J(HS6]A%K]0BU^G MIO UXH?$GXW&I].D[1Q_43-(#54E5@=V5M=&=JV1N5-0I]K"H5I(G->CB-?R( M^5JY'!6)$K>%;6=&'@R6NWVT!A1R& MCQ<>/J/U2_T>PO40MBWO>!!33R;SZ]%/[!*;O/>&T4@ M)LI_BINCXRY21"_'.2!0='S@ $B" HL"819>RPA^,'M",I%X].'W^U9]?DOY MSK1_M"QF-^9+'FTI2*WHV5QE^9B69]9I*C>7!4QK6 ]I1E!VF-3_ %B=D%F@ M" PL PA':7Q<>,0;1%F!!Q]S7^%(1QL<;;4$-80)'E#!USL]L9QY2400RY.W MK90I4'C5_5SH!ZB736,QL#AMP0-( I4:9U3IC3-#TEU\H6-D/)_,TMF-A MV%*:&JF1SFVHGJ!6=+'R$,+J_3R$:;4#1J(RER6HCU+Q&]-[6F+TB.$)/K9! M8O9[PZ%H(=;O&7X\FI(G0(^*N9](DK PQ=,E54]"G DACC*AQ6,Z,HM>T*0@ M$0M=3SC#M?UU)P_D.&8,(1!#/M.V4(_9@@[.'OU]1BWL.;:M+ M\^6,^U[,[HK2J9E(ZZD*-35LGL6-1EX=H9*E[HU*D!T)=G]**/J9TNYJ(1I6VW'&OHJLL= 0W)S4C>!),E#68_I]MZ0 M\91 @GZ$24+8 ;T'?I@=#259_K6-TL--$RB7 UG:'SV-L\LC3C\(O>2)8ROB1S9H4A1OP%^FQ>FO3 Q"6VT:,!HOBV2>#96Q;V#V[WZX%..-N#F/D-RO&V;AF=/V M]8T[MJU+O!=1E$1*J)97+39;DMET\C!DW4R:7OBF')'52H/(V>O3E(D@AEBT M(.Q#V%XH*AIV2F[N*LT=:/Y\Y;0$BM."IXLZFS!G2*/B+*W-X^ \<@;4RM'[ M0A^T<4 PKTUZ;#^@85ICY_*6UM*V<>! M*69\)?IL?MT(/J%:^;^+F.@+GZMO5=/76RIMU=:$?LF0;?(I$65%"_VA%RX5 M%8_%QL[>%U-2M<93$D#.5*C1G& $;H(!FF^\)GG=Z\_TY/*SK>?V' ('8M^R M%7':MB#LO0-LELR0(B?LKDC$VA#I8[&) J0:--V'XBS5!18AZ,.+",)A0M36 MV!- VMJ!O >/1IP4*-.D"<9K7MT8:$@LO1@]!_3UWZ[],#VFH4)Y!R8]&E.3 M*![,4)S4Y)A!XQ#"8(9Q0P;+-&(8="WL6M[WO6MX$-6[;] \_(H9);FF,!K- M)+9Q%*K@CK*!H&P;S.Y>I&VQ2(,!NR=GF.3D9H>BRR_0)90!C'L!8!BT$R?0 M0Z2"0:1)-(1@,*$B^L3]019NQ"-+$F]GP[ 8(6]BUL/IO>]^N![2DZ<@!)9! M!)):1S@N(NTF8I1U MYS_'G>%/2F.3% \V9&6X^*/R-8-O4M$CTJ7%!9' M:6(KXE.RA;'KTUK?Z8% MRD2U&Y(TCBWJTR]O7IB%J%PC#O6] M;WK>!RX7*OQ-CV2M3UNL?$T;32@#H>VEL M*M&<^*@I_82J,.T9H7N!KV"] FS K?TOU-5W*\49)%81BBQ\MC*10[Z B^98C*) M^V>07H6]GD[&'ZKOR#\Q6):\>HS]Q3FN+=F38:\0.!7?4%JT@]6"W)VTMW6G M0$5H0^+M\Q/;FPXL]2F;SSU1!8];&6']?0)=H3HJ#=%I+150AEL)BW45PS6C MY8CL: R& +SI?!-MVW1M!/7IK_+7 MZ?PP'IK_ "U_I@1K7"2HU&YI,:G)@:CFO\M?Z8$ R[EJ@)[>M>=+3 M.LV*3794\><(Q7,V>!N*PZ)-;DK4+E!C4S&K=QXMW*4+#]D. D@ER71Y@23@ M:&+6PG_T]/X8&!6E8;)4E<3FT)(@D3G'Z_BSU+GI!$H\YRN3*FQA0'.*TIEC MK.0IK)3.!:%Q $X #30!,UO01BUZ;V$F>FO\M?Z:P'IK_+7 M^FL!Z:_RU_IK >FO\M?Z:P'IK_+7^FL!Z:_RU_IK J;V_P!:1KAOFJPNG)E M9O8D2K<#,=(&.O@QS;ZF1/3RA82'8[]S/K B"THG%R(TI$48>H SW ),UH7 MH$@79>"6F>>I_P!":@DVL1M@%A;"1L"$+5Z!KJJ%#O'G5T+=[ M'25!9UVL57-2A("82Z$5*0T?NQ:S!\S4ITU%8Z\1./77 F:=M<:D)J%0],A#J ?N;G!0VFG(5!R8XH0 M?D*%[1A]!>@=[]N@L9Z:_P M?Z8'G 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# M8# 8# 8# UP]+=]2*G;)F-:TSS3.NGG>DHS65@]))81)FN-/];0&VI(XL414 MP6-.[4O67'-36V.N[N>S(3$ "6YO]/N;5'E)MAJIY5[OMGGKJ/NR$RVJKDNV MCWWRVE42INQ]N!L7LM"&76&N876,)BD0F;PYRV3M">8N^CG!"V 0-[&VK"30 M&'&C^OH+HE^7[X^OXURHZ_-\XE5%GL MY;E"*7M=X9'!NC$E/>3P+])/M?7"28' J3(_,9V7=--5':G/?%[=4%?V?US4 M'.+/:UM7Q!GPR6R%WNYVKV8P:+0F,0F6N#.!:*+&H%\QR*WXM'[V:^8I<_P!:N%BO\R;;1"F0ZGPIC''Z!:0.@C"QOC]\@M]]PS*]^56&IQ3;G"W/-E<'*N[;D] MR.SO8<Y/%XBDA24#RM'7*7D6R*3B-?H[1C_2I;,T,%M*)1<-8)J35HT"(J\T$=9R(C#G^U8PM, M=V]L:7U4\LB<:?[@ "."9H-;OBW9488I_P!OW*]G.QCZ?_[FT.4*CWY]4IU4 M>0!N9X1I%38>XF-2I2G<1[&%680)9Z>@/E]FM!T&RWSI$.#=SGSA/(S7X[2G MD%[PY-6PFO?W.^QU--G=WLE&UZAZL#2!6B<$\G$:!&8):D5%(B#3%(0;&5H( M@@&7^;BVZCL*=\DW-S"P-/=[1:,*CL(JRKI)95SP685++Z[564HMMH.A57*; M/DFHZVLJQN.:&U@,5FN1J78]ITNU"D@-O'$M[V[TASQ&+1NZ@Y1S79;FY25M M=JVEJ9S)-TC:GA4FCTK:DKXB9),0PRQA^LN*3NB) XI3##$YY(1E>X0:]Z\\ MH=WOUL3#FF94G6K/TM">]X%RVH@3++)XL;I+1LGKYQM9VZ,85:V%)UZ9L0UR MP.+J22H*^GH*4)!RD!AY6Q! 44\K)'6TKM/E*\*0NO9_8*J(6(^S MQ;6+-5CDIBZVNYG)&".B@4RF#G7SL4ZN?[2=EFV!8<%&;O:@.O4(QY*MVO>> MH'X?+&LBC8JXPR.>)F[+&9.@T,QE&[#KM%5M7PNQ;MBS54R0A/$GQ++XP)J4 M%N:@\2\Q5M02$)>OYC RBL9_8G0WEG\9'3=X0RN(0FN?B'I:P^&V'K/JFR:] MN_F;DSGMHKEPOWI<^PI(GD5L*5RJ 5G5%0-C6[3V7O,2C4S>R MMB%6B+.4#.//5%$I3-##6.U^6GN"=S;FFE8=S7S[![DM;I?KKDBR";.G]D*X MM&K/YAB"26[ED=)CT;2/(H"^,3TD

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`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�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b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�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end GRAPHIC 20 pg8img1_ex3-1.jpg GRAPHIC begin 644 pg8img1_ex3-1.jpg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

  •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end GRAPHIC 21 pg1img1_ex10-4.jpg GRAPHIC begin 644 pg1img1_ex10-4.jpg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

    OQR2*WNO=%AQ?\I7^73B>L^P>H(OBOL3);#[1K]I9 M/>^/W+E-Z;NS.4K]AY"7+[,J:+>6ZMT9G>FWI-KY6IFJ:'^&Y"C%//432( T MTI?W7NI-+_*K^"N(GZLK]J=*1[&SG2>=[)W=U;NG9.]-^[_!S&Z]TKMI?R:_Y:^P/+%L/XO[7V9CZ_KGL/IW<>%V_N/?=+@MY=1=K??S] MA=8[QQ$VZ:BBW%LO<^9K$RD])4(P&5I*:J1EEA5O?NO=2.A/Y?\ N'K#Y/4_ M='8?<.([1ZLZ*Z[R/4'P&Z;?J_%8;*_%'KC>6,V=B^R,97=MU>9SN]^VLMN' M&]>XC'T57DGA?&XN.H@ E^Y=Q[KW1O?D#\;NI?D]M#"[.[

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

  •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pg54img1_s1.jpg GRAPHIC begin 644 pg54img1_s1.jpg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